
<html lang="en"     class="pb-page"  data-request-id="82bd6f8d-3540-4dc1-8820-76257c000e16"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2019.62.issue-10;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.8b01298"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Evolution of PI3Kγ and δ Inhibitors for Inflammatory and Autoimmune Diseases" /></meta><meta name="dc.Creator" content="Matthew W. D.  Perry" /></meta><meta name="dc.Creator" content="Raolat  Abdulai" /></meta><meta name="dc.Creator" content="Mickael  Mogemark" /></meta><meta name="dc.Creator" content="Jens  Petersen" /></meta><meta name="dc.Creator" content="Matthew J.  Thomas" /></meta><meta name="dc.Creator" content="Barbara  Valastro" /></meta><meta name="dc.Creator" content="Annika  Westin Eriksson" /></meta><meta name="dc.Description" content="Phosphoinositol 3-kinases (PI3Ks) γ and δ are key enzymes in hematopoietic cells and have been seen as high-value targets for the treatment of diseases with inflammatory and immunomodulatory compon..." /></meta><meta name="Description" content="Phosphoinositol 3-kinases (PI3Ks) γ and δ are key enzymes in hematopoietic cells and have been seen as high-value targets for the treatment of diseases with inflammatory and immunomodulatory compon..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 24, 2018" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b01298" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01298" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b01298" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01298" /></link>
        
    
    

<title>Evolution of PI3Kγ and δ Inhibitors for Inflammatory and Autoimmune Diseases | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b01298" /></meta><meta property="og:title" content="Evolution of PI3Kγ and δ Inhibitors for Inflammatory and Autoimmune Diseases" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0001.jpeg" /></meta><meta property="og:description" content="Phosphoinositol 3-kinases (PI3Ks) γ and δ are key enzymes in hematopoietic cells and have been seen as high-value targets for the treatment of diseases with inflammatory and immunomodulatory components since their discovery and the identification of their roles. In this Perspective we review progress in the application of inhibitors of PI3Kγ and δ to inflammatory and immunological conditions over the past 6 years. We consider progress in the understanding of the roles of PI3Kγ and PI3Kδ in immunology and inflammation, the experience from clinical trials where inhibitors have been tested, and what has been learned about the safety of their use. The extensive medicinal chemistry efforts to discover both isoform selective and dual PI3Kγδ inhibitors are analyzed and detailed. Developments in understanding the structural chemistry of the PI3K enzymes and the factors that govern isoform selectivity are discussed. The effects observed with the known inhibitor compounds in animal models are described." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b01298"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01298">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b01298&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b01298&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b01298&amp;href=/doi/10.1021/acs.jmedchem.8b01298" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 10</span><span class="cit-fg-pageRange">, 4783-4814</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/10" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.8b01492" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Evolution of PI3Kγ and δ Inhibitors for Inflammatory and Autoimmune Diseases</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Matthew W. D. Perry</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Matthew W. D. Perry</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Respiratory, Inflammation & Autoimmunity, AstraZeneca Gothenburg, Mölndal SE-431 83, Sweden</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#026f6376766a67752c726770707b42637176706378676c6761632c616d6f"><span class="__cf_email__" data-cfemail="5934382d2d313c2e77293c2b2b2019382a2d2b38233c373c3a38773a3634">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+W.+D.++Perry">Matthew W. D. Perry</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9799-0746" title="Orcid link">http://orcid.org/0000-0002-9799-0746</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Raolat Abdulai</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Raolat Abdulai</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Respiratory, Inflammation & Autoimmunity Translational Medicine Unit, Early Clinical Development, IMED Biotech Unit, AstraZeneca, Boston, Massachusetts 02451, United States</div><div class="loa-info-affiliations-info">Brigham and Women’s Hospital, Boston, Massachusetts 02115, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Raolat++Abdulai">Raolat Abdulai</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mickael Mogemark</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mickael Mogemark</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Safety and Metabolism, AstraZeneca Gothenburg, Mölndal SE-431 83, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mickael++Mogemark">Mickael Mogemark</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jens Petersen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jens Petersen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Sciences, IMED Biotech Unit, AstraZeneca Gothenburg, Mölndal SE-431 83, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jens++Petersen">Jens Petersen</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Matthew J. Thomas</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Matthew J. Thomas</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Respiratory, Inflammation & Autoimmunity, AstraZeneca Gothenburg, Mölndal SE-431 83, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+J.++Thomas">Matthew J. Thomas</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath5">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Barbara Valastro</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Barbara Valastro</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Respiratory, Inflammation & Autoimmunity Translational Medicine Unit, Early Clinical Development, AstraZeneca Gothenburg, Mölndal SE-431 83, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Barbara++Valastro">Barbara Valastro</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath6">View Biography</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Annika Westin Eriksson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Annika Westin Eriksson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Safety and Metabolism, AstraZeneca Gothenburg, Mölndal SE-431 83, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Annika++Westin+Eriksson">Annika Westin Eriksson</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath7">View Biography</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01298&amp;href=/doi/10.1021%2Facs.jmedchem.8b01298" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 10</span><span class="cit-pageRange">, 4783–4814</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 24, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>16 August 2018</li><li><span class="item_label"><b>Published</b> online</span>24 December 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 May 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b01298" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01298</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4783%26pageCount%3D32%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMatthew%2BW.%2BD.%2BPerry%252C%2BRaolat%2BAbdulai%252C%2BMickael%2BMogemark%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D10%26contentID%3Dacs.jmedchem.8b01298%26title%3DEvolution%2Bof%2BPI3K%25CE%25B3%2Band%2B%25CE%25B4%2BInhibitors%2Bfor%2BInflammatory%2Band%2BAutoimmune%2BDiseases%26numPages%3D32%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4814%26publicationDate%3DMay%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b01298"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3390</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">35</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b01298" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Evolution of PI3Kγ and δ Inhibitors for Inflammatory and Autoimmune Diseases&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;W. D. Perry&quot;},{&quot;first_name&quot;:&quot;Raolat&quot;,&quot;last_name&quot;:&quot;Abdulai&quot;},{&quot;first_name&quot;:&quot;Mickael&quot;,&quot;last_name&quot;:&quot;Mogemark&quot;},{&quot;first_name&quot;:&quot;Jens&quot;,&quot;last_name&quot;:&quot;Petersen&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;J. Thomas&quot;},{&quot;first_name&quot;:&quot;Barbara&quot;,&quot;last_name&quot;:&quot;Valastro&quot;},{&quot;first_name&quot;:&quot;Annika&quot;,&quot;last_name&quot;:&quot;Westin Eriksson&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;10&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;4783-4814&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b01298&quot;},&quot;abstract&quot;:&quot;Phosphoinositol 3-kinases (PI3Ks) γ and δ are key enzymes in hematopoietic cells and have been seen as high-value targets for the treatment of diseases with inflammatory and immunomodulatory components since their discovery and the identification of their roles. In this Perspective we review progress in the application of inhibitors of PI3Kγ and δ to inflammatory and immunological conditions over the past 6 years. We consider progress in the understanding of the roles of PI3Kγ and PI3Kδ in immunology and inflammation, the experience from clinical trials where inhibitors have been tested, and what has been learned about the safety of their use. The extensive medicinal chemistry efforts to discover both isoform selective and dual PI3Kγδ inhibitors are analyzed and detailed. Developments in understanding the structural chemistry of the PI3K enzymes and the factors that govern isoform selectivity are discussed. The effects observed with the known inhibitor compounds in animal models are described.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01298&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01298" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01298&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01298" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01298&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01298" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01298&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01298&amp;href=/doi/10.1021/acs.jmedchem.8b01298" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b01298" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b01298" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (8 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b01298%26sid%3Dliteratum%253Aachs%26genre%3Darticle%26aulast%3DPerry%26date%3D2019%26atitle%3DEvolution%2Bof%2BPI3K%25CE%25B3%2Band%2B%25CE%25B4%2BInhibitors%2Bfor%2BInflammatory%2Band%2BAutoimmune%2BDiseases%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D10%26spage%3D4783%26epage%3D4814%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/10" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/jmcmar.2019.62.issue-10/20190523/jmcmar.2019.62.issue-10.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0001.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01298&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Phosphoinositol 3-kinases (PI3Ks) γ and δ are key enzymes in hematopoietic cells and have been seen as high-value targets for the treatment of diseases with inflammatory and immunomodulatory components since their discovery and the identification of their roles. In this Perspective we review progress in the application of inhibitors of PI3Kγ and δ to inflammatory and immunological conditions over the past 6 years. We consider progress in the understanding of the roles of PI3Kγ and PI3Kδ in immunology and inflammation, the experience from clinical trials where inhibitors have been tested, and what has been learned about the safety of their use. The extensive medicinal chemistry efforts to discover both isoform selective and dual PI3Kγδ inhibitors are analyzed and detailed. Developments in understanding the structural chemistry of the PI3K enzymes and the factors that govern isoform selectivity are discussed. The effects observed with the known inhibitor compounds in animal models are described.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70461" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70461" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In 2012 Cushing et al.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> published a Perspective on inhibitors of PI3Kγ and δ in inflammatory and autoimmune disease. In the past 6 years there has been a great deal of progress in both chemistry and biology in the field, as judged by the numbers of patents (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>; <a href="/doi/suppl/10.1021/acs.jmedchem.8b01298/suppl_file/jm8b01298_si_001.pdf" class="ext-link">Supporting Information</a>) and papers that have been published.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Patents for PI3Kγ, δ, and γδ grouped by publication year and colored by isoform selectivity. In some instances the isoform selectivity is not defined or may cover two groups, for example, δ and γδ; in these cases a decision has been made based on the best estimate of the selectivity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01298&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Between 2012 and 2018, 15 compounds have progressed into clinical trials<named-content content-type="anchor" rid="fig2" type="simple"></named-content> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>–<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>), <named-content content-type="anchor" rid="fig4" type="simple"></named-content><named-content content-type="anchor" rid="fig5" type="simple"></named-content><named-content content-type="anchor" rid="fig6" type="simple"></named-content>and one, idelalisib (<b>1</b>), has been launched as a treatment for lymphoma (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). We review these developments; readers interested in the basics of PI3Kγ and δ biology and early medicinal chemistry are referred to the earlier Perspective. Only where significant additional data on earlier compounds have been released do we discuss these results.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0016.jpeg" id="GRAPHIC-d7e273-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Launched PI3Kδ inhibitor idelalisib (<b>1</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01298&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. PI3Kδ inhibitors in development for oncology indications.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01298&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. PI3Kδ inhibitors in clinical trials for respiratory, immunodeficiency, inflammatory, and autoimmune conditions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01298&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. PI3Kγ inhibitor <b>14</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01298&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. PI3Kγδ inhibitors in clinical trials.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01298&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Advances in Understanding the Biology of PI3Kγ and δ</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21273" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21273" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Since the 1990s, the importance of PI3K signaling for a diverse array of cellular functions, such as cell growth, proliferation, migration, and survival, has been recognized.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Early studies on murine knockouts revealed structure and function of PI3Ks and enabled their classification.<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3−5)</a> Specific roles for PI3Kγ and δ isoforms, based on expression profiles apparently restricted to immune populations, and activity downstream of G-protein-coupled receptors (GPCRs) and tyrosine kinase-associated receptors, respectively, began to emerge.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> PI3Kγ-mediated innate immune cell influx and PI3Kδ-mediated adaptive immune activation became the basis of the first drug discovery efforts. However, studies of more sophisticated kinase-dead knock-in mouse strains, the generation of selective pharmacologic tools enabling translational studies to human cells, and first findings from initial clinical trials changed the initial picture of PI3Kγ and δ signaling.</div><div class="NLM_p">The expression profile for PI3Kγ has expanded to include structural populations such as cardiomyocytes, fibroblasts, and smooth muscle cells. Cardiac PI3Kγ has been shown to regulate phosphodiesterases in the sarcoplasmic reticulum, a potential protective mechanism against catecholamine-induced ventricular arrythmias.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Increased PI3Kγ expression in fibroblasts and basal cells has been implicated in idiopathic pulmonary fibrosis.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Unlike in hematopoietic cells, PI3Kγ activity in nonhematopoietic cells appears to play an important role in the development of obesity and insulin resistance as observed in knockout mice.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Similarly, PI3Kδ expression in the epithelium may have a role in fungal-induced endoplasmic reticulum stress, thereby contributing to corticosteroid resistance.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Furthermore, PI3Kδ inhibition has been shown to relax human airway smooth muscle cells, producing dilation comparable to that obtained with β adrenergic compounds, the standard in asthma treatment.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">Beyond these findings the understanding of how PI3Kγ and δ isoforms interconnect within complex signaling cascades during inflammation and/or autoimmunity has increased. The well-established role for PI3Kδ in the co-stimulation of T:B cell interactions is complemented by a secondary mechanism by which δ activity acts as a negative regulator of IgE class switching.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Studies exploring immune response to tumors have, in addition to mediation by PI3Kδ, also identified PI3Kγ as a central node within the signaling cascade stimulating growth factor and Toll-like receptor activation.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Furthermore, PI3Kδ has shown clinical relevance in B cell malignancies, where <b>1</b> (an inhibitor of PI3Kδ) dampened the responsiveness of the tumor cells to supportive stimuli from the microenvironment.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p">Numerous examples of innate immune cells show coordinated signaling through both PI3Kγ and δ isoforms for complete functionality. Both isoforms are required for effective mast cell function, where PI3Kδ features downstream of survival signals from c-kit and as part of the FcεR1-mediated degranulation cascade,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> whereas PI3Kγ potentiates the initial IgE signal both via PKCβ and via paracrine release of adenosine to affect full degranulation. PI3Kγ signaling is essential for the appropriate distribution of mast cells to inflamed tissue.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Neutrophils primed with TNFα move in two phases; the first (chemokinetic) phase is driven by PI3Kγ-mediated PIP<sub>3</sub> accumulation at the leading edge of the cell, while the subsequent second (chemotactic) phase is dependent on PI3Kδ.<a onclick="showRef(event, 'ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19">(17−19)</a> We have further demonstrated roles for both PI3Kγ and δ in neutrophil degranulation and superoxide generation, respectively.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> These findings have led to the development of a first wave of selective PI3Kδ inhibitors as a more subtle immune modulatory therapy aimed at fine-tuning neutrophilic host defense. The therapeutic hypothesis was based upon rejuvenation of effective directionality in neutrophil movement and therefore a reduction in “collateral damage” observed in a neutrophil with upregulated PI3Kδ.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> This hypothesis is intriguing, as it focuses on effective neutrophil function in tissue to minimize potential liabilities attributed to immune suppression.</div><div class="NLM_p last">Early preclinical work highlighted risks of reduced resistance to infection with PI3Kγ knock-down.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> More recently, however, subtler effects of PI3Kγ inhibition on viral infections have been observed.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> In contrast, although there is little preclinical data linking inhibition of PI3Kδ with infection, in clinical studies of <b>1</b> with cancer patients, a significantly increased risk of infection relative to controls, including fatalities, has been observed.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24,25)</a> Infections have also been observed as a significant side effect of treatment with the PI3Kγδ inhibitor <b>15</b>.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Clinical studies with PI3Kγ inhibitors are at a much earlier stage than PI3Kδ inhibitors, so it is too early to say how they will fare under similar circumstances. We are yet to understand the significance of systemic PI3Kδ inhibitor safety vs the interconnected pathologic roles for both PI3Kγ and δ pathways, which may be safely inhibited through local antagonism (e.g., inhalation for respiratory diseases). A second wave of mixed PI3Kγδ inhibitors will now address the efficacy and safety profiles of PI3Kγδ inhibitors in comparison to selective PI3Kδ inhibitors in the clinic.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">PI3Kγ, PI3Kδ, and Dual PI3Kγδ Inhibitors under Clinical Development</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05835" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05835" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Since the 2012 Perspective, several PI3K inhibitors have progressed to clinical development and the oral inhibitor idelalisib (<b>1</b>) has been approved in oncology (note added after review: Duvelisib (<b>15</b>) has now also been approved in oncology by the U.S. FDA). An overview of the different PI3K inhibitors and their development status will be discussed in this section.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> PI3Kδ Selective Inhibitors</h3><div class="NLM_p">Several inhibitors of PI3Kδ are being developed in oncology, respiratory diseases, immunodeficiency, and autoimmunity. To date, the most advanced oral selective inhibitor of PI3Kδ is idelalisib (<b>1</b>, Zydelig, Gilead Sciences), which has been launched for the treatment of cancer, more specifically for relapsed chronic lymphocytic leukemia (CLL), relapsed follicular B-cell non-Hodgkin lymphoma, relapsed small lymphocytic lymphoma (SLL), and leukemia. Several additional cancer indications are also being investigated in phase 1 and phase 2, but no development has been reported for <b>1</b> in inflammatory diseases. Although <b>1</b> is recognized as an effective drug, a pattern of unpredictable immune-mediated toxicity has led to a black box warning in the U.S., which is limiting its current use as immunomodulating agent.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_p">Another advanced oral PI3Kδ inhibitor currently in phase 3 is umbralisib (<b>2</b>, also referred to as TGR-1202, Rhizen Pharmaceuticals). Several combination studies are ongoing, and the current registration-directed phase 2b/3 study in patients with previously treated diffuse large B-cell lymphoma (UNITY-DLBCL trial<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a>) is investigating the efficacy of the compound alone and with ublituximab (TG-1101 iv; CD20 antibody). A triple combination arm with TG-1101, <b>2</b>, and bendamustine has also been added recently after a successful interim analysis (UNITY-NHL trial<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a>). In 2017, the combination of <b>2</b> and TG-1101 was granted orphan drug designation by the FDA for the treatment of patients with CLL, and regulatory filing is expected in 2018.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Additionally, the <b>2</b>/ublituximab duo is also being evaluated against a combination of <b>2</b>, obinutuzumab, and chlorambucil (UNITY-CLL trial).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><div class="NLM_p">In oncology, AMG-319 (<b>3</b>, Amgen, also known as ACP319),<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32,33)</a> INCB-050465 (putative structure <b>4</b>, parsaclisib, Incyte Corporation),<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> HMPL-689 (<b>5</b>, Hutchisson China MediTech, structure not disclosed),<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and ME-401/PWT-143 (<b>6</b>, MEI Pharma),<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36,37)</a> all orally available compounds, are active or have completed phase 1 programs. In addition, <b>3</b>, and <b>4</b> have progressed to phase 2 for head and neck cancer (<b>3</b>) or various lymphomas and myelofibrosis (<b>4</b>). MEI Pharma has also communicated their intention to start a phase 3 registration trial with <b>6</b> in patients with relapsed/refractory follicular lymphoma in 2018.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Another compound from Incyte Corporation, dezapelisib (<b>7</b>), which started clinical development in 2013, is reported to have been discontinued, with the exception of one trial in subjects with previously treated B-cell malignancies, which is expected to be completed in May 2019.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><div class="NLM_p">Two additional PI3Kδ inhibitors, both from Gilead Sciences, GS9901 (<b>8</b>, oncology, phase 1) and acalisib (<b>9</b>, oncology, phase 2), have been in clinical trials; however no further progress has been reported since 2017.</div><div class="NLM_p">Two inhaled compounds in development are nemiralisib (<b>10</b>) and GSK-2292767 (<b>11</b>). Currently in phase 2, <b>10</b> is being developed for the treatment of asthma<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> and COPD<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> but also toward activated PI3Kδ syndrome/p110 δ activating mutation causing senescent T cells, lymphadenopathy, and immunodeficiency (APDS/PASLI)<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> and bronchiectasis (the latter a phase 1 study). The second compound, <b>11</b>, is also being developed for asthma and COPD; a phase 1 study in healthy smokers was completed in 2017.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> The results of a phase 2a study with <b>10</b> in patients with persistent, uncontrolled asthma were recently published and demonstrated that <b>10</b> inhibited PI3Kδ locally in the lung but that this inhibition did not translate into meaningful clinical improvement in this patient population.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> On the other hand, recent positive results in the COPD phase 2a study with <b>10</b>, based on imaging studies, led to further investment in a phase 2b trial in COPD.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Development for COPD has been confirmed in April 2018.</div><div class="NLM_p last">Leniosilib (<b>12</b>, Novartis) and seletalisib (<b>13</b>, UCB Celltech), two oral PI3Kδ selective inhibitors, have entered clinical development in rare autoimmune and immunodeficiency diseases, where both compounds have reached phase 3 for APDS/PASLI<a onclick="showRef(event, 'ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref46 ref47">(46,47)</a> and phase 2 for Sjögren syndrome.<a onclick="showRef(event, 'ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref48 ref49">(48,49)</a> Compounds <b>12</b><a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> and <b>13</b><a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> have both been granted orphan drug designation from the FDA for APDS; compound <b>12</b> has also received orphan designation in the EU (2018).<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> PI3Kγ Selective Inhibitors</h3><div class="NLM_p">Infinity Pharmaceuticals have initiated clinical development of their PI3Kγ selective inhibitor IPI-549 (<b>14</b>) as an immuno-oncology treatment targeting myeloid cells. Compound <b>14</b> is an oral PI3Kγ inhibitor currently in phase 1/1b for the treatment of subjects with advanced solid cancers.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Compound <b>14</b> is also being tested as a combination therapy with nivolumab, a PD-1 inhibitor,<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> as well as in triple-combination studies with different assets from Arcus Biosciences.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a></div><div class="NLM_p last">Inhibition of PI3Kγ by <b>14</b> can inhibit myeloid cells from modifying the microenvironment that promotes tumor regrowth. It is therefore hoped that <b>14</b> may be especially meaningful in preventing spread and recurrence of malignant disease, particularly following initial treatment with chemotherapy and radiation therapy.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Dual PI3Kγδ Inhibitors</h3><div class="NLM_p">Dual PI3Kγδ inhibitors are being developed in oncology (Verastem Oncology and Rhizen Pharmaceuticals), as well as in respiratory diseases (RespiVert Ltd. and AstraZeneca).</div><div class="NLM_p">In oncology duvelisib (<b>15</b>, Copiktra, Verastem Oncology, licensed from Infinity Pharmaceuticals) is the most advanced dual PI3Kγδ inhibitor and it has recently been approved in the U.S. for the treatment of adult patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) or relapsed/refractory follicular lymphoma. EU filing for CLL is expected by the end of 2018.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Compound <b>15</b> was also a candidate for asthma and rheumatoid arthritis, but further development in nononcologic diseases has been stopped. In a trial involving an allergen challenge with mild asthmatic patients <b>15</b> missed the primary end point (maximum decrease in allergen-induced FEV1 changes). Significant effects were seen, however, against a range of secondary end points, such as a reduction of exhaled nitric oxide, decreased sensitivity to methacholine treatment, and decreases in biomarkers for the asthmatic inflammatory response.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> These effects were observed at the highest dose of 25 mg b.i.d., the current dose approved in oncology with a black box warning in the U.S., and demonstrated that systemic administration of <b>15</b> could have positive effect on parameters relevant to asthma but that an inhalation-based drug delivery is probably needed to overcome the adverse effect seen with systemic PI3K inhibitors.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Similarly, for rheumatoid arthritis, <b>15</b> failed to provide any added benefit compared to placebo.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a></div><div class="NLM_p">Tenalisib (<b>16</b>, Rhizen Pharmaceuticals) is currently studied in combination with pembrolizumab (phase 2) for the treatment of classical Hodgkin’s lymphomas.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> Compound <b>16</b> has received orphan drug designation and expedited review designation from the FDA for the treatment of peripheral and cutaneous T-cell lymphoma.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a></div><div class="NLM_p last">In respiratory diseases, RespiVert has completed two phase 1 studies in asthmatics<a onclick="showRef(event, 'ref63 ref64'); return false;" href="javascript:void(0);" class="ref ref63 ref64">(63,64)</a> and one in COPD patients for their compound RV1729 (<b>17</b>)<a onclick="showRef(event, 'ref65 ref66'); return false;" href="javascript:void(0);" class="ref ref65 ref66">(65,66)</a> as well as an additional phase 1 study with a second compound, RV6153 (putative structure <b>18</b>).<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> No further development has been reported recently for either compound. AstraZeneca has initiated a phase 1 study of inhaled AZD8154 (<b>19</b>, asthma, structure not disclosed) in healthy subjects.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Toxicity of PI3Kγ, PI3Kδ, and Dual PI3Kγδ Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31616" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31616" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> summarizes safety data/adverse events reported from ongoing or completed clinical trials.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Safety Data/Adverse Events Reported from Clinical Trials</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">inhibitor/isoform</th><th class="colsep0 rowsep0" align="center">study phase</th><th class="colsep0 rowsep0" align="center">patient population</th><th class="colsep0 rowsep0" align="center">dosing information on PI3K inhibitor</th><th class="colsep0 rowsep0" align="center">adverse events AE ≥ grade 3 (grade 3 = severe or medically significant but not immediately life-threatening)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">PI3Kδ</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">Relapsed or refractory CLL</td><td class="colsep0 rowsep0" align="left">50–350 mg q.d. or b.i.d., po for 48 weeks</td><td class="colsep0 rowsep0" align="left">Pneumonia (20%), neutropenic fever (11%), diarrhea (6%), pyrexia (4%), cough (4%), fatigue (2%), transaminitis (2%), no reported dose-limiting toxicities<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b> + various doublet and triplet combinations of chemotherapy and monoclonal antibodies</td><td class="colsep0 rowsep0" align="left">PI3Kδ</td><td class="colsep0 rowsep0" align="left">1b</td><td class="colsep0 rowsep0" align="left">Relapsed and refractory CLL</td><td class="colsep0 rowsep0" align="left">150 mg b.i.d., po in 3–12 28-day cycles</td><td class="colsep0 rowsep0" align="left">Neutropenia, thrombocytopenia, diarrhea, transaminitis<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b> + rituximab</td><td class="colsep0 rowsep0" align="left">PI3Kδ</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">Treatment-naive older patients with CLL or small lymphocytic leukemia</td><td class="colsep0 rowsep0" align="left">150 mg b.i.d., po for 48 weeks</td><td class="colsep0 rowsep0" align="left">Diarrhea/colitis, rash, pyrexia, nausea, chills, cough, fatigue, elevated AST (aspartate aminotransferase)/ALT (alanine aminotransferase)<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b> + rituximab</td><td class="colsep0 rowsep0" align="left">PI3Kδ</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">Previously treated recurrent CLL</td><td class="colsep0 rowsep0" align="left">150 mg b.i.d., po (the study was stopped early due to overwhelming efficacy)</td><td class="colsep0 rowsep0" align="left">Neutropenia (37%), thrombocytopenia (11%), anemia (7%), pneumonia (8%), transaminitis (8%), diarrhea/colitis (5%), pneumonitis (4%)<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b> + ofatumumab</td><td class="colsep0 rowsep0" align="left">PI3Kδ</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">Previously treated CLL</td><td class="colsep0 rowsep0" align="left">150 mg b.i.d., po for 24 weeks</td><td class="colsep0 rowsep0" align="left">Diarrhea/colitis (20%), pneumonia (13%), febrile neutropenia (12%)<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b> + bendamustine + rituximab</td><td class="colsep0 rowsep0" align="left">PI3Kδ</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">Untreated CLL</td><td class="colsep0 rowsep0" align="left">150 mg b.i.d., po</td><td class="colsep0 rowsep0" align="left">Terminated due to an increased rate of severe adverse events (SAEs) including deaths, mostly due to infections<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b> + rituximab</td><td class="colsep0 rowsep0" align="left">PI3Kδ</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">Previously treated indolent non-Hodgkin lymphoma (NHL)</td><td class="colsep0 rowsep0" align="left">150 mg b.i.d., po</td><td class="colsep0 rowsep0" align="left">Terminated due to an increased rate of SAEs including deaths, mostly due to infections<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b> + rituximab or chlorambucil</td><td class="colsep0 rowsep0" align="left">PI3Kδ</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">Untreated CLL</td><td class="colsep0 rowsep0" align="left">100 or 150 mg b.i.d., po</td><td class="colsep0 rowsep0" align="left">Terminated due to an increased rate of deaths and SAEs<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">PI3Kδ</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">Relapsed or refractory CLL, small lymphocytic lymphoma, B-cell and T-cell NHL, Hodgkin’s lymphoma</td><td class="colsep0 rowsep0" align="left">50, 100, 200, 400, 800, 1200, 1800 mg q.d., po in 28-day cycles</td><td class="colsep0 rowsep0" align="left">Neutropenia (13%), anemia (9%), thrombocytopenia (7%), pneumonia (3%), lung infection (1%), fibrile neutropenia (1%), colitis (2%)<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">PI3Kδ</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">Intolerant to prior ibrutinib (Bruton tyrosine kinase inhibitor) or <b>1</b> (PI3Kδ inhibitor) treatment</td><td class="colsep0 rowsep0" align="left">800 mg q.d., po</td><td class="colsep0 rowsep0" align="left">6% discontinuing due to AE<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">PI3Kδ</td><td class="colsep0 rowsep0" align="left">I/2</td><td class="colsep0 rowsep0" align="left">Previously treated indolent/aggressive B-cell NHL and Hodgkin’s lymphoma</td><td class="colsep0 rowsep0" align="left">5–45 mg b.i.d., po</td><td class="colsep0 rowsep0" align="left">Nausea (38%), diarrhea (31%), vomiting (25%). 40% SAEs most frequently colitis, diarrhea, hypotension. 25% discontinued due to AEs<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">PI3Kδ</td><td class="colsep0 rowsep0" align="left">1b</td><td class="colsep0 rowsep0" align="left">CLL, small lymphocytic lymphoma, follicular lymphoma</td><td class="colsep0 rowsep0" align="left">60, 120, 180 mg b.i.d., po</td><td class="colsep0 rowsep0" align="left">Neutropenia, no patients had discontinued due to AEs (May 2017)<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">PI3Kδ</td><td class="colsep0 rowsep0" align="left">1b</td><td class="colsep0 rowsep0" align="left">Recurrent lymphoid malignancies</td><td class="colsep0 rowsep0" align="left">50, 100, 200, 400 mg b.i.d., po</td><td class="colsep0 rowsep0" align="left">Diarrhea (10%), rash (10%), elevated liver transaminases (5%), infections (13%)<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">PI3Kδ</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">Acute exacerbation of chronic obstructive pulmonary disease (COPD) (in addition to standard of care)</td><td class="colsep0 rowsep0" align="left">1000 μg q.d., inhaled for 12-weeks</td><td class="colsep0 rowsep0" align="left">Coronary artery stenosis (2%), pneumonia (2%), other lung infection (2%), blood sodium decreased (2%), cough (35%)<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b> or <b>14</b> + nivolumab</td><td class="colsep0 rowsep0" align="left">PI3Kγ</td><td class="colsep0 rowsep0" align="left">1/1b</td><td class="colsep0 rowsep0" align="left">Advanced solid tumors</td><td class="colsep0 rowsep0" align="left">20, 30, 40 mg q.d., po</td><td class="colsep0 rowsep0" align="left">Rash and AST/ALT increase (<b>14</b> + nivolumab)<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">Dual PI3Kγδ</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">CLL, indolent NHL, or mantle cell lymphoma</td><td class="colsep0 rowsep0" align="left">25 mg b.i.d., po</td><td class="colsep0 rowsep0" align="left">Cytopenias, liver enzyme elevations, diarrhea, rash, pneumonia. No dose-related trends in adverse events<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">Dual PI3Kγδ</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">Relapsed or refractory peripheral (PTCL) or cutaneous (CTCL) T-cell lymphoma</td><td class="colsep0 rowsep0" align="left">25, 50, 60, 75, 100 mg b.i.d., po in 28-day cycles</td><td class="colsep0 rowsep0" align="left">Transaminase increases (40% alanine aminotransferase, 17% aspartate aminotransferase), maculopapular rash (17%), neutropenia (17%), pneumonias/lung infections (20%), colitis (11%), pyrexia (9%)<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">Dual PI3Kγδ</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">Refractory indolent NHL</td><td class="colsep0 rowsep0" align="left">25 mg b.i.d., po in 28-day cycles, up to 13 cycles</td><td class="colsep0 rowsep0" align="left">Infections of all types, pneumonitis (9%), colitis (5%)<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">Dual PI3Kγδ</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">Relapsed or refractory CLL or small lymphocytic lymphoma</td><td class="colsep0 rowsep0" align="left">25 mg b.i.d., po initial 21-day cycle followed by 28-day cycles for up to 18 cycles with potential addition of cycles</td><td class="colsep0 rowsep0" align="left">Neutropenia, anemia, diarrhea, pneumonia, colitis<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a></td></tr></tbody></table></div></div><div class="NLM_p last">Safety data from clinical trials with different selective PI3Kδ inhibitors demonstrate similar adverse event profiles. Neutropenia, thrombocytopenia, anemia, transaminitis, diarrhea/colitis, and pneumonia/pneumonitis were the most frequent grade ≥3 adverse events observed. The U.S. FDA prescribing information for <b>1</b> contains a black box warning for fatal and/or severe diarrhea or colitis, hepatotoxicity, pneumonitis, and intestinal perforation. An expert panel reviewed the pathology of these treatment-emergent adverse events (TEAEs) and proposed key management tools for patients receiving <b>1</b> therapy.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> Compound <b>1</b> should not be used concomitantly with other hepatotoxic drugs, and serum transaminase levels should be evaluated at regular intervals during treatment to identify signs of hepatotoxicity. Any patient presenting pulmonary symptoms should be evaluated for pneumonitis. Overall, although the U.S. FDA prescribing information carries black box warnings for fatal and/or severe diarrhea or colitis, hepatotoxicity, and pneumonitis, their risk and severity have the potential to be mitigated through proper identification and management.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> EMA announced in March 2016 the recommendation of new safety measures for <b>1</b>. EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) recommends that all patients treated with <b>1</b> should receive antibiotics to prevent a particular type of lung infection. Patients should also be monitored for infection and have regular blood tests for white cell counts because low counts can increase their risk of infection. Compound <b>1</b> should not be started in patients with a generalized infection. These are provisional recommendations that the PRAC has issued, as a precaution, to protect patients while the medicine is being reviewed. The review started after a higher rate of serious adverse events was seen in three clinical trials among patients receiving <b>1</b> compared with placebo.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> Less information is currently available for selective PI3Kγ inhibitors, but data indicate a potentially favorable toxicity profile compared to PI3Kδ inhibitors. Reported safety data on one dual PI3Kγδ inhibitor (<b>15</b>) indicate similar toxicity as for a selective PI3Kδ inhibitor. Careful monitoring is required when dosing these kinds of inhibitors to patients to ensure adequate management of adverse events.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Medicinal Chemistry of PI3K Inhibitors “Propeller” Shaped Inhibitors 6,6-Fused Systems</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66658" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66658" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The first truly selective PI3Kδ inhibitor, <b>1</b>, had what has been described<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> as a propeller shape with three “blades” at an angle of approximately 120° to each other. These “blades” consist of a central core heterocycle, typically a bicyclic aromatic system, a hinge binding moiety linked to the core by one or two atoms that allows it to adopt an orthogonal arrangement, and a “third blade”, typically, though not exclusively, an aromatic ring. This type of molecule gained selectivity through access to an induced pocket that was preferentially formed in the δ isoform. Medicinal chemists worldwide have subsequently varied this theme. No fewer than 13 of the 19 compounds that have proceeded to clinical trials have a structure that belongs to this class. (For details of the protein structures of PI3K enzymes and the ways that isoform selectivity relates to inhibitor structure see the section <a class="ref internalNav" href="#sec22" aria-label="Structural Determinants Driving Selectivity toward PI3Kγ or δ">Structural Determinants Driving Selectivity toward PI3Kγ or δ</a> below).</div><div class="NLM_p">The most successful core structures for propeller-shaped inhibitors have been 6,6-fused ring systems, pioneered by the quinazolinone of <b>1</b>. ICOS, and their successors at Gilead, further explored the quinazolinone core (<b>8</b>, <b>9</b>).<a onclick="showRef(event, 'ref84 ref85'); return false;" href="javascript:void(0);" class="ref ref84 ref85">(84,85)</a> RespiVert also used this core, though, targeting inhaled administration, their molecules look quite different (<b>17</b>, <b>18</b>);<a onclick="showRef(event, 'ref86 ref87'); return false;" href="javascript:void(0);" class="ref ref86 ref87">(86,87)</a><b>17</b> has a more marked dual PI3Kγδ inhibition profile than <b>18</b>, showing subtle differences of isoform selectivity between apparently quite minor structural changes (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. 6,6-Fused Propeller Inhibitors<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0017.gif" alt="" id="GRAPHIC-d7e1121-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">IC<sub>50</sub> (nM)</th><th class="rowsep1 colsep0" colspan="2" align="center">fold selectivity</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">originator</th><th class="colsep0 rowsep0" align="center">PI3Kδ</th><th class="colsep0 rowsep0" align="center">PI3Kγ</th><th class="colsep0 rowsep0" align="center">α/δ</th><th class="colsep0 rowsep0" align="center">β/δ</th><th class="colsep0 rowsep0" align="center">cell IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b><a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a></td><td class="colsep0 rowsep0" align="left">Gilead</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">89</td><td class="colsep0 rowsep0" align="left">330</td><td class="colsep0 rowsep0" align="left">230</td><td class="colsep0 rowsep0" align="left">8<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b><a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a></td><td class="colsep0 rowsep0" align="left">Rhizen</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">>120</td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left">>54</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b><a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a></td><td class="colsep0 rowsep0" align="left">Amgen</td><td class="colsep0 rowsep0" align="left">18</td><td class="colsep0 rowsep0" align="left">850</td><td class="colsep0 rowsep0" align="left">1800</td><td class="colsep0 rowsep0" align="left">150</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b><a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a></td><td class="colsep0 rowsep0" align="left">Gilead</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">190</td><td class="colsep0 rowsep0" align="left">750</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">1<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b><a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a></td><td class="colsep0 rowsep0" align="left">Gilead</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">3000<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">>1000<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">63<a class="ref internalNav" href="#t2fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">19<a class="ref internalNav" href="#t2fn7" aria-label="g">g</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b><a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a></td><td class="colsep0 rowsep0" align="left">UCB</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">280</td><td class="colsep0 rowsep0" align="left">300</td><td class="colsep0 rowsep0" align="left">180</td><td class="colsep0 rowsep0" align="left">16<a class="ref internalNav" href="#t2fn8" aria-label="h">h</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b><a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a></td><td class="colsep0 rowsep0" align="left">Infinity</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">27</td><td class="colsep0 rowsep0" align="left">640</td><td class="colsep0 rowsep0" align="left">34</td><td class="colsep0 rowsep0" align="left">0.36<a class="ref internalNav" href="#t2fn9" aria-label="i">i</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b><a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a></td><td class="colsep0 rowsep0" align="left">Rhizen</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">33</td><td class="colsep0 rowsep0" align="left">>400</td><td class="colsep0 rowsep0" align="left">160</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b><a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a></td><td class="colsep0 rowsep0" align="left">RespiVert</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.1<a class="ref internalNav" href="#t2fn10" aria-label="j">j</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b><a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a></td><td class="colsep0 rowsep0" align="left">RespiVert</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">28</td><td class="colsep0 rowsep0" align="left">5600</td><td class="colsep0 rowsep0" align="left">2000</td><td class="colsep0 rowsep0" align="left">7.4<a class="ref internalNav" href="#t2fn10" aria-label="j">j</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b><a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a></td><td class="colsep0 rowsep0" align="left">Nanjing</td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left">5.7</td><td class="colsep0 rowsep0" align="left">110</td><td class="colsep0 rowsep0" align="left">60</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b><a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a></td><td class="colsep0 rowsep0" align="left">Lupin</td><td class="colsep0 rowsep0" align="left">0.1–10</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b><a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a></td><td class="colsep0 rowsep0" align="left">Lupin</td><td class="colsep0 rowsep0" align="left">1–100</td><td class="colsep0 rowsep0" align="left">90–2000</td><td class="colsep0 rowsep0" align="left">500–5000<a class="ref internalNav" href="#t2fn11" aria-label="k">k</a></td><td class="colsep0 rowsep0" align="left">75–3000<a class="ref internalNav" href="#t2fn11" aria-label="k">k</a></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b><a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a></td><td class="colsep0 rowsep0" align="left">Zhejiang University</td><td class="colsep0 rowsep0" align="left">0–20</td><td class="colsep0 rowsep0" align="left">34</td><td class="colsep0 rowsep0" align="left">790</td><td class="colsep0 rowsep0" align="left">170</td><td class="colsep0 rowsep0" align="left">6<a class="ref internalNav" href="#t2fn12" aria-label="l">l</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b><a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a></td><td class="colsep0 rowsep0" align="left">Chiesi</td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">The asterisk ∗ in the above table section containing drawn chemical structures indicates undefined absolute stereochemistry.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Basophils.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">Human whole blood.</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">Basophils (fMLP stimulation).</p></div><div class="footnote" id="t2fn5"><sup><sup>e</sup></sup><p class="last">SW3T3 cells stimulated with PDGF.</p></div><div class="footnote" id="t2fn6"><sup><sup>f</sup></sup><p class="last">Mouse embryonic fibroblasts.</p></div><div class="footnote" id="t2fn7"><sup><sup>g</sup></sup><p class="last">Basophils (anti FcεR1 stimulation).</p></div><div class="footnote" id="t2fn8"><sup><sup>h</sup></sup><p class="last">fMLP stimulated release of superoxide from neutrophils.</p></div><div class="footnote" id="t2fn9"><sup><sup>i</sup></sup><p class="last">RAJI cells.</p></div><div class="footnote" id="t2fn10"><sup><sup>j</sup></sup><p class="last">U937 cells.</p></div><div class="footnote" id="t2fn11"><sup><sup>k</sup></sup><p class="last">Ranges in nM given, not fold selectivity.</p></div><div class="footnote" id="t2fn12"><sup><sup>l</sup></sup><p class="last">SU-DHL cells.</p></div></div></div><div class="NLM_p">Intellikine pioneered the isosteric isoquinolinone core; their first compound, the dual PI3Kγδ inhibitor <b>15</b>,<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> was licensed by Infinity, who subsequently made further modifications to give the selective PI3Kγ inhibitor <b>14</b>.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> It is worth noting that, though described as a dual PI3Kγδ inhibitor, <b>15</b> has an 11-fold potency difference for PI3Kδ vs PI3Kγ and only 3-fold greater potency for PI3Kγ than for PI3Kβ.</div><div class="NLM_p">Rhizen Pharmaceuticals chose a chromenone core as an alternative fused 6,6-ring system for their two development candidates (<b>2</b>, <b>16</b>);<a onclick="showRef(event, 'ref89 ref90'); return false;" href="javascript:void(0);" class="ref ref89 ref90">(89,90)</a> despite the apparent structural similarity between <b>1</b>, <b>9</b>, and <b>16</b>, there is a notable difference in selectivity toward PI3Kγ. Compound <b>16</b> is essentially equipotent at γ and δ, while <b>1</b> and <b>9</b> are more than 100-fold δ-selective (on the enzyme level). It is surprising that <b>16</b>, without the additional aryl ring in the affinity pocket, is more potent than <b>2</b>.</div><div class="NLM_p">Amgen and UCB used a quinoline core for their candidates (<b>3</b>, <b>13</b>);<a onclick="showRef(event, 'ref91 ref92'); return false;" href="javascript:void(0);" class="ref ref91 ref92">(91,92)</a> the additional lipophilicity of this system compared to the quinazolinone may explain why both feature pyridine rings as their “3rd blade”.</div><div class="NLM_p last">Since 2011 there have been additional variations on the 6,6-fused theme. Nanjing chemists claimed a quinolinone with the carbonyl group in a different orientation (<b>20</b>),<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> while Lupin have produced two patents with a quinolizin-4-one core (<b>21</b>, <b>22</b>).<a onclick="showRef(event, 'ref94 ref95'); return false;" href="javascript:void(0);" class="ref ref94 ref95">(94,95)</a> The second of these patents includes an additional aryl group that is unique among PI3Kδ inhibitors; however given the broad activity ranges given for PI3K inhibition in the patent, it is impossible to judge the potency or selectivity that these variations provide. Zheijiang University have described a benzothiadiazine dioxide based class of inhibitors (<b>23</b>).<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> One additional 6,6-fused ring system has appeared in the period reviewed, the isochromenone ring used by Chiesi in a 2015 patent (<b>24</b>);<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> however it appears that these compounds must adopt a somewhat different orientation in the binding pocket, possibly with the tetrahydropyridine ring adopting a similar orientation to the fluorophenyl of <b>22</b>.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">“Propeller” Shaped Inhibitors: 5,6- and 6,5-Fused Systems</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01745" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01745" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">5,6-Fused systems (<b>7</b>, <b>25</b>–<b>33</b>) allow for a wide range of heterocycles to be investigated; these include the first Incyte clinical candidate (<b>7</b>)<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> and, potentially, the clinical candidate of Hutchison, <b>5</b>, which may well be related to <b>26</b> or <b>27</b> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. 5,6-Fused Propeller Inhibitors<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0018.gif" alt="" id="GRAPHIC-d7e1626-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">IC<sub>50</sub> (nM)</th><th class="rowsep1 colsep0" colspan="2" align="center">fold selectivity</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">originator</th><th class="colsep0 rowsep0" align="center">PI3Kδ</th><th class="colsep0 rowsep0" align="center">PI3Kγ</th><th class="colsep0 rowsep0" align="center">α/δ</th><th class="colsep0 rowsep0" align="center">β/δ</th><th class="colsep0 rowsep0" align="center">cell IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b><a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a></td><td class="colsep0 rowsep0" align="left">Incyte</td><td class="colsep0 rowsep0" align="left">31</td><td class="colsep0 rowsep0" align="left">2300</td><td class="colsep0 rowsep0" align="left">930</td><td class="colsep0 rowsep0" align="left">120</td><td class="colsep0 rowsep0" align="left">35<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b><a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a></td><td class="colsep0 rowsep0" align="left">Almirall</td><td class="colsep0 rowsep0" align="left">2.6</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">7.8<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b><a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a></td><td class="colsep0 rowsep0" align="left">Hutchison</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">42</td><td class="colsep0 rowsep0" align="left">∼500</td><td class="colsep0 rowsep0" align="left">∼500</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b><a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a></td><td class="colsep0 rowsep0" align="left">Hutchison</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">250</td><td class="colsep0 rowsep0" align="left">250</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b><a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a></td><td class="colsep0 rowsep0" align="left">Hutchison</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">38</td><td class="colsep0 rowsep0" align="left">3000</td><td class="colsep0 rowsep0" align="left">290</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b><a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a></td><td class="colsep0 rowsep0" align="left">Ye</td><td class="colsep0 rowsep0" align="left"><20</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><20<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b><a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a></td><td class="colsep0 rowsep0" align="left">Qianwan</td><td class="colsep0 rowsep0" align="left">0.2</td><td class="colsep0 rowsep0" align="left">87</td><td class="colsep0 rowsep0" align="left">16000</td><td class="colsep0 rowsep0" align="left">1400</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b><a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a></td><td class="colsep0 rowsep0" align="left">Takeda</td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b><a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a></td><td class="colsep0 rowsep0" align="left">Fochon</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">36<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b><a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a></td><td class="colsep0 rowsep0" align="left">AstraZeneca</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">>130</td><td class="colsep0 rowsep0" align="left">130</td><td class="colsep0 rowsep0" align="left">10<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">The asterisk ∗ in the above table section containing drawn chemical structures indicates undefined absolute stereochemistry.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Basophils.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">THP-1 cells.</p></div><div class="footnote" id="t3fn4"><sup><sup>d</sup></sup><p class="last">SU-DHL-6 cells.</p></div><div class="footnote" id="t3fn5"><sup><sup>e</sup></sup><p class="last">Jeko-1 cells.</p></div></div></div><div class="NLM_p">Almirall has described in detail the discovery and SAR exploration around pyrrolotriazinone <b>25</b>.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> This compound has good PK and was optimized to minimize metabolism-related safety risks. Hutchison utilized the same ring system, though in their case a cyclized linker between the hinge-binding motif and the central bicycle provides structural differentiation (<b>26</b>, <b>27</b>).<a onclick="showRef(event, 'ref101 ref102'); return false;" href="javascript:void(0);" class="ref ref101 ref102">(101,102)</a> The second of their patents discloses a highly dual selective PI3Kγδ inhibitor (<b>27</b>).</div><div class="NLM_p">Hutchison further described an imidazopyridazine core (<b>28</b>),<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> while a closely related pyrazolopyrimidine core has been claimed by Ye (<b>29</b>);<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> related series of imidazopyridines by Qianwan (<b>30</b>)<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> and pyrrolopyridines by Takeda (<b>31</b>)<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> have also been claimed.</div><div class="NLM_p">In another case of two companies working on the same heterocyclic system, Shanghai Fochon (<b>32</b>)<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> and AstraZeneca (<b>33</b>)<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> have both disclosed thiazolopyridone cores, though in AstraZeneca’s case these molecules were significantly extended around the “3rd blade”.</div><div class="NLM_p">Investigation of 6,5-fused systems has given fewer PI3Kδ inhibitor classes (<b>34</b>, <b>35</b>, <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). In these compounds the fused ring takes an intermediate position relative to the hinge-binding group as compared to <b>1</b> and similar compounds and the alternative orientation exemplified by <b>24</b>. Earlier examples of compounds of this subtype appeared in 2011 (Amgen and Incyte) followed in 2012 by compounds from Almirall (<b>34</b>)<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> and then later, in a more elaborate example (<b>35</b>, 2015), from Chiesi. In this latter patent<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> it appears, from the limited data given, that isoform selectivity is more challenging in this subseries with a tendency to pan inhibition or PI3Kγ selectivity. This may explain why there are fewer ring systems described and no examples in development.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Data for 6,5-Fused Propeller Inhibitors<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0019.gif" alt="" id="GRAPHIC-d7e1945-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">IC<sub>50</sub> (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">originator</th><th class="colsep0 rowsep0" align="center">PI3Kδ</th><th class="colsep0 rowsep0" align="center">PI3Kγ</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">Almirall<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a></td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b><a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">Chiesi<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a></td><td class="colsep0 rowsep0" align="left">10–1000</td><td class="colsep0 rowsep0" align="left"><10</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">The asterisk ∗ in the above table section containing drawn chemical structures indicates undefined absolute stereochemistry.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">PI3Kα and β IC<sub>50</sub> of 10–1000 nM.</p></div></div></div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Other “Propeller” Shaped Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63740" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63740" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Significant changes to the “propeller” structure have been pioneered by Incyte who have removed the fused ring altogether (<b>36</b>, <b>37</b>, <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>);<a onclick="showRef(event, 'ref111 ref112'); return false;" href="javascript:void(0);" class="ref ref111 ref112">(111,112)</a> the optimized compound of this type appears to be the highly isoform selective compound <b>4</b><a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> (PI3Kα, β and γ IC<sub>50</sub> ∼ 20 μM) which is advancing in clinical trials. A later patent describes a further series where a new ring is fused (<b>38</b>).<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> Chiesi have subsequently reported a nonfused “propeller” core (<b>39</b>)<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> that appears to be a development of their previous 5,6-fused series (<b>35</b>).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Data for Nonfused Propeller Inhibitors<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0020.gif" alt="" id="GRAPHIC-d7e2056-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">IC<sub>50</sub> (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">originator</th><th class="colsep0 rowsep0" align="center">PI3Kδ</th><th class="colsep0 rowsep0" align="center">cell</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b><a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a></td><td class="colsep0 rowsep0" align="left">Incyte</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">0.15<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b><a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a></td><td class="colsep0 rowsep0" align="left">Incyte</td><td class="colsep0 rowsep0" align="left"><50</td><td class="colsep0 rowsep0" align="left"><50<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b><a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a></td><td class="colsep0 rowsep0" align="left">Incyte</td><td class="colsep0 rowsep0" align="left"><20</td><td class="colsep0 rowsep0" align="left"><20<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b><a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a></td><td class="colsep0 rowsep0" align="left">Incyte</td><td class="colsep0 rowsep0" align="left"><100</td><td class="colsep0 rowsep0" align="left"><500<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b><a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a></td><td class="colsep0 rowsep0" align="left">Chiesi</td><td class="colsep0 rowsep0" align="left"><1000</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">The asterisk ∗ in the above table section containing drawn chemical structures indicates undefined absolute stereochemistry.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">B-cells.</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last">Pfeiffer cells.</p></div><div class="footnote" id="t5fn4"><sup><sup>d</sup></sup><p class="last">SUDHL cells.</p></div></div></div></div><div id="sec8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Hinge Binding Groups for Propeller Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42644" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42644" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In addition to variation of the core propeller structure, the molecules have been investigated across all other regions. For the kinase hinge binding motif the earliest examples feature 6-substituted purines, typically adenine. Attachment was initially through the 9-position via a simple methylene linker (<b>40</b>, IC87114 a widely used tool compound)<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> until the alternative orientation 6-substition, and an (<i>S</i>)-configured alkyl linker (for example <b>1</b>, <b>3</b>, <b>7</b>, <b>9</b>, <b>15</b>, <b>16</b>) was identified. The linker between the hinge and the core heterocycle appears to enforce a suitable stereochemical relationship between the core and the hinge of the molecule; Chiesi<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> have reported a study where they looked at <b>40</b> and methyl substituted analogues (<b>41</b>, <b>42</b>) where atropisomeric forms could be isolated and correlated their potencies with conformational calculations and a published X-ray crystal structure of <b>40</b> in PI3Kδ. A clear preference for <i>S</i> configuration was observed (more active atropisomers for <b>40</b>, <b>41</b>, and <b>42</b><i>K</i><sub>i</sub> = 13, 13, 1.6 nM) with an additional effect of atropisomerism from the pendant <i>ortho</i>-tolyl group. The <i>S</i>-configured isomer (<b>42</b>) had an energy minimum that almost exactly matched the conformation of <b>40</b> from the crystal structure in PI3Kδ;<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> none of the low-energy conformations of the <i>R</i>-isomer <b>41</b> were similar (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (a) Comparison of the bound structure of <b>40</b> from <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2X38">2X38</a> (green) with preferred conformations of <b>41</b> (light blue) and <b>42</b> (gray) overlaid. (b) Structures of <b>40</b>, <b>41</b>, and <b>42</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01298&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Overall purines remained the preferred hinge binding residue until the identification of cyanopyrimidines by Amgen in 2010 (<b>43</b> (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>), PI3Kδ 5 nM compared to the corresponding purine analogue as a racemate, PI3Kδ 80 nM).<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> This heterocyclic system was widely adopted in later publications.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Compound <b>43</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01298&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Variation of the hinge-binder has been described in detail for three different series in recent papers.<a onclick="showRef(event, 'ref56 ref100 ref119'); return false;" href="javascript:void(0);" class="ref ref56 ref100 ref119">(56,100,119)</a> Almirall report extensive exploration of both the hinge binding group and the linking alkylene moiety (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>).<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> For the alkylene moiety, <i>S</i>-methyl (<b>44</b>) was judged optimal, though ethyl (<b>45</b>) or cyclization to a pyrrolidine (<b>46</b>) was tolerated; other groups, including Hutchison (<b>26</b>, <b>27</b>) and Novartis<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> (<b>58</b>, <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>, IC<sub>50</sub> PI3Kδ 8 nM, γ 4.1 nM) have also reported cyclized linkers. Hydroxyl substitution on the alkyl group (<b>47</b>, <b>48</b>) was tolerated, but addition of trifluoromethyl (<b>49</b>) was deleterious. Monocyclic and bicyclic hinge binders with 0, 1, or 2 hydrogen bond donors and some fluorine or cyano substituents were evaluated. Bicyclic groups (<b>53</b>–<b>57</b>) are comparable to monocyclic in terms of potency (<b>44</b>, <b>50</b>–<b>52</b>); however there was a strong effect from addition of electron-withdrawing substituents (CN> CF<sub>3</sub>> F > H; <b>44</b>, <b>50</b>, <b>51</b>, <b>52</b>; <b>54</b>, <b>55</b>). Although a diaminopurine hinge-binder (<b>56</b>) was the most potent in the enzyme assay, the cyanopyrimidine (<b>44</b>) was the most potent in a cell assay; this compound was also more stable metabolically and was retained in the key compound (<b>25</b>, LAS191954).<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Data from Almirall for Variations of Linker and Hinge Binding Group<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0021.gif" alt="" id="GRAPHIC-d7e2413-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">IC<sub>50</sub> (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">parent</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup> hinge</th><th class="colsep0 rowsep0" align="center">PI3Kδ</th><th class="colsep0 rowsep0" align="center">cell<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">4.3</td><td class="colsep0 rowsep0" align="left">4.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">4.6</td><td class="colsep0 rowsep0" align="left">6.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">4.8</td><td class="colsep0 rowsep0" align="left">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">51</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">610</td><td class="colsep0 rowsep0" align="left">1600</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">1200</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">E</td><td class="colsep0 rowsep0" align="left">73</td><td class="colsep0 rowsep0" align="left">210</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">G</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">52</td><td class="colsep0 rowsep0" align="left">150</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">I</td><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left">47</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>56</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">J</td><td class="colsep0 rowsep0" align="left">3.1</td><td class="colsep0 rowsep0" align="left">6.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>57</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">K</td><td class="colsep0 rowsep0" align="left">60</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">THP-1 cells.</p></div></div></div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Cyclized linker compound <b>58</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01298&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In contrast the Gilead group observed for their quinazolinone series that, although the cyanopyrimidine gave excellent potency, metabolism of this moiety by aldehyde oxidase became a problem. This issue was ultimately solved by replacement with a diaminopyrimidine (<b>59</b>).<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> Further optimization of this structure led to the clinical candidate (<b>8</b>)<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>).</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Data for Propeller Inhibitors with Modified Hinge Binding Groups</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0022.gif" alt="" id="GRAPHIC-d7e2698-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">fold selectivity</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">originator</th><th class="colsep0 rowsep0" align="center">PI3Kδ IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">α/δ</th><th class="colsep0 rowsep0" align="center">β/δ</th><th class="colsep0 rowsep0" align="center">γ/δ</th><th class="colsep0 rowsep0" align="center">cell IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">Gilead</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">750</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">190</td><td class="colsep0 rowsep0" align="left">1<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>59</b></td><td class="colsep0 rowsep0" align="left">Gilead</td><td class="colsep0 rowsep0" align="left">2.2</td><td class="colsep0 rowsep0" align="left">1900</td><td class="colsep0 rowsep0" align="left">650</td><td class="colsep0 rowsep0" align="left">180</td><td class="colsep0 rowsep0" align="left">1<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last">Human whole blood.</p></div></div></div><div class="NLM_p">Other hinge binders reported in the patent literature, but without any discussion of their pros and cons, lack an H-bond donor function (<b>13</b>, <b>27</b>).<a onclick="showRef(event, 'ref102 ref121'); return false;" href="javascript:void(0);" class="ref ref102 ref121">(102,121)</a> Interestingly these compounds show sufficient binding without one of the groups usually regarded as essential; the only published data on this replacement however are from a single example in the Almirall work cited above,<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> where a pyrazolopyrimidine (<b>57</b>) showed similar potency (60 nM) to the nearest analogue with a donor (<b>54</b>, 52 nM). The metabolic stability of <b>57</b> was poor however.</div><div class="NLM_p">Finally, Infinity have described the investigation of alternative hinge binding groups to promote selectivity for PI3Kγ over PI3Kδ.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> The preferred hinge binder has an unusual acceptor–donor pair with an aminoheterocycle as the donor and an amide carbonyl group as acceptor. This hinge binder is part of clinical candidate <b>14</b> and will be further discussed below under PI3Kγ inhibitors.</div><div class="NLM_p">Since the first report by the Shokat group in 2006,<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> several groups have added to the hinge binding moiety to pick up additional interactions deeper in the affinity pocket (<a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>). At least in some cases, this also led to increased PI3Kγ affinity (<a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>). Following the first compound PIK 294 (<b>60</b>) Almirall, Gilead, and others have incorporated pyrazolopyrimidines (<b>4</b>, <b>17</b>, <b>18</b>, <b>24</b>, <b>35</b>, <b>39</b>) and subsequently explored other vectors building out from aminopyrimidines (<b>61</b>–<b>63</b>)<a onclick="showRef(event, 'ref123 ref124 ref125'); return false;" href="javascript:void(0);" class="ref ref123 ref124 ref125">(123−125)</a> and aminopyrrolopyrimidines (<b>64</b>, <b>65</b>).<a onclick="showRef(event, 'ref126 ref127'); return false;" href="javascript:void(0);" class="ref ref126 ref127">(126,127)</a></div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Data for Propeller Inhibitors with Additional Substitution on Hinge Binding Groups</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0023.gif" alt="" id="GRAPHIC-d7e2877-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">fold selectivity</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">originator</th><th class="colsep0 rowsep0" align="center">PI3Kδ IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">α/δ</th><th class="colsep0 rowsep0" align="center">β/δ</th><th class="colsep0 rowsep0" align="center">γ/δ</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>60</b></td><td class="colsep0 rowsep0" align="left">UCSF</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">10000</td><td class="colsep0 rowsep0" align="left">490</td><td class="colsep0 rowsep0" align="left">160</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>61</b></td><td class="colsep0 rowsep0" align="left">Almirall</td><td class="colsep0 rowsep0" align="left">0.2</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>62</b></td><td class="colsep0 rowsep0" align="left">Sunshine Lake</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">>1500</td><td class="colsep0 rowsep0" align="left">340</td><td class="colsep0 rowsep0" align="left">19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>63</b></td><td class="colsep0 rowsep0" align="left">Gilead</td><td class="colsep0 rowsep0" align="left"><100</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>64</b></td><td class="colsep0 rowsep0" align="left">Almirall</td><td class="colsep0 rowsep0" align="left">0.04</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>65</b></td><td class="colsep0 rowsep0" align="left">Almirall</td><td class="colsep0 rowsep0" align="left">0.43</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div></div></div><div id="sec9" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">The “3rd Blade”</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26388" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26388" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In early compounds the “3rd blade” of the propeller was typically phenyl (<b>1</b>, <b>15</b>) though the original disclosure of this series back in 2001<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> included examples with aliphatic, alicyclic, saturated heterocycles and benzylic groups in this position. Quite quickly fluorination of the phenyl, particularly meta fluorination, was identified as beneficial (<b>2</b>, <b>7</b>, <b>16</b>). Alternatively, pyridyl (<b>3</b>, <b>8</b>) or pyridine <i>N</i>-oxide (<b>13</b>) replacements of phenyl and <i>N</i>-benzyl substituents (<b>17</b>, <b>18</b>) were used. Subsequently it was demonstrated that a very wide range of groups are tolerated in this position (<a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a></a>). This residue acts as a conformational lock on the two key parts of the molecule, the hinge binder and the core. Examples of diverse groups at this position include further aromatic heterocyclic (<b>66</b>, <b>67</b>),<a onclick="showRef(event, 'ref129 ref130'); return false;" href="javascript:void(0);" class="ref ref129 ref130">(129,130)</a> saturated heterocyclic (<b>68</b>, <b>69</b>),<a onclick="showRef(event, 'ref131 ref132'); return false;" href="javascript:void(0);" class="ref ref131 ref132">(131,132)</a> and cyclopropyl groups (<b>70</b>,<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> compare to <b>62</b>). AstraZeneca used the meta position of the phenyl residue to explore a variety of basic groups (<b>33</b>)<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> that affected p<i>K</i><sub>a</sub> and lipophilicity and thus lung retention and cell activity of the compounds. In the case of <b>67</b>, activity at PI3Kβ was similar to PI3Kδ (modeling showed formation of a hydrogen bond to Asp856 of PI3Kβ); AstraZeneca further observed increased PI3Kβ activity with less hindered amines in their series.</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Data for Propeller Inhibitors with Changes to the “3rd Blade”</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0024.gif" alt="" id="GRAPHIC-d7e3088-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">fold selectivity</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">originator</th><th class="colsep0 rowsep0" align="center">PI3Kδ IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">α/δ</th><th class="colsep0 rowsep0" align="center">β/δ</th><th class="colsep0 rowsep0" align="center">γ/δ</th><th class="colsep0 rowsep0" align="center">cell IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>66</b></td><td class="colsep0 rowsep0" align="left">Takeda</td><td class="colsep0 rowsep0" align="left">6.9</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>67</b></td><td class="colsep0 rowsep0" align="left">Gilead</td><td class="colsep0 rowsep0" align="left">5.3</td><td class="colsep0 rowsep0" align="left">160</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">>1900</td><td class="colsep0 rowsep0" align="left">20<a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>68</b></td><td class="colsep0 rowsep0" align="left">Roche</td><td class="colsep0 rowsep0" align="left">0.85</td><td class="colsep0 rowsep0" align="left">2500</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">29<a class="ref internalNav" href="#t9fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>69</b></td><td class="colsep0 rowsep0" align="left">Gilead</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">62</td><td class="colsep0 rowsep0" align="left">>10000</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>70</b></td><td class="colsep0 rowsep0" align="left">Sunshine Lake</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">280</td><td class="colsep0 rowsep0" align="left">33</td><td class="colsep0 rowsep0" align="left">74</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>71</b></td><td class="colsep0 rowsep0" align="left">Infinity</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">420</td><td class="colsep0 rowsep0" align="left">170</td><td class="colsep0 rowsep0" align="left">310</td><td class="colsep0 rowsep0" align="left">13<a class="ref internalNav" href="#t9fn3" aria-label="c">c</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup><sup>a</sup></sup><p class="last">PC3 cells.</p></div><div class="footnote" id="t9fn2"><sup><sup>b</sup></sup><p class="last">Human peripheral blood mononuclear cells.</p></div><div class="footnote" id="t9fn3"><sup><sup>c</sup></sup><p class="last">Raji cells.</p></div></div></div><div class="NLM_p last">Infinity then migrated the residue to another ring position, and, despite the significant structural difference, the compound showed high selectivity for PI3Kδ inhibition (<b>71</b>).<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a></div></div><div id="sec10" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Second (Fused) Ring of the Core</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23877" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23877" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The second fused ring of the core is most commonly substituted in the 5-position (quinazolinone numbering) or equivalent. The other positions have generally been left unsubstituted, though halogens, particularly fluorine, have been attached (note 6-F substitution on <b>2</b>, <b>3</b>, <b>9</b>); the PK optimization leading to <b>8</b> shows the options.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> Many of the groups attached to the “5”-position have been small. 5-Aryl substitutions (<b>58</b>, <b>72</b>, <b>73</b>; <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a></a>), however, were pioneered by Infinity but have also been adopted by other groups; this additional substitution contributes to the excellent PI3Kδ-selectivity profile of <b>72</b>, though <b>58</b> is much less selective against PI3Kγ. Substitution via an acetylene linker has been successful for attaching a variety of groups, principally heterocycles, of which <b>14</b> is the most notable example; it appears to contribute to the high PI3Kγ-selectivity observed. Aliphatic groups have been attached too, such as those of <b>17</b> and <b>18</b>; in these two the acetylenic group may be contributing to PI3Kγ-potency for the dual PI3Kγδ-inhibition (<b>17</b>) but may also be important for obtaining the desired physicochemical properties for inhaled administration.</div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. Data for Substitutions on the Fused Ring</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0025.gif" alt="" id="GRAPHIC-d7e3301-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">fold selectivity</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">originator</th><th class="colsep0 rowsep0" align="center">PI3Kδ IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">α/δ</th><th class="colsep0 rowsep0" align="center">β/δ</th><th class="colsep0 rowsep0" align="center">γ/δ</th><th class="colsep0 rowsep0" align="center">cell IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>72</b></td><td class="colsep0 rowsep0" align="left">Infinity</td><td class="colsep0 rowsep0" align="left"><100</td><td class="colsep0 rowsep0" align="left">>1000<a class="ref internalNav" href="#t10fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">>1000<a class="ref internalNav" href="#t10fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"><100<a class="ref internalNav" href="#t10fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"><100<a class="ref internalNav" href="#t10fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>73</b></td><td class="colsep0 rowsep0" align="left">Yuhan</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">1600</td><td class="colsep0 rowsep0" align="left">10000</td><td class="colsep0 rowsep0" align="left">650</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t10fn1"><div class="footnote" id="t10fn1"><sup><sup>a</sup></sup><p class="last">Value in nM.</p></div><div class="footnote" id="t10fn2"><sup><sup>b</sup></sup><p class="last">B-cell proliferation.</p></div></div></div><div class="NLM_p last">One additional subclass of propeller-shaped compound in the patent literature is deuterated analogues of clinical compounds. Patents have been published claiming analogues of both <b>1</b><a onclick="showRef(event, 'ref134 ref135 ref136'); return false;" href="javascript:void(0);" class="ref ref134 ref135 ref136">(134−136)</a> and <b>15</b>,<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> with deuterium replacing one or more hydrogen atoms. In one case there is evidence of improved pharmacokinetic half-life in preclinical species.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a></div></div><div id="sec11" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Selectivity of Propeller Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35651" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35651" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Isoform selectivity of propeller-shaped molecules is not always easy to assess. There is limited data available in patents, and comparison of assays from different sources is not straightforward, particularly where ATP concentrations vary. Nevertheless, for those compounds with published data, a range of different selectivity profiles is evident. The reported compounds are often PI3Kδ-selective, though the degree of selectivity varies considerably. Of the compounds for which data are available, only <b>4</b>, <b>8</b>, <b>28</b>, <b>30</b>, <b>33</b>, <b>59</b>, <b>71</b>, and <b>73</b> are >100-fold selective against all three other isoforms at the enzyme level. <b>15</b>, <b>16</b>, and <b>17</b> are described as PI3Kγδ dual inhibitors, though for <b>15</b> there is an approximately 10-fold difference between the potency at both isoforms; in the cases of <b>15</b> (PI3Kβ, 34-fold vs δ, 3-fold vs γ) and <b>17</b> (PI3Kα, 16-fold vs δ, 8-fold vs γ; no value reported for β), a third isoform is also inhibited within 10-fold of the weaker activity (<a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">Table <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a></a>). Other compounds inhibit either PI3Kγ or β with selectivities of 10- to 100-fold vs PI3Kδ. Given that effective selectivity depends on the level of activity at an undesired target at the peak concentration, while the desired target typically needs to be inhibited at trough concentration, the PK profile of each compound will have as significant an impact on the likelihood of effects from inhibition of undesired isoforms as the in vitro isoform selectivities. The exception to the PI3Kδ selective profile is <b>14</b> which exhibits >200-fold selectivity for PI3Kγ against all three other isoforms, a remarkable turnaround, based on the combination of altering both the hinge binder and addition of the acetylene linked heterocycle.</div><div class="NLM_table-wrap" id="tbl11"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 11. Selectivity of Dual PI3Kγδ Inhibitors Based on PI3Kγ activity</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">fold selectivity</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">α/δ</th><th class="colsep0 rowsep0" align="center">β/δ</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">58</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">310</td><td class="colsep0 rowsep0" align="left">120</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">no data</td></tr></tbody></table></div></div><div class="NLM_p">Beyond PI3K isoform selectivity there have been disclosures for multiple advanced compounds on their selectivity against both wider panels of kinases and other targets (<a class="ref showTableEvent internalNav" data-ID="tbl12" href="#tbl12">Table <a class="ref showTableEvent internalNav" data-ID="tbl12" href="#tbl12">12</a></a>). In contrast to protein kinase inhibitors, where achieving selectivity with ATP competitive inhibitors is often highly challenging, for these propeller-shaped PI3K inhibitors protein kinase selectivity is excellent for all reported examples, with only two examples showing even modest activity, each at a single protein kinase. Even toward other lipid kinases selectivity is always good; the class III PI3K Vps34 is the most common off-target but with a large margin compared to PI3K inhibition.</div><div class="NLM_table-wrap" id="tbl12"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 12. Selectivity Profiles for Propeller-Shaped PI3K Inhibitors</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">no. of kinases screened (concn)</th><th class="colsep0 rowsep0" align="center">kinase hits</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b><a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a></td><td class="colsep0 rowsep0" align="left">402 (10 μM)</td><td class="colsep0 rowsep0" align="left">Vps34 IC<sub>50</sub> = 0.98 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b><a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a></td><td class="colsep0 rowsep0" align="left">359 (1 μM) protein kinases</td><td class="colsep0 rowsep0" align="left">casein kinase 1ε, >60% at 1 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b><a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a></td><td class="colsep0 rowsep0" align="left">359 (10 μM)</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b><a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a></td><td class="colsep0 rowsep0" align="left">456 (10 μM) (56 mutant kinases, 11 lipid kinases)</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b><a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a></td><td class="colsep0 rowsep0" align="left">lipid kinases (undefined concn)</td><td class="colsep0 rowsep0" align="left">Vps34 IC<sub>50</sub> = 2.5 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b><a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></td><td class="colsep0 rowsep0" align="left">468 (1 μM)</td><td class="colsep0 rowsep0" align="left">DNAPK IC<sub>50</sub> = 4.8 μM; Vps34 IC<sub>50</sub> = 40 μM; SIK 88% inhibition at 1 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b><a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a></td><td class="colsep0 rowsep0" align="left">442 (1 μM) (includes lipid kinases and 56 mutant kinases)</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b><a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a></td><td class="colsep0 rowsep0" align="left">“extensive panel of protein and lipid kinases”</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b><a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a></td><td class="colsep0 rowsep0" align="left">345 (1 μM)</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>67</b><a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a></td><td class="colsep0 rowsep0" align="left">456 (10 μM)</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div></div></div><div id="sec12" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">“Nonpropeller” Shaped Inhibitors Indazole Hinge-Binders</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48010" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48010" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">GSK has published the discovery of a series with an indazole hinge binder (<b>74</b>)<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> by selective optimization of side activities from a series that originated as PIM kinase inhibitors and was also investigated against GSK3β. This series was optimized to two compounds (<b>10</b>, <b>11</b>)<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> with excellent isoform selectivity that have been taken forward to clinical trials as inhaled agents for the treatment of asthma and/or COPD (<a class="ref showTableEvent internalNav" data-ID="tbl13" href="#tbl13">Table <a class="ref showTableEvent internalNav" data-ID="tbl13" href="#tbl13">13</a></a>). Compound <b>10</b> exhibits very good isoform selectivity and excellent cell potency that translated into good in vivo potency. Compound <b>11</b> was selected because of a beneficial pharmacokinetic profile (higher systemic clearance, very low oral bioavailability) and improved selectivity for the hERG ion channel and thus reduced risk of cardiovascular side effects. GSK, in collaboration with Strathclyde University, has further used this template to develop the only reported covalent inhibitors of PI3Kδ (<b>75</b>).<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> In a another extension of this work GSK has reported modifying the indazole hinge-binding group to a benzofuran that, coupled with other modifications, converts the series from one suitable for inhalation to a series targeting oral administration (<b>76</b>).<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> Finally, a further GSK patent has appeared with another follow-up compound (<b>77</b>) to this series using a different template but retaining some features from the earlier compounds.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a></div><div class="NLM_table-wrap" id="tbl13"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 13. PI3Kδ Inhibitors with Indazole Hinge Binding Groups and Related Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0026.gif" alt="" id="GRAPHIC-d7e3697-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">fold selectivity</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">PI3Kδ IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">α/δ</th><th class="colsep0 rowsep0" align="center">β/δ</th><th class="colsep0 rowsep0" align="center">γ/δ</th><th class="colsep0 rowsep0" align="center">cell IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">0.13</td><td class="colsep0 rowsep0" align="left">39000</td><td class="colsep0 rowsep0" align="left">13000</td><td class="colsep0 rowsep0" align="left">50000</td><td class="colsep0 rowsep0" align="left">0.2<a class="ref internalNav" href="#t13fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">0.08</td><td class="colsep0 rowsep0" align="left">6300</td><td class="colsep0 rowsep0" align="left">7900</td><td class="colsep0 rowsep0" align="left">6300</td><td class="colsep0 rowsep0" align="left">0.6<a class="ref internalNav" href="#t13fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>74</b></td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">63</td><td class="colsep0 rowsep0" align="left">63</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>75</b></td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">400</td><td class="colsep0 rowsep0" align="left">630</td><td class="colsep0 rowsep0" align="left">3100</td><td class="colsep0 rowsep0" align="left">13<a class="ref internalNav" href="#t13fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>76</b></td><td class="colsep0 rowsep0" align="left">160</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">63</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">250<a class="ref internalNav" href="#t13fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>77</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>78</b></td><td class="colsep0 rowsep0" align="left">4.5</td><td class="colsep0 rowsep0" align="left">320</td><td class="colsep0 rowsep0" align="left">120</td><td class="colsep0 rowsep0" align="left">>2200</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t13fn1"><div class="footnote" id="t13fn1"><sup><sup>a</sup></sup><p class="last">Human whole blood.</p></div></div></div><div class="NLM_p last">Surprisingly, until very recently there had not been any reports where others have attempted to take advantage of this motif; however in 2018 Astellas described a series with a pyrazolopyridine hinge binder that also exhibited good isoform selectivity (<b>78</b>).<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a></div></div><div id="sec13" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30">Pyrimidine/Quinoxaline Hinge-Binders</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70276" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70276" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Novartis described the conversion of a nonselective PI3K and mTOR inhibitor (<b>79</b>) to a PI3Kδ inhibitor (<b>80</b>);<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> compounds were unusual in that the hinge-binding motif contained only an aromatic nitrogen as hydrogen bond acceptor and no donor. This series was modified by side chain simplification to improve physicochemical properties (<b>81</b>).<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> Further optimization involving a scaffold hop that increased f(sp3) gave two new series represented by <b>82</b><a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> and the clinical candidate (<b>12</b>).<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> Interestingly in selecting <b>12</b> the team sacrificed some of the isoform selectivity in order to achieve suitable properties for oral dosing. Compound <b>12</b> is advancing in development despite a poorer isoform selectivity profile than many other PI3Kδ inhibitors (<a class="ref showTableEvent internalNav" data-ID="tbl14" href="#tbl14">Table <a class="ref showTableEvent internalNav" data-ID="tbl14" href="#tbl14">14</a></a>).</div><div class="NLM_table-wrap" id="tbl14"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 14. Quinoline, Quinazoline, and Related Inhibitors</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0027.gif" alt="" id="GRAPHIC-d7e3889-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">fold selectivity</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">originator</th><th class="colsep0 rowsep0" align="center">PI3Kδ IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">α/δ</th><th class="colsep0 rowsep0" align="center">β/δ</th><th class="colsep0 rowsep0" align="center">γ/δ</th><th class="colsep0 rowsep0" align="center">cell IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">Novartis</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">22</td><td class="colsep0 rowsep0" align="left">38</td><td class="colsep0 rowsep0" align="left">200</td><td class="colsep0 rowsep0" align="left">56<a class="ref internalNav" href="#t14fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>79</b></td><td class="colsep0 rowsep0" align="left">Novartis</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left">7.7</td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>80</b></td><td class="colsep0 rowsep0" align="left">Novartis</td><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left">29</td><td class="colsep0 rowsep0" align="left">180</td><td class="colsep0 rowsep0" align="left">510</td><td class="colsep0 rowsep0" align="left">9<a class="ref internalNav" href="#t14fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>81</b></td><td class="colsep0 rowsep0" align="left">Novartis</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">77</td><td class="colsep0 rowsep0" align="left">72</td><td class="colsep0 rowsep0" align="left">200</td><td class="colsep0 rowsep0" align="left">79<a class="ref internalNav" href="#t14fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>82</b></td><td class="colsep0 rowsep0" align="left">Novartis</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">36</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>83</b></td><td class="colsep0 rowsep0" align="left">Cadila</td><td class="colsep0 rowsep0" align="left">22</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>84</b></td><td class="colsep0 rowsep0" align="left">Xi’an Jiantong University</td><td class="colsep0 rowsep0" align="left">2.7</td><td class="colsep0 rowsep0" align="left">9.5</td><td class="colsep0 rowsep0" align="left">98</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>85</b></td><td class="colsep0 rowsep0" align="left">Xi’an Jiantong University</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">110</td><td class="colsep0 rowsep0" align="left">34</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t14fn1"><div class="footnote" id="t14fn1"><sup><sup>a</sup></sup><p class="last">Rat-1 cells.</p></div></div></div><div class="NLM_p">Cadila has claimed a structurally related series of PI3K inhibitors (<b>83</b>)<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> for which only PI3Kδ inhibition data are reported.</div><div class="NLM_p last">A group from Xi’an Jiaotong University has published a patent and three papers on quinazoline based inhibitors<a onclick="showRef(event, 'ref150 ref151 ref152 ref153'); return false;" href="javascript:void(0);" class="ref ref150 ref151 ref152 ref153">(150−153)</a> with good potency but only modest selectivity against PI3Kα; two representative examples (<b>84</b>, <b>85</b>) are shown.</div></div><div id="sec14" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i32">Aminopyrrolotriazine Hinge Binding Groups</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21463" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21463" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Bristol-Myers Squibb has described its medicinal chemistry program targeting PI3Kδ inhibitors in a series of papers (<a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a></a>). Their starting point, <b>86</b>, was a potent but nonselective PI3K inhibitor (broader kinase inhibitory potency and a potent CYP inhibitor).<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a> Replacement of the pyridyl group with meta substituted phenyl analogues removed the CYP liability and improved PI3K and general kinase selectivity, while replacement of the cyclohexyl group with 4-pyranyl improved both isoform selectivity and physical properties, resulting in the preferred compound <b>87</b>. Efficacy was shown in an in vivo model at 30 mg/kg.<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a> Toxicity issues enforced further optimization which was guided by structural information. The group targeted the open face of Trp760 of PI3Kδ through increasing the size of the meta substituent, leading to acyl piperazine <b>88</b><a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> that was active at 3 mg/kg orally in vivo. Further optimization of the scaffold to improve selectivity and permeability began with attempts to reduce PSA that ultimately identified that the pyrazole moiety could be replaced with a halogen or trifluoromethyl group without a detrimental effect on the PI3Kδ potency but gave improved selectivity against PI3Kγ coupled with greatly improved permeability. These small groups did not exhibit inhibition of the hERG channel as was seen for larger lipophilic groups. Further optimization by addition of a group in the 4-position of the phenyl ring improved metabolic stability and potency. The heterocyclic substituent on the phenyl ring was optimized to either a highly selective morpholinone <b>89</b>,<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> though this turned out to have poor metabolic stability, or an acetylpiperazinone <b>90</b>,<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> with methyl substitutions to control metabolism and influence potency. Compound <b>90</b> was evaluated in a mouse arthritis model and gave an ED<sub>50</sub> of 1.25 mg/kg; <b>90</b> appears to be the most advanced candidate disclosed but has not been reported to have entered clinical development.</div><div class="NLM_table-wrap" id="tbl15"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 15. Bristol-Myers Squibb PI3Kδ Inhibitors</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0028.gif" alt="" id="GRAPHIC-d7e4133-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">fold selectivity</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">PI3Kδ IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">α/δ</th><th class="colsep0 rowsep0" align="center">β/δ</th><th class="colsep0 rowsep0" align="center">γ/δ</th><th class="colsep0 rowsep0" align="center">cell IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>86</b></td><td class="colsep0 rowsep0" align="left">22</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">120</td><td class="colsep0 rowsep0" align="left">0.4</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>87</b></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">670</td><td class="colsep0 rowsep0" align="left">800</td><td class="colsep0 rowsep0" align="left">130</td><td class="colsep0 rowsep0" align="left">6<a class="ref internalNav" href="#t15fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>88</b></td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">610</td><td class="colsep0 rowsep0" align="left">1400</td><td class="colsep0 rowsep0" align="left">44</td><td class="colsep0 rowsep0" align="left">50<a class="ref internalNav" href="#t15fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>89</b></td><td class="colsep0 rowsep0" align="left">0.2</td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left">7<a class="ref internalNav" href="#t15fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>90</b></td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">700</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">35<a class="ref internalNav" href="#t15fn2" aria-label="b">b</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t15fn1"><div class="footnote" id="t15fn1"><sup><sup>a</sup></sup><p class="last">Human B-cells.</p></div><div class="footnote" id="t15fn2"><sup><sup>b</sup></sup><p class="last">Human whole blood.</p></div></div></div></div><div id="sec15" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i34">Morpholine Hinge Binders</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63551" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63551" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The use of a morpholine as an H-bond acceptor in the hinge-binding motif was a common feature in several early PI3Kδ inhibitor series going back to the early promiscuous pan-PI3K inhibitor tool compound LY294002 (<b>91</b> (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>); IC<sub>50</sub> PI3Kα 720 nM; β 306 nM; γ 7260 nM; δ 1330 nM <a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a>). Since 2012, there has been less emphasis on this structural class, though patents and papers have continued to appear with both monocyclic and bicyclic cores (<a class="ref showTableEvent internalNav" data-ID="tbl16" href="#tbl16">Tables <a class="ref showTableEvent internalNav" data-ID="tbl16" href="#tbl16">16</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl17" href="#tbl17">17</a>). A Perspective has been published on morpholine-based inhibitors of PI3K and related kinases.<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a></div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Early PI3K inhibitor with morpholine hinge binder.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01298&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl16"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 16. PI3Kδ Inhibitors with Morpholine Hinge Binding Groups and a Monocyclic Core</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0029.gif" alt="" id="GRAPHIC-d7e4294-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">fold selectivity</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">originator</th><th class="colsep0 rowsep0" align="center">PI3Kδ IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">α/δ</th><th class="colsep0 rowsep0" align="center">β/δ</th><th class="colsep0 rowsep0" align="center">γ/δ</th><th class="colsep0 rowsep0" align="center">cell IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b><a onclick="showRef(event, 'ref165 ref169'); return false;" href="javascript:void(0);" class="ref ref165 ref169">(165,169)</a></td><td class="colsep0 rowsep0" align="left">MEI</td><td class="colsep0 rowsep0" align="left">8.4</td><td class="colsep0 rowsep0" align="left">2200<a class="ref internalNav" href="#t16fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">30<a class="ref internalNav" href="#t16fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">230</td><td class="colsep0 rowsep0" align="left">0.9<a class="ref internalNav" href="#t16fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>92</b></td><td class="colsep0 rowsep0" align="left">Astellas</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">>500</td><td class="colsep0 rowsep0" align="left">120</td><td class="colsep0 rowsep0" align="left">>500</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>93</b></td><td class="colsep0 rowsep0" align="left">Pathway</td><td class="colsep0 rowsep0" align="left"><100</td><td class="colsep0 rowsep0" align="left">>5</td><td class="colsep0 rowsep0" align="left">>2 to >5</td><td class="colsep0 rowsep0" align="left">>5</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>94</b></td><td class="colsep0 rowsep0" align="left">Pathway</td><td class="colsep0 rowsep0" align="left"><100</td><td class="colsep0 rowsep0" align="left">>5</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>95</b></td><td class="colsep0 rowsep0" align="left">Pathway</td><td class="colsep0 rowsep0" align="left"><100</td><td class="colsep0 rowsep0" align="left">>5<a class="ref internalNav" href="#t16fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">>5</td><td class="colsep0 rowsep0" align="left">>5</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>96</b></td><td class="colsep0 rowsep0" align="left">Monash University</td><td class="colsep0 rowsep0" align="left">26</td><td class="colsep0 rowsep0" align="left">170</td><td class="colsep0 rowsep0" align="left">70</td><td class="colsep0 rowsep0" align="left">210</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>97</b></td><td class="colsep0 rowsep0" align="left">Takeda</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t16fn1"><div class="footnote" id="t16fn1"><sup><sup>a</sup></sup><p class="last">Cellular selectivity.</p></div><div class="footnote" id="t16fn2"><sup><sup>b</sup></sup><p class="last">Raji cells.</p></div></div></div><div class="NLM_table-wrap" id="tbl17"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 17. PI3Kδ Inhibitors with Morpholine Hinge Binding Groups and a Bicyclic Core</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0030.gif" alt="" id="GRAPHIC-d7e4463-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">fold selectivity</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">originator</th><th class="colsep0 rowsep0" align="center">PI3Kδ IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">α/δ</th><th class="colsep0 rowsep0" align="center">β/δ</th><th class="colsep0 rowsep0" align="center">γ/δ</th><th class="colsep0 rowsep0" align="center">cell IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>98</b></td><td class="colsep0 rowsep0" align="left">Piramed/Roche</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">8300<a class="ref internalNav" href="#t17fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>99</b></td><td class="colsep0 rowsep0" align="left">Roche</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">46<a class="ref internalNav" href="#t17fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>100</b></td><td class="colsep0 rowsep0" align="left">Roche</td><td class="colsep0 rowsep0" align="left">3.8</td><td class="colsep0 rowsep0" align="left">340</td><td class="colsep0 rowsep0" align="left">200</td><td class="colsep0 rowsep0" align="left">410</td><td class="colsep0 rowsep0" align="left">40<a class="ref internalNav" href="#t17fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>101</b></td><td class="colsep0 rowsep0" align="left">Roche</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">260</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>102</b></td><td class="colsep0 rowsep0" align="left">Roche</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">84</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>5000</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>103</b></td><td class="colsep0 rowsep0" align="left">Roche</td><td class="colsep0 rowsep0" align="left">0.47</td><td class="colsep0 rowsep0" align="left">260</td><td class="colsep0 rowsep0" align="left">420</td><td class="colsep0 rowsep0" align="left">220</td><td class="colsep0 rowsep0" align="left">4.4<a class="ref internalNav" href="#t17fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>104</b><a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a></td><td class="colsep0 rowsep0" align="left">Roche</td><td class="colsep0 rowsep0" align="left">0.58</td><td class="colsep0 rowsep0" align="left">150</td><td class="colsep0 rowsep0" align="left">160</td><td class="colsep0 rowsep0" align="left">190</td><td class="colsep0 rowsep0" align="left">12<a class="ref internalNav" href="#t17fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>105</b></td><td class="colsep0 rowsep0" align="left">Shanghai Xingli</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>106</b></td><td class="colsep0 rowsep0" align="left">Shanghai Xingli</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>107</b></td><td class="colsep0 rowsep0" align="left">Jilin</td><td class="colsep0 rowsep0" align="left">450</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>108</b></td><td class="colsep0 rowsep0" align="left">Daiichi</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">>70</td><td class="colsep0 rowsep0" align="left">>700</td><td class="colsep0 rowsep0" align="left">>70</td><td class="colsep0 rowsep0" align="left">6<a class="ref internalNav" href="#t17fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>109</b></td><td class="colsep0 rowsep0" align="left">Celon</td><td class="colsep0 rowsep0" align="left"><100</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t17fn1"><div class="footnote" id="t17fn1"><sup><sup>a</sup></sup><p class="last">U87MG glioblastoma cell line.</p></div><div class="footnote" id="t17fn2"><sup><sup>b</sup></sup><p class="last">B-cells.</p></div><div class="footnote" id="t17fn3"><sup><sup>c</sup></sup><p class="last">Human whole blood.</p></div><div class="footnote" id="t17fn4"><sup><sup>d</sup></sup><p class="last">Mouse splenocytes.</p></div></div></div></div><div id="sec16" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i37">Monocyclic Cores</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12666" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12666" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Astellas has claimed PI3Kδ inhibitors with a monocyclic pyrimidine core and a morpholine hinge with impressive selectivity against PI3Kα.<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a> Very recently, an apparent lead compound from this series, AS2541019, has been disclosed (<b>92</b>).<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a></div><div class="NLM_p">Three somewhat similar patents with a 1,3,5-triazine monocyclic core and a morpholine hinge appeared from Pathway in 2012 (<b>93</b>, <b>94</b>, <b>95</b>).<a onclick="showRef(event, 'ref162 ref163 ref164'); return false;" href="javascript:void(0);" class="ref ref162 ref163 ref164">(162−164)</a> A further patent from MEI, who licensed the rights to <b>6</b> from Pathway, claimed a single compound along similar lines in 2014;<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a> this is likely to be the development compound, though an official declaration has not been made.</div><div class="NLM_p">A group from Monash University has investigated structurally related triazines and probed the factors that drive isoform selectivity.<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a> By targeting Asp832 and Ans 836 (PI3Kδ) with a pendant amide that was designed to form a charge interaction or hydrogen bond, they were able to increase δ-selectivity; experiments with mutated analogues of PI3Kδ confirmed the involvement of the targeted residues. A related patent describes some more examples, the best of which exhibits further enhanced selectivity (<b>96</b>).<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a></div><div class="NLM_p last">Takeda have claimed a series of structurally related compounds carrying a morpholine attached to a pyrimidine but fused via an additional ring to give a series of tricycles (<b>97</b>).<a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(168)</a> They reported excellent potencies at PI3Kδ, but no data were given for the other isoforms.</div></div><div id="sec17" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i38">Bicyclic Cores</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61856" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61856" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Genentech/Roche have published several papers on their collaborations with Piramed and Argenta. Although the order of their discoveries is not clear, it appears that they started from a series discovered at Piramed based on a thienopyrimidine core <b>98</b><a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a> with pan-PI3K inhibitory activity (PI3Kα IC<sub>50</sub> = 100 nM). This core was optimized to the pan-PI3K inhibitor <b>99</b>.<a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a> Variation of substituents gave selectivity in favor of PI3Kδ; scaffold-hopping to a pyridopyrimidine core and further changes of substituents gave >200-fold selectivity against all other isoforms leading to compound <b>100</b>.<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a> Unfortunately, this molecule exhibited time-dependent CYP inhibition.<a onclick="showRef(event, 'ref172'); return false;" href="javascript:void(0);" class="ref ref172">(172)</a> An alternative scaffold-hop to a purine core, however, gave, after reoptimization of substituents, new leads <b>101</b>, <b>102</b><a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a> without the CYP liabilities. More detailed profiling revealed that <b>102</b> exhibited an Ames liability, requiring a further cycle of modifications to give a highly selective compound <b>103</b> without Ames issues.<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a> A further compound from the same series appears to have been investigated extensively but turned out to have bioavailability issues relating to low solubility <b>104</b>.<a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">(175)</a> None of these compounds have yet entered human trials.</div><div class="NLM_p">Two patents have since appeared from Shanghai Xingli using the same thienopyrimidine <b>105</b><a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">(176)</a> and purine cores <b>106</b><a onclick="showRef(event, 'ref177'); return false;" href="javascript:void(0);" class="ref ref177">(177)</a> albeit with a different arrangement of the substituents.</div><div class="NLM_p last">Further bicyclic cores such as isoxazolopyrimidines (Jilin, <b>107</b>),<a onclick="showRef(event, 'ref178'); return false;" href="javascript:void(0);" class="ref ref178">(178)</a> imidazopyridine (Daiichi, <b>108</b>),<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a> and pyrazolopyrimidine (Celon, <b>109</b>)<a onclick="showRef(event, 'ref180'); return false;" href="javascript:void(0);" class="ref ref180">(180)</a> have also been reported.</div></div><div id="sec18" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i39">6,8,9 Trisubstituted Purines</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10414" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10414" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Exelixis claimed a series of PI3Kδ inhibitors based on a purine core substituted at the 6, 8, and 9 positions (<b>110</b>).<a onclick="showRef(event, 'ref181'); return false;" href="javascript:void(0);" class="ref ref181">(181)</a> This series was licensed by Merck (<a class="ref showTableEvent internalNav" data-ID="tbl18" href="#tbl18">Table <a class="ref showTableEvent internalNav" data-ID="tbl18" href="#tbl18">18</a></a>). The first two Merck patents then differed principally in the heteroatom linking to the 6-substituent (<b>111</b>, <b>112</b>).<a onclick="showRef(event, 'ref182 ref183'); return false;" href="javascript:void(0);" class="ref ref182 ref183">(182,183)</a> These compounds were clearly very potent inhibitors with subnanomolar IC<sub>50</sub> values against PI3Kδ, but selectivity was only claimed as >10-fold. Further patents in 2015 (<b>113</b>),<a onclick="showRef(event, 'ref184'); return false;" href="javascript:void(0);" class="ref ref184">(184)</a> 2016 (<b>114</b>),<a onclick="showRef(event, 'ref185'); return false;" href="javascript:void(0);" class="ref ref185">(185)</a> and 2017 (<b>115</b>, <b>116</b>)<a onclick="showRef(event, 'ref186 ref187'); return false;" href="javascript:void(0);" class="ref ref186 ref187">(186,187)</a> showed additional variations; however isoform selectivity is still reported as >10-fold. Whether any compound with sufficient selectivity coupled with suitable PK properties for development has been identified is as yet unclear.</div><div class="NLM_table-wrap" id="tbl18"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 18. Exelixis and Merck PI3Kδ Inhibitors<a class="ref internalNav" href="#t18fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0031.gif" alt="" id="GRAPHIC-d7e4884-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">fold selectivity</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">originator</th><th class="colsep0 rowsep0" align="center">PI3Kδ IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">α/δ</th><th class="colsep0 rowsep0" align="center">β/δ</th><th class="colsep0 rowsep0" align="center">γ/δ</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>110</b></td><td class="colsep0 rowsep0" align="left">Exelixis</td><td class="colsep0 rowsep0" align="left">7.5<a onclick="showRef(event, 'ref188'); return false;" href="javascript:void(0);" class="ref ref188">(188)</a></td><td class="colsep0 rowsep0" align="left">>13</td><td class="colsep0 rowsep0" align="left">>13</td><td class="colsep0 rowsep0" align="left">>13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>111</b></td><td class="colsep0 rowsep0" align="left">Merck</td><td class="colsep0 rowsep0" align="left"><1</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>112</b></td><td class="colsep0 rowsep0" align="left">Merck</td><td class="colsep0 rowsep0" align="left"><1</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>113</b></td><td class="colsep0 rowsep0" align="left">Merck</td><td class="colsep0 rowsep0" align="left"><1</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>114</b></td><td class="colsep0 rowsep0" align="left">Merck</td><td class="colsep0 rowsep0" align="left"><1</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>115</b></td><td class="colsep0 rowsep0" align="left">Merck</td><td class="colsep0 rowsep0" align="left">2.8</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>116</b></td><td class="colsep0 rowsep0" align="left">Merck</td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t18fn1"><div class="footnote" id="t18fn1"><sup><sup>a</sup></sup><p class="last">The asterisk ∗ in the above table section containing drawn chemical structures indicates undefined absolute stereochemistry.</p></div></div></div></div><div id="sec19" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i41">Other Hinge Binding Groups</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72557" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72557" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A group from the Chinese Academy of Sciences in Heifei has claimed a series of PI3Kδ inhibitors based on an aminothiazole hinge binding group (<b>117</b>)<a onclick="showRef(event, 'ref189'); return false;" href="javascript:void(0);" class="ref ref189">(189)</a> (<a class="ref showTableEvent internalNav" data-ID="tbl19" href="#tbl19">Table <a class="ref showTableEvent internalNav" data-ID="tbl19" href="#tbl19">19</a></a>). The best of these compounds shows modest selectivity against the other isoforms. A recent AstraZeneca patent discloses a series of dual PI3Kγδ inhibitors that also feature a thiazole hinge binding group (<b>118</b>).<a onclick="showRef(event, 'ref190'); return false;" href="javascript:void(0);" class="ref ref190">(190)</a></div><div class="NLM_table-wrap" id="tbl19"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 19. Other PI3Kδ Inhibitors</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0032.gif" alt="" id="GRAPHIC-d7e5037-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">fold selectivity</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">originator</th><th class="colsep0 rowsep0" align="center">PI3Kδ IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">α/δ</th><th class="colsep0 rowsep0" align="center">β/δ</th><th class="colsep0 rowsep0" align="center">γ/δ</th><th class="colsep0 rowsep0" align="center">cell IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>117</b></td><td class="colsep0 rowsep0" align="left">Heifei</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">35</td><td class="colsep0 rowsep0" align="left">71</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>118</b></td><td class="colsep0 rowsep0" align="left">AstraZeneca</td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left">78</td><td class="colsep0 rowsep0" align="left">1900</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>119</b></td><td class="colsep0 rowsep0" align="left">DanaFarber</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">28</td><td class="colsep0 rowsep0" align="left">2400</td><td class="colsep0 rowsep0" align="left">3.5</td><td class="colsep0 rowsep0" align="left">1400<a class="ref internalNav" href="#t19fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>120</b></td><td class="colsep0 rowsep0" align="left">AstraZeneca</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">5000</td><td class="colsep0 rowsep0" align="left">20000</td><td class="colsep0 rowsep0" align="left">2000</td><td class="colsep0 rowsep0" align="left">120<a class="ref internalNav" href="#t19fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>121</b></td><td class="colsep0 rowsep0" align="left">Genentech</td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="left">110</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t19fn1"><div class="footnote" id="t19fn1"><sup><sup>a</sup></sup><p class="last">Jurkat.</p></div><div class="footnote" id="t19fn2"><sup><sup>b</sup></sup><p class="last">JeKo1.</p></div></div></div><div class="NLM_p">An aminopyrimidine is used as the hinge binding group in a series of tricyclic dual PI3Kγδ inhibitors from the Dana Farber Institute (<b>119</b>).<a onclick="showRef(event, 'ref191'); return false;" href="javascript:void(0);" class="ref ref191">(191)</a> These molecules show good selectivity against PI3Kβ but modest selectivity against PI3Kα; some members of the class further show activity against Aurora kinases.</div><div class="NLM_p">AstraZeneca has reported another series that were derived from a PI3Kα series using an aminopyrazine (<b>120</b>) as the hinge binding group.<a onclick="showRef(event, 'ref192'); return false;" href="javascript:void(0);" class="ref ref192">(192)</a> These compounds were highly selective for PI3Kδ in enzyme assays but had weaker cell activities.</div><div class="NLM_p last">A combined Genentech–Charles River group has reported a series derived by chemical modification of a PI3Kα selective benzoxazepin starting point. This involved replacement of an amide, designed to interact with Glu-859 (PI3Kα numbering) that is specific to PI3Kα, with a piperazine designed to occupy the tryptophan shelf.<a onclick="showRef(event, 'ref193'); return false;" href="javascript:void(0);" class="ref ref193">(193)</a> Potency was optimized through addition of an α-methyl group to control the conformation of the piperazine, while metabolic stability was controlled by modulation of lipophilicity, leading to the identification of <b>121</b>.</div></div><div id="sec20" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43">Kinase Selectivity of Nonpropeller PI3Kδ Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65826" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65826" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Selectivity against panels of kinases has been reported for a variety of nonpropeller PI3Kδ inhibitors (<a class="ref showTableEvent internalNav" data-ID="tbl20" href="#tbl20">Table <a class="ref showTableEvent internalNav" data-ID="tbl20" href="#tbl20">20</a></a>). As with the propeller-shaped inhibitors discussed above (<a class="ref showTableEvent internalNav" data-ID="tbl12" href="#tbl12">Table <a class="ref showTableEvent internalNav" data-ID="tbl12" href="#tbl12">12</a></a>), selectivity is generally excellent, with at least 100-fold margin over all other kinases tested in every case. The kinases that are inhibited by these compounds show no obvious pattern with only one kinase, the related class III PI3K, Vps34, being inhibited by two molecules.</div><div class="NLM_table-wrap" id="tbl20"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 20. Selectivity Profiles for Nonpropeller-Shaped PI3Kδ Inhibitors</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">no. of kinases screened (concn)</th><th class="colsep0 rowsep0" align="center">kinase hits</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b><a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a></td><td class="colsep0 rowsep0" align="left">∼450 kinases (1 μM) “no activity against unrelated kinases”</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b><a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a></td><td class="colsep0 rowsep0" align="left">>250, all >1000-fold selectivity</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b><a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a></td><td class="colsep0 rowsep0" align="left">>250, all >100-fold selectivity</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b><a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a></td><td class="colsep0 rowsep0" align="left">442 protein and lipid kinases (10 μM)</td><td class="colsep0 rowsep0" align="left">DNAPK IC<sub>50</sub> = 0.88 μM; RPS6KA5 76% at 10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>75</b><a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a></td><td class="colsep0 rowsep0" align="left">140 protein kinases, 10 lipid kinases (1 μM)</td><td class="colsep0 rowsep0" align="left">Vps34 IC<sub>50</sub> = 0.063 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>80</b><a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a></td><td class="colsep0 rowsep0" align="left">40 protein kinases, 3 lipid kinases (10 μM)</td><td class="colsep0 rowsep0" align="left">Vps34 IC<sub>50</sub> = 4.1 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>89</b><a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a></td><td class="colsep0 rowsep0" align="left">All tested kinases >100-fold selectivity</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>90</b><a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a></td><td class="colsep0 rowsep0" align="left">253 kinases, all >660-fold selectivity</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>92</b><a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a></td><td class="colsep0 rowsep0" align="left">29 kinases (10 μM), maximum 34% inhibition</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>101</b><a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a></td><td class="colsep0 rowsep0" align="left">55 kinases (1 μM), <25% inhibition</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>102</b><a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a></td><td class="colsep0 rowsep0" align="left">55 kinases (1 μM), <25% inhibition</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>103</b><a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a></td><td class="colsep0 rowsep0" align="left">239 kinases (1 μM), B-Raf 61% and PI4Kb 71% inhibition</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>119</b><a onclick="showRef(event, 'ref191'); return false;" href="javascript:void(0);" class="ref ref191">(191)</a></td><td class="colsep0 rowsep0" align="left">Full kinome scan (1 μM), 8 kinases inhibited >50%</td><td class="colsep0 rowsep0" align="left">Aurora A 0.15 μM, Aurora B 0.15 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>120</b><a onclick="showRef(event, 'ref192'); return false;" href="javascript:void(0);" class="ref ref192">(192)</a></td><td class="colsep0 rowsep0" align="left">350 kinases (1 μM), 5 inhibited >50%</td><td class="colsep0 rowsep0" align="left">DYRK1A IC<sub>50</sub> = 0.14 μM, DYRK1B IC<sub>50</sub> = 0.33 μM, CSNK1G3 IC<sub>50</sub> = 0.46 μM</td></tr></tbody></table></div></div></div><div id="sec21" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i45">Selective PI3Kγ Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12674" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12674" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">PI3Kγ selective compounds are of great interest for inflammation and autoimmune diseases. Lately their potential in immuno-oncology applications and for the treatment of cardiovascular diseases has further increased the interest. Development of isoform selective PI3Kγ inhibitors has been difficult given the high sequence similarity between the isoforms. From a safety perspective, a high isoform selectivity is required, especially toward PI3Kα, which has been shown to affect glucose and insulin signaling,<a onclick="showRef(event, 'ref194'); return false;" href="javascript:void(0);" class="ref ref194">(194)</a> while PI3Kβ inhibition has been shown to cause thrombus instability and increase the shedding of platelet emboli.<a onclick="showRef(event, 'ref195'); return false;" href="javascript:void(0);" class="ref ref195">(195)</a> Furthermore, PI3Kα and β are ubiquitously expressed and genetic inactivation of PI3Kα or β results in embryonic lethality in mice.<a onclick="showRef(event, 'ref196 ref197'); return false;" href="javascript:void(0);" class="ref ref196 ref197">(196,197)</a> Compounds with good isoform and wider kinase selectivity are highly desirable in order to develop drug candidates with sufficient therapeutic index, especially for non-life-threatening indications, and also for use as pharmacological tools to further investigate the biological role of PI3Ks. Several promising selective inhibitors have been disclosed since 2012 that are potentially opening further therapeutic applications (<a class="ref showTableEvent internalNav" data-ID="tbl21" href="#tbl21">Table <a class="ref showTableEvent internalNav" data-ID="tbl21" href="#tbl21">21</a></a>).</div><div class="NLM_table-wrap" id="tbl21"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 21. Examples of PI3Kγ Inhibitors from Literature and Patents<a class="ref internalNav" href="#t21fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0033.gif" alt="" id="GRAPHIC-d7e5410-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">fold selectivity</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">originator</th><th class="colsep0 rowsep0" align="center">PI3Kγ IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">α/γ</th><th class="colsep0 rowsep0" align="center">β/γ</th><th class="colsep0 rowsep0" align="center">δ/γ</th><th class="colsep0 rowsep0" align="center">cell IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">Infinity</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">200</td><td class="colsep0 rowsep0" align="left">220</td><td class="colsep0 rowsep0" align="left">>530</td><td class="colsep0 rowsep0" align="left">180<a class="ref internalNav" href="#t21fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>122</b></td><td class="colsep0 rowsep0" align="left">Cellzome</td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">500<a class="ref internalNav" href="#t21fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>123</b></td><td class="colsep0 rowsep0" align="left">Cellzome</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">400</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">317</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>124</b></td><td class="colsep0 rowsep0" align="left">Pfizer</td><td class="colsep0 rowsep0" align="left">190</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">5.0</td><td class="colsep0 rowsep0" align="left">6.5</td><td class="colsep0 rowsep0" align="left">67<a class="ref internalNav" href="#t21fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>125</b></td><td class="colsep0 rowsep0" align="left">Pfizer</td><td class="colsep0 rowsep0" align="left">69</td><td class="colsep0 rowsep0" align="left">5.6</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">170<a class="ref internalNav" href="#t21fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>126</b></td><td class="colsep0 rowsep0" align="left">Pfizer</td><td class="colsep0 rowsep0" align="left">110</td><td class="colsep0 rowsep0" align="left">5.9</td><td class="colsep0 rowsep0" align="left">26</td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">140<a class="ref internalNav" href="#t21fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>127</b></td><td class="colsep0 rowsep0" align="left">Taisho</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">110<a class="ref internalNav" href="#t21fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>128</b></td><td class="colsep0 rowsep0" align="left">Taisho</td><td class="colsep0 rowsep0" align="left">29</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">290<a class="ref internalNav" href="#t21fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>129</b></td><td class="colsep0 rowsep0" align="left">Sha</td><td class="colsep0 rowsep0" align="left">56</td><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">>18</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>130</b></td><td class="colsep0 rowsep0" align="left">Temple University</td><td class="colsep0 rowsep0" align="left">1000</td><td class="colsep0 rowsep0" align="left">25000</td><td class="colsep0 rowsep0" align="left">8500</td><td class="colsep0 rowsep0" align="left">26000</td><td class="colsep0 rowsep0" align="left">150<a class="ref internalNav" href="#t21fn6" aria-label="f">f</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>131</b></td><td class="colsep0 rowsep0" align="left">Novartis</td><td class="colsep0 rowsep0" align="left">36</td><td class="colsep0 rowsep0" align="left">39</td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left">270<a class="ref internalNav" href="#t21fn7" aria-label="g">g</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>132</b></td><td class="colsep0 rowsep0" align="left">Novartis</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">87</td><td class="colsep0 rowsep0" align="left">390</td><td class="colsep0 rowsep0" align="left">67</td><td class="colsep0 rowsep0" align="left">500<a class="ref internalNav" href="#t21fn8" aria-label="h">h</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>133</b></td><td class="colsep0 rowsep0" align="left">Vertex</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">66</td><td class="colsep0 rowsep0" align="left">21</td><td class="colsep0 rowsep0" align="left">61</td><td class="colsep0 rowsep0" align="left">83<a class="ref internalNav" href="#t21fn9" aria-label="i">i</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>134</b></td><td class="colsep0 rowsep0" align="left">Vertex</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">150</td><td class="colsep0 rowsep0" align="left">58</td><td class="colsep0 rowsep0" align="left">120</td><td class="colsep0 rowsep0" align="left">180<a class="ref internalNav" href="#t21fn9" aria-label="i">i</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>135</b></td><td class="colsep0 rowsep0" align="left">Vertex</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">26</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">240<a class="ref internalNav" href="#t21fn9" aria-label="i">i</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>136</b></td><td class="colsep0 rowsep0" align="left">Vertex</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">60</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">170<a class="ref internalNav" href="#t21fn9" aria-label="i">i</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>137</b></td><td class="colsep0 rowsep0" align="left">Incyte</td><td class="colsep0 rowsep0" align="left"><50</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>138</b></td><td class="colsep0 rowsep0" align="left">Incyte</td><td class="colsep0 rowsep0" align="left"><100</td><td class="colsep0 rowsep0" align="left"><500<a class="ref internalNav" href="#t21fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><100<a class="ref internalNav" href="#t21fn9" aria-label="i">i</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>139</b></td><td class="colsep0 rowsep0" align="left">AstraZeneca</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">7800</td><td class="colsep0 rowsep0" align="left">>33000</td><td class="colsep0 rowsep0" align="left">350</td><td class="colsep0 rowsep0" align="left">8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t21fn1"><div class="footnote" id="t21fn1"><sup><sup>a</sup></sup><p class="last">The asterisk ∗ in the above table section containing drawn chemical structures indicates undefined absolute stereochemistry.</p></div><div class="footnote" id="t21fn2"><sup><sup>b</sup></sup><p class="last">IC<sub>50</sub> (nM).</p></div><div class="footnote" id="t21fn3"><sup><sup>c</sup></sup><p class="last">Neutrophil migration.</p></div><div class="footnote" id="t21fn4"><sup><sup>d</sup></sup><p class="last">Neutrophil shape in human lysed blood.</p></div><div class="footnote" id="t21fn5"><sup><sup>e</sup></sup><p class="last">RAW 264 murine macrophages.</p></div><div class="footnote" id="t21fn6"><sup><sup>f</sup></sup><p class="last">K562 cells.</p></div><div class="footnote" id="t21fn7"><sup><sup>g</sup></sup><p class="last">fMLP stimulated human neutrophil assay.</p></div><div class="footnote" id="t21fn8"><sup><sup>h</sup></sup><p class="last">Whole blood neutrophil shape change.</p></div><div class="footnote" id="t21fn9"><sup><sup>i</sup></sup><p class="last">THP-1 cells.</p></div></div></div><div class="NLM_p">Cellzome disclosed <b>122</b> that was suitable for oral dosing and showed promising 50-fold selectivity toward PI3Kα and good pan kinase selectivity.<a onclick="showRef(event, 'ref198'); return false;" href="javascript:void(0);" class="ref ref198">(198)</a> The margins toward β and δ were somewhat lower (20-fold). Another close analogue, <b>123</b>, was reported to have significantly improved isoform selectivity (400-fold toward PI3Kα) but exhibited poor thermodynamic solubility that limited the preclinical development.<a onclick="showRef(event, 'ref199'); return false;" href="javascript:void(0);" class="ref ref199">(199)</a> Pfizer published three lead series that were optimized to give <b>124</b>, <b>125</b>, and <b>126</b>.<a onclick="showRef(event, 'ref200'); return false;" href="javascript:void(0);" class="ref ref200">(200)</a> These were not further pursued since the combination of a suitable pharmacokinetic profile with adequate isoform selectivity could not be achieved.</div><div class="NLM_p">Taisho discovered compound <b>127</b> that displayed high potency against PI3Kγ (3 nM), but the compound still displayed poor selectivity against PI3Kα (15 nM).<a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a> The deacetylated analogue was positive in an Ames test, and further optimization was undertaken to yield <b>128</b> that was Ames negative and demonstrated oral in vivo efficacy in a collagen-induced arthritis (CIA) mouse model. Selectivity against the other isoforms was not reported.<a onclick="showRef(event, 'ref202'); return false;" href="javascript:void(0);" class="ref ref202">(202)</a> Sha et al. published fluoroquinolone derivatives as selective and potent PI3Kγ inhibitors, exemplified by compound <b>129</b> having improved potency; <b>129</b> showed >18-fold selectivity against PI3Kβ but only 6.5-fold selectivity against PI3Kα.<a onclick="showRef(event, 'ref203'); return false;" href="javascript:void(0);" class="ref ref203">(203)</a></div><div class="NLM_p">A group from Temple University published a patent which was exemplified by <b>130</b> with a modest potency for PI3Kγ and >8.5-fold selectivity against the other isoforms (25-fold selectivity against PI3Kα).<a onclick="showRef(event, 'ref204'); return false;" href="javascript:void(0);" class="ref ref204">(204)</a></div><div class="NLM_p">An article from Novartis describes the optimization of a pan PI3K HTS hit to increase isoform selectivity. Improved PI3Kγ selectivity could be obtained by extending the urea moiety to the hydrophobic binding cleft at the outer part of the binding site to provide compound <b>131</b> that displayed a 39-fold selectivity toward PI3Kα and >9-fold selectivity against PI3Kβ and PI3Kδ, respectively.<a onclick="showRef(event, 'ref205'); return false;" href="javascript:void(0);" class="ref ref205">(205)</a> A subsequent patent from Novartis exemplifies compounds with improved selectivity; for example, <b>132</b> exhibited 86-fold selectivity toward PI3Kα.<a onclick="showRef(event, 'ref206'); return false;" href="javascript:void(0);" class="ref ref206">(206)</a></div><div class="NLM_p">Vertex further explored this hydrophobic binding. By taking advantage of the isoform sequence differences, an improved isoform selectivity could be obtained to provide urea containing compound, <b>133</b>, having 66-fold selectivity over PI3Kα.<a onclick="showRef(event, 'ref207'); return false;" href="javascript:void(0);" class="ref ref207">(207)</a> Further optimization led to inhibitors with yet higher levels of selectivity, such as <b>134</b>, that displayed 150-fold selectivity over PI3Kα as well as good selectivity against the other isoforms.<a onclick="showRef(event, 'ref208'); return false;" href="javascript:void(0);" class="ref ref208">(208)</a> In addition, <b>134</b> was selective in a pan kinase panel containing 65 kinases at 2 μM. Vertex claimed a series containing a pyridopyrrolidinone core exemplified by <b>135</b> that shows good potency toward PI3Kγ and 30-fold selectivity over PI3Kα.<a onclick="showRef(event, 'ref209'); return false;" href="javascript:void(0);" class="ref ref209">(209)</a> The preferred compound <b>135</b> has been reported to show good toxicology margins and in vivo efficacy in mouse models for pancreas, colon, lymphoma, and bladder cancers to support progression into clinical evaluations; however no clinical trials have been reported yet.<a onclick="showRef(event, 'ref209'); return false;" href="javascript:void(0);" class="ref ref209">(209)</a> The series was further optimized to yield <b>136</b> that had improved CNS exposure in order to explore the potential for the treatment of multiple sclerosis.<a onclick="showRef(event, 'ref210'); return false;" href="javascript:void(0);" class="ref ref210">(210)</a></div><div class="NLM_p">Incyte published two patents claiming PI3Kγ inhibitors in 2017; in the first patent, <b>137</b> showed modest selectivity against δ and poor cell potency.<a onclick="showRef(event, 'ref211'); return false;" href="javascript:void(0);" class="ref ref211">(211)</a> In the second patent, <b>138</b> showed increased activity toward γ which was also reflected in cell.<a onclick="showRef(event, 'ref212'); return false;" href="javascript:void(0);" class="ref ref212">(212)</a> Selectivity data toward PI3Kα and β were not disclosed however.</div><div class="NLM_p">Infinity published a remarkable selectivity profile for the clinical candidate <b>14</b>.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> The compound was very potent against PI3Kγ (16 nM) and had 200-fold selectivity against PI3Kα in biochemical assays. The high level of selectivity was achieved by taking advantage of isoform sequence differences around the selectivity pocket. As discussed above, “propeller” shaped inhibitors are normally PI3Kδ selective or dual PI3Kγδ selective. For this group of compounds the selectivity was altered by use of a modified hinge binding group that subtly modified the orientation of the core, which, coupled with the pyrazolylalkyne on the isoquinolinone moiety, exploited differences between PI3Kγ and δ on the periphery of the binding site, resulting in a switch from the normal PI3Kδ selectivity for this chemotype to PI3Kγ.</div><div class="NLM_p last">AstraZeneca recently described compounds with an alternative binding mode and with high isoform selectivity.<a onclick="showRef(event, 'ref213'); return false;" href="javascript:void(0);" class="ref ref213">(213)</a> The potent compound <b>139</b> had ADME properties suitable for oral administration and showed >7800-fold selectivity against PI3Kα as well as excellent pan kinase selectivity. In addition, the compound also displayed 8 nM cellular potency and efficacy could be demonstrated in vivo. This series has been further expanded to yield dual PI3Kγ/δ selective compounds such as <b>118</b>.<a onclick="showRef(event, 'ref190'); return false;" href="javascript:void(0);" class="ref ref190">(190)</a></div></div><div id="sec22" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i47">Structural Determinants Driving Selectivity toward PI3Kγ or δ</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80841" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80841" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Considerable understanding has been gained regarding structural determinants driving selectivity toward PI3Kγ and δ. Four distinct regions in the active site have been identified: (1) the selectivity pocket, (2) the tryptophan shelf, (3) the hydrophobic cleft next to the ATP binding site, and (4) the alkyl push around the DFG motif and the Kα3 helix (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>–<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a>).</div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. (a) The selectivity pocket <b>140</b> (yellow) induces a pocket between Trp760 and Met752 in PI3Kδ (blue) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WHX">2WHX</a>). (b) Structure of <b>140</b>; IC<sub>50</sub> PI3Kδ 10 nM, α 10000 nM, β 490 nM, γ 160 nM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01298&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Berndt et al. showed that the propeller class of PI3Kδ inhibitors induces a pocket around Trp760 and Met752 (selectivity pocket) exploring dynamic differences between isoforms in the P-Loop (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>).<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> They further claimed that extending into the affinity pocket and interacting with the hydrogen bond network can lead to increased activity at PI3Kδ and, in some cases, PI3Kγ as well (<b>17</b> but compare <b>2</b>, <b>18</b>, <b>60</b> to <b>15</b>, <b>16</b>) sometimes producing dual PI3Kγδ activity.</div><div class="NLM_p">Genentech described the steric differences between PI3Kδ and the other three PI3K class 1 isoforms at Trp760 (the so-called tryptophan shelf, <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>) as a means to obtain isoform selectivity;<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a> they showed that the residue corresponding to Thr750 in PI3Kδ is in PI3Kα, β, and γ an Arg, Lys, and Lys, respectively, and that these residues occlude the face of the tryptophan, resulting in steric blockage. Compounds that occupy this region have disfavored binding to PI3Kα, β and γ. They exploited this in the synthesis of selective inhibitors like <b>100</b>. This selectivity feature is also used by some other nonpropeller inhibitors to obtain selectivity for PI3Kδ (<b>10</b>, <b>11</b>, <b>120</b>).</div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. (a) Tryptophan shelf, showing the phenyl ring of <b>141</b> (yellow) occupying the pocket above Trp760 in PI3Kδ (blue) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T2M">5T2M</a>) and compound <b>100</b> (green) with a dimethyl alcohol group interacting with Trp760 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EZJ">4EZJ</a>). Compound <b>10</b> shown in purple places a piperidine over Trp760 (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5AE8">5AE8</a>). (b) Structure of <b>141</b>: IC<sub>50</sub> PI3Kδ 0.6 nM, α 1300 nM, β 10000 nM, γ 1000 nM.<a onclick="showRef(event, 'ref192'); return false;" href="javascript:void(0);" class="ref ref192">(192)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01298&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">It has proven considerably more challenging to obtain PI3Kγ selective inhibitors. Collier et al. showed that they could gain selectivity by targeting a hydrophobic cleft adjacent to the ATP binding pocket (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>).<a onclick="showRef(event, 'ref207'); return false;" href="javascript:void(0);" class="ref ref207">(207)</a><named-content content-type="anchor" rid="fig14" type="simple"></named-content>Here differences in the hinge region were explored where the residue corresponding to Ala885 in PI3Kγ is a serine in PI3Kα, β, and δ, believed to cause steric hindrance. Additionally, Gly829 in PI3Kγ corresponds to Glu in PI3Kα, enhancing the selectivity over PI3Kα.</div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Hydrophobic binding cleft next to the ATP binding pocket. The propylimidazole group of <b>134</b> (yellow) occupies a hydrophobic cleft next to the ATP binding pocket. The equivalent residue to Ala885 in PI3Kγ (blue) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PS3">4PS3</a>) is a serine in the class Ia PI3Ks, whereas the equivalent residue to Gly829 in PI3Kγ is a glutamine in PI3Kα.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01298&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. (a) Alkyl push in back pocket of the affinity pocket. The cyclopropylethyl moiety from <b>142</b> (yellow) induces a conformational change in the Kα3 helix and DFG motif of PI3Kδ (blue) PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6FTN">6FTN</a>. Protein backbone from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T2M">5T2M</a> is shown for reference (violet). (b) Structure of <b>142</b>: IC<sub>50</sub> PI3Kδ 250 nM, α 3200 nM, β 20000 nM, γ 0.6 nM.<a onclick="showRef(event, 'ref213'); return false;" href="javascript:void(0);" class="ref ref213">(213)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01298&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Recently a new class of inhibitors have been described that bind deep in the conserved ATP binding pocket.<a onclick="showRef(event, 'ref213'); return false;" href="javascript:void(0);" class="ref ref213">(213)</a> This class of inhibitors achieve their selectivity by introducing a branched alkyl group that induces a pocket within the affinity pocket by a so-called “alkyl push” leading to conformational changes around the DFG motif and the Kα3 helix (equivalent to the α-C helix in a protein kinase; <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>). These inhibitors have reached up to 1000-fold selectivity over PI3Kα, β, and δ; the selectivity has been explained as a consequence of greater flexibility of the PI3Kγ protein as compared to the other isoforms.</div></div><div id="sec23" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i48">Evaluations of PI3K Inhibitors in in Vivo Models</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86105" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86105" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A number of industrial groups have published their lead compounds and described experimental animal studies in inflammatory and immunological models. Additional studies have been carried out in the academic community using some of these optimized compounds.</div><div class="NLM_p">Initial studies have shown effects on B-cell activation or production of cytokines or antibodies in vivo. Using the inhibition of CD86 expression on B-cells in response to IgD stimulation, oral dosing of <b>102</b> achieved a pharmacological effect at doses of 1 mg/kg and greater.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a> The PI3Kδ inhibitor <b>3</b> and related compounds were shown to have a dose-dependent effect on IgM and IgG production in a keyhole limpet hemocyanin (KLH) induced inflammatory model, where the response is antibody production from B-cells in a T-cell dependent manner.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> Compound <b>3</b> itself was active at doses between 0.3 and 3 mg/kg/day po. The same KLH model was used to show in vivo efficacy of PI3Kδ inhibitors <b>88</b><a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> and <b>90</b>.<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> In the same study, <b>90</b> also inhibited a T-cell independent IgM antibody production using stimulation with TNP-Ficoll. Compound <b>12</b> was active in an assay measuring the reduction of IgM production in rats after inoculation with sheep red blood cells.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a></div><div class="NLM_p">Inhibition of IL2 cytokine production in vivo was shown for the PI3Kδ inhibitors <b>13</b><a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> (po doses of 1 mg/kg and greater essentially abolished IL-2 production), <b>1</b><a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> (ID<sub>50</sub> = 1.6 mg/kg po), and <b>25</b><a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> (ID<sub>50</sub> = 0.13 mg/kg po).</div><div class="NLM_p">PI3Kγ inhibitors <b>14</b><a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> and <b>122</b><a onclick="showRef(event, 'ref198'); return false;" href="javascript:void(0);" class="ref ref198">(198)</a> showed inhibition of neutrophil migration in murine air-pouch models. A similar experiment in rats was used for the dual PI3Kγδ inhibitor <b>15</b>,<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> while a PI3Kδ inhibitor was inactive in this model, confirming the PI3Kγ drive.</div><div id="sec23_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Arthritis</h3><div class="NLM_p">In vivo models of arthritis, such as collagen-induced arthritis (CIA), have been widely used for PI3Kγ, PI3Kδ, and PI3Kγδ inhibitors, with both isoforms contributing to efficacy (<a class="ref showTableEvent internalNav" data-ID="tbl22" href="#tbl22">Table <a class="ref showTableEvent internalNav" data-ID="tbl22" href="#tbl22">22</a></a>).</div><div class="NLM_table-wrap" id="tbl22"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 22. CIA Experiments with PI3K Inhibitors</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center">dosing route and frequency</th><th class="colsep0 rowsep0" align="center">dose range (mg/kg)</th><th class="colsep0 rowsep0" align="center">ED<sub>50</sub><a class="ref internalNav" href="#t22fn1" aria-label="a">a</a> (mg/kg)</th><th class="colsep0 rowsep0" align="center">other outcome measures<a class="ref internalNav" href="#t22fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b><a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">po, b.i.d.</td><td class="colsep0 rowsep0" align="left">0.3–3</td><td class="colsep0 rowsep0" align="left">0.6–2.3</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b><a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">po, b.i.d.</td><td class="colsep0 rowsep0" align="left">3 and 10 (prophylactic)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Prophylactic: full inhibition at both doses</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">10 (therapeutic)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Therapeutic: markedly significant reduction in disease severity</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b><a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">po, q.d.</td><td class="colsep0 rowsep0" align="left">0.1–10</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Swelling reduced 0.5 mg/kg and higher</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Effects on histopathology from 0.1 mg/kg</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Additional benefit at 10 mg/kg ascribed to inhibition of PI3Kγ and PI3Kδ</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b><a onclick="showRef(event, 'ref214'); return false;" href="javascript:void(0);" class="ref ref214">(214)</a></td><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="left">po, q.d.</td><td class="colsep0 rowsep0" align="left">10 and 50 (prophylactic)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" rowspan="2" align="left">Prophylactic treatment effective at both doses; therapeutic treatment ineffective</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">50 (therapeutic)</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>59</b><a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">po, b.i.d.</td><td class="colsep0 rowsep0" align="left">0.34–10</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>87</b><a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a></td><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="left">po, b.i.d.</td><td class="colsep0 rowsep0" align="left">30 and 100</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Significant inhibition at both doses, almost complete at top dose</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>90</b><a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a></td><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="left">po, b.i.d.</td><td class="colsep0 rowsep0" align="left">0.5–5</td><td class="colsep0 rowsep0" align="left">1.25</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>123</b><a onclick="showRef(event, 'ref198'); return false;" href="javascript:void(0);" class="ref ref198">(198)</a></td><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="left">po, b.i.d</td><td class="colsep0 rowsep0" align="left">3 and 10</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">42% inhibition at 10 mg/kg</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>128</b><a onclick="showRef(event, 'ref202'); return false;" href="javascript:void(0);" class="ref ref202">(202)</a></td><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="left">po, b.i.d.</td><td class="colsep0 rowsep0" align="left">10–100</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Significant inhibition at 30 and 100 mg/kg</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t22fn1"><div class="footnote" id="t22fn1"><sup><sup>a</sup></sup><p class="last">All studies evaluated joint swelling and histopathological outcomes.</p></div></div></div><div class="NLM_p last">The most detailed report<a onclick="showRef(event, 'ref214'); return false;" href="javascript:void(0);" class="ref ref214">(214)</a> studied the effects of <b>15</b> on MMP-3 and 13 mRNA production, which were reduced, as were autoantibodies to type II collagen. Effects were also seen on immunoglobulin class switching with lower ratios of IgG2a and, at the highest dose, higher levels of serum IgE suggesting reduced switching to IgG. The same paper also reported a study using <b>15</b> in an adjuvant arthritis model in rats, dosing at 50 mg/kg both prophylactically and therapeutically; significant effects were seen for all measured criteria with prophylactic dosing; therapeutic dosing showed an effect on swelling but no significant effects on histopathology or radiographic measures.</div></div><div id="sec23_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Asthma and COPD</h3><div class="NLM_p">The main model used with PI3K inhibitors for asthma has been a rat or mouse ovalbumin model with the primary readout migration of inflammatory cells to the lung as measured in bronchio-alveolar lavage (BAL). Alternatively, transgenic OTII mice were dosed with anti-CD3 intranasally, and inhibition of the phosphorylation of phospho S6 ribosomal protein (S6RP), a biomarker for PI3Kδ inhibition, was measured. A similar model, LPS induced neutrophilia, a COPD directed model, has been used with PI3Kγ inhibitors. Outcomes are shown in <a class="ref showTableEvent internalNav" data-ID="tbl23" href="#tbl23">Table <a class="ref showTableEvent internalNav" data-ID="tbl23" href="#tbl23">23</a></a>.</div><div class="NLM_table-wrap" id="tbl23"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 23. PI3K Inhibitors in Models of Lung Inflammation</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">model</th><th class="colsep0 rowsep0" align="center">dose range (mg/kg) and route</th><th class="colsep0 rowsep0" align="center">outcome</th><th class="colsep0 rowsep0" align="center">comments</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b><a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a></td><td class="colsep0 rowsep0" align="left">Rat OVA</td><td class="colsep0 rowsep0" align="left">0.028–0.69 i.t.</td><td class="colsep0 rowsep0" align="left">ED<sub>50</sub> = 67 μg/kg for eosinophil recruitment</td><td class="colsep0 rowsep0" align="left">Multiple leukocytes and cytokines dose-dependently reduced</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b><a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a></td><td class="colsep0 rowsep0" align="left">Rat OVA</td><td class="colsep0 rowsep0" align="left">i.t.</td><td class="colsep0 rowsep0" align="left">ED<sub>50</sub> = 35 μg/kg for eosinophil recruitment</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b><a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a></td><td class="colsep0 rowsep0" align="left">Rat OVA</td><td class="colsep0 rowsep0" align="left">0.1–10 q.d., po</td><td class="colsep0 rowsep0" align="left">Significant reduction in eosinophils in BAL at 1 and 10 mg/kg</td><td class="colsep0 rowsep0" align="left">10 mg/kg dose also showed lower cytokine levels in BAL and fewer inflammatory lesions</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b><a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a></td><td class="colsep0 rowsep0" align="left">Mouse OVA</td><td class="colsep0 rowsep0" align="left">1 μg and 4 μg/animal i.n.</td><td class="colsep0 rowsep0" align="left">Eosinophil (25%, 62%) and neutrophil (21%, 56%) influx reduced</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b><a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a></td><td class="colsep0 rowsep0" align="left">Mouse OVA</td><td class="colsep0 rowsep0" align="left">1, 4, 20 μg/animal i.t.<a class="ref internalNav" href="#t23fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">Eosinophil (20%, 85%, 91%) and neutrophil (18%, 70%, 80%) influx reduced</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b><a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a></td><td class="colsep0 rowsep0" align="left">Mouse LPS</td><td class="colsep0 rowsep0" align="left">1, 4, 20 μg/animal i.t.</td><td class="colsep0 rowsep0" align="left">Neutrophil numbers in BAL reduced (19%, 53%, 68%) at 2 h postdose</td><td class="colsep0 rowsep0" align="left">Time-course experiment (4 μg/animal) gave 45% inhibition at 8 h and 23% at 12 h</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b><a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a></td><td class="colsep0 rowsep0" align="left">Rat LPS</td><td class="colsep0 rowsep0" align="left">5, 20, 100 μg/animal i.t.</td><td class="colsep0 rowsep0" align="left">Neutrophil numbers in BAL reduced (9%, 58%, 73%) at 2 h postdose</td><td class="colsep0 rowsep0" align="left">Time-course experiment (20 μg/animal) gave 33% inhibition at 8 h and 10% at 12 h</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b><a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a></td><td class="colsep0 rowsep0" align="left">Rat OVA</td><td class="colsep0 rowsep0" align="left">0.1–3 b.i.d., po</td><td class="colsep0 rowsep0" align="left">ED<sub>50</sub> = 0.16 mg/kg for eosinophil accumulation</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b><a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a></td><td class="colsep0 rowsep0" align="left">OTII mouse</td><td class="colsep0 rowsep0" align="left">0.15–1.5 mg/kg i.t.</td><td class="colsep0 rowsep0" align="left">Inhibition of pS6RP at 0.15 and 1.5 mg/kg</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>76</b><a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a></td><td class="colsep0 rowsep0" align="left">Rat OVA</td><td class="colsep0 rowsep0" align="left">3 and 9 mg/kg po</td><td class="colsep0 rowsep0" align="left">Inhibition of eosinophil migration at 3 mg/kg</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>124</b><a onclick="showRef(event, 'ref200'); return false;" href="javascript:void(0);" class="ref ref200">(200)</a></td><td class="colsep0 rowsep0" align="left">Rat LPS</td><td class="colsep0 rowsep0" align="left">0.1–3000 mg/kg po</td><td class="colsep0 rowsep0" align="left">Inhibition of neutrophilia EC<sub>50</sub> = 1.3 μM</td><td class="colsep0 rowsep0" align="left">17-fold margin over insulin elevation</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>125</b><a onclick="showRef(event, 'ref200'); return false;" href="javascript:void(0);" class="ref ref200">(200)</a></td><td class="colsep0 rowsep0" align="left">Rat LPS</td><td class="colsep0 rowsep0" align="left">0.1–3000 mg/kg po</td><td class="colsep0 rowsep0" align="left">Inhibition of neutrophilia EC<sub>50</sub> = 0.26 μM</td><td class="colsep0 rowsep0" align="left">13-fold margin over insulin elevation</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>126</b><a onclick="showRef(event, 'ref200'); return false;" href="javascript:void(0);" class="ref ref200">(200)</a></td><td class="colsep0 rowsep0" align="left">Rat LPS</td><td class="colsep0 rowsep0" align="left">0.1–3000 mg/kg po</td><td class="colsep0 rowsep0" align="left">Inhibition of neutrophilia EC<sub>50</sub> = 3.2 μM</td><td class="colsep0 rowsep0" align="left">1.9-fold margin over insulin elevation</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>139</b><a onclick="showRef(event, 'ref213'); return false;" href="javascript:void(0);" class="ref ref213">(213)</a></td><td class="colsep0 rowsep0" align="left">Rat LPS</td><td class="colsep0 rowsep0" align="left">0.1–2.5 mg/kg po</td><td class="colsep0 rowsep0" align="left">All doses significant and >50% inhibition of neutrophil migration</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t23fn1"><div class="footnote" id="t23fn1"><sup><sup>a</sup></sup><p class="last">Volume administered not defined but assumed to be the same as mouse LPS study.</p></div></div></div><div class="NLM_p last">In addition to the ovalbumin study reported above Respivert describe two additional models where inhibition of cell accumulation in mouse lung airways was investigated.<a onclick="showRef(event, 'ref86 ref87'); return false;" href="javascript:void(0);" class="ref ref86 ref87">(86,87)</a> In the first model mice were challenged with poly-I:C; influx of both macrophages and neutrophils was shown to be inhibited with an IC<sub>50</sub> of approximately 7 μg/animal i.n. for <b>17</b> and 0.8 μg/animal i.n. for <b>18</b>. The second model involved inhibition of cigarette-smoke-induced cell accumulation in murine BAL; an IC<sub>50</sub> of about 7 μg/animal (inhibition of both macrophages and neutrophils) was achieved with <b>17</b>, while <b>18</b> appeared to be somewhat less effective (63% and 54% inhibition at 70 μg/animal). If, however, fluticasone propionate (1.75 μg/animal) was co-dosed with <b>17</b>, the effects were much greater with 60% inhibition of both macrophages and neutrophils achieved at a dose of 0.7 μg/animal, even though fluticasone alone at this concentration was ineffective as a monotherapy. A similar claim is made for <b>18</b>, but the data presented do not show any difference in the presence of fluticasone.</div></div><div id="sec23_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> Organ Transplantation</h3><div class="NLM_p">In an extensive study, Uehara et al.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> investigated the roles of PI3Kγ and δ inhibition through both knock-out/inactive knock-in mice models plus studies using a PI3Kδ inhibitor (<b>72</b>) and a relatively balanced PI3Kγδ dual inhibitor (<b>143</b>; enzyme IC<sub>50</sub> PI3Kα 3000 nM, β 18000 nM, γ 800 nM, δ 600 nM; <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>). In a mouse heart allograft survival model, treatment with <b>61</b> (50 mg/kg, po, b.i.d.) extended allograft survival from a mean of 7 days to 13.5 days. The dual inhibitor <b>132</b> (100 mg/kg, po, q.d.) had a significantly greater effect (mean survival time 35 days). Addition of multiple doses of a CTLA4 antibody to treatment with <b>72</b> increased survival to a mean of 91 days in wild-type animals. In PI3Kγ KO animals, even a single dose of antibody in combination with <b>72</b> ensured that all transplants survived for >100 days.</div><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Structures of dual PI3Kγδ inhibitor <b>143</b> and PI3Kγ inhibitor <b>144</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01298&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">A hamster to rat xenotransplantation model was used to assess the effectiveness of PI3Kδ inhibition using <b>90</b> (1, 2, or 4 mg/kg po) in addition to tacrolimus and mycophenolate mofetil.<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a> Statistically significant reductions in IgM after 7 days (all doses), in IgG1/2a after 14 days (only 2 and 4 mg/kg), and in the prolongation of graft survival (dose-proportional, all doses) were observed.</div></div><div id="sec23_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Lupus</h3><div class="NLM_p last">A mouse model of systemic lupus erythematosus nephritis was used to study the effects of PI3Kγ and δ inhibition on kidney damage using <b>15</b>.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> Over a 20-week period doses of 5 and 10 mg/kg po, q.d. gave significant reductions in the levels of anti dsDNA antibodies in plasma. Proteinuria, however, was significantly reduced not only at these doses but also at a lower dose of 1 mg/kg. Histopathological assessments at termination showed dose-dependent significant reductions in the levels of glomerulonephritis, kidney vessels, and protein casts at all doses and for interstitial nephritis at 5 and 10 mg/kg.</div></div><div id="sec23_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Multiple Sclerosis</h3><div class="NLM_p last">The CNS-penetrant PI3Kγ inhibitor <b>136</b> was evaluated in a murine EAE model of multiple sclerosis.<a onclick="showRef(event, 'ref210'); return false;" href="javascript:void(0);" class="ref ref210">(210)</a> Significant reduction in clinical scores was obtained at doses of 3, 10, and 30 mg/kg po, b.i.d., and good exposure in brain with levels reaching or exceeding the functional IC<sub>50</sub> was shown. The older PI3Kγ inhibitor <b>144</b> (PI3Kγ IC<sub>50</sub> = 0.25 μM; <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>) has also been tested in the same EAE model<a onclick="showRef(event, 'ref215'); return false;" href="javascript:void(0);" class="ref ref215">(215)</a> with subcutaneous dosing (7.5 mg/kg q.d. for 7 or 14 days; higher doses proved fatal). Symptoms were significantly reduced, and histopathological investigation revealed enhanced myelination and axon numbers in the spinal cord.</div></div><div id="sec23_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Sjögren’s Syndrome</h3><div class="NLM_p last">The involvement of PI3Kδ in the salivary glands of Sjögren’s syndrome patients but not those with nonspecific chronic sialoadenitis was established by histological staining for the downstream marker pS6. Following this, a mouse model of ectopic lymphoneogenesis was used to show that inhibition of PI3Kδ with compound <b>13</b> (po) resolved the inflammation through reduction of the influx of T and B cells.<a onclick="showRef(event, 'ref216'); return false;" href="javascript:void(0);" class="ref ref216">(216)</a></div></div></div><div id="sec24" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i57">Summary</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67470" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67470" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">PI3Kγ and δ inhibition has progressed significantly since 2012. The first PI3Kδ inhibitor, <b>1</b>, is now established in clinical use in leukemia and lymphoma, although in a relatively restricted role in part because of the restrictive label and black-box warning that limits wider use.</div><div class="NLM_p">The dual PI3Kγδ inhibitor <b>15</b> showed some efficacy in a clinical trial of allergic challenge in asthmatic patients but was not effective at a lower dose against RA and has not been further developed in any nononcology indications. Compound <b>15</b> has continued development for leukemias and lymphomas at higher doses that appear not to be acceptable for asthma and RA. Compound <b>15</b> is expected to be launched soon. As with <b>1</b>, toxicity concerns may limit the take-up of the drug.</div><div class="NLM_p">Similar patterns of toxicity have been reported for other PI3Kδ and γδ inhibitors; it will be interesting to see if the compounds targeting nononcologic applications are sufficiently safe in clinical practice. The most advanced of these compounds appears to be <b>10</b>, which is both highly isoform selective and dosed via inhalation, thereby potentially minimizing systemic exposure and undesired side effects.</div><div class="NLM_p">The biological understanding of the roles of PI3Kγ and δ in inflammatory processes has increased significantly, in part aided by the development of more isoform selective inhibitors allowing greater precision in the dissection of biological effects. The two isoforms have a complex interrelationship in cells of the immune system, with each isoform playing an important role. The risk/benefit equation between degree of inhibition and undesired mechanism-related side effects, such as the increased risk of infection observed with <b>1</b> and <b>15</b> in clinical trials, will be a key factor in the success or failure of this class of compounds. This risk comes on top of the risks associated with off-target activity.</div><div class="NLM_p">The medicinal chemistry of PI3Kδ inhibition is still dominated by the propeller-shaped type of molecules with ever-increasing numbers of scaffolds being disclosed. Isoform selectivity in this class is subtle, with marked variations between pure PI3Kδ and dual PI3Kγδ inhibition; the choice of substituents, particularly in the affinity pocket and extending from the “5-position”, appears to be the most relevant factor. Levels of PI3Kβ inhibition vary; here interaction with Asp856 (PI3Kβ) appears to be significant. Selectivity against PI3Kα is typically good in this series. Of the nonpropeller PI3Kδ inhibitors <b>10</b> continues to advance in clinical trials; with high isoform selectivity and inhaled administration <b>10</b> has a promising future. The other two nonpropeller compounds in development, <b>6</b> and <b>12</b>, are both less selective against one or two of the other isoforms. It remains to be seen how this will affect tolerability in patients; to date, only a single study for <b>6</b> has been reported. The compound is only developed for cancer. Other nonpropeller classes have been extensively worked on and patented during the past 6 years; however, isoform selectivity has been a challenge, and this may be a block to further progress.</div><div class="NLM_p">The field of PI3Kγ inhibition has been revolutionized in the past few years with some genuinely selective molecules; in spite of this, much of the biological validation of the target has used tool compounds of questionable selectivity. The difficulty of obtaining isoform selectivity was highlighted by a publication detailing extensive optimization of a series that ultimately yielded only modest selectivity for PI3Kγ (<b>136</b>, 60-, 10-, 14-fold, respectively, against PI3Kα, β, δ <a onclick="showRef(event, 'ref210'); return false;" href="javascript:void(0);" class="ref ref210">(210)</a>). The trailblazer compound <b>14</b> provided the first truly isoform selective PI3Kγ inhibitor with greater than 200-fold selectivity against the other three isoforms and is progressing in clinical trials in the oncology setting.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> An even more selective PI3Kγ inhibitor (<b>139</b>) has been disclosed recently with 350-fold selectivity against PI3Kδ and greater than 1000-fold against PI3Kα and β.<a onclick="showRef(event, 'ref199'); return false;" href="javascript:void(0);" class="ref ref199">(199)</a> These two latter compounds provide greatly improved tools for study of the role of the PI3Kγ isoform in inflammatory models and disease.</div><div class="NLM_p">PI3Kγδ dual inhibition has potential to provide a broader effect than inhibition of either single isoform alone;<a onclick="showRef(event, 'ref217'); return false;" href="javascript:void(0);" class="ref ref217">(217)</a> however the challenges of selectivity are at least as great as for a compound targeting a single isoform and are on top of the difficulty of balancing activity at two isoforms with all the other requirements for any compound to become a drug. Any undesired mechanism-based side effects from inhibition of either isoform will be a potential issue. How many genuinely dual inhibitors have been identified remains to be seen, as it is often not clear from patents what the actual balance of selectivity is. Few papers provide details of biological or clinical studies using dual inhibitors,<a onclick="showRef(event, 'ref58 ref88 ref214'); return false;" href="javascript:void(0);" class="ref ref58 ref88 ref214">(58,88,214)</a> mostly using <b>15</b> as the inhibitor. Direct evidence for an advantage of dual inhibition over a single isoform is extremely limited.<a onclick="showRef(event, 'ref218'); return false;" href="javascript:void(0);" class="ref ref218">(218)</a> The field of dual inhibition thus represents an area that remains significantly open for further work.</div><div class="NLM_p last">Despite the progress made in developing inhibitors of PI3Kγ and δ, the limitations of the current most advanced compounds mean that the full potential of this class of drugs is yet to be revealed, particularly for inflammatory conditions. Whether it will be possible for a safe and effective PI3Kγ, or δ, let alone γδ, inhibitor to be launched for widespread use in inflammatory conditions remains an open question.</div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i58"><a href="/doi/suppl/10.1021/acs.jmedchem.8b01298" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64517" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64517" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b01298" class="ext-link">10.1021/acs.jmedchem.8b01298</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">List of patents (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01298/suppl_file/jm8b01298_si_001.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01298/suppl_file/jm8b01298_si_001.pdf">jm8b01298_si_001.pdf (484.83 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b01298" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50766" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50766" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew W. D. Perry</span> - <span class="hlFld-Affiliation affiliation">Respiratory,
Inflammation & Autoimmunity, , , and , AstraZeneca Gothenburg, Mölndal SE-431
83, Sweden</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9799-0746" title="Orcid link">http://orcid.org/0000-0002-9799-0746</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#9ef3ffeaeaf6fbe9b0eefbecece7deffedeaecffe4fbf0fbfdffb0fdf1f3"><span class="__cf_email__" data-cfemail="214c4055554944560f51445353586140525553405b444f4442400f424e4c">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Raolat Abdulai</span> - <span class="hlFld-Affiliation affiliation">Respiratory,
Inflammation & Autoimmunity Translational Medicine Unit, Early
Clinical Development, IMED Biotech Unit, AstraZeneca, Boston, Massachusetts 02451, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Brigham
and Women’s Hospital, Boston, Massachusetts 02115, United States</span>; 
    <span>Present Address:
                        R.A.: Sanofi US, 640 Memorial Drive, Cambridge, MA 02139, USA</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mickael Mogemark</span> - <span class="hlFld-Affiliation affiliation">Drug Safety and Metabolism, , , and , AstraZeneca Gothenburg, Mölndal SE-431
83, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jens Petersen</span> - <span class="hlFld-Affiliation affiliation">Discovery Sciences,
IMED Biotech Unit, , , and , AstraZeneca Gothenburg, Mölndal SE-431
83, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew J. Thomas</span> - <span class="hlFld-Affiliation affiliation">Respiratory,
Inflammation & Autoimmunity, , , and , AstraZeneca Gothenburg, Mölndal SE-431
83, Sweden</span>; 
    <span>Present Address:
                        M.J.T.: Department of Immunology and Respiratory Diseases Research Germany, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Strasse 65, 88397 Biberach an der Riss, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Barbara Valastro</span> - <span class="hlFld-Affiliation affiliation">Respiratory, Inflammation
& Autoimmunity Translational Medicine Unit, Early Clinical Development, , , and , AstraZeneca Gothenburg, Mölndal SE-431
83, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Annika Westin Eriksson</span> - <span class="hlFld-Affiliation affiliation">Drug Safety and Metabolism, , , and , AstraZeneca Gothenburg, Mölndal SE-431
83, Sweden</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): All authors were employees and/or shareholders of AstraZeneca when this work was written. M.W.D.P., M.M., and J.P. are inventors of patents assigned to AstraZeneca covering inhibitors of PI3Ks.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38636" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38636" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Matthew W. D. Perry</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01298&amp;id=BIO-d7e7008-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Matthew W. D. Perry</b> is a Medicinal Chemist at AstraZeneca Gothenburg, where he has spent the past 7 years. He has a long history in medicinal chemistry, having started his career with Fisons in Loughborough, U.K., in 1988, staying at that site through changes in ownership to Astra and then AstraZeneca before moving to Sweden. His career has been spent working in the areas of immunological and respiratory conditions, particularly immunomodulatory approaches to treating asthma. He studied chemistry at Oxford University, staying on to do a D.Phil. with Professor J. E. Baldwin. He had postdoctoral positions in Belgium and the U.S. prior to beginning his industrial career.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Raolat Abdulai</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01298&amp;id=BIO-d7e7013-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Raolat Abdulai</b> is a physician and biomedical informatician. Dr. Abdulai is a medical director at AstraZeneca. She earned her M.D. at Howard University in Washington, DC. From 2010 to 2013, she completed a residency at the Mayo Clinic. She then completed a fellowship in the Harvard/Brigham and Women’s Hospital Pulmonary and Critical Care program. She is currently Associate Physician at Brigham and Women’s Hospital. During her fellowship, she completed a Masters of Medical Science in Biomedical Informatics at Harvard Medical School. Her research interests include immunology in respiratory diseases, muscle dysfunction in COPD, and drug development informatics.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Mickael Mogemark</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01298&amp;id=BIO-d7e7018-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Mickael Mogemark</b> is a medicinal chemist/chemical toxicologist at AstraZeneca Gothenburg. He was awarded his Ph.D. in chemistry from Umeå University, Sweden, in January 2005. He joined AstraZeneca as a medicinal chemist in 2004 where he has worked across several therapy areas. His research interests are focused on chemical toxicology and on the development of novel therapeutic agents, especially in the field of kinase inhibitors.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Jens Petersen</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01298&amp;id=BIO-d7e7023-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Jens Petersen</b> is an Associate Principal Scientist and structural biologist from AstraZeneca in Gothenburg. He graduated from the University of Copenhagen where he was involved in establishing the first group in X-ray crystallography and carried out structural studies on plant peroxidases. He did his postdoc with Prof Michael N. G. James at the University of Alberta where he carried out studies on viral proteases and protease inhibitors. Since 1999 he has been working within the Structure, Biophysics and Fragments Department in AstraZeneca in Gothenburg. He is an expert within structural biology and structure based drug design with specific target class expertise within nuclear hormone receptors, proteases, and lipid kinases. He has coauthored more than 30 papers, patents, posters, and presentations.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Matthew J. Thomas</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01298&amp;id=BIO-d7e7028-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Matthew J. Thomas</b> gained a Ph.D. in immunology in 2000 at Kings College, London, then moved into respiratory drug discovery at Novartis, U.K., in 2001. In 2014, he moved to AstraZeneca, and in 2018 he moved on to Boehringer Ingelheim, where he now leads Exploratory Innovation in Respiratory Research. He has specialized in respiratory diseases, including pulmonary arterial hypertension, idiopathic pulmonary fibrosis, cystic fibrosis, severe asthma, and chronic obstructive pulmonary disease. His drug discovery experience ranges from target finding, pathways investigation, and pathophysiology to translational preclinical systems/biomarkers and the route into patients. His current focus is on effective pulmonary repair and regenerative biology in chronic lung disease. He is a Visiting Professor at Bath University, which enables him to lecture/tutor/supervise the next generation of scientists.</p></figure></div><div class="bio" rid="ath6"><figure id="ath6" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Barbara Valastro</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01298&amp;id=BIO-d7e7033-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Barbara Valastro</b> obtained a Ph.D. in pharmacology from the University of Montréal (Canada) in 2003 followed by a postdoctoral training at Lund University (2004–2006). Between 2006 and 2012, she held several positions from CRO manager to director of in vitro screening at Merz Pharmaceutical GmbH in Frankfurt am Main (Germany), where she coordinated early screening activities for different CNS-related drug projects and outsourced preclinical activities. Since joining AstraZeneca in 2012, Barbara has led in vitro teams, been involved in drug discovery projects across different therapeutic areas, and been part of strategic initiatives. She is currently Director of Scientific Project Management in the Early Clinical Development IMED Biotech Unit at AstraZeneca in Sweden.</p></figure></div><div class="bio" rid="ath7"><figure id="ath7" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Annika Westin Eriksson</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01298&amp;id=BIO-d7e7038-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Annika Westin Eriksson</b> received her B.Sc. in biomedical science from the University of Gothenburg in 1994. When joining AstraZeneca in 1991, she performed efficacy studies and has broad knowledge in the cardiovascular field, vessel biology, and atherosclerosis. Annika moved into safety assessment in 2002 holding a position as Project Safety Pharmacologist for 10 years which included delivery of preclinical regulatory studies and writing parts of high level documents for regulatory submissions. In her present role at AstraZeneca as Discovery Safety Specialist, Annika acts as safety lead in discovery projects designing project-specific strategies to predict, assess, and mitigate target- and chemistry-related safety risks. During her 27 years in the pharmaceutical industry she has gained experience in work from target selection to end of phase II.</p></figure></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i69">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21845" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21845" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Werngard Czechtizky for her critical reading of the manuscript and insightful suggestions.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AE</td><td class="NLM_def"><p class="first last">adverse effect</p></td></tr><tr><td class="NLM_term">b.i.d.</td><td class="NLM_def"><p class="first last">twice daily</p></td></tr><tr><td class="NLM_term">q.d.</td><td class="NLM_def"><p class="first last">once daily</p></td></tr><tr><td class="NLM_term">ALT</td><td class="NLM_def"><p class="first last">alanine aminotransferase</p></td></tr><tr><td class="NLM_term">AST</td><td class="NLM_def"><p class="first last">aspartate aminotransferase</p></td></tr><tr><td class="NLM_term">BAL</td><td class="NLM_def"><p class="first last">bronchioalveolar lavage</p></td></tr><tr><td class="NLM_term">CLL</td><td class="NLM_def"><p class="first last">chronic lymphoctic lymphoma</p></td></tr><tr><td class="NLM_term">COPD</td><td class="NLM_def"><p class="first last">chronic obstructive pulmonary disease</p></td></tr><tr><td class="NLM_term">KLH</td><td class="NLM_def"><p class="first last">keyhole limpet hemocyanin</p></td></tr><tr><td class="NLM_term">i.n.</td><td class="NLM_def"><p class="first last">intranasal</p></td></tr><tr><td class="NLM_term">i.t.</td><td class="NLM_def"><p class="first last">intratracheal administration</p></td></tr><tr><td class="NLM_term">LPS</td><td class="NLM_def"><p class="first last">lipopolysaccharide</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">po</td><td class="NLM_def"><p class="first last">oral administration</p></td></tr><tr><td class="NLM_term">RA</td><td class="NLM_def"><p class="first last">rheumatoid arthritis</p></td></tr><tr><td class="NLM_term">SAE</td><td class="NLM_def"><p class="first last">severe adverse effect</p></td></tr><tr><td class="NLM_term">SLL</td><td class="NLM_def"><p class="first last">small lymphocytic lymphoma</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i71">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15610" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15610" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 218 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cushing, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metz, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittington, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGee, L. R.</span></span> <span> </span><span class="NLM_article-title">PI3Kδ and PI3Kγ as Targets for Autoimmune and Inflammatory Diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">8559</span>– <span class="NLM_lpage">8581</span>, <span class="refDoi"> DOI: 10.1021/jm300847w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300847w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1KjsrjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8559-8581&issue=20&author=T.+D.+Cushingauthor=D.+P.+Metzauthor=D.+A.+Whittingtonauthor=L.+R.+McGee&title=PI3K%CE%B4+and+PI3K%CE%B3+as+Targets+for+Autoimmune+and+Inflammatory+Diseases&doi=10.1021%2Fjm300847w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">PI3Kδ and PI3Kγ as Targets for Autoimmune and Inflammatory Diseases</span></div><div class="casAuthors">Cushing, Timothy D.; Metz, Daniela P.; Whittington, Douglas A.; McGee, Lawrence R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8559-8581</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Targeting signaling mols. that are required for the activation of multiple immune cells may be a more likely route to success in combating chronic, immune cell-mediated diseases (such as rheumatoid arthritis, systemic lupus erythematosus, and asthma).  This review will highlight two such signaling mols., the related lipid kinases, class I PI3K (phosphoinositide 3-kinase) δ and γ, both of which are primarily expressed in leukocytes and seem to play important roles in their function and activation.  This review will compare and contrast these two kinases as targets for autoimmune and inflammatory diseases and summarize efforts toward the development of small mol. inhibitors of PI3Kδ and PI3Kγ.  Phosphoinositides (PIs) act as second messengers in a wide variety of cellular roles including signal transduction, control of membrane trafficking and transport, cytoskeleton organization, cell survival and death, among many other functions.  The target of PI3K kinase activity is the phosphoinositides within cell membranes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMqItqgMiGp7Vg90H21EOLACvtfcHk0ljiD3vRJ46yvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1KjsrjL&md5=76fc05c3bf303174add4aca98f526f8f</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fjm300847w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300847w%26sid%3Dliteratum%253Aachs%26aulast%3DCushing%26aufirst%3DT.%2BD.%26aulast%3DMetz%26aufirst%3DD.%2BP.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DMcGee%26aufirst%3DL.%2BR.%26atitle%3DPI3K%25CE%25B4%2520and%2520PI3K%25CE%25B3%2520as%2520Targets%2520for%2520Autoimmune%2520and%2520Inflammatory%2520Diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D20%26spage%3D8559%26epage%3D8581%26doi%3D10.1021%2Fjm300847w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wymann, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirola, L.</span></span> <span> </span><span class="NLM_article-title">Structure and Function of Phosphoinositide 3-Kinases</span>. <i>Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>1436</i></span> (<span class="NLM_issue">1–2</span>),  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">150</span>, <span class="refDoi"> DOI: 10.1016/S0005-2760(98)00139-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2FS0005-2760%2898%2900139-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=9838078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADyaK1cXns1Klur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1436&publication_year=1998&pages=127-150&issue=1%E2%80%932&author=M.+P.+Wymannauthor=L.+Pirola&title=Structure+and+Function+of+Phosphoinositide+3-Kinases&doi=10.1016%2FS0005-2760%2898%2900139-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of phosphoinositide 3-kinases</span></div><div class="casAuthors">Wymann, Matthias P.; Pirola, Luciano</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">1436</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">127-150</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review with 311 refs.  Phosphoinositide kinases (PI3Ks) play an important role in mitogenic signaling and cell survival, cytoskeletal remodeling, metabolic control, and vesicular trafficking.  Here, the authors summarize structure-function relations delineating the activation process of class I PI3Ks involving various domains of adapter subunits, Ras, and interacting proteins.  The resulting product, phosphatidylinositol (PtdIns) 3,4,5-bisphosphate, targets Akt/protein kinase B (PKB), Bruton's tyrosine kinase (Btk), phosphoinositide-dependent kinases (PDK), integrin-linked kinase (ILK), atypical protein kinases C (PKC), phosphatidylinositol phospholipase Cγ, and more.  Surface receptor-activated PI3Ks function in mammals, insects, nematodes, and slime mold, but not yeast.  Whereas many members of the class II family have been identified and characterized biochem., it is presently unknown how these C2-domain contg. PI3Ks are activated, and which PI substrate they phosphorylate in vivo.  PtdIns 3-phosphate is produced by Vps34p/class III PI3Ks and operates via the PtdIns 3-phosphate-binding proteins, early endosomal antigen (EEA1) and yeast Vac1p, Vps27p, and Pip1p, in lysosomal protein targeting.  Besides the prodn. of D3 phosphorylated lipids, PI3Ks have an intrinsic protein kinase activity.  For trimeric GTP-binding protein-activated PI3Kγ, protein kinase activity seems to be sufficient to trigger mitogen-activated protein kinase (MAPK).  Recent disruption of PI3K genes in the slime mold, Caenorhabditis elegans, Drosophila melanogaster, and mice further underlines the importance of PI3K signaling systems and elucidates the role of PI3K signaling in multicellular organisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuKz1Hg1qwhLVg90H21EOLACvtfcHk0lhyyomQq-zXPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXns1Klur8%253D&md5=b93d9a7245d3d09b6a3a938cceedc1c2</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0005-2760%2898%2900139-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0005-2760%252898%252900139-8%26sid%3Dliteratum%253Aachs%26aulast%3DWymann%26aufirst%3DM.%2BP.%26aulast%3DPirola%26aufirst%3DL.%26atitle%3DStructure%2520and%2520Function%2520of%2520Phosphoinositide%25203-Kinases%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D1998%26volume%3D1436%26issue%3D1%25E2%2580%25932%26spage%3D127%26epage%3D150%26doi%3D10.1016%2FS0005-2760%2898%2900139-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stephens, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, P. T.</span></span> <span> </span><span class="NLM_article-title">Agonist-Stimulated Synthesis of Phosphatidylinositol(3,4,5)-Trisphosphate: A New Intracellular Signalling System?</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>1179</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">75</span>, <span class="refDoi"> DOI: 10.1016/0167-4889(93)90072-W</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2F0167-4889%2893%2990072-W" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=8399352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADyaK2cXitlKltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1179&publication_year=1993&pages=27-75&issue=1&author=L.+R.+Stephensauthor=T.+R.+Jacksonauthor=P.+T.+Hawkins&title=Agonist-Stimulated+Synthesis+of+Phosphatidylinositol%283%2C4%2C5%29-Trisphosphate%3A+A+New+Intracellular+Signalling+System%3F&doi=10.1016%2F0167-4889%2893%2990072-W"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Agonist-stimulated synthesis of phosphatidylinositol(3,4,5)-trisphosphate: a new intracellular signalling system?</span></div><div class="casAuthors">Stephens, L. R.; Jackson, T. R.; Hawkins, P. T.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">1179</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-75</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review, with 348 refs., of the metab. and functions of the family of membrane phospholipids, the 3-phosphorylated phosphoinositides.  The integration of these phosphorylated phosphoinositides in the signal transduction pathways for receptors (e.g. those activated by cytokines, growth factors, small hormones, and antigens) is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQHYu3stFDt7Vg90H21EOLACvtfcHk0lhyyomQq-zXPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitlKltg%253D%253D&md5=e54e47e570cc96df6b38794dcaabb818</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2F0167-4889%2893%2990072-W&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0167-4889%252893%252990072-W%26sid%3Dliteratum%253Aachs%26aulast%3DStephens%26aufirst%3DL.%2BR.%26aulast%3DJackson%26aufirst%3DT.%2BR.%26aulast%3DHawkins%26aufirst%3DP.%2BT.%26atitle%3DAgonist-Stimulated%2520Synthesis%2520of%2520Phosphatidylinositol%25283%252C4%252C5%2529-Trisphosphate%253A%2520A%2520New%2520Intracellular%2520Signalling%2520System%253F%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D1993%26volume%3D1179%26issue%3D1%26spage%3D27%26epage%3D75%26doi%3D10.1016%2F0167-4889%2893%2990072-W" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cantley, L. C.</span></span> <span> </span><span class="NLM_article-title">The Phosphoinositide 3-Kinase Pathway</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>296</i></span> (<span class="NLM_issue">5573</span>),  <span class="NLM_fpage">1655</span>– <span class="NLM_lpage">1657</span>, <span class="refDoi"> DOI: 10.1126/science.296.5573.1655</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1126%2Fscience.296.5573.1655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=12040186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BD38XktlChu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=1655-1657&issue=5573&author=L.+C.+Cantley&title=The+Phosphoinositide+3-Kinase+Pathway&doi=10.1126%2Fscience.296.5573.1655"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The phosphoinositide 3-kinase pathway</span></div><div class="casAuthors">Cantley, Lewis C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue">5573</span>),
    <span class="NLM_cas:pages">1655-1657</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review with 8 refs.  Phosphorylated lipids are produced at cellular membranes during signaling events and contribute to the recruitment and activation of various signaling components.  The role of phosphoinositide 3-kinase (PI3K), which catalyzes the prodn. of phosphatidylinositol 3,4,5-trisphosphate, in cell survival pathways; the regulation of gene expression and cell metab.; and cytoskeletal rearrangements are highlighted.  The PI3K pathway is implicated in human diseases including diabetes and cancer, and understanding the intricacies of this pathway may provide new avenues for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9pxSplxmS1rVg90H21EOLACvtfcHk0lhyyomQq-zXPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktlChu7s%253D&md5=110c8a351448aed6ab938b9ccf90a655</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscience.296.5573.1655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.296.5573.1655%26sid%3Dliteratum%253Aachs%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DThe%2520Phosphoinositide%25203-Kinase%2520Pathway%26jtitle%3DScience%26date%3D2002%26volume%3D296%26issue%3D5573%26spage%3D1655%26epage%3D1657%26doi%3D10.1126%2Fscience.296.5573.1655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suire, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coadwell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephens, L.</span></span> <span> </span><span class="NLM_article-title">p84, a New Gβγ-Activated Regulatory Subunit of the Type IB Phosphoinositide 3-Kinase p110γ</span>. <i>Curr. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">566</span>– <span class="NLM_lpage">570</span>, <span class="refDoi"> DOI: 10.1016/j.cub.2005.02.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.cub.2005.02.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=15797027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BD2MXis1Kmtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=566-570&issue=6&author=S.+Suireauthor=J.+Coadwellauthor=G.+J.+Fergusonauthor=K.+Davidsonauthor=P.+Hawkinsauthor=L.+Stephens&title=p84%2C+a+New+G%CE%B2%CE%B3-Activated+Regulatory+Subunit+of+the+Type+IB+Phosphoinositide+3-Kinase+p110%CE%B3&doi=10.1016%2Fj.cub.2005.02.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">p84, a New Gβγ-Activated Regulatory Subunit of the Type IB Phosphoinositide 3-Kinase p110γ</span></div><div class="casAuthors">Suire, Sabine; Coadwell, John; Ferguson, G. John; Davidson, Keith; Hawkins, Phillip; Stephens, Len</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">566-570</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: A variety of genetic and inhibitor studies have shown that phosphoinositide 3-kinase γ (PI3Kγ) plays an essential role in a no. of physiol. responses, including neutrophil chemotaxis, mast cell degranulation, and cardiac function.  PI3Kγ is currently thought to be composed of a p110γ catalytic subunit and a single regulatory subunit, p101.  The binding of p110γ to p101 dramatically increases the activation of the complex by Gβγ subunits and, hence, is thought to be crit. for the coupling of PI3Kγ to G protein coupled receptors.  Here, we characterize a new regulatory subunit for PI3Kγ.  P84 is present in human, mouse, chicken, frog, and fugu genomes and is located beside the p101 locus.  It is broadly expressed in cells of the murine immune system.  Both recombinant and endogenous p84 bind p110γ specifically and with high affinity.  Binding of p84 to p110γ substantially increases the ability of Gβγ to stimulate phosphatidylinositol (3,4,5)-trisphosphate (PtdIns(3,4,5)P3) prodn. both in vitro and in vivo.  However, the p84/p110γ heterodimer is approx. 4-fold less sensitive to Gβγs than p101/p110γ.  Endogenous murine p84 expression is substantially reduced in the absence of p110γ expression.  We conclude that p110γ has two potential regulatory subunits in vivo, p84 and p101.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQGpd-AMWRvrVg90H21EOLACvtfcHk0ljAqODgP9pOug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXis1Kmtb8%253D&md5=24a5c9e85ff28c30a4bc128478dd9df3</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2005.02.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2005.02.020%26sid%3Dliteratum%253Aachs%26aulast%3DSuire%26aufirst%3DS.%26aulast%3DCoadwell%26aufirst%3DJ.%26aulast%3DFerguson%26aufirst%3DG.%2BJ.%26aulast%3DDavidson%26aufirst%3DK.%26aulast%3DHawkins%26aufirst%3DP.%26aulast%3DStephens%26aufirst%3DL.%26atitle%3Dp84%252C%2520a%2520New%2520G%25CE%25B2%25CE%25B3-Activated%2520Regulatory%2520Subunit%2520of%2520the%2520Type%2520IB%2520Phosphoinositide%25203-Kinase%2520p110%25CE%25B3%26jtitle%3DCurr.%2520Biol.%26date%3D2005%26volume%3D15%26issue%3D6%26spage%3D566%26epage%3D570%26doi%3D10.1016%2Fj.cub.2005.02.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katanaev, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garlanda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azzolino, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirola, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silengo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sozzani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantovani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altruda, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wymann, M. P.</span></span> <span> </span><span class="NLM_article-title">Central Role for G Protein-Coupled Phosphoinositide 3-Kinase Gamma in Inflammation</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>287</i></span> (<span class="NLM_issue">5455</span>),  <span class="NLM_fpage">1049</span>– <span class="NLM_lpage">1053</span>, <span class="refDoi"> DOI: 10.1126/science.287.5455.1049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1126%2Fscience.287.5455.1049" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2000&pages=1049-1053&issue=5455&author=E.+Hirschauthor=V.+L.+Katanaevauthor=C.+Garlandaauthor=O.+Azzolinoauthor=L.+Pirolaauthor=L.+Silengoauthor=S.+Sozzaniauthor=A.+Mantovaniauthor=F.+Altrudaauthor=M.+P.+Wymann&title=Central+Role+for+G+Protein-Coupled+Phosphoinositide+3-Kinase+Gamma+in+Inflammation&doi=10.1126%2Fscience.287.5455.1049"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1126%2Fscience.287.5455.1049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.287.5455.1049%26sid%3Dliteratum%253Aachs%26aulast%3DHirsch%26aufirst%3DE.%26aulast%3DKatanaev%26aufirst%3DV.%2BL.%26aulast%3DGarlanda%26aufirst%3DC.%26aulast%3DAzzolino%26aufirst%3DO.%26aulast%3DPirola%26aufirst%3DL.%26aulast%3DSilengo%26aufirst%3DL.%26aulast%3DSozzani%26aufirst%3DS.%26aulast%3DMantovani%26aufirst%3DA.%26aulast%3DAltruda%26aufirst%3DF.%26aulast%3DWymann%26aufirst%3DM.%2BP.%26atitle%3DCentral%2520Role%2520for%2520G%2520Protein-Coupled%2520Phosphoinositide%25203-Kinase%2520Gamma%2520in%2520Inflammation%26jtitle%3DScience%26date%3D2000%26volume%3D287%26issue%3D5455%26spage%3D1049%26epage%3D1053%26doi%3D10.1126%2Fscience.287.5455.1049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghigo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perino, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zahradníková, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morello, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolaev, V. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damilano, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cimino, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Luca, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westenbroek, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catterall, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandecasteele, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischmeister, R.</span></span> <span> </span><span class="NLM_article-title">Phosphoinositide 3-Kinase γ Protects against Catecholamine-Induced Ventricular Arrhythmia through Protein Kinase A-Mediated Regulation of Distinct Phosphodiesterases</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>126</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">2073</span>– <span class="NLM_lpage">2083</span>, <span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.112.114074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1161%2FCIRCULATIONAHA.112.114074" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2012&pages=2073-2083&issue=17&author=A.+Ghigoauthor=A.+Perinoauthor=H.+Mehelauthor=A.+Zahradn%C3%ADkov%C3%A1author=F.+Morelloauthor=J.+Leroyauthor=V.+O.+Nikolaevauthor=F.+Damilanoauthor=J.+Ciminoauthor=E.+De+Lucaauthor=W.+Richterauthor=R.+Westenbroekauthor=W.+A.+Catterallauthor=J.+Zhangauthor=C.+Yanauthor=M.+Contiauthor=A.+M.+Gomezauthor=G.+Vandecasteeleauthor=E.+Hirschauthor=R.+Fischmeister&title=Phosphoinositide+3-Kinase+%CE%B3+Protects+against+Catecholamine-Induced+Ventricular+Arrhythmia+through+Protein+Kinase+A-Mediated+Regulation+of+Distinct+Phosphodiesterases&doi=10.1161%2FCIRCULATIONAHA.112.114074"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.112.114074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.112.114074%26sid%3Dliteratum%253Aachs%26aulast%3DGhigo%26aufirst%3DA.%26aulast%3DPerino%26aufirst%3DA.%26aulast%3DMehel%26aufirst%3DH.%26aulast%3DZahradn%25C3%25ADkov%25C3%25A1%26aufirst%3DA.%26aulast%3DMorello%26aufirst%3DF.%26aulast%3DLeroy%26aufirst%3DJ.%26aulast%3DNikolaev%26aufirst%3DV.%2BO.%26aulast%3DDamilano%26aufirst%3DF.%26aulast%3DCimino%26aufirst%3DJ.%26aulast%3DDe%2BLuca%26aufirst%3DE.%26aulast%3DRichter%26aufirst%3DW.%26aulast%3DWestenbroek%26aufirst%3DR.%26aulast%3DCatterall%26aufirst%3DW.%2BA.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DC.%26aulast%3DConti%26aufirst%3DM.%26aulast%3DGomez%26aufirst%3DA.%2BM.%26aulast%3DVandecasteele%26aufirst%3DG.%26aulast%3DHirsch%26aufirst%3DE.%26aulast%3DFischmeister%26aufirst%3DR.%26atitle%3DPhosphoinositide%25203-Kinase%2520%25CE%25B3%2520Protects%2520against%2520Catecholamine-Induced%2520Ventricular%2520Arrhythmia%2520through%2520Protein%2520Kinase%2520A-Mediated%2520Regulation%2520of%2520Distinct%2520Phosphodiesterases%26jtitle%3DCirculation%26date%3D2012%26volume%3D126%26issue%3D17%26spage%3D2073%26epage%3D2083%26doi%3D10.1161%2FCIRCULATIONAHA.112.114074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gili, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fruciano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korfei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fagone, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iemmolo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo Furno, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giuffrida, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crimi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guenther, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vancheri, C.</span></span> <span> </span><span class="NLM_article-title">PI3K p110γ Overexpression in Idiopathic Pulmonary Fibrosis Lung Tissue and Fibroblast Cells: In Vitro Effects of Its Inhibition</span>. <i>Lab. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>93</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">566</span>– <span class="NLM_lpage">576</span>, <span class="refDoi"> DOI: 10.1038/labinvest.2013.6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1038%2Flabinvest.2013.6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2013&pages=566-576&issue=5&author=E.+Conteauthor=E.+Giliauthor=M.+Frucianoauthor=M.+Korfeiauthor=E.+Fagoneauthor=M.+Iemmoloauthor=D.+Lo+Furnoauthor=R.+Giuffridaauthor=N.+Crimiauthor=A.+Guentherauthor=C.+Vancheri&title=PI3K+p110%CE%B3+Overexpression+in+Idiopathic+Pulmonary+Fibrosis+Lung+Tissue+and+Fibroblast+Cells%3A+In+Vitro+Effects+of+Its+Inhibition&doi=10.1038%2Flabinvest.2013.6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Flabinvest.2013.6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Flabinvest.2013.6%26sid%3Dliteratum%253Aachs%26aulast%3DConte%26aufirst%3DE.%26aulast%3DGili%26aufirst%3DE.%26aulast%3DFruciano%26aufirst%3DM.%26aulast%3DKorfei%26aufirst%3DM.%26aulast%3DFagone%26aufirst%3DE.%26aulast%3DIemmolo%26aufirst%3DM.%26aulast%3DLo%2BFurno%26aufirst%3DD.%26aulast%3DGiuffrida%26aufirst%3DR.%26aulast%3DCrimi%26aufirst%3DN.%26aulast%3DGuenther%26aufirst%3DA.%26aulast%3DVancheri%26aufirst%3DC.%26atitle%3DPI3K%2520p110%25CE%25B3%2520Overexpression%2520in%2520Idiopathic%2520Pulmonary%2520Fibrosis%2520Lung%2520Tissue%2520and%2520Fibroblast%2520Cells%253A%2520In%2520Vitro%2520Effects%2520of%2520Its%2520Inhibition%26jtitle%3DLab.%2520Invest.%26date%3D2013%26volume%3D93%26issue%3D5%26spage%3D566%26epage%3D576%26doi%3D10.1038%2Flabinvest.2013.6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Becattini, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marone, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arsenijevic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seydoux, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montani, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dulloo, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorens, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preitner, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wymann, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solinas, G.</span></span> <span> </span><span class="NLM_article-title">PI3Kγ within a Nonhematopoietic Cell Type Negatively Regulates Diet-Induced Thermogenesis and Promotes Obesity and Insulin Resistance</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span> (<span class="NLM_issue">42</span>),  <span class="NLM_fpage">E854</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1073/pnas.1106698108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1073%2Fpnas.1106698108" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=E854-63&issue=42&author=B.+Becattiniauthor=R.+Maroneauthor=F.+Zaniauthor=D.+Arsenijevicauthor=J.+Seydouxauthor=J.-P.+Montaniauthor=A.+G.+Dullooauthor=B.+Thorensauthor=F.+Preitnerauthor=M.+P.+Wymannauthor=G.+Solinas&title=PI3K%CE%B3+within+a+Nonhematopoietic+Cell+Type+Negatively+Regulates+Diet-Induced+Thermogenesis+and+Promotes+Obesity+and+Insulin+Resistance&doi=10.1073%2Fpnas.1106698108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1106698108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1106698108%26sid%3Dliteratum%253Aachs%26aulast%3DBecattini%26aufirst%3DB.%26aulast%3DMarone%26aufirst%3DR.%26aulast%3DZani%26aufirst%3DF.%26aulast%3DArsenijevic%26aufirst%3DD.%26aulast%3DSeydoux%26aufirst%3DJ.%26aulast%3DMontani%26aufirst%3DJ.-P.%26aulast%3DDulloo%26aufirst%3DA.%2BG.%26aulast%3DThorens%26aufirst%3DB.%26aulast%3DPreitner%26aufirst%3DF.%26aulast%3DWymann%26aufirst%3DM.%2BP.%26aulast%3DSolinas%26aufirst%3DG.%26atitle%3DPI3K%25CE%25B3%2520within%2520a%2520Nonhematopoietic%2520Cell%2520Type%2520Negatively%2520Regulates%2520Diet-Induced%2520Thermogenesis%2520and%2520Promotes%2520Obesity%2520and%2520Insulin%2520Resistance%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26issue%3D42%26spage%3DE854%26epage%3D63%26doi%3D10.1073%2Fpnas.1106698108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolliputi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. C.</span></span> <span> </span><span class="NLM_article-title">Phosphoinositide 3-Kinase-δ Regulates Fungus-Induced Allergic Lung Inflammation through Endoplasmic Reticulum Stress</span>. <i>Thorax</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>71</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">52</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1136/thoraxjnl-2015-207096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1136%2Fthoraxjnl-2015-207096" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2016&pages=52-63&issue=1&author=K.+S.+Leeauthor=J.+S.+Jeongauthor=S.+R.+Kimauthor=S.+H.+Choauthor=N.+Kolliputiauthor=Y.+H.+Koauthor=K.+B.+Leeauthor=S.+C.+Parkauthor=H.+J.+Parkauthor=Y.+C.+Lee&title=Phosphoinositide+3-Kinase-%CE%B4+Regulates+Fungus-Induced+Allergic+Lung+Inflammation+through+Endoplasmic+Reticulum+Stress&doi=10.1136%2Fthoraxjnl-2015-207096"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1136%2Fthoraxjnl-2015-207096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fthoraxjnl-2015-207096%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%2BS.%26aulast%3DJeong%26aufirst%3DJ.%2BS.%26aulast%3DKim%26aufirst%3DS.%2BR.%26aulast%3DCho%26aufirst%3DS.%2BH.%26aulast%3DKolliputi%26aufirst%3DN.%26aulast%3DKo%26aufirst%3DY.%2BH.%26aulast%3DLee%26aufirst%3DK.%2BB.%26aulast%3DPark%26aufirst%3DS.%2BC.%26aulast%3DPark%26aufirst%3DH.%2BJ.%26aulast%3DLee%26aufirst%3DY.%2BC.%26atitle%3DPhosphoinositide%25203-Kinase-%25CE%25B4%2520Regulates%2520Fungus-Induced%2520Allergic%2520Lung%2520Inflammation%2520through%2520Endoplasmic%2520Reticulum%2520Stress%26jtitle%3DThorax%26date%3D2016%26volume%3D71%26issue%3D1%26spage%3D52%26epage%3D63%26doi%3D10.1136%2Fthoraxjnl-2015-207096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koziol-White, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papanikolaou, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pushkarsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Himes, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damoiseaux, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liggett, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Carlo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurten, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panettieri, R. A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of PI3K Promotes Dilation of Human Small Airways in a Rho Kinase-Dependent Manner</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>173</i></span>,  <span class="NLM_fpage">2726</span>– <span class="NLM_lpage">2738</span>, <span class="refDoi"> DOI: 10.1111/bph.13542</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1111%2Fbph.13542" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=27352269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1ygtL%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2016&pages=2726-2738&author=C.+J.+Koziol-Whiteauthor=E.+J.+Yooauthor=G.+Caoauthor=J.+Zhangauthor=E.+Papanikolaouauthor=I.+Pushkarskyauthor=A.+Andrewsauthor=B.+E.+Himesauthor=R.+D.+Damoiseauxauthor=S.+B.+Liggettauthor=D.+Di+Carloauthor=R.+C.+Kurtenauthor=R.+A.+Panettieri&title=Inhibition+of+PI3K+Promotes+Dilation+of+Human+Small+Airways+in+a+Rho+Kinase-Dependent+Manner&doi=10.1111%2Fbph.13542"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of PI3K promotes dilation of human small airways in a rho kinase-dependent manner</span></div><div class="casAuthors">Koziol-White, Cynthia J.; Yoo, Edwin J.; Cao, Gaoyuan; Zhang, Jie; Papanikolaou, Eleni; Pushkarsky, Ivan; Andrews, Adam; Himes, Blanca E.; Damoiseaux, Robert D.; Liggett, Stephen B.; Di Carlo, Dino; Kurten, Richard C.; Panettieri, Reynold A., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2726-2738</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : Asthma manifests as a heterogeneous syndrome characterized by airway obstruction, inflammation and hyperresponsiveness (AHR).  Although the mol. mechanisms remain unclear, activation of specific PI3K isoforms mediate inflammation and AHR.  We aimed to det. whether inhibition of PI3Kδ evokes dilation of airways and to elucidate potential mechanisms.  Exptl. Approach : Human precision cut lung slices from non-asthma donors and primary human airway smooth muscle (HASM) cells from both non-asthma and asthma donors were utilized.  Phosphorylation of Akt, myosin phosphatase target subunit 1 (MYPT1) and myosin light chain (MLC) were assessed in HASM cells following either PI3K inhibitor or siRNA treatment.  HASM relaxation was assessed by micro-pattern deformation.  Reversal of constriction of airways was assessed following stimulation with PI3K or ROCK inhibitors.  Key Results : Sol. inhibitors or PI3Kδ knockdown reversed carbachol-induced constriction of human airways, relaxed agonist-contracted HASM and inhibited pAkt, pMYPT1 and pMLC in HASM.  Similarly, inhibition of Rho kinase also dilated human PCLS airways and suppressed pMYPT1 and pMLC.  Baseline pMYPT1 was significantly elevated in HASM cells derived from asthma donors in comparison with non-asthma donors.  After desensitization of the β2-adrenoceptors, a PI3Kδ inhibitor remained an effective dilator.  In the presence of IL-13, dilation by a β agonist, but not PI3K inhibitor, was attenuated.  Conclusion and Implications : PI3Kδ inhibitors act as dilators of human small airways.  Taken together, these findings provide alternative approaches to the clin. management of airway obstruction in asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOOSEc7OTND7Vg90H21EOLACvtfcHk0ljfMONzezZHVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1ygtL%252FF&md5=2120999fc20751655bba4f11faa6ace6</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1111%2Fbph.13542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.13542%26sid%3Dliteratum%253Aachs%26aulast%3DKoziol-White%26aufirst%3DC.%2BJ.%26aulast%3DYoo%26aufirst%3DE.%2BJ.%26aulast%3DCao%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DPapanikolaou%26aufirst%3DE.%26aulast%3DPushkarsky%26aufirst%3DI.%26aulast%3DAndrews%26aufirst%3DA.%26aulast%3DHimes%26aufirst%3DB.%2BE.%26aulast%3DDamoiseaux%26aufirst%3DR.%2BD.%26aulast%3DLiggett%26aufirst%3DS.%2BB.%26aulast%3DDi%2BCarlo%26aufirst%3DD.%26aulast%3DKurten%26aufirst%3DR.%2BC.%26aulast%3DPanettieri%26aufirst%3DR.%2BA.%26atitle%3DInhibition%2520of%2520PI3K%2520Promotes%2520Dilation%2520of%2520Human%2520Small%2520Airways%2520in%2520a%2520Rho%2520Kinase-Dependent%2520Manner%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2016%26volume%3D173%26spage%3D2726%26epage%3D2738%26doi%3D10.1111%2Fbph.13542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makondo, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, A. J.</span></span> <span> </span><span class="NLM_article-title">p110δ Phosphoinositide 3-Kinase Represses IgE Switch by Potentiating BCL6 Expression</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>188</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">3700</span>– <span class="NLM_lpage">3708</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1103302</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.4049%2Fjimmunol.1103302" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=188&publication_year=2012&pages=3700-3708&issue=8&author=T.+Zhangauthor=K.+J.+Makondoauthor=A.+J.+Marshall&title=p110%CE%B4+Phosphoinositide+3-Kinase+Represses+IgE+Switch+by+Potentiating+BCL6+Expression&doi=10.4049%2Fjimmunol.1103302"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1103302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1103302%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DMakondo%26aufirst%3DK.%2BJ.%26aulast%3DMarshall%26aufirst%3DA.%2BJ.%26atitle%3Dp110%25CE%25B4%2520Phosphoinositide%25203-Kinase%2520Represses%2520IgE%2520Switch%2520by%2520Potentiating%2520BCL6%2520Expression%26jtitle%3DJ.%2520Immunol.%26date%3D2012%26volume%3D188%26issue%3D8%26spage%3D3700%26epage%3D3708%26doi%3D10.4049%2Fjimmunol.1103302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avraamides, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dippold, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foubert, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellies, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acevedo, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manglicmot, J. R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrasidlo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blair, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ginsberg, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheresh, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Field, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varner, J. A.</span></span> <span> </span><span class="NLM_article-title">Receptor Tyrosine Kinases and TLR/IL1Rs Unexpectedly Activate Myeloid Cell PI3Kγ, a Single Convergent Point Promoting Tumor Inflammation and Progression</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">715</span>– <span class="NLM_lpage">727</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2011.04.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.ccr.2011.04.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=715-727&issue=6&author=M.+C.+Schmidauthor=C.+J.+Avraamidesauthor=H.+C.+Dippoldauthor=I.+Francoauthor=P.+Foubertauthor=L.+G.+Elliesauthor=L.+M.+Acevedoauthor=J.+R.+E.+Manglicmotauthor=X.+Songauthor=W.+Wrasidloauthor=S.+L.+Blairauthor=M.+H.+Ginsbergauthor=D.+A.+Chereshauthor=E.+Hirschauthor=S.+J.+Fieldauthor=J.+A.+Varner&title=Receptor+Tyrosine+Kinases+and+TLR%2FIL1Rs+Unexpectedly+Activate+Myeloid+Cell+PI3K%CE%B3%2C+a+Single+Convergent+Point+Promoting+Tumor+Inflammation+and+Progression&doi=10.1016%2Fj.ccr.2011.04.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2011.04.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2011.04.016%26sid%3Dliteratum%253Aachs%26aulast%3DSchmid%26aufirst%3DM.%2BC.%26aulast%3DAvraamides%26aufirst%3DC.%2BJ.%26aulast%3DDippold%26aufirst%3DH.%2BC.%26aulast%3DFranco%26aufirst%3DI.%26aulast%3DFoubert%26aufirst%3DP.%26aulast%3DEllies%26aufirst%3DL.%2BG.%26aulast%3DAcevedo%26aufirst%3DL.%2BM.%26aulast%3DManglicmot%26aufirst%3DJ.%2BR.%2BE.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DWrasidlo%26aufirst%3DW.%26aulast%3DBlair%26aufirst%3DS.%2BL.%26aulast%3DGinsberg%26aufirst%3DM.%2BH.%26aulast%3DCheresh%26aufirst%3DD.%2BA.%26aulast%3DHirsch%26aufirst%3DE.%26aulast%3DField%26aufirst%3DS.%2BJ.%26aulast%3DVarner%26aufirst%3DJ.%2BA.%26atitle%3DReceptor%2520Tyrosine%2520Kinases%2520and%2520TLR%252FIL1Rs%2520Unexpectedly%2520Activate%2520Myeloid%2520Cell%2520PI3K%25CE%25B3%252C%2520a%2520Single%2520Convergent%2520Point%2520Promoting%2520Tumor%2520Inflammation%2520and%2520Progression%26jtitle%3DCancer%2520Cell%26date%3D2011%26volume%3D19%26issue%3D6%26spage%3D715%26epage%3D727%26doi%3D10.1016%2Fj.ccr.2011.04.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okkenhaug, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burger, J. A.</span></span> <span> </span><span class="NLM_article-title">PI3K Signaling in Normal B Cells and Chronic Lymphocytic Leukemia (CLL)</span>. <i>Curr. Top. Microbiol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>393</i></span>,  <span class="NLM_fpage">123</span>– <span class="NLM_lpage">142</span>, <span class="refDoi"> DOI: 10.1007/82_2015_484</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1007%2F82_2015_484" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=393&publication_year=2015&pages=123-142&author=K.+Okkenhaugauthor=J.+A.+Burger&title=PI3K+Signaling+in+Normal+B+Cells+and+Chronic+Lymphocytic+Leukemia+%28CLL%29&doi=10.1007%2F82_2015_484"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1007%2F82_2015_484&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F82_2015_484%26sid%3Dliteratum%253Aachs%26aulast%3DOkkenhaug%26aufirst%3DK.%26aulast%3DBurger%26aufirst%3DJ.%2BA.%26atitle%3DPI3K%2520Signaling%2520in%2520Normal%2520B%2520Cells%2520and%2520Chronic%2520Lymphocytic%2520Leukemia%2520%2528CLL%2529%26jtitle%3DCurr.%2520Top.%2520Microbiol.%2520Immunol.%26date%3D2015%26volume%3D393%26spage%3D123%26epage%3D142%26doi%3D10.1007%2F82_2015_484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ali, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilancio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearce, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilfillan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tkaczyk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuehn, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giddings, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peskett, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruce, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawyer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okkenhaug, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanhaesebroeck, B.</span></span> <span> </span><span class="NLM_article-title">Essential Role for the p110δ Phosphoinositide 3-Kinase in the Allergic Response</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>431</i></span> (<span class="NLM_issue">7011</span>),  <span class="NLM_fpage">1007</span>– <span class="NLM_lpage">1011</span>, <span class="refDoi"> DOI: 10.1038/nature02991</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1038%2Fnature02991" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=431&publication_year=2004&pages=1007-1011&issue=7011&author=K.+Aliauthor=A.+Bilancioauthor=M.+Thomasauthor=W.+Pearceauthor=A.+M.+Gilfillanauthor=C.+Tkaczykauthor=N.+Kuehnauthor=A.+Grayauthor=J.+Giddingsauthor=E.+Peskettauthor=R.+Foxauthor=I.+Bruceauthor=C.+Walkerauthor=C.+Sawyerauthor=K.+Okkenhaugauthor=P.+Finanauthor=B.+Vanhaesebroeck&title=Essential+Role+for+the+p110%CE%B4+Phosphoinositide+3-Kinase+in+the+Allergic+Response&doi=10.1038%2Fnature02991"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnature02991&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02991%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DK.%26aulast%3DBilancio%26aufirst%3DA.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DPearce%26aufirst%3DW.%26aulast%3DGilfillan%26aufirst%3DA.%2BM.%26aulast%3DTkaczyk%26aufirst%3DC.%26aulast%3DKuehn%26aufirst%3DN.%26aulast%3DGray%26aufirst%3DA.%26aulast%3DGiddings%26aufirst%3DJ.%26aulast%3DPeskett%26aufirst%3DE.%26aulast%3DFox%26aufirst%3DR.%26aulast%3DBruce%26aufirst%3DI.%26aulast%3DWalker%26aufirst%3DC.%26aulast%3DSawyer%26aufirst%3DC.%26aulast%3DOkkenhaug%26aufirst%3DK.%26aulast%3DFinan%26aufirst%3DP.%26aulast%3DVanhaesebroeck%26aufirst%3DB.%26atitle%3DEssential%2520Role%2520for%2520the%2520p110%25CE%25B4%2520Phosphoinositide%25203-Kinase%2520in%2520the%2520Allergic%2520Response%26jtitle%3DNature%26date%3D2004%26volume%3D431%26issue%3D7011%26spage%3D1007%26epage%3D1011%26doi%3D10.1038%2Fnature02991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Collmann, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohnacker, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marone, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stringer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krombach, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkhart, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollingworth, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wymann, M. P.</span></span> <span> </span><span class="NLM_article-title">Transient Targeting of Phosphoinositide 3-Kinase Acts as a Roadblock in Mast Cells’ Route to Allergy</span>. <i>J. Allergy Clin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>132</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">959</span>– <span class="NLM_lpage">968</span>, <span class="refDoi"> DOI: 10.1016/j.jaci.2013.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.jaci.2013.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=23683463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnslerurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2013&pages=959-968&issue=4&author=E.+Collmannauthor=T.+Bohnackerauthor=R.+Maroneauthor=J.+Dawsonauthor=M.+Rehbergauthor=R.+Stringerauthor=F.+Krombachauthor=C.+Burkhartauthor=E.+Hirschauthor=G.+J.+Hollingworthauthor=M.+Thomasauthor=M.+P.+Wymann&title=Transient+Targeting+of+Phosphoinositide+3-Kinase+Acts+as+a+Roadblock+in+Mast+Cells%E2%80%99+Route+to+Allergy&doi=10.1016%2Fj.jaci.2013.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Transient targeting of phosphoinositide 3-kinase acts as a roadblock in mast cells' route to allergy</span></div><div class="casAuthors">Collmann, Emilie; Bohnacker, Thomas; Marone, Romina; Dawson, Janet; Rehberg, Markus; Stringer, Rowan; Krombach, Fritz; Burkhart, Christoph; Hirsch, Emilio; Hollingworth, Gregory J.; Thomas, Matthew; Wymann, Matthias P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">959-968</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Background: Tissue mast cell nos. are dynamically regulated by recruitment of progenitors from the vasculature.  It is unclear whether progenitors are recruited during allergic sensitization and whether recruitment promotes allergic responses.  Objective: We sought to (1) det. the effect of mast cell recruitment on acute allergic responses and (2) to define the role of phosphoinositide 3-kinase (PI3K) isoforms in sequential steps to allergic responses.  Methods: Gene-targeted mice for PI3Kγ or PI3Kδ or mice treated with isoform-specific PI3K inhibitors (a novel PI3Kγ-specific inhibitor [NVS-PI3-4] and the PI3Kδ inhibitor IC87114) were used to monitor IgE-mediated mast cell recruitment, migration, adhesion by means of intravital microscopy, degranulation, TNF-α release, and subsequent endothelial cell activation in vivo or in bone marrow-derived mast cells.  Results: Functional PI3Kγ, but not PI3Kδ, was crucial for mast cell accumulation in IgE-challenged skin, TNF-α release from IgE/antigen-stimulated mast cells, and mast cell/endothelial interactions and chemotaxis.  PI3Kγ-deficient bone marrow-derived mast cells did not adhere to the endothelium in TNF-α-treated cremaster muscle, whereas PI3Kδ was not required.  Depletion of TNF-α blocked IgE-induced mast cell recruitment, which links tissue mast cell-derived cytokine release to endothelial activation and mast cell recruitment.  Interference with mast cell recruitment protected against anaphylaxis and was superior to blockage of tissue mast cell degranulation.  Conclusions: Interference with mast cell recruitment to exacerbated tissues provides a novel strategy to alleviate allergic reactions and surpassed attenuation of tissue mast cell degranulation.  This results in prolonged drug action and allows for redn. of drug doses required to block anaphylaxis, an important feature for drugs targeting inflammatory disease in general.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRAijfMWMmaLVg90H21EOLACvtfcHk0lh_1qwdux_13A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnslerurk%253D&md5=688f46658743dd6b6e6ca70dc5ba783b</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.jaci.2013.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaci.2013.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DCollmann%26aufirst%3DE.%26aulast%3DBohnacker%26aufirst%3DT.%26aulast%3DMarone%26aufirst%3DR.%26aulast%3DDawson%26aufirst%3DJ.%26aulast%3DRehberg%26aufirst%3DM.%26aulast%3DStringer%26aufirst%3DR.%26aulast%3DKrombach%26aufirst%3DF.%26aulast%3DBurkhart%26aufirst%3DC.%26aulast%3DHirsch%26aufirst%3DE.%26aulast%3DHollingworth%26aufirst%3DG.%2BJ.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DWymann%26aufirst%3DM.%2BP.%26atitle%3DTransient%2520Targeting%2520of%2520Phosphoinositide%25203-Kinase%2520Acts%2520as%2520a%2520Roadblock%2520in%2520Mast%2520Cells%25E2%2580%2599%2520Route%2520to%2520Allergy%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2013%26volume%3D132%26issue%3D4%26spage%3D959%26epage%3D968%26doi%3D10.1016%2Fj.jaci.2013.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Condliffe, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellson, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crabbe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okkenhaug, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanhaesebroeck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wymann, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruckle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camps, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rommel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chilvers, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephens, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, P. T.</span></span> <span> </span><span class="NLM_article-title">Sequential Activation of Class IB and Class IA PI3K Is Important for the Primed Respiratory Burst of Human but Not Murine Neutrophils</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>106</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1432</span>– <span class="NLM_lpage">1440</span>, <span class="refDoi"> DOI: 10.1182/blood-2005-03-0944</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1182%2Fblood-2005-03-0944" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2005&pages=1432-1440&issue=4&author=A.+M.+Condliffeauthor=K.+Davidsonauthor=K.+E.+Andersonauthor=C.+D.+Ellsonauthor=T.+Crabbeauthor=K.+Okkenhaugauthor=B.+Vanhaesebroeckauthor=M.+Turnerauthor=L.+Webbauthor=M.+P.+Wymannauthor=E.+Hirschauthor=T.+Ruckleauthor=M.+Campsauthor=C.+Rommelauthor=S.+P.+Jacksonauthor=E.+R.+Chilversauthor=L.+R.+Stephensauthor=P.+T.+Hawkins&title=Sequential+Activation+of+Class+IB+and+Class+IA+PI3K+Is+Important+for+the+Primed+Respiratory+Burst+of+Human+but+Not+Murine+Neutrophils&doi=10.1182%2Fblood-2005-03-0944"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1182%2Fblood-2005-03-0944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2005-03-0944%26sid%3Dliteratum%253Aachs%26aulast%3DCondliffe%26aufirst%3DA.%2BM.%26aulast%3DDavidson%26aufirst%3DK.%26aulast%3DAnderson%26aufirst%3DK.%2BE.%26aulast%3DEllson%26aufirst%3DC.%2BD.%26aulast%3DCrabbe%26aufirst%3DT.%26aulast%3DOkkenhaug%26aufirst%3DK.%26aulast%3DVanhaesebroeck%26aufirst%3DB.%26aulast%3DTurner%26aufirst%3DM.%26aulast%3DWebb%26aufirst%3DL.%26aulast%3DWymann%26aufirst%3DM.%2BP.%26aulast%3DHirsch%26aufirst%3DE.%26aulast%3DRuckle%26aufirst%3DT.%26aulast%3DCamps%26aufirst%3DM.%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DJackson%26aufirst%3DS.%2BP.%26aulast%3DChilvers%26aufirst%3DE.%2BR.%26aulast%3DStephens%26aufirst%3DL.%2BR.%26aulast%3DHawkins%26aufirst%3DP.%2BT.%26atitle%3DSequential%2520Activation%2520of%2520Class%2520IB%2520and%2520Class%2520IA%2520PI3K%2520Is%2520Important%2520for%2520the%2520Primed%2520Respiratory%2520Burst%2520of%2520Human%2520but%2520Not%2520Murine%2520Neutrophils%26jtitle%3DBlood%26date%3D2005%26volume%3D106%26issue%3D4%26spage%3D1432%26epage%3D1440%26doi%3D10.1182%2Fblood-2005-03-0944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heit, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colarusso, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puri, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubes, P.</span></span> <span> </span><span class="NLM_article-title">PI3K Accelerates, but Is Not Required for, Neutrophil Chemotaxis to FMLP</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>121</i></span> (<span class="NLM_issue">Part 2</span>),  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">214</span>, <span class="refDoi"> DOI: 10.1242/jcs.020412</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1242%2Fjcs.020412" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=18187452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitFWrsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2008&pages=205-214&issue=Part+2&author=B.+Heitauthor=L.+Liuauthor=P.+Colarussoauthor=K.+D.+Puriauthor=P.+Kubes&title=PI3K+Accelerates%2C+but+Is+Not+Required+for%2C+Neutrophil+Chemotaxis+to+FMLP&doi=10.1242%2Fjcs.020412"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">PI3K accelerates, but is not required for, neutrophil chemotaxis to fMLP</span></div><div class="casAuthors">Heit, Bryan; Liu, Lixin; Colarusso, Pina; Puri, Kamal D.; Kubes, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-214</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">PI3K activity, resulting in the accumulation of PIP3 along the leading edge of a chemotaxing cell, has been proposed to be an indispensable signaling event that is required for cells to undergo chemotaxis to endogenous and exogenous chemoattractants.  Some studies have suggested that this might be the case for chemoattractants such as IL8, whereas chemotaxis to other stimuli, such as the bacterial peptide N-formyl-methionyl-leucyl-phenylalanine (fMLP), might occur normally in the absence of PI3K activity.  Herein, the authors systematically analyze the role of PI3K in mediating chemotaxis to fMLP, both in vitro and in vivo.  Using short- and long-term in vitro assays, as well as an in vivo chemotaxis assay, the authors investigated the importance of PI3K in response to the prototypic chemoattractant fMLP.  Exposure of neutrophils to fMLP induced an immediate polarization, which resulted in directional migration towards fMLP within 2-3 min.  PI3K-inhibited cells also polarized and migrated in a directional fashion towards fMLP; however, this process was delayed by ∼15 min, demonstrating that PI3K accelerates the initial response to fMLP, but an alternative pathway replaces PI3K over time.  By contrast, p38-MAPK-inhibited cells, or cells lacking MK2, were unable to polarize in response to fMLP.  Long-term chemotaxis assays using a pan-PI3K inhibitor, a PI3Kδ-specific inhibitor or PI3Kγ-knockout neutrophils, demonstrated no role for PI3K in mediating chemotaxis to fMLP, regardless of the steepness of the fMLP gradient.  Similar results were obsd. in vivo, with PI3Kγ-/- cells displaying a delayed, but otherwise normal, chemotactic response to gradients of fMLP.  Together, these data demonstrate that, although PI3K can enhance early responses to the bacterial chemoattractant fMLP, it is not required for migration towards this chemoattractant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJDIR_4vZGnrVg90H21EOLACvtfcHk0lh_1qwdux_13A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitFWrsrs%253D&md5=73aa9311d863135af1b1fb6e2d1796cd</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1242%2Fjcs.020412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.020412%26sid%3Dliteratum%253Aachs%26aulast%3DHeit%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DColarusso%26aufirst%3DP.%26aulast%3DPuri%26aufirst%3DK.%2BD.%26aulast%3DKubes%26aufirst%3DP.%26atitle%3DPI3K%2520Accelerates%252C%2520but%2520Is%2520Not%2520Required%2520for%252C%2520Neutrophil%2520Chemotaxis%2520to%2520FMLP%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2008%26volume%3D121%26issue%3DPart%25202%26spage%3D205%26epage%3D214%26doi%3D10.1242%2Fjcs.020412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milne, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crabbe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camps, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rommel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wymann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephens, L.</span></span> <span> </span><span class="NLM_article-title">PI(3)Kγ Has an Important Context-Dependent Role in Neutrophil Chemokinesis</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">86</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1038/ncb1517</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1038%2Fncb1517" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=17173040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltV2n" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=86-91&issue=1&author=G.+J.+Fergusonauthor=L.+Milneauthor=S.+Kulkarniauthor=T.+Sasakiauthor=S.+Walkerauthor=S.+Andrewsauthor=T.+Crabbeauthor=P.+Finanauthor=G.+Jonesauthor=S.+Jacksonauthor=M.+Campsauthor=C.+Rommelauthor=M.+Wymannauthor=E.+Hirschauthor=P.+Hawkinsauthor=L.+Stephens&title=PI%283%29K%CE%B3+Has+an+Important+Context-Dependent+Role+in+Neutrophil+Chemokinesis&doi=10.1038%2Fncb1517"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">PI(3)Kγ has an important context-dependent role in neutrophil chemokinesis</span></div><div class="casAuthors">Ferguson, G. John; Milne, Laura; Kulkarni, Suhasini; Sasaki, Takehiko; Walker, Simon; Andrews, Simon; Crabbe, Tom; Finan, Peter; Jones, Gareth; Jackson, Shaun; Camps, Montserrat; Rommel, Christian; Wymann, Matthias; Hirsch, Emilio; Hawkins, Phillip; Stephens, Len</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">86-91</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The directional movement of cells in a gradient of external stimulus is termed chemotaxis and is important in many aspects of development and differentiated cell function.  Phosphoinositide 3-kinases (PI(3)Ks) are thought to have crit. roles within the gradient-sensing machinery of a variety of highly motile cells, such as mammalian phagocytes, allowing these cells to respond quickly and efficiently to shallow gradients of sol. stimuli.  Our anal. of mammalian neutrophil migration towards ligands such as fMLP shows that, although PtdIns(3,4)P2 and PtdIns(3,4,5)P3 accumulate in a PI(3)Kγ-dependent fashion at the up-gradient leading-edge, this signal is not required for efficient gradient-sensing and gradient-biased movement.  PI(3)Kγ activity is however, a crit. determinant of the proportion of cells that can move, i.e., respond chemokinetically, in reaction to fMLP.  Furthermore, this dependence of chemokinesis on PI(3)Kγ activity is context dependent, both with respect to the state of priming of the neutrophils and the type of surface on which they are migrating.  We propose this effect of PI(3)Kγ is through roles in the regulation of some aspects of neutrophil polarization that are relevant to movement, such as integrin-based adhesion and the accumulation of polymd. (F)-actin at the leading-edge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8YzmdcdMuk7Vg90H21EOLACvtfcHk0lg501Znm4Adgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltV2n&md5=f1eeab9aa59a08a896a5fc0c9464e0ad</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fncb1517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb1517%26sid%3Dliteratum%253Aachs%26aulast%3DFerguson%26aufirst%3DG.%2BJ.%26aulast%3DMilne%26aufirst%3DL.%26aulast%3DKulkarni%26aufirst%3DS.%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DWalker%26aufirst%3DS.%26aulast%3DAndrews%26aufirst%3DS.%26aulast%3DCrabbe%26aufirst%3DT.%26aulast%3DFinan%26aufirst%3DP.%26aulast%3DJones%26aufirst%3DG.%26aulast%3DJackson%26aufirst%3DS.%26aulast%3DCamps%26aufirst%3DM.%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DWymann%26aufirst%3DM.%26aulast%3DHirsch%26aufirst%3DE.%26aulast%3DHawkins%26aufirst%3DP.%26aulast%3DStephens%26aufirst%3DL.%26atitle%3DPI%25283%2529K%25CE%25B3%2520Has%2520an%2520Important%2520Context-Dependent%2520Role%2520in%2520Neutrophil%2520Chemokinesis%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2007%26volume%3D9%26issue%3D1%26spage%3D86%26epage%3D91%26doi%3D10.1038%2Fncb1517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mårdh, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Root, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uddin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenvall, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malmgren, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karabelas, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, M.</span></span> <span> </span><span class="NLM_article-title">Targets of Neutrophil Influx and Weaponry: Therapeutic Opportunities for Chronic Obstructive Airway Disease</span>. <i>J. Immunol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2017</i></span>,  <span class="NLM_fpage">5273201</span>, <span class="refDoi"> DOI: 10.1155/2017/5273201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1155%2F2017%2F5273201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=28596972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A280%3ADC%252BC1cnmsFGktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2017&publication_year=2017&pages=5273201&author=C.+K.+M%C3%A5rdhauthor=J.+Rootauthor=M.+Uddinauthor=K.+Stenvallauthor=A.+Malmgrenauthor=K.+Karabelasauthor=M.+Thomas&title=Targets+of+Neutrophil+Influx+and+Weaponry%3A+Therapeutic+Opportunities+for+Chronic+Obstructive+Airway+Disease&doi=10.1155%2F2017%2F5273201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Targets of Neutrophil Influx and Weaponry: Therapeutic Opportunities for Chronic Obstructive Airway Disease</span></div><div class="casAuthors">Mardh Carina Karrman; Root James; Uddin Mohib; Stenvall Kristina; Malmgren Anna; Karabelas Kostas; Thomas Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of immunology research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">2017</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5273201</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Neutrophils are important effector cells of antimicrobial immunity in an acute inflammatory response, with a primary role in the clearance of extracellular pathogens.  However, in respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD), there is excessive infiltration and activation of neutrophils, subsequent production of reactive oxygen species, and release of serine proteases, matrix metalloproteinases, and myeloperoxidase-resulting in collateral damage as the cells infiltrate into the tissue.  Increased neutrophil survival through dysregulated apoptosis facilitates continued release of neutrophil-derived mediators to perpetuate airway inflammation and tissue injury.  Several target mechanisms have been investigated to address pathologic neutrophil biology and thereby provide a novel therapy for respiratory disease.  These include neutrophil influx through inhibition of chemokine receptors CXCR2, CXCR1, and PI3Kγ signaling and neutrophil weaponry by protease inhibitors, targeting matrix metalloproteinases and neutrophil serine proteases.  In addition, neutrophil function can be modulated using selective PI3Kδ inhibitors.  This review highlights the latest advances in targeting neutrophils and their function, discusses the opportunities and risks of neutrophil inhibition, and explores how we might better develop future strategies to regulate neutrophil influx and function for respiratory diseases in dire need of novel effective therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS8tE7xBBHMvr0AGQpJZWpJfW6udTcc2eYg61Z7jMYjILntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cnmsFGktQ%253D%253D&md5=959897af161450bc2aa73a092cb20d0a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1155%2F2017%2F5273201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2017%252F5273201%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25A5rdh%26aufirst%3DC.%2BK.%26aulast%3DRoot%26aufirst%3DJ.%26aulast%3DUddin%26aufirst%3DM.%26aulast%3DStenvall%26aufirst%3DK.%26aulast%3DMalmgren%26aufirst%3DA.%26aulast%3DKarabelas%26aufirst%3DK.%26aulast%3DThomas%26aufirst%3DM.%26atitle%3DTargets%2520of%2520Neutrophil%2520Influx%2520and%2520Weaponry%253A%2520Therapeutic%2520Opportunities%2520for%2520Chronic%2520Obstructive%2520Airway%2520Disease%26jtitle%3DJ.%2520Immunol.%2520Res.%26date%3D2017%26volume%3D2017%26spage%3D5273201%26doi%3D10.1155%2F2017%2F5273201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sapey, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenwood, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walton, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Love, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aaronson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Insall, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockley, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, J. M.</span></span> <span> </span><span class="NLM_article-title">Phosphoinositide 3-Kinase Inhibition Restores Neutrophil Accuracy in the Elderly: Toward Targeted Treatments for Immunosenescence</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>123</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">239</span>– <span class="NLM_lpage">248</span>, <span class="refDoi"> DOI: 10.1182/blood-2013-08-519520</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1182%2Fblood-2013-08-519520" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2014&pages=239-248&issue=2&author=E.+Sapeyauthor=H.+Greenwoodauthor=G.+Waltonauthor=E.+Mannauthor=A.+Loveauthor=N.+Aaronsonauthor=R.+H.+Insallauthor=R.+A.+Stockleyauthor=J.+M.+Lord&title=Phosphoinositide+3-Kinase+Inhibition+Restores+Neutrophil+Accuracy+in+the+Elderly%3A+Toward+Targeted+Treatments+for+Immunosenescence&doi=10.1182%2Fblood-2013-08-519520"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1182%2Fblood-2013-08-519520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2013-08-519520%26sid%3Dliteratum%253Aachs%26aulast%3DSapey%26aufirst%3DE.%26aulast%3DGreenwood%26aufirst%3DH.%26aulast%3DWalton%26aufirst%3DG.%26aulast%3DMann%26aufirst%3DE.%26aulast%3DLove%26aufirst%3DA.%26aulast%3DAaronson%26aufirst%3DN.%26aulast%3DInsall%26aufirst%3DR.%2BH.%26aulast%3DStockley%26aufirst%3DR.%2BA.%26aulast%3DLord%26aufirst%3DJ.%2BM.%26atitle%3DPhosphoinositide%25203-Kinase%2520Inhibition%2520Restores%2520Neutrophil%2520Accuracy%2520in%2520the%2520Elderly%253A%2520Toward%2520Targeted%2520Treatments%2520for%2520Immunosenescence%26jtitle%3DBlood%26date%3D2014%26volume%3D123%26issue%3D2%26spage%3D239%26epage%3D248%26doi%3D10.1182%2Fblood-2013-08-519520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maus, U. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Backi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rückle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paton, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briles, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mack, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welte, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maus, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohle, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seeger, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rommel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohmeyer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preissner, K. T.</span></span> <span> </span><span class="NLM_article-title">Importance of Phosphoinositide 3-Kinase γ in the Host Defense against Pneumococcal Infection</span>. <i>Am. J. Respir. Crit. Care Med.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>175</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">958</span>– <span class="NLM_lpage">966</span>, <span class="refDoi"> DOI: 10.1164/rccm.200610-1533OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1164%2Frccm.200610-1533OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=17322108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BD2sXls12ru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2007&pages=958-966&issue=9&author=U.+A.+Mausauthor=M.+Backiauthor=C.+Winterauthor=M.+Srivastavaauthor=M.+K.+Schwarzauthor=T.+R%C3%BCckleauthor=J.+C.+Patonauthor=D.+Brilesauthor=M.+Mackauthor=T.+Welteauthor=R.+Mausauthor=R.+M.+Bohleauthor=W.+Seegerauthor=C.+Rommelauthor=E.+Hirschauthor=J.+Lohmeyerauthor=K.+T.+Preissner&title=Importance+of+Phosphoinositide+3-Kinase+%CE%B3+in+the+Host+Defense+against+Pneumococcal+Infection&doi=10.1164%2Frccm.200610-1533OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Importance of phosphoinositide 3-kinase γ in the host defense against pneumococcal infection</span></div><div class="casAuthors">Maus, Ulrich A.; Backi, Myriam; Winter, Christine; Srivastava, Mrigank; Schwarz, Matthias K.; Rueckle, Thomas; Paton, James C.; Briles, David; Mack, Matthias; Welte, Tobias; Maus, Regina; Bohle, Rainer M.; Seeger, Werner; Rommel, Christian; Hirsch, Emilio; Lohmeyer, Juergen; Preissner, Klaus T.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory and Critical Care Medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">958-966</span>CODEN:
                <span class="NLM_cas:coden">AJCMED</span>;
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Rationale: The pivotal role of phosphoinositide 3-kinase γ (PI3Kγ) in leukocyte recruitment makes it an attractive target for immunomodulatory therapy.  However, interfering with PI3Kγ signaling might increase the risk of bacterial infections in humans.  Objectives: We hypothesized that deletion or pharmacol. inhibition of PI3Kγ would impair the lung inflammatory response to the prototypic gram-pos. bacterial pathogen Streptococcus pneumoniae.  Methods: PI3Kγ knockout (KO) and wild-type mice were infected with S. pneumoniae or challenged with the pneumococcal virulence factor pneumolysin (PLY), and inflammatory leukocyte recruitment, bacterial pathogen elimination, and resoln./repair processes were detd.  Measurements and Main Results: PI3Kγ KO mice challenged with PLY responded with lung edema and neutrophilic alveolitis, but showed a drop in alveolar macrophages and failed to recruit exudate macrophages when compared with wild-type mice.  S. pneumoniae-infected PI3Kγ KO mice and wild-type mice pretreated with the pharmacol. inhibitor AS-605240 recruited similar nos. of neutrophils but substantially fewer exudate macrophages into their lungs than control animals.  They also displayed a significantly reduced lung pneumococcal clearance and showed an impaired resoln./repair process, leading to progressive pneumococcal pneumonia.  Conclusions: PI3Kγ gene deletion or pharmacol. inhibition of PI3Kγ leads to perturbations of crit. innate immune responses of the lung to challenge with S. pneumoniae.  These data are of clin. relevance for the treatment of chronic inflammatory diseases where pharmacol. inhibition of PI3Kγ signaling to attenuate effector cell recruitment may have implications for innate immune surveillance of remote organ systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9WofA-p6NnrVg90H21EOLACvtfcHk0liaYJBRjzikhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXls12ru7k%253D&md5=fc2ced3374d5191c75ff664dfa5036eb</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1164%2Frccm.200610-1533OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.200610-1533OC%26sid%3Dliteratum%253Aachs%26aulast%3DMaus%26aufirst%3DU.%2BA.%26aulast%3DBacki%26aufirst%3DM.%26aulast%3DWinter%26aufirst%3DC.%26aulast%3DSrivastava%26aufirst%3DM.%26aulast%3DSchwarz%26aufirst%3DM.%2BK.%26aulast%3DR%25C3%25BCckle%26aufirst%3DT.%26aulast%3DPaton%26aufirst%3DJ.%2BC.%26aulast%3DBriles%26aufirst%3DD.%26aulast%3DMack%26aufirst%3DM.%26aulast%3DWelte%26aufirst%3DT.%26aulast%3DMaus%26aufirst%3DR.%26aulast%3DBohle%26aufirst%3DR.%2BM.%26aulast%3DSeeger%26aufirst%3DW.%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DHirsch%26aufirst%3DE.%26aulast%3DLohmeyer%26aufirst%3DJ.%26aulast%3DPreissner%26aufirst%3DK.%2BT.%26atitle%3DImportance%2520of%2520Phosphoinositide%25203-Kinase%2520%25CE%25B3%2520in%2520the%2520Host%2520Defense%2520against%2520Pneumococcal%2520Infection%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2007%26volume%3D175%26issue%3D9%26spage%3D958%26epage%3D966%26doi%3D10.1164%2Frccm.200610-1533OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavares, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dias, A. C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehdy, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarado-Arnez, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Queiroz-Junior, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galvão, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lima, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matos, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonçalves, A. P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soriani, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraes, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marques, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siqueira, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machado, A. M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sousa, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teixeira, M. M.</span></span> <span> </span><span class="NLM_article-title">Phosphatidyl Inositol 3 Kinase-Gamma Balances Antiviral and Inflammatory Responses During Influenza A H1N1 Infection: From Murine Model to Genetic Association in Patients</span>. <i>Front. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">975</span>, <span class="refDoi"> DOI: 10.3389/fimmu.2018.00975</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.3389%2Ffimmu.2018.00975" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=29867955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1Cqu7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=975&author=C.+C.+Garciaauthor=L.+P.+Tavaresauthor=A.+C.+F.+Diasauthor=F.+Kehdyauthor=L.+E.+Alvarado-Arnezauthor=C.+M.+Queiroz-Juniorauthor=I.+Galv%C3%A3oauthor=B.+H.+Limaauthor=A.+R.+Matosauthor=A.+P.+F.+Gon%C3%A7alvesauthor=F.+M.+Sorianiauthor=M.+O.+Moraesauthor=J.+T.+Marquesauthor=M.+M.+Siqueiraauthor=A.+M.+V.+Machadoauthor=L.+P.+Sousaauthor=R.+C.+Russoauthor=M.+M.+Teixeira&title=Phosphatidyl+Inositol+3+Kinase-Gamma+Balances+Antiviral+and+Inflammatory+Responses+During+Influenza+A+H1N1+Infection%3A+From+Murine+Model+to+Genetic+Association+in+Patients&doi=10.3389%2Ffimmu.2018.00975"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphatidyl inositol 3 kinase-gamma balances antiviral and inflammatory responses during influenza A H1N1 infection: from murine model to genetic association in patients</span></div><div class="casAuthors">Garcia, Cristiana C.; Tavares, Luciana P.; Dias, Ana Carolina F.; Kehdy, Fernanda; Alvarado-Arnez, Lucia Elena; Queiroz-Junior, Celso M.; Galvao, Izabela; Lima, Braulio H.; Matos, Aline R.; Goncalves, Ana Paula F.; Soriani, Frederico M.; Moraes, Milton O.; Marques, Joao T.; Siqueira, Marilda M.; Machado, Alexandre M. V.; Sousa, Lirlandia P.; Russo, Remo C.; Teixeira, Mauro M.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Immunology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">975/1-975/18</span>CODEN:
                <span class="NLM_cas:coden">FIRMCW</span>;
        ISSN:<span class="NLM_cas:issn">1664-3224</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Influenza A virus (IAV) infection causes severe pulmonary disease characterized by intense leukocyte infiltration.  Phosphoinositide-3 kinases (PI3Ks) are central signaling enzymes, involved in cell growth, survival, and migration.  Class IB PI3K or phosphatidyl inositol 3 kinase-gamma (PI3K γ), mainly expressed by leukocytes, is involved in cell migration during inflammation.  Here, we investigated the contribution of PI3K γ for the inflammatory and antiviral responses to IAV.  PI3K γ knockout (KO) mice were highly susceptible to lethality following infection with influenza A/WSN/33 H1N1.  In the early time points of infection, infiltration of neutrophils was higher than WT mice whereas type-I and type-III IFN expression and p38 activation were reduced in PI3K γ KO mice resulting in higher viral loads when compared with WT mice.  Blockade of p38 in WT macrophages infected with IAV reduced levels of interferon-stimulated gene 15 protein to those induced in PI3K γ KO macrophages, suggesting that p38 is downstream of antiviral responses mediated by PI3K γ.  PI3K γ KO-derived fibroblasts or macrophages showed reduced type-I IFN transcription and altered pro-inflammatory cytokines suggesting a cell autonomous imbalance between inflammatory and antiviral responses.  Seven days after IAV infection, there were reduced infiltration of natural killer cells and CD8+ T lymphocytes, increased concn. of inflammatory cytokines in bronchoalveolar fluid, reduced nos. of resolving macrophages, and IL-10 levels in PI3K γ KO.  This imbalanced environment in PI3K γ KO-infected mice culminated in enhanced lung neutrophil infiltration, reactive oxygen species release, and lung damage that together with the increased viral loads, contributed to higher mortality in PI3K γ KO mice compared with WT mice.  In humans, we tested the genetic assocn. of disease severity in influenza A/H1N1pdm09-infected patients with three potentially functional PIK3CG single-nucleotide polymorphisms (SNPs), rs1129293, rs17847825, and rs2230460.  We obsd. that SNPs rs17847825 and rs2230460 (A and T alleles, resp.) were significantly assocd. with protection from severe disease using the recessive model in patients infected with influenza A(H1N1)pdm09.  Altogether, our results suggest that PI3K γ is crucial in balancing antiviral and inflammatory responses to IAV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIFUkPV_mYwrVg90H21EOLACvtfcHk0liaYJBRjzikhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1Cqu7rO&md5=a6539381a1e742799fa711785cc10eac</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2018.00975&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2018.00975%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia%26aufirst%3DC.%2BC.%26aulast%3DTavares%26aufirst%3DL.%2BP.%26aulast%3DDias%26aufirst%3DA.%2BC.%2BF.%26aulast%3DKehdy%26aufirst%3DF.%26aulast%3DAlvarado-Arnez%26aufirst%3DL.%2BE.%26aulast%3DQueiroz-Junior%26aufirst%3DC.%2BM.%26aulast%3DGalv%25C3%25A3o%26aufirst%3DI.%26aulast%3DLima%26aufirst%3DB.%2BH.%26aulast%3DMatos%26aufirst%3DA.%2BR.%26aulast%3DGon%25C3%25A7alves%26aufirst%3DA.%2BP.%2BF.%26aulast%3DSoriani%26aufirst%3DF.%2BM.%26aulast%3DMoraes%26aufirst%3DM.%2BO.%26aulast%3DMarques%26aufirst%3DJ.%2BT.%26aulast%3DSiqueira%26aufirst%3DM.%2BM.%26aulast%3DMachado%26aufirst%3DA.%2BM.%2BV.%26aulast%3DSousa%26aufirst%3DL.%2BP.%26aulast%3DRusso%26aufirst%3DR.%2BC.%26aulast%3DTeixeira%26aufirst%3DM.%2BM.%26atitle%3DPhosphatidyl%2520Inositol%25203%2520Kinase-Gamma%2520Balances%2520Antiviral%2520and%2520Inflammatory%2520Responses%2520During%2520Influenza%2520A%2520H1N1%2520Infection%253A%2520From%2520Murine%2520Model%2520to%2520Genetic%2520Association%2520in%2520Patients%26jtitle%3DFront.%2520Immunol.%26date%3D2018%26volume%3D9%26spage%3D975%26doi%3D10.3389%2Ffimmu.2018.00975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zelenetz, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrientos, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coiffier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egyed, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghia, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Illés, Á.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jurczak, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marlton, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montillo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morschhauser, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pristupa, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robak, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharman, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smolej, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tausch, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adewoye, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dreiling, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stilgenbauer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillmen, P.</span></span> <span> </span><span class="NLM_article-title">Idelalisib or Placebo in Combination with Bendamustine and Rituximab in Patients with Relapsed or Refractory Chronic Lymphocytic Leukaemia: Interim Results from a Phase 3, Randomised, Double-Blind, Placebo-Controlled Trial</span>. <i>Lancet Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">297</span>– <span class="NLM_lpage">311</span>, <span class="refDoi"> DOI: 10.1016/S1470-2045(16)30671-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2FS1470-2045%2816%2930671-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=28139405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslSlsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=297-311&issue=3&author=A.+D.+Zelenetzauthor=J.+C.+Barrientosauthor=J.+R.+Brownauthor=B.+Coiffierauthor=J.+Delgadoauthor=M.+Egyedauthor=P.+Ghiaauthor=%C3%81.+Ill%C3%A9sauthor=W.+Jurczakauthor=P.+Marltonauthor=M.+Montilloauthor=F.+Morschhauserauthor=A.+S.+Pristupaauthor=T.+Robakauthor=J.+P.+Sharmanauthor=D.+Simpsonauthor=L.+Smolejauthor=E.+Tauschauthor=A.+H.+Adewoyeauthor=L.+K.+Dreilingauthor=Y.+Kimauthor=S.+Stilgenbauerauthor=P.+Hillmen&title=Idelalisib+or+Placebo+in+Combination+with+Bendamustine+and+Rituximab+in+Patients+with+Relapsed+or+Refractory+Chronic+Lymphocytic+Leukaemia%3A+Interim+Results+from+a+Phase+3%2C+Randomised%2C+Double-Blind%2C+Placebo-Controlled+Trial&doi=10.1016%2FS1470-2045%2816%2930671-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial</span></div><div class="casAuthors">Zelenetz, Andrew D.; Barrientos, Jacqueline C.; Brown, Jennifer R.; Coiffier, Bertrand; Delgado, Julio; Egyed, Miklos; Ghia, Paolo; Illes, Arpad; Jurczak, Wojciech; Marlton, Paula; Montillo, Marco; Morschhauser, Franck; Pristupa, Alexander S.; Robak, Tadeusz; Sharman, Jeff P.; Simpson, David; Smolej, Lukas; Tausch, Eugen; Adewoye, Adeboye H.; Dreiling, Lyndah K.; Kim, Yeonhee; Stilgenbauer, Stephan; Hillmen, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-311</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Bendamustine plus rituximab is a std. of care for the management of patients with relapsed or refractory chronic lymphocytic leukemia.  New therapies are needed to improve clin. relevant outcomes in these patients.  We assessed the efficacy and safety of adding idelalisib, a first-in-class targeted phosphoinositide-3-kinase δ inhibitor, to bendamustine plus rituximab in this population.  For this international, multicentre, double-blind, placebo-controlled trial, adult patients (≥18 years) with relapsed or refractory chronic lymphocytic leukemia requiring treatment who had measurable lymphadenopathy by CT or MRI and disease progression within 36 mo since their last previous therapy were enrolled.  Patients were randomly assigned (1:1) by a central interactive web response system to receive bendamustine plus rituximab for a max. of six cycles (bendamustine: 70 mg/m2 i.v. on days 1 and 2 for six 28-day cycles; rituximab: 375 mg/m2 on day 1 of cycle 1, and 500 mg/m2 on day 1 of cycles 2-6) in addn. to either twice-daily oral idelalisib (150 mg) or placebo until disease progression or intolerable study drug-related toxicity.  Randomisation was stratified by high-risk features (IGHV, del[17p], or TP53 mutation) and refractory vs. relapsed disease.  The primary endpoint was progression-free survival assessed by an independent review committee in the intention-to-treat population.  This trial is ongoing and is registered with ClinicalTrials.gov, no. NCT01569295.  Between June 26, 2012, and Aug 21, 2014, 416 patients were enrolled and randomly assigned to the idelalisib (n=207) and placebo (n=209) groups.  At a median follow-up of 14 mo (IQR 7-18), median progression-free survival was 20·8 mo (95% CI 16·6-26·4) in the idelalisib group and 11·1 mo (8·9-11·1) in the placebo group (hazard ratio [HR] 0·33, 95% CI 0·25-0·44; p<0·0001).  The most frequent grade 3 or worse adverse events in the idelalisib group were neutropenia (124 [60%] of 207 patients) and febrile neutropenia (48 [23%]), whereas in the placebo group they were neutropenia (99 [47%] of 209) and thrombocytopenia (27 [13%]).  An increased risk of infection was reported in the idelalisib group compared with the placebo group (grade ≥3 infections and infestations: 80 [39%] of 207 vs 52 [25%] of 209).  Serious adverse events, including febrile neutropenia, pneumonia, and pyrexia, were more common in the idelalisib group (140 [68%] of 207 patients) than in the placebo group (92 [44%] of 209).  Treatment-emergent adverse events leading to death occurred in 23 (11%) patients in the idelalisib group and 15 (7%) in the placebo group, including six deaths from infections in the idelalisib group and three from infections in the placebo group.  Idelalisib in combination with bendamustine plus rituximab improved progression-free survival compared with bendamustine plus rituximab alone in patients with relapsed or refractory chronic lymphocytic leukemia.  However, careful attention needs to be paid to management of serious adverse events and infections assocd. with this regimen during treatment selection.Gilead Sciences Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2ueUBdljrRrVg90H21EOLACvtfcHk0liaYJBRjzikhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslSlsL8%253D&md5=42826c924d88962211c8c6a9a9b74ab5</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2816%2930671-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252816%252930671-4%26sid%3Dliteratum%253Aachs%26aulast%3DZelenetz%26aufirst%3DA.%2BD.%26aulast%3DBarrientos%26aufirst%3DJ.%2BC.%26aulast%3DBrown%26aufirst%3DJ.%2BR.%26aulast%3DCoiffier%26aufirst%3DB.%26aulast%3DDelgado%26aufirst%3DJ.%26aulast%3DEgyed%26aufirst%3DM.%26aulast%3DGhia%26aufirst%3DP.%26aulast%3DIll%25C3%25A9s%26aufirst%3D%25C3%2581.%26aulast%3DJurczak%26aufirst%3DW.%26aulast%3DMarlton%26aufirst%3DP.%26aulast%3DMontillo%26aufirst%3DM.%26aulast%3DMorschhauser%26aufirst%3DF.%26aulast%3DPristupa%26aufirst%3DA.%2BS.%26aulast%3DRobak%26aufirst%3DT.%26aulast%3DSharman%26aufirst%3DJ.%2BP.%26aulast%3DSimpson%26aufirst%3DD.%26aulast%3DSmolej%26aufirst%3DL.%26aulast%3DTausch%26aufirst%3DE.%26aulast%3DAdewoye%26aufirst%3DA.%2BH.%26aulast%3DDreiling%26aufirst%3DL.%2BK.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DStilgenbauer%26aufirst%3DS.%26aulast%3DHillmen%26aufirst%3DP.%26atitle%3DIdelalisib%2520or%2520Placebo%2520in%2520Combination%2520with%2520Bendamustine%2520and%2520Rituximab%2520in%2520Patients%2520with%2520Relapsed%2520or%2520Refractory%2520Chronic%2520Lymphocytic%2520Leukaemia%253A%2520Interim%2520Results%2520from%2520a%2520Phase%25203%252C%2520Randomised%252C%2520Double-Blind%252C%2520Placebo-Controlled%2520Trial%26jtitle%3DLancet%2520Oncol.%26date%3D2017%26volume%3D18%26issue%3D3%26spage%3D297%26epage%3D311%26doi%3D10.1016%2FS1470-2045%2816%2930671-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robak, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awan, F. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badoux, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coutre, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loscertales, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenberghe, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wach, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner-Johnston, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ysebaert, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dreiling, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubowy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flinn, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, C.</span></span> <span> </span><span class="NLM_article-title">Efficacy and Safety of Idelalisib in Combination with Ofatumumab for Previously Treated Chronic Lymphocytic Leukaemia: An Open-Label, Randomised Phase 3 Trial</span>. <i>Lancet. Haematol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">e114</span>– <span class="NLM_lpage">e126</span>, <span class="refDoi"> DOI: 10.1016/S2352-3026(17)30019-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2FS2352-3026%2817%2930019-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=28257752" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2017&pages=e114-e126&issue=3&author=J.+A.+Jonesauthor=T.+Robakauthor=J.+R.+Brownauthor=F.+T.+Awanauthor=X.+Badouxauthor=S.+Coutreauthor=J.+Loscertalesauthor=K.+Taylorauthor=E.+Vandenbergheauthor=M.+Wachauthor=N.+Wagner-Johnstonauthor=L.+Ysebaertauthor=L.+Dreilingauthor=R.+Dubowyauthor=G.+Xingauthor=I.+W.+Flinnauthor=C.+Owen&title=Efficacy+and+Safety+of+Idelalisib+in+Combination+with+Ofatumumab+for+Previously+Treated+Chronic+Lymphocytic+Leukaemia%3A+An+Open-Label%2C+Randomised+Phase+3+Trial&doi=10.1016%2FS2352-3026%2817%2930019-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2FS2352-3026%2817%2930019-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS2352-3026%252817%252930019-4%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DJ.%2BA.%26aulast%3DRobak%26aufirst%3DT.%26aulast%3DBrown%26aufirst%3DJ.%2BR.%26aulast%3DAwan%26aufirst%3DF.%2BT.%26aulast%3DBadoux%26aufirst%3DX.%26aulast%3DCoutre%26aufirst%3DS.%26aulast%3DLoscertales%26aufirst%3DJ.%26aulast%3DTaylor%26aufirst%3DK.%26aulast%3DVandenberghe%26aufirst%3DE.%26aulast%3DWach%26aufirst%3DM.%26aulast%3DWagner-Johnston%26aufirst%3DN.%26aulast%3DYsebaert%26aufirst%3DL.%26aulast%3DDreiling%26aufirst%3DL.%26aulast%3DDubowy%26aufirst%3DR.%26aulast%3DXing%26aufirst%3DG.%26aulast%3DFlinn%26aufirst%3DI.%2BW.%26aulast%3DOwen%26aufirst%3DC.%26atitle%3DEfficacy%2520and%2520Safety%2520of%2520Idelalisib%2520in%2520Combination%2520with%2520Ofatumumab%2520for%2520Previously%2520Treated%2520Chronic%2520Lymphocytic%2520Leukaemia%253A%2520An%2520Open-Label%252C%2520Randomised%2520Phase%25203%2520Trial%26jtitle%3DLancet.%2520Haematol.%26date%3D2017%26volume%3D4%26issue%3D3%26spage%3De114%26epage%3De126%26doi%3D10.1016%2FS2352-3026%2817%2930019-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Horwitz, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porcu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moskowitz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myskowski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Officer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaffe, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrow, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douglas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aster, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weaver, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foss, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstock, D. M.</span></span> <span> </span><span class="NLM_article-title">Activity of the PI3K-δ,γ Inhibitor Duvelisib in a Phase 1 Trial and Preclinical Models of T-Cell Lymphoma</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>131</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">888</span>– <span class="NLM_lpage">898</span>, <span class="refDoi"> DOI: 10.1182/blood-2017-08-802470</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1182%2Fblood-2017-08-802470" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2018&pages=888-898&issue=8&author=S.+M.+Horwitzauthor=R.+Kochauthor=P.+Porcuauthor=Y.+Okiauthor=A.+Moskowitzauthor=M.+Perezauthor=P.+Myskowskiauthor=A.+Officerauthor=J.+D.+Jaffeauthor=S.+N.+Morrowauthor=K.+Allenauthor=M.+Douglasauthor=H.+Sternauthor=J.+Sweeneyauthor=P.+Kellyauthor=V.+Kellyauthor=J.+C.+Asterauthor=D.+Weaverauthor=F.+M.+Fossauthor=D.+M.+Weinstock&title=Activity+of+the+PI3K-%CE%B4%2C%CE%B3+Inhibitor+Duvelisib+in+a+Phase+1+Trial+and+Preclinical+Models+of+T-Cell+Lymphoma&doi=10.1182%2Fblood-2017-08-802470"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1182%2Fblood-2017-08-802470&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2017-08-802470%26sid%3Dliteratum%253Aachs%26aulast%3DHorwitz%26aufirst%3DS.%2BM.%26aulast%3DKoch%26aufirst%3DR.%26aulast%3DPorcu%26aufirst%3DP.%26aulast%3DOki%26aufirst%3DY.%26aulast%3DMoskowitz%26aufirst%3DA.%26aulast%3DPerez%26aufirst%3DM.%26aulast%3DMyskowski%26aufirst%3DP.%26aulast%3DOfficer%26aufirst%3DA.%26aulast%3DJaffe%26aufirst%3DJ.%2BD.%26aulast%3DMorrow%26aufirst%3DS.%2BN.%26aulast%3DAllen%26aufirst%3DK.%26aulast%3DDouglas%26aufirst%3DM.%26aulast%3DStern%26aufirst%3DH.%26aulast%3DSweeney%26aufirst%3DJ.%26aulast%3DKelly%26aufirst%3DP.%26aulast%3DKelly%26aufirst%3DV.%26aulast%3DAster%26aufirst%3DJ.%2BC.%26aulast%3DWeaver%26aufirst%3DD.%26aulast%3DFoss%26aufirst%3DF.%2BM.%26aulast%3DWeinstock%26aufirst%3DD.%2BM.%26atitle%3DActivity%2520of%2520the%2520PI3K-%25CE%25B4%252C%25CE%25B3%2520Inhibitor%2520Duvelisib%2520in%2520a%2520Phase%25201%2520Trial%2520and%2520Preclinical%2520Models%2520of%2520T-Cell%2520Lymphoma%26jtitle%3DBlood%26date%3D2018%26volume%3D131%26issue%3D8%26spage%3D888%26epage%3D898%26doi%3D10.1182%2Fblood-2017-08-802470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheah, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fowler, N. H.</span></span> <span> </span><span class="NLM_article-title">Idelalisib in the Management of Lymphoma</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>128</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">331</span>– <span class="NLM_lpage">336</span>, <span class="refDoi"> DOI: 10.1182/blood-2016-02-702761</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1182%2Fblood-2016-02-702761" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2016&pages=331-336&issue=3&author=C.+Y.+Cheahauthor=N.+H.+Fowler&title=Idelalisib+in+the+Management+of+Lymphoma&doi=10.1182%2Fblood-2016-02-702761"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1182%2Fblood-2016-02-702761&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2016-02-702761%26sid%3Dliteratum%253Aachs%26aulast%3DCheah%26aufirst%3DC.%2BY.%26aulast%3DFowler%26aufirst%3DN.%2BH.%26atitle%3DIdelalisib%2520in%2520the%2520Management%2520of%2520Lymphoma%26jtitle%3DBlood%26date%3D2016%26volume%3D128%26issue%3D3%26spage%3D331%26epage%3D336%26doi%3D10.1182%2Fblood-2016-02-702761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span>TG Therapeutics,
Inc. Announces First Patient Enrolled in the Registration-Directed
UNITY-DLBCL Phase 2b Trial. TG Therapeutics, Inc. <a href="http://ir.tgtherapeutics.com/news-releases/news-release-details/tg-therapeutics-inc-announces-first-patient-enrolled?ReleaseID=974602" class="extLink">http://ir.tgtherapeutics.com/news-releases/news-release-details/tg-therapeutics-inc-announces-first-patient-enrolled?ReleaseID=974602</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=TG+Therapeutics%2C%0AInc.+Announces+First+Patient+Enrolled+in+the+Registration-Directed%0AUNITY-DLBCL+Phase+2b+Trial.+TG+Therapeutics%2C+Inc.+http%3A%2F%2Fir.tgtherapeutics.com%2Fnews-releases%2Fnews-release-details%2Ftg-therapeutics-inc-announces-first-patient-enrolled%3FReleaseID%3D974602+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span>Study
To Assess the Efficacy and Safety of Ublituximab + TGR-1202 with or
without Bendamustine and TGR-1202 Alone in Patients with Previously
Treated Non-Hodgkins Lymphoma. ClinicalTrials.gov. <a href="https://clinicaltrials.gov/ct2/show/NCT02793583" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02793583</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Study%0ATo+Assess+the+Efficacy+and+Safety+of+Ublituximab+%2B+TGR-1202+with+or%0Awithout+Bendamustine+and+TGR-1202+Alone+in+Patients+with+Previously%0ATreated+Non-Hodgkins+Lymphoma.+ClinicalTrials.gov.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02793583+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span>TG Therapeutics
Announces Orphan Drug Designation for the Combination of TG-1101 and
TGR-1202 for Treatment of Chronic Lymphocytic Leukemia. <a href="http://ir.tgtherapeutics.com/news-releases/news-release-details/tg-therapeutics-announces-orphan-drug-designation-combination-tg" class="extLink">ir.tgtherapeutics.com/news-releases/news-release-details/tg-therapeutics-announces-orphan-drug-designation-combination-tg</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=TG+Therapeutics%0AAnnounces+Orphan+Drug+Designation+for+the+Combination+of+TG-1101+and%0ATGR-1202+for+Treatment+of+Chronic+Lymphocytic+Leukemia.+ir.tgtherapeutics.com%2Fnews-releases%2Fnews-release-details%2Ftg-therapeutics-announces-orphan-drug-designation-combination-tg+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span>Ublituximab
+ TGR-1202 Compared to Obinutuzumab + Chlorambucil in Patients with
Untreated and Previously Treated Chronic Lymphocytic Leukemia. ClinicalTrials.gov. <a href="https://clinicaltrials.gov/ct2/show/NCT02612311" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02612311</a> (accessed Jun 19, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Ublituximab%0A%2B+TGR-1202+Compared+to+Obinutuzumab+%2B+Chlorambucil+in+Patients+with%0AUntreated+and+Previously+Treated+Chronic+Lymphocytic+Leukemia.+ClinicalTrials.gov.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02612311+%28accessed+Jun+19%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span>Acalabrutinib
in Combination with ACP-319, for Treatment of Chronic Lymphocytic
Leukemia. ClinicalTrials.gov. <a href="https://www.clinicaltrials.gov/ct2/show/NCT02157324" class="extLink">https://www.clinicaltrials.gov/ct2/show/NCT02157324</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Acalabrutinib%0Ain+Combination+with+ACP-319%2C+for+Treatment+of+Chronic+Lymphocytic%0ALeukemia.+ClinicalTrials.gov.+https%3A%2F%2Fwww.clinicaltrials.gov%2Fct2%2Fshow%2FNCT02157324+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span>ACP-196
in Combination with ACP-319, for Treatment of B-Cell Malignancies.
ClinicalTrials.gov. <a href="https://www.clinicaltrials.gov/ct2/show/NCT02328014" class="extLink">https://www.clinicaltrials.gov/ct2/show/NCT02328014</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ACP-196%0Ain+Combination+with+ACP-319%2C+for+Treatment+of+B-Cell+Malignancies.%0AClinicalTrials.gov.+https%3A%2F%2Fwww.clinicaltrials.gov%2Fct2%2Fshow%2FNCT02328014+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span>A Phase
1/2, Open-Label, Dose Escalation, Safety and Tolerability Study of
INCB050465 and Itacitinib (INCB039110) in Subjects with Previously
Treated B-Cell Malignancies (CITADEL-101). ClinicalTrials.gov. <a href="https://clinicaltrials.gov/ct2/show/NCT02018861" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02018861</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Phase%0A1%2F2%2C+Open-Label%2C+Dose+Escalation%2C+Safety+and+Tolerability+Study+of%0AINCB050465+and+Itacitinib+%28INCB039110%29+in+Subjects+with+Previously%0ATreated+B-Cell+Malignancies+%28CITADEL-101%29.+ClinicalTrials.gov.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02018861+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span>A Study
of HMPL-689 in Healthy Volunteers. ClinicalTrials.gov. <a href="https://clinicaltrials.gov/ct2/show/NCT02631642" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02631642</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Study%0Aof+HMPL-689+in+Healthy+Volunteers.+ClinicalTrials.gov.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02631642+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span>Assessment
of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of
Various Formulations and Doses of PWT-143. ClinicalTrials.gov. <a href="https://clinicaltrials.gov/ct2/show/NCT02521389" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02521389</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Assessment%0Aof+Safety%2C+Tolerability%2C+Pharmacokinetics+and+Pharmacodynamics+of%0AVarious+Formulations+and+Doses+of+PWT-143.+ClinicalTrials.gov.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02521389+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soumerai, J. D.</span>; <span class="NLM_string-name">Pagel, J. M.</span>; <span class="NLM_string-name">Jagadeesh, D.</span>; <span class="NLM_string-name">Salman, H. S.</span>; <span class="NLM_string-name">Kenkre, V. P.</span>; <span class="NLM_string-name">Asch, A. S.</span>; <span class="NLM_string-name">Stathis, A.</span>; <span class="NLM_string-name">Reddy, N.
M.</span>; <span class="NLM_string-name">Iasonos, A.</span>; <span class="NLM_string-name">Ghalie, R.</span>; <span class="NLM_string-name">Zelenetz, A. D.</span></span> <span> </span><span class="NLM_article-title">Initial Results of a Dose Escalation Study of a Selective and Structurally Differentiated PI3Kδ Inhibitor, ME-401, in Relapsed/Refractory (R/R) Follicular Lymphoma (FL) and Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)</span>. In  <i>Journal of Clinical Oncology</i>, 2018 Annual Meeting of the American Society of Clinical Oncology (ASCO); <span class="NLM_publisher-name">ASCO</span>, <span class="NLM_year">2018</span>; 7519, <a href="http://ascopubs.org/doi/abs/10.1200/JCO.2018.36.15_suppl.7519" class="extLink">http://ascopubs.org/doi/abs/10.1200/JCO.2018.36.15_suppl.7519</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1200%2FJCO.2018.36.15_suppl.7519" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=J.+D.+Soumerai&author=J.+M.+Pagel&author=D.+Jagadeesh&author=H.+S.+Salman&author=V.+P.+Kenkre&author=A.+S.+Asch&author=A.+Stathis&author=N.%0AM.+Reddy&author=A.+Iasonos&author=R.+Ghalie&author=A.+D.+Zelenetz&title=Journal+of+Clinical+Oncology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1200%2FJCO.2018.36.15_suppl.7519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1200%252FJCO.2018.36.15_suppl.7519%26sid%3Dliteratum%253Aachs%26aulast%3DSoumerai%26aufirst%3DJ.%2BD.%26atitle%3DInitial%2520Results%2520of%2520a%2520Dose%2520Escalation%2520Study%2520of%2520a%2520Selective%2520and%2520Structurally%2520Differentiated%2520PI3K%25CE%25B4%2520Inhibitor%252C%2520ME-401%252C%2520in%2520Relapsed%252FRefractory%2520%2528R%252FR%2529%2520Follicular%2520Lymphoma%2520%2528FL%2529%2520and%2520Chronic%2520Lymphocytic%2520Leukemia%2520%2528CLL%2529%252FSmall%2520Lymphocytic%2520Lymphoma%2520%2528SLL%2529%26btitle%3DJournal%2520of%2520Clinical%2520Oncology%26pub%3DASCO%26date%3D2018%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span>MEI Pharma
Reports Third Quarter Fiscal Year 2018 Results. May 9, 2018. <a href="http://investor.meipharma.com/2018-05-09-MEI-Pharma-Reports-Third-Quarter-Fiscal-Year-2018-Results" class="extLink">http://investor.meipharma.com/2018-05-09-MEI-Pharma-Reports-Third-Quarter-Fiscal-Year-2018-Results</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=MEI+Pharma%0AReports+Third+Quarter+Fiscal+Year+2018+Results.+May+9%2C+2018.+http%3A%2F%2Finvestor.meipharma.com%2F2018-05-09-MEI-Pharma-Reports-Third-Quarter-Fiscal-Year-2018-Results+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span>Study
of INCB040093 in Subjects with Previously Treated B-Cell Malignancies. <a href="https://clinicaltrials.gov/ct2/show/study/NCT01905813" class="extLink">https://clinicaltrials.gov/ct2/show/study/NCT01905813</a> (accessed May 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Study%0Aof+INCB040093+in+Subjects+with+Previously+Treated+B-Cell+Malignancies.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2Fstudy%2FNCT01905813+%28accessed+May+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span>A Study
To Investigate the Efficacy, Safety, and Tolerability of Repeat Doses
of Inhaled GSK2269557 in Adults with Persistent, Uncontrolled Asthma.
ClinicalTrials.gov. <a href="https://clinicaltrials.gov/ct2/show/NCT02567708" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02567708</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Study%0ATo+Investigate+the+Efficacy%2C+Safety%2C+and+Tolerability+of+Repeat+Doses%0Aof+Inhaled+GSK2269557+in+Adults+with+Persistent%2C+Uncontrolled+Asthma.%0AClinicalTrials.gov.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02567708+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span>A Study
To Evaluate the Safety, Efficacy and Changes in Induced Sputum and
Blood Biomarkers Following Daily Repeat Doses of Inhaled GSK2269557
in Chronic Obstructive Pulmonary Disease (COPD) Subjects with Acute
Exacerbation. ClinicalTrials.gov. <a href="https://clinicaltrials.gov/ct2/show/NCT02522299" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02522299</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Study%0ATo+Evaluate+the+Safety%2C+Efficacy+and+Changes+in+Induced+Sputum+and%0ABlood+Biomarkers+Following+Daily+Repeat+Doses+of+Inhaled+GSK2269557%0Ain+Chronic+Obstructive+Pulmonary+Disease+%28COPD%29+Subjects+with+Acute%0AExacerbation.+ClinicalTrials.gov.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02522299+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span>Safety,
Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Repeat Doses
of Inhaled GSK2269557 in Patients with APDS/PASLI. ClinicalTrials.gov. <a href="https://clinicaltrials.gov/ct2/show/NCT02593539" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02593539</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Safety%2C%0APharmacokinetic+%28PK%29+and+Pharmacodynamic+%28PD%29+Study+of+Repeat+Doses%0Aof+Inhaled+GSK2269557+in+Patients+with+APDS%2FPASLI.+ClinicalTrials.gov.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02593539+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span>Safety,
Tolerability and Pharmacokinetics of Single and Repeat Doses of GSK2292767
in Healthy Participants Who Smoke Cigarettes. ClinicalTrials.gov. <a href="https://clinicaltrials.gov/ct2/show/record/NCT03045887" class="extLink">https://clinicaltrials.gov/ct2/show/record/NCT03045887</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Safety%2C%0ATolerability+and+Pharmacokinetics+of+Single+and+Repeat+Doses+of+GSK2292767%0Ain+Healthy+Participants+Who+Smoke+Cigarettes.+ClinicalTrials.gov.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2Frecord%2FNCT03045887+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khindri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cahn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Begg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montembault, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leemereise, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wajdner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamblin, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludwig-Sengpiel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornmann, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hessel, E.</span></span> <span> </span><span class="NLM_article-title">A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Crossover Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of Repeat Doses of Inhaled Nemiralisib in Adults with Persistent, Uncontrolled Asthma</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>367</i></span>,  <span class="NLM_fpage">405</span>– <span class="NLM_lpage">413</span>, <span class="refDoi"> DOI: 10.1124/jpet.118.249516</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1124%2Fjpet.118.249516" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=30217958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVWgsr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2018&pages=405-413&author=S.+Khindriauthor=A.+Cahnauthor=M.+Beggauthor=M.+Montembaultauthor=C.+Leemereiseauthor=Y.+Cuiauthor=A.+Hoggauthor=H.+Wajdnerauthor=S.+Yangauthor=J.+Robertsonauthor=J.+N.+Hamblinauthor=A.+Ludwig-Sengpielauthor=O.+Kornmannauthor=E.+Hessel&title=A+Multicentre%2C+Randomised%2C+Double-Blind%2C+Placebo-Controlled%2C+Crossover+Study+to+Investigate+the+Efficacy%2C+Safety%2C+Tolerability+and+Pharmacokinetics+of+Repeat+Doses+of+Inhaled+Nemiralisib+in+Adults+with+Persistent%2C+Uncontrolled+Asthma&doi=10.1124%2Fjpet.118.249516"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">A multicentre, randomized, double-blind, placebo-controlled, crossover study to investigate the efficacy, safety, tolerability, and pharmacokinetics of repeat doses of inhaled nemiralisib in adults with persistent, uncontrolled asthma</span></div><div class="casAuthors">Khindri, Sanjeev; Cahn, Anthony; Begg, Malcolm; Montembault, Mickael; Leemereise, Claudia; Cui, Yi; Hogg, Annabel; Wajdner, Hannah; Yang, Shuying; Robertson, Jon; Hamblin, J. Nicole; Ludwig-Sengpiel, Andrea; Kornmann, Oliver; Hessel, Edith M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">405-413</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Phosphoinositide 3-kinase δ (PI3Kδ) is a lipid kinase involved in leukocyte recruitment and activation.  Activation of PI3Kδ has been linked to airway inflammation and asthma pathogenesis.  This randomized, double-blind, placebo-controlled, crossover study investigated the efficacy, safety, tolerability, and pharmacokinetics of a PI3Kδ inhibitor, nemiralisib (GSK2269557), in patients with persistent, uncontrolled asthma.  Patients (n = 50) received once-daily inhaled nemiralisib (1000 μg) or placebo for 28 days, with a crossover to the alternative treatment following a 4-wk washout period.  Spirometry demonstrated no discernible difference in trough forced expiratory vol. in 1 s (FEV1) from baseline (adjusted posterior median 7 mL; 95% credible interval -83, 102 mL) between nemiralisib and placebo treatment at day 28 (primary endpoint).  These results were supported by most secondary endpoints, including weighted mean FEV1 (0-4 h) and change in trough forced vital capacity at day 28.  Nemiralisib was generally well-tolerated, with few side effects except for post-inhalation cough (nemiralisib: 35%; placebo: 9%).  At day 14, sputum interleukin (IL)-5, IL-13, IL-6, and IL-8 levels were reduced by a median of 17%, 7%, 15%, and 8%, resp., when comparing nemiralisib with placebo [n = 15 (IL-5, IL-8) or 16 (IL-6, IL-13); posterior probability of a true ratio. >0%: 78%, 64%, 76%, and 63%, resp.].  These results suggest that nemiralisib inhibited PI3Kδ locally; however, this did not translate into meaningful clin. improvement.  Further studies will investigate the potential efficacy of nemiralisib in patients with asthma with other specific more severe phenotypes, including those who are colonized with bacteria and frequently exacerbate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYx837TIJvr7Vg90H21EOLACvtfcHk0ljDCqlzFjlYBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVWgsr%252FO&md5=fbad4b66d64f945225b2bdccfd88dd57</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1124%2Fjpet.118.249516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.118.249516%26sid%3Dliteratum%253Aachs%26aulast%3DKhindri%26aufirst%3DS.%26aulast%3DCahn%26aufirst%3DA.%26aulast%3DBegg%26aufirst%3DM.%26aulast%3DMontembault%26aufirst%3DM.%26aulast%3DLeemereise%26aufirst%3DC.%26aulast%3DCui%26aufirst%3DY.%26aulast%3DHogg%26aufirst%3DA.%26aulast%3DWajdner%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DRobertson%26aufirst%3DJ.%26aulast%3DHamblin%26aufirst%3DJ.%2BN.%26aulast%3DLudwig-Sengpiel%26aufirst%3DA.%26aulast%3DKornmann%26aufirst%3DO.%26aulast%3DHessel%26aufirst%3DE.%26atitle%3DA%2520Multicentre%252C%2520Randomised%252C%2520Double-Blind%252C%2520Placebo-Controlled%252C%2520Crossover%2520Study%2520to%2520Investigate%2520the%2520Efficacy%252C%2520Safety%252C%2520Tolerability%2520and%2520Pharmacokinetics%2520of%2520Repeat%2520Doses%2520of%2520Inhaled%2520Nemiralisib%2520in%2520Adults%2520with%2520Persistent%252C%2520Uncontrolled%2520Asthma%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2018%26volume%3D367%26spage%3D405%26epage%3D413%26doi%3D10.1124%2Fjpet.118.249516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span>Dose
Finding Study of Nemiralisib (GSK2269557) in Subjects with an Acute
Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease
(COPD). ClinicalTrials.gov. <a href="https://www.clinicaltrials.gov/ct2/show/NCT03345407" class="extLink">https://www.clinicaltrials.gov/ct2/show/NCT03345407</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Dose%0AFinding+Study+of+Nemiralisib+%28GSK2269557%29+in+Subjects+with+an+Acute%0AModerate+or+Severe+Exacerbation+of+Chronic+Obstructive+Pulmonary+Disease%0A%28COPD%29.+ClinicalTrials.gov.+https%3A%2F%2Fwww.clinicaltrials.gov%2Fct2%2Fshow%2FNCT03345407+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rao, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalm, V. A. S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Šedivá, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Hagen, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holland, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenzweig, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christ, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sloth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabanski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Buck, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doucet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pylvaenaeinen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soldermann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashyap, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uzel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenardo, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkhart, C.</span></span> <span> </span><span class="NLM_article-title">Effective “Activated PI3Kδ Syndrome”-Targeted Therapy with the PI3Kδ Inhibitor Leniolisib</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>130</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">2307</span>– <span class="NLM_lpage">2316</span>, <span class="refDoi"> DOI: 10.1182/blood-2017-08-801191</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1182%2Fblood-2017-08-801191" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2017&pages=2307-2316&issue=21&author=V.+K.+Raoauthor=S.+Websterauthor=V.+A.+S.+H.+Dalmauthor=A.+%C5%A0ediv%C3%A1author=P.+M.+van+Hagenauthor=S.+Hollandauthor=S.+D.+Rosenzweigauthor=A.+D.+Christauthor=B.+Slothauthor=M.+Cabanskiauthor=A.+D.+Joshiauthor=S.+de+Buckauthor=J.+Doucetauthor=D.+Gueriniauthor=C.+Kalisauthor=I.+Pylvaenaeinenauthor=N.+Soldermannauthor=A.+Kashyapauthor=G.+Uzelauthor=M.+J.+Lenardoauthor=D.+D.+Patelauthor=C.+L.+Lucasauthor=C.+Burkhart&title=Effective+%E2%80%9CActivated+PI3K%CE%B4+Syndrome%E2%80%9D-Targeted+Therapy+with+the+PI3K%CE%B4+Inhibitor+Leniolisib&doi=10.1182%2Fblood-2017-08-801191"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1182%2Fblood-2017-08-801191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2017-08-801191%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DV.%2BK.%26aulast%3DWebster%26aufirst%3DS.%26aulast%3DDalm%26aufirst%3DV.%2BA.%2BS.%2BH.%26aulast%3D%25C5%25A0ediv%25C3%25A1%26aufirst%3DA.%26aulast%3Dvan%2BHagen%26aufirst%3DP.%2BM.%26aulast%3DHolland%26aufirst%3DS.%26aulast%3DRosenzweig%26aufirst%3DS.%2BD.%26aulast%3DChrist%26aufirst%3DA.%2BD.%26aulast%3DSloth%26aufirst%3DB.%26aulast%3DCabanski%26aufirst%3DM.%26aulast%3DJoshi%26aufirst%3DA.%2BD.%26aulast%3Dde%2BBuck%26aufirst%3DS.%26aulast%3DDoucet%26aufirst%3DJ.%26aulast%3DGuerini%26aufirst%3DD.%26aulast%3DKalis%26aufirst%3DC.%26aulast%3DPylvaenaeinen%26aufirst%3DI.%26aulast%3DSoldermann%26aufirst%3DN.%26aulast%3DKashyap%26aufirst%3DA.%26aulast%3DUzel%26aufirst%3DG.%26aulast%3DLenardo%26aufirst%3DM.%2BJ.%26aulast%3DPatel%26aufirst%3DD.%2BD.%26aulast%3DLucas%26aufirst%3DC.%2BL.%26aulast%3DBurkhart%26aufirst%3DC.%26atitle%3DEffective%2520%25E2%2580%259CActivated%2520PI3K%25CE%25B4%2520Syndrome%25E2%2580%259D-Targeted%2520Therapy%2520with%2520the%2520PI3K%25CE%25B4%2520Inhibitor%2520Leniolisib%26jtitle%3DBlood%26date%3D2017%26volume%3D130%26issue%3D21%26spage%3D2307%26epage%3D2316%26doi%3D10.1182%2Fblood-2017-08-801191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span>An Open-Label,
Exploratory, Multicenter, Extension Study To Evaluate the Long-Term
Safety, Tolerability, Pharmacokinetics and Efficacy of UCB5857 in
Subjects with Activated Phosphoinositide 3 Kinase (PI3K) Delta Syndrome. <a href="https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-005541-30" class="extLink">https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-005541-30</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=An+Open-Label%2C%0AExploratory%2C+Multicenter%2C+Extension+Study+To+Evaluate+the+Long-Term%0ASafety%2C+Tolerability%2C+Pharmacokinetics+and+Efficacy+of+UCB5857+in%0ASubjects+with+Activated+Phosphoinositide+3+Kinase+%28PI3K%29+Delta+Syndrome.+https%3A%2F%2Fwww.clinicaltrialsregister.eu%2Fctr-search%2Fsearch%3Fquery%3Deudract_number%3A2015-005541-30+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span>Safety,
Pharmacokinetics, and Preliminary Efficacy Study of CDZ173 in Patients
with Primary Sjögren’s Syndrome. ClinicalTrials.gov. <a href="https://clinicaltrials.gov/ct2/show/NCT02775916" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02775916</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Safety%2C%0APharmacokinetics%2C+and+Preliminary+Efficacy+Study+of+CDZ173+in+Patients%0Awith+Primary+Sj%C3%B6gren%E2%80%99s+Syndrome.+ClinicalTrials.gov.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02775916+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span>UCB Proof
of Concept Study in Patients with Primary Sjögren’s
Syndrome. ClinicalTrials.gov. <a href="https://clinicaltrials.gov/ct2/show/NCT02610543" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02610543</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=UCB+Proof%0Aof+Concept+Study+in+Patients+with+Primary+Sj%C3%B6gren%E2%80%99s%0ASyndrome.+ClinicalTrials.gov.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02610543+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span>Orphan
Drug Designations and Approvals. <a href="https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=504315" class="extLink">https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=504315</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Orphan%0ADrug+Designations+and+Approvals.+https%3A%2F%2Fwww.accessdata.fda.gov%2Fscripts%2Fopdlisting%2Foopd%2FdetailedIndex.cfm%3Fcfgridkey%3D504315+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span>Orphan
Drug Designations and Approvals. <a href="https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=579917" class="extLink">https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=579917</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Orphan%0ADrug+Designations+and+Approvals.+https%3A%2F%2Fwww.accessdata.fda.gov%2Fscripts%2Fopdlisting%2Foopd%2FdetailedIndex.cfm%3Fcfgridkey%3D579917+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span>Community
Register of Orphan Medicinal Products. <a href="http://ec.europa.eu/health/documents/community-register/html/o1986.htm" class="extLink">http://ec.europa.eu/health/documents/community-register/html/o1986.htm</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Community%0ARegister+of+Orphan+Medicinal+Products.+http%3A%2F%2Fec.europa.eu%2Fhealth%2Fdocuments%2Fcommunity-register%2Fhtml%2Fo1986.htm+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span>IPI-549.
Infinity Pharmaceuticals, Inc. <a href="http://www.infi.com/home/our-development-program/ipi-549/" class="extLink">http://www.infi.com/home/our-development-program/ipi-549/</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=IPI-549.%0AInfinity+Pharmaceuticals%2C+Inc.+http%3A%2F%2Fwww.infi.com%2Fhome%2Four-development-program%2Fipi-549%2F+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span>Bristol-Myers
Squibb and Infinity Pharmaceuticals Announce Clinical Collaboration
To Evaluate Opdivo (Nivolumab) in Combination with IPI-549 in Advanced
Solid Tumors. BMS Newsroom. <a href="https://news.bms.com/press-release/partnering-news/bristol-myers-squibb-and-infinity-pharmaceuticals-announce-clinical-co" class="extLink">https://news.bms.com/press-release/partnering-news/bristol-myers-squibb-and-infinity-pharmaceuticals-announce-clinical-co</a> (accessed Jun 19, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Bristol-Myers%0ASquibb+and+Infinity+Pharmaceuticals+Announce+Clinical+Collaboration%0ATo+Evaluate+Opdivo+%28Nivolumab%29+in+Combination+with+IPI-549+in+Advanced%0ASolid+Tumors.+BMS+Newsroom.+https%3A%2F%2Fnews.bms.com%2Fpress-release%2Fpartnering-news%2Fbristol-myers-squibb-and-infinity-pharmaceuticals-announce-clinical-co+%28accessed+Jun+19%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span>Arcus
Biosciences and Infinity Pharmaceuticals Announce Clinical Collaboration
To Evaluate Lead Programs in Triple-Combination Studies. <a href="https://www.prnewswire.com/news-releases/arcus-biosciences-and-infinity-pharmaceuticals-announce-clinical-collaboration-to-evaluate-lead-programs-in-triple-combination-studies-300672016.html" class="extLink">https://www.prnewswire.com/news-releases/arcus-biosciences-and-infinity-pharmaceuticals-announce-clinical-collaboration-to-evaluate-lead-programs-in-triple-combination-studies-300672016.html</a> (accessed Jul 5, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Arcus%0ABiosciences+and+Infinity+Pharmaceuticals+Announce+Clinical+Collaboration%0ATo+Evaluate+Lead+Programs+in+Triple-Combination+Studies.+https%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Farcus-biosciences-and-infinity-pharmaceuticals-announce-clinical-collaboration-to-evaluate-lead-programs-in-triple-combination-studies-300672016.html+%28accessed+Jul+5%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evans, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lescarbeau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grenier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pradeilles, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glenadel, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tibbitts, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowley, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiNitto, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brophy, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Hearn, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Hearn, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyt, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soglia, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pink, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proctor, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palombella, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremblay, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, A. C.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-γ Inhibitor (IPI-549) as an Immuno-Oncology Clinical Candidate</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">862</span>– <span class="NLM_lpage">867</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00238</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00238" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=862-867&issue=9&author=C.+A.+Evansauthor=T.+Liuauthor=A.+Lescarbeauauthor=S.+J.+Nairauthor=L.+Grenierauthor=J.+A.+Pradeillesauthor=Q.+Glenadelauthor=T.+Tibbittsauthor=A.+M.+Rowleyauthor=J.+P.+DiNittoauthor=E.+E.+Brophyauthor=E.+L.+O%E2%80%99Hearnauthor=J.+A.+Aliauthor=D.+G.+Winklerauthor=S.+I.+Goldsteinauthor=P.+O%E2%80%99Hearnauthor=C.+M.+Martinauthor=J.+G.+Hoytauthor=J.+R.+Sogliaauthor=C.+Cheungauthor=M.+M.+Pinkauthor=J.+L.+Proctorauthor=V.+J.+Palombellaauthor=M.+R.+Tremblayauthor=A.+C.+Castro&title=Discovery+of+a+Selective+Phosphoinositide-3-Kinase+%28PI3K%29-%CE%B3+Inhibitor+%28IPI-549%29+as+an+Immuno-Oncology+Clinical+Candidate&doi=10.1021%2Facsmedchemlett.6b00238"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00238%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DC.%2BA.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DLescarbeau%26aufirst%3DA.%26aulast%3DNair%26aufirst%3DS.%2BJ.%26aulast%3DGrenier%26aufirst%3DL.%26aulast%3DPradeilles%26aufirst%3DJ.%2BA.%26aulast%3DGlenadel%26aufirst%3DQ.%26aulast%3DTibbitts%26aufirst%3DT.%26aulast%3DRowley%26aufirst%3DA.%2BM.%26aulast%3DDiNitto%26aufirst%3DJ.%2BP.%26aulast%3DBrophy%26aufirst%3DE.%2BE.%26aulast%3DO%25E2%2580%2599Hearn%26aufirst%3DE.%2BL.%26aulast%3DAli%26aufirst%3DJ.%2BA.%26aulast%3DWinkler%26aufirst%3DD.%2BG.%26aulast%3DGoldstein%26aufirst%3DS.%2BI.%26aulast%3DO%25E2%2580%2599Hearn%26aufirst%3DP.%26aulast%3DMartin%26aufirst%3DC.%2BM.%26aulast%3DHoyt%26aufirst%3DJ.%2BG.%26aulast%3DSoglia%26aufirst%3DJ.%2BR.%26aulast%3DCheung%26aufirst%3DC.%26aulast%3DPink%26aufirst%3DM.%2BM.%26aulast%3DProctor%26aufirst%3DJ.%2BL.%26aulast%3DPalombella%26aufirst%3DV.%2BJ.%26aulast%3DTremblay%26aufirst%3DM.%2BR.%26aulast%3DCastro%26aufirst%3DA.%2BC.%26atitle%3DDiscovery%2520of%2520a%2520Selective%2520Phosphoinositide-3-Kinase%2520%2528PI3K%2529-%25CE%25B3%2520Inhibitor%2520%2528IPI-549%2529%2520as%2520an%2520Immuno-Oncology%2520Clinical%2520Candidate%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26issue%3D9%26spage%3D862%26epage%3D867%26doi%3D10.1021%2Facsmedchemlett.6b00238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span>Press
Release: Verastem. <a href="http://investor.verastem.com/phoenix.zhtml?c=250749&amp;p=irol-newsArticle&amp;ID=2341489" class="extLink">http://investor.verastem.com/phoenix.zhtml?c=250749&p=irol-newsArticle&ID=2341489</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Press%0ARelease%3A+Verastem.+http%3A%2F%2Finvestor.verastem.com%2Fphoenix.zhtml%3Fc%3D250749%26p%3Dirol-newsArticle%26ID%3D2341489+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmalbach, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuhr, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albayaty, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douglas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunbar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKee, C.</span></span> <span> </span><span class="NLM_article-title">Duvelisib, a PI3K-δ,γ Inhibitor, in Subjects with Mild Asthma</span>. <i>Eur. Respir. J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">Suppl. 59</span>),  <span class="NLM_fpage">PA2122</span>, <span class="refDoi"> DOI: 10.1183/13993003.congress-2015.PA2122</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1183%2F13993003.congress-2015.PA2122" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2015&pages=PA2122&issue=Suppl.+59&author=T.+Schmalbachauthor=R.+Fuhrauthor=M.+Albayatyauthor=K.+Allenauthor=M.+Douglasauthor=J.+Dunbarauthor=J.+McLaughlinauthor=L.+Alexanderauthor=C.+McKee&title=Duvelisib%2C+a+PI3K-%CE%B4%2C%CE%B3+Inhibitor%2C+in+Subjects+with+Mild+Asthma&doi=10.1183%2F13993003.congress-2015.PA2122"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1183%2F13993003.congress-2015.PA2122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1183%252F13993003.congress-2015.PA2122%26sid%3Dliteratum%253Aachs%26aulast%3DSchmalbach%26aufirst%3DT.%26aulast%3DFuhr%26aufirst%3DR.%26aulast%3DAlbayaty%26aufirst%3DM.%26aulast%3DAllen%26aufirst%3DK.%26aulast%3DDouglas%26aufirst%3DM.%26aulast%3DDunbar%26aufirst%3DJ.%26aulast%3DMcLaughlin%26aufirst%3DJ.%26aulast%3DAlexander%26aufirst%3DL.%26aulast%3DMcKee%26aufirst%3DC.%26atitle%3DDuvelisib%252C%2520a%2520PI3K-%25CE%25B4%252C%25CE%25B3%2520Inhibitor%252C%2520in%2520Subjects%2520with%2520Mild%2520Asthma%26jtitle%3DEur.%2520Respir.%2520J.%26date%3D2015%26volume%3D46%26issue%3DSuppl.%252059%26spage%3DPA2122%26doi%3D10.1183%2F13993003.congress-2015.PA2122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ojiaku, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunder, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panettieri, R. A.</span></span> <span> </span><span class="NLM_article-title">Phosphoinositide 3-Kinase in Asthma: Novel Roles and Therapeutic Approaches</span>. <i>Am. J. Respir. Cell Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">700</span>– <span class="NLM_lpage">707</span>, <span class="refDoi"> DOI: 10.1165/rcmb.2016-0308TR</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1165%2Frcmb.2016-0308TR" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=27977296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1artrrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=700-707&issue=6&author=E.+J.+Yooauthor=C.+A.+Ojiakuauthor=K.+Sunderauthor=R.+A.+Panettieri&title=Phosphoinositide+3-Kinase+in+Asthma%3A+Novel+Roles+and+Therapeutic+Approaches&doi=10.1165%2Frcmb.2016-0308TR"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphoinositide 3-kinase in asthma: novel roles and therapeutic approaches</span></div><div class="casAuthors">Yoo, Edwin J.; Ojiaku, Christie A.; Sunder, Krishna; Panettieri, Reynold A., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">700-707</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Asthma manifests as airway hyperresponsiveness and inflammation, including coughing, wheezing, and shortness of breath.  Immune cells and airway structural cells orchestrate asthma pathophysiol., leading to mucus secretion, airway narrowing, and obstruction.  Phosphoinositide 3-kinase, a lipid kinase, plays a crucial role in many of the cellular and mol. mechanisms driving asthma pathophysiol. and represents an attractive therapeutic target.  Here, we summarize the diverse roles of phosphoinositide 3-kinase in the pathogenesis of asthma and discuss novel therapeutic approaches to treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraWH_Lnj-6X7Vg90H21EOLACvtfcHk0liXhRqZKFr7Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1artrrI&md5=67d7e791406eae6be3ebb2a352a13e9d</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2016-0308TR&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2016-0308TR%26sid%3Dliteratum%253Aachs%26aulast%3DYoo%26aufirst%3DE.%2BJ.%26aulast%3DOjiaku%26aufirst%3DC.%2BA.%26aulast%3DSunder%26aufirst%3DK.%26aulast%3DPanettieri%26aufirst%3DR.%2BA.%26atitle%3DPhosphoinositide%25203-Kinase%2520in%2520Asthma%253A%2520Novel%2520Roles%2520and%2520Therapeutic%2520Approaches%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2017%26volume%3D56%26issue%3D6%26spage%3D700%26epage%3D707%26doi%3D10.1165%2Frcmb.2016-0308TR" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leff, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikulenkova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaidashev, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunbar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinblatt, M.</span></span> <span> </span><span class="NLM_article-title">Safety and Efficacy Results of a Phase 2, Double-Blind, Placebo-Controlled Clinical Study of Duvelisib with Background Methotrexate (MTX) in Adults with Moderate-to-Severe Rheumatoid Arthritis (RA) - ACR Meeting Abstracts</span>. <i>Arthritis Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">Suppl. 10</span>),  <span class="NLM_fpage">2138</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2015&pages=2138&issue=Suppl.+10&author=R.+Leffauthor=S.+Kumarauthor=N.+Nikulenkovaauthor=I.+Kaidashevauthor=K.+Allenauthor=J.+Dunbarauthor=H.+Sternauthor=J.+Adamsauthor=M.+Weinblatt&title=Safety+and+Efficacy+Results+of+a+Phase+2%2C+Double-Blind%2C+Placebo-Controlled+Clinical+Study+of+Duvelisib+with+Background+Methotrexate+%28MTX%29+in+Adults+with+Moderate-to-Severe+Rheumatoid+Arthritis+%28RA%29+-+ACR+Meeting+Abstracts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeff%26aufirst%3DR.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DNikulenkova%26aufirst%3DN.%26aulast%3DKaidashev%26aufirst%3DI.%26aulast%3DAllen%26aufirst%3DK.%26aulast%3DDunbar%26aufirst%3DJ.%26aulast%3DStern%26aufirst%3DH.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DWeinblatt%26aufirst%3DM.%26atitle%3DSafety%2520and%2520Efficacy%2520Results%2520of%2520a%2520Phase%25202%252C%2520Double-Blind%252C%2520Placebo-Controlled%2520Clinical%2520Study%2520of%2520Duvelisib%2520with%2520Background%2520Methotrexate%2520%2528MTX%2529%2520in%2520Adults%2520with%2520Moderate-to-Severe%2520Rheumatoid%2520Arthritis%2520%2528RA%2529%2520-%2520ACR%2520Meeting%2520Abstracts%26jtitle%3DArthritis%2520Rheumatol.%26date%3D2015%26volume%3D67%26issue%3DSuppl.%252010%26spage%3D2138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span>Safety
and Efficacy Study of Tenalisib (RP6530) in Combination with Pembrolizumab
in Relapsed or Refractory cHL. ClinicalTrials.gov. <a href="https://clinicaltrials.gov/ct2/show/NCT03471351" class="extLink">https://clinicaltrials.gov/ct2/show/NCT03471351</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Safety%0Aand+Efficacy+Study+of+Tenalisib+%28RP6530%29+in+Combination+with+Pembrolizumab%0Ain+Relapsed+or+Refractory+cHL.+ClinicalTrials.gov.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT03471351+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span>Rhizen
Pharmaceuticals S.A. Receives FDA Fast Track Designation for Tenalisib
(RP6530), a Highly Selective Dual PI3K Delta/Gamma Inhibitor for the
Treatment of Patients with Relapsed and/or Refractory Cutaneous T-cell
Lymphoma (CTCL). <a href="https://globenewswire.com/news-release/2018/04/13/1471290/0/en/Rhizen-Pharmaceuticals-S-A-receives-FDA-Fast-Track-Designation-for-Tenalisib-RP6530-a-highly-selective-dual-PI3K-delta-gamma-inhibitor-for-the-treatment-of-patients-with-relapsed-a.html" class="extLink">https://globenewswire.com/news-release/2018/04/13/1471290/0/en/Rhizen-Pharmaceuticals-S-A-receives-FDA-Fast-Track-Designation-for-Tenalisib-RP6530-a-highly-selective-dual-PI3K-delta-gamma-inhibitor-for-the-treatment-of-patients-with-relapsed-a.html</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Rhizen%0APharmaceuticals+S.A.+Receives+FDA+Fast+Track+Designation+for+Tenalisib%0A%28RP6530%29%2C+a+Highly+Selective+Dual+PI3K+Delta%2FGamma+Inhibitor+for+the%0ATreatment+of+Patients+with+Relapsed+and%2For+Refractory+Cutaneous+T-cell%0ALymphoma+%28CTCL%29.+https%3A%2F%2Fglobenewswire.com%2Fnews-release%2F2018%2F04%2F13%2F1471290%2F0%2Fen%2FRhizen-Pharmaceuticals-S-A-receives-FDA-Fast-Track-Designation-for-Tenalisib-RP6530-a-highly-selective-dual-PI3K-delta-gamma-inhibitor-for-the-treatment-of-patients-with-relapsed-a.html+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span>A Study
To Investigate the Safety, Tolerability and Pharmacokinetics of Single
and Repeat Doses of RV1729 for up to 28 Days. ClinicalTrials.gov. <a href="https://clinicaltrials.gov/ct2/show/study/NCT02140320" class="extLink">https://clinicaltrials.gov/ct2/show/study/NCT02140320</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Study%0ATo+Investigate+the+Safety%2C+Tolerability+and+Pharmacokinetics+of+Single%0Aand+Repeat+Doses+of+RV1729+for+up+to+28+Days.+ClinicalTrials.gov.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2Fstudy%2FNCT02140320+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span>A Study
To Investigate the Safety, Tolerability and Pharmacokinetics of Single
and Repeat Doses of RV1729. ClinicalTrials.gov. <a href="https://www.clinicaltrials.gov/ct2/show/NCT01813084" class="extLink">https://www.clinicaltrials.gov/ct2/show/NCT01813084</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Study%0ATo+Investigate+the+Safety%2C+Tolerability+and+Pharmacokinetics+of+Single%0Aand+Repeat+Doses+of+RV1729.+ClinicalTrials.gov.+https%3A%2F%2Fwww.clinicaltrials.gov%2Fct2%2Fshow%2FNCT01813084+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span>A Study
To Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics
of Repeat Doses of RV1729 for 28 Days in Patients with COPD. ClinicalTrials.gov <a href="https://www.clinicaltrials.gov/ct2/show/NCT02140346" class="extLink">https://www.clinicaltrials.gov/ct2/show/NCT02140346</a> (accessed Oct 12, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Study%0ATo+Investigate+Safety%2C+Tolerability%2C+Pharmacokinetics+and+Pharmacodynamics%0Aof+Repeat+Doses+of+RV1729+for+28+Days+in+Patients+with+COPD.+ClinicalTrials.gov+https%3A%2F%2Fwww.clinicaltrials.gov%2Fct2%2Fshow%2FNCT02140346+%28accessed+Oct+12%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Norman, P.</span></span> <span> </span><span class="NLM_article-title">Evaluation of WO2013136076: Two Crystalline Forms of the Phosphatidylinositol 3-Kinase-δ Inhibitor RV-1729</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">471</span>– <span class="NLM_lpage">475</span>, <span class="refDoi"> DOI: 10.1517/13543776.2014.865725</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1517%2F13543776.2014.865725" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=24283201" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC2cXksFOqu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=471-475&issue=4&author=P.+Norman&title=Evaluation+of+WO2013136076%3A+Two+Crystalline+Forms+of+the+Phosphatidylinositol+3-Kinase-%CE%B4+Inhibitor+RV-1729&doi=10.1517%2F13543776.2014.865725"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of WO2013136076: two crystalline forms of the phosphatidylinositol 3-kinase-δ inhibitor RV-1729</span></div><div class="casAuthors">Norman, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">471-475</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">This application claims two cryst. forms and inhaled formulations of a the selective phosphatidylinositol 3-kinase-δ inhibitor (PI3Kδ) inhibitor 6-(2-((4-amino-3-(3-hydroxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)-3-(2-chlorobenzyl)-4-oxo-3,4-dihydroquinazolin-5-yl)-N, N-bis(2-methoxyethyl)hex-5-ynamide.  These formulations are claimed to be useful in the treatment of respiratory diseases including asthma and chronic obstructive pulmonary disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZoor0AnthnbVg90H21EOLACvtfcHk0ljxPCfCxObtcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXksFOqu7k%253D&md5=d3b0f3c4b492e3eae072793137b46fa2</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1517%2F13543776.2014.865725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2014.865725%26sid%3Dliteratum%253Aachs%26aulast%3DNorman%26aufirst%3DP.%26atitle%3DEvaluation%2520of%2520WO2013136076%253A%2520Two%2520Crystalline%2520Forms%2520of%2520the%2520Phosphatidylinositol%25203-Kinase-%25CE%25B4%2520Inhibitor%2520RV-1729%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2014%26volume%3D24%26issue%3D4%26spage%3D471%26epage%3D475%26doi%3D10.1517%2F13543776.2014.865725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span>A Study
To Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics
of Single and Repeat Doses of RV6153. ClinicalTrials.gov. <a href="https://www.clinicaltrials.gov/ct2/show/NCT02517359" class="extLink">https://www.clinicaltrials.gov/ct2/show/NCT02517359</a> (accessed Oct 18, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Study%0ATo+Investigate+the+Safety%2C+Tolerability%2C+Pharmacokinetics+and+Pharmacodynamics%0Aof+Single+and+Repeat+Doses+of+RV6153.+ClinicalTrials.gov.+https%3A%2F%2Fwww.clinicaltrials.gov%2Fct2%2Fshow%2FNCT02517359+%28accessed+Oct+18%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span>A Study
To Evaluate the Safety, Tolerability and Study Drug Absorption to
the Blood After Administration of Single Ascending Doses of AZD8154
in Healthy Subjects. ClinicalTrials.gov. <a href="https://www.clinicaltrials.gov/ct2/show/NCT03436316" class="extLink">https://www.clinicaltrials.gov/ct2/show/NCT03436316</a> (accessed Jul 5, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Study%0ATo+Evaluate+the+Safety%2C+Tolerability+and+Study+Drug+Absorption+to%0Athe+Blood+After+Administration+of+Single+Ascending+Doses+of+AZD8154%0Ain+Healthy+Subjects.+ClinicalTrials.gov.+https%3A%2F%2Fwww.clinicaltrials.gov%2Fct2%2Fshow%2FNCT03436316+%28accessed+Jul+5%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nair, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheson, B.</span></span> <span> </span><span class="NLM_article-title">The Role of Idelalisib in the Treatment of Relapsed and Refractory Chronic Lymphocytic Leukemia</span>. <i>Ther. Adv. Hematol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">69</span>– <span class="NLM_lpage">84</span>, <span class="refDoi"> DOI: 10.1177/2040620715625966</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1177%2F2040620715625966" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=27054023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvVWgsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=69-84&issue=2&author=K.+S.+Nairauthor=B.+Cheson&title=The+Role+of+Idelalisib+in+the+Treatment+of+Relapsed+and+Refractory+Chronic+Lymphocytic+Leukemia&doi=10.1177%2F2040620715625966"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">The role of idelalisib in the treatment of relapsed and refractory chronic lymphocytic leukemia</span></div><div class="casAuthors">Nair, Kruti Sheth; Cheson, Bruce</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutic Advances in Hematology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">69-84</span>CODEN:
                <span class="NLM_cas:coden">TAHHAT</span>;
        ISSN:<span class="NLM_cas:issn">2040-6207</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">Idelalisib is a first in class, delta isoform specific, PI3-kinase inhibitor.  Based on its high level of efficacy and acceptable safety profile, this oral drug has been approved by the US Food and Drug Administration as a single agent for the treatment of relapsed or refractory small lymphocytic lymphoma, and follicular non-Hodgkin lymphoma, and in combination with rituximab for patients with chronic lymphocytic leukemia.  Adverse effects of particular concern include diarrhea, pneumonitis, and transient elevations of hepatic transaminase levels.  Efforts to improve on the activity of this drug have included combinations with std. chemotherapy agents, such as bendamustine, and other targeted therapies, including checkpoint inhibitors.  However, other combinations have been assocd. with life-threatening and fatal toxicities.  Thus, the development of such regimens should be conducted carefully in the context of a clin. research study.  Idelalisib has a vital role as second-line therapy for chronic lymphocytic leukemia, esp. for patients with high-risk disease and multiple comorbidities, and studies are exploring the use of this agent as front-line therapy to improve the outcome of patients with indolent B-cell malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUxNiF55aL1bVg90H21EOLACvtfcHk0ljxPCfCxObtcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvVWgsr8%253D&md5=295f67243254ea3ff1df0327c6bbedc1</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1177%2F2040620715625966&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F2040620715625966%26sid%3Dliteratum%253Aachs%26aulast%3DNair%26aufirst%3DK.%2BS.%26aulast%3DCheson%26aufirst%3DB.%26atitle%3DThe%2520Role%2520of%2520Idelalisib%2520in%2520the%2520Treatment%2520of%2520Relapsed%2520and%2520Refractory%2520Chronic%2520Lymphocytic%2520Leukemia%26jtitle%3DTher.%2520Adv.%2520Hematol.%26date%3D2016%26volume%3D7%26issue%3D2%26spage%3D69%26epage%3D84%26doi%3D10.1177%2F2040620715625966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamanna, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kipps, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flinn, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zelenetz, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burger, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keating, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dansey, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubowy, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coutre, S. E.</span></span> <span> </span><span class="NLM_article-title">A Phase 2 Study of Idelalisib plus Rituximab in Treatment-Naïve Older Patients with Chronic Lymphocytic Leukemia</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>126</i></span> (<span class="NLM_issue">25</span>),  <span class="NLM_fpage">2686</span>– <span class="NLM_lpage">2694</span>, <span class="refDoi"> DOI: 10.1182/blood-2015-03-630947</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1182%2Fblood-2015-03-630947" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2015&pages=2686-2694&issue=25&author=S.+M.+O%E2%80%99Brienauthor=N.+Lamannaauthor=T.+J.+Kippsauthor=I.+Flinnauthor=A.+D.+Zelenetzauthor=J.+A.+Burgerauthor=M.+Keatingauthor=S.+Mitraauthor=L.+Holesauthor=A.+S.+Yuauthor=D.+M.+Johnsonauthor=L.+L.+Millerauthor=Y.+Kimauthor=R.+D.+Danseyauthor=R.+L.+Dubowyauthor=S.+E.+Coutre&title=A+Phase+2+Study+of+Idelalisib+plus+Rituximab+in+Treatment-Na%C3%AFve+Older+Patients+with+Chronic+Lymphocytic+Leukemia&doi=10.1182%2Fblood-2015-03-630947"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1182%2Fblood-2015-03-630947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2015-03-630947%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DS.%2BM.%26aulast%3DLamanna%26aufirst%3DN.%26aulast%3DKipps%26aufirst%3DT.%2BJ.%26aulast%3DFlinn%26aufirst%3DI.%26aulast%3DZelenetz%26aufirst%3DA.%2BD.%26aulast%3DBurger%26aufirst%3DJ.%2BA.%26aulast%3DKeating%26aufirst%3DM.%26aulast%3DMitra%26aufirst%3DS.%26aulast%3DHoles%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DA.%2BS.%26aulast%3DJohnson%26aufirst%3DD.%2BM.%26aulast%3DMiller%26aufirst%3DL.%2BL.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DDansey%26aufirst%3DR.%2BD.%26aulast%3DDubowy%26aufirst%3DR.%2BL.%26aulast%3DCoutre%26aufirst%3DS.%2BE.%26atitle%3DA%2520Phase%25202%2520Study%2520of%2520Idelalisib%2520plus%2520Rituximab%2520in%2520Treatment-Na%25C3%25AFve%2520Older%2520Patients%2520with%2520Chronic%2520Lymphocytic%2520Leukemia%26jtitle%3DBlood%26date%3D2015%26volume%3D126%26issue%3D25%26spage%3D2686%26epage%3D2694%26doi%3D10.1182%2Fblood-2015-03-630947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span>Idelalisib
Pharmaprojects. <a href="https://pharmaintelligence.informa.com/products-and-services/data-and-analysis/pharmaprojects" class="extLink">https://pharmaintelligence.informa.com/products-and-services/data-and-analysis/pharmaprojects</a> (accessed Jun 22, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Idelalisib%0APharmaprojects.+https%3A%2F%2Fpharmaintelligence.informa.com%2Fproducts-and-services%2Fdata-and-analysis%2Fpharmaprojects+%28accessed+Jun+22%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span>Efficacy
and Safety of Idelalisib in Combination with Obinutuzumab Compared
to Chlorambucil in Combination with Obinutuzumab for Previously Untreated
Chronic Lymphocytic Leukemia. ClinicalTrials.gov. <a href="https://clinicaltrials.gov/ct2/show/NCT01980875" class="extLink">https://clinicaltrials.gov/ct2/show/NCT01980875</a> (accessed Jun 18, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Efficacy%0Aand+Safety+of+Idelalisib+in+Combination+with+Obinutuzumab+Compared%0Ato+Chlorambucil+in+Combination+with+Obinutuzumab+for+Previously+Untreated%0AChronic+Lymphocytic+Leukemia.+ClinicalTrials.gov.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01980875+%28accessed+Jun+18%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burris, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flinn, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenske, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brander, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutierrez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Essell, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miskin, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sportelli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vakkalanka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savona, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, O. A.</span></span> <span> </span><span class="NLM_article-title">Umbralisib, a Novel PI3Kδ and Casein Kinase-1ε Inhibitor, in Relapsed or Refractory Chronic Lymphocytic Leukaemia and Lymphoma: An Open-Label, Phase 1, Dose-Escalation, First-in-Human Study</span>. <i>Lancet Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">496</span>, <span class="refDoi"> DOI: 10.1016/S1470-2045(18)30082-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2FS1470-2045%2818%2930082-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=29475723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjs1eis78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=486-496&issue=4&author=H.+A.+Burrisauthor=I.+W.+Flinnauthor=M.+R.+Patelauthor=T.+S.+Fenskeauthor=C.+Dengauthor=D.+M.+Branderauthor=M.+Gutierrezauthor=J.+H.+Essellauthor=J.+G.+Kuhnauthor=H.+P.+Miskinauthor=P.+Sportelliauthor=M.+S.+Weissauthor=S.+Vakkalankaauthor=M.+R.+Savonaauthor=O.+A.+O%E2%80%99Connor&title=Umbralisib%2C+a+Novel+PI3K%CE%B4+and+Casein+Kinase-1%CE%B5+Inhibitor%2C+in+Relapsed+or+Refractory+Chronic+Lymphocytic+Leukaemia+and+Lymphoma%3A+An+Open-Label%2C+Phase+1%2C+Dose-Escalation%2C+First-in-Human+Study&doi=10.1016%2FS1470-2045%2818%2930082-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Umbralisib, a novel PI3Kδ and casein kinase-1ε inhibitor, in relapsed or refractory chronic lymphocytic leukaemia and lymphoma: an open-label, phase 1, dose-escalation, first-in-human study</span></div><div class="casAuthors">Burris, Howard A., III; Flinn, Ian W.; Patel, Manish R.; Fenske, Timothy S.; Deng, Changchun; Brander, Danielle M.; Gutierrez, Martin; Essell, James H.; Kuhn, John G.; Miskin, Hari P.; Sportelli, Peter; Weiss, Michael S.; Vakkalanka, Swaroop; Savona, Michael R.; O'Connor, Owen A.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-496</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Umbralisib (TGR-1202) is a novel next-generation inhibitor of phosphatidylinositol 3-kinase (PI3K) isoform p110δ (PI3Kδ), which is structurally distinct from other PI3Kδ inhibitors and shows improved isoform selectivity.  Umbralisib also uniquely inhibits casein kinase-1ε, a major regulator of protein translation.  The aim of this first-in-human phase 1 study was to establish the safety and preliminary activity profile of umbralisib in patients with haematol. malignancies.  We did an open-label, phase 1, dose-escalation study at seven clinics in the USA.  We recruited patients aged at least 18 years with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma, B-cell and T-cell non-Hodgkin lymphoma, or Hodgkin's lymphoma, who had received one or more previous lines of therapy, with measurable and assessable disease, and adequate organ system function.  Patients self-administered an umbralisib oral tablet once per day in 28-day cycles, with dose escalation done in a traditional 3 + 3 design to establish safety and det. the max. tolerated dose.  In initial cohorts, patients took umbralisib in a fasting state at a starting dose of 50 mg, increasing to 100, 200, 400, 800, 1200, and 1800 mg until the max. tolerated dose was reached, or the maximal dose cohort was accrued without a dose-limiting toxicity.  Subsequent cohorts self-administered a micronized formulation of umbralisib tablet in a fed state at an initial dose of 200 mg, increased in increments to 400, 800, 1200, and 1800 mg until the max. tolerated dose or the maximal dose level was accrued.  In August, 2014, all patients still on study were transitioned to 800 mg of the micronized formulation and dosing of the initial formulation was discontinued.  The primary endpoints of the study were investigator-assessed safety in all treated patients (the safety population), the max. tolerated dose, and the pharmacokinetics of umbralisib.  Secondary endpoints included preliminary assessments of anti-cancer activity (objective responses and duration of response).  Follow-up stopped for a patient once they discontinued therapy.  This study has been completed and is registered with ClinicalTrials.gov, no. NCT01767766.  Between Jan 17, 2013, and Jan 14, 2016, we enrolled and treated 90 patients with umbralisib.  The median duration of treatment and follow-up was 4·7 cycles (IQR 2·0-14·0) or 133 days (IQR 55-335).  The most common treatment-emergent adverse events irresp. of causality were diarrhea (in 39 [43%] of 90 patients), nausea (38 [42%]), and fatigue (28 [31%]).  The most common grade 3 or 4 adverse events were neutropenia (in 12 [13%] patients), anemia (eight [9%]) and thrombocytopenia (six [7%]).  Serious adverse events considered at least possibly related to umbralisib occurred in seven patients: pneumonia in three (3%) patients, lung infection in one (1%), febrile neutropenia in one (1%), and colitis in two (2%), one of whom also had febrile neutropenia.  The max. tolerated dose was 1200 mg of the micronized formulation, with 800 mg of this formulation selected as the recommended phase 2 dose.  Both cases of colitis occurred at above the recommended phase 2 dose. 33 (37%) of the 90 patients enrolled had an objective response to treatment with umbralisib.  Umbralisib was well tolerated and showed preliminary signs of activity in patients with relapsed or refractory haematol. malignancies.  The safety profile of umbralisib in this phase 1 study was distinct from that of other PI3Kδ inhibitors, with fewer occurrences of autoimmune-like toxicities such as colitis.  These findings warrant further evaluation of this agent in this setting.TG Therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6a2gayrthBrVg90H21EOLACvtfcHk0lhe2TlEaNttnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjs1eis78%253D&md5=fc763abd079ae4d06a0a1ae977c5bddb</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2818%2930082-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252818%252930082-2%26sid%3Dliteratum%253Aachs%26aulast%3DBurris%26aufirst%3DH.%2BA.%26aulast%3DFlinn%26aufirst%3DI.%2BW.%26aulast%3DPatel%26aufirst%3DM.%2BR.%26aulast%3DFenske%26aufirst%3DT.%2BS.%26aulast%3DDeng%26aufirst%3DC.%26aulast%3DBrander%26aufirst%3DD.%2BM.%26aulast%3DGutierrez%26aufirst%3DM.%26aulast%3DEssell%26aufirst%3DJ.%2BH.%26aulast%3DKuhn%26aufirst%3DJ.%2BG.%26aulast%3DMiskin%26aufirst%3DH.%2BP.%26aulast%3DSportelli%26aufirst%3DP.%26aulast%3DWeiss%26aufirst%3DM.%2BS.%26aulast%3DVakkalanka%26aufirst%3DS.%26aulast%3DSavona%26aufirst%3DM.%2BR.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DO.%2BA.%26atitle%3DUmbralisib%252C%2520a%2520Novel%2520PI3K%25CE%25B4%2520and%2520Casein%2520Kinase-1%25CE%25B5%2520Inhibitor%252C%2520in%2520Relapsed%2520or%2520Refractory%2520Chronic%2520Lymphocytic%2520Leukaemia%2520and%2520Lymphoma%253A%2520An%2520Open-Label%252C%2520Phase%25201%252C%2520Dose-Escalation%252C%2520First-in-Human%2520Study%26jtitle%3DLancet%2520Oncol.%26date%3D2018%26volume%3D19%26issue%3D4%26spage%3D486%26epage%3D496%26doi%3D10.1016%2FS1470-2045%2818%2930082-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span>Umbralisib
Pharmaprojects. <a href="https://pharmaintelligence.informa.com/products-and-services/data-and-analysis/pharmaprojects" class="extLink">https://pharmaintelligence.informa.com/products-and-services/data-and-analysis/pharmaprojects</a> (accessed May 21, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Umbralisib%0APharmaprojects.+https%3A%2F%2Fpharmaintelligence.informa.com%2Fproducts-and-services%2Fdata-and-analysis%2Fpharmaprojects+%28accessed+May+21%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span>INCB-050465
Pharmaprojects. <a href="https://pharmaintelligence.informa.com/products-and-services/data-and-analysis/pharmaprojects" class="extLink">https://pharmaintelligence.informa.com/products-and-services/data-and-analysis/pharmaprojects</a> (accessed May 24, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=INCB-050465%0APharmaprojects.+https%3A%2F%2Fpharmaintelligence.informa.com%2Fproducts-and-services%2Fdata-and-analysis%2Fpharmaprojects+%28accessed+May+24%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span>ME-401
Pharmaprojects. <a href="https://pharmaintelligence.informa.com/products-and-services/data-and-analysis/pharmaprojects" class="extLink">https://pharmaintelligence.informa.com/products-and-services/data-and-analysis/pharmaprojects</a> (accessed May 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ME-401%0APharmaprojects.+https%3A%2F%2Fpharmaintelligence.informa.com%2Fproducts-and-services%2Fdata-and-analysis%2Fpharmaprojects+%28accessed+May+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kater, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonino, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiering, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chamuleau, M. E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adewoye, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dreiling, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doorduijn, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kersten, M. J.</span></span> <span> </span><span class="NLM_article-title">Final Results of a Phase 1b Study of the Safety and Efficacy of the PI3Kδ Inhibitor Acalisib (GS-9820) in Relapsed/Refractory Lymphoid Malignancies</span>. <i>Blood Cancer J.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">16</span>, <span class="refDoi"> DOI: 10.1038/s41408-018-0055-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1038%2Fs41408-018-0055-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=29434192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A280%3ADC%252BC1MrgslSjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=16&issue=2&author=A.+P.+Katerauthor=S.+H.+Toninoauthor=M.+Spieringauthor=M.+E.+D.+Chamuleauauthor=R.+Liuauthor=A.+H.+Adewoyeauthor=J.+Gaoauthor=L.+Dreilingauthor=Y.+Xinauthor=J.+K.+Doorduijnauthor=M.+J.+Kersten&title=Final+Results+of+a+Phase+1b+Study+of+the+Safety+and+Efficacy+of+the+PI3K%CE%B4+Inhibitor+Acalisib+%28GS-9820%29+in+Relapsed%2FRefractory+Lymphoid+Malignancies&doi=10.1038%2Fs41408-018-0055-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Final results of a phase 1b study of the safety and efficacy of the PI3Kδ inhibitor acalisib (GS-9820) in relapsed/refractory lymphoid malignancies</span></div><div class="casAuthors">Kater Arnon P; Tonino Sanne H; Spiering Marjolein; Kersten Marie Jose; Kater Arnon P; Tonino Sanne H; Kersten Marie Jose; Chamuleau Martine E D; Liu Roberto; Adewoye Adeboye Henry; Gao Jie; Dreiling Lyndah; Xin Yan; Doorduijn Jeanette K</div><div class="citationInfo"><span class="NLM_cas:title">Blood cancer journal</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">16</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT9xn_VdnX4CUBuFdjgVNKSfW6udTcc2eYK6NZOnmX48bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MrgslSjtg%253D%253D&md5=6992eb2b0978baa671e6e172330f8b2f</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1038%2Fs41408-018-0055-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41408-018-0055-x%26sid%3Dliteratum%253Aachs%26aulast%3DKater%26aufirst%3DA.%2BP.%26aulast%3DTonino%26aufirst%3DS.%2BH.%26aulast%3DSpiering%26aufirst%3DM.%26aulast%3DChamuleau%26aufirst%3DM.%2BE.%2BD.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DAdewoye%26aufirst%3DA.%2BH.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DDreiling%26aufirst%3DL.%26aulast%3DXin%26aufirst%3DY.%26aulast%3DDoorduijn%26aufirst%3DJ.%2BK.%26aulast%3DKersten%26aufirst%3DM.%2BJ.%26atitle%3DFinal%2520Results%2520of%2520a%2520Phase%25201b%2520Study%2520of%2520the%2520Safety%2520and%2520Efficacy%2520of%2520the%2520PI3K%25CE%25B4%2520Inhibitor%2520Acalisib%2520%2528GS-9820%2529%2520in%2520Relapsed%252FRefractory%2520Lymphoid%2520Malignancies%26jtitle%3DBlood%2520Cancer%2520J.%26date%3D2018%26volume%3D8%26issue%3D2%26spage%3D16%26doi%3D10.1038%2Fs41408-018-0055-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span>An Efficacy
Study of GSK2269557 Added to Standard Care in Subjects with an Acute
Exacerbation of Chronic Obstructive Pulmonary Disease. Study Results.
ClinicalTrials.gov. <a href="https://clinicaltrials.gov/ct2/show/results/NCT02294734" class="extLink">https://clinicaltrials.gov/ct2/show/results/NCT02294734</a> (accessed Jul 7, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=An+Efficacy%0AStudy+of+GSK2269557+Added+to+Standard+Care+in+Subjects+with+an+Acute%0AExacerbation+of+Chronic+Obstructive+Pulmonary+Disease.+Study+Results.%0AClinicalTrials.gov.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2Fresults%2FNCT02294734+%28accessed+Jul+7%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span>Initial
Results From First-In-Human Study of IPI-549, a Tumor Macrophage-Targeting
Agent, Combined with Nivolumab in Advanced Solid Tumors. 2018 ASCO
Annual Meeting Abstracts. <a href="http://abstracts.asco.org/214/AbstView_214_230109.html" class="extLink">http://abstracts.asco.org/214/AbstView_214_230109.html</a> (accessed Jul 6, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Initial%0AResults+From+First-In-Human+Study+of+IPI-549%2C+a+Tumor+Macrophage-Targeting%0AAgent%2C+Combined+with+Nivolumab+in+Advanced+Solid+Tumors.+2018+ASCO%0AAnnual+Meeting+Abstracts.+http%3A%2F%2Fabstracts.asco.org%2F214%2FAbstView_214_230109.html+%28accessed+Jul+6%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span>Duvelisib.
Pharmaprojects. <a href="https://pharmaintelligence.informa.com/products-and-services/data-and-analysis/pharmaprojects" class="extLink">https://pharmaintelligence.informa.com/products-and-services/data-and-analysis/pharmaprojects</a> (accessed May 22, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Duvelisib.%0APharmaprojects.+https%3A%2F%2Fpharmaintelligence.informa.com%2Fproducts-and-services%2Fdata-and-analysis%2Fpharmaprojects+%28accessed+May+22%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coutre, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrientos, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furman, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keating, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagel, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poleski, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharman, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, N.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zelenetz, A. D.</span></span> <span> </span><span class="NLM_article-title">Management of Adverse Events Associated with Idelalisib Treatment:  Expert Panel Opinion</span>. <i>Leuk. Lymphoma</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2779</span>– <span class="NLM_lpage">2786</span>, <span class="refDoi"> DOI: 10.3109/10428194.2015.1022770</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.3109%2F10428194.2015.1022770" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=25726955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFKju73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2015&pages=2779-2786&issue=10&author=S.+E.+Coutreauthor=J.+C.+Barrientosauthor=J.+R.+Brownauthor=S.+de+Vosauthor=R.+R.+Furmanauthor=M.+J.+Keatingauthor=D.+Liauthor=S.+M.+O%E2%80%99Brienauthor=J.+M.+Pagelauthor=M.+H.+Poleskiauthor=J.+P.+Sharmanauthor=N.-S.+Yaoauthor=A.+D.+Zelenetz&title=Management+of+Adverse+Events+Associated+with+Idelalisib+Treatment%3A++Expert+Panel+Opinion&doi=10.3109%2F10428194.2015.1022770"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Management of adverse events associated with idelalisib treatment: expert panel opinion</span></div><div class="casAuthors">Coutre, Steven E.; Barrientos, Jacqueline C.; Brown, Jennifer R.; de Vos, Sven; Furman, Richard R.; Keating, Michael J.; Li, Daniel; O'Brien, Susan M.; Pagel, John M.; Poleski, Martin H.; Sharman, Jeff P.; Yao, Nai-Shun; Zelenetz, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia & Lymphoma</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2779-2786</span>CODEN:
                <span class="NLM_cas:coden">LELYEA</span>;
        ISSN:<span class="NLM_cas:issn">1029-2403</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Idelalisib is a first-in-class selective, oral, phosphatidylinositol 3-kinase delta (PI3Kδ) inhibitor approved for the treatment of several types of blood cancer.  Idelalisib has demonstrated significant efficacy and a tolerable safety profile in clin. trials.  However, the US prescribing information contains a black box warning for fatal and/or severe diarrhea or colitis, hepatotoxicity, pneumonitis and intestinal perforation.  An expert panel was convened to review the pathol. of these treatment-emergent adverse events (TEAEs) to propose key management tools for patients receiving idelalisib therapy.  This article provides an overview of idelalisib TEAEs reported in clin. trials, and a summary of the panel's recommendations for identification and management of idelalisib treatment-emergent diarrhea or colitis as well as a discussion of transaminitis and pneumonitis.  For idelalisib-related diarrhea or colitis (including unresolved grade 2 and grade ≥ 3), after exclusion of infectious causes, the panel recommends individualized treatment with budesonide or oral or i.v. steroid therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVGi1H-woJu7Vg90H21EOLACvtfcHk0lguOCN-N8I1gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFKju73O&md5=649cb8c3d6fe0a60f74b3f9413e4706a</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.3109%2F10428194.2015.1022770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10428194.2015.1022770%26sid%3Dliteratum%253Aachs%26aulast%3DCoutre%26aufirst%3DS.%2BE.%26aulast%3DBarrientos%26aufirst%3DJ.%2BC.%26aulast%3DBrown%26aufirst%3DJ.%2BR.%26aulast%3Dde%2BVos%26aufirst%3DS.%26aulast%3DFurman%26aufirst%3DR.%2BR.%26aulast%3DKeating%26aufirst%3DM.%2BJ.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DS.%2BM.%26aulast%3DPagel%26aufirst%3DJ.%2BM.%26aulast%3DPoleski%26aufirst%3DM.%2BH.%26aulast%3DSharman%26aufirst%3DJ.%2BP.%26aulast%3DYao%26aufirst%3DN.-S.%26aulast%3DZelenetz%26aufirst%3DA.%2BD.%26atitle%3DManagement%2520of%2520Adverse%2520Events%2520Associated%2520with%2520Idelalisib%2520Treatment%253A%2520%2520Expert%2520Panel%2520Opinion%26jtitle%3DLeuk.%2520Lymphoma%26date%3D2015%26volume%3D56%26issue%3D10%26spage%3D2779%26epage%3D2786%26doi%3D10.3109%2F10428194.2015.1022770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span>European
Medicines Agency. News and Events. EMA Recommends New Safety Measures
for Zydelig. <a href="http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/03/news_detail_002490.jsp&amp;mid=WC0b01ac058004d5c1" class="extLink">http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/03/news_detail_002490.jsp&mid=WC0b01ac058004d5c1</a> (accessed Jul 7, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=European%0AMedicines+Agency.+News+and+Events.+EMA+Recommends+New+Safety+Measures%0Afor+Zydelig.+http%3A%2F%2Fwww.ema.europa.eu%2Fema%2Findex.jsp%3Fcurl%3Dpages%2Fnews_and_events%2Fnews%2F2016%2F03%2Fnews_detail_002490.jsp%26mid%3DWC0b01ac058004d5c1+%28accessed+Jul+7%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berndt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houseman, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacold, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorrec, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hon, W.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rommel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaillard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rückle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R. L.</span></span> <span> </span><span class="NLM_article-title">The p110δ Structure: Mechanisms for Selectivity and Potency of New PI(3)K Inhibitors</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">117</span>– <span class="NLM_lpage">124</span>, <span class="refDoi"> DOI: 10.1038/nchembio.293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1038%2Fnchembio.293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=20081827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvFGrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=117-124&issue=2&author=A.+Berndtauthor=S.+Millerauthor=O.+Williamsauthor=D.+D.+Leauthor=B.+T.+Housemanauthor=J.+I.+Pacoldauthor=F.+Gorrecauthor=W.-C.+Honauthor=P.+Renauthor=Y.+Liuauthor=C.+Rommelauthor=P.+Gaillardauthor=T.+R%C3%BCckleauthor=M.+K.+Schwarzauthor=K.+M.+Shokatauthor=J.+P.+Shawauthor=R.+L.+Williams&title=The+p110%CE%B4+Structure%3A+Mechanisms+for+Selectivity+and+Potency+of+New+PI%283%29K+Inhibitors&doi=10.1038%2Fnchembio.293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">The p110δ structure: mechanisms for selectivity and potency of new PI(3)K inhibitors</span></div><div class="casAuthors">Berndt, Alex; Miller, Simon; Williams, Olusegun; Le, Daniel D.; Houseman, Benjamin T.; Pacold, Joseph I.; Gorrec, Fabrice; Hon, Wai-Ching; Liu, Yi; Rommel, Christian; Gaillard, Pascale; Rueckle, Thomas; Schwarz, Matthias K.; Shokat, Kevan M.; Shaw, Jeffrey P.; Williams, Roger L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">117-124</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Deregulation of the phosphoinositide-3-OH kinase (PI(3)K) pathway has been implicated in numerous pathologies including cancer, diabetes, thrombosis, rheumatoid arthritis, and asthma.  Recently, small-mol. and ATP-competitive PI(3)K inhibitors with a wide range of selectivities have entered clin. development.  To understand the mechanisms underlying the isoform selectivity of these inhibitors, we developed a new expression strategy that enabled us to det. to our knowledge the first crystal structure of the catalytic subunit of the class IA PI(3)K p110δ.  Structures of this enzyme in complex with a broad panel of isoform- and pan-selective class I PI(3)K inhibitors reveal that selectivity toward p110δ can be achieved by exploiting its conformational flexibility and the sequence diversity of active site residues that do not contact ATP.  We have used these observations to rationalize and synthesize highly selective inhibitors for p110δ with greatly improved potencies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL8d01cEl_y7Vg90H21EOLACvtfcHk0lguOCN-N8I1gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvFGrsw%253D%253D&md5=8a0ce73ab8ca88ea9a48a2cb7fdb1975</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.293%26sid%3Dliteratum%253Aachs%26aulast%3DBerndt%26aufirst%3DA.%26aulast%3DMiller%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DO.%26aulast%3DLe%26aufirst%3DD.%2BD.%26aulast%3DHouseman%26aufirst%3DB.%2BT.%26aulast%3DPacold%26aufirst%3DJ.%2BI.%26aulast%3DGorrec%26aufirst%3DF.%26aulast%3DHon%26aufirst%3DW.-C.%26aulast%3DRen%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DGaillard%26aufirst%3DP.%26aulast%3DR%25C3%25BCckle%26aufirst%3DT.%26aulast%3DSchwarz%26aufirst%3DM.%2BK.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DShaw%26aufirst%3DJ.%2BP.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26atitle%3DThe%2520p110%25CE%25B4%2520Structure%253A%2520Mechanisms%2520for%2520Selectivity%2520and%2520Potency%2520of%2520New%2520PI%25283%2529K%2520Inhibitors%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26issue%3D2%26spage%3D117%26epage%3D124%26doi%3D10.1038%2Fnchembio.293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrasekhar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evarts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forseth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haran, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ip, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashishian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koditek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koppenol, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lad, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepist, E.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perreault, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puri, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villaseñor, A.
G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somoza, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiner, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Therrien, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treiberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, G.</span></span> <span> </span><span class="NLM_article-title">Discovery of Orally Efficacious Phosphoinositide 3-Kinase δ Inhibitors with Improved Metabolic Stability</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">9228</span>– <span class="NLM_lpage">9242</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01169</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01169" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9228-9242&issue=19&author=L.+Patelauthor=J.+Chandrasekharauthor=J.+Evartsauthor=K.+Forsethauthor=A.+C.+Haranauthor=C.+Ipauthor=A.+Kashishianauthor=M.+Kimauthor=D.+Koditekauthor=S.+Koppenolauthor=L.+Ladauthor=E.-I.+Lepistauthor=M.+E.+McGrathauthor=S.+Perreaultauthor=K.+D.+Puriauthor=A.%0AG.+Villase%C3%B1orauthor=J.+R.+Somozaauthor=B.+H.+Steinerauthor=J.+Therrienauthor=J.+Treibergauthor=G.+Phillips&title=Discovery+of+Orally+Efficacious+Phosphoinositide+3-Kinase+%CE%B4+Inhibitors+with+Improved+Metabolic+Stability&doi=10.1021%2Facs.jmedchem.6b01169"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01169%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DL.%26aulast%3DChandrasekhar%26aufirst%3DJ.%26aulast%3DEvarts%26aufirst%3DJ.%26aulast%3DForseth%26aufirst%3DK.%26aulast%3DHaran%26aufirst%3DA.%2BC.%26aulast%3DIp%26aufirst%3DC.%26aulast%3DKashishian%26aufirst%3DA.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DKoditek%26aufirst%3DD.%26aulast%3DKoppenol%26aufirst%3DS.%26aulast%3DLad%26aufirst%3DL.%26aulast%3DLepist%26aufirst%3DE.-I.%26aulast%3DMcGrath%26aufirst%3DM.%2BE.%26aulast%3DPerreault%26aufirst%3DS.%26aulast%3DPuri%26aufirst%3DK.%2BD.%26aulast%3DVillase%25C3%25B1or%26aufirst%3DA.%2BG.%26aulast%3DSomoza%26aufirst%3DJ.%2BR.%26aulast%3DSteiner%26aufirst%3DB.%2BH.%26aulast%3DTherrien%26aufirst%3DJ.%26aulast%3DTreiberg%26aufirst%3DJ.%26aulast%3DPhillips%26aufirst%3DG.%26atitle%3DDiscovery%2520of%2520Orally%2520Efficacious%2520Phosphoinositide%25203-Kinase%2520%25CE%25B4%2520Inhibitors%2520with%2520Improved%2520Metabolic%2520Stability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D19%26spage%3D9228%26epage%3D9242%26doi%3D10.1021%2Facs.jmedchem.6b01169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Puri, K. D.</span>; <span class="NLM_string-name">Evarts, J. B.</span>; <span class="NLM_string-name">Lannutti, B.</span>; <span class="NLM_string-name">Giese, N.
A.</span></span> <span> </span><span class="NLM_article-title">Methods of Treatment for Solid Tumors</span>. <span class="NLM_patent">WO2010123931</span>, October 29, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=K.+D.+Puri&author=J.+B.+Evarts&author=B.+Lannutti&author=N.%0AA.+Giese&title=Methods+of+Treatment+for+Solid+Tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPuri%26aufirst%3DK.%2BD.%26atitle%3DMethods%2520of%2520Treatment%2520for%2520Solid%2520Tumors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">King-Underwood, J.</span>; <span class="NLM_string-name">Ito, K.</span>; <span class="NLM_string-name">Murray, P. J.</span>; <span class="NLM_string-name">Hardy, G.</span>; <span class="NLM_string-name">Brookfield, F. A.</span>; <span class="NLM_string-name">Brown, C. J.</span></span> <span> </span><span class="NLM_article-title">Quinazolin-4(3H)one Derivatives Used as PI3 Kinase Inhibitors</span>. <span class="NLM_patent">WO2012052753</span>, April 27, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=J.+King-Underwood&author=K.+Ito&author=P.+J.+Murray&author=G.+Hardy&author=F.+A.+Brookfield&author=C.+J.+Brown&title=Quinazolin-4%283H%29one+Derivatives+Used+as+PI3+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKing-Underwood%26aufirst%3DJ.%26atitle%3DQuinazolin-4%25283H%2529one%2520Derivatives%2520Used%2520as%2520PI3%2520Kinase%2520Inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Onions, S. T.</span>; <span class="NLM_string-name">Copmans, A. H.</span>; <span class="NLM_string-name">Broeckx, R. L. M.</span>; <span class="NLM_string-name">Smith, A. J.</span>; <span class="NLM_string-name">Taddei, D. M. A.</span></span> <span> </span><span class="NLM_article-title">2-((4-Amino-3-(3-fluoro-5-hydroxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)-3-(2-(trifluoromethyl)benzyl)quinazolin-4(3H)-one Derivatives and Their Use as Phosphoinositide 3-Kinase Inhibitors</span>. <span class="NLM_patent">WO2014140597</span>, September 19, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=S.+T.+Onions&author=A.+H.+Copmans&author=R.+L.+M.+Broeckx&author=A.+J.+Smith&author=D.+M.+A.+Taddei&title=2-%28%284-Amino-3-%283-fluoro-5-hydroxyphenyl%29-1H-pyrazolo%5B3%2C4-d%5Dpyrimidin-1-yl%29methyl%29-3-%282-%28trifluoromethyl%29benzyl%29quinazolin-4%283H%29-one+Derivatives+and+Their+Use+as+Phosphoinositide+3-Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DOnions%26aufirst%3DS.%2BT.%26atitle%3D2-%2528%25284-Amino-3-%25283-fluoro-5-hydroxyphenyl%2529-1H-pyrazolo%255B3%252C4-d%255Dpyrimidin-1-yl%2529methyl%2529-3-%25282-%2528trifluoromethyl%2529benzyl%2529quinazolin-4%25283H%2529-one%2520Derivatives%2520and%2520Their%2520Use%2520as%2520Phosphoinositide%25203-Kinase%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faia, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinitto, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brophy, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pink, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proctor, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lussier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyt, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tillotson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDougall, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jessen, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritz, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunbar, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rommel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palombella, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Changelian, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kutok, J. L.</span></span> <span> </span><span class="NLM_article-title">PI3K-δ and PI3K-γ Inhibition by IPI-145 Abrogates Immune Responses and Suppresses Activity in Autoimmune and Inflammatory Disease Models</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1364</span>– <span class="NLM_lpage">1374</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2013.09.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.chembiol.2013.09.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=24211136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslClsrvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=1364-1374&issue=11&author=D.+G.+Winklerauthor=K.+L.+Faiaauthor=J.+P.+Dinittoauthor=J.+A.+Aliauthor=K.+F.+Whiteauthor=E.+E.+Brophyauthor=M.+M.+Pinkauthor=J.+L.+Proctorauthor=J.+Lussierauthor=C.+M.+Martinauthor=J.+G.+Hoytauthor=B.+Tillotsonauthor=E.+L.+Murphyauthor=A.+R.+Limauthor=B.+D.+Thomasauthor=J.+R.+MacDougallauthor=P.+Renauthor=Y.+Liuauthor=L.+S.+Liauthor=K.+A.+Jessenauthor=C.+C.+Fritzauthor=J.+L.+Dunbarauthor=J.+R.+Porterauthor=C.+Rommelauthor=V.+J.+Palombellaauthor=P.+S.+Changelianauthor=J.+L.+Kutok&title=PI3K-%CE%B4+and+PI3K-%CE%B3+Inhibition+by+IPI-145+Abrogates+Immune+Responses+and+Suppresses+Activity+in+Autoimmune+and+Inflammatory+Disease+Models&doi=10.1016%2Fj.chembiol.2013.09.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">PI3K-δ and PI3K-γ Inhibition by IPI-145 Abrogates Immune Responses and Suppresses Activity in Autoimmune and Inflammatory Disease Models</span></div><div class="casAuthors">Winkler, David G.; Faia, Kerrie L.; DiNitto, Jonathan P.; Ali, Janid A.; White, Kerry F.; Brophy, Erin E.; Pink, Melissa M.; Proctor, Jennifer L.; Lussier, Jennifer; Martin, Christian M.; Hoyt, Jennifer G.; Tillotson, Bonnie; Murphy, Erin L.; Lim, Alice R.; Thomas, Brian D.; MacDougall, John R.; Ren, Pingda; Liu, Yi; Li, Lian-Sheng; Jessen, Katti A.; Fritz, Christian C.; Dunbar, Joi L.; Porter, James R.; Rommel, Christian; Palombella, Vito J.; Changelian, Paul S.; Kutok, Jeffery L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1364-1374</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Phosphoinositide-3 kinase (PI3K)-δ and PI3K-γ are preferentially expressed in immune cells, and inhibitors targeting these isoforms are hypothesized to have anti-inflammatory activity by affecting the adaptive and innate immune response.  We report on a potent oral PI3K-δ and PI3K-γ inhibitor (IPI-145) and characterize this compd. in biochem., cellular, and in vivo assays.  These studies demonstrate that IPI-145 exerts profound effects on adaptive and innate immunity by inhibiting B and T cell proliferation, blocking neutrophil migration, and inhibiting basophil activation.  We explored the therapeutic value of combined PI3K-δ and PI3K-γ blockade, and IPI-145 showed potent activity in collagen-induced arthritis, ovalbumin-induced asthma, and systemic lupus erythematosus rodent models.  These findings support the hypothesis that inhibition of immune function can be achieved through PI3K-δ and PI3K-γ blockade, potentially leading to significant therapeutic effects in multiple inflammatory, autoimmune, and hematol. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHLymau7LdZrVg90H21EOLACvtfcHk0li5jzfKUj4d1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslClsrvN&md5=b9fdfd9444ac255430ff6c8a0fb71ab9</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2013.09.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2013.09.017%26sid%3Dliteratum%253Aachs%26aulast%3DWinkler%26aufirst%3DD.%2BG.%26aulast%3DFaia%26aufirst%3DK.%2BL.%26aulast%3DDinitto%26aufirst%3DJ.%2BP.%26aulast%3DAli%26aufirst%3DJ.%2BA.%26aulast%3DWhite%26aufirst%3DK.%2BF.%26aulast%3DBrophy%26aufirst%3DE.%2BE.%26aulast%3DPink%26aufirst%3DM.%2BM.%26aulast%3DProctor%26aufirst%3DJ.%2BL.%26aulast%3DLussier%26aufirst%3DJ.%26aulast%3DMartin%26aufirst%3DC.%2BM.%26aulast%3DHoyt%26aufirst%3DJ.%2BG.%26aulast%3DTillotson%26aufirst%3DB.%26aulast%3DMurphy%26aufirst%3DE.%2BL.%26aulast%3DLim%26aufirst%3DA.%2BR.%26aulast%3DThomas%26aufirst%3DB.%2BD.%26aulast%3DMacDougall%26aufirst%3DJ.%2BR.%26aulast%3DRen%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DL.%2BS.%26aulast%3DJessen%26aufirst%3DK.%2BA.%26aulast%3DFritz%26aufirst%3DC.%2BC.%26aulast%3DDunbar%26aufirst%3DJ.%2BL.%26aulast%3DPorter%26aufirst%3DJ.%2BR.%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DPalombella%26aufirst%3DV.%2BJ.%26aulast%3DChangelian%26aufirst%3DP.%2BS.%26aulast%3DKutok%26aufirst%3DJ.%2BL.%26atitle%3DPI3K-%25CE%25B4%2520and%2520PI3K-%25CE%25B3%2520Inhibition%2520by%2520IPI-145%2520Abrogates%2520Immune%2520Responses%2520and%2520Suppresses%2520Activity%2520in%2520Autoimmune%2520and%2520Inflammatory%2520Disease%2520Models%26jtitle%3DChem.%2520Biol.%26date%3D2013%26volume%3D20%26issue%3D11%26spage%3D1364%26epage%3D1374%26doi%3D10.1016%2Fj.chembiol.2013.09.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sneha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nivetha, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viswanadha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vakkalanka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, T.</span></span> <span> </span><span class="NLM_article-title">Abstract 3331: RP6530, a Dual PI3K δ/γ Inhibitor Attenuates Cancer Stem Cell Proliferation in Serous Adenocarcinoma of Ovary</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>76</i></span> (<span class="NLM_issue">14 Suppl.</span>),  <span class="NLM_fpage">3331</span>, <span class="refDoi"> DOI: 10.1158/1538-7445.AM2016-3331</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1158%2F1538-7445.AM2016-3331" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=3331&issue=14+Suppl.&author=S.+Snehaauthor=R.+Nivethaauthor=S.+Viswanadhaauthor=S.+Vakkalankaauthor=T.+Ganesan&title=Abstract+3331%3A+RP6530%2C+a+Dual+PI3K+%CE%B4%2F%CE%B3+Inhibitor+Attenuates+Cancer+Stem+Cell+Proliferation+in+Serous+Adenocarcinoma+of+Ovary&doi=10.1158%2F1538-7445.AM2016-3331"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2016-3331&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM2016-3331%26sid%3Dliteratum%253Aachs%26aulast%3DSneha%26aufirst%3DS.%26aulast%3DNivetha%26aufirst%3DR.%26aulast%3DViswanadha%26aufirst%3DS.%26aulast%3DVakkalanka%26aufirst%3DS.%26aulast%3DGanesan%26aufirst%3DT.%26atitle%3DAbstract%25203331%253A%2520RP6530%252C%2520a%2520Dual%2520PI3K%2520%25CE%25B4%252F%25CE%25B3%2520Inhibitor%2520Attenuates%2520Cancer%2520Stem%2520Cell%2520Proliferation%2520in%2520Serous%2520Adenocarcinoma%2520of%2520Ovary%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26issue%3D14%2520Suppl%26spage%3D3331%26doi%3D10.1158%2F1538-7445.AM2016-3331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vakkalanka, S. K. V. S.</span>; <span class="NLM_string-name">Muthuppalaniappan, M.</span>; <span class="NLM_string-name">Nagarathnam, D.</span></span> <span> </span><span class="NLM_article-title">Selective PI3K Delta Inhibitors</span>. <span class="NLM_patent">WO2014006572</span>, January 10, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=S.+K.+V.+S.+Vakkalanka&author=M.+Muthuppalaniappan&author=D.+Nagarathnam&title=Selective+PI3K+Delta+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVakkalanka%26aufirst%3DS.%2BK.%2BV.%2BS.%26atitle%3DSelective%2520PI3K%2520Delta%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cushing, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardozo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duquette, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Lopez
de Turiso, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henne, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hungate, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarter, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGee, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">San Miguel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pattaropong, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettus, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichelt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rzasa, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seganish, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tasker, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahl, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wannberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittington, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whoriskey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zalameda, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metz, D. P.</span></span> <span> </span><span class="NLM_article-title">Discovery and in Vivo Evaluation of (S)-N-(1-(7-Fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine (AMG319) and Related PI3Kδ Inhibitors for Inflammation and Autoimmune Disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">480</span>– <span class="NLM_lpage">511</span>, <span class="refDoi"> DOI: 10.1021/jm501624r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501624r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=480-511&issue=1&author=T.+D.+Cushingauthor=X.+Haoauthor=Y.+Shinauthor=K.+Andrewsauthor=M.+Brownauthor=M.+Cardozoauthor=Y.+Chenauthor=J.+Duquetteauthor=B.+Fisherauthor=F.+Gonzalez-Lopez%0Ade+Turisoauthor=X.+Heauthor=K.+R.+Henneauthor=Y.-L.+Huauthor=R.+Hungateauthor=M.+G.+Johnsonauthor=R.+C.+Kellyauthor=B.+Lucasauthor=J.+D.+McCarterauthor=L.+R.+McGeeauthor=J.+C.+Medinaauthor=T.+San+Miguelauthor=D.+Mohnauthor=V.+Pattaropongauthor=L.+H.+Pettusauthor=A.+Reicheltauthor=R.+M.+Rzasaauthor=J.+Seganishauthor=A.+S.+Taskerauthor=R.+C.+Wahlauthor=S.+Wannbergauthor=D.+A.+Whittingtonauthor=J.+Whoriskeyauthor=G.+Yuauthor=L.+Zalamedaauthor=D.+Zhangauthor=D.+P.+Metz&title=Discovery+and+in+Vivo+Evaluation+of+%28S%29-N-%281-%287-Fluoro-2-%28pyridin-2-yl%29quinolin-3-yl%29ethyl%29-9H-purin-6-amine+%28AMG319%29+and+Related+PI3K%CE%B4+Inhibitors+for+Inflammation+and+Autoimmune+Disease&doi=10.1021%2Fjm501624r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1021%2Fjm501624r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501624r%26sid%3Dliteratum%253Aachs%26aulast%3DCushing%26aufirst%3DT.%2BD.%26aulast%3DHao%26aufirst%3DX.%26aulast%3DShin%26aufirst%3DY.%26aulast%3DAndrews%26aufirst%3DK.%26aulast%3DBrown%26aufirst%3DM.%26aulast%3DCardozo%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DDuquette%26aufirst%3DJ.%26aulast%3DFisher%26aufirst%3DB.%26aulast%3DGonzalez-Lopez%2Bde%2BTuriso%26aufirst%3DF.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DHenne%26aufirst%3DK.%2BR.%26aulast%3DHu%26aufirst%3DY.-L.%26aulast%3DHungate%26aufirst%3DR.%26aulast%3DJohnson%26aufirst%3DM.%2BG.%26aulast%3DKelly%26aufirst%3DR.%2BC.%26aulast%3DLucas%26aufirst%3DB.%26aulast%3DMcCarter%26aufirst%3DJ.%2BD.%26aulast%3DMcGee%26aufirst%3DL.%2BR.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26aulast%3DSan%2BMiguel%26aufirst%3DT.%26aulast%3DMohn%26aufirst%3DD.%26aulast%3DPattaropong%26aufirst%3DV.%26aulast%3DPettus%26aufirst%3DL.%2BH.%26aulast%3DReichelt%26aufirst%3DA.%26aulast%3DRzasa%26aufirst%3DR.%2BM.%26aulast%3DSeganish%26aufirst%3DJ.%26aulast%3DTasker%26aufirst%3DA.%2BS.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWannberg%26aufirst%3DS.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DWhoriskey%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DG.%26aulast%3DZalameda%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DMetz%26aufirst%3DD.%2BP.%26atitle%3DDiscovery%2520and%2520in%2520Vivo%2520Evaluation%2520of%2520%2528S%2529-N-%25281-%25287-Fluoro-2-%2528pyridin-2-yl%2529quinolin-3-yl%2529ethyl%2529-9H-purin-6-amine%2520%2528AMG319%2529%2520and%2520Related%2520PI3K%25CE%25B4%2520Inhibitors%2520for%2520Inflammation%2520and%2520Autoimmune%2520Disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D1%26spage%3D480%26epage%3D511%26doi%3D10.1021%2Fjm501624r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allen, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brookings, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuttleworth, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merriman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fahy, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tewari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Healy, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, G. C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Twomey, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cutler, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crosby, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCluskey, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watt, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, A.</span></span> <span> </span><span class="NLM_article-title">Seletalisib: Characterization of a Novel, Potent, and Selective Inhibitor of PI3K δ</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>361</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">429</span>– <span class="NLM_lpage">440</span>, <span class="refDoi"> DOI: 10.1124/jpet.116.237347</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1124%2Fjpet.116.237347" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=28442583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFOqsLbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2017&pages=429-440&issue=3&author=R.+A.+Allenauthor=D.+C.+Brookingsauthor=M.+J.+Powellauthor=J.+Delgadoauthor=L.+K.+Shuttleworthauthor=M.+Merrimanauthor=I.+J.+Fahyauthor=R.+Tewariauthor=J.+P.+Silvaauthor=L.+J.+Healyauthor=G.+C.+G.+Daviesauthor=B.+Twomeyauthor=R.+M.+Cutlerauthor=A.+Kotianauthor=A.+Crosbyauthor=G.+McCluskeyauthor=G.+F.+Wattauthor=A.+Payne&title=Seletalisib%3A+Characterization+of+a+Novel%2C+Potent%2C+and+Selective+Inhibitor+of+PI3K+%CE%B4&doi=10.1124%2Fjpet.116.237347"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Seletalisib: characterization of a novel, potent, and selective inhibitor of PI3Kδ</span></div><div class="casAuthors">Allen, Rodger A.; Brookings, Daniel C.; Powell, Mark J.; Delgado, Jean; Shuttleworth, Lindsay K.; Merriman, Mark; Fahy, Ian J.; Tewari, Roohi; Silva, John P.; Healy, Louise J.; Davies, Gareth C. G.; Twomey, Breda; Cutler, Rona M.; Kotian, Apoorva; Crosby, Andrea; McCluskey, Gillian; Watt, Gillian F.; Payne, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">429-440</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Phosphoinositide 3-kinases (PI3K) are key signaling enzymes regulating cellular survival, development, and function.  Expression of the PI3Kδ isoform is largely restricted to leukocytes and it plays a key role in immune cell development and function.  Seletalisib is a novel small-mol. inhibitor of PI3Kδ that was evaluated in biochem. assays, cellular assays of adaptive and innate immunity, and an in vivo rat model of inflammation.  Our findings show that seletalisib is a potent, ATP-competitive, and selective PI3Kδ inhibitor able to block protein kinase B (AKT) phosphorylation following activation of the B-cell receptor in a B-cell line.  Moreover, seletalisib inhibited N-formyl peptide-stimulated but not phorbol myristate acetate-stimulated superoxide release from human neutrophils, consistent with a PI3Kδ-specific activity.  No indications of cytotoxicity were obsd. in peripheral blood mononuclear cells (PBMCs) or other cell types treated with seletalisib.  Findings from cellular assays of adaptive immunity demonstrated that seletalisib blocks human T-cell prodn. of several cytokines from activated T-cells.  Addnl., seletalisib inhibited B-cell proliferation and cytokine release.  In human whole blood assays, seletalisib inhibited CD69 expression upon B-cell activation and anti-IgE-mediated basophil degranulation.  Seletalisib showed dose-dependent inhibition in an in vivo rat model of anti-CD3-antibody-induced interleukin 2 release.  Collectively, these data characterize seletalisib as a selective PI3Kδ inhibitor and potential therapeutic candidate for the treatment of B-cell malignancies and autoimmune diseases driven by dysregulated proinflammatory cytokine secretion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyxgOubZ1Ic7Vg90H21EOLACvtfcHk0lgrFsWObNLITQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFOqsLbI&md5=270c4866fe19b97aada323e9945715ab</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1124%2Fjpet.116.237347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.116.237347%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DR.%2BA.%26aulast%3DBrookings%26aufirst%3DD.%2BC.%26aulast%3DPowell%26aufirst%3DM.%2BJ.%26aulast%3DDelgado%26aufirst%3DJ.%26aulast%3DShuttleworth%26aufirst%3DL.%2BK.%26aulast%3DMerriman%26aufirst%3DM.%26aulast%3DFahy%26aufirst%3DI.%2BJ.%26aulast%3DTewari%26aufirst%3DR.%26aulast%3DSilva%26aufirst%3DJ.%2BP.%26aulast%3DHealy%26aufirst%3DL.%2BJ.%26aulast%3DDavies%26aufirst%3DG.%2BC.%2BG.%26aulast%3DTwomey%26aufirst%3DB.%26aulast%3DCutler%26aufirst%3DR.%2BM.%26aulast%3DKotian%26aufirst%3DA.%26aulast%3DCrosby%26aufirst%3DA.%26aulast%3DMcCluskey%26aufirst%3DG.%26aulast%3DWatt%26aufirst%3DG.%2BF.%26aulast%3DPayne%26aufirst%3DA.%26atitle%3DSeletalisib%253A%2520Characterization%2520of%2520a%2520Novel%252C%2520Potent%252C%2520and%2520Selective%2520Inhibitor%2520of%2520PI3K%2520%25CE%25B4%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2017%26volume%3D361%26issue%3D3%26spage%3D429%26epage%3D440%26doi%3D10.1124%2Fjpet.116.237347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span>; <span class="NLM_string-name">Liu, X.</span>; <span class="NLM_string-name">Huang, D.</span>; <span class="NLM_string-name">Zhang, Y.</span>; <span class="NLM_string-name">Kai, Y.</span></span> <span> </span><span class="NLM_article-title">Substituted Pyrimidine Compounds as Phosphatidylinositol 3-Kinase δ Inhibitor and Use Thereof</span>. <span class="NLM_patent">WO2016141855</span>, September 16, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=Y.+Wang&author=X.+Liu&author=D.+Huang&author=Y.+Zhang&author=Y.+Kai&title=Substituted+Pyrimidine+Compounds+as+Phosphatidylinositol+3-Kinase+%CE%B4+Inhibitor+and+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26atitle%3DSubstituted%2520Pyrimidine%2520Compounds%2520as%2520Phosphatidylinositol%25203-Kinase%2520%25CE%25B4%2520Inhibitor%2520and%2520Use%2520Thereof%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shukla, M. R.</span>; <span class="NLM_string-name">Jana, N. K.</span>; <span class="NLM_string-name">Mahangare, S. J.</span>; <span class="NLM_string-name">Vidhate, P. P.</span>; <span class="NLM_string-name">Lagad, D. R.</span>; <span class="NLM_string-name">Tarage, A. J.</span>; <span class="NLM_string-name">Kulkarni, S. A.</span>; <span class="NLM_string-name">Palle, V. P.</span>; <span class="NLM_string-name">Kamboj, R. K.</span></span> <span> </span><span class="NLM_article-title">Quinolizinone Derivatives as PI3K Inhibitors</span>. <span class="NLM_patent">WO2016001855</span>, January 8, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=M.+R.+Shukla&author=N.+K.+Jana&author=S.+J.+Mahangare&author=P.+P.+Vidhate&author=D.+R.+Lagad&author=A.+J.+Tarage&author=S.+A.+Kulkarni&author=V.+P.+Palle&author=R.+K.+Kamboj&title=Quinolizinone+Derivatives+as+PI3K+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DShukla%26aufirst%3DM.%2BR.%26atitle%3DQuinolizinone%2520Derivatives%2520as%2520PI3K%2520Inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shukla, M. R.</span>; <span class="NLM_string-name">Jana, N. K.</span>; <span class="NLM_string-name">Mahangare, S. J.</span>; <span class="NLM_string-name">Vidhate, P. P.</span>; <span class="NLM_string-name">Lagad, D. R.</span>; <span class="NLM_string-name">Tarage, A. J.</span>; <span class="NLM_string-name">Kulkarni, S. A.</span>; <span class="NLM_string-name">Palle, V. P.</span>; <span class="NLM_string-name">Kamboj, R. K.</span></span> <span> </span><span class="NLM_article-title">Quinolizinone Derivatives as PI3K Inhibitors</span>. <span class="NLM_patent">WO2017103825</span>, June 23, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=M.+R.+Shukla&author=N.+K.+Jana&author=S.+J.+Mahangare&author=P.+P.+Vidhate&author=D.+R.+Lagad&author=A.+J.+Tarage&author=S.+A.+Kulkarni&author=V.+P.+Palle&author=R.+K.+Kamboj&title=Quinolizinone+Derivatives+as+PI3K+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DShukla%26aufirst%3DM.%2BR.%26atitle%3DQuinolizinone%2520Derivatives%2520as%2520PI3K%2520Inhibitors%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, R.</span>; <span class="NLM_string-name">Hu, Y.</span>; <span class="NLM_string-name">Wei, J.</span>; <span class="NLM_string-name">Ma, X.</span></span> <span> </span><span class="NLM_article-title">Benzothiazine and Benzothiadiazine Compounds and Preparation and Use</span>. <span class="NLM_patent">WO2017133655</span>, August 11, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=R.+Sheng&author=Y.+Hu&author=J.+Wei&author=X.+Ma&title=Benzothiazine+and+Benzothiadiazine+Compounds+and+Preparation+and+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DR.%26atitle%3DBenzothiazine%2520and%2520Benzothiadiazine%2520Compounds%2520and%2520Preparation%2520and%2520Use%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biagetti, M.</span>; <span class="NLM_string-name">Capelli, A. M.</span>; <span class="NLM_string-name">Accetta, A.</span>; <span class="NLM_string-name">Carzaniga, L.</span></span> <span> </span><span class="NLM_article-title">Isochromene Derivatives as Phosphoinositide 3-Kinases Inhibitors</span>. <span class="NLM_patent">WO2015091685</span>, June 26, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+Biagetti&author=A.+M.+Capelli&author=A.+Accetta&author=L.+Carzaniga&title=Isochromene+Derivatives+as+Phosphoinositide+3-Kinases+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBiagetti%26aufirst%3DM.%26atitle%3DIsochromene%2520Derivatives%2520as%2520Phosphoinositide%25203-Kinases%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lannutti, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meadows, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herman, S. E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashishian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byrd, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyner, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loriaux, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deininger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Druker, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puri, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulrich, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giese, N. A.</span></span> <span> </span><span class="NLM_article-title">CAL-101, a p110delta Selective Phosphatidylinositol-3-Kinase Inhibitor for the Treatment of B-Cell Malignancies, Inhibits PI3K Signaling and Cellular Viability</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>117</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">591</span>– <span class="NLM_lpage">594</span>, <span class="refDoi"> DOI: 10.1182/blood-2010-03-275305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1182%2Fblood-2010-03-275305" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2011&pages=591-594&issue=2&author=B.+J.+Lannuttiauthor=S.+A.+Meadowsauthor=S.+E.+M.+Hermanauthor=A.+Kashishianauthor=B.+Steinerauthor=A.+J.+Johnsonauthor=J.+C.+Byrdauthor=J.+W.+Tynerauthor=M.+M.+Loriauxauthor=M.+Deiningerauthor=B.+J.+Drukerauthor=K.+D.+Puriauthor=R.+G.+Ulrichauthor=N.+A.+Giese&title=CAL-101%2C+a+p110delta+Selective+Phosphatidylinositol-3-Kinase+Inhibitor+for+the+Treatment+of+B-Cell+Malignancies%2C+Inhibits+PI3K+Signaling+and+Cellular+Viability&doi=10.1182%2Fblood-2010-03-275305"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1182%2Fblood-2010-03-275305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2010-03-275305%26sid%3Dliteratum%253Aachs%26aulast%3DLannutti%26aufirst%3DB.%2BJ.%26aulast%3DMeadows%26aufirst%3DS.%2BA.%26aulast%3DHerman%26aufirst%3DS.%2BE.%2BM.%26aulast%3DKashishian%26aufirst%3DA.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DJohnson%26aufirst%3DA.%2BJ.%26aulast%3DByrd%26aufirst%3DJ.%2BC.%26aulast%3DTyner%26aufirst%3DJ.%2BW.%26aulast%3DLoriaux%26aufirst%3DM.%2BM.%26aulast%3DDeininger%26aufirst%3DM.%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26aulast%3DPuri%26aufirst%3DK.%2BD.%26aulast%3DUlrich%26aufirst%3DR.%2BG.%26aulast%3DGiese%26aufirst%3DN.%2BA.%26atitle%3DCAL-101%252C%2520a%2520p110delta%2520Selective%2520Phosphatidylinositol-3-Kinase%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520B-Cell%2520Malignancies%252C%2520Inhibits%2520PI3K%2520Signaling%2520and%2520Cellular%2520Viability%26jtitle%3DBlood%26date%3D2011%26volume%3D117%26issue%3D2%26spage%3D591%26epage%3D594%26doi%3D10.1182%2Fblood-2010-03-275305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katiyar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rumberger, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leffet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rupar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Covington, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koblish, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soloviev, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuey, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamond, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fridman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Combs, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeleswaram, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaddi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherle, P.</span></span> <span> </span><span class="NLM_article-title">INCB040093 Is a Novel PI3Kδ Inhibitor for the Treatment of B Cell Lymphoid Malignancies</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>364</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">120</span>– <span class="NLM_lpage">130</span>, <span class="refDoi"> DOI: 10.1124/jpet.117.244947</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1124%2Fjpet.117.244947" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=29127109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsF2rtLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=364&publication_year=2018&pages=120-130&issue=1&author=N.+Shinauthor=Y.-L.+Liauthor=S.+Meiauthor=K.+H.+Wangauthor=L.+Hallauthor=K.+Katiyarauthor=Q.+Wangauthor=G.+Yangauthor=B.+Rumbergerauthor=L.+Leffetauthor=X.+Heauthor=M.+Ruparauthor=K.+Bowmanauthor=M.+Favataauthor=J.+Liauthor=M.+Liuauthor=Y.+Liauthor=M.+Covingtonauthor=H.+Koblishauthor=M.+Solovievauthor=D.+Shueyauthor=T.+Burnauthor=S.+Diamondauthor=J.+Fridmanauthor=A.+Combsauthor=W.+Yaoauthor=S.+Yeleswaramauthor=G.+Hollisauthor=K.+Vaddiauthor=R.+Huberauthor=R.+Newtonauthor=P.+Scherle&title=INCB040093+Is+a+Novel+PI3K%CE%B4+Inhibitor+for+the+Treatment+of+B+Cell+Lymphoid+Malignancies&doi=10.1124%2Fjpet.117.244947"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">INCB040093 is a novel PI3Kδ inhibitor for the treatment of B cell lymphoid malignancies</span></div><div class="casAuthors">Shin, Niu; Li, Yun-Long; Mei, Song; Wang, Kathy He; Hall, Leslie; Katiyar, Kamna; Wang, Qian; Yang, Gengjie; Rumberger, Beth; Leffet, Lynn; He, Xin; Rupar, Mark; Bowman, Kevin; Favata, Margaret; Li, Jun; Liu, Mike; Li, Yanlong; Covington, Maryanne; Koblish, Holly; Soloviev, Maxim; Shuey, Dana; Burn, Timothy; Diamond, Sharon; Fridman, Jordan; Combs, Andrew; Yao, Wenqing; Yeleswaram, Swamy; Hollis, Gregory; Vaddi, Kris; Huber, Reid; Newton, Robert; Scherle, Peggy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">364</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">120-130</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Phosphatidylinositol 3-kinase delta (PI3Kδ) is a crit. signaling mol. in B cells and is considered a target for development of therapies against various B cell malignancies.  INCB040093 is a novel PI3Kδ small-mol. inhibitor and has demonstrated promising efficacy in patients with Hodgkin's lymphoma in clin. studies.  In this study, we disclose the chem. structure and the preclin. activity of the compd.  In biochem. assays, INCB040093 potently inhibits the PI3Kδ kinase, with 74- to >900-fold selectivity against other PI3K family members.  In vitro and ex vivo studies using primary B cells, cell lines from B cell malignancies, and human whole blood show that INCB040093 inhibits PI3Kδ-mediated functions, including cell signaling and proliferation.  INCB040093 has no significant effect on the growth of nonlymphoid cell lines and was less potent in assays that measure human T and natural killer cell proliferation and neutrophil and monocyte functions, suggesting that the impact of INCB040093 on the human immune system will likely be restricted to B cells.  INCB040093 inhibits the prodn. of macrophage-inflammatory protein-1β (MIP-1beta) and tumor necrosis factor-β (TNF-beta) from a B cell line, suggesting a potential effect on the tumor microenvironment.  In vivo, INCB040093 demonstrates single-agent activity in inhibiting tumor growth and potentiates the antitumor growth effect of the clin. relevant chemotherapeutic agent, bendamustine, in the Pfeiffer cell xenograft model of non-Hodgkin's lymphoma.  INCB040093 has a favorable exposure profile in rats and an acceptable safety margin in rats and dogs.  Taken together, data presented in this report support the potential utility of orally administered INCB040093 in the treatment of B cell malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAfVvCSgFZrbVg90H21EOLACvtfcHk0ljImRlgqbCHNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsF2rtLbE&md5=4d43da71159c3543090f9df59e377299</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1124%2Fjpet.117.244947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.117.244947%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DY.-L.%26aulast%3DMei%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DK.%2BH.%26aulast%3DHall%26aufirst%3DL.%26aulast%3DKatiyar%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DRumberger%26aufirst%3DB.%26aulast%3DLeffet%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DRupar%26aufirst%3DM.%26aulast%3DBowman%26aufirst%3DK.%26aulast%3DFavata%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DCovington%26aufirst%3DM.%26aulast%3DKoblish%26aufirst%3DH.%26aulast%3DSoloviev%26aufirst%3DM.%26aulast%3DShuey%26aufirst%3DD.%26aulast%3DBurn%26aufirst%3DT.%26aulast%3DDiamond%26aufirst%3DS.%26aulast%3DFridman%26aufirst%3DJ.%26aulast%3DCombs%26aufirst%3DA.%26aulast%3DYao%26aufirst%3DW.%26aulast%3DYeleswaram%26aufirst%3DS.%26aulast%3DHollis%26aufirst%3DG.%26aulast%3DVaddi%26aufirst%3DK.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DNewton%26aufirst%3DR.%26aulast%3DScherle%26aufirst%3DP.%26atitle%3DINCB040093%2520Is%2520a%2520Novel%2520PI3K%25CE%25B4%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520B%2520Cell%2520Lymphoid%2520Malignancies%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2018%26volume%3D364%26issue%3D1%26spage%3D120%26epage%3D130%26doi%3D10.1124%2Fjpet.117.244947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taltavull, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gréco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernal, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caturla, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gràcia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domínguez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabaté, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paris, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soria, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernández, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armengol, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabedo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bravo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calama, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miralpeix, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehner, M. D.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Potent, Selective, and Orally Available PI3Kδ Inhibitor for the Treatment of Inflammatory Diseases</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">118</span>– <span class="NLM_lpage">123</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00438</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00438" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=118-123&issue=1&author=M.+Erraauthor=J.+Taltavullauthor=A.+Gr%C3%A9coauthor=F.+J.+Bernalauthor=J.+F.+Caturlaauthor=J.+Gr%C3%A0ciaauthor=M.+Dom%C3%ADnguezauthor=M.+Sabat%C3%A9author=S.+Parisauthor=S.+Soriaauthor=B.+Hern%C3%A1ndezauthor=C.+Armengolauthor=J.+Cabedoauthor=M.+Bravoauthor=E.+Calamaauthor=M.+Miralpeixauthor=M.+D.+Lehner&title=Discovery+of+a+Potent%2C+Selective%2C+and+Orally+Available+PI3K%CE%B4+Inhibitor+for+the+Treatment+of+Inflammatory+Diseases&doi=10.1021%2Facsmedchemlett.6b00438"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00438%26sid%3Dliteratum%253Aachs%26aulast%3DErra%26aufirst%3DM.%26aulast%3DTaltavull%26aufirst%3DJ.%26aulast%3DGr%25C3%25A9co%26aufirst%3DA.%26aulast%3DBernal%26aufirst%3DF.%2BJ.%26aulast%3DCaturla%26aufirst%3DJ.%2BF.%26aulast%3DGr%25C3%25A0cia%26aufirst%3DJ.%26aulast%3DDom%25C3%25ADnguez%26aufirst%3DM.%26aulast%3DSabat%25C3%25A9%26aufirst%3DM.%26aulast%3DParis%26aufirst%3DS.%26aulast%3DSoria%26aufirst%3DS.%26aulast%3DHern%25C3%25A1ndez%26aufirst%3DB.%26aulast%3DArmengol%26aufirst%3DC.%26aulast%3DCabedo%26aufirst%3DJ.%26aulast%3DBravo%26aufirst%3DM.%26aulast%3DCalama%26aufirst%3DE.%26aulast%3DMiralpeix%26aufirst%3DM.%26aulast%3DLehner%26aufirst%3DM.%2BD.%26atitle%3DDiscovery%2520of%2520a%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Available%2520PI3K%25CE%25B4%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Inflammatory%2520Diseases%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26issue%3D1%26spage%3D118%26epage%3D123%26doi%3D10.1021%2Facsmedchemlett.6b00438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Su, W.-G.</span>; <span class="NLM_string-name">Dai, G.</span>; <span class="NLM_string-name">Xiao, K.</span>; <span class="NLM_string-name">Jia, H.</span>; <span class="NLM_string-name">Venable, J. D.</span>; <span class="NLM_string-name">Bembenek, S. D.</span></span> <span> </span><span class="NLM_article-title">Novel Heteroaryl and Heterocycle Compounds, Compositions and Methods</span>. <span class="NLM_patent">WO2014015523</span>, January 31, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=W.-G.+Su&author=G.+Dai&author=K.+Xiao&author=H.+Jia&author=J.+D.+Venable&author=S.+D.+Bembenek&title=Novel+Heteroaryl+and+Heterocycle+Compounds%2C+Compositions+and+Methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DW.-G.%26atitle%3DNovel%2520Heteroaryl%2520and%2520Heterocycle%2520Compounds%252C%2520Compositions%2520and%2520Methods%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Su, W.-G.</span>; <span class="NLM_string-name">Dai, G.</span>; <span class="NLM_string-name">Jia, H.</span>; <span class="NLM_string-name">Zhang, Z.</span>; <span class="NLM_string-name">Weng, J.</span>; <span class="NLM_string-name">Venable, J. D.</span>; <span class="NLM_string-name">Bembenek, S. D.</span>; <span class="NLM_string-name">Chai, W.</span>; <span class="NLM_string-name">Meduna, S. P.</span>; <span class="NLM_string-name">Keith, J. M.</span>; <span class="NLM_string-name">Eccles, W.</span>; <span class="NLM_string-name">Lebsack, A. D.</span>; <span class="NLM_string-name">Jones, W. M.</span>; <span class="NLM_string-name">Smith, R. C.</span></span> <span> </span><span class="NLM_article-title">Novel Heteroaryl and Heterocycle Compounds, Compositions and Methods</span>. <span class="NLM_patent">WO2016119707</span>, August 5, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=W.-G.+Su&author=G.+Dai&author=H.+Jia&author=Z.+Zhang&author=J.+Weng&author=J.+D.+Venable&author=S.+D.+Bembenek&author=W.+Chai&author=S.+P.+Meduna&author=J.+M.+Keith&author=W.+Eccles&author=A.+D.+Lebsack&author=W.+M.+Jones&author=R.+C.+Smith&title=Novel+Heteroaryl+and+Heterocycle+Compounds%2C+Compositions+and+Methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DW.-G.%26atitle%3DNovel%2520Heteroaryl%2520and%2520Heterocycle%2520Compounds%252C%2520Compositions%2520and%2520Methods%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Su, W.-G.</span>; <span class="NLM_string-name">Dai, G.</span>; <span class="NLM_string-name">Zhang, W.</span>; <span class="NLM_string-name">Deng, W.</span></span> <span> </span><span class="NLM_article-title">Novel Imidazopyridazine Compounds and Their Use</span>. <span class="NLM_patent">WO2016045591</span>, April 1, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=W.-G.+Su&author=G.+Dai&author=W.+Zhang&author=W.+Deng&title=Novel+Imidazopyridazine+Compounds+and+Their+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DW.-G.%26atitle%3DNovel%2520Imidazopyridazine%2520Compounds%2520and%2520Their%2520Use%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, B.</span></span> <span> </span><span class="NLM_article-title">Pyrazolopyrimidine Compound as PI3K Inhibitor and Use Thereof</span>. <span class="NLM_patent">WO2018082444</span>, May 12, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=B.+Ye&title=Pyrazolopyrimidine+Compound+as+PI3K+Inhibitor+and+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DB.%26atitle%3DPyrazolopyrimidine%2520Compound%2520as%2520PI3K%2520Inhibitor%2520and%2520Use%2520Thereof%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Imidazopyridine Compound and Uses in Preparation of PI3K Inhibitor</span>. <span class="NLM_patent">WO2017049498</span>, March 31, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=Z.+Liu&title=Imidazopyridine+Compound+and+Uses+in+Preparation+of+PI3K+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DImidazopyridine%2520Compound%2520and%2520Uses%2520in%2520Preparation%2520of%2520PI3K%2520Inhibitor%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, E.</span>; <span class="NLM_string-name">Smith, C.</span>; <span class="NLM_string-name">Wang, X.</span>; <span class="NLM_string-name">Wallace, M. B.</span></span> <span> </span><span class="NLM_article-title">Azaindole Derivatives</span>. <span class="NLM_patent">WO2015106012</span>, July 17, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=E.+Chang&author=C.+Smith&author=X.+Wang&author=M.+B.+Wallace&title=Azaindole+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DE.%26atitle%3DAzaindole%2520Derivatives%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span>; <span class="NLM_string-name">Ding, J.</span>; <span class="NLM_string-name">Meng, L.</span>; <span class="NLM_string-name">Geng, M.</span>; <span class="NLM_string-name">Li, T.</span>; <span class="NLM_string-name">Zhou, Z.</span>; <span class="NLM_string-name">Chen, L.</span>; <span class="NLM_string-name">Liu, Q.</span>; <span class="NLM_string-name">Wang, X.</span>; <span class="NLM_string-name">Yang, L.</span>; <span class="NLM_string-name">Rong, Y.</span>; <span class="NLM_string-name">Tan, R.</span>; <span class="NLM_string-name">Yu, C.</span>; <span class="NLM_string-name">Jiang, L.</span>; <span class="NLM_string-name">Liu, Y.</span>; <span class="NLM_string-name">Linghu, L.</span>; <span class="NLM_string-name">Sun, J.</span>; <span class="NLM_string-name">Wang, W.</span></span> <span> </span><span class="NLM_article-title">Certain Protein Kinase Inhibitors</span>. <span class="NLM_patent">WO2016066142</span>, May 7, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=X.+Zhao&author=J.+Ding&author=L.+Meng&author=M.+Geng&author=T.+Li&author=Z.+Zhou&author=L.+Chen&author=Q.+Liu&author=X.+Wang&author=L.+Yang&author=Y.+Rong&author=R.+Tan&author=C.+Yu&author=L.+Jiang&author=Y.+Liu&author=L.+Linghu&author=J.+Sun&author=W.+Wang&title=Certain+Protein+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DX.%26atitle%3DCertain%2520Protein%2520Kinase%2520Inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perry, M. W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Björhall, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlsson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eriksson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fredlund, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holden, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karabelas, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindmark, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pemberton, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigo Blomqvist, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svensson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terstiege, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyrchan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Öster, L.</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of Soluble and Cell-Permeable PI3Kδ Inhibitors for Long-Acting Inhaled Administration</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">5057</span>– <span class="NLM_lpage">5071</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00401</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00401" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotVGlu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5057-5071&issue=12&author=M.+W.+D.+Perryauthor=K.+Bj%C3%B6rhallauthor=B.+Bonnauthor=J.+Carlssonauthor=Y.+Chenauthor=A.+Erikssonauthor=L.+Fredlundauthor=H.+Haoauthor=N.+S.+Holdenauthor=K.+Karabelasauthor=H.+Lindmarkauthor=F.+Liuauthor=N.+Pembertonauthor=J.+Petersenauthor=S.+Rodrigo+Blomqvistauthor=R.+W.+Smithauthor=T.+Svenssonauthor=I.+Terstiegeauthor=C.+Tyrchanauthor=W.+Yangauthor=S.+Zhaoauthor=L.+%C3%96ster&title=Design+and+Synthesis+of+Soluble+and+Cell-Permeable+PI3K%CE%B4+Inhibitors+for+Long-Acting+Inhaled+Administration&doi=10.1021%2Facs.jmedchem.7b00401"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Soluble and Cell-Permeable PI3Kδ Inhibitors for Long-Acting Inhaled Administration</span></div><div class="casAuthors">Perry, Matthew W. D.; Bjoerhall, Karin; Bonn, Britta; Carlsson, Johan; Chen, Yunhua; Eriksson, Anders; Fredlund, Linda; Hao, Hai'e; Holden, Neil S.; Karabelas, Kostas; Lindmark, Helena; Liu, Feifei; Pemberton, Nils; Petersen, Jens; Rodrigo Blomqvist, Sandra; Smith, Reed W.; Svensson, Tor; Terstiege, Ina; Tyrchan, Christian; Yang, Wenzhen; Zhao, Shuchun; Oester, Linda</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5057-5071</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">PI3Kδ is a lipid kinase that is believed to be important in the migration and activation of cells of the immune system.  Inhibition is hypothesized to provide a powerful yet selective immunomodulatory effect that may be beneficial for the treatment of conditions such as asthma or rheumatoid arthritis.  In this work, identification of inhibitors based on a thiazolopyridone core structure and their subsequent optimization for inhalation is described.  The initially identified compd. I had good potency and isoform selectivity but was not suitable for inhalation.  Addn. of basic substituents to a region of the mol. pointing to solvent was tolerated (enzyme inhibition pIC50 > 9), and by careful manipulation of the pKa and lipophilicity, the authors were able to discover compds. II (R = Me or i-Bu) with good lung retention and cell potency that could be taken forward to in vivo studies where significant target engagement could be demonstrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4lo9sRrhhb7Vg90H21EOLACvtfcHk0lgrLEPU6iB2Tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotVGlu7w%253D&md5=dafb9cfdf6c06e30c599dcceec85497a</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00401%26sid%3Dliteratum%253Aachs%26aulast%3DPerry%26aufirst%3DM.%2BW.%2BD.%26aulast%3DBj%25C3%25B6rhall%26aufirst%3DK.%26aulast%3DBonn%26aufirst%3DB.%26aulast%3DCarlsson%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DEriksson%26aufirst%3DA.%26aulast%3DFredlund%26aufirst%3DL.%26aulast%3DHao%26aufirst%3DH.%26aulast%3DHolden%26aufirst%3DN.%2BS.%26aulast%3DKarabelas%26aufirst%3DK.%26aulast%3DLindmark%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DPemberton%26aufirst%3DN.%26aulast%3DPetersen%26aufirst%3DJ.%26aulast%3DRodrigo%2BBlomqvist%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DR.%2BW.%26aulast%3DSvensson%26aufirst%3DT.%26aulast%3DTerstiege%26aufirst%3DI.%26aulast%3DTyrchan%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3D%25C3%2596ster%26aufirst%3DL.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Soluble%2520and%2520Cell-Permeable%2520PI3K%25CE%25B4%2520Inhibitors%2520for%2520Long-Acting%2520Inhaled%2520Administration%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D12%26spage%3D5057%26epage%3D5071%26doi%3D10.1021%2Facs.jmedchem.7b00401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carrascal
Riera, M.</span>; <span class="NLM_string-name">Gracia
Ferrer, J.</span>; <span class="NLM_string-name">Matassa, V. G.</span>; <span class="NLM_string-name">Santacana, L. M. P.</span>; <span class="NLM_string-name">Terricabras
Belart, E.</span></span> <span> </span><span class="NLM_article-title">Imidazopyridine Derivatives as PI3K Inhibitors</span>. <span class="NLM_patent">WO2012146667</span>, November 2, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=M.+Carrascal%0ARiera&author=J.+Gracia%0AFerrer&author=V.+G.+Matassa&author=L.+M.+P.+Santacana&author=E.+Terricabras%0ABelart&title=Imidazopyridine+Derivatives+as+PI3K+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCarrascal%2BRiera%26aufirst%3DM.%26atitle%3DImidazopyridine%2520Derivatives%2520as%2520PI3K%2520Inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biagetti, M.</span>; <span class="NLM_string-name">Accetta, A.</span>; <span class="NLM_string-name">Capelli, A. M.</span>; <span class="NLM_string-name">Guala, M.</span>; <span class="NLM_string-name">Retini, M.</span></span> <span> </span><span class="NLM_article-title">Indolizine Derivatives as Phoshoinositide 3-Kinases Inhibitors</span>. <span class="NLM_patent">WO2015193263</span>, December 24, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+Biagetti&author=A.+Accetta&author=A.+M.+Capelli&author=M.+Guala&author=M.+Retini&title=Indolizine+Derivatives+as+Phoshoinositide+3-Kinases+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBiagetti%26aufirst%3DM.%26atitle%3DIndolizine%2520Derivatives%2520as%2520Phoshoinositide%25203-Kinases%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.-L.</span>; <span class="NLM_string-name">Combs, A. P.</span>; <span class="NLM_string-name">Yue, E. W.</span>; <span class="NLM_string-name">Maduskuie, T. P.,  Jr.</span>; <span class="NLM_string-name">Sparks, R. B.</span></span> <span> </span><span class="NLM_article-title">N-(1-(Substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K Inhibitors</span>. <span class="NLM_patent">WO2012087881</span>, June 29, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=Y.-L.+Li&author=A.+P.+Combs&author=E.+W.+Yue&author=T.+P.+Maduskuie&author=R.+B.+Sparks&title=N-%281-%28Substituted-phenyl%29ethyl%29-9H-purin-6-amines+as+PI3K+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.-L.%26atitle%3DN-%25281-%2528Substituted-phenyl%2529ethyl%2529-9H-purin-6-amines%2520as%2520PI3K%2520Inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Combs, A. P.</span>; <span class="NLM_string-name">Li, Y.-L.</span>; <span class="NLM_string-name">Yue, E. W.</span>; <span class="NLM_string-name">Mei, S.</span></span> <span> </span><span class="NLM_article-title">Pyrimidine-4,6-diamine Derivatives as PI3K Inhibitors</span>. <span class="NLM_patent">WO2012135009</span>, October 5, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+P.+Combs&author=Y.-L.+Li&author=E.+W.+Yue&author=S.+Mei&title=Pyrimidine-4%2C6-diamine+Derivatives+as+PI3K+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCombs%26aufirst%3DA.%2BP.%26atitle%3DPyrimidine-4%252C6-diamine%2520Derivatives%2520as%2520PI3K%2520Inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koblish, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Covington, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katiyar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maduskuie, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douty, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, C.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Combs, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamond-Fosbenner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeleswaram, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaddi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherle, P.</span></span> <span> </span><span class="NLM_article-title">INCB050465, a Novel PI3Kδ Inhibitor, Synergizes with PIM Protein Kinase Inhibition to Cause Tumor Regression in a Model of DLBCL</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>75</i></span> (<span class="NLM_issue">15 Suppl.</span>),  <span class="NLM_fpage">2671</span>, <span class="refDoi"> DOI: 10.1158/1538-7445.AM2015-2671</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1158%2F1538-7445.AM2015-2671" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=2671&issue=15+Suppl.&author=N.+Shinauthor=H.+Koblishauthor=M.+Covingtonauthor=Y.+Liauthor=K.+Wangauthor=Q.+Wangauthor=P.+Feldmanauthor=L.+Hallauthor=S.+O%E2%80%99Connorauthor=X.+Heauthor=K.+Katiyarauthor=Y.+Liauthor=E.+W.+Yueauthor=T.+P.+Maduskuieauthor=B.+Doutyauthor=S.+Meiauthor=Y.-L.+Liauthor=C.-B.+Xueauthor=A.+Combsauthor=W.+Yaoauthor=S.+Diamond-Fosbennerauthor=S.+Yeleswaramauthor=R.+Newtonauthor=K.+Vaddiauthor=R.+Huberauthor=P.+Scherle&title=INCB050465%2C+a+Novel+PI3K%CE%B4+Inhibitor%2C+Synergizes+with+PIM+Protein+Kinase+Inhibition+to+Cause+Tumor+Regression+in+a+Model+of+DLBCL&doi=10.1158%2F1538-7445.AM2015-2671"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2015-2671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM2015-2671%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DN.%26aulast%3DKoblish%26aufirst%3DH.%26aulast%3DCovington%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DFeldman%26aufirst%3DP.%26aulast%3DHall%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DKatiyar%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DYue%26aufirst%3DE.%2BW.%26aulast%3DMaduskuie%26aufirst%3DT.%2BP.%26aulast%3DDouty%26aufirst%3DB.%26aulast%3DMei%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DY.-L.%26aulast%3DXue%26aufirst%3DC.-B.%26aulast%3DCombs%26aufirst%3DA.%26aulast%3DYao%26aufirst%3DW.%26aulast%3DDiamond-Fosbenner%26aufirst%3DS.%26aulast%3DYeleswaram%26aufirst%3DS.%26aulast%3DNewton%26aufirst%3DR.%26aulast%3DVaddi%26aufirst%3DK.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DScherle%26aufirst%3DP.%26atitle%3DINCB050465%252C%2520a%2520Novel%2520PI3K%25CE%25B4%2520Inhibitor%252C%2520Synergizes%2520with%2520PIM%2520Protein%2520Kinase%2520Inhibition%2520to%2520Cause%2520Tumor%2520Regression%2520in%2520a%2520Model%2520of%2520DLBCL%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26issue%3D15%2520Suppl%26spage%3D2671%26doi%3D10.1158%2F1538-7445.AM2015-2671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Combs, A. P.</span>; <span class="NLM_string-name">Sparks, R. B.</span>; <span class="NLM_string-name">Maduskuie, T. P.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Bicyclic Azaheterocyclobenzylamines as PI3K Inhibitors</span>. <span class="NLM_patent">WO2013151930</span>, October 11, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=A.+P.+Combs&author=R.+B.+Sparks&author=T.+P.+Maduskuie&title=Bicyclic+Azaheterocyclobenzylamines+as+PI3K+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCombs%26aufirst%3DA.%2BP.%26atitle%3DBicyclic%2520Azaheterocyclobenzylamines%2520as%2520PI3K%2520Inhibitors%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biagetti, M.</span>; <span class="NLM_string-name">Capelli, A. M.</span>; <span class="NLM_string-name">Retini, M.</span></span> <span> </span><span class="NLM_article-title">Pyrazole Derivatives as Phosphoinositide 3-Kinases Inhibitors</span>. <span class="NLM_patent">WO2017134053</span>, August 11, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=M.+Biagetti&author=A.+M.+Capelli&author=M.+Retini&title=Pyrazole+Derivatives+as+Phosphoinositide+3-Kinases+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBiagetti%26aufirst%3DM.%26atitle%3DPyrazole%2520Derivatives%2520as%2520Phosphoinositide%25203-Kinases%2520Inhibitors%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayflick, J. S.</span>; <span class="NLM_string-name">Pefaur, N.</span>; <span class="NLM_string-name">Puri, K.
D.</span>; <span class="NLM_string-name">Tino, W.</span>; <span class="NLM_string-name">Kawakami, T.</span>; <span class="NLM_string-name">Kawakami, Y.</span></span> <span> </span><span class="NLM_article-title">Methods for Treating Mast Cell Disorders</span>. <span class="NLM_patent">WO2005120511</span>, December 23, <span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=J.+S.+Hayflick&author=N.+Pefaur&author=K.%0AD.+Puri&author=W.+Tino&author=T.+Kawakami&author=Y.+Kawakami&title=Methods+for+Treating+Mast+Cell+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHayflick%26aufirst%3DJ.%2BS.%26atitle%3DMethods%2520for%2520Treating%2520Mast%2520Cell%2520Disorders%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lodola, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertolini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biagetti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capacchi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Facchinetti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallo, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pappani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pala, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visentini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corsi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capelli, A. M.</span></span> <span> </span><span class="NLM_article-title">Atropisomerism and Conformational Equilibria: Impact on PI3Kδ Inhibition of 2-((6-Amino-9H-purin-9-yl)methyl)-5-methyl-3-(o-tolyl)quinazolin-4(3H)-one (IC87114) and Its Conformationally Restricted Analogs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">4304</span>– <span class="NLM_lpage">4315</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00247</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00247" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4304-4315&issue=10&author=A.+Lodolaauthor=S.+Bertoliniauthor=M.+Biagettiauthor=S.+Capacchiauthor=F.+Facchinettiauthor=P.+M.+Galloauthor=A.+Pappaniauthor=M.+Morauthor=D.+Palaauthor=S.+Rivaraauthor=F.+Visentiniauthor=M.+Corsiauthor=A.+M.+Capelli&title=Atropisomerism+and+Conformational+Equilibria%3A+Impact+on+PI3K%CE%B4+Inhibition+of+2-%28%286-Amino-9H-purin-9-yl%29methyl%29-5-methyl-3-%28o-tolyl%29quinazolin-4%283H%29-one+%28IC87114%29+and+Its+Conformationally+Restricted+Analogs&doi=10.1021%2Facs.jmedchem.7b00247"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00247%26sid%3Dliteratum%253Aachs%26aulast%3DLodola%26aufirst%3DA.%26aulast%3DBertolini%26aufirst%3DS.%26aulast%3DBiagetti%26aufirst%3DM.%26aulast%3DCapacchi%26aufirst%3DS.%26aulast%3DFacchinetti%26aufirst%3DF.%26aulast%3DGallo%26aufirst%3DP.%2BM.%26aulast%3DPappani%26aufirst%3DA.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DPala%26aufirst%3DD.%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DVisentini%26aufirst%3DF.%26aulast%3DCorsi%26aufirst%3DM.%26aulast%3DCapelli%26aufirst%3DA.%2BM.%26atitle%3DAtropisomerism%2520and%2520Conformational%2520Equilibria%253A%2520Impact%2520on%2520PI3K%25CE%25B4%2520Inhibition%2520of%25202-%2528%25286-Amino-9H-purin-9-yl%2529methyl%2529-5-methyl-3-%2528o-tolyl%2529quinazolin-4%25283H%2529-one%2520%2528IC87114%2529%2520and%2520Its%2520Conformationally%2520Restricted%2520Analogs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D10%26spage%3D4304%26epage%3D4315%26doi%3D10.1021%2Facs.jmedchem.7b00247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cushing, T. D.</span>; <span class="NLM_string-name">Hao, X.</span>; <span class="NLM_string-name">Lohman, J. W.</span>; <span class="NLM_string-name">Shin, Y.</span></span> <span> </span><span class="NLM_article-title">4H-Pyrido[1,2-a]pyrimidin-4-one Derivatives as PI3K Inhibitors</span>. <span class="NLM_patent">WO2010151735</span>, December 30, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=T.+D.+Cushing&author=X.+Hao&author=J.+W.+Lohman&author=Y.+Shin&title=4H-Pyrido%5B1%2C2-a%5Dpyrimidin-4-one+Derivatives+as+PI3K+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCushing%26aufirst%3DT.%2BD.%26atitle%3D4H-Pyrido%255B1%252C2-a%255Dpyrimidin-4-one%2520Derivatives%2520as%2520PI3K%2520Inhibitors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrasekhar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evarts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haran, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ip, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaplan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koditek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lad, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepist, E.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novikov, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perreault, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puri, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somoza, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiner, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Therrien, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treiberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villaseñor, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, G.</span></span> <span> </span><span class="NLM_article-title">2,4,6-Triaminopyrimidine as a Novel Hinge Binder in a Series of PI3Kδ Selective Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">3532</span>– <span class="NLM_lpage">3548</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00213</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00213" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3532-3548&issue=7&author=L.+Patelauthor=J.+Chandrasekharauthor=J.+Evartsauthor=A.+C.+Haranauthor=C.+Ipauthor=J.+A.+Kaplanauthor=M.+Kimauthor=D.+Koditekauthor=L.+Ladauthor=E.-I.+Lepistauthor=M.+E.+McGrathauthor=N.+Novikovauthor=S.+Perreaultauthor=K.+D.+Puriauthor=J.+R.+Somozaauthor=B.+H.+Steinerauthor=K.+L.+Stevensauthor=J.+Therrienauthor=J.+Treibergauthor=A.+G.+Villase%C3%B1orauthor=A.+Yeungauthor=G.+Phillips&title=2%2C4%2C6-Triaminopyrimidine+as+a+Novel+Hinge+Binder+in+a+Series+of+PI3K%CE%B4+Selective+Inhibitors&doi=10.1021%2Facs.jmedchem.6b00213"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00213%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DL.%26aulast%3DChandrasekhar%26aufirst%3DJ.%26aulast%3DEvarts%26aufirst%3DJ.%26aulast%3DHaran%26aufirst%3DA.%2BC.%26aulast%3DIp%26aufirst%3DC.%26aulast%3DKaplan%26aufirst%3DJ.%2BA.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DKoditek%26aufirst%3DD.%26aulast%3DLad%26aufirst%3DL.%26aulast%3DLepist%26aufirst%3DE.-I.%26aulast%3DMcGrath%26aufirst%3DM.%2BE.%26aulast%3DNovikov%26aufirst%3DN.%26aulast%3DPerreault%26aufirst%3DS.%26aulast%3DPuri%26aufirst%3DK.%2BD.%26aulast%3DSomoza%26aufirst%3DJ.%2BR.%26aulast%3DSteiner%26aufirst%3DB.%2BH.%26aulast%3DStevens%26aufirst%3DK.%2BL.%26aulast%3DTherrien%26aufirst%3DJ.%26aulast%3DTreiberg%26aufirst%3DJ.%26aulast%3DVillase%25C3%25B1or%26aufirst%3DA.%2BG.%26aulast%3DYeung%26aufirst%3DA.%26aulast%3DPhillips%26aufirst%3DG.%26atitle%3D2%252C4%252C6-Triaminopyrimidine%2520as%2520a%2520Novel%2520Hinge%2520Binder%2520in%2520a%2520Series%2520of%2520PI3K%25CE%25B4%2520Selective%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D7%26spage%3D3532%26epage%3D3548%26doi%3D10.1021%2Facs.jmedchem.6b00213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Du, Z.</span>; <span class="NLM_string-name">Hintermann, S.</span>; <span class="NLM_string-name">Hurth, K.</span>; <span class="NLM_string-name">Jacquier, S.</span>; <span class="NLM_string-name">Lehmann, H.</span>; <span class="NLM_string-name">Moebitz, H.</span>; <span class="NLM_string-name">Soldermann, N.</span>; <span class="NLM_string-name">Stojanovic, A.</span></span> <span> </span><span class="NLM_article-title">Substituted Quinazolin-4-one Derivatives</span>. <span class="NLM_patent">WO2015010641</span>, January 30, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=Z.+Du&author=S.+Hintermann&author=K.+Hurth&author=S.+Jacquier&author=H.+Lehmann&author=H.+Moebitz&author=N.+Soldermann&author=A.+Stojanovic&title=Substituted+Quinazolin-4-one+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DZ.%26atitle%3DSubstituted%2520Quinazolin-4-one%2520Derivatives%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bürli, R.</span>; <span class="NLM_string-name">Haughan, A. F.</span>; <span class="NLM_string-name">Matteucci, M.</span>; <span class="NLM_string-name">Owens, A. P.</span>; <span class="NLM_string-name">Raphy, G.</span>; <span class="NLM_string-name">Sharpe, A.</span></span> <span> </span><span class="NLM_article-title">Quinoline and Quinoxaline Derivatives as Kinase Inhibitors</span>. <span class="NLM_patent">WO2011058110</span>, May 20, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=R.+B%C3%BCrli&author=A.+F.+Haughan&author=M.+Matteucci&author=A.+P.+Owens&author=G.+Raphy&author=A.+Sharpe&title=Quinoline+and+Quinoxaline+Derivatives+as+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25BCrli%26aufirst%3DR.%26atitle%3DQuinoline%2520and%2520Quinoxaline%2520Derivatives%2520as%2520Kinase%2520Inhibitors%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knight, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldman, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zunder, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldenberg, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loewith, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stokoe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balla, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span> <span> </span><span class="NLM_article-title">A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>125</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">733</span>– <span class="NLM_lpage">747</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2006.03.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.cell.2006.03.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=16647110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BD28XltlSkt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2006&pages=733-747&issue=4&author=Z.+A.+Knightauthor=B.+Gonzalezauthor=M.+E.+Feldmanauthor=E.+R.+Zunderauthor=D.+D.+Goldenbergauthor=O.+Williamsauthor=R.+Loewithauthor=D.+Stokoeauthor=A.+Ballaauthor=B.+Tothauthor=T.+Ballaauthor=W.+A.+Weissauthor=R.+L.+Williamsauthor=K.+M.+Shokat&title=A+Pharmacological+Map+of+the+PI3-K+Family+Defines+a+Role+for+p110%CE%B1+in+Insulin+Signaling&doi=10.1016%2Fj.cell.2006.03.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">A pharmacological map of the PI3-K family defines a role for p110α in insulin signaling</span></div><div class="casAuthors">Knight, Zachary A.; Gonzalez, Beatriz; Feldman, Morri E.; Zunder, Eli R.; Goldenberg, David D.; Williams, Olusegun; Loewith, Robbie; Stokoe, David; Balla, Andras; Toth, Balazs; Balla, Tamas; Weiss, William A.; Williams, Roger L.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">733-747</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Phosphoinositide 3-kinases (PI3-Ks) are an important emerging class of drug targets, but the unique roles of PI3-K isoforms remain poorly defined.  We describe here an approach to pharmacol. interrogate the PI3-K family.  A chem. diverse panel of PI3-K inhibitors was synthesized, and their target selectivity was biochem. enumerated, revealing cryptic homologies across targets and chemotypes.  Crystal structures of three inhibitors bound to p110γ identify a conformationally mobile region that is uniquely exploited by selective compds.  This chem. array was then used to define the PI3-K isoforms required for insulin signaling.  We find that p110α is the primary insulin-responsive PI3-K in cultured cells, whereas p110β is dispensable but sets a phenotypic threshold for p110α activity.  Compds. targeting p110α block the acute effects of insulin treatment in vivo, whereas a p110β inhibitor has no effect.  These results illustrate systematic target validation using a matrix of inhibitors that span a protein family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrozjvOeMXP3bVg90H21EOLACvtfcHk0lhnh9eM5DH4-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltlSkt7o%253D&md5=b95a8cb433927ff9a75b33fc4ac2c8a0</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.03.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.03.035%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DGonzalez%26aufirst%3DB.%26aulast%3DFeldman%26aufirst%3DM.%2BE.%26aulast%3DZunder%26aufirst%3DE.%2BR.%26aulast%3DGoldenberg%26aufirst%3DD.%2BD.%26aulast%3DWilliams%26aufirst%3DO.%26aulast%3DLoewith%26aufirst%3DR.%26aulast%3DStokoe%26aufirst%3DD.%26aulast%3DBalla%26aufirst%3DA.%26aulast%3DToth%26aufirst%3DB.%26aulast%3DBalla%26aufirst%3DT.%26aulast%3DWeiss%26aufirst%3DW.%2BA.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DA%2520Pharmacological%2520Map%2520of%2520the%2520PI3-K%2520Family%2520Defines%2520a%2520Role%2520for%2520p110%25CE%25B1%2520in%2520Insulin%2520Signaling%26jtitle%3DCell%26date%3D2006%26volume%3D125%26issue%3D4%26spage%3D733%26epage%3D747%26doi%3D10.1016%2Fj.cell.2006.03.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erra
Sola, M.</span>; <span class="NLM_string-name">Carrascal
Riera, M.</span>; <span class="NLM_string-name">Taltavull
Moll, J.</span>; <span class="NLM_string-name">Caturla
Javaloyes, J. F.</span>; <span class="NLM_string-name">Bernal Anchuela, F. J.</span>; <span class="NLM_string-name">Pages Santacana, L. M.</span>; <span class="NLM_string-name">Mir Cepeda, M.</span>; <span class="NLM_string-name">Casals Coll, G.</span>; <span class="NLM_string-name">Hernandez Olasagarre, M. B.</span></span> <span> </span><span class="NLM_article-title">Pyrrolotriazinone Derivatives as PI3K Inhibitors</span>. <span class="NLM_patent">WO2014060432</span>, April 25, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=M.+Erra%0ASola&author=M.+Carrascal%0ARiera&author=J.+Taltavull%0AMoll&author=J.+F.+Caturla%0AJavaloyes&author=F.+J.+Bernal+Anchuela&author=L.+M.+Pages+Santacana&author=M.+Mir+Cepeda&author=G.+Casals+Coll&author=M.+B.+Hernandez+Olasagarre&title=Pyrrolotriazinone+Derivatives+as+PI3K+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DErra%2BSola%26aufirst%3DM.%26atitle%3DPyrrolotriazinone%2520Derivatives%2520as%2520PI3K%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xi, N.</span>; <span class="NLM_string-name">Wang, L.</span>; <span class="NLM_string-name">Wang, T.</span></span> <span> </span><span class="NLM_article-title">Substituted Aminopyrimidine Compounds and Methods of Use</span>. <span class="NLM_patent">WO2015042078</span>, March 27, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=N.+Xi&author=L.+Wang&author=T.+Wang&title=Substituted+Aminopyrimidine+Compounds+and+Methods+of+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DXi%26aufirst%3DN.%26atitle%3DSubstituted%2520Aminopyrimidine%2520Compounds%2520and%2520Methods%2520of%2520Use%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evarts, J.</span>; <span class="NLM_string-name">Kaplan, J.</span>; <span class="NLM_string-name">Kim, M.</span>; <span class="NLM_string-name">Patel, L.</span>; <span class="NLM_string-name">Perreault, S.</span>; <span class="NLM_string-name">Phillips, G.</span>; <span class="NLM_string-name">Treiberg, J. A.</span>; <span class="NLM_string-name">Van Veldhuizen, J.</span></span> <span> </span><span class="NLM_article-title">Phosphatidylinositol 3-Kinase Inhibitors</span>. <span class="NLM_patent">WO2014201409</span>, December 19, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=J.+Evarts&author=J.+Kaplan&author=M.+Kim&author=L.+Patel&author=S.+Perreault&author=G.+Phillips&author=J.+A.+Treiberg&author=J.+Van+Veldhuizen&title=Phosphatidylinositol+3-Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEvarts%26aufirst%3DJ.%26atitle%3DPhosphatidylinositol%25203-Kinase%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gracia Ferrer, J.</span>; <span class="NLM_string-name">Erra Sola, M.</span></span> <span> </span><span class="NLM_article-title">Pyrrolopyrimidine Derivatives as PI3K Inhibitors</span>. <span class="NLM_patent">WO2015091532</span>, June 26, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=J.+Gracia+Ferrer&author=M.+Erra+Sola&title=Pyrrolopyrimidine+Derivatives+as+PI3K+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGracia%2BFerrer%26aufirst%3DJ.%26atitle%3DPyrrolopyrimidine%2520Derivatives%2520as%2520PI3K%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taltavull Moll, J.</span>; <span class="NLM_string-name">Mir Cepeda, M.</span>; <span class="NLM_string-name">Forns Berenguel, M. P.</span>; <span class="NLM_string-name">Erra Sola, M.</span></span> <span> </span><span class="NLM_article-title">Pyrrolotriazinone Derivatives as PI3K Inhibitors</span>. <span class="NLM_patent">WO2016202800</span>, December 23, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=J.+Taltavull+Moll&author=M.+Mir+Cepeda&author=M.+P.+Forns+Berenguel&author=M.+Erra+Sola&title=Pyrrolotriazinone+Derivatives+as+PI3K+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTaltavull%2BMoll%26aufirst%3DJ.%26atitle%3DPyrrolotriazinone%2520Derivatives%2520as%2520PI3K%2520Inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sadhu, C.</span>; <span class="NLM_string-name">Dick, K.</span>; <span class="NLM_string-name">Treiberg, J.</span>; <span class="NLM_string-name">Sowell, C. G.</span>; <span class="NLM_string-name">Kesicki, E. A.</span>; <span class="NLM_string-name">Oliver, A.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of Human Phosphatidyl-Inositol 3-Kinase Delta</span>. <span class="NLM_patent">WO2001081346</span>, November 2, <span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=C.+Sadhu&author=K.+Dick&author=J.+Treiberg&author=C.+G.+Sowell&author=E.+A.+Kesicki&author=A.+Oliver&title=Inhibitors+of+Human+Phosphatidyl-Inositol+3-Kinase+Delta"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSadhu%26aufirst%3DC.%26atitle%3DInhibitors%2520of%2520Human%2520Phosphatidyl-Inositol%25203-Kinase%2520Delta%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, E.</span>; <span class="NLM_string-name">Notz, W.
R. L.</span>; <span class="NLM_string-name">Wallace, M. B.</span></span> <span> </span><span class="NLM_article-title">Azaindole Derivatives Which Act as PI3K Inhibitors</span>. <span class="NLM_patent">WO2014011568</span>, January 17, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=E.+Chang&author=W.%0AR.+L.+Notz&author=M.+B.+Wallace&title=Azaindole+Derivatives+Which+Act+as+PI3K+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DE.%26atitle%3DAzaindole%2520Derivatives%2520Which%2520Act%2520as%2520PI3K%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perreault, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrasekhar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Z.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evarts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaplan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashishian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keegan, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenney, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koditek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lad, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepist, E.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Therrien, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treiberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yahiaoui, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, G.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Phosphoinositide 3-Kinase (PI3K) β/δ Inhibitor for the Treatment of Phosphatase and Tensin Homolog (PTEN) Deficient Tumors: Building PI3Kβ Potency in a PI3Kδ-Selective Template by Targeting Nonconserved Asp856</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1555</span>– <span class="NLM_lpage">1567</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01821</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01821" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1555-1567&issue=4&author=S.+Perreaultauthor=J.+Chandrasekharauthor=Z.-H.+Cuiauthor=J.+Evartsauthor=J.+Haoauthor=J.+A.+Kaplanauthor=A.+Kashishianauthor=K.+S.+Keeganauthor=T.+Kenneyauthor=D.+Koditekauthor=L.+Ladauthor=E.-I.+Lepistauthor=M.+E.+McGrathauthor=L.+Patelauthor=B.+Phillipsauthor=J.+Therrienauthor=J.+Treibergauthor=A.+Yahiaouiauthor=G.+Phillips&title=Discovery+of+a+Phosphoinositide+3-Kinase+%28PI3K%29+%CE%B2%2F%CE%B4+Inhibitor+for+the+Treatment+of+Phosphatase+and+Tensin+Homolog+%28PTEN%29+Deficient+Tumors%3A+Building+PI3K%CE%B2+Potency+in+a+PI3K%CE%B4-Selective+Template+by+Targeting+Nonconserved+Asp856&doi=10.1021%2Facs.jmedchem.6b01821"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01821%26sid%3Dliteratum%253Aachs%26aulast%3DPerreault%26aufirst%3DS.%26aulast%3DChandrasekhar%26aufirst%3DJ.%26aulast%3DCui%26aufirst%3DZ.-H.%26aulast%3DEvarts%26aufirst%3DJ.%26aulast%3DHao%26aufirst%3DJ.%26aulast%3DKaplan%26aufirst%3DJ.%2BA.%26aulast%3DKashishian%26aufirst%3DA.%26aulast%3DKeegan%26aufirst%3DK.%2BS.%26aulast%3DKenney%26aufirst%3DT.%26aulast%3DKoditek%26aufirst%3DD.%26aulast%3DLad%26aufirst%3DL.%26aulast%3DLepist%26aufirst%3DE.-I.%26aulast%3DMcGrath%26aufirst%3DM.%2BE.%26aulast%3DPatel%26aufirst%3DL.%26aulast%3DPhillips%26aufirst%3DB.%26aulast%3DTherrien%26aufirst%3DJ.%26aulast%3DTreiberg%26aufirst%3DJ.%26aulast%3DYahiaoui%26aufirst%3DA.%26aulast%3DPhillips%26aufirst%3DG.%26atitle%3DDiscovery%2520of%2520a%2520Phosphoinositide%25203-Kinase%2520%2528PI3K%2529%2520%25CE%25B2%252F%25CE%25B4%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Phosphatase%2520and%2520Tensin%2520Homolog%2520%2528PTEN%2529%2520Deficient%2520Tumors%253A%2520Building%2520PI3K%25CE%25B2%2520Potency%2520in%2520a%2520PI3K%25CE%25B4-Selective%2520Template%2520by%2520Targeting%2520Nonconserved%2520Asp856%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D4%26spage%3D1555%26epage%3D1567%26doi%3D10.1021%2Facs.jmedchem.6b01821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heald, R.</span>; <span class="NLM_string-name">Price, S.</span>; <span class="NLM_string-name">Safina, B.</span>; <span class="NLM_string-name">Savy, P. P. A.</span>; <span class="NLM_string-name">Seward, E. M.</span>; <span class="NLM_string-name">Sutherlin, D. P.</span>; <span class="NLM_string-name">Waszkowycz, B.</span></span> <span> </span><span class="NLM_article-title">Heterocyclic Compounds as PI3 Kinase Inhibitors</span>. <span class="NLM_patent">WO2012107465</span>, August 17, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=R.+Heald&author=S.+Price&author=B.+Safina&author=P.+P.+A.+Savy&author=E.+M.+Seward&author=D.+P.+Sutherlin&author=B.+Waszkowycz&title=Heterocyclic+Compounds+as+PI3+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHeald%26aufirst%3DR.%26atitle%3DHeterocyclic%2520Compounds%2520as%2520PI3%2520Kinase%2520Inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, S.</span>; <span class="NLM_string-name">Du, Z.</span>; <span class="NLM_string-name">Kaplan, J.</span>; <span class="NLM_string-name">Loyer-Drew, J. A.</span>; <span class="NLM_string-name">Naduthambi, D.</span>; <span class="NLM_string-name">Phillips, B. W.</span>; <span class="NLM_string-name">Phillips, G.</span>; <span class="NLM_string-name">Van Veldhuizen, J.</span>; <span class="NLM_string-name">Watxins, W. J.</span>; <span class="NLM_string-name">Yeung, S. C.</span></span> <span> </span><span class="NLM_article-title">Phosphatidylinositol 3-Kinase Inhibitors</span>. <span class="NLM_patent">WO2015191752</span>, December 18, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=S.+Cai&author=Z.+Du&author=J.+Kaplan&author=J.+A.+Loyer-Drew&author=D.+Naduthambi&author=B.+W.+Phillips&author=G.+Phillips&author=J.+Van+Veldhuizen&author=W.+J.+Watxins&author=S.+C.+Yeung&title=Phosphatidylinositol+3-Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DS.%26atitle%3DPhosphatidylinositol%25203-Kinase%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uehara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solhjou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banouni, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Routray, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiNitto, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkhal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turka, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strom, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tullius, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azzi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdi, R.</span></span> <span> </span><span class="NLM_article-title">Regulation of T Cell Alloimmunity by PI3Kγ and PI3Kδ</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">951</span>, <span class="refDoi"> DOI: 10.1038/s41467-017-00982-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1038%2Fs41467-017-00982-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=29038423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A280%3ADC%252BC1M7htlelsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=951&issue=1&author=M.+Ueharaauthor=M.+M.+McGrathauthor=S.+Ohoriauthor=Z.+Solhjouauthor=N.+Banouniauthor=S.+Routrayauthor=C.+Evansauthor=J.+P.+DiNittoauthor=A.+Elkhalauthor=L.+A.+Turkaauthor=T.+B.+Stromauthor=S.+G.+Tulliusauthor=D.+G.+Winklerauthor=J.+Azziauthor=R.+Abdi&title=Regulation+of+T+Cell+Alloimmunity+by+PI3K%CE%B3+and+PI3K%CE%B4&doi=10.1038%2Fs41467-017-00982-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of T cell alloimmunity by PI3Kγ and PI3Kδ</span></div><div class="casAuthors">Uehara Mayuko; McGrath Martina M; Ohori Shunsuke; Solhjou Zhabiz; Banouni Naima; Routray Sujit; Azzi Jamil; Abdi Reza; Evans Catherine; DiNitto Jonathan P; Winkler David G; Elkhal Abdallah; Tullius Stefan G; Turka Laurence A; Strom Terry B</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">951</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Phosphatidylinositol-3-kinases (PI3K) γ and δ are preferentially enriched in leukocytes, and defects in these signaling pathways have been shown to impair T cell activation.  The effects of PI3Kγ and PI3Kδ on alloimmunity remain underexplored.  Here, we show that both PI3Kγ (-/-) and PI3Kδ (D910A/D910A) mice receiving heart allografts have suppression of alloreactive T effector cells and delayed acute rejection.  However, PI3Kδ mutation also dampens regulatory T cells (Treg).  After treatment with low dose CTLA4-Ig, PI3Kγ (-/-) , but not PI3Κδ (D910A/D910A) , recipients exhibit indefinite prolongation of heart allograft survival.  PI3Kδ (D910A/D910A) Tregs have increased apoptosis and impaired survival.  Selective inhibition of PI3Kγ and PI3Kδ (using PI3Kδ and dual PI3Kγδ chemical inhibitors) shows that PI3Kγ inhibition compensates for the negative effect of PI3Kδ inhibition on long-term allograft survival.  These data serve as a basis for future PI3K-based immune therapies for transplantation.Phosphatidylinositol-3-kinases (PI3K) γ and δ are key regulators of T cell signaling.  Here the author show, using mouse heart allograft transplantation models, that PI3Kγ or PI3Kδ deficiency prolongs graft survival, but selective inhibition of PI3Kγ or PI3Kδ reveals alternative transplant survival outcomes post CTLA4-Ig treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSaaQcrZV62XC6Ufuk_1xoTfW6udTcc2eYzdfdvaIox87ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M7htlelsg%253D%253D&md5=e615c38cd030e11b35d90418d65b4ae3</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1038%2Fs41467-017-00982-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-017-00982-x%26sid%3Dliteratum%253Aachs%26aulast%3DUehara%26aufirst%3DM.%26aulast%3DMcGrath%26aufirst%3DM.%2BM.%26aulast%3DOhori%26aufirst%3DS.%26aulast%3DSolhjou%26aufirst%3DZ.%26aulast%3DBanouni%26aufirst%3DN.%26aulast%3DRoutray%26aufirst%3DS.%26aulast%3DEvans%26aufirst%3DC.%26aulast%3DDiNitto%26aufirst%3DJ.%2BP.%26aulast%3DElkhal%26aufirst%3DA.%26aulast%3DTurka%26aufirst%3DL.%2BA.%26aulast%3DStrom%26aufirst%3DT.%2BB.%26aulast%3DTullius%26aufirst%3DS.%2BG.%26aulast%3DWinkler%26aufirst%3DD.%2BG.%26aulast%3DAzzi%26aufirst%3DJ.%26aulast%3DAbdi%26aufirst%3DR.%26atitle%3DRegulation%2520of%2520T%2520Cell%2520Alloimmunity%2520by%2520PI3K%25CE%25B3%2520and%2520PI3K%25CE%25B4%26jtitle%3DNat.%2520Commun.%26date%3D2017%26volume%3D8%26issue%3D1%26spage%3D951%26doi%3D10.1038%2Fs41467-017-00982-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lv, B.</span>; <span class="NLM_string-name">Li, C.</span></span> <span> </span><span class="NLM_article-title">Deuterated Quinazolinone Compound and Pharmaceutical Composition Comprising Same</span>. <span class="NLM_patent">WO2015113521</span>, August 7, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=B.+Lv&author=C.+Li&title=Deuterated+Quinazolinone+Compound+and+Pharmaceutical+Composition+Comprising+Same"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLv%26aufirst%3DB.%26atitle%3DDeuterated%2520Quinazolinone%2520Compound%2520and%2520Pharmaceutical%2520Composition%2520Comprising%2520Same%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harbeson, S. L.</span></span> <span> </span><span class="NLM_article-title">Deuterated Phenylquinazolinone and Phenylisoquinolinone Compounds</span>. <span class="NLM_patent">WO2015179772</span>, November 27, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=S.+L.+Harbeson&title=Deuterated+Phenylquinazolinone+and+Phenylisoquinolinone+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26atitle%3DDeuterated%2520Phenylquinazolinone%2520and%2520Phenylisoquinolinone%2520Compounds%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span>; <span class="NLM_string-name">Cheng, C.</span></span> <span> </span><span class="NLM_article-title">Deuterated Compounds for Treating Blood Cancers, and Compositions and Methods Thereof</span>. <span class="NLM_patent">WO2017079003</span>, May 12, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=C.+Huang&author=C.+Cheng&title=Deuterated+Compounds+for+Treating+Blood+Cancers%2C+and+Compositions+and+Methods+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DC.%26atitle%3DDeuterated%2520Compounds%2520for%2520Treating%2520Blood%2520Cancers%252C%2520and%2520Compositions%2520and%2520Methods%2520Thereof%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, C.</span>; <span class="NLM_string-name">Huang, C.</span></span> <span> </span><span class="NLM_article-title">Deuterated Compounds for Treating Hematologic Malignant, Inflammatory and Autoimmune Diseases</span>. <span class="NLM_patent">WO2017087207</span>, May 27, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=C.+Cheng&author=C.+Huang&title=Deuterated+Compounds+for+Treating+Hematologic+Malignant%2C+Inflammatory+and+Autoimmune+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DC.%26atitle%3DDeuterated%2520Compounds%2520for%2520Treating%2520Hematologic%2520Malignant%252C%2520Inflammatory%2520and%2520Autoimmune%2520Diseases%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deng, C.</span>; <span class="NLM_string-name">Deng, S.-X.</span>; <span class="NLM_string-name">Landry, D. W.</span>; <span class="NLM_string-name">Lipstein, M.</span>; <span class="NLM_string-name">Mangone, M.</span>; <span class="NLM_string-name">O’Connor, O.</span>; <span class="NLM_string-name">Serrano, X. O. J.</span>; <span class="NLM_string-name">Scotto, L.</span>; <span class="NLM_string-name">Xu, X.</span></span> <span> </span><span class="NLM_article-title">Targeting Casein Kinase-1 and PI3K/AKT/mTOR Pathways for Treatment of c-Myc-Overexpressing Cancers, Organ Transplant Associated Complications and Autoimmune Diseases</span>. <span class="NLM_patent">WO2017079558</span>, May 12, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=C.+Deng&author=S.-X.+Deng&author=D.+W.+Landry&author=M.+Lipstein&author=M.+Mangone&author=O.+O%E2%80%99Connor&author=X.+O.+J.+Serrano&author=L.+Scotto&author=X.+Xu&title=Targeting+Casein+Kinase-1+and+PI3K%2FAKT%2FmTOR+Pathways+for+Treatment+of+c-Myc-Overexpressing+Cancers%2C+Organ+Transplant+Associated+Complications+and+Autoimmune+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DC.%26atitle%3DTargeting%2520Casein%2520Kinase-1%2520and%2520PI3K%252FAKT%252FmTOR%2520Pathways%2520for%2520Treatment%2520of%2520c-Myc-Overexpressing%2520Cancers%252C%2520Organ%2520Transplant%2520Associated%2520Complications%2520and%2520Autoimmune%2520Diseases%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Henley, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bax, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inglesby, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Champigny, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaines, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faulder, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Washio, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldwin, I. R.</span></span> <span> </span><span class="NLM_article-title">From PIM1 to PI3K δ via GSK3 Β : Target Hopping through the Kinome</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1093</span>– <span class="NLM_lpage">1098</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00296</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00296" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1093-1098&issue=10&author=Z.+A.+Henleyauthor=B.+D.+Baxauthor=L.+M.+Inglesbyauthor=A.+Champignyauthor=S.+Gainesauthor=P.+Faulderauthor=J.+Leauthor=D.+A.+Thomasauthor=Y.+Washioauthor=I.+R.+Baldwin&title=From+PIM1+to+PI3K+%CE%B4+via+GSK3+%CE%92%E2%80%AF%3A+Target+Hopping+through+the+Kinome&doi=10.1021%2Facsmedchemlett.7b00296"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00296%26sid%3Dliteratum%253Aachs%26aulast%3DHenley%26aufirst%3DZ.%2BA.%26aulast%3DBax%26aufirst%3DB.%2BD.%26aulast%3DInglesby%26aufirst%3DL.%2BM.%26aulast%3DChampigny%26aufirst%3DA.%26aulast%3DGaines%26aufirst%3DS.%26aulast%3DFaulder%26aufirst%3DP.%26aulast%3DLe%26aufirst%3DJ.%26aulast%3DThomas%26aufirst%3DD.%2BA.%26aulast%3DWashio%26aufirst%3DY.%26aulast%3DBaldwin%26aufirst%3DI.%2BR.%26atitle%3DFrom%2520PIM1%2520to%2520PI3K%2520%25CE%25B4%2520via%2520GSK3%2520%25CE%2592%25E2%2580%25AF%253A%2520Target%2520Hopping%2520through%2520the%2520Kinome%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26issue%3D10%26spage%3D1093%26epage%3D1098%26doi%3D10.1021%2Facsmedchemlett.7b00296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Down, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amour, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldwin, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, A. W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deakin, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felton, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guntrip, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keeling, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lunniss, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parr, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowland, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitulli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Washio, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamblin, J. N.</span></span> <span> </span><span class="NLM_article-title">Optimization of Novel Indazoles as Highly Potent and Selective Inhibitors of Phosphoinositide 3-Kinase δ for the Treatment of Respiratory Disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">7381</span>– <span class="NLM_lpage">7399</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00767</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00767" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlyjsrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7381-7399&issue=18&author=K.+Downauthor=A.+Amourauthor=I.+R.+Baldwinauthor=A.+W.+J.+Cooperauthor=A.+M.+Deakinauthor=L.+M.+Feltonauthor=S.+B.+Guntripauthor=C.+Hardyauthor=Z.+A.+Harrisonauthor=K.+L.+Jonesauthor=P.+Jonesauthor=S.+E.+Keelingauthor=J.+Leauthor=S.+Liviaauthor=F.+Lucasauthor=C.+J.+Lunnissauthor=N.+J.+Parrauthor=E.+Robinsonauthor=P.+Rowlandauthor=S.+Smithauthor=D.+A.+Thomasauthor=G.+Vitulliauthor=Y.+Washioauthor=J.+N.+Hamblin&title=Optimization+of+Novel+Indazoles+as+Highly+Potent+and+Selective+Inhibitors+of+Phosphoinositide+3-Kinase+%CE%B4+for+the+Treatment+of+Respiratory+Disease&doi=10.1021%2Facs.jmedchem.5b00767"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of Novel Indazoles as Highly Potent and Selective Inhibitors of Phosphoinositide 3-Kinase δ for the Treatment of Respiratory Disease</span></div><div class="casAuthors">Down, Kenneth; Amour, Augustin; Baldwin, Ian R.; Cooper, Anthony W. J.; Deakin, Angela M.; Felton, Leigh M.; Guntrip, Stephen B.; Hardy, Charlotte; Harrison, Zoe A.; Jones, Katherine L.; Jones, Paul; Keeling, Suzanne E.; Le, Joelle; Livia, Stefano; Lucas, Fiona; Lunniss, Christopher J.; Parr, Nigel J.; Robinson, Ed; Rowland, Paul; Smith, Sarah; Thomas, Daniel A.; Vitulli, Giovanni; Washio, Yoshiaki; Hamblin, J. Nicole</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7381-7399</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Optimization of lead compd., through extensive use of structure-based design and a focus on PI3Kδ potency, isoform selectivity, and inhaled PK properties, led to the discovery of clin. candidates I (GSK2269557) and II (GSK2292767) for the treatment of respiratory indications via inhalation.  Compds. I and II are both highly selective for PI3Kδ over the closely related isoforms and are active in a disease relevant brown Norway rat acute OVA model of Th2-driven lung inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUYzpPxn_ArbVg90H21EOLACvtfcHk0lhfC4Noo8NdhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlyjsrvJ&md5=2fe8e51a64e6f7c798bdcb63781d02ad</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00767&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00767%26sid%3Dliteratum%253Aachs%26aulast%3DDown%26aufirst%3DK.%26aulast%3DAmour%26aufirst%3DA.%26aulast%3DBaldwin%26aufirst%3DI.%2BR.%26aulast%3DCooper%26aufirst%3DA.%2BW.%2BJ.%26aulast%3DDeakin%26aufirst%3DA.%2BM.%26aulast%3DFelton%26aufirst%3DL.%2BM.%26aulast%3DGuntrip%26aufirst%3DS.%2BB.%26aulast%3DHardy%26aufirst%3DC.%26aulast%3DHarrison%26aufirst%3DZ.%2BA.%26aulast%3DJones%26aufirst%3DK.%2BL.%26aulast%3DJones%26aufirst%3DP.%26aulast%3DKeeling%26aufirst%3DS.%2BE.%26aulast%3DLe%26aufirst%3DJ.%26aulast%3DLivia%26aufirst%3DS.%26aulast%3DLucas%26aufirst%3DF.%26aulast%3DLunniss%26aufirst%3DC.%2BJ.%26aulast%3DParr%26aufirst%3DN.%2BJ.%26aulast%3DRobinson%26aufirst%3DE.%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DSmith%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DD.%2BA.%26aulast%3DVitulli%26aufirst%3DG.%26aulast%3DWashio%26aufirst%3DY.%26aulast%3DHamblin%26aufirst%3DJ.%2BN.%26atitle%3DOptimization%2520of%2520Novel%2520Indazoles%2520as%2520Highly%2520Potent%2520and%2520Selective%2520Inhibitors%2520of%2520Phosphoinositide%25203-Kinase%2520%25CE%25B4%2520for%2520the%2520Treatment%2520of%2520Respiratory%2520Disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D18%26spage%3D7381%26epage%3D7399%26doi%3D10.1021%2Facs.jmedchem.5b00767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dalton, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dittus, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Convery, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bush, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werner, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bantscheff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campos, S.</span></span> <span> </span><span class="NLM_article-title">Selectively Targeting the Kinome-Conserved Lysine of PI3Kδ as a General Approach to Covalent Kinase Inhibition</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>140</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">932</span>– <span class="NLM_lpage">939</span>, <span class="refDoi"> DOI: 10.1021/jacs.7b08979</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.7b08979" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFKitrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2018&pages=932-939&issue=3&author=S.+E.+Daltonauthor=L.+Dittusauthor=D.+A.+Thomasauthor=M.+A.+Converyauthor=J.+Nunesauthor=J.+T.+Bushauthor=J.+P.+Evansauthor=T.+Wernerauthor=M.+Bantscheffauthor=J.+A.+Murphyauthor=S.+Campos&title=Selectively+Targeting+the+Kinome-Conserved+Lysine+of+PI3K%CE%B4+as+a+General+Approach+to+Covalent+Kinase+Inhibition&doi=10.1021%2Fjacs.7b08979"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Selectively Targeting the Kinome-Conserved Lysine of PI3Kδ as a General Approach to Covalent Kinase Inhibition</span></div><div class="casAuthors">Dalton, Samuel E.; Dittus, Lars; Thomas, Daniel A.; Convery, Maire A.; Nunes, Joao; Bush, Jacob T.; Evans, John P.; Werner, Thilo; Bantscheff, Marcus; Murphy, John A.; Campos, Sebastien</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">932-939</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selective covalent inhibition of kinases by targeting poorly conserved cysteines has proven highly fruitful to date in the development of chem. probes and approved drugs.  However, this approach is limited to ∼200 kinases possessing such a cysteine near the ATP-binding pocket.  Herein, we report a novel approach to achieve selective, irreversible kinase inhibition, by targeting the conserved catalytic lysine residue.  We have illustrated our approach by developing selective, covalent PI3Kδ inhibitors that exhibit nanomolar potency in cellular assays, and a duration of action >48 h in CD4+ T cells.  Despite conservation of the lysine residue throughout the kinome, the lead compd. shows high levels of selectivity over a selection of lipid and protein kinases in biochem. assays, as well as covalent binding to very few off-target proteins in live-cell proteomic studies.  We anticipate this approach could offer a general strategy, as an alternative to targeting non-conserved cysteines, for the development of selective covalent kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGvT7h2D9zf7Vg90H21EOLACvtfcHk0lhfC4Noo8NdhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFKitrrK&md5=90bb399303a942fb87f1b9096eb8bdc6</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1021%2Fjacs.7b08979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.7b08979%26sid%3Dliteratum%253Aachs%26aulast%3DDalton%26aufirst%3DS.%2BE.%26aulast%3DDittus%26aufirst%3DL.%26aulast%3DThomas%26aufirst%3DD.%2BA.%26aulast%3DConvery%26aufirst%3DM.%2BA.%26aulast%3DNunes%26aufirst%3DJ.%26aulast%3DBush%26aufirst%3DJ.%2BT.%26aulast%3DEvans%26aufirst%3DJ.%2BP.%26aulast%3DWerner%26aufirst%3DT.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DMurphy%26aufirst%3DJ.%2BA.%26aulast%3DCampos%26aufirst%3DS.%26atitle%3DSelectively%2520Targeting%2520the%2520Kinome-Conserved%2520Lysine%2520of%2520PI3K%25CE%25B4%2520as%2520a%2520General%2520Approach%2520to%2520Covalent%2520Kinase%2520Inhibition%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2018%26volume%3D140%26issue%3D3%26spage%3D932%26epage%3D939%26doi%3D10.1021%2Fjacs.7b08979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amour, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, A. W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inglis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamieson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luscombe, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peace, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowland, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tame, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uddin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitulli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wellaway, N.</span></span> <span> </span><span class="NLM_article-title">Evolution of a Novel, Orally Bioavailable Series of PI3Kδ Inhibitors from an Inhaled Lead for the Treatment of Respiratory Disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">7239</span>– <span class="NLM_lpage">7251</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00799</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00799" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7239-7251&issue=15&author=A.+Amourauthor=N.+Bartonauthor=A.+W.+J.+Cooperauthor=G.+Inglisauthor=C.+Jamiesonauthor=C.+N.+Luscombeauthor=J.+Morrellauthor=S.+Peaceauthor=D.+Perezauthor=P.+Rowlandauthor=C.+Tameauthor=S.+Uddinauthor=G.+Vitulliauthor=N.+Wellaway&title=Evolution+of+a+Novel%2C+Orally+Bioavailable+Series+of+PI3K%CE%B4+Inhibitors+from+an+Inhaled+Lead+for+the+Treatment+of+Respiratory+Disease&doi=10.1021%2Facs.jmedchem.6b00799"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00799%26sid%3Dliteratum%253Aachs%26aulast%3DAmour%26aufirst%3DA.%26aulast%3DBarton%26aufirst%3DN.%26aulast%3DCooper%26aufirst%3DA.%2BW.%2BJ.%26aulast%3DInglis%26aufirst%3DG.%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DLuscombe%26aufirst%3DC.%2BN.%26aulast%3DMorrell%26aufirst%3DJ.%26aulast%3DPeace%26aufirst%3DS.%26aulast%3DPerez%26aufirst%3DD.%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DTame%26aufirst%3DC.%26aulast%3DUddin%26aufirst%3DS.%26aulast%3DVitulli%26aufirst%3DG.%26aulast%3DWellaway%26aufirst%3DN.%26atitle%3DEvolution%2520of%2520a%2520Novel%252C%2520Orally%2520Bioavailable%2520Series%2520of%2520PI3K%25CE%25B4%2520Inhibitors%2520from%2520an%2520Inhaled%2520Lead%2520for%2520the%2520Treatment%2520of%2520Respiratory%2520Disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D15%26spage%3D7239%26epage%3D7251%26doi%3D10.1021%2Facs.jmedchem.6b00799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, N. A.</span>; <span class="NLM_string-name">Barton, N. P.</span>; <span class="NLM_string-name">Campos, S. A.</span>; <span class="NLM_string-name">Cannons, E. P.</span>; <span class="NLM_string-name">Cooper, A. W. J.</span>; <span class="NLM_string-name">Down, K. D.</span>; <span class="NLM_string-name">Doyle, K. J.</span>; <span class="NLM_string-name">Hamblin, J. N.</span>; <span class="NLM_string-name">Inglis, G. G. A.</span>; <span class="NLM_string-name">Le Gall, A.</span>; <span class="NLM_string-name">Patel, V.
K.</span>; <span class="NLM_string-name">Peace, S.</span>; <span class="NLM_string-name">Sharpe, A.</span>; <span class="NLM_string-name">White, G. V.</span></span> <span> </span><span class="NLM_article-title">Chemical Compounds as Inhibitors of Kinase Activity</span>. <span class="NLM_patent">WO2017137535</span>, August 18, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=N.+A.+Anderson&author=N.+P.+Barton&author=S.+A.+Campos&author=E.+P.+Cannons&author=A.+W.+J.+Cooper&author=K.+D.+Down&author=K.+J.+Doyle&author=J.+N.+Hamblin&author=G.+G.+A.+Inglis&author=A.+Le+Gall&author=V.%0AK.+Patel&author=S.+Peace&author=A.+Sharpe&author=G.+V.+White&title=Chemical+Compounds+as+Inhibitors+of+Kinase+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DN.%2BA.%26atitle%3DChemical%2520Compounds%2520as%2520Inhibitors%2520of%2520Kinase%2520Activity%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamajima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukoyoshi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moritomo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamagami, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukahori, H.</span></span> <span> </span><span class="NLM_article-title">Discovery and Biological Evaluation of Novel Pyrazolopyridine Derivatives as Potent and Orally Available PI3Kδ Inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2410</span>– <span class="NLM_lpage">2419</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2018.03.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.bmc.2018.03.042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=2410-2419&issue=9&author=T.+Hamajimaauthor=F.+Takahashiauthor=K.+Katoauthor=K.+Mukoyoshiauthor=K.+Yoshiharaauthor=S.+Yamakiauthor=Y.+Suganoauthor=A.+Moritomoauthor=K.+Yamagamiauthor=K.+Yokooauthor=H.+Fukahori&title=Discovery+and+Biological+Evaluation+of+Novel+Pyrazolopyridine+Derivatives+as+Potent+and+Orally+Available+PI3K%CE%B4+Inhibitors&doi=10.1016%2Fj.bmc.2018.03.042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2018.03.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2018.03.042%26sid%3Dliteratum%253Aachs%26aulast%3DHamajima%26aufirst%3DT.%26aulast%3DTakahashi%26aufirst%3DF.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DMukoyoshi%26aufirst%3DK.%26aulast%3DYoshihara%26aufirst%3DK.%26aulast%3DYamaki%26aufirst%3DS.%26aulast%3DSugano%26aufirst%3DY.%26aulast%3DMoritomo%26aufirst%3DA.%26aulast%3DYamagami%26aufirst%3DK.%26aulast%3DYokoo%26aufirst%3DK.%26aulast%3DFukahori%26aufirst%3DH.%26atitle%3DDiscovery%2520and%2520Biological%2520Evaluation%2520of%2520Novel%2520Pyrazolopyridine%2520Derivatives%2520as%2520Potent%2520and%2520Orally%2520Available%2520PI3K%25CE%25B4%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26issue%3D9%26spage%3D2410%26epage%3D2419%26doi%3D10.1016%2Fj.bmc.2018.03.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoegenauer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soldermann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stauffer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graveleau, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hebach, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollingworth, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rummel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feifel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkhart, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zécri, F.</span></span> <span> </span><span class="NLM_article-title">Discovery and Pharmacological Characterization of Novel Quinazoline-Based PI3K Delta-Selective Inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">762</span>– <span class="NLM_lpage">767</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00119</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00119" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=762-767&issue=8&author=K.+Hoegenauerauthor=N.+Soldermannauthor=F.+Staufferauthor=P.+Furetauthor=N.+Graveleauauthor=A.+B.+Smithauthor=C.+Hebachauthor=G.+J.+Hollingworthauthor=I.+Lewisauthor=S.+Gutmannauthor=G.+Rummelauthor=M.+Knappauthor=R.+M.+Wolfauthor=J.+Blanzauthor=R.+Feifelauthor=C.+Burkhartauthor=F.+Z%C3%A9cri&title=Discovery+and+Pharmacological+Characterization+of+Novel+Quinazoline-Based+PI3K+Delta-Selective+Inhibitors&doi=10.1021%2Facsmedchemlett.6b00119"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00119%26sid%3Dliteratum%253Aachs%26aulast%3DHoegenauer%26aufirst%3DK.%26aulast%3DSoldermann%26aufirst%3DN.%26aulast%3DStauffer%26aufirst%3DF.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DGraveleau%26aufirst%3DN.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26aulast%3DHebach%26aufirst%3DC.%26aulast%3DHollingworth%26aufirst%3DG.%2BJ.%26aulast%3DLewis%26aufirst%3DI.%26aulast%3DGutmann%26aufirst%3DS.%26aulast%3DRummel%26aufirst%3DG.%26aulast%3DKnapp%26aufirst%3DM.%26aulast%3DWolf%26aufirst%3DR.%2BM.%26aulast%3DBlanz%26aufirst%3DJ.%26aulast%3DFeifel%26aufirst%3DR.%26aulast%3DBurkhart%26aufirst%3DC.%26aulast%3DZ%25C3%25A9cri%26aufirst%3DF.%26atitle%3DDiscovery%2520and%2520Pharmacological%2520Characterization%2520of%2520Novel%2520Quinazoline-Based%2520PI3K%2520Delta-Selective%2520Inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26issue%3D8%26spage%3D762%26epage%3D767%26doi%3D10.1021%2Facsmedchemlett.6b00119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoegenauer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soldermann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hebach, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollingworth, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Matt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilcken, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haasen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkhart, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zécri, F.</span></span> <span> </span><span class="NLM_article-title">Discovery of Novel Pyrrolidineoxy-Substituted Heteroaromatics as Potent and Selective PI3K Delta Inhibitors with Improved Physicochemical Properties</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">5657</span>– <span class="NLM_lpage">5662</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.10.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.bmcl.2016.10.069" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=5657-5662&issue=23&author=K.+Hoegenauerauthor=N.+Soldermannauthor=C.+Hebachauthor=G.+J.+Hollingworthauthor=I.+Lewisauthor=A.+von+Mattauthor=A.+B.+Smithauthor=R.+M.+Wolfauthor=R.+Wilckenauthor=D.+Haasenauthor=C.+Burkhartauthor=F.+Z%C3%A9cri&title=Discovery+of+Novel+Pyrrolidineoxy-Substituted+Heteroaromatics+as+Potent+and+Selective+PI3K+Delta+Inhibitors+with+Improved+Physicochemical+Properties&doi=10.1016%2Fj.bmcl.2016.10.069"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.10.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.10.069%26sid%3Dliteratum%253Aachs%26aulast%3DHoegenauer%26aufirst%3DK.%26aulast%3DSoldermann%26aufirst%3DN.%26aulast%3DHebach%26aufirst%3DC.%26aulast%3DHollingworth%26aufirst%3DG.%2BJ.%26aulast%3DLewis%26aufirst%3DI.%26aulast%3Dvon%2BMatt%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26aulast%3DWolf%26aufirst%3DR.%2BM.%26aulast%3DWilcken%26aufirst%3DR.%26aulast%3DHaasen%26aufirst%3DD.%26aulast%3DBurkhart%26aufirst%3DC.%26aulast%3DZ%25C3%25A9cri%26aufirst%3DF.%26atitle%3DDiscovery%2520of%2520Novel%2520Pyrrolidineoxy-Substituted%2520Heteroaromatics%2520as%2520Potent%2520and%2520Selective%2520PI3K%2520Delta%2520Inhibitors%2520with%2520Improved%2520Physicochemical%2520Properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26issue%3D23%26spage%3D5657%26epage%3D5662%26doi%3D10.1016%2Fj.bmcl.2016.10.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caravatti, G.</span>; <span class="NLM_string-name">Chamoin, S.</span>; <span class="NLM_string-name">Furet, P.</span>; <span class="NLM_string-name">Högenauer, K.</span>; <span class="NLM_string-name">Hurth, K.</span>; <span class="NLM_string-name">Kalis, C.</span>; <span class="NLM_string-name">Kammertoens, K.</span>; <span class="NLM_string-name">Lewis, I.</span>; <span class="NLM_string-name">Moebitz, H.</span>; <span class="NLM_string-name">Smith, A. B.</span>; <span class="NLM_string-name">Soldermann, N.</span>; <span class="NLM_string-name">Wolf, R.</span>; <span class="NLM_string-name">Zecri, F.</span></span> <span> </span><span class="NLM_article-title">Dihydro-benzo-oxazine and Dihydro-pyrido-oxazine Derivatives</span>. <span class="NLM_patent">WO2013093849</span>, June 28, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=G.+Caravatti&author=S.+Chamoin&author=P.+Furet&author=K.+H%C3%B6genauer&author=K.+Hurth&author=C.+Kalis&author=K.+Kammertoens&author=I.+Lewis&author=H.+Moebitz&author=A.+B.+Smith&author=N.+Soldermann&author=R.+Wolf&author=F.+Zecri&title=Dihydro-benzo-oxazine+and+Dihydro-pyrido-oxazine+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCaravatti%26aufirst%3DG.%26atitle%3DDihydro-benzo-oxazine%2520and%2520Dihydro-pyrido-oxazine%2520Derivatives%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoegenauer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soldermann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zécri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strang, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graveleau, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollingworth, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rummel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littlewood-Evans, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkhart, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of CDZ173 (Leniolisib), Representing a Structurally Novel Class of PI3K Delta-Selective Inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">975</span>– <span class="NLM_lpage">980</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00293</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00293" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=975-980&issue=9&author=K.+Hoegenauerauthor=N.+Soldermannauthor=F.+Z%C3%A9criauthor=R.+S.+Strangauthor=N.+Graveleauauthor=R.+M.+Wolfauthor=N.+G.+Cookeauthor=A.+B.+Smithauthor=G.+J.+Hollingworthauthor=J.+Blanzauthor=S.+Gutmannauthor=G.+Rummelauthor=A.+Littlewood-Evansauthor=C.+Burkhart&title=Discovery+of+CDZ173+%28Leniolisib%29%2C+Representing+a+Structurally+Novel+Class+of+PI3K+Delta-Selective+Inhibitors&doi=10.1021%2Facsmedchemlett.7b00293"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00293%26sid%3Dliteratum%253Aachs%26aulast%3DHoegenauer%26aufirst%3DK.%26aulast%3DSoldermann%26aufirst%3DN.%26aulast%3DZ%25C3%25A9cri%26aufirst%3DF.%26aulast%3DStrang%26aufirst%3DR.%2BS.%26aulast%3DGraveleau%26aufirst%3DN.%26aulast%3DWolf%26aufirst%3DR.%2BM.%26aulast%3DCooke%26aufirst%3DN.%2BG.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26aulast%3DHollingworth%26aufirst%3DG.%2BJ.%26aulast%3DBlanz%26aufirst%3DJ.%26aulast%3DGutmann%26aufirst%3DS.%26aulast%3DRummel%26aufirst%3DG.%26aulast%3DLittlewood-Evans%26aufirst%3DA.%26aulast%3DBurkhart%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520CDZ173%2520%2528Leniolisib%2529%252C%2520Representing%2520a%2520Structurally%2520Novel%2520Class%2520of%2520PI3K%2520Delta-Selective%2520Inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26issue%3D9%26spage%3D975%26epage%3D980%26doi%3D10.1021%2Facsmedchemlett.7b00293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Desai, R.</span>; <span class="NLM_string-name">Bahekar, R. H.</span>; <span class="NLM_string-name">Chopade, R.</span></span> <span> </span><span class="NLM_article-title">Novel Heterocyclic Compounds</span>. <span class="NLM_patent">IN2012MU02281</span>, June 6, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=R.+Desai&author=R.+H.+Bahekar&author=R.+Chopade&title=Novel+Heterocyclic+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDesai%26aufirst%3DR.%26atitle%3DNovel%2520Heterocyclic%2520Compounds%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hei, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.-Q.</span></span> <span> </span><span class="NLM_article-title">Novel 6-Aryl Substituted 4-Pyrrolidineaminoquinazoline Derivatives as Potent Phosphoinositide 3-Kinase Delta (PI3Kδ) Inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2028</span>– <span class="NLM_lpage">2040</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2018.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.bmc.2018.03.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=2028-2040&issue=8&author=M.+Xinauthor=W.+Duanauthor=Y.+Fengauthor=Y.-Y.+Heiauthor=H.+Zhangauthor=Y.+Shenauthor=H.-Y.+Zhaoauthor=S.+Maoauthor=S.-Q.+Zhang&title=Novel+6-Aryl+Substituted+4-Pyrrolidineaminoquinazoline+Derivatives+as+Potent+Phosphoinositide+3-Kinase+Delta+%28PI3K%CE%B4%29+Inhibitors&doi=10.1016%2Fj.bmc.2018.03.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2018.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2018.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DXin%26aufirst%3DM.%26aulast%3DDuan%26aufirst%3DW.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DHei%26aufirst%3DY.-Y.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DH.-Y.%26aulast%3DMao%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DS.-Q.%26atitle%3DNovel%25206-Aryl%2520Substituted%25204-Pyrrolidineaminoquinazoline%2520Derivatives%2520as%2520Potent%2520Phosphoinositide%25203-Kinase%2520Delta%2520%2528PI3K%25CE%25B4%2529%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26issue%3D8%26spage%3D2028%26epage%3D2040%26doi%3D10.1016%2Fj.bmc.2018.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hei, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.-Q.</span></span> <span> </span><span class="NLM_article-title">Introduction of Pyrrolidineoxy or Piperidineamino Group at the 4-Position of Quinazoline Leading to Novel Quinazoline-Based Phosphoinositide 3-Kinase Delta (PI3Kδ) Inhibitors</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">651</span>– <span class="NLM_lpage">656</span>, <span class="refDoi"> DOI: 10.1080/14756366.2018.1444608</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1080%2F14756366.2018.1444608" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=29536777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC1cXks12mu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2018&pages=651-656&issue=1&author=M.+Xinauthor=W.+Duanauthor=Y.+Fengauthor=Y.-Y.+Heiauthor=H.+Zhangauthor=Y.+Shenauthor=H.-Y.+Zhaoauthor=S.+Maoauthor=S.-Q.+Zhang&title=Introduction+of+Pyrrolidineoxy+or+Piperidineamino+Group+at+the+4-Position+of+Quinazoline+Leading+to+Novel+Quinazoline-Based+Phosphoinositide+3-Kinase+Delta+%28PI3K%CE%B4%29+Inhibitors&doi=10.1080%2F14756366.2018.1444608"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Introduction of pyrrolidineoxy or piperidineamino group at the 4-position of quinazoline leading to novel quinazoline-based phosphoinositide 3-kinase delta (PI3Kδ) inhibitors</span></div><div class="casAuthors">Xin, Minhang; Duan, Weiming; Feng, Yifan; Hei, Yuan-Yuan; Zhang, Hao; Shen, Ying; Zhao, Hong-Yi; Mao, Shuai; Zhang, San-Qi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">651-656</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Phosphoinositide 3-kinase Delta (PI3Kδ) plays a key role in B-cell signal transduction and inhibition of PI3Kδ was confirmed to have clin. benefit in certain types of activation of B-cell malignancies.  Herein, the authors reported a novel series of 4-pyrrolidineoxy or 4-piperidineamino substituted quinazolines, showing potent PI3Kδ inhibitory activities.  Among these compds., and demonstrated higher potency against PI3Kδ with the half maximal inhibitory concn. (IC50) values of 4.5, 3.0, and 3.9 nM, resp., which were comparable to idelalisib (IC50 = 2.7 nM).  The further PI3K isoforms selectivity evaluation showed that compds., and have excellent PI3Kδ selectivity over PI3Kα, PI3Kβ, and PI3Kγ.  Moreover, compds., and also displayed different antiproliferative profiles against a panel of four human B cell lines including Ramos, Raji, RPMI-8226, and SU-DHL-6.  The mol. docking simulation indicated several key hydrogen bonding interactions were formed.  This study suggests the introduction of pyrrolidineoxy or piperidineamino groups into the 4-position of quinazoline leads to new potent and selective PI3Kδ inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP2LRij6gn7LVg90H21EOLACvtfcHk0liPkAoL_GEPew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXks12mu7w%253D&md5=c876559eb3ea3594c0a349c1f3b162e5</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1080%2F14756366.2018.1444608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756366.2018.1444608%26sid%3Dliteratum%253Aachs%26aulast%3DXin%26aufirst%3DM.%26aulast%3DDuan%26aufirst%3DW.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DHei%26aufirst%3DY.-Y.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DH.-Y.%26aulast%3DMao%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DS.-Q.%26atitle%3DIntroduction%2520of%2520Pyrrolidineoxy%2520or%2520Piperidineamino%2520Group%2520at%2520the%25204-Position%2520of%2520Quinazoline%2520Leading%2520to%2520Novel%2520Quinazoline-Based%2520Phosphoinositide%25203-Kinase%2520Delta%2520%2528PI3K%25CE%25B4%2529%2520Inhibitors%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2018%26volume%3D33%26issue%3D1%26spage%3D651%26epage%3D656%26doi%3D10.1080%2F14756366.2018.1444608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hei, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.-Q.</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of Novel 6-Aryl Substituted 4-Anilinequinazoline Derivatives as Potential PI3Kδ Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1972</span>– <span class="NLM_lpage">1977</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.03.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.bmcl.2017.03.020" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=1972-1977&issue=9&author=M.+Xinauthor=Y.-Y.+Heiauthor=H.+Zhangauthor=Y.+Shenauthor=S.-Q.+Zhang&title=Design+and+Synthesis+of+Novel+6-Aryl+Substituted+4-Anilinequinazoline+Derivatives+as+Potential+PI3K%CE%B4+Inhibitors&doi=10.1016%2Fj.bmcl.2017.03.020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.03.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.03.020%26sid%3Dliteratum%253Aachs%26aulast%3DXin%26aufirst%3DM.%26aulast%3DHei%26aufirst%3DY.-Y.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DS.-Q.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Novel%25206-Aryl%2520Substituted%25204-Anilinequinazoline%2520Derivatives%2520as%2520Potential%2520PI3K%25CE%25B4%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26issue%3D9%26spage%3D1972%26epage%3D1977%26doi%3D10.1016%2Fj.bmcl.2017.03.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xin, M.</span>; <span class="NLM_string-name">Zhang, S.</span>; <span class="NLM_string-name">Zhang, H.</span>; <span class="NLM_string-name">Xie, X.</span>; <span class="NLM_string-name">Hei, Y.</span>; <span class="NLM_string-name">Zuo, S.</span>; <span class="NLM_string-name">Mao, S.</span></span> <span> </span><span class="NLM_article-title">Preparation of 6-Arylquinoline Compounds as PI3Kδ Inhibitors for Treating Inflammation and Tumor</span>. <span class="NLM_patent">CN105237484</span>, January 13, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=M.+Xin&author=S.+Zhang&author=H.+Zhang&author=X.+Xie&author=Y.+Hei&author=S.+Zuo&author=S.+Mao&title=Preparation+of+6-Arylquinoline+Compounds+as+PI3K%CE%B4+Inhibitors+for+Treating+Inflammation+and+Tumor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DXin%26aufirst%3DM.%26atitle%3DPreparation%2520of%25206-Arylquinoline%2520Compounds%2520as%2520PI3K%25CE%25B4%2520Inhibitors%2520for%2520Treating%2520Inflammation%2520and%2520Tumor%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhide, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neels, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, L.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stachura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigelt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sack, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefanski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstine, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skala, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedicord, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruepp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, T. G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salter-Cid, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poss, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, P.</span></span> <span> </span><span class="NLM_article-title">Discovery and SAR of Pyrrolo[2,1-f][1,2,4]triazin-4-amines as Potent and Selective PI3Kδ Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">4256</span>– <span class="NLM_lpage">4260</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.07.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.bmcl.2016.07.047" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=4256-4260&issue=17&author=R.+S.+Bhideauthor=J.+Neelsauthor=L.-Y.+Qinauthor=Z.+Ruanauthor=S.+Stachuraauthor=C.+Weigeltauthor=J.+S.+Sackauthor=K.+Stefanskiauthor=X.+Guauthor=J.+H.+Xieauthor=C.+B.+Goldstineauthor=S.+Skalaauthor=D.+L.+Pedicordauthor=S.+Rueppauthor=T.+G.+M.+Dharauthor=P.+H.+Carterauthor=L.+M.+Salter-Cidauthor=M.+A.+Possauthor=P.+Davies&title=Discovery+and+SAR+of+Pyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazin-4-amines+as+Potent+and+Selective+PI3K%CE%B4+Inhibitors&doi=10.1016%2Fj.bmcl.2016.07.047"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.07.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.07.047%26sid%3Dliteratum%253Aachs%26aulast%3DBhide%26aufirst%3DR.%2BS.%26aulast%3DNeels%26aufirst%3DJ.%26aulast%3DQin%26aufirst%3DL.-Y.%26aulast%3DRuan%26aufirst%3DZ.%26aulast%3DStachura%26aufirst%3DS.%26aulast%3DWeigelt%26aufirst%3DC.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DStefanski%26aufirst%3DK.%26aulast%3DGu%26aufirst%3DX.%26aulast%3DXie%26aufirst%3DJ.%2BH.%26aulast%3DGoldstine%26aufirst%3DC.%2BB.%26aulast%3DSkala%26aufirst%3DS.%26aulast%3DPedicord%26aufirst%3DD.%2BL.%26aulast%3DRuepp%26aufirst%3DS.%26aulast%3DDhar%26aufirst%3DT.%2BG.%2BM.%26aulast%3DCarter%26aufirst%3DP.%2BH.%26aulast%3DSalter-Cid%26aufirst%3DL.%2BM.%26aulast%3DPoss%26aufirst%3DM.%2BA.%26aulast%3DDavies%26aufirst%3DP.%26atitle%3DDiscovery%2520and%2520SAR%2520of%2520Pyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazin-4-amines%2520as%2520Potent%2520and%2520Selective%2520PI3K%25CE%25B4%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26issue%3D17%26spage%3D4256%26epage%3D4260%26doi%3D10.1016%2Fj.bmcl.2016.07.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qin, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherney, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, T. G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neels, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigelt, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sack, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornelius, L. A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tino, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefanski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Susulic, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarde-Chinn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skala, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosnius, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruepp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salter-Cid, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhide, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poss, M. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of 7-(3-(Piperazin-1-yl)phenyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine Derivatives as Highly Potent and Selective PI3Kδ Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">855</span>– <span class="NLM_lpage">861</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.01.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.bmcl.2017.01.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=855-861&issue=4&author=L.+Y.+Qinauthor=Z.+Ruanauthor=R.+J.+Cherneyauthor=T.+G.+M.+Dharauthor=J.+Neelsauthor=C.+A.+Weigeltauthor=J.+S.+Sackauthor=A.+S.+Srivastavaauthor=L.+A.+M.+Corneliusauthor=J.+A.+Tinoauthor=K.+Stefanskiauthor=X.+Guauthor=J.+Xieauthor=V.+Susulicauthor=X.+Yangauthor=M.+Yarde-Chinnauthor=S.+Skalaauthor=R.+Bosniusauthor=C.+Goldsteinauthor=P.+Daviesauthor=S.+Rueppauthor=L.+Salter-Cidauthor=R.+S.+Bhideauthor=M.+A.+Poss&title=Discovery+of+7-%283-%28Piperazin-1-yl%29phenyl%29pyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazin-4-amine+Derivatives+as+Highly+Potent+and+Selective+PI3K%CE%B4+Inhibitors&doi=10.1016%2Fj.bmcl.2017.01.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.01.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.01.016%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DL.%2BY.%26aulast%3DRuan%26aufirst%3DZ.%26aulast%3DCherney%26aufirst%3DR.%2BJ.%26aulast%3DDhar%26aufirst%3DT.%2BG.%2BM.%26aulast%3DNeels%26aufirst%3DJ.%26aulast%3DWeigelt%26aufirst%3DC.%2BA.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DSrivastava%26aufirst%3DA.%2BS.%26aulast%3DCornelius%26aufirst%3DL.%2BA.%2BM.%26aulast%3DTino%26aufirst%3DJ.%2BA.%26aulast%3DStefanski%26aufirst%3DK.%26aulast%3DGu%26aufirst%3DX.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DSusulic%26aufirst%3DV.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DYarde-Chinn%26aufirst%3DM.%26aulast%3DSkala%26aufirst%3DS.%26aulast%3DBosnius%26aufirst%3DR.%26aulast%3DGoldstein%26aufirst%3DC.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DRuepp%26aufirst%3DS.%26aulast%3DSalter-Cid%26aufirst%3DL.%26aulast%3DBhide%26aufirst%3DR.%2BS.%26aulast%3DPoss%26aufirst%3DM.%2BA.%26atitle%3DDiscovery%2520of%25207-%25283-%2528Piperazin-1-yl%2529phenyl%2529pyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazin-4-amine%2520Derivatives%2520as%2520Highly%2520Potent%2520and%2520Selective%2520PI3K%25CE%25B4%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26issue%3D4%26spage%3D855%26epage%3D861%26doi%3D10.1016%2Fj.bmcl.2017.01.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marcoux, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigelt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schieven, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hynes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhide, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poss, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tino, J.</span></span> <span> </span><span class="NLM_article-title">Identification of Highly Potent and Selective PI3Kδ Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">2849</span>– <span class="NLM_lpage">2853</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.01.077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.bmcl.2017.01.077" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2849-2853&issue=13&author=D.+Marcouxauthor=L.+Y.+Qinauthor=Z.+Ruanauthor=Q.+Shiauthor=Q.+Ruanauthor=C.+Weigeltauthor=H.+Qiuauthor=G.+Schievenauthor=J.+Hynesauthor=R.+Bhideauthor=M.+Possauthor=J.+Tino&title=Identification+of+Highly+Potent+and+Selective+PI3K%CE%B4+Inhibitors&doi=10.1016%2Fj.bmcl.2017.01.077"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.01.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.01.077%26sid%3Dliteratum%253Aachs%26aulast%3DMarcoux%26aufirst%3DD.%26aulast%3DQin%26aufirst%3DL.%2BY.%26aulast%3DRuan%26aufirst%3DZ.%26aulast%3DShi%26aufirst%3DQ.%26aulast%3DRuan%26aufirst%3DQ.%26aulast%3DWeigelt%26aufirst%3DC.%26aulast%3DQiu%26aufirst%3DH.%26aulast%3DSchieven%26aufirst%3DG.%26aulast%3DHynes%26aufirst%3DJ.%26aulast%3DBhide%26aufirst%3DR.%26aulast%3DPoss%26aufirst%3DM.%26aulast%3DTino%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520Highly%2520Potent%2520and%2520Selective%2520PI3K%25CE%25B4%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26issue%3D13%26spage%3D2849%26epage%3D2853%26doi%3D10.1016%2Fj.bmcl.2017.01.077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcoux, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batt, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornelius, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neels, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudoin-Bertrand, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherney, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watterson, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigelt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillooly, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntyre, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obermeier, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sleczka, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefanski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fancher, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padmanabhan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">RP, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kundu, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajareddy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennan, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levesque, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedicord, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarde, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstine, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skala, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rampulla, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathur, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arunachalam, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sack, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muckelbauer, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cvijic, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salter-Cid, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhide, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poss, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hynes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macor, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruepp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schieven, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tino, J. A.</span></span> <span> </span><span class="NLM_article-title">Identification of a Potent, Selective, and Efficacious Phosphatidylinositol 3-Kinase δ (PI3Kδ) Inhibitor for the Treatment of Immunological Disorders</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">5193</span>– <span class="NLM_lpage">5208</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00618</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00618" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5193-5208&issue=12&author=Q.+Liuauthor=Q.+Shiauthor=D.+Marcouxauthor=D.+G.+Battauthor=L.+Corneliusauthor=L.+Y.+Qinauthor=Z.+Ruanauthor=J.+Neelsauthor=M.+Beaudoin-Bertrandauthor=A.+S.+Srivastavaauthor=L.+Liauthor=R.+J.+Cherneyauthor=H.+Gongauthor=S.+H.+Wattersonauthor=C.+Weigeltauthor=K.+M.+Gilloolyauthor=K.+W.+McIntyreauthor=J.+H.+Xieauthor=M.+T.+Obermeierauthor=A.+Furaauthor=B.+Sleczkaauthor=K.+Stefanskiauthor=R.+M.+Fancherauthor=S.+Padmanabhanauthor=T.+RPauthor=I.+Kunduauthor=K.+Rajareddyauthor=R.+Smithauthor=J.+K.+Hennanauthor=D.+Xingauthor=J.+Fanauthor=P.+C.+Levesqueauthor=Q.+Ruanauthor=S.+Pittauthor=R.+Zhangauthor=D.+Pedicordauthor=J.+Panauthor=M.+Yardeauthor=H.+Luauthor=J.+Lippyauthor=C.+Goldstineauthor=S.+Skalaauthor=R.+A.+Rampullaauthor=A.+Mathurauthor=A.+Guptaauthor=P.+N.+Arunachalamauthor=J.+S.+Sackauthor=J.+K.+Muckelbauerauthor=M.+E.+Cvijicauthor=L.+M.+Salter-Cidauthor=R.+S.+Bhideauthor=M.+A.+Possauthor=J.+Hynesauthor=P.+H.+Carterauthor=J.+E.+Macorauthor=S.+Rueppauthor=G.+L.+Schievenauthor=J.+A.+Tino&title=Identification+of+a+Potent%2C+Selective%2C+and+Efficacious+Phosphatidylinositol+3-Kinase+%CE%B4+%28PI3K%CE%B4%29+Inhibitor+for+the+Treatment+of+Immunological+Disorders&doi=10.1021%2Facs.jmedchem.7b00618"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00618%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DShi%26aufirst%3DQ.%26aulast%3DMarcoux%26aufirst%3DD.%26aulast%3DBatt%26aufirst%3DD.%2BG.%26aulast%3DCornelius%26aufirst%3DL.%26aulast%3DQin%26aufirst%3DL.%2BY.%26aulast%3DRuan%26aufirst%3DZ.%26aulast%3DNeels%26aufirst%3DJ.%26aulast%3DBeaudoin-Bertrand%26aufirst%3DM.%26aulast%3DSrivastava%26aufirst%3DA.%2BS.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DCherney%26aufirst%3DR.%2BJ.%26aulast%3DGong%26aufirst%3DH.%26aulast%3DWatterson%26aufirst%3DS.%2BH.%26aulast%3DWeigelt%26aufirst%3DC.%26aulast%3DGillooly%26aufirst%3DK.%2BM.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DXie%26aufirst%3DJ.%2BH.%26aulast%3DObermeier%26aufirst%3DM.%2BT.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DSleczka%26aufirst%3DB.%26aulast%3DStefanski%26aufirst%3DK.%26aulast%3DFancher%26aufirst%3DR.%2BM.%26aulast%3DPadmanabhan%26aufirst%3DS.%26aulast%3DRP%26aufirst%3DT.%26aulast%3DKundu%26aufirst%3DI.%26aulast%3DRajareddy%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DHennan%26aufirst%3DJ.%2BK.%26aulast%3DXing%26aufirst%3DD.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DLevesque%26aufirst%3DP.%2BC.%26aulast%3DRuan%26aufirst%3DQ.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DPedicord%26aufirst%3DD.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DYarde%26aufirst%3DM.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DLippy%26aufirst%3DJ.%26aulast%3DGoldstine%26aufirst%3DC.%26aulast%3DSkala%26aufirst%3DS.%26aulast%3DRampulla%26aufirst%3DR.%2BA.%26aulast%3DMathur%26aufirst%3DA.%26aulast%3DGupta%26aufirst%3DA.%26aulast%3DArunachalam%26aufirst%3DP.%2BN.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DMuckelbauer%26aufirst%3DJ.%2BK.%26aulast%3DCvijic%26aufirst%3DM.%2BE.%26aulast%3DSalter-Cid%26aufirst%3DL.%2BM.%26aulast%3DBhide%26aufirst%3DR.%2BS.%26aulast%3DPoss%26aufirst%3DM.%2BA.%26aulast%3DHynes%26aufirst%3DJ.%26aulast%3DCarter%26aufirst%3DP.%2BH.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DRuepp%26aufirst%3DS.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DTino%26aufirst%3DJ.%2BA.%26atitle%3DIdentification%2520of%2520a%2520Potent%252C%2520Selective%252C%2520and%2520Efficacious%2520Phosphatidylinositol%25203-Kinase%2520%25CE%25B4%2520%2528PI3K%25CE%25B4%2529%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Immunological%2520Disorders%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D12%26spage%3D5193%26epage%3D5208%26doi%3D10.1021%2Facs.jmedchem.7b00618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pomel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klicic, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Covini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Church, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roulin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgat-Charvillon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valognes, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camps, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chabert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillieron, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Françon, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gretener, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitte, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carboni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rommel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rückle, T.</span></span> <span> </span><span class="NLM_article-title">Furan-2-ylmethylene thiazolidinediones as Novel, Potent, and Selective Inhibitors of Phosphoinositide 3-Kinase γ</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">3857</span>– <span class="NLM_lpage">3871</span>, <span class="refDoi"> DOI: 10.1021/jm0601598</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0601598" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3857-3871&author=V.+Pomelauthor=J.+Klicicauthor=D.+Coviniauthor=D.+D.+Churchauthor=J.+P.+Shawauthor=K.+Roulinauthor=F.+Burgat-Charvillonauthor=D.+Valognesauthor=M.+Campsauthor=C.+Chabertauthor=C.+Gillieronauthor=B.+Fran%C3%A7onauthor=D.+Perrinauthor=D.+Leroyauthor=D.+Gretenerauthor=A.+Nicholsauthor=P.+A.+Vitteauthor=S.+Carboniauthor=C.+Rommelauthor=M.+K.+Schwarzauthor=T.+R%C3%BCckle&title=Furan-2-ylmethylene+thiazolidinediones+as+Novel%2C+Potent%2C+and+Selective+Inhibitors+of+Phosphoinositide+3-Kinase+%CE%B3&doi=10.1021%2Fjm0601598"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1021%2Fjm0601598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0601598%26sid%3Dliteratum%253Aachs%26aulast%3DPomel%26aufirst%3DV.%26aulast%3DKlicic%26aufirst%3DJ.%26aulast%3DCovini%26aufirst%3DD.%26aulast%3DChurch%26aufirst%3DD.%2BD.%26aulast%3DShaw%26aufirst%3DJ.%2BP.%26aulast%3DRoulin%26aufirst%3DK.%26aulast%3DBurgat-Charvillon%26aufirst%3DF.%26aulast%3DValognes%26aufirst%3DD.%26aulast%3DCamps%26aufirst%3DM.%26aulast%3DChabert%26aufirst%3DC.%26aulast%3DGillieron%26aufirst%3DC.%26aulast%3DFran%25C3%25A7on%26aufirst%3DB.%26aulast%3DPerrin%26aufirst%3DD.%26aulast%3DLeroy%26aufirst%3DD.%26aulast%3DGretener%26aufirst%3DD.%26aulast%3DNichols%26aufirst%3DA.%26aulast%3DVitte%26aufirst%3DP.%2BA.%26aulast%3DCarboni%26aufirst%3DS.%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DSchwarz%26aufirst%3DM.%2BK.%26aulast%3DR%25C3%25BCckle%26aufirst%3DT.%26atitle%3DFuran-2-ylmethylene%2520thiazolidinediones%2520as%2520Novel%252C%2520Potent%252C%2520and%2520Selective%2520Inhibitors%2520of%2520Phosphoinositide%25203-Kinase%2520%25CE%25B3%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3857%26epage%3D3871%26doi%3D10.1021%2Fjm0601598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andrs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korabecny, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodny, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuca, K.</span></span> <span> </span><span class="NLM_article-title">Phosphatidylinositol 3-Kinase (PI3K) and Phosphatidylinositol 3-Kinase-Related Kinase (PIKK) Inhibitors: Importance of the Morpholine Ring</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">41</span>– <span class="NLM_lpage">71</span>, <span class="refDoi"> DOI: 10.1021/jm501026z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501026z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=41-71&issue=1&author=M.+Andrsauthor=J.+Korabecnyauthor=D.+Junauthor=Z.+Hodnyauthor=J.+Bartekauthor=K.+Kuca&title=Phosphatidylinositol+3-Kinase+%28PI3K%29+and+Phosphatidylinositol+3-Kinase-Related+Kinase+%28PIKK%29+Inhibitors%3A+Importance+of+the+Morpholine+Ring&doi=10.1021%2Fjm501026z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1021%2Fjm501026z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501026z%26sid%3Dliteratum%253Aachs%26aulast%3DAndrs%26aufirst%3DM.%26aulast%3DKorabecny%26aufirst%3DJ.%26aulast%3DJun%26aufirst%3DD.%26aulast%3DHodny%26aufirst%3DZ.%26aulast%3DBartek%26aufirst%3DJ.%26aulast%3DKuca%26aufirst%3DK.%26atitle%3DPhosphatidylinositol%25203-Kinase%2520%2528PI3K%2529%2520and%2520Phosphatidylinositol%25203-Kinase-Related%2520Kinase%2520%2528PIKK%2529%2520Inhibitors%253A%2520Importance%2520of%2520the%2520Morpholine%2520Ring%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D1%26spage%3D41%26epage%3D71%26doi%3D10.1021%2Fjm501026z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fumie, T.</span>; <span class="NLM_string-name">Sunao, I.</span>; <span class="NLM_string-name">Toru, A.</span>; <span class="NLM_string-name">Yoshihiro, K.</span>; <span class="NLM_string-name">Junko, M.</span>; <span class="NLM_string-name">Koji, K.</span>; <span class="NLM_string-name">Hidehiko, F.</span>; <span class="NLM_string-name">Masahiko, S.</span></span> <span> </span><span class="NLM_article-title">Heterocyclic Compound</span>. <span class="NLM_patent">WO2012020762</span>, February 16, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=T.+Fumie&author=I.+Sunao&author=A.+Toru&author=K.+Yoshihiro&author=M.+Junko&author=K.+Koji&author=F.+Hidehiko&author=S.+Masahiko&title=Heterocyclic+Compound"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFumie%26aufirst%3DT.%26atitle%3DHeterocyclic%2520Compound%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marui, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukahori, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawashima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akamatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaneko, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morokata, T.</span></span> <span> </span><span class="NLM_article-title">Effects of AS2541019, a Novel Selective PI3Kδ Inhibitor, on Antibody Production and Hamster to Rat Xenotransplantation</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>826</i></span>,  <span class="NLM_fpage">179</span>– <span class="NLM_lpage">186</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2018.02.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.ejphar.2018.02.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=29518396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC1cXkslShs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=826&publication_year=2018&pages=179-186&author=T.+Maruiauthor=H.+Fukahoriauthor=T.+Kawashimaauthor=M.+Itoauthor=M.+Akamatsuauthor=Y.+Kanekoauthor=F.+Takahashiauthor=S.+Imadaauthor=T.+Morokata&title=Effects+of+AS2541019%2C+a+Novel+Selective+PI3K%CE%B4+Inhibitor%2C+on+Antibody+Production+and+Hamster+to+Rat+Xenotransplantation&doi=10.1016%2Fj.ejphar.2018.02.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of AS2541019, a novel selective PI3Kδ inhibitor, on antibody production and hamster to rat xenotransplantation</span></div><div class="casAuthors">Marui, Takanori; Fukahori, Hidehiko; Kawashima, Tomoko; Ito, Misato; Akamatsu, Masahiko; Kaneko, Yoko; Takahashi, Fumie; Imada, Sunao; Morokata, Tatsuaki</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">826</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">179-186</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">B cell-mediated antibodies play a crit. role in protecting the body from infections; however, excessive antibody prodn. is involved in the pathogenesis of autoimmune diseases and transplanted organ rejection.  Regulation of antibody prodn. is therefore crucial for overcoming these complications.  Phosphatidylinositol-3-kinase p110δ (PI3Kδ), a member of the family of PI3K lipid kinases, is a key mediator of B cell activation and proliferation, with a small mol. PI3Kδ inhibitor having been approved for the treatment of B cell lymphoma.  However, the effect of PI3Kδ inhibitors on B cell-mediated antibody prodn. has not been clearly elucidated.  In this study, we investigated the effect of the selective PI3Kδ inhibitor, AS2541019, on B cell immunity and antibody prodn.  Our results show that AS2541019 effectively prevented B cell activation and proliferation in vitro, and that oral administration of AS2541019 resulted in significant inhibition of both T-dependent and T-independent de novo antibody prodn. in peripheral blood.  Further, in a hamster to rat concordant xenotransplant model, AS2541019 significantly prolonged graft survival time by inhibiting xenoreactive antibody prodn.  Therefore, our study demonstrates that the selective PI3Kδ inhibitor AS2541019 inhibits antibody prodn. through potent inhibitory effects on B cell activation, and can protect against organ dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOY5eNJgY4S7Vg90H21EOLACvtfcHk0lg_wPmmKqkcCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXkslShs7o%253D&md5=83f75d8a5efbb76420854f34ddf5ed63</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2018.02.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2018.02.046%26sid%3Dliteratum%253Aachs%26aulast%3DMarui%26aufirst%3DT.%26aulast%3DFukahori%26aufirst%3DH.%26aulast%3DKawashima%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DM.%26aulast%3DAkamatsu%26aufirst%3DM.%26aulast%3DKaneko%26aufirst%3DY.%26aulast%3DTakahashi%26aufirst%3DF.%26aulast%3DImada%26aufirst%3DS.%26aulast%3DMorokata%26aufirst%3DT.%26atitle%3DEffects%2520of%2520AS2541019%252C%2520a%2520Novel%2520Selective%2520PI3K%25CE%25B4%2520Inhibitor%252C%2520on%2520Antibody%2520Production%2520and%2520Hamster%2520to%2520Rat%2520Xenotransplantation%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2018%26volume%3D826%26spage%3D179%26epage%3D186%26doi%3D10.1016%2Fj.ejphar.2018.02.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, S. D.</span>; <span class="NLM_string-name">Matthews, D. J.</span></span>, <span> </span><span class="NLM_article-title">(Alpha- Substituted Aralkylamino and Heteroarylalkylamino) Pyrimidinyl and 1,3,5 -Triazinyl Benzimidazoles, Pharmaceutical Compositions Containing Them, and These Compounds for Use in Treating Proliferative Diseases</span>. <span class="NLM_patent">WO2012135160</span>, October 5, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=S.+D.+Brown&author=D.+J.+Matthews&title=%28Alpha-+Substituted+Aralkylamino+and+Heteroarylalkylamino%29+Pyrimidinyl+and+1%2C3%2C5+-Triazinyl+Benzimidazoles%2C+Pharmaceutical+Compositions+Containing+Them%2C+and+These+Compounds+for+Use+in+Treating+Proliferative+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DS.%2BD.%26atitle%3D%2528Alpha-%2520Substituted%2520Aralkylamino%2520and%2520Heteroarylalkylamino%2529%2520Pyrimidinyl%2520and%25201%252C3%252C5%2520-Triazinyl%2520Benzimidazoles%252C%2520Pharmaceutical%2520Compositions%2520Containing%2520Them%252C%2520and%2520These%2520Compounds%2520for%2520Use%2520in%2520Treating%2520Proliferative%2520Diseases%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, S. D.</span>; <span class="NLM_string-name">Matthews, D. J.</span></span>, <span> </span><span class="NLM_article-title">(Fused Ring Arylamino and Heterocyclylamino) Pyrimidynyl and 1,3,5-Triazinyl Benzimidazoles, Pharmaceutical Compositions Thereof, and Their Use in Treating Proliferative Diseases</span>. <span class="NLM_patent">WO2012135166</span>, October 5, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=S.+D.+Brown&author=D.+J.+Matthews&title=%28Fused+Ring+Arylamino+and+Heterocyclylamino%29+Pyrimidynyl+and+1%2C3%2C5-Triazinyl+Benzimidazoles%2C+Pharmaceutical+Compositions+Thereof%2C+and+Their+Use+in+Treating+Proliferative+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DS.%2BD.%26atitle%3D%2528Fused%2520Ring%2520Arylamino%2520and%2520Heterocyclylamino%2529%2520Pyrimidynyl%2520and%25201%252C3%252C5-Triazinyl%2520Benzimidazoles%252C%2520Pharmaceutical%2520Compositions%2520Thereof%252C%2520and%2520Their%2520Use%2520in%2520Treating%2520Proliferative%2520Diseases%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, S. D.</span>; <span class="NLM_string-name">Matthews, D. J.</span></span>, <span> </span><span class="NLM_article-title">(Alpha-Substituted Cycloalkylamino and Heterocyclylamino) Pyrimidinyl and 1,3,5-Triazinyl Benzimidazoles, Pharmaceutical Compositions Thereof, and Their Use in Treating Proliferative Diseases</span>. <span class="NLM_patent">WO2012135175</span>, October 5, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=S.+D.+Brown&author=D.+J.+Matthews&title=%28Alpha-Substituted+Cycloalkylamino+and+Heterocyclylamino%29+Pyrimidinyl+and+1%2C3%2C5-Triazinyl+Benzimidazoles%2C+Pharmaceutical+Compositions+Thereof%2C+and+Their+Use+in+Treating+Proliferative+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DS.%2BD.%26atitle%3D%2528Alpha-Substituted%2520Cycloalkylamino%2520and%2520Heterocyclylamino%2529%2520Pyrimidinyl%2520and%25201%252C3%252C5-Triazinyl%2520Benzimidazoles%252C%2520Pharmaceutical%2520Compositions%2520Thereof%252C%2520and%2520Their%2520Use%2520in%2520Treating%2520Proliferative%2520Diseases%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, S. D.</span>; <span class="NLM_string-name">Matthews, D. J.</span></span>, <span> </span><span class="NLM_article-title">(Sulfinyl and Sulfonyl Benzimidazolyl) Pyrimidines and Triazines, Pharmaceutical Compositions Thereof, and Their Use for Treating Proliferative Diseases</span>. <span class="NLM_patent">WO2014055647</span>, April 11, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=S.+D.+Brown&author=D.+J.+Matthews&title=%28Sulfinyl+and+Sulfonyl+Benzimidazolyl%29+Pyrimidines+and+Triazines%2C+Pharmaceutical+Compositions+Thereof%2C+and+Their+Use+for+Treating+Proliferative+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DS.%2BD.%26atitle%3D%2528Sulfinyl%2520and%2520Sulfonyl%2520Benzimidazolyl%2529%2520Pyrimidines%2520and%2520Triazines%252C%2520Pharmaceutical%2520Compositions%2520Thereof%252C%2520and%2520Their%2520Use%2520for%2520Treating%2520Proliferative%2520Diseases%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mountford, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinson, J.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Künzli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogg, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shortt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jennings, I. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, P. E.</span></span> <span> </span><span class="NLM_article-title">Development of Single and Mixed Isoform Selectivity PI3Kδ Inhibitors by Targeting Asn836 of PI3Kδ</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">4790</span>– <span class="NLM_lpage">4794</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.08.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.bmcl.2016.08.028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=4790-4794&issue=19&author=M.+S.+Millerauthor=S.+J.+Mountfordauthor=J.-A.+Pinsonauthor=Z.+Zhengauthor=M.+K%C3%BCnzliauthor=V.+Patelauthor=S.+J.+Hoggauthor=J.+Shorttauthor=I.+G.+Jenningsauthor=P.+E.+Thompson&title=Development+of+Single+and+Mixed+Isoform+Selectivity+PI3K%CE%B4+Inhibitors+by+Targeting+Asn836+of+PI3K%CE%B4&doi=10.1016%2Fj.bmcl.2016.08.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.08.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.08.028%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DM.%2BS.%26aulast%3DMountford%26aufirst%3DS.%2BJ.%26aulast%3DPinson%26aufirst%3DJ.-A.%26aulast%3DZheng%26aufirst%3DZ.%26aulast%3DK%25C3%25BCnzli%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DV.%26aulast%3DHogg%26aufirst%3DS.%2BJ.%26aulast%3DShortt%26aufirst%3DJ.%26aulast%3DJennings%26aufirst%3DI.%2BG.%26aulast%3DThompson%26aufirst%3DP.%2BE.%26atitle%3DDevelopment%2520of%2520Single%2520and%2520Mixed%2520Isoform%2520Selectivity%2520PI3K%25CE%25B4%2520Inhibitors%2520by%2520Targeting%2520Asn836%2520of%2520PI3K%25CE%25B4%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26issue%3D19%26spage%3D4790%26epage%3D4794%26doi%3D10.1016%2Fj.bmcl.2016.08.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, P. E.</span>; <span class="NLM_string-name">Pinson, J.-A.</span>; <span class="NLM_string-name">Jennings, I. G.</span>; <span class="NLM_string-name">Zheng, Z.</span></span> <span> </span><span class="NLM_article-title">Phosphoinositide 3-Kinase (PI3K) Inhibitors</span>. <span class="NLM_patent">WO2014005182</span>, January 10, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=P.+E.+Thompson&author=J.-A.+Pinson&author=I.+G.+Jennings&author=Z.+Zheng&title=Phosphoinositide+3-Kinase+%28PI3K%29+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DP.%2BE.%26atitle%3DPhosphoinositide%25203-Kinase%2520%2528PI3K%2529%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, E.</span>; <span class="NLM_string-name">Gibson, T.</span>; <span class="NLM_string-name">Jin, B.</span>; <span class="NLM_string-name">Scorah, N.</span>; <span class="NLM_string-name">Dong, Q.</span></span> <span> </span><span class="NLM_article-title">N-Substituted Oxazinopteridines and Oxazinopteridinones</span>. <span class="NLM_patent">WO2012148548</span>, November 2, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=E.+Chang&author=T.+Gibson&author=B.+Jin&author=N.+Scorah&author=Q.+Dong&title=N-Substituted+Oxazinopteridines+and+Oxazinopteridinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DE.%26atitle%3DN-Substituted%2520Oxazinopteridines%2520and%2520Oxazinopteridinones%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Farrell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ventura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyner, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loriaux, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahadevan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, D. J.</span></span> <span> </span><span class="NLM_article-title">Preclinical Characterization of PWT143, a Novel Selective and Potent Phosphatidylinositol 3-Kinase Delta (PI3K Delta) Inhibitor with Ex-Vivo Activity in Hematologic Malignancies</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>120</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">2907</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=2907&issue=21&author=M.+O%E2%80%99Farrellauthor=R.+Venturaauthor=A.+Taiauthor=J.+W.+Tynerauthor=M.+M.+Loriauxauthor=D.+Mahadevanauthor=C.+Moralesauthor=S.+D.+Brownauthor=D.+J.+Matthews&title=Preclinical+Characterization+of+PWT143%2C+a+Novel+Selective+and+Potent+Phosphatidylinositol+3-Kinase+Delta+%28PI3K+Delta%29+Inhibitor+with+Ex-Vivo+Activity+in+Hematologic+Malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Farrell%26aufirst%3DM.%26aulast%3DVentura%26aufirst%3DR.%26aulast%3DTai%26aufirst%3DA.%26aulast%3DTyner%26aufirst%3DJ.%2BW.%26aulast%3DLoriaux%26aufirst%3DM.%2BM.%26aulast%3DMahadevan%26aufirst%3DD.%26aulast%3DMorales%26aufirst%3DC.%26aulast%3DBrown%26aufirst%3DS.%2BD.%26aulast%3DMatthews%26aufirst%3DD.%2BJ.%26atitle%3DPreclinical%2520Characterization%2520of%2520PWT143%252C%2520a%2520Novel%2520Selective%2520and%2520Potent%2520Phosphatidylinositol%25203-Kinase%2520Delta%2520%2528PI3K%2520Delta%2529%2520Inhibitor%2520with%2520Ex-Vivo%2520Activity%2520in%2520Hematologic%2520Malignancies%26jtitle%3DBlood%26date%3D2012%26volume%3D120%26issue%3D21%26spage%3D2907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Folkes, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmadi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alderton, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alix, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Box, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuckowree, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Depledge, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancox, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kugendradas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lensun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivero, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pergl-Wilson, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saghir, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salphati, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sohal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ultsch, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H. J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiesmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhyvoloup, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zvelebil, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuttleworth, S. J.</span></span> <span> </span><span class="NLM_article-title">The Identification of 2-(1H-Indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a Potent, Selective, Orally Bioavailable Inhibitor of Class I PI3 Kinase for the Treatment of Cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">5522</span>– <span class="NLM_lpage">5532</span>, <span class="refDoi"> DOI: 10.1021/jm800295d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800295d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5522-5532&issue=18&author=A.+J.+Folkesauthor=K.+Ahmadiauthor=W.+K.+Aldertonauthor=S.+Alixauthor=S.+J.+Bakerauthor=G.+Boxauthor=I.+S.+Chuckowreeauthor=P.+A.+Clarkeauthor=P.+Depledgeauthor=S.+A.+Ecclesauthor=L.+S.+Friedmanauthor=A.+Hayesauthor=T.+C.+Hancoxauthor=A.+Kugendradasauthor=L.+Lensunauthor=P.+Mooreauthor=A.+G.+Oliveroauthor=J.+Pangauthor=S.+Patelauthor=G.+H.+Pergl-Wilsonauthor=F.+I.+Raynaudauthor=A.+Robsonauthor=N.+Saghirauthor=L.+Salphatiauthor=S.+Sohalauthor=M.+H.+Ultschauthor=M.+Valentiauthor=H.+J.+A.+Wallweberauthor=N.+C.+Wanauthor=C.+Wiesmannauthor=P.+Workmanauthor=A.+Zhyvoloupauthor=M.+J.+Zvelebilauthor=S.+J.+Shuttleworth&title=The+Identification+of+2-%281H-Indazol-4-yl%29-6-%284-methanesulfonyl-piperazin-1-ylmethyl%29-4-morpholin-4-yl-thieno%5B3%2C2-d%5Dpyrimidine+%28GDC-0941%29+as+a+Potent%2C+Selective%2C+Orally+Bioavailable+Inhibitor+of+Class+I+PI3+Kinase+for+the+Treatment+of+Cancer&doi=10.1021%2Fjm800295d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1021%2Fjm800295d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800295d%26sid%3Dliteratum%253Aachs%26aulast%3DFolkes%26aufirst%3DA.%2BJ.%26aulast%3DAhmadi%26aufirst%3DK.%26aulast%3DAlderton%26aufirst%3DW.%2BK.%26aulast%3DAlix%26aufirst%3DS.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DChuckowree%26aufirst%3DI.%2BS.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DDepledge%26aufirst%3DP.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DFriedman%26aufirst%3DL.%2BS.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHancox%26aufirst%3DT.%2BC.%26aulast%3DKugendradas%26aufirst%3DA.%26aulast%3DLensun%26aufirst%3DL.%26aulast%3DMoore%26aufirst%3DP.%26aulast%3DOlivero%26aufirst%3DA.%2BG.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DPergl-Wilson%26aufirst%3DG.%2BH.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DRobson%26aufirst%3DA.%26aulast%3DSaghir%26aufirst%3DN.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSohal%26aufirst%3DS.%26aulast%3DUltsch%26aufirst%3DM.%2BH.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%2BA.%26aulast%3DWan%26aufirst%3DN.%2BC.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DZhyvoloup%26aufirst%3DA.%26aulast%3DZvelebil%26aufirst%3DM.%2BJ.%26aulast%3DShuttleworth%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520Identification%2520of%25202-%25281H-Indazol-4-yl%2529-6-%25284-methanesulfonyl-piperazin-1-ylmethyl%2529-4-morpholin-4-yl-thieno%255B3%252C2-d%255Dpyrimidine%2520%2528GDC-0941%2529%2520as%2520a%2520Potent%252C%2520Selective%252C%2520Orally%2520Bioavailable%2520Inhibitor%2520of%2520Class%2520I%2520PI3%2520Kinase%2520for%2520the%2520Treatment%2520of%2520Cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D18%26spage%3D5522%26epage%3D5532%26doi%3D10.1021%2Fjm800295d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisconte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaney, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chantry, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castanedo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Depledge, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldsmith, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancox, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knowles, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondru, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesnick, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadin, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonomiya, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pegg, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reif, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safina, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salphati, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staben, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seward, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuttleworth, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sohal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, Z. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ultsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waszkowycz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, B.</span></span> <span> </span><span class="NLM_article-title">Potent and Selective Inhibitors of PI3Kδ: Obtaining Isoform Selectivity from the Affinity Pocket and Tryptophan Shelf</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">4296</span>– <span class="NLM_lpage">4302</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.05.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.bmcl.2012.05.027" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=4296-4302&issue=13&author=D.+P.+Sutherlinauthor=S.+Bakerauthor=A.+Bisconteauthor=P.+M.+Blaneyauthor=A.+Brownauthor=B.+K.+Chanauthor=D.+Chantryauthor=G.+Castanedoauthor=P.+Depledgeauthor=P.+Goldsmithauthor=D.+M.+Goldsteinauthor=T.+Hancoxauthor=J.+Kaurauthor=D.+Knowlesauthor=R.+Kondruauthor=J.+Lesnickauthor=M.+C.+Lucasauthor=C.+Lewisauthor=J.+Murrayauthor=A.+J.+Nadinauthor=J.+Nonomiyaauthor=J.+Pangauthor=N.+Peggauthor=S.+Priceauthor=K.+Reifauthor=B.+S.+Safinaauthor=L.+Salphatiauthor=S.+Stabenauthor=E.+M.+Sewardauthor=S.+Shuttleworthauthor=S.+Sohalauthor=Z.+K.+Sweeneyauthor=M.+Ultschauthor=B.+Waszkowyczauthor=B.+Wei&title=Potent+and+Selective+Inhibitors+of+PI3K%CE%B4%3A+Obtaining+Isoform+Selectivity+from+the+Affinity+Pocket+and+Tryptophan+Shelf&doi=10.1016%2Fj.bmcl.2012.05.027"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.05.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.05.027%26sid%3Dliteratum%253Aachs%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DBaker%26aufirst%3DS.%26aulast%3DBisconte%26aufirst%3DA.%26aulast%3DBlaney%26aufirst%3DP.%2BM.%26aulast%3DBrown%26aufirst%3DA.%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DChantry%26aufirst%3DD.%26aulast%3DCastanedo%26aufirst%3DG.%26aulast%3DDepledge%26aufirst%3DP.%26aulast%3DGoldsmith%26aufirst%3DP.%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DHancox%26aufirst%3DT.%26aulast%3DKaur%26aufirst%3DJ.%26aulast%3DKnowles%26aufirst%3DD.%26aulast%3DKondru%26aufirst%3DR.%26aulast%3DLesnick%26aufirst%3DJ.%26aulast%3DLucas%26aufirst%3DM.%2BC.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DNadin%26aufirst%3DA.%2BJ.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPegg%26aufirst%3DN.%26aulast%3DPrice%26aufirst%3DS.%26aulast%3DReif%26aufirst%3DK.%26aulast%3DSafina%26aufirst%3DB.%2BS.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DStaben%26aufirst%3DS.%26aulast%3DSeward%26aufirst%3DE.%2BM.%26aulast%3DShuttleworth%26aufirst%3DS.%26aulast%3DSohal%26aufirst%3DS.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26aulast%3DUltsch%26aufirst%3DM.%26aulast%3DWaszkowycz%26aufirst%3DB.%26aulast%3DWei%26aufirst%3DB.%26atitle%3DPotent%2520and%2520Selective%2520Inhibitors%2520of%2520PI3K%25CE%25B4%253A%2520Obtaining%2520Isoform%2520Selectivity%2520from%2520the%2520Affinity%2520Pocket%2520and%2520Tryptophan%2520Shelf%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26issue%3D13%26spage%3D4296%26epage%3D4302%26doi%3D10.1016%2Fj.bmcl.2012.05.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Safina, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumgardner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaney, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cartwright, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castanedo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chabot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheguillaume, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldsmith, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goyal, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancox, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Handa, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondru, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenny, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krintel, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesnick, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukadam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadin, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonomiya, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padilla, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pegg, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reif, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salphati, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savy, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seward, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuttleworth, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sohal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, Z. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tivitmahaisoon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waszkowycz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D. P.</span></span> <span> </span><span class="NLM_article-title">Discovery of Novel PI3-Kinase δ Specific Inhibitors for the Treatment of Rheumatoid Arthritis: Taming CYP3A4 Time-Dependent Inhibition</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">5887</span>– <span class="NLM_lpage">5900</span>, <span class="refDoi"> DOI: 10.1021/jm3003747</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3003747" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5887-5900&author=B.+S.+Safinaauthor=S.+Bakerauthor=M.+Baumgardnerauthor=P.+M.+Blaneyauthor=B.+K.+Chanauthor=Y.+Chenauthor=M.+W.+Cartwrightauthor=G.+Castanedoauthor=C.+Chabotauthor=A.+J.+Cheguillaumeauthor=P.+Goldsmithauthor=D.+M.+Goldsteinauthor=B.+Goyalauthor=T.+Hancoxauthor=R.+K.+Handaauthor=P.+S.+Iyerauthor=J.+Kaurauthor=R.+Kondruauthor=J.+R.+Kennyauthor=S.+L.+Krintelauthor=J.+Liauthor=J.+Lesnickauthor=M.+C.+Lucasauthor=C.+Lewisauthor=S.+Mukadamauthor=J.+Murrayauthor=A.+J.+Nadinauthor=J.+Nonomiyaauthor=F.+Padillaauthor=W.+S.+Palmerauthor=J.+Pangauthor=N.+Peggauthor=S.+Priceauthor=K.+Reifauthor=L.+Salphatiauthor=P.+A.+Savyauthor=E.+M.+Sewardauthor=S.+Shuttleworthauthor=S.+Sohalauthor=Z.+K.+Sweeneyauthor=S.+Tayauthor=P.+Tivitmahaisoonauthor=B.+Waszkowyczauthor=B.+Weiauthor=Q.+Yueauthor=C.+Zhangauthor=D.+P.+Sutherlin&title=Discovery+of+Novel+PI3-Kinase+%CE%B4+Specific+Inhibitors+for+the+Treatment+of+Rheumatoid+Arthritis%3A+Taming+CYP3A4+Time-Dependent+Inhibition&doi=10.1021%2Fjm3003747"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1021%2Fjm3003747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3003747%26sid%3Dliteratum%253Aachs%26aulast%3DSafina%26aufirst%3DB.%2BS.%26aulast%3DBaker%26aufirst%3DS.%26aulast%3DBaumgardner%26aufirst%3DM.%26aulast%3DBlaney%26aufirst%3DP.%2BM.%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DCartwright%26aufirst%3DM.%2BW.%26aulast%3DCastanedo%26aufirst%3DG.%26aulast%3DChabot%26aufirst%3DC.%26aulast%3DCheguillaume%26aufirst%3DA.%2BJ.%26aulast%3DGoldsmith%26aufirst%3DP.%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DGoyal%26aufirst%3DB.%26aulast%3DHancox%26aufirst%3DT.%26aulast%3DHanda%26aufirst%3DR.%2BK.%26aulast%3DIyer%26aufirst%3DP.%2BS.%26aulast%3DKaur%26aufirst%3DJ.%26aulast%3DKondru%26aufirst%3DR.%26aulast%3DKenny%26aufirst%3DJ.%2BR.%26aulast%3DKrintel%26aufirst%3DS.%2BL.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLesnick%26aufirst%3DJ.%26aulast%3DLucas%26aufirst%3DM.%2BC.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DMukadam%26aufirst%3DS.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DNadin%26aufirst%3DA.%2BJ.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DPadilla%26aufirst%3DF.%26aulast%3DPalmer%26aufirst%3DW.%2BS.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPegg%26aufirst%3DN.%26aulast%3DPrice%26aufirst%3DS.%26aulast%3DReif%26aufirst%3DK.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSavy%26aufirst%3DP.%2BA.%26aulast%3DSeward%26aufirst%3DE.%2BM.%26aulast%3DShuttleworth%26aufirst%3DS.%26aulast%3DSohal%26aufirst%3DS.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26aulast%3DTay%26aufirst%3DS.%26aulast%3DTivitmahaisoon%26aufirst%3DP.%26aulast%3DWaszkowycz%26aufirst%3DB.%26aulast%3DWei%26aufirst%3DB.%26aulast%3DYue%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26atitle%3DDiscovery%2520of%2520Novel%2520PI3-Kinase%2520%25CE%25B4%2520Specific%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Rheumatoid%2520Arthritis%253A%2520Taming%2520CYP3A4%2520Time-Dependent%2520Inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5887%26epage%3D5900%26doi%3D10.1021%2Fjm3003747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, Z. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balazs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castanedo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chabot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chantry, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flagella, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondru, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesnick, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonomiya, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salphati, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safina, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savy, P. P. a.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seward, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ultsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D. P.</span></span> <span> </span><span class="NLM_article-title">Potent and Highly Selective Benzimidazole Inhibitors of PI3-Kinase Delta</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">7686</span>– <span class="NLM_lpage">7695</span>, <span class="refDoi"> DOI: 10.1021/jm300717c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300717c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7686-7695&issue=17&author=J.+M.+Murrayauthor=Z.+K.+Sweeneyauthor=B.+K.+Chanauthor=M.+Balazsauthor=E.+Bradleyauthor=G.+Castanedoauthor=C.+Chabotauthor=D.+Chantryauthor=M.+Flagellaauthor=D.+M.+Goldsteinauthor=R.+Kondruauthor=J.+Lesnickauthor=J.+Liauthor=M.+C.+Lucasauthor=J.+Nonomiyaauthor=J.+Pangauthor=S.+Priceauthor=L.+Salphatiauthor=B.+Safinaauthor=P.+P.+a.+Savyauthor=E.+M.+Sewardauthor=M.+Ultschauthor=D.+P.+Sutherlin&title=Potent+and+Highly+Selective+Benzimidazole+Inhibitors+of+PI3-Kinase+Delta&doi=10.1021%2Fjm300717c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1021%2Fjm300717c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300717c%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DJ.%2BM.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DBalazs%26aufirst%3DM.%26aulast%3DBradley%26aufirst%3DE.%26aulast%3DCastanedo%26aufirst%3DG.%26aulast%3DChabot%26aufirst%3DC.%26aulast%3DChantry%26aufirst%3DD.%26aulast%3DFlagella%26aufirst%3DM.%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DKondru%26aufirst%3DR.%26aulast%3DLesnick%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLucas%26aufirst%3DM.%2BC.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DS.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSafina%26aufirst%3DB.%26aulast%3DSavy%26aufirst%3DP.%2BP.%2Ba.%26aulast%3DSeward%26aufirst%3DE.%2BM.%26aulast%3DUltsch%26aufirst%3DM.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26atitle%3DPotent%2520and%2520Highly%2520Selective%2520Benzimidazole%2520Inhibitors%2520of%2520PI3-Kinase%2520Delta%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D17%26spage%3D7686%26epage%3D7695%26doi%3D10.1021%2Fjm300717c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Safina, B.
S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, Z. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisconte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrera, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castanedo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flagella, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heald, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonomiya, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reif, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salphati, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seward, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D. P.</span></span> <span> </span><span class="NLM_article-title">Identification of GNE-293, a Potent and Selective PI3Kδ Inhibitor: Navigating in Vitro Genotoxicity While Improving Potency and Selectivity</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">4953</span>– <span class="NLM_lpage">4959</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.06.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.bmcl.2013.06.052" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4953-4959&issue=17&author=B.%0AS.+Safinaauthor=Z.+K.+Sweeneyauthor=J.+Liauthor=B.+K.+Chanauthor=A.+Bisconteauthor=D.+Carreraauthor=G.+Castanedoauthor=M.+Flagellaauthor=R.+Healdauthor=C.+Lewisauthor=J.+M.+Murrayauthor=J.+Nonomiyaauthor=J.+Pangauthor=S.+Priceauthor=K.+Reifauthor=L.+Salphatiauthor=E.+M.+Sewardauthor=B.+Weiauthor=D.+P.+Sutherlin&title=Identification+of+GNE-293%2C+a+Potent+and+Selective+PI3K%CE%B4+Inhibitor%3A+Navigating+in+Vitro+Genotoxicity+While+Improving+Potency+and+Selectivity&doi=10.1016%2Fj.bmcl.2013.06.052"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.06.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.06.052%26sid%3Dliteratum%253Aachs%26aulast%3DSafina%26aufirst%3DB.%2BS.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DBisconte%26aufirst%3DA.%26aulast%3DCarrera%26aufirst%3DD.%26aulast%3DCastanedo%26aufirst%3DG.%26aulast%3DFlagella%26aufirst%3DM.%26aulast%3DHeald%26aufirst%3DR.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DMurray%26aufirst%3DJ.%2BM.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DS.%26aulast%3DReif%26aufirst%3DK.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSeward%26aufirst%3DE.%2BM.%26aulast%3DWei%26aufirst%3DB.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26atitle%3DIdentification%2520of%2520GNE-293%252C%2520a%2520Potent%2520and%2520Selective%2520PI3K%25CE%25B4%2520Inhibitor%253A%2520Navigating%2520in%2520Vitro%2520Genotoxicity%2520While%2520Improving%2520Potency%2520and%2520Selectivity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26issue%3D17%26spage%3D4953%26epage%3D4959%26doi%3D10.1016%2Fj.bmcl.2013.06.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salphati, L.</span></span> <span> </span><span class="NLM_article-title">Investigation of Dose-Dependent Factors Limiting Oral Bioavailability: Case Study with the PI3K-δ Inhibitor</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>105</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1802</span>– <span class="NLM_lpage">1809</span>, <span class="refDoi"> DOI: 10.1016/j.xphs.2016.04.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.xphs.2016.04.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2016&pages=1802-1809&issue=6&author=P.+C.+Chiangauthor=D.+Sutherlinauthor=J.+Pangauthor=L.+Salphati&title=Investigation+of+Dose-Dependent+Factors+Limiting+Oral+Bioavailability%3A+Case+Study+with+the+PI3K-%CE%B4+Inhibitor&doi=10.1016%2Fj.xphs.2016.04.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1016%2Fj.xphs.2016.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.xphs.2016.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DChiang%26aufirst%3DP.%2BC.%26aulast%3DSutherlin%26aufirst%3DD.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DSalphati%26aufirst%3DL.%26atitle%3DInvestigation%2520of%2520Dose-Dependent%2520Factors%2520Limiting%2520Oral%2520Bioavailability%253A%2520Case%2520Study%2520with%2520the%2520PI3K-%25CE%25B4%2520Inhibitor%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2016%26volume%3D105%26issue%3D6%26spage%3D1802%26epage%3D1809%26doi%3D10.1016%2Fj.xphs.2016.04.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span> <span> </span><span class="NLM_article-title">Fused Pyrimidine Compound, Intermediate, Preparation Method Therefor, and Composition and Application Thereof</span>. <span class="NLM_patent">WO2015043398</span>, April 3, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=Z.+Xu&title=Fused+Pyrimidine+Compound%2C+Intermediate%2C+Preparation+Method+Therefor%2C+and+Composition+and+Application+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DZ.%26atitle%3DFused%2520Pyrimidine%2520Compound%252C%2520Intermediate%252C%2520Preparation%2520Method%2520Therefor%252C%2520and%2520Composition%2520and%2520Application%2520Thereof%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span>; <span class="NLM_string-name">Lou, Y.</span></span> <span> </span><span class="NLM_article-title">Fused Heterocyclic Compound, Preparation Method Therefor, Pharmaceutical Composition, and Uses Thereof</span>. <span class="NLM_patent">WO2015055071</span>, April 24, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=Z.+Xu&author=Y.+Lou&title=Fused+Heterocyclic+Compound%2C+Preparation+Method+Therefor%2C+Pharmaceutical+Composition%2C+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DZ.%26atitle%3DFused%2520Heterocyclic%2520Compound%252C%2520Preparation%2520Method%2520Therefor%252C%2520Pharmaceutical%2520Composition%252C%2520and%2520Uses%2520Thereof%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.</span>; <span class="NLM_string-name">Pei, Y.</span>; <span class="NLM_string-name">Lang, H.</span></span> <span> </span><span class="NLM_article-title">Pyrimidine Derivative, Cytotoxic Agent, Pharmaceutical Composition and Use Thereof</span>. <span class="NLM_patent">WO2016127455</span>, August 19, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=J.+Guo&author=Y.+Pei&author=H.+Lang&title=Pyrimidine+Derivative%2C+Cytotoxic+Agent%2C+Pharmaceutical+Composition+and+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DJ.%26atitle%3DPyrimidine%2520Derivative%252C%2520Cytotoxic%2520Agent%252C%2520Pharmaceutical%2520Composition%2520and%2520Use%2520Thereof%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Samby, K. K.</span>; <span class="NLM_string-name">Surase, Y. B.</span>; <span class="NLM_string-name">Amale, S. R.</span>; <span class="NLM_string-name">Gorla, S. K.</span>; <span class="NLM_string-name">Patel, P.</span>; <span class="NLM_string-name">Verma, A.
K.</span></span> <span> </span><span class="NLM_article-title">6-Morpholinyl-2-pyrazolyl-9H-purine Derivatives and Their Use as PI3K Inhibitors</span>. <span class="NLM_patent">WO2016157074</span>, October 7, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=K.+K.+Samby&author=Y.+B.+Surase&author=S.+R.+Amale&author=S.+K.+Gorla&author=P.+Patel&author=A.%0AK.+Verma&title=6-Morpholinyl-2-pyrazolyl-9H-purine+Derivatives+and+Their+Use+as+PI3K+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSamby%26aufirst%3DK.%2BK.%26atitle%3D6-Morpholinyl-2-pyrazolyl-9H-purine%2520Derivatives%2520and%2520Their%2520Use%2520as%2520PI3K%2520Inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref180"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref180'); return false;" data-citation="" class="refNumLink">180</a></strong><div class="NLM_citation" id="cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dymek, B.</span>; <span class="NLM_string-name">Zagozda, M.</span>; <span class="NLM_string-name">Wieczorek, M.</span>; <span class="NLM_string-name">Dubiel, K.</span>; <span class="NLM_string-name">Stanczak, A.</span>; <span class="NLM_string-name">Zdzalik, D.</span>; <span class="NLM_string-name">Gunerka, P.</span>; <span class="NLM_string-name">Sekular, M.</span>; <span class="NLM_string-name">Dziachan, M.</span></span> <span> </span><span class="NLM_article-title">7-(Morpholin-4-yl)pyrazole[1,5-a]pyrimidine Derivatives Which Are Useful for the Treatment of Immune or Inflammatory Diseases or Cancer</span>. <span class="NLM_patent">WO2016157091</span>, October 7, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=B.+Dymek&author=M.+Zagozda&author=M.+Wieczorek&author=K.+Dubiel&author=A.+Stanczak&author=D.+Zdzalik&author=P.+Gunerka&author=M.+Sekular&author=M.+Dziachan&title=7-%28Morpholin-4-yl%29pyrazole%5B1%2C5-a%5Dpyrimidine+Derivatives+Which+Are+Useful+for+the+Treatment+of+Immune+or+Inflammatory+Diseases+or+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDymek%26aufirst%3DB.%26atitle%3D7-%2528Morpholin-4-yl%2529pyrazole%255B1%252C5-a%255Dpyrimidine%2520Derivatives%2520Which%2520Are%2520Useful%2520for%2520the%2520Treatment%2520of%2520Immune%2520or%2520Inflammatory%2520Diseases%2520or%2520Cancer%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref181"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref181'); return false;" data-citation="" class="refNumLink">181</a></strong><div class="NLM_citation" id="cit181"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kearney, P.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of PI3K-δ and Methods of Their Use and Manufacture</span>. <span class="NLM_patent">WO2012037226</span>, March 23, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=P.+Kearney&title=Inhibitors+of+PI3K-%CE%B4+and+Methods+of+Their+Use+and+Manufacture"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKearney%26aufirst%3DP.%26atitle%3DInhibitors%2520of%2520PI3K-%25CE%25B4%2520and%2520Methods%2520of%2520Their%2520Use%2520and%2520Manufacture%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref182"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref182'); return false;" data-citation="" class="refNumLink">182</a></strong><div class="NLM_citation" id="cit182"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Achab, A. A.</span>; <span class="NLM_string-name">Altman, M. D.</span>; <span class="NLM_string-name">Deng, Y.</span>; <span class="NLM_string-name">Guzi, T.</span>; <span class="NLM_string-name">Kattar, S.</span>; <span class="NLM_string-name">Katz, J. D.</span>; <span class="NLM_string-name">Methot, J. L.</span>; <span class="NLM_string-name">Zhou, H.</span>; <span class="NLM_string-name">McGowan, M.</span>; <span class="NLM_string-name">Christopher, M. P.</span>; <span class="NLM_string-name">Garcia, Y.</span>; <span class="NLM_string-name">Anthony, N. J.</span>; <span class="NLM_string-name">Fradera Llinas, F. X.</span>; <span class="NLM_string-name">Mu, C.</span>; <span class="NLM_string-name">Zhang, S.</span>; <span class="NLM_string-name">Zhang, R.</span>; <span class="NLM_string-name">Fong, K. C.</span>; <span class="NLM_string-name">Leng, X.</span></span> <span> </span><span class="NLM_article-title">Purine Inhibitors of Human Phosphatidylinositol 3-Kinase Delta</span>. <span class="NLM_patent">WO2014075392</span>, May 23, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=A.+A.+Achab&author=M.+D.+Altman&author=Y.+Deng&author=T.+Guzi&author=S.+Kattar&author=J.+D.+Katz&author=J.+L.+Methot&author=H.+Zhou&author=M.+McGowan&author=M.+P.+Christopher&author=Y.+Garcia&author=N.+J.+Anthony&author=F.+X.+Fradera+Llinas&author=C.+Mu&author=S.+Zhang&author=R.+Zhang&author=K.+C.+Fong&author=X.+Leng&title=Purine+Inhibitors+of+Human+Phosphatidylinositol+3-Kinase+Delta"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAchab%26aufirst%3DA.%2BA.%26atitle%3DPurine%2520Inhibitors%2520of%2520Human%2520Phosphatidylinositol%25203-Kinase%2520Delta%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref183"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref183'); return false;" data-citation="" class="refNumLink">183</a></strong><div class="NLM_citation" id="cit183"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Achab, A. A.</span>; <span class="NLM_string-name">Altman, M. D.</span>; <span class="NLM_string-name">Deng, Y.</span>; <span class="NLM_string-name">Kattar, S.</span>; <span class="NLM_string-name">Katz, J.
D.</span>; <span class="NLM_string-name">Methot, J.
L.</span>; <span class="NLM_string-name">Zhou, H.</span>; <span class="NLM_string-name">McGowan, M.</span>; <span class="NLM_string-name">Christopher, M. P.</span>; <span class="NLM_string-name">Garcia, Y.</span>; <span class="NLM_string-name">Anthony, N. J.</span>; <span class="NLM_string-name">Fradera Llinas, F. X.</span>; <span class="NLM_string-name">Yang, L.</span>; <span class="NLM_string-name">Mu, C.</span>; <span class="NLM_string-name">Wang, X.</span>; <span class="NLM_string-name">Shi, F.</span>; <span class="NLM_string-name">Ye, B.</span>; <span class="NLM_string-name">Zhang, S.</span>; <span class="NLM_string-name">Zhao, X.</span>; <span class="NLM_string-name">Zhang, R.</span>; <span class="NLM_string-name">Fong, K. C.</span>; <span class="NLM_string-name">Leng, X.</span></span> <span> </span><span class="NLM_article-title">Purine Inhibitors of Human Phosphatidylinositol 3-Kinase Delta</span>. <span class="NLM_patent">WO2014075393</span>, May 23, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=A.+A.+Achab&author=M.+D.+Altman&author=Y.+Deng&author=S.+Kattar&author=J.%0AD.+Katz&author=J.%0AL.+Methot&author=H.+Zhou&author=M.+McGowan&author=M.+P.+Christopher&author=Y.+Garcia&author=N.+J.+Anthony&author=F.+X.+Fradera+Llinas&author=L.+Yang&author=C.+Mu&author=X.+Wang&author=F.+Shi&author=B.+Ye&author=S.+Zhang&author=X.+Zhao&author=R.+Zhang&author=K.+C.+Fong&author=X.+Leng&title=Purine+Inhibitors+of+Human+Phosphatidylinositol+3-Kinase+Delta"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAchab%26aufirst%3DA.%2BA.%26atitle%3DPurine%2520Inhibitors%2520of%2520Human%2520Phosphatidylinositol%25203-Kinase%2520Delta%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref184"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref184'); return false;" data-citation="" class="refNumLink">184</a></strong><div class="NLM_citation" id="cit184"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, M. A.</span>; <span class="NLM_string-name">Fong, K. C.</span>; <span class="NLM_string-name">Anthony, N. J.</span>; <span class="NLM_string-name">Zhou, H.</span>; <span class="NLM_string-name">Katz, J.
D.</span>; <span class="NLM_string-name">Yang, L.</span>; <span class="NLM_string-name">Li, C.</span>; <span class="NLM_string-name">Tian, Y.</span>; <span class="NLM_string-name">Mu, C.</span>; <span class="NLM_string-name">Ye, B.</span>; <span class="NLM_string-name">Shi, F.</span>; <span class="NLM_string-name">Zhao, X.</span>; <span class="NLM_string-name">Fu, J.</span></span> <span> </span><span class="NLM_article-title">Purine Inhibitors of Human Phosphatidylinositol 3-Kinase Delta</span>. <span class="NLM_patent">WO2015188369</span>, December 18, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+A.+McGowan&author=K.+C.+Fong&author=N.+J.+Anthony&author=H.+Zhou&author=J.%0AD.+Katz&author=L.+Yang&author=C.+Li&author=Y.+Tian&author=C.+Mu&author=B.+Ye&author=F.+Shi&author=X.+Zhao&author=J.+Fu&title=Purine+Inhibitors+of+Human+Phosphatidylinositol+3-Kinase+Delta"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMcGowan%26aufirst%3DM.%2BA.%26atitle%3DPurine%2520Inhibitors%2520of%2520Human%2520Phosphatidylinositol%25203-Kinase%2520Delta%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref185"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref185'); return false;" data-citation="" class="refNumLink">185</a></strong><div class="NLM_citation" id="cit185"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, M. A.</span>; <span class="NLM_string-name">Fong, K. C.</span>; <span class="NLM_string-name">Anthony, N. J.</span>; <span class="NLM_string-name">Zhou, H.</span>; <span class="NLM_string-name">Katz, J.
D.</span>; <span class="NLM_string-name">Yang, L.</span>; <span class="NLM_string-name">Li, C.</span>; <span class="NLM_string-name">Tian, Y.</span>; <span class="NLM_string-name">Mu, C.</span>; <span class="NLM_string-name">Ye, B.</span>; <span class="NLM_string-name">Shi, F.</span>; <span class="NLM_string-name">Zhao, X.</span>; <span class="NLM_string-name">Fu, J.</span>; <span class="NLM_string-name">Li, Y.</span></span> <span> </span><span class="NLM_article-title">Purine Inhibitors of Human Phosphatidylinositol 3-Kinase Delta</span>. <span class="NLM_patent">WO2016004807</span>, January 15, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=M.+A.+McGowan&author=K.+C.+Fong&author=N.+J.+Anthony&author=H.+Zhou&author=J.%0AD.+Katz&author=L.+Yang&author=C.+Li&author=Y.+Tian&author=C.+Mu&author=B.+Ye&author=F.+Shi&author=X.+Zhao&author=J.+Fu&author=Y.+Li&title=Purine+Inhibitors+of+Human+Phosphatidylinositol+3-Kinase+Delta"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMcGowan%26aufirst%3DM.%2BA.%26atitle%3DPurine%2520Inhibitors%2520of%2520Human%2520Phosphatidylinositol%25203-Kinase%2520Delta%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref186"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref186'); return false;" data-citation="" class="refNumLink">186</a></strong><div class="NLM_citation" id="cit186"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, M. A.</span>; <span class="NLM_string-name">Zhou, H.</span>; <span class="NLM_string-name">Katz, J.
D.</span>; <span class="NLM_string-name">Yang, L.</span>; <span class="NLM_string-name">Methot, J. L.</span>; <span class="NLM_string-name">Lipford, K. A.</span>; <span class="NLM_string-name">Xu, S.</span>; <span class="NLM_string-name">Fu, N.</span>; <span class="NLM_string-name">Xu, G.</span>; <span class="NLM_string-name">Bian, D.</span>; <span class="NLM_string-name">Fu, J.</span>; <span class="NLM_string-name">Li, Y.</span>; <span class="NLM_string-name">Fong, K.
C.</span></span> <span> </span><span class="NLM_article-title">Purine Inhibitors of Human Phosphatidylinositol 3-Kinase Delta</span>. <span class="NLM_patent">WO2017003836</span>, January 6, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=M.+A.+McGowan&author=H.+Zhou&author=J.%0AD.+Katz&author=L.+Yang&author=J.+L.+Methot&author=K.+A.+Lipford&author=S.+Xu&author=N.+Fu&author=G.+Xu&author=D.+Bian&author=J.+Fu&author=Y.+Li&author=K.%0AC.+Fong&title=Purine+Inhibitors+of+Human+Phosphatidylinositol+3-Kinase+Delta"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMcGowan%26aufirst%3DM.%2BA.%26atitle%3DPurine%2520Inhibitors%2520of%2520Human%2520Phosphatidylinositol%25203-Kinase%2520Delta%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref187"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref187'); return false;" data-citation="" class="refNumLink">187</a></strong><div class="NLM_citation" id="cit187"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Achab, A. A.</span>; <span class="NLM_string-name">Christopher, M. P.</span>; <span class="NLM_string-name">Fradera Llinas, F. X.</span>; <span class="NLM_string-name">Katz, J. D.</span>; <span class="NLM_string-name">Methot, J. L.</span>; <span class="NLM_string-name">Zhou, H.</span>; <span class="NLM_string-name">Xu, S.</span>; <span class="NLM_string-name">Fu, J.</span>; <span class="NLM_string-name">Fu, N.</span>; <span class="NLM_string-name">Li, Y.</span>; <span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">Purine Inhibitors of Human Phosphatidylinositol 3-Kinase Delta</span>. <span class="NLM_patent">WO2017166104</span>, October 6, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=A.+A.+Achab&author=M.+P.+Christopher&author=F.+X.+Fradera+Llinas&author=J.+D.+Katz&author=J.+L.+Methot&author=H.+Zhou&author=S.+Xu&author=J.+Fu&author=N.+Fu&author=Y.+Li&author=X.+Wang&title=Purine+Inhibitors+of+Human+Phosphatidylinositol+3-Kinase+Delta"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAchab%26aufirst%3DA.%2BA.%26atitle%3DPurine%2520Inhibitors%2520of%2520Human%2520Phosphatidylinositol%25203-Kinase%2520Delta%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref188"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref188'); return false;" data-citation="" class="refNumLink">188</a></strong><div class="NLM_citation" id="cit188"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Norman, P.</span></span> <span> </span><span class="NLM_article-title">Evaluation of WO2012037204 and WO2012037226: Exelixis’ Selective PI3Kδ Inhibitors; the Basis of a US$251 Million Deal</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">971</span>– <span class="NLM_lpage">976</span>, <span class="refDoi"> DOI: 10.1517/13543776.2012.701282</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1517%2F13543776.2012.701282" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=22768915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVKgtb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=971-976&issue=8&author=P.+Norman&title=Evaluation+of+WO2012037204+and+WO2012037226%3A+Exelixis%E2%80%99+Selective+PI3K%CE%B4+Inhibitors%3B+the+Basis+of+a+US%24251+Million+Deal&doi=10.1517%2F13543776.2012.701282"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of WO2012037204 and WO2012037226: Exelixis' selective PI3Kδ inhibitors; the basis of a US$251 million deal</span></div><div class="casAuthors">Norman, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">971-976</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Two applications each claim compds. described as selective PI3Kδ inhibitors.  The first claims 2-amino-3-substituted-8-methylquinoline derivs.  The second, more substantial, application claims a broad range of cyclic amine derivs. of 6-aminopurines.  These are the first patent applications from Exelixis relating to its PI3Kδ inhibitor program despite its disclosure of the biol. profile of its lead inhibitor XL-499 in late 2010.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj1idcywNF_bVg90H21EOLACvtfcHk0lhmgO8NlCuUUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVKgtb7M&md5=2b0917ed7db219c2ca9aa55c527884ba</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1517%2F13543776.2012.701282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2012.701282%26sid%3Dliteratum%253Aachs%26aulast%3DNorman%26aufirst%3DP.%26atitle%3DEvaluation%2520of%2520WO2012037204%2520and%2520WO2012037226%253A%2520Exelixis%25E2%2580%2599%2520Selective%2520PI3K%25CE%25B4%2520Inhibitors%253B%2520the%2520Basis%2520of%2520a%2520US%2524251%2520Million%2520Deal%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2012%26volume%3D22%26issue%3D8%26spage%3D971%26epage%3D976%26doi%3D10.1517%2F13543776.2012.701282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref189"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref189'); return false;" data-citation="" class="refNumLink">189</a></strong><div class="NLM_citation" id="cit189"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span>; <span class="NLM_string-name">Liu, J.</span>; <span class="NLM_string-name">Zhang, X.</span>; <span class="NLM_string-name">Liang, X.</span>; <span class="NLM_string-name">Liu, X.</span>; <span class="NLM_string-name">Liu, J.</span>; <span class="NLM_string-name">Chen, C.</span>; <span class="NLM_string-name">Zhao, Z.</span>; <span class="NLM_string-name">Wang, A.</span>; <span class="NLM_string-name">Wang, W.</span>; <span class="NLM_string-name">Wu, H.</span>; <span class="NLM_string-name">Wang, B.</span>; <span class="NLM_string-name">Wang, L.</span></span> <span> </span><span class="NLM_article-title">New PI3K Kinase Inhibitor</span>. <span class="NLM_patent">WO2016101553</span>, July 1,<span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=Q.+Liu&author=J.+Liu&author=X.+Zhang&author=X.+Liang&author=X.+Liu&author=J.+Liu&author=C.+Chen&author=Z.+Zhao&author=A.+Wang&author=W.+Wang&author=H.+Wu&author=B.+Wang&author=L.+Wang&title=New+PI3K+Kinase+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26atitle%3DNew%2520PI3K%2520Kinase%2520Inhibitor%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref190"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref190'); return false;" data-citation="" class="refNumLink">190</a></strong><div class="NLM_citation" id="cit190"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perry, M.</span>; <span class="NLM_string-name">Karabelas, K.</span>; <span class="NLM_string-name">Mogemark, M.</span>; <span class="NLM_string-name">Bold, P.</span>; <span class="NLM_string-name">Tyrchan, C.</span>; <span class="NLM_string-name">Nikitidis, A.</span>; <span class="NLM_string-name">Petersen, J.</span>; <span class="NLM_string-name">Börjesson, U.</span></span> <span> </span><span class="NLM_article-title">5-[2-(Pyridin-2-ylamino)-1,3-thiazol-5-yl]-2,3-dihydro-1H-isoindol-1-one Derivatives and Their Use as Dual Inhibitors of Phosphatidylinositol 3-Kinase Delta & Gamma</span>. <span class="NLM_patent">WO2018055040</span>, March 30, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=M.+Perry&author=K.+Karabelas&author=M.+Mogemark&author=P.+Bold&author=C.+Tyrchan&author=A.+Nikitidis&author=J.+Petersen&author=U.+B%C3%B6rjesson&title=5-%5B2-%28Pyridin-2-ylamino%29-1%2C3-thiazol-5-yl%5D-2%2C3-dihydro-1H-isoindol-1-one+Derivatives+and+Their+Use+as+Dual+Inhibitors+of+Phosphatidylinositol+3-Kinase+Delta+%26+Gamma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPerry%26aufirst%3DM.%26atitle%3D5-%255B2-%2528Pyridin-2-ylamino%2529-1%252C3-thiazol-5-yl%255D-2%252C3-dihydro-1H-isoindol-1-one%2520Derivatives%2520and%2520Their%2520Use%2520as%2520Dual%2520Inhibitors%2520of%2520Phosphatidylinositol%25203-Kinase%2520Delta%2520%2526%2520Gamma%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref191"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref191'); return false;" data-citation="" class="refNumLink">191</a></strong><div class="NLM_citation" id="cit191"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tesar, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Series of 5,11-Dihydro-6H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6-ones as Selective PI3K-δ/γ Inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">908</span>– <span class="NLM_lpage">912</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00209</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00209" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=908-912&issue=10&author=F.+M.+Fergusonauthor=J.+Niauthor=T.+Zhangauthor=B.+Tesarauthor=T.+Simauthor=N.+D.+Kimauthor=X.+Dengauthor=J.+R.+Brownauthor=J.+J.+Zhaoauthor=N.+S.+Gray&title=Discovery+of+a+Series+of+5%2C11-Dihydro-6H-benzo%5Be%5Dpyrimido%5B5%2C4-b%5D%5B1%2C4%5Ddiazepin-6-ones+as+Selective+PI3K-%CE%B4%2F%CE%B3+Inhibitors&doi=10.1021%2Facsmedchemlett.6b00209"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00209%26sid%3Dliteratum%253Aachs%26aulast%3DFerguson%26aufirst%3DF.%2BM.%26aulast%3DNi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DTesar%26aufirst%3DB.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DKim%26aufirst%3DN.%2BD.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DBrown%26aufirst%3DJ.%2BR.%26aulast%3DZhao%26aufirst%3DJ.%2BJ.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DDiscovery%2520of%2520a%2520Series%2520of%25205%252C11-Dihydro-6H-benzo%255Be%255Dpyrimido%255B5%252C4-b%255D%255B1%252C4%255Ddiazepin-6-ones%2520as%2520Selective%2520PI3K-%25CE%25B4%252F%25CE%25B3%2520Inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26issue%3D10%26spage%3D908%26epage%3D912%26doi%3D10.1021%2Facsmedchemlett.6b00209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref192"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref192'); return false;" data-citation="" class="refNumLink">192</a></strong><div class="NLM_citation" id="cit192"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Terstiege, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyrchan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svensson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindmark, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Öster, L.</span></span> <span> </span><span class="NLM_article-title">Discovery of Triazole Aminopyrazines as a Highly Potent and Selective Series of PI3Kδ Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">679</span>– <span class="NLM_lpage">687</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.11.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.bmcl.2016.11.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=28017532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFCltr3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=679-687&issue=3&author=I.+Terstiegeauthor=M.+Perryauthor=J.+Petersenauthor=C.+Tyrchanauthor=T.+Svenssonauthor=H.+Lindmarkauthor=L.+%C3%96ster&title=Discovery+of+Triazole+Aminopyrazines+as+a+Highly+Potent+and+Selective+Series+of+PI3K%CE%B4+Inhibitors&doi=10.1016%2Fj.bmcl.2016.11.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of triazole aminopyrazines as a highly potent and selective series of PI3Kδ inhibitors</span></div><div class="casAuthors">Terstiege, Ina; Perry, Matthew; Petersen, Jens; Tyrchan, Christian; Svensson, Tor; Lindmark, Helena; Oester, Linda</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">679-687</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A novel class of potent PI3Kδ inhibitors with >1000-fold selectivity against other class I PI3K isoforms is described.  Optimization of the substituents on a triazole aminopyrazine scaffold, emerging from an inhouse PI3Kα program, turned moderately selective PI3Kδ compds. into highly potent and selective PI3Kδ inhibitors.  These efforts resulted in a series of aminopyrazines with PI3Kδ IC50 ≤ 1 nM in the enzyme assay, some of the most selective PI3Kδ inhibitors published to date, with a cell potency in a JeKo-cell assay of 20-120 nM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq30_ESCcDWabVg90H21EOLACvtfcHk0lieWGXk4_agLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFCltr3M&md5=a23e39caed37cd7f969dc4bba666ede5</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.11.004%26sid%3Dliteratum%253Aachs%26aulast%3DTerstiege%26aufirst%3DI.%26aulast%3DPerry%26aufirst%3DM.%26aulast%3DPetersen%26aufirst%3DJ.%26aulast%3DTyrchan%26aufirst%3DC.%26aulast%3DSvensson%26aufirst%3DT.%26aulast%3DLindmark%26aufirst%3DH.%26aulast%3D%25C3%2596ster%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520Triazole%2520Aminopyrazines%2520as%2520a%2520Highly%2520Potent%2520and%2520Selective%2520Series%2520of%2520PI3K%25CE%25B4%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26issue%3D3%26spage%3D679%26epage%3D687%26doi%3D10.1016%2Fj.bmcl.2016.11.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref193"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref193'); return false;" data-citation="" class="refNumLink">193</a></strong><div class="NLM_citation" id="cit193"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Safina, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forrest, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heald, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonomiya, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salphati, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seward, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staben, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ultsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D. P.</span></span> <span> </span><span class="NLM_article-title">Design of Selective Benzoxazepin PI3Kδ Inhibitors Through Control of Dihedral Angles</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">936</span>– <span class="NLM_lpage">940</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00170</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00170" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=936-940&issue=9&author=B.+S.+Safinaauthor=R.+L.+Elliottauthor=A.+K.+Forrestauthor=R.+A.+Healdauthor=J.+M.+Murrayauthor=J.+Nonomiyaauthor=J.+Pangauthor=L.+Salphatiauthor=E.+M.+Sewardauthor=S.+T.+Stabenauthor=M.+Ultschauthor=B.+Weiauthor=W.+Yangauthor=D.+P.+Sutherlin&title=Design+of+Selective+Benzoxazepin+PI3K%CE%B4+Inhibitors+Through+Control+of+Dihedral+Angles&doi=10.1021%2Facsmedchemlett.7b00170"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00170%26sid%3Dliteratum%253Aachs%26aulast%3DSafina%26aufirst%3DB.%2BS.%26aulast%3DElliott%26aufirst%3DR.%2BL.%26aulast%3DForrest%26aufirst%3DA.%2BK.%26aulast%3DHeald%26aufirst%3DR.%2BA.%26aulast%3DMurray%26aufirst%3DJ.%2BM.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSeward%26aufirst%3DE.%2BM.%26aulast%3DStaben%26aufirst%3DS.%2BT.%26aulast%3DUltsch%26aufirst%3DM.%26aulast%3DWei%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26atitle%3DDesign%2520of%2520Selective%2520Benzoxazepin%2520PI3K%25CE%25B4%2520Inhibitors%2520Through%2520Control%2520of%2520Dihedral%2520Angles%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26issue%3D9%26spage%3D936%26epage%3D940%26doi%3D10.1021%2Facsmedchemlett.7b00170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref194"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref194'); return false;" data-citation="" class="refNumLink">194</a></strong><div class="NLM_citation" id="cit194"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knight, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldman, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zunder, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldenberg, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loewith, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stokoe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balla, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span> <span> </span><span class="NLM_article-title">A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>125</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">733</span>– <span class="NLM_lpage">747</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2006.03.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.cell.2006.03.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=16647110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BD28XltlSkt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2006&pages=733-747&issue=4&author=Z.+A.+Knightauthor=B.+Gonzalezauthor=M.+E.+Feldmanauthor=E.+R.+Zunderauthor=D.+D.+Goldenbergauthor=O.+Williamsauthor=R.+Loewithauthor=D.+Stokoeauthor=A.+Ballaauthor=B.+Tothauthor=T.+Ballaauthor=W.+A.+Weissauthor=R.+L.+Williamsauthor=K.+M.+Shokat&title=A+Pharmacological+Map+of+the+PI3-K+Family+Defines+a+Role+for+p110%CE%B1+in+Insulin+Signaling&doi=10.1016%2Fj.cell.2006.03.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">A pharmacological map of the PI3-K family defines a role for p110α in insulin signaling</span></div><div class="casAuthors">Knight, Zachary A.; Gonzalez, Beatriz; Feldman, Morri E.; Zunder, Eli R.; Goldenberg, David D.; Williams, Olusegun; Loewith, Robbie; Stokoe, David; Balla, Andras; Toth, Balazs; Balla, Tamas; Weiss, William A.; Williams, Roger L.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">733-747</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Phosphoinositide 3-kinases (PI3-Ks) are an important emerging class of drug targets, but the unique roles of PI3-K isoforms remain poorly defined.  We describe here an approach to pharmacol. interrogate the PI3-K family.  A chem. diverse panel of PI3-K inhibitors was synthesized, and their target selectivity was biochem. enumerated, revealing cryptic homologies across targets and chemotypes.  Crystal structures of three inhibitors bound to p110γ identify a conformationally mobile region that is uniquely exploited by selective compds.  This chem. array was then used to define the PI3-K isoforms required for insulin signaling.  We find that p110α is the primary insulin-responsive PI3-K in cultured cells, whereas p110β is dispensable but sets a phenotypic threshold for p110α activity.  Compds. targeting p110α block the acute effects of insulin treatment in vivo, whereas a p110β inhibitor has no effect.  These results illustrate systematic target validation using a matrix of inhibitors that span a protein family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrozjvOeMXP3bVg90H21EOLACvtfcHk0lieWGXk4_agLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltlSkt7o%253D&md5=b95a8cb433927ff9a75b33fc4ac2c8a0</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.03.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.03.035%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DGonzalez%26aufirst%3DB.%26aulast%3DFeldman%26aufirst%3DM.%2BE.%26aulast%3DZunder%26aufirst%3DE.%2BR.%26aulast%3DGoldenberg%26aufirst%3DD.%2BD.%26aulast%3DWilliams%26aufirst%3DO.%26aulast%3DLoewith%26aufirst%3DR.%26aulast%3DStokoe%26aufirst%3DD.%26aulast%3DBalla%26aufirst%3DA.%26aulast%3DToth%26aufirst%3DB.%26aulast%3DBalla%26aufirst%3DT.%26aulast%3DWeiss%26aufirst%3DW.%2BA.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DA%2520Pharmacological%2520Map%2520of%2520the%2520PI3-K%2520Family%2520Defines%2520a%2520Role%2520for%2520p110%25CE%25B1%2520in%2520Insulin%2520Signaling%26jtitle%3DCell%26date%3D2006%26volume%3D125%26issue%3D4%26spage%3D733%26epage%3D747%26doi%3D10.1016%2Fj.cell.2006.03.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref195"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref195'); return false;" data-citation="" class="refNumLink">195</a></strong><div class="NLM_citation" id="cit195"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laurent, P.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Séverin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hechler, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanhaesebroeck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payrastre, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gratacap, M.-P.</span></span> <span> </span><span class="NLM_article-title">Platelet PI3Kâ and GSK3 Regulate Thrombus Stability at a High Shear Rate</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>125</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">881</span>– <span class="NLM_lpage">888</span>, <span class="refDoi"> DOI: 10.1182/blood-2014-07-588335</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1182%2Fblood-2014-07-588335" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2015&pages=881-888&issue=5&author=P.-A.+Laurentauthor=S.+S%C3%A9verinauthor=B.+Hechlerauthor=B.+Vanhaesebroeckauthor=B.+Payrastreauthor=M.-P.+Gratacap&title=Platelet+PI3K%C3%A2+and+GSK3+Regulate+Thrombus+Stability+at+a+High+Shear+Rate&doi=10.1182%2Fblood-2014-07-588335"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1182%2Fblood-2014-07-588335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2014-07-588335%26sid%3Dliteratum%253Aachs%26aulast%3DLaurent%26aufirst%3DP.-A.%26aulast%3DS%25C3%25A9verin%26aufirst%3DS.%26aulast%3DHechler%26aufirst%3DB.%26aulast%3DVanhaesebroeck%26aufirst%3DB.%26aulast%3DPayrastre%26aufirst%3DB.%26aulast%3DGratacap%26aufirst%3DM.-P.%26atitle%3DPlatelet%2520PI3K%25C3%25A2%2520and%2520GSK3%2520Regulate%2520Thrombus%2520Stability%2520at%2520a%2520High%2520Shear%2520Rate%26jtitle%3DBlood%26date%3D2015%26volume%3D125%26issue%3D5%26spage%3D881%26epage%3D888%26doi%3D10.1182%2Fblood-2014-07-588335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref196"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref196'); return false;" data-citation="" class="refNumLink">196</a></strong><div class="NLM_citation" id="cit196"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okabe, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nussbaum, R. L.</span></span> <span> </span><span class="NLM_article-title">Early Embryonic Lethality in Mice Deficient in the p110β Catalytic Subunit of PI3-Kinase</span>. <i>Mamm. Genome</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">172</span>, <span class="refDoi"> DOI: 10.1007/BF02684023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1007%2FBF02684023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=11919689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BD38Xislaltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2002&pages=169-172&author=L.+Biauthor=I.+Okabeauthor=D.+J.+Bernardauthor=R.+L.+Nussbaum&title=Early+Embryonic+Lethality+in+Mice+Deficient+in+the+p110%CE%B2+Catalytic+Subunit+of+PI3-Kinase&doi=10.1007%2FBF02684023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">Early embryonic lethality in mice deficient in the p110β catalytic subunit of PI 3-kinase</span></div><div class="casAuthors">Bi, Lei; Okabe, Ichiro; Bernard, David J.; Nussbaum, Robert L.</div><div class="citationInfo"><span class="NLM_cas:title">Mammalian Genome</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">169-172</span>CODEN:
                <span class="NLM_cas:coden">MAMGEC</span>;
        ISSN:<span class="NLM_cas:issn">0938-8990</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag New York Inc.</span>)
        </div><div class="casAbstract">Partial deletion of the allele for the p110β catalytic subunit of phosphatidylinositol 3-kinase causes death in mouse embryos.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxU7TUOwYNhbVg90H21EOLACvtfcHk0ljcaa9l1HnnQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xislaltb0%253D&md5=d9b1b8b399d68722b9c2c1eab016d377</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1007%2FBF02684023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02684023%26sid%3Dliteratum%253Aachs%26aulast%3DBi%26aufirst%3DL.%26aulast%3DOkabe%26aufirst%3DI.%26aulast%3DBernard%26aufirst%3DD.%2BJ.%26aulast%3DNussbaum%26aufirst%3DR.%2BL.%26atitle%3DEarly%2520Embryonic%2520Lethality%2520in%2520Mice%2520Deficient%2520in%2520the%2520p110%25CE%25B2%2520Catalytic%2520Subunit%2520of%2520PI3-Kinase%26jtitle%3DMamm.%2520Genome%26date%3D2002%26volume%3D13%26spage%3D169%26epage%3D172%26doi%3D10.1007%2FBF02684023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref197"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref197'); return false;" data-citation="" class="refNumLink">197</a></strong><div class="NLM_citation" id="cit197"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okabe, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wynshaw-Boris, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nussbaum, R. L.</span></span> <span> </span><span class="NLM_article-title">Proliferative Defect and Embryonic Lethality in Mice Homozygous for a Deletion in the p110alpha Subunit of Phosphoinositide 3-Kinase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>274</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">10963</span>– <span class="NLM_lpage">10968</span>, <span class="refDoi"> DOI: 10.1074/jbc.274.16.10963</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1074%2Fjbc.274.16.10963" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=10963-10968&issue=16&author=L.+Biauthor=I.+Okabeauthor=D.+J.+Bernardauthor=A.+Wynshaw-Borisauthor=R.+L.+Nussbaum&title=Proliferative+Defect+and+Embryonic+Lethality+in+Mice+Homozygous+for+a+Deletion+in+the+p110alpha+Subunit+of+Phosphoinositide+3-Kinase&doi=10.1074%2Fjbc.274.16.10963"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.16.10963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.16.10963%26sid%3Dliteratum%253Aachs%26aulast%3DBi%26aufirst%3DL.%26aulast%3DOkabe%26aufirst%3DI.%26aulast%3DBernard%26aufirst%3DD.%2BJ.%26aulast%3DWynshaw-Boris%26aufirst%3DA.%26aulast%3DNussbaum%26aufirst%3DR.%2BL.%26atitle%3DProliferative%2520Defect%2520and%2520Embryonic%2520Lethality%2520in%2520Mice%2520Homozygous%2520for%2520a%2520Deletion%2520in%2520the%2520p110alpha%2520Subunit%2520of%2520Phosphoinositide%25203-Kinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26issue%3D16%26spage%3D10963%26epage%3D10968%26doi%3D10.1074%2Fjbc.274.16.10963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref198"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref198'); return false;" data-citation="" class="refNumLink">198</a></strong><div class="NLM_citation" id="cit198"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sunose, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellard, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergamini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubauer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werner, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsden, N.</span></span> <span> </span><span class="NLM_article-title">Discovery of 5-(2-Amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-(tert-butyl)pyridine-3-sulfonamide (CZC24758), as a Potent, Orally Bioavailable and Selective Inhibitor of PI3K for the Treatment of Inflammatory Disease</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">4613</span>– <span class="NLM_lpage">4618</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.05.090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.bmcl.2012.05.090" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=4613-4618&issue=14&author=M.+Sunoseauthor=K.+Bellauthor=K.+Ellardauthor=G.+Bergaminiauthor=G.+Neubauerauthor=T.+Wernerauthor=N.+Ramsden&title=Discovery+of+5-%282-Amino-%5B1%2C2%2C4%5Dtriazolo%5B1%2C5-a%5Dpyridin-7-yl%29-N-%28tert-butyl%29pyridine-3-sulfonamide+%28CZC24758%29%2C+as+a+Potent%2C+Orally+Bioavailable+and+Selective+Inhibitor+of+PI3K+for+the+Treatment+of+Inflammatory+Disease&doi=10.1016%2Fj.bmcl.2012.05.090"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.05.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.05.090%26sid%3Dliteratum%253Aachs%26aulast%3DSunose%26aufirst%3DM.%26aulast%3DBell%26aufirst%3DK.%26aulast%3DEllard%26aufirst%3DK.%26aulast%3DBergamini%26aufirst%3DG.%26aulast%3DNeubauer%26aufirst%3DG.%26aulast%3DWerner%26aufirst%3DT.%26aulast%3DRamsden%26aufirst%3DN.%26atitle%3DDiscovery%2520of%25205-%25282-Amino-%255B1%252C2%252C4%255Dtriazolo%255B1%252C5-a%255Dpyridin-7-yl%2529-N-%2528tert-butyl%2529pyridine-3-sulfonamide%2520%2528CZC24758%2529%252C%2520as%2520a%2520Potent%252C%2520Orally%2520Bioavailable%2520and%2520Selective%2520Inhibitor%2520of%2520PI3K%2520for%2520the%2520Treatment%2520of%2520Inflammatory%2520Disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26issue%3D14%26spage%3D4613%26epage%3D4618%26doi%3D10.1016%2Fj.bmcl.2012.05.090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref199"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref199'); return false;" data-citation="" class="refNumLink">199</a></strong><div class="NLM_citation" id="cit199"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bell, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunose, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellard, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cansfield, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsden, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergamini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubauer, G.</span></span> <span> </span><span class="NLM_article-title">SAR Studies around a Series of Triazolopyridines as Potent and Selective PI3Kγ Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">5257</span>– <span class="NLM_lpage">5263</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.06.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.bmcl.2012.06.049" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5257-5263&issue=16&author=K.+Bellauthor=M.+Sunoseauthor=K.+Ellardauthor=A.+Cansfieldauthor=J.+Taylorauthor=W.+Millerauthor=N.+Ramsdenauthor=G.+Bergaminiauthor=G.+Neubauer&title=SAR+Studies+around+a+Series+of+Triazolopyridines+as+Potent+and+Selective+PI3K%CE%B3+Inhibitors&doi=10.1016%2Fj.bmcl.2012.06.049"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.06.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.06.049%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DK.%26aulast%3DSunose%26aufirst%3DM.%26aulast%3DEllard%26aufirst%3DK.%26aulast%3DCansfield%26aufirst%3DA.%26aulast%3DTaylor%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DW.%26aulast%3DRamsden%26aufirst%3DN.%26aulast%3DBergamini%26aufirst%3DG.%26aulast%3DNeubauer%26aufirst%3DG.%26atitle%3DSAR%2520Studies%2520around%2520a%2520Series%2520of%2520Triazolopyridines%2520as%2520Potent%2520and%2520Selective%2520PI3K%25CE%25B3%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26issue%3D16%26spage%3D5257%26epage%3D5263%26doi%3D10.1016%2Fj.bmcl.2012.06.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref200"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref200'); return false;" data-citation="" class="refNumLink">200</a></strong><div class="NLM_citation" id="cit200"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lamb, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lunn, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Reilly, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilty, I.</span></span> <span> </span><span class="NLM_article-title">In Vitro and In Vivo Assessment of Pi3Kγ Inhibitors for Anti-Inflammatory Indications: Challenges of Selectivity over Pi3Kα</span>. <i>J. Pulm. Respir. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">157</span>, <span class="refDoi"> DOI: 10.4172/2161-105X.1000157</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.4172%2F2161-105X.1000157" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=157&author=D.+Lambauthor=G.+Lunnauthor=M.+O%E2%80%99Reillyauthor=C.+Butlerauthor=I.+Kilty&title=In+Vitro+and+In+Vivo+Assessment+of+Pi3K%CE%B3+Inhibitors+for+Anti-Inflammatory+Indications%3A+Challenges+of+Selectivity+over+Pi3K%CE%B1&doi=10.4172%2F2161-105X.1000157"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.4172%2F2161-105X.1000157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4172%252F2161-105X.1000157%26sid%3Dliteratum%253Aachs%26aulast%3DLamb%26aufirst%3DD.%26aulast%3DLunn%26aufirst%3DG.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DM.%26aulast%3DButler%26aufirst%3DC.%26aulast%3DKilty%26aufirst%3DI.%26atitle%3DIn%2520Vitro%2520and%2520In%2520Vivo%2520Assessment%2520of%2520Pi3K%25CE%25B3%2520Inhibitors%2520for%2520Anti-Inflammatory%2520Indications%253A%2520Challenges%2520of%2520Selectivity%2520over%2520Pi3K%25CE%25B1%26jtitle%3DJ.%2520Pulm.%2520Respir.%2520Med.%26date%3D2013%26volume%3D3%26spage%3D157%26doi%3D10.4172%2F2161-105X.1000157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref201"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref201'); return false;" data-citation="" class="refNumLink">201</a></strong><div class="NLM_citation" id="cit201"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yabuuchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohtake, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakahara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sekiguchi, Y.</span></span> <span> </span><span class="NLM_article-title">Discovery and Optimization of a Series of 2-Aminothiazole-Oxazoles as Potent Phosphoinositide 3-Kinase γ Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">7534</span>– <span class="NLM_lpage">7538</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.10.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.bmcl.2012.10.028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=7534-7538&issue=24&author=Y.+Okaauthor=T.+Yabuuchiauthor=Y.+Fujiiauthor=H.+Ohtakeauthor=S.+Wakaharaauthor=K.+Matsumotoauthor=M.+Endoauthor=Y.+Tamuraauthor=Y.+Sekiguchi&title=Discovery+and+Optimization+of+a+Series+of+2-Aminothiazole-Oxazoles+as+Potent+Phosphoinositide+3-Kinase+%CE%B3+Inhibitors&doi=10.1016%2Fj.bmcl.2012.10.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.10.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.10.028%26sid%3Dliteratum%253Aachs%26aulast%3DOka%26aufirst%3DY.%26aulast%3DYabuuchi%26aufirst%3DT.%26aulast%3DFujii%26aufirst%3DY.%26aulast%3DOhtake%26aufirst%3DH.%26aulast%3DWakahara%26aufirst%3DS.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DEndo%26aufirst%3DM.%26aulast%3DTamura%26aufirst%3DY.%26aulast%3DSekiguchi%26aufirst%3DY.%26atitle%3DDiscovery%2520and%2520Optimization%2520of%2520a%2520Series%2520of%25202-Aminothiazole-Oxazoles%2520as%2520Potent%2520Phosphoinositide%25203-Kinase%2520%25CE%25B3%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26issue%3D24%26spage%3D7534%26epage%3D7538%26doi%3D10.1016%2Fj.bmcl.2012.10.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref202"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref202'); return false;" data-citation="" class="refNumLink">202</a></strong><div class="NLM_citation" id="cit202"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yabuuchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuroda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohtake, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakahara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sekiguchi, Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of N-{5-[3-(3-Hydroxypiperidin-1-yl)-1,2,4-oxadiazol-5-yl]-4-methyl-1,3-thiazol-2-yl}acetamide (TASP0415914) as an Orally Potent Phosphoinositide 3-Kinase γ Inhibitor for the Treatment of Inflammatory Diseases</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">7578</span>– <span class="NLM_lpage">7583</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.10.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.bmc.2013.10.042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=7578-7583&issue=24&author=Y.+Okaauthor=T.+Yabuuchiauthor=T.+Oiauthor=S.+Kurodaauthor=Y.+Fujiiauthor=H.+Ohtakeauthor=T.+Inoueauthor=S.+Wakaharaauthor=K.+Kimuraauthor=K.+Fujitaauthor=M.+Endoauthor=K.+Taguchiauthor=Y.+Sekiguchi&title=Discovery+of+N-%7B5-%5B3-%283-Hydroxypiperidin-1-yl%29-1%2C2%2C4-oxadiazol-5-yl%5D-4-methyl-1%2C3-thiazol-2-yl%7Dacetamide+%28TASP0415914%29+as+an+Orally+Potent+Phosphoinositide+3-Kinase+%CE%B3+Inhibitor+for+the+Treatment+of+Inflammatory+Diseases&doi=10.1016%2Fj.bmc.2013.10.042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.10.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.10.042%26sid%3Dliteratum%253Aachs%26aulast%3DOka%26aufirst%3DY.%26aulast%3DYabuuchi%26aufirst%3DT.%26aulast%3DOi%26aufirst%3DT.%26aulast%3DKuroda%26aufirst%3DS.%26aulast%3DFujii%26aufirst%3DY.%26aulast%3DOhtake%26aufirst%3DH.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DWakahara%26aufirst%3DS.%26aulast%3DKimura%26aufirst%3DK.%26aulast%3DFujita%26aufirst%3DK.%26aulast%3DEndo%26aufirst%3DM.%26aulast%3DTaguchi%26aufirst%3DK.%26aulast%3DSekiguchi%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520N-%257B5-%255B3-%25283-Hydroxypiperidin-1-yl%2529-1%252C2%252C4-oxadiazol-5-yl%255D-4-methyl-1%252C3-thiazol-2-yl%257Dacetamide%2520%2528TASP0415914%2529%2520as%2520an%2520Orally%2520Potent%2520Phosphoinositide%25203-Kinase%2520%25CE%25B3%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Inflammatory%2520Diseases%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26issue%3D24%26spage%3D7578%26epage%3D7583%26doi%3D10.1016%2Fj.bmc.2013.10.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref203"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref203'); return false;" data-citation="" class="refNumLink">203</a></strong><div class="NLM_citation" id="cit203"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, H.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, W.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.-L.</span></span> <span> </span><span class="NLM_article-title">Discovery of Fluoroquinolone Derivatives as Potent, Selective Inhibitors of PI3Kγ</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2029</span>– <span class="NLM_lpage">2035</span>, <span class="refDoi"> DOI: 10.1039/C5MD00364D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1039%2FC5MD00364D" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=2029-2035&issue=11&author=S.+Shaauthor=H.-W.+Hanauthor=F.+Gaoauthor=T.-B.+Liuauthor=Z.+Liauthor=C.+Xuauthor=W.-Q.+Zhongauthor=H.-L.+Zhu&title=Discovery+of+Fluoroquinolone+Derivatives+as+Potent%2C+Selective+Inhibitors+of+PI3K%CE%B3&doi=10.1039%2FC5MD00364D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.1039%2FC5MD00364D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5MD00364D%26sid%3Dliteratum%253Aachs%26aulast%3DSha%26aufirst%3DS.%26aulast%3DHan%26aufirst%3DH.-W.%26aulast%3DGao%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DT.-B.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DZhong%26aufirst%3DW.-Q.%26aulast%3DZhu%26aufirst%3DH.-L.%26atitle%3DDiscovery%2520of%2520Fluoroquinolone%2520Derivatives%2520as%2520Potent%252C%2520Selective%2520Inhibitors%2520of%2520PI3K%25CE%25B3%26jtitle%3DMedChemComm%26date%3D2015%26volume%3D6%26issue%3D11%26spage%3D2029%26epage%3D2035%26doi%3D10.1039%2FC5MD00364D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref204"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref204'); return false;" data-citation="" class="refNumLink">204</a></strong><div class="NLM_citation" id="cit204"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, E. P.</span>; <span class="NLM_string-name">Reddy, M. V. R.</span></span> <span> </span><span class="NLM_article-title">3-Aminothieno[3,2-c]quinoline Derivatives, Methods of Preparation and Uses</span>. <span class="NLM_patent">WO2013142010</span>, September 27, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=E.+P.+Reddy&author=M.+V.+R.+Reddy&title=3-Aminothieno%5B3%2C2-c%5Dquinoline+Derivatives%2C+Methods+of+Preparation+and+Uses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DE.%2BP.%26atitle%3D3-Aminothieno%255B3%252C2-c%255Dquinoline%2520Derivatives%252C%2520Methods%2520of%2520Preparation%2520and%2520Uses%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref205"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref205'); return false;" data-citation="" class="refNumLink">205</a></strong><div class="NLM_citation" id="cit205"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruce, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akhlaq, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloomfield, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budd, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuenoud, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gedeck, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatto, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayler, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Head, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblanc, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grand, D. Le</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarthy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oza, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilgrim, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Press, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sviridenko, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitehead, L.</span></span> <span> </span><span class="NLM_article-title">Development of Isoform Selective PI3-Kinase Inhibitors as Pharmacological Tools for Elucidating the PI3K Pathway</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">5445</span>– <span class="NLM_lpage">5450</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.07.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.bmcl.2012.07.042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5445-5450&issue=17&author=I.+Bruceauthor=M.+Akhlaqauthor=G.+C.+Bloomfieldauthor=E.+Buddauthor=B.+Coxauthor=B.+Cuenoudauthor=P.+Finanauthor=P.+Gedeckauthor=J.+Hattoauthor=J.+F.+Haylerauthor=D.+Headauthor=T.+Kellerauthor=L.+Kirmanauthor=C.+Leblancauthor=D.+Le+Grandauthor=C.+McCarthyauthor=D.+O%E2%80%99Connorauthor=C.+Owenauthor=M.+S.+Ozaauthor=G.+Pilgrimauthor=N.+E.+Pressauthor=L.+Sviridenkoauthor=L.+Whitehead&title=Development+of+Isoform+Selective+PI3-Kinase+Inhibitors+as+Pharmacological+Tools+for+Elucidating+the+PI3K+Pathway&doi=10.1016%2Fj.bmcl.2012.07.042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.07.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.07.042%26sid%3Dliteratum%253Aachs%26aulast%3DBruce%26aufirst%3DI.%26aulast%3DAkhlaq%26aufirst%3DM.%26aulast%3DBloomfield%26aufirst%3DG.%2BC.%26aulast%3DBudd%26aufirst%3DE.%26aulast%3DCox%26aufirst%3DB.%26aulast%3DCuenoud%26aufirst%3DB.%26aulast%3DFinan%26aufirst%3DP.%26aulast%3DGedeck%26aufirst%3DP.%26aulast%3DHatto%26aufirst%3DJ.%26aulast%3DHayler%26aufirst%3DJ.%2BF.%26aulast%3DHead%26aufirst%3DD.%26aulast%3DKeller%26aufirst%3DT.%26aulast%3DKirman%26aufirst%3DL.%26aulast%3DLeblanc%26aufirst%3DC.%26aulast%3DGrand%26aufirst%3DD.%2BLe%26aulast%3DMcCarthy%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DD.%26aulast%3DOwen%26aufirst%3DC.%26aulast%3DOza%26aufirst%3DM.%2BS.%26aulast%3DPilgrim%26aufirst%3DG.%26aulast%3DPress%26aufirst%3DN.%2BE.%26aulast%3DSviridenko%26aufirst%3DL.%26aulast%3DWhitehead%26aufirst%3DL.%26atitle%3DDevelopment%2520of%2520Isoform%2520Selective%2520PI3-Kinase%2520Inhibitors%2520as%2520Pharmacological%2520Tools%2520for%2520Elucidating%2520the%2520PI3K%2520Pathway%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26issue%3D17%26spage%3D5445%26epage%3D5450%26doi%3D10.1016%2Fj.bmcl.2012.07.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref206"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref206'); return false;" data-citation="" class="refNumLink">206</a></strong><div class="NLM_citation" id="cit206"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bellenie, B. R.</span>; <span class="NLM_string-name">Bloomfield, G. C.</span>; <span class="NLM_string-name">Bruce, I.</span>; <span class="NLM_string-name">Culshaw, A. J.</span>; <span class="NLM_string-name">Hall, E. C.</span>; <span class="NLM_string-name">Hollingworth, G.</span>; <span class="NLM_string-name">Neef, J.</span>; <span class="NLM_string-name">Spendiff, M.</span>; <span class="NLM_string-name">Watson, S. J.</span></span> <span> </span><span class="NLM_article-title">Amino Pyrazine Derivatives as Phosphatidylinositol 3-Kinase Inhibitors</span>. <span class="NLM_patent">WO2015162459</span>, October 30, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=B.+R.+Bellenie&author=G.+C.+Bloomfield&author=I.+Bruce&author=A.+J.+Culshaw&author=E.+C.+Hall&author=G.+Hollingworth&author=J.+Neef&author=M.+Spendiff&author=S.+J.+Watson&title=Amino+Pyrazine+Derivatives+as+Phosphatidylinositol+3-Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBellenie%26aufirst%3DB.%2BR.%26atitle%3DAmino%2520Pyrazine%2520Derivatives%2520as%2520Phosphatidylinositol%25203-Kinase%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref207"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref207'); return false;" data-citation="" class="refNumLink">207</a></strong><div class="NLM_citation" id="cit207"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Collier, P.
N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Botella, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornebise, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottrell, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahajan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maltais, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huck, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aronov, A. M.</span></span> <span> </span><span class="NLM_article-title">Structural Basis for Isoform Selectivity in a Class of Benzothiazole Inhibitors of Phosphoinositide 3-Kinase γ</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">517</span>– <span class="NLM_lpage">521</span>, <span class="refDoi"> DOI: 10.1021/jm500362j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500362j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=517-521&issue=1&author=P.%0AN.+Collierauthor=G.+Martinez-Botellaauthor=M.+Cornebiseauthor=K.+M.+Cottrellauthor=J.+D.+Doranauthor=J.+P.+Griffithauthor=S.+Mahajanauthor=F.+Maltaisauthor=C.+S.+Moodyauthor=E.+P.+Huckauthor=T.+Wangauthor=A.+M.+Aronov&title=Structural+Basis+for+Isoform+Selectivity+in+a+Class+of+Benzothiazole+Inhibitors+of+Phosphoinositide+3-Kinase+%CE%B3&doi=10.1021%2Fjm500362j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1021%2Fjm500362j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500362j%26sid%3Dliteratum%253Aachs%26aulast%3DCollier%26aufirst%3DP.%2BN.%26aulast%3DMartinez-Botella%26aufirst%3DG.%26aulast%3DCornebise%26aufirst%3DM.%26aulast%3DCottrell%26aufirst%3DK.%2BM.%26aulast%3DDoran%26aufirst%3DJ.%2BD.%26aulast%3DGriffith%26aufirst%3DJ.%2BP.%26aulast%3DMahajan%26aufirst%3DS.%26aulast%3DMaltais%26aufirst%3DF.%26aulast%3DMoody%26aufirst%3DC.%2BS.%26aulast%3DHuck%26aufirst%3DE.%2BP.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DAronov%26aufirst%3DA.%2BM.%26atitle%3DStructural%2520Basis%2520for%2520Isoform%2520Selectivity%2520in%2520a%2520Class%2520of%2520Benzothiazole%2520Inhibitors%2520of%2520Phosphoinositide%25203-Kinase%2520%25CE%25B3%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D1%26spage%3D517%26epage%3D521%26doi%3D10.1021%2Fjm500362j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref208"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref208'); return false;" data-citation="" class="refNumLink">208</a></strong><div class="NLM_citation" id="cit208"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Collier, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messersmith, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Tiran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandarage, U. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boucher, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Come, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottrell, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damagnez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khare-Pandit, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krueger, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ledeboer, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ledford, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahajan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roday, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aronov, A. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of Highly Isoform Selective Thiazolopiperidine Inhibitors of Phosphoinositide 3-Kinase γ</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">5684</span>– <span class="NLM_lpage">5688</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00498</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00498" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5684-5688&issue=14&author=P.+N.+Collierauthor=D.+Messersmithauthor=A.+Le+Tiranauthor=U.+K.+Bandarageauthor=C.+Boucherauthor=J.+Comeauthor=K.+M.+Cottrellauthor=V.+Damagnezauthor=J.+D.+Doranauthor=J.+P.+Griffithauthor=S.+Khare-Panditauthor=E.+B.+Kruegerauthor=M.+W.+Ledeboerauthor=B.+Ledfordauthor=Y.+Liaoauthor=S.+Mahajanauthor=C.+S.+Moodyauthor=S.+Rodayauthor=T.+Wangauthor=J.+Xuauthor=A.+M.+Aronov&title=Discovery+of+Highly+Isoform+Selective+Thiazolopiperidine+Inhibitors+of+Phosphoinositide+3-Kinase+%CE%B3&doi=10.1021%2Facs.jmedchem.5b00498"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00498%26sid%3Dliteratum%253Aachs%26aulast%3DCollier%26aufirst%3DP.%2BN.%26aulast%3DMessersmith%26aufirst%3DD.%26aulast%3DLe%2BTiran%26aufirst%3DA.%26aulast%3DBandarage%26aufirst%3DU.%2BK.%26aulast%3DBoucher%26aufirst%3DC.%26aulast%3DCome%26aufirst%3DJ.%26aulast%3DCottrell%26aufirst%3DK.%2BM.%26aulast%3DDamagnez%26aufirst%3DV.%26aulast%3DDoran%26aufirst%3DJ.%2BD.%26aulast%3DGriffith%26aufirst%3DJ.%2BP.%26aulast%3DKhare-Pandit%26aufirst%3DS.%26aulast%3DKrueger%26aufirst%3DE.%2BB.%26aulast%3DLedeboer%26aufirst%3DM.%2BW.%26aulast%3DLedford%26aufirst%3DB.%26aulast%3DLiao%26aufirst%3DY.%26aulast%3DMahajan%26aufirst%3DS.%26aulast%3DMoody%26aufirst%3DC.%2BS.%26aulast%3DRoday%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DAronov%26aufirst%3DA.%2BM.%26atitle%3DDiscovery%2520of%2520Highly%2520Isoform%2520Selective%2520Thiazolopiperidine%2520Inhibitors%2520of%2520Phosphoinositide%25203-Kinase%2520%25CE%25B3%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D14%26spage%3D5684%26epage%3D5688%26doi%3D10.1021%2Facs.jmedchem.5b00498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref209"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref209'); return false;" data-citation="" class="refNumLink">209</a></strong><div class="NLM_citation" id="cit209"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, M. J.</span>; <span class="NLM_string-name">Aronov, A.</span>; <span class="NLM_string-name">O’Dowd, H.</span>; <span class="NLM_string-name">Green, J.</span></span> <span> </span><span class="NLM_article-title">A Selective Inhibitor of Phosphatidylinositol 3-Kinase-Gamma</span>. <span class="NLM_patent">WO2015048318</span>, April 3, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+J.+Boyd&author=A.+Aronov&author=H.+O%E2%80%99Dowd&author=J.+Green&title=A+Selective+Inhibitor+of+Phosphatidylinositol+3-Kinase-Gamma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBoyd%26aufirst%3DM.%2BJ.%26atitle%3DA%2520Selective%2520Inhibitor%2520of%2520Phosphatidylinositol%25203-Kinase-Gamma%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref210"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref210'); return false;" data-citation="" class="refNumLink">210</a></strong><div class="NLM_citation" id="cit210"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Come, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collier, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Tiran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Dowd, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandarage, U. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deininger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krueger, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messersmith, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nanthakumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sizensky, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damagnez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dworakowski, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khare-Pandit, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahajan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aronov, A. M.</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of a Novel Series of Orally Bioavailable, CNS-Penetrant, Isoform Selective Phosphoinositide 3-Kinase γ Inhibitors (PI3Kγ) with Potential for the Treatment of Multiple Sclerosis (MS)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">5245</span>– <span class="NLM_lpage">5256</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00085</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00085" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5245-5256&issue=12&author=J.+H.+Comeauthor=P.+N.+Collierauthor=J.+A.+Hendersonauthor=A.+C.+Pierceauthor=R.+J.+Daviesauthor=A.+Le+Tiranauthor=H.+O%E2%80%99Dowdauthor=U.+K.+Bandarageauthor=J.+Caoauthor=D.+Deiningerauthor=R.+Greyauthor=E.+B.+Kruegerauthor=D.+B.+Loweauthor=J.+Liangauthor=Y.+Liaoauthor=D.+Messersmithauthor=S.+Nanthakumarauthor=E.+Sizenskyauthor=J.+Wangauthor=J.+Xuauthor=E.+Y.+Chinauthor=V.+Damagnezauthor=J.+D.+Doranauthor=W.+Dworakowskiauthor=J.+P.+Griffithauthor=M.+D.+Jacobsauthor=S.+Khare-Panditauthor=S.+Mahajanauthor=C.+S.+Moodyauthor=A.+M.+Aronov&title=Design+and+Synthesis+of+a+Novel+Series+of+Orally+Bioavailable%2C+CNS-Penetrant%2C+Isoform+Selective+Phosphoinositide+3-Kinase+%CE%B3+Inhibitors+%28PI3K%CE%B3%29+with+Potential+for+the+Treatment+of+Multiple+Sclerosis+%28MS%29&doi=10.1021%2Facs.jmedchem.8b00085"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00085%26sid%3Dliteratum%253Aachs%26aulast%3DCome%26aufirst%3DJ.%2BH.%26aulast%3DCollier%26aufirst%3DP.%2BN.%26aulast%3DHenderson%26aufirst%3DJ.%2BA.%26aulast%3DPierce%26aufirst%3DA.%2BC.%26aulast%3DDavies%26aufirst%3DR.%2BJ.%26aulast%3DLe%2BTiran%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Dowd%26aufirst%3DH.%26aulast%3DBandarage%26aufirst%3DU.%2BK.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DDeininger%26aufirst%3DD.%26aulast%3DGrey%26aufirst%3DR.%26aulast%3DKrueger%26aufirst%3DE.%2BB.%26aulast%3DLowe%26aufirst%3DD.%2BB.%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DLiao%26aufirst%3DY.%26aulast%3DMessersmith%26aufirst%3DD.%26aulast%3DNanthakumar%26aufirst%3DS.%26aulast%3DSizensky%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DChin%26aufirst%3DE.%2BY.%26aulast%3DDamagnez%26aufirst%3DV.%26aulast%3DDoran%26aufirst%3DJ.%2BD.%26aulast%3DDworakowski%26aufirst%3DW.%26aulast%3DGriffith%26aufirst%3DJ.%2BP.%26aulast%3DJacobs%26aufirst%3DM.%2BD.%26aulast%3DKhare-Pandit%26aufirst%3DS.%26aulast%3DMahajan%26aufirst%3DS.%26aulast%3DMoody%26aufirst%3DC.%2BS.%26aulast%3DAronov%26aufirst%3DA.%2BM.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520a%2520Novel%2520Series%2520of%2520Orally%2520Bioavailable%252C%2520CNS-Penetrant%252C%2520Isoform%2520Selective%2520Phosphoinositide%25203-Kinase%2520%25CE%25B3%2520Inhibitors%2520%2528PI3K%25CE%25B3%2529%2520with%2520Potential%2520for%2520the%2520Treatment%2520of%2520Multiple%2520Sclerosis%2520%2528MS%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D12%26spage%3D5245%26epage%3D5256%26doi%3D10.1021%2Facs.jmedchem.8b00085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref211"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref211'); return false;" data-citation="" class="refNumLink">211</a></strong><div class="NLM_citation" id="cit211"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sparks, R. B.</span>; <span class="NLM_string-name">Shepard, S.</span>; <span class="NLM_string-name">Combs, A.
P.</span>; <span class="NLM_string-name">Buesking, A. W.</span>; <span class="NLM_string-name">Shao, L.</span>; <span class="NLM_string-name">Wang, H.</span>; <span class="NLM_string-name">Falahatpisheh, N.</span></span> <span> </span><span class="NLM_article-title">Pyridine and Pyridimine Compounds as PI3K-Gamma Inhibitors</span>. <span class="NLM_patent">WO2017120194</span>, July 14, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=R.+B.+Sparks&author=S.+Shepard&author=A.%0AP.+Combs&author=A.+W.+Buesking&author=L.+Shao&author=H.+Wang&author=N.+Falahatpisheh&title=Pyridine+and+Pyridimine+Compounds+as+PI3K-Gamma+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSparks%26aufirst%3DR.%2BB.%26atitle%3DPyridine%2520and%2520Pyridimine%2520Compounds%2520as%2520PI3K-Gamma%2520Inhibitors%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref212"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref212'); return false;" data-citation="" class="refNumLink">212</a></strong><div class="NLM_citation" id="cit212"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buesking, A. W.</span>; <span class="NLM_string-name">Sparks, R. B.</span>; <span class="NLM_string-name">Combs, A. P.</span>; <span class="NLM_string-name">Douty, B.</span>; <span class="NLM_string-name">Falahatpisheh, N.</span>; <span class="NLM_string-name">Shao, L.</span>; <span class="NLM_string-name">Shepard, S.</span>; <span class="NLM_string-name">Yue, E.
W.</span></span> <span> </span><span class="NLM_article-title">Heterocyclic Compounds as PI3K-γ Inhibitors</span>. <span class="NLM_patent">WO2017223414</span>, December 29, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=A.+W.+Buesking&author=R.+B.+Sparks&author=A.+P.+Combs&author=B.+Douty&author=N.+Falahatpisheh&author=L.+Shao&author=S.+Shepard&author=E.%0AW.+Yue&title=Heterocyclic+Compounds+as+PI3K-%CE%B3+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBuesking%26aufirst%3DA.%2BW.%26atitle%3DHeterocyclic%2520Compounds%2520as%2520PI3K-%25CE%25B3%2520Inhibitors%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref213"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref213'); return false;" data-citation="" class="refNumLink">213</a></strong><div class="NLM_citation" id="cit213"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pemberton, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mogemark, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arlbrandt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bold, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holden, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karabelas, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlsson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lever, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindmark, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, M. W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigo Blomqvist, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyrchan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westin Eriksson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zlatoidsky, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Öster, L.</span></span> <span> </span><span class="NLM_article-title">Discovery of Highly Isoform Selective Orally Bioavailable Phosphoinositide-3-Kinase (PI3K)-γ Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5435</span>– <span class="NLM_lpage">5441</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00447</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00447" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5435-5441&author=N.+Pembertonauthor=M.+Mogemarkauthor=S.+Arlbrandtauthor=P.+Boldauthor=R.+J.+Coxauthor=C.+Gardelliauthor=N.+S.+Holdenauthor=K.+Karabelasauthor=J.+Karlssonauthor=S.+Leverauthor=X.+Liauthor=H.+Lindmarkauthor=M.+Norbergauthor=M.+W.+D.+Perryauthor=J.+Petersenauthor=S.+Rodrigo+Blomqvistauthor=M.+J.+Thomasauthor=C.+Tyrchanauthor=A.+Westin+Erikssonauthor=P.+Zlatoidskyauthor=L.+%C3%96ster&title=Discovery+of+Highly+Isoform+Selective+Orally+Bioavailable+Phosphoinositide-3-Kinase+%28PI3K%29-%CE%B3+Inhibitors&doi=10.1021%2Facs.jmedchem.8b00447"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit213&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00447%26sid%3Dliteratum%253Aachs%26aulast%3DPemberton%26aufirst%3DN.%26aulast%3DMogemark%26aufirst%3DM.%26aulast%3DArlbrandt%26aufirst%3DS.%26aulast%3DBold%26aufirst%3DP.%26aulast%3DCox%26aufirst%3DR.%2BJ.%26aulast%3DGardelli%26aufirst%3DC.%26aulast%3DHolden%26aufirst%3DN.%2BS.%26aulast%3DKarabelas%26aufirst%3DK.%26aulast%3DKarlsson%26aufirst%3DJ.%26aulast%3DLever%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLindmark%26aufirst%3DH.%26aulast%3DNorberg%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DM.%2BW.%2BD.%26aulast%3DPetersen%26aufirst%3DJ.%26aulast%3DRodrigo%2BBlomqvist%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DM.%2BJ.%26aulast%3DTyrchan%26aufirst%3DC.%26aulast%3DWestin%2BEriksson%26aufirst%3DA.%26aulast%3DZlatoidsky%26aufirst%3DP.%26aulast%3D%25C3%2596ster%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520Highly%2520Isoform%2520Selective%2520Orally%2520Bioavailable%2520Phosphoinositide-3-Kinase%2520%2528PI3K%2529-%25CE%25B3%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5435%26epage%3D5441%26doi%3D10.1021%2Facs.jmedchem.8b00447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref214"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref214'); return false;" data-citation="" class="refNumLink">214</a></strong><div class="NLM_citation" id="cit214"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boyle, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Topolewski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartok, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestein, G. S.</span></span> <span> </span><span class="NLM_article-title">Novel Phosphoinositide 3-Kinase δ,γ Inhibitor: Potent Anti-Inflammatory Effects and Joint Protection in Models of Rheumatoid Arthritis</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>348</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">271</span>– <span class="NLM_lpage">280</span>, <span class="refDoi"> DOI: 10.1124/jpet.113.205955</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1124%2Fjpet.113.205955" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=24244039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtV2nsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2014&pages=271-280&issue=2&author=D.+L.+Boyleauthor=H.-R.+Kimauthor=K.+Topolewskiauthor=B.+Bartokauthor=G.+S.+Firestein&title=Novel+Phosphoinositide+3-Kinase+%CE%B4%2C%CE%B3+Inhibitor%3A+Potent+Anti-Inflammatory+Effects+and+Joint+Protection+in+Models+of+Rheumatoid+Arthritis&doi=10.1124%2Fjpet.113.205955"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit214R"><div class="casContent"><span class="casTitleNuber">214</span><div class="casTitle"><span class="NLM_cas:atitle">Novel phosphoinositide 3-kinase δ,γ inhibitor: potent anti-inflammatory effects and joint protection in models of rheumatoid arthritis</span></div><div class="casAuthors">Boyle, David L.; Kim, Hae-Rim; Topolewski, Katharyn; Bartok, Beatrix; Firestein, Gary S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">271-280, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Phosphoinositide 3-kinases γ and δ (PI3Kγ and PI3Kδ) are expressed in rheumatoid arthritis (RA) synovium and regulate innate and adaptive immune responses.  We detd. the effect of a potent PI3Kδ,γ inhibitor, IPI-145, in two preclin. models of RA.  IPI-145 was administered orally in rat adjuvant-induced arthritis (AA) and i.p. in mouse collagen-induced arthritis (CIA).  Efficacy was assessed by paw swelling, clin. scores, histopathol. and radiog., and microcomputed tomog. scanning.  Gene expression and Akt phosphorylation in joint tissues were detd. by quant. real-time polymerase chain reaction and Western blot anal.  Serum concns. of anti-type II collagen (CII) IgG and IgE were measured by immunoassay.  T-cell responses to CII were assayed using thymidine incorporation and immunoassay.  IPI-145 significantly reduced arthritis severity in both RA models using dosing regimens initiated before onset of clin. disease.  Treatment of established arthritis with IPI-145 in AA, but not CIA, significantly decreased arthritis progression.  In AA, histol. scores, radiog. joint damage, and matrix metalloproteinase (MMP)-13 expression were reduced in IPI-145 treated rats.  In CIA, joint histol. scores and expression of MMP-3 and MMP-13 mRNA were lower in the IPI-145 early treatment group than in the vehicle group.  The ratio of anti-CII IgG2a to total IgG in CIA was modestly reduced.  Interleukin-17 prodn. in response to CII was decreased in the IPI-145-treated group, suggesting an inhibitory effect on T-helper cell 17 differentiation.  These data show that PI3Kδ,γ inhibition suppresses inflammatory arthritis, as well as bone and cartilage damage, through effects on innate and adaptive immunity and that IPI-145 is a potential therapy for RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpITPLaidXBWrVg90H21EOLACvtfcHk0lim4Nldz4fkkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtV2nsLk%253D&md5=46b5375d66642cac66008d80c76a5fee</span></div><a href="/servlet/linkout?suffix=cit214&amp;dbid=16384&amp;doi=10.1124%2Fjpet.113.205955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.113.205955%26sid%3Dliteratum%253Aachs%26aulast%3DBoyle%26aufirst%3DD.%2BL.%26aulast%3DKim%26aufirst%3DH.-R.%26aulast%3DTopolewski%26aufirst%3DK.%26aulast%3DBartok%26aufirst%3DB.%26aulast%3DFirestein%26aufirst%3DG.%2BS.%26atitle%3DNovel%2520Phosphoinositide%25203-Kinase%2520%25CE%25B4%252C%25CE%25B3%2520Inhibitor%253A%2520Potent%2520Anti-Inflammatory%2520Effects%2520and%2520Joint%2520Protection%2520in%2520Models%2520of%2520Rheumatoid%2520Arthritis%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D348%26issue%3D2%26spage%3D271%26epage%3D280%26doi%3D10.1124%2Fjpet.113.205955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref215"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref215'); return false;" data-citation="" class="refNumLink">215</a></strong><div class="NLM_citation" id="cit215"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdul-Muneer, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span> <span> </span><span class="NLM_article-title">PI3Kγ Inhibition Alleviates Symptoms and Increases Axon Number in Experimental Autoimmune Encephalomyelitis Mice</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>253</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.1016/j.neuroscience.2013.08.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.neuroscience.2013.08.051" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=253&publication_year=2013&pages=89-99&author=H.+Liauthor=D.+Parkauthor=P.+M.+Abdul-Muneerauthor=B.+Xuauthor=H.+Wangauthor=B.+Xingauthor=D.+Wuauthor=S.+Li&title=PI3K%CE%B3+Inhibition+Alleviates+Symptoms+and+Increases+Axon+Number+in+Experimental+Autoimmune+Encephalomyelitis+Mice&doi=10.1016%2Fj.neuroscience.2013.08.051"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit215&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2013.08.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2013.08.051%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DPark%26aufirst%3DD.%26aulast%3DAbdul-Muneer%26aufirst%3DP.%2BM.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DXing%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DS.%26atitle%3DPI3K%25CE%25B3%2520Inhibition%2520Alleviates%2520Symptoms%2520and%2520Increases%2520Axon%2520Number%2520in%2520Experimental%2520Autoimmune%2520Encephalomyelitis%2520Mice%26jtitle%3DNeuroscience%26date%3D2013%26volume%3D253%26spage%3D89%26epage%3D99%26doi%3D10.1016%2Fj.neuroscience.2013.08.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref216"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref216'); return false;" data-citation="" class="refNumLink">216</a></strong><div class="NLM_citation" id="cit216"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nayar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fahy, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barone, F.</span></span> <span> </span><span class="NLM_article-title">Phosphatidylinositol-3-Kinase Delta Pathway a Novel Therapeutic Target for Sjogren’s Syndrome</span>. <i>Arthritis Rheumat.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">Suppl. 10</span>),  <span class="NLM_fpage">1053</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=25605296" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2015&pages=1053&issue=Suppl.+10&author=S.+Nayarauthor=J.+Camposauthor=C.+Buckleyauthor=R.+Allenauthor=W.+Fahyauthor=A.+Payneauthor=F.+Barone&title=Phosphatidylinositol-3-Kinase+Delta+Pathway+a+Novel+Therapeutic+Target+for+Sjogren%E2%80%99s+Syndrome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit216&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNayar%26aufirst%3DS.%26aulast%3DCampos%26aufirst%3DJ.%26aulast%3DBuckley%26aufirst%3DC.%26aulast%3DAllen%26aufirst%3DR.%26aulast%3DFahy%26aufirst%3DW.%26aulast%3DPayne%26aufirst%3DA.%26aulast%3DBarone%26aufirst%3DF.%26atitle%3DPhosphatidylinositol-3-Kinase%2520Delta%2520Pathway%2520a%2520Novel%2520Therapeutic%2520Target%2520for%2520Sjogren%25E2%2580%2599s%2520Syndrome%26jtitle%3DArthritis%2520Rheumat.%26date%3D2015%26volume%3D67%26issue%3DSuppl.%252010%26spage%3D1053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref217"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref217'); return false;" data-citation="" class="refNumLink">217</a></strong><div class="NLM_citation" id="cit217"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rommel, C.</span></span> <span> </span><span class="NLM_article-title">Taking PI3Kδ and PI3Kγ One Step Ahead: Dual Active PI3Kδ/γ Inhibitors for the Treatment of Immune-Mediated Inflammatory Diseases</span>. In  <i>Phosphoinositide 3-Kinase in Health and Disease</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rommel, C.</span>, <span class="NLM_string-name">Vanhaesebroeck, B.</span>, <span class="NLM_string-name">Vogt, P. K.</span></span>, Eds.; Current Topics in Microbiology and Immunology, Vol. 346.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Berlin</span>, <span class="NLM_year">2010</span>; pp  <span class="NLM_fpage">279</span>– <span class="NLM_lpage">299</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1007%2F82_2010_79" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=279-299&author=C.+Rommelauthor=C.+Rommel&author=B.+Vanhaesebroeck&author=P.+K.+Vogt&title=Phosphoinositide+3-Kinase+in+Health+and+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit217&amp;dbid=16384&amp;doi=10.1007%2F82_2010_79&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F82_2010_79%26sid%3Dliteratum%253Aachs%26aulast%3DRommel%26aufirst%3DC.%26atitle%3DTaking%2520PI3K%25CE%25B4%2520and%2520PI3K%25CE%25B3%2520One%2520Step%2520Ahead%253A%2520Dual%2520Active%2520PI3K%25CE%25B4%252F%25CE%25B3%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Immune-Mediated%2520Inflammatory%2520Diseases%26btitle%3DPhosphoinositide%25203-Kinase%2520in%2520Health%2520and%2520Disease%26aulast%3DRommel%26aufirst%3DC.%26pub%3DSpringer%26date%3D2010%26spage%3D279%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref218"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref218'); return false;" data-citation="" class="refNumLink">218</a></strong><div class="NLM_citation" id="cit218"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ito, K.</span>; <span class="NLM_string-name">Coates, M.</span>; <span class="NLM_string-name">Murray, J.</span>; <span class="NLM_string-name">Davis, A.</span>; <span class="NLM_string-name">Strong, P.</span>; <span class="NLM_string-name">Rapeport, G.</span></span> <span> </span><span class="NLM_article-title">Effects of RV1729, a Phosphoinositide 3 Kinase γ and δ Inhibitor, on TNFα-Induced CXCL8 Release in Peripheral Blood Neutrophils Obtained from Patients with COPD</span>. In  <i>109th International Conference of the American Thoracic Society (ATS)</i>; <span class="NLM_publisher-name">ATS</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span>, <span class="NLM_year">2013</span>; p  <span class="NLM_fpage">F78</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=F78&author=K.+Ito&author=M.+Coates&author=J.+Murray&author=A.+Davis&author=P.+Strong&author=G.+Rapeport&title=109th+International+Conference+of+the+American+Thoracic+Society+%28ATS%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit218&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DIto%26aufirst%3DK.%26atitle%3DEffects%2520of%2520RV1729%252C%2520a%2520Phosphoinositide%25203%2520Kinase%2520%25CE%25B3%2520and%2520%25CE%25B4%2520Inhibitor%252C%2520on%2520TNF%25CE%25B1-Induced%2520CXCL8%2520Release%2520in%2520Peripheral%2520Blood%2520Neutrophils%2520Obtained%2520from%2520Patients%2520with%2520COPD%26btitle%3D109th%2520International%2520Conference%2520of%2520the%2520American%2520Thoracic%2520Society%2520%2528ATS%2529%26pub%3DATS%26date%3D2013%26spage%3DF78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179'],'ref180':['cit180'],'ref181':['cit181'],'ref182':['cit182'],'ref183':['cit183'],'ref184':['cit184'],'ref185':['cit185'],'ref186':['cit186'],'ref187':['cit187'],'ref188':['cit188'],'ref189':['cit189'],'ref190':['cit190'],'ref191':['cit191'],'ref192':['cit192'],'ref193':['cit193'],'ref194':['cit194'],'ref195':['cit195'],'ref196':['cit196'],'ref197':['cit197'],'ref198':['cit198'],'ref199':['cit199'],'ref200':['cit200'],'ref201':['cit201'],'ref202':['cit202'],'ref203':['cit203'],'ref204':['cit204'],'ref205':['cit205'],'ref206':['cit206'],'ref207':['cit207'],'ref208':['cit208'],'ref209':['cit209'],'ref210':['cit210'],'ref211':['cit211'],'ref212':['cit212'],'ref213':['cit213'],'ref214':['cit214'],'ref215':['cit215'],'ref216':['cit216'],'ref217':['cit217'],'ref218':['cit218']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 35 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Kongjun Liu, Dan Li, Wei Zheng, Mingsong Shi, Yong Chen, Minghai Tang, Tao Yang, Min Zhao, Dexin Deng, Chufeng Zhang, Jiang Liu, Xue Yuan, Zhuang Yang, <span class="NLM_string-name hlFld-ContribAuthor">Lijuan Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery, Optimization, and Evaluation of Quinazolinone Derivatives with Novel Linkers as Orally Efficacious Phosphoinositide-3-Kinase Delta Inhibitors for Treatment of Inflammatory Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (13)
                                     , 8951-8970. <a href="https://doi.org/10.1021/acs.jmedchem.1c00004" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00004%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%25252C%252BOptimization%25252C%252Band%252BEvaluation%252Bof%252BQuinazolinone%252BDerivatives%252Bwith%252BNovel%252BLinkers%252Bas%252BOrally%252BEfficacious%252BPhosphoinositide-3-Kinase%252BDelta%252BInhibitors%252Bfor%252BTreatment%252Bof%252BInflammatory%252BDiseases%26aulast%3DLiu%26aufirst%3DKongjun%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D03012021%26date%3D17062021%26volume%3D64%26issue%3D13%26spage%3D8951%26epage%3D8970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Matthew W. D. Perry, Karin Björhall, Peter Bold, Mikael Brűlls, Ulf Börjesson, Johan Carlsson, Hui-Fang Amy Chang, Yunhua Chen, Anders Eriksson, Britt-Marie Fihn, Rebecca Fransson, Linda Fredlund, Hongbin Ge, Haijuan Huang, Kostas Karabelas, Eva Lamm Bergström, Sarah Lever, Helena Lindmark, Mickael Mogemark, Antonios Nikitidis, Anna-Pia Palmgren, Nils Pemberton, Jens Petersen, Mio Rodrigo Blomqvist, Reed W. Smith, Matthew J. Thomas, Victoria Ullah, Christian Tyrchan, Tiiu Wennberg, Annika Westin Eriksson, Wenzhen Yang, Shuchun Zhao, <span class="NLM_string-name hlFld-ContribAuthor">Linda Öster</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of AZD8154, a Dual PI3Kγδ Inhibitor for the Treatment of Asthma. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (12)
                                     , 8053-8075. <a href="https://doi.org/10.1021/acs.jmedchem.1c00434" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00434</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00434%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BAZD8154%25252C%252Ba%252BDual%252BPI3K%2525CE%2525B3%2525CE%2525B4%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BAsthma%26aulast%3DPerry%26aufirst%3DMatthew%2BW.%2BD.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D10032021%26date%3D03062021%26volume%3D64%26issue%3D12%26spage%3D8053%26epage%3D8075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Joey L. Methot, Hua Zhou, Meredeth A. McGowan, Neville John Anthony, Matthew Christopher, Yudith Garcia, Abdelghani Achab, Kathryn Lipford, Benjamin Wesley Trotter, Michael D. Altman, Xavier Fradera, Charles A. Lesburg, Chaomin Li, Stephen Alves, Craig P. Chappell, Renu Jain, Ruban Mangado, Elaine Pinheiro, Sybill M. G. Williams, Peter Goldenblatt, Armetta Hill, Lynsey Shaffer, Dapeng Chen, Vincent Tong, Robbie L. McLeod, Hyun-Hee Lee, Hongshi Yu, Sanjiv Shah, <span class="NLM_string-name hlFld-ContribAuthor">Jason D. Katz</span>. </span><span class="cited-content_cbyCitation_article-title">Projected Dose Optimization of Amino- and Hydroxypyrrolidine Purine PI3Kδ Immunomodulators. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (8)
                                     , 5137-5156. <a href="https://doi.org/10.1021/acs.jmedchem.1c00237" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00237</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00237%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DProjected%252BDose%252BOptimization%252Bof%252BAmino-%252Band%252BHydroxypyrrolidine%252BPurine%252BPI3K%2525CE%2525B4%252BImmunomodulators%26aulast%3DMethot%26aufirst%3DJoey%2BL.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D06022021%26date%3D02042021%26volume%3D64%26issue%3D8%26spage%3D5137%26epage%3D5156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Manojkumar R. Shukla, Sukanya Patra, Mahip Verma, Gayathri Sadasivam, Nirmal Jana, Sachin J. Mahangare, Prashant Vidhate, Dipak Lagad, Anand Tarage, Murthy Cheemala, Chaitanya Kulkarni, Shankar Bhagwat, Vinod D. Chaudhari, Majid Sayyed, Vipul Pachpute, Ramesh Phadtare, Gopal Gole, Samiron Phukan, Brahmam Sunkara, Charudatt Samant, Manisha Shingare, Aditya Naik, Sneha Trivedi, Ajit Kumar Marisetti, Madhusudhan Reddy, Milind Gholve, Nilesh Mahajan, Sudeep Sabde, Vinod Patil, Dipak Modi, Maneesh Mehta, Prashant Nigade, Kaustubh Tamane, Swati Tota, Hemant Goyal, Harish Volam, Shashikant Pawar, Prajakta Ahirrao, Lal Dinchhana, Sadanand Mallurwar, Atul Akarte, Anand Bokare, Rupesh Kanhere, Neetinkumar Reddy, Sarita Koul, Manoj Dandekar, Minakshi Singh, Peter R. Bernstein, Lakshmi Narasimham, Mandar Bhonde, Jayasagar Gundu, Rajan Goel, Sanjeev Kulkarni, Sharad Sharma, Rajender Kumar Kamboj, <span class="NLM_string-name hlFld-ContribAuthor">Venkata P. Palle</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent and Selective PI3Kδ Inhibitor (S)-2,4-Diamino-6-((1-(7-fluoro-1-(4-fluorophenyl)-4-oxo-3-phenyl-4H-quinolizin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile with Improved Pharmacokinetic Profile and Superior Efficacy in Hematological Cancer Models. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (23)
                                     , 14700-14723. <a href="https://doi.org/10.1021/acs.jmedchem.0c01264" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01264</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01264%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%252Band%252BSelective%252BPI3K%2525CE%2525B4%252BInhibitor%252B%252528S%252529-2%25252C4-Diamino-6-%252528%2525281-%2525287-fluoro-1-%2525284-fluorophenyl%252529-4-oxo-3-phenyl-4H-quinolizin-2-yl%252529ethyl%252529amino%252529pyrimidine-5-carbonitrile%252Bwith%252BImproved%252BPharmacokinetic%252BProfile%252Band%252BSuperior%252BEfficacy%252Bin%252BHematological%252BCancer%252BModels%26aulast%3DShukla%26aufirst%3DManojkumar%2BR.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D20072020%26date%3D02122020%26volume%3D63%26issue%3D23%26spage%3D14700%26epage%3D14723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Joey L. Methot, Abdelghani Achab, Matthew Christopher, Hua Zhou, Meredeth A. McGowan, B. Wesley Trotter, Xavier Fradera, Charles A. Lesburg, Peter Goldenblatt, Armetta Hill, Dapeng Chen, Karin M. Otte, Martin Augustin, Sanjiv Shah, <span class="NLM_string-name hlFld-ContribAuthor">Jason D. Katz</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of Versatile Oxindoles as Selective PI3Kδ Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (12)
                                     , 2461-2469. <a href="https://doi.org/10.1021/acsmedchemlett.0c00441" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00441</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00441%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DOptimization%252Bof%252BVersatile%252BOxindoles%252Bas%252BSelective%252BPI3K%2525CE%2525B4%252BInhibitors%26aulast%3DMethot%26aufirst%3DJoey%2BL.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D12082020%26date%3D17112020%26date%3D19112020%26volume%3D11%26issue%3D12%26spage%3D2461%26epage%3D2469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Feng Li, Xiaofei Liang, Zongru Jiang, Aoli Wang, Junjie Wang, Cheng Chen, Wenliang Wang, Fengming Zou, Ziping Qi, Qingwang Liu, Zhenquan Hu, Jiangyan Cao, Hong Wu, Beilei Wang, Li Wang, Jing Liu, <span class="NLM_string-name hlFld-ContribAuthor">Qingsong Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of (S)-2-(1-(4-Amino-3-(3-fluoro-4-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)propyl)-3-cyclopropyl-5-fluoroquinazolin-4(3H)-one (IHMT-PI3Kδ-372) as a Potent and Selective PI3Kδ Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (22)
                                     , 13973-13993. <a href="https://doi.org/10.1021/acs.jmedchem.0c01544" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01544</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01544%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B%252528S%252529-2-%2525281-%2525284-Amino-3-%2525283-fluoro-4-methoxyphenyl%252529-1H-pyrazolo%25255B3%25252C4-d%25255Dpyrimidin-1-yl%252529propyl%252529-3-cyclopropyl-5-fluoroquinazolin-4%2525283H%252529-one%252B%252528IHMT-PI3K%2525CE%2525B4-372%252529%252Bas%252Ba%252BPotent%252Band%252BSelective%252BPI3K%2525CE%2525B4%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BChronic%252BObstructive%252BPulmonary%252BDisease%26aulast%3DLi%26aufirst%3DFeng%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D03092020%26date%3D12112020%26volume%3D63%26issue%3D22%26spage%3D13973%26epage%3D13993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dillon H. Miles, Xuelei Yan, Rhiannon Thomas-Tran, Jeremy Fournier, Ehesan U. Sharif, Samuel L. Drew, Guillaume Mata, Kenneth V. Lawson, Elaine Ginn, Kent Wong, Divyank Soni, Puja Dhanota, Stefan G. Shaqfeh, Cesar Meleza, Ada Chen, Amber T. Pham, Timothy Park, Debbie Swinarski, Jesus Banuelos, Ulrike Schindler, Matthew J. Walters, Nigel P. Walker, Xiaoning Zhao, Stephen W. Young, Jie Chen, Lixia Jin, Manmohan Reddy Leleti, Jay P. Powers, <span class="NLM_string-name hlFld-ContribAuthor">Jenna L. Jeffrey</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Potent and Selective 7-Azaindole Isoindolinone-Based PI3Kγ Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (11)
                                     , 2244-2252. <a href="https://doi.org/10.1021/acsmedchemlett.0c00387" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00387</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00387&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00387%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BPotent%252Band%252BSelective%252B7-Azaindole%252BIsoindolinone-Based%252BPI3K%2525CE%2525B3%252BInhibitors%26aulast%3DMiles%26aufirst%3DDillon%2BH.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D11072020%26date%3D24092020%26date%3D30092020%26date%3D24092020%26volume%3D11%26issue%3D11%26spage%3D2244%26epage%3D2252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Samuel L. Drew, Rhiannon Thomas-Tran, Joel W. Beatty, Jeremy Fournier, Kenneth V. Lawson, Dillon H. Miles, Guillaume Mata, Ehesan U. Sharif, Xuelei Yan, Artur K. Mailyan, Elaine Ginn, Jie Chen, Kent Wong, Divyank Soni, Puja Dhanota, Pei-Yu Chen, Stefan G. Shaqfeh, Cesar Meleza, Amber T. Pham, Ada Chen, Xiaoning Zhao, Jesus Banuelos, Lixia Jin, Ulrike Schindler, Matthew J. Walters, Stephen W. Young, Nigel P. Walker, Manmohan Reddy Leleti, Jay P. Powers, <span class="NLM_string-name hlFld-ContribAuthor">Jenna L. Jeffrey</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Potent and Selective PI3Kγ Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (19)
                                     , 11235-11257. <a href="https://doi.org/10.1021/acs.jmedchem.0c01203" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01203</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01203%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPotent%252Band%252BSelective%252BPI3K%2525CE%2525B3%252BInhibitors%26aulast%3DDrew%26aufirst%3DSamuel%2BL.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D11072020%26date%3D16092020%26date%3D31082020%26volume%3D63%26issue%3D19%26spage%3D11235%26epage%3D11257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Aimie E. Garces, Mohammed Al-Hayali, Jong Bong Lee, Jiaxin Li, Pavel Gershkovich, Tracey D. Bradshaw, <span class="NLM_string-name hlFld-ContribAuthor">Michael J. Stocks</span>. </span><span class="cited-content_cbyCitation_article-title">Codrug Approach for the Potential Treatment of EML4-ALK Positive Lung Cancer. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (3)
                                     , 316-321. <a href="https://doi.org/10.1021/acsmedchemlett.9b00378" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00378</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00378%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DCodrug%252BApproach%252Bfor%252Bthe%252BPotential%252BTreatment%252Bof%252BEML4-ALK%252BPositive%252BLung%252BCancer%26aulast%3DGarces%26aufirst%3DAimie%2BE.%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D13082019%26date%3D27092019%26date%3D01102019%26date%3D27092019%26volume%3D11%26issue%3D3%26spage%3D316%26epage%3D321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Songwen Lin, Jing Jin, Ying Liu, Hua Tian, Yan Zhang, Rong Fu, Jingbo Zhang, Mingjin Wang, Tingting Du, Ming Ji, Deyu Wu, Kehui Zhang, Li Sheng, Yan Li, Xiaoguang Chen, <span class="NLM_string-name hlFld-ContribAuthor">Heng Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 4-Methylquinazoline Based PI3K Inhibitors for the Potential Treatment of Idiopathic Pulmonary Fibrosis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (19)
                                     , 8873-8879. <a href="https://doi.org/10.1021/acs.jmedchem.9b00969" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00969</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00969&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00969%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B4-Methylquinazoline%252BBased%252BPI3K%252BInhibitors%252Bfor%252Bthe%252BPotential%252BTreatment%252Bof%252BIdiopathic%252BPulmonary%252BFibrosis%26aulast%3DLin%26aufirst%3DSongwen%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D18062019%26date%3D06082019%26date%3D23072019%26volume%3D62%26issue%3D19%26spage%3D8873%26epage%3D8879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kehui Zhang, Fangfang Lai, Songwen Lin, Ming Ji, Jingbo Zhang, Yan Zhang, Jing Jin, Rong Fu, Deyu Wu, Hua Tian, Nina Xue, Li Sheng, Xiaowen Zou, Yan Li, Xiaoguang Chen, <span class="NLM_string-name hlFld-ContribAuthor">Heng Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of 4-Methyl Quinazoline Derivatives as Anticancer Agents Simultaneously Targeting Phosphoinositide 3-Kinases and Histone Deacetylases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (15)
                                     , 6992-7014. <a href="https://doi.org/10.1021/acs.jmedchem.9b00390" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00390</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00390%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252B4-Methyl%252BQuinazoline%252BDerivatives%252Bas%252BAnticancer%252BAgents%252BSimultaneously%252BTargeting%252BPhosphoinositide%252B3-Kinases%252Band%252BHistone%252BDeacetylases%26aulast%3DZhang%26aufirst%3DKehui%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D03032019%26date%3D29052019%26date%3D22052019%26volume%3D62%26issue%3D15%26spage%3D6992%26epage%3D7014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chengbin  Yang</span>, <span class="hlFld-ContribAuthor ">Chenyue  Xu</span>, <span class="hlFld-ContribAuthor ">Zhipeng  Li</span>, <span class="hlFld-ContribAuthor ">Yi  Chen</span>, <span class="hlFld-ContribAuthor ">Tianze  Wu</span>, <span class="hlFld-ContribAuthor ">Hui  Hong</span>, <span class="hlFld-ContribAuthor ">Mingzhu  Lu</span>, <span class="hlFld-ContribAuthor ">Yu  Jia</span>, <span class="hlFld-ContribAuthor ">Yongtai  Yang</span>, <span class="hlFld-ContribAuthor ">Xiaofeng  Liu</span>, <span class="hlFld-ContribAuthor ">Mingli  Deng</span>, <span class="hlFld-ContribAuthor ">Zhenxia  Chen</span>, <span class="hlFld-ContribAuthor ">Qingquan  Li</span>, <span class="hlFld-ContribAuthor ">Yun  Ling</span>, <span class="hlFld-ContribAuthor ">Yaming  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Bioisosteric replacements of the indole moiety for the development of a potent and selective PI3Kδ inhibitor: Design, synthesis and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>223 </em>, 113661. <a href="https://doi.org/10.1016/j.ejmech.2021.113661" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113661</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113661%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBioisosteric%252Breplacements%252Bof%252Bthe%252Bindole%252Bmoiety%252Bfor%252Bthe%252Bdevelopment%252Bof%252Ba%252Bpotent%252Band%252Bselective%252BPI3K%2525CE%2525B4%252Binhibitor%25253A%252BDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%26aulast%3DYang%26aufirst%3DChengbin%26date%3D2021%26volume%3D223%26spage%3D113661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jincheng  Wang</span>, <span class="hlFld-ContribAuthor ">Kaili  Hu</span>, <span class="hlFld-ContribAuthor ">Xuanyan  Cai</span>, <span class="hlFld-ContribAuthor ">Bo  Yang</span>, <span class="hlFld-ContribAuthor ">Qiaojun  He</span>, <span class="hlFld-ContribAuthor ">Jiajia  Wang</span>, <span class="hlFld-ContribAuthor ">Qinjie  Weng</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>3 </em><a href="https://doi.org/10.1016/j.apsb.2021.07.023" title="DOI URL">https://doi.org/10.1016/j.apsb.2021.07.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2021.07.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2021.07.023%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DTargeting%252BPI3K%25252FAKT%252Bsignaling%252Bfor%252Btreatment%252Bof%252Bidiopathic%252Bpulmonary%252Bfibrosis%26aulast%3DWang%26aufirst%3DJincheng%26date%3D2021%26volume%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bart  Vanhaesebroeck</span>, <span class="hlFld-ContribAuthor ">Matthew W. D.  Perry</span>, <span class="hlFld-ContribAuthor ">Jennifer R.  Brown</span>, <span class="hlFld-ContribAuthor ">Fabrice  André</span>, <span class="hlFld-ContribAuthor ">Klaus  Okkenhaug</span>. </span><span class="cited-content_cbyCitation_article-title">PI3K inhibitors are finally coming of age. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2021,</strong> <em>170 </em><a href="https://doi.org/10.1038/s41573-021-00209-1" title="DOI URL">https://doi.org/10.1038/s41573-021-00209-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41573-021-00209-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41573-021-00209-1%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DPI3K%252Binhibitors%252Bare%252Bfinally%252Bcoming%252Bof%252Bage%26aulast%3DVanhaesebroeck%26aufirst%3DBart%26date%3D2021%26date%3D2021%26volume%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xavier  Fradera</span>, <span class="hlFld-ContribAuthor ">Qiaolin  Deng</span>, <span class="hlFld-ContribAuthor ">Abdelganhi  Achab</span>, <span class="hlFld-ContribAuthor ">Yudith  Garcia</span>, <span class="hlFld-ContribAuthor ">Solomon D.  Kattar</span>, <span class="hlFld-ContribAuthor ">Meredeth A.  McGowan</span>, <span class="hlFld-ContribAuthor ">Joey L.  Methot</span>, <span class="hlFld-ContribAuthor ">Kevin  Wilson</span>, <span class="hlFld-ContribAuthor ">Hua  Zhou</span>, <span class="hlFld-ContribAuthor ">Lynsey  Shaffer</span>, <span class="hlFld-ContribAuthor ">Peter  Goldenblatt</span>, <span class="hlFld-ContribAuthor ">Vincent  Tong</span>, <span class="hlFld-ContribAuthor ">Martin A  Augustin</span>, <span class="hlFld-ContribAuthor ">Michael D.  Altman</span>, <span class="hlFld-ContribAuthor ">Charles A.  Lesburg</span>, <span class="hlFld-ContribAuthor ">Sanjiv  Shah</span>, <span class="hlFld-ContribAuthor ">Jason D.  Katz</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a new series of PI3K-δ inhibitors from Virtual Screening. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>42 </em>, 128046. <a href="https://doi.org/10.1016/j.bmcl.2021.128046" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128046%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252Bnew%252Bseries%252Bof%252BPI3K-%2525CE%2525B4%252Binhibitors%252Bfrom%252BVirtual%252BScreening%26aulast%3DFradera%26aufirst%3DXavier%26date%3D2021%26volume%3D42%26spage%3D128046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingyu  Zhu</span>, <span class="hlFld-ContribAuthor ">Haoer  Zhang</span>, <span class="hlFld-ContribAuthor ">Li  Yu</span>, <span class="hlFld-ContribAuthor ">Heyang  Sun</span>, <span class="hlFld-ContribAuthor ">Yun  Chen</span>, <span class="hlFld-ContribAuthor ">Yanfei  Cai</span>, <span class="hlFld-ContribAuthor ">Huazhong  Li</span>, <span class="hlFld-ContribAuthor ">Jian  Jin</span>. </span><span class="cited-content_cbyCitation_article-title">Computational investigation of the selectivity mechanisms of PI3Kδ inhibition with marketed idelalisib: combined molecular dynamics simulation and free energy calculation. </span><span class="cited-content_cbyCitation_journal-name">Structural Chemistry</span><span> <strong>2021,</strong> <em>32 </em>
                                    (2)
                                     , 699-707. <a href="https://doi.org/10.1007/s11224-020-01643-4" title="DOI URL">https://doi.org/10.1007/s11224-020-01643-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11224-020-01643-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11224-020-01643-4%26sid%3Dliteratum%253Aachs%26jtitle%3DStructural%2520Chemistry%26atitle%3DComputational%252Binvestigation%252Bof%252Bthe%252Bselectivity%252Bmechanisms%252Bof%252BPI3K%2525CE%2525B4%252Binhibition%252Bwith%252Bmarketed%252Bidelalisib%25253A%252Bcombined%252Bmolecular%252Bdynamics%252Bsimulation%252Band%252Bfree%252Benergy%252Bcalculation%26aulast%3DZhu%26aufirst%3DJingyu%26date%3D2021%26date%3D2020%26volume%3D32%26issue%3D2%26spage%3D699%26epage%3D707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiamin  Zheng</span>, <span class="hlFld-ContribAuthor ">Jun  Wu</span>, <span class="hlFld-ContribAuthor ">Xiao  Ding</span>, <span class="hlFld-ContribAuthor ">Hong C.  Shen</span>, <span class="hlFld-ContribAuthor ">Ge  Zou</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecule approaches to treat autoimmune and inflammatory diseases (Part I): Kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>38 </em>, 127862. <a href="https://doi.org/10.1016/j.bmcl.2021.127862" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.127862</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.127862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.127862%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSmall%252Bmolecule%252Bapproaches%252Bto%252Btreat%252Bautoimmune%252Band%252Binflammatory%252Bdiseases%252B%252528Part%252BI%252529%25253A%252BKinase%252Binhibitors%26aulast%3DZheng%26aufirst%3DJiamin%26date%3D2021%26volume%3D38%26spage%3D127862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoyu  Li</span>, <span class="hlFld-ContribAuthor ">Jennifer E.  Golden</span>. </span><span class="cited-content_cbyCitation_article-title">Construction of
              N
              ‐Boc‐2‐Alkylaminoquinazolin‐4(3
              H
              )‐Ones via a Three‐Component, One‐Pot Protocol Mediated by Copper(II) Chloride that Spares Enantiomeric Purity. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2021,</strong> <em>363 </em>
                                    (6)
                                     , 1638-1645. <a href="https://doi.org/10.1002/adsc.202001279" title="DOI URL">https://doi.org/10.1002/adsc.202001279</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.202001279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.202001279%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DConstruction%252Bof%252BN%252B%2525E2%252580%252590Boc%2525E2%252580%2525902%2525E2%252580%252590Alkylaminoquinazolin%2525E2%252580%2525904%2525283%252BH%252B%252529%2525E2%252580%252590Ones%252Bvia%252Ba%252BThree%2525E2%252580%252590Component%25252C%252BOne%2525E2%252580%252590Pot%252BProtocol%252BMediated%252Bby%252BCopper%252528II%252529%252BChloride%252Bthat%252BSpares%252BEnantiomeric%252BPurity%26aulast%3DLi%26aufirst%3DXiaoyu%26date%3D2021%26date%3D2021%26volume%3D363%26issue%3D6%26spage%3D1638%26epage%3D1645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria  Juarez</span>, <span class="hlFld-ContribAuthor ">Nieves  Diaz</span>, <span class="hlFld-ContribAuthor ">Geoffrey I  Johnston</span>, <span class="hlFld-ContribAuthor ">Saba  Nayar</span>, <span class="hlFld-ContribAuthor ">Andrew  Payne</span>, <span class="hlFld-ContribAuthor ">Eric  Helmer</span>, <span class="hlFld-ContribAuthor ">Dionne  Cain</span>, <span class="hlFld-ContribAuthor ">Paulette  Williams</span>, <span class="hlFld-ContribAuthor ">Valerie  Devauchelle-Pensec</span>, <span class="hlFld-ContribAuthor ">Benjamin A  Fisher</span>, <span class="hlFld-ContribAuthor ">Roberto  Giacomelli</span>, <span class="hlFld-ContribAuthor ">Jacques-Eric  Gottenberg</span>, <span class="hlFld-ContribAuthor ">Giuliana  Guggino</span>, <span class="hlFld-ContribAuthor ">Marika  Kvarnström</span>, <span class="hlFld-ContribAuthor ">Xavier  Mariette</span>, <span class="hlFld-ContribAuthor ">Wan Fai  Ng</span>, <span class="hlFld-ContribAuthor ">José  Rosas</span>, <span class="hlFld-ContribAuthor ">Juan  Sánchez Bursón</span>, <span class="hlFld-ContribAuthor ">Giovanni  Triolo</span>, <span class="hlFld-ContribAuthor ">Francesca  Barone</span>, <span class="hlFld-ContribAuthor ">Simon J  Bowman</span>. </span><span class="cited-content_cbyCitation_article-title">A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren’s syndrome. </span><span class="cited-content_cbyCitation_journal-name">Rheumatology</span><span> <strong>2021,</strong> <em>60 </em>
                                    (3)
                                     , 1364-1375. <a href="https://doi.org/10.1093/rheumatology/keaa410" title="DOI URL">https://doi.org/10.1093/rheumatology/keaa410</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/rheumatology/keaa410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Frheumatology%2Fkeaa410%26sid%3Dliteratum%253Aachs%26jtitle%3DRheumatology%26atitle%3DA%252Bphase%252B2%252Brandomized%25252C%252Bdouble-blind%25252C%252Bplacebo-controlled%25252C%252Bproof-of-concept%252Bstudy%252Bof%252Boral%252Bseletalisib%252Bin%252Bprimary%252BSj%2525C3%2525B6gren%2525E2%252580%252599s%252Bsyndrome%26aulast%3DJuarez%26aufirst%3DMaria%26date%3D2021%26date%3D2020%26volume%3D60%26issue%3D3%26spage%3D1364%26epage%3D1375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dongyan  Gu</span>, <span class="hlFld-ContribAuthor ">Gang  Cheng</span>, <span class="hlFld-ContribAuthor ">Mengmeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Yu-Bo  Zhou</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">Rong  Sheng</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 2-(5-(quinolin-6-yl)-1,3,4-oxadiazol-2-yl)acetamide derivatives as novel PI3Kα inhibitors via docking-based virtual screening. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>29 </em>, 115863. <a href="https://doi.org/10.1016/j.bmc.2020.115863" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115863</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115863&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115863%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B2-%2525285-%252528quinolin-6-yl%252529-1%25252C3%25252C4-oxadiazol-2-yl%252529acetamide%252Bderivatives%252Bas%252Bnovel%252BPI3K%2525CE%2525B1%252Binhibitors%252Bvia%252Bdocking-based%252Bvirtual%252Bscreening%26aulast%3DGu%26aufirst%3DDongyan%26date%3D2021%26volume%3D29%26spage%3D115863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Sun</span>, <span class="hlFld-ContribAuthor ">Rong  Fu</span>, <span class="hlFld-ContribAuthor ">Songwen  Lin</span>, <span class="hlFld-ContribAuthor ">Jingbo  Zhang</span>, <span class="hlFld-ContribAuthor ">Ming  Ji</span>, <span class="hlFld-ContribAuthor ">Yan  Zhang</span>, <span class="hlFld-ContribAuthor ">Deyu  Wu</span>, <span class="hlFld-ContribAuthor ">Kehui  Zhang</span>, <span class="hlFld-ContribAuthor ">Hua  Tian</span>, <span class="hlFld-ContribAuthor ">Mingyi  Zhang</span>, <span class="hlFld-ContribAuthor ">Li  Sheng</span>, <span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Jing  Jin</span>, <span class="hlFld-ContribAuthor ">Xiaoguang  Chen</span>, <span class="hlFld-ContribAuthor ">Heng  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of new thieno[2,3-d]pyrimidine and thiazolo[5,4-d]pyrimidine derivatives as orally active phosphoinositide 3-kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>29 </em>, 115890. <a href="https://doi.org/10.1016/j.bmc.2020.115890" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115890</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115890%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnew%252Bthieno%25255B2%25252C3-d%25255Dpyrimidine%252Band%252Bthiazolo%25255B5%25252C4-d%25255Dpyrimidine%252Bderivatives%252Bas%252Borally%252Bactive%252Bphosphoinositide%252B3-kinase%252Binhibitors%26aulast%3DSun%26aufirst%3DYan%26date%3D2021%26volume%3D29%26spage%3D115890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiajia  Sun</span>, <span class="hlFld-ContribAuthor ">Yifan  Feng</span>, <span class="hlFld-ContribAuthor ">Yuan  Huang</span>, <span class="hlFld-ContribAuthor ">San-Qi  Zhang</span>, <span class="hlFld-ContribAuthor ">Minhang  Xin</span>. </span><span class="cited-content_cbyCitation_article-title">Research advances on selective phosphatidylinositol 3 kinase δ (PI3Kδ) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (19)
                                     , 127457. <a href="https://doi.org/10.1016/j.bmcl.2020.127457" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127457</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127457%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DResearch%252Badvances%252Bon%252Bselective%252Bphosphatidylinositol%252B3%252Bkinase%252B%2525CE%2525B4%252B%252528PI3K%2525CE%2525B4%252529%252Binhibitors%26aulast%3DSun%26aufirst%3DJiajia%26date%3D2020%26volume%3D30%26issue%3D19%26spage%3D127457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rammohan R.Y.  Bheemanaboina</span>. </span><span class="cited-content_cbyCitation_article-title">Isoform-Selective PI3K Inhibitors for Various Diseases. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2020,</strong> <em>20 </em>
                                    (12)
                                     , 1074-1092. <a href="https://doi.org/10.2174/1568026620666200106141717" title="DOI URL">https://doi.org/10.2174/1568026620666200106141717</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026620666200106141717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026620666200106141717%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DIsoform-Selective%252BPI3K%252BInhibitors%252Bfor%252BVarious%252BDiseases%26aulast%3DBheemanaboina%26aufirst%3DRammohan%2BR.Y.%26date%3D2020%26volume%3D20%26issue%3D12%26spage%3D1074%26epage%3D1092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiangqiang  Tao</span>, <span class="hlFld-ContribAuthor ">Yuqing  Chen</span>, <span class="hlFld-ContribAuthor ">Xiao  Liang</span>, <span class="hlFld-ContribAuthor ">Yongzhou  Hu</span>, <span class="hlFld-ContribAuthor ">Jiaming  Li</span>, <span class="hlFld-ContribAuthor ">Fang  Fang</span>, <span class="hlFld-ContribAuthor ">Huchuan  Wang</span>, <span class="hlFld-ContribAuthor ">Chang  Meng</span>, <span class="hlFld-ContribAuthor ">Jingtai  Liang</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Ma</span>, <span class="hlFld-ContribAuthor ">Shuangying  Gui</span>. </span><span class="cited-content_cbyCitation_article-title">Structurally novel PI3Kδ/γ dual inhibitors characterized by a seven-membered spirocyclic spacer: The SARs investigation and PK evaluation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>191 </em>, 112143. <a href="https://doi.org/10.1016/j.ejmech.2020.112143" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112143</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112143%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructurally%252Bnovel%252BPI3K%2525CE%2525B4%25252F%2525CE%2525B3%252Bdual%252Binhibitors%252Bcharacterized%252Bby%252Ba%252Bseven-membered%252Bspirocyclic%252Bspacer%25253A%252BThe%252BSARs%252Binvestigation%252Band%252BPK%252Bevaluation%26aulast%3DTao%26aufirst%3DQiangqiang%26date%3D2020%26volume%3D191%26spage%3D112143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Cai</span>, <span class="hlFld-ContribAuthor ">Jun  Yu</span>, <span class="hlFld-ContribAuthor ">Ping  Ren</span>, <span class="hlFld-ContribAuthor ">Jianlin  He</span>, <span class="hlFld-ContribAuthor ">Zhipeng  Wu</span>, <span class="hlFld-ContribAuthor ">Kun  Xiao</span>, <span class="hlFld-ContribAuthor ">Hong  Jia</span>, <span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Yang  Sai</span>, <span class="hlFld-ContribAuthor ">Guangxiu  Dai</span>, <span class="hlFld-ContribAuthor ">Xiong  Li</span>, <span class="hlFld-ContribAuthor ">Weiguo  Su</span>, <span class="hlFld-ContribAuthor ">Karen  Ngo</span>, <span class="hlFld-ContribAuthor ">Glenda  Castro</span>, <span class="hlFld-ContribAuthor ">Paul D.  Acton</span>, <span class="hlFld-ContribAuthor ">Wai‐Ping  Fung‐Leung</span>, <span class="hlFld-ContribAuthor ">James P.  Edwards</span>, <span class="hlFld-ContribAuthor ">Jennifer  Venable</span>, <span class="hlFld-ContribAuthor ">Tadimeti S.  Rao</span>. </span><span class="cited-content_cbyCitation_article-title">Immunological characterization of HM5023507, an orally active PI3Kδ/γ inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology Research & Perspectives</span><span> <strong>2020,</strong> <em>8 </em>
                                    (1)
                                     <a href="https://doi.org/10.1002/prp2.559" title="DOI URL">https://doi.org/10.1002/prp2.559</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/prp2.559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fprp2.559%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520Research%2520%2526%2520Perspectives%26atitle%3DImmunological%252Bcharacterization%252Bof%252BHM5023507%25252C%252Ban%252Borally%252Bactive%252BPI3K%2525CE%2525B4%25252F%2525CE%2525B3%252Binhibitor%26aulast%3DCai%26aufirst%3DYu%26date%3D2020%26date%3D2020%26volume%3D8%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yifan  Feng</span>, <span class="hlFld-ContribAuthor ">Xiaochuan  Cu</span>, <span class="hlFld-ContribAuthor ">Minhang  Xin</span>. </span><span class="cited-content_cbyCitation_article-title">PI3Kδ inhibitors for the treatment of cancer: a patent review (2015-present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2019,</strong> <em>29 </em>
                                    (12)
                                     , 925-941. <a href="https://doi.org/10.1080/13543776.2019.1687685" title="DOI URL">https://doi.org/10.1080/13543776.2019.1687685</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2019.1687685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2019.1687685%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DPI3K%2525CE%2525B4%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Bcancer%25253A%252Ba%252Bpatent%252Breview%252B%2525282015-present%252529%26aulast%3DFeng%26aufirst%3DYifan%26date%3D2019%26date%3D2019%26volume%3D29%26issue%3D12%26spage%3D925%26epage%3D941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fatma M.  Elmenier</span>, <span class="hlFld-ContribAuthor ">Deena S.  Lasheen</span>, <span class="hlFld-ContribAuthor ">Khaled A.M.  Abouzid</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphatidylinositol 3 kinase (PI3K) inhibitors as new weapon to combat cancer. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>183 </em>, 111718. <a href="https://doi.org/10.1016/j.ejmech.2019.111718" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111718</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111718%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPhosphatidylinositol%252B3%252Bkinase%252B%252528PI3K%252529%252Binhibitors%252Bas%252Bnew%252Bweapon%252Bto%252Bcombat%252Bcancer%26aulast%3DElmenier%26aufirst%3DFatma%2BM.%26date%3D2019%26volume%3D183%26spage%3D111718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gong</span>, <span class="hlFld-ContribAuthor ">Tang</span>, <span class="hlFld-ContribAuthor ">Liu</span>, <span class="hlFld-ContribAuthor ">Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Evaluation of Novel 2H-Benzo[e]-[1,2,4]thiadiazine 1,1-Dioxide Derivatives as PI3Kδ Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (23)
                                     , 4299. <a href="https://doi.org/10.3390/molecules24234299" title="DOI URL">https://doi.org/10.3390/molecules24234299</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24234299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24234299%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Band%252BEvaluation%252Bof%252BNovel%252B2H-Benzo%25255Be%25255D-%25255B1%25252C2%25252C4%25255Dthiadiazine%252B1%25252C1-Dioxide%252BDerivatives%252Bas%252BPI3K%2525CE%2525B4%252BInhibitors%26aulast%3DGong%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D23%26spage%3D4299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yifan  Feng</span>, <span class="hlFld-ContribAuthor ">Weiming  Duan</span>, <span class="hlFld-ContribAuthor ">Shu  Fan</span>, <span class="hlFld-ContribAuthor ">Hao  Zhang</span>, <span class="hlFld-ContribAuthor ">San-Qi  Zhang</span>, <span class="hlFld-ContribAuthor ">Minhang  Xin</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of 4-(piperid-3-yl)amino substituted 6-pyridylquinazolines as potent PI3Kδ inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (19)
                                     , 115035. <a href="https://doi.org/10.1016/j.bmc.2019.07.051" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.07.051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.07.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.07.051%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B4-%252528piperid-3-yl%252529amino%252Bsubstituted%252B6-pyridylquinazolines%252Bas%252Bpotent%252BPI3K%2525CE%2525B4%252Binhibitors%26aulast%3DFeng%26aufirst%3DYifan%26date%3D2019%26volume%3D27%26issue%3D19%26spage%3D115035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xavier  Fradera</span>, <span class="hlFld-ContribAuthor ">Joey L.  Methot</span>, <span class="hlFld-ContribAuthor ">Abdelghani  Achab</span>, <span class="hlFld-ContribAuthor ">Matthew  Christopher</span>, <span class="hlFld-ContribAuthor ">Michael D.  Altman</span>, <span class="hlFld-ContribAuthor ">Hua  Zhou</span>, <span class="hlFld-ContribAuthor ">Meredeth A.  McGowan</span>, <span class="hlFld-ContribAuthor ">Sam D.  Kattar</span>, <span class="hlFld-ContribAuthor ">Kevin  Wilson</span>, <span class="hlFld-ContribAuthor ">Yudith  Garcia</span>, <span class="hlFld-ContribAuthor ">Martin A.  Augustin</span>, <span class="hlFld-ContribAuthor ">Charles A.  Lesburg</span>, <span class="hlFld-ContribAuthor ">Sanjiv  Shah</span>, <span class="hlFld-ContribAuthor ">Peter  Goldenblatt</span>, <span class="hlFld-ContribAuthor ">Jason D.  Katz</span>. </span><span class="cited-content_cbyCitation_article-title">Design of selective PI3Kδ inhibitors using an iterative scaffold-hopping workflow. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (18)
                                     , 2575-2580. <a href="https://doi.org/10.1016/j.bmcl.2019.08.004" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.08.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.08.004%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Bof%252Bselective%252BPI3K%2525CE%2525B4%252Binhibitors%252Busing%252Ban%252Biterative%252Bscaffold-hopping%252Bworkflow%26aulast%3DFradera%26aufirst%3DXavier%26date%3D2019%26volume%3D29%26issue%3D18%26spage%3D2575%26epage%3D2580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bernd  Nürnberg</span>, <span class="hlFld-ContribAuthor ">Sandra  Beer-Hammer</span>. </span><span class="cited-content_cbyCitation_article-title">Function, Regulation and Biological Roles of PI3Kγ Variants. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2019,</strong> <em>9 </em>
                                    (9)
                                     , 427. <a href="https://doi.org/10.3390/biom9090427" title="DOI URL">https://doi.org/10.3390/biom9090427</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom9090427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom9090427%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DFunction%25252C%252BRegulation%252Band%252BBiological%252BRoles%252Bof%252BPI3K%2525CE%2525B3%252BVariants%26aulast%3DN%25C3%25BCrnberg%26aufirst%3DBernd%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D9%26spage%3D427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel A.  Rodrigues</span>, <span class="hlFld-ContribAuthor ">Fernanda S.  Sagrillo</span>, <span class="hlFld-ContribAuthor ">Carlos A. M.  Fraga</span>. </span><span class="cited-content_cbyCitation_article-title">Duvelisib: A 2018 Novel FDA-Approved Small Molecule Inhibiting Phosphoinositide 3-Kinases. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2019,</strong> <em>12 </em>
                                    (2)
                                     , 69. <a href="https://doi.org/10.3390/ph12020069" title="DOI URL">https://doi.org/10.3390/ph12020069</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph12020069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph12020069%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DDuvelisib%25253A%252BA%252B2018%252BNovel%252BFDA-Approved%252BSmall%252BMolecule%252BInhibiting%252BPhosphoinositide%252B3-Kinases%26aulast%3DRodrigues%26aufirst%3DDaniel%2BA.%26date%3D2019%26date%3D2019%26volume%3D12%26issue%3D2%26spage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaodong  Ma</span>, <span class="hlFld-ContribAuthor ">Jun  Wei</span>, <span class="hlFld-ContribAuthor ">Chang  Wang</span>, <span class="hlFld-ContribAuthor ">Dongyan  Gu</span>, <span class="hlFld-ContribAuthor ">Yongzhou  Hu</span>, <span class="hlFld-ContribAuthor ">Rong  Sheng</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel benzothiadiazine derivatives as potent PI3Kδ-selective inhibitors for treating B-cell-mediated malignancies. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>170 </em>, 112-125. <a href="https://doi.org/10.1016/j.ejmech.2019.03.005" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.03.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.03.005%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bbenzothiadiazine%252Bderivatives%252Bas%252Bpotent%252BPI3K%2525CE%2525B4-selective%252Binhibitors%252Bfor%252Btreating%252BB-cell-mediated%252Bmalignancies%26aulast%3DMa%26aufirst%3DXiaodong%26date%3D2019%26volume%3D170%26spage%3D112%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robbie L.  McLeod</span>, <span class="hlFld-ContribAuthor ">Malgorzata A.  Gil</span>, <span class="hlFld-ContribAuthor ">Dapeng  Chen</span>, <span class="hlFld-ContribAuthor ">Antonio  Cabal</span>, <span class="hlFld-ContribAuthor ">Jason  Katz</span>, <span class="hlFld-ContribAuthor ">Joey  Methot</span>, <span class="hlFld-ContribAuthor ">Janice D.  Woodhouse</span>, <span class="hlFld-ContribAuthor ">Lauren  Dorosh</span>, <span class="hlFld-ContribAuthor ">Prasanthi  Geda</span>, <span class="hlFld-ContribAuthor ">Khamir  Mehta</span>, <span class="hlFld-ContribAuthor ">Milenko  Cicmil</span>, <span class="hlFld-ContribAuthor ">Gretchen A.  Baltus</span>, <span class="hlFld-ContribAuthor ">Alan  Bass</span>, <span class="hlFld-ContribAuthor ">Hani  Houshyar</span>, <span class="hlFld-ContribAuthor ">Michael  Caniga</span>, <span class="hlFld-ContribAuthor ">Hongshi  Yu</span>, <span class="hlFld-ContribAuthor ">Francois  Gervais</span>, <span class="hlFld-ContribAuthor ">Stephen  Alves</span>, <span class="hlFld-ContribAuthor ">Sanjiv  Shah</span>. </span><span class="cited-content_cbyCitation_article-title">Characterizing Pharmacokinetic–Pharmacodynamic Relationships and Efficacy of PI3K
              δ
              Inhibitors in Respiratory Models of TH2 and TH1 Inflammation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2019,</strong> <em>369 </em>
                                    (2)
                                     , 223-233. <a href="https://doi.org/10.1124/jpet.118.252551" title="DOI URL">https://doi.org/10.1124/jpet.118.252551</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.118.252551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.118.252551%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DCharacterizing%252BPharmacokinetic%2525E2%252580%252593Pharmacodynamic%252BRelationships%252Band%252BEfficacy%252Bof%252BPI3K%252B%2525CE%2525B4%252BInhibitors%252Bin%252BRespiratory%252BModels%252Bof%252BTH2%252Band%252BTH1%252BInflammation%26aulast%3DMcLeod%26aufirst%3DRobbie%2BL.%26date%3D2019%26date%3D2019%26volume%3D369%26issue%3D2%26spage%3D223%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michelle  Miller</span>, <span class="hlFld-ContribAuthor ">Philip  Thompson</span>, <span class="hlFld-ContribAuthor ">Sandra  Gabelli</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Determinants of Isoform Selectivity in PI3K Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2019,</strong> <em>9 </em>
                                    (3)
                                     , 82. <a href="https://doi.org/10.3390/biom9030082" title="DOI URL">https://doi.org/10.3390/biom9030082</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom9030082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom9030082%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DStructural%252BDeterminants%252Bof%252BIsoform%252BSelectivity%252Bin%252BPI3K%252BInhibitors%26aulast%3DMiller%26aufirst%3DMichelle%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D3%26spage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0001.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01298&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Patents for PI3Kγ, δ, and γδ grouped by publication year and colored by isoform selectivity. In some instances the isoform selectivity is not defined or may cover two groups, for example, δ and γδ; in these cases a decision has been made based on the best estimate of the selectivity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01298&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0016.jpeg" id="rightTab-GRAPHIC-d7e273-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Launched PI3Kδ inhibitor idelalisib (<b>1</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01298&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. PI3Kδ inhibitors in development for oncology indications.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01298&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. PI3Kδ inhibitors in clinical trials for respiratory, immunodeficiency, inflammatory, and autoimmune conditions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01298&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. PI3Kγ inhibitor <b>14</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01298&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. PI3Kγδ inhibitors in clinical trials.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01298&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (a) Comparison of the bound structure of <b>40</b> from <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2X38">2X38</a> (green) with preferred conformations of <b>41</b> (light blue) and <b>42</b> (gray) overlaid. (b) Structures of <b>40</b>, <b>41</b>, and <b>42</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01298&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Compound <b>43</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01298&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Cyclized linker compound <b>58</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01298&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Early PI3K inhibitor with morpholine hinge binder.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01298&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. (a) The selectivity pocket <b>140</b> (yellow) induces a pocket between Trp760 and Met752 in PI3Kδ (blue) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WHX">2WHX</a>). (b) Structure of <b>140</b>; IC<sub>50</sub> PI3Kδ 10 nM, α 10000 nM, β 490 nM, γ 160 nM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01298&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. (a) Tryptophan shelf, showing the phenyl ring of <b>141</b> (yellow) occupying the pocket above Trp760 in PI3Kδ (blue) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T2M">5T2M</a>) and compound <b>100</b> (green) with a dimethyl alcohol group interacting with Trp760 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EZJ">4EZJ</a>). Compound <b>10</b> shown in purple places a piperidine over Trp760 (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5AE8">5AE8</a>). (b) Structure of <b>141</b>: IC<sub>50</sub> PI3Kδ 0.6 nM, α 1300 nM, β 10000 nM, γ 1000 nM.<a onclick="showRef(event, 'ref192'); return false;" href="javascript:void(0);" class="ref ref192">(192)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01298&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Hydrophobic binding cleft next to the ATP binding pocket. The propylimidazole group of <b>134</b> (yellow) occupies a hydrophobic cleft next to the ATP binding pocket. The equivalent residue to Ala885 in PI3Kγ (blue) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PS3">4PS3</a>) is a serine in the class Ia PI3Ks, whereas the equivalent residue to Gly829 in PI3Kγ is a glutamine in PI3Kα.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01298&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. (a) Alkyl push in back pocket of the affinity pocket. The cyclopropylethyl moiety from <b>142</b> (yellow) induces a conformational change in the Kα3 helix and DFG motif of PI3Kδ (blue) PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6FTN">6FTN</a>. Protein backbone from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T2M">5T2M</a> is shown for reference (violet). (b) Structure of <b>142</b>: IC<sub>50</sub> PI3Kδ 250 nM, α 3200 nM, β 20000 nM, γ 0.6 nM.<a onclick="showRef(event, 'ref213'); return false;" href="javascript:void(0);" class="ref ref213">(213)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01298&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/medium/jm-2018-012989_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Structures of dual PI3Kγδ inhibitor <b>143</b> and PI3Kγ inhibitor <b>144</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.8b01298/20190516/images/large/jm-2018-012989_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01298&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i71">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27170" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27170" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 218 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cushing, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metz, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittington, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGee, L. R.</span></span> <span> </span><span class="NLM_article-title">PI3Kδ and PI3Kγ as Targets for Autoimmune and Inflammatory Diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">8559</span>– <span class="NLM_lpage">8581</span>, <span class="refDoi"> DOI: 10.1021/jm300847w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300847w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1KjsrjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8559-8581&issue=20&author=T.+D.+Cushingauthor=D.+P.+Metzauthor=D.+A.+Whittingtonauthor=L.+R.+McGee&title=PI3K%CE%B4+and+PI3K%CE%B3+as+Targets+for+Autoimmune+and+Inflammatory+Diseases&doi=10.1021%2Fjm300847w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">PI3Kδ and PI3Kγ as Targets for Autoimmune and Inflammatory Diseases</span></div><div class="casAuthors">Cushing, Timothy D.; Metz, Daniela P.; Whittington, Douglas A.; McGee, Lawrence R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8559-8581</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Targeting signaling mols. that are required for the activation of multiple immune cells may be a more likely route to success in combating chronic, immune cell-mediated diseases (such as rheumatoid arthritis, systemic lupus erythematosus, and asthma).  This review will highlight two such signaling mols., the related lipid kinases, class I PI3K (phosphoinositide 3-kinase) δ and γ, both of which are primarily expressed in leukocytes and seem to play important roles in their function and activation.  This review will compare and contrast these two kinases as targets for autoimmune and inflammatory diseases and summarize efforts toward the development of small mol. inhibitors of PI3Kδ and PI3Kγ.  Phosphoinositides (PIs) act as second messengers in a wide variety of cellular roles including signal transduction, control of membrane trafficking and transport, cytoskeleton organization, cell survival and death, among many other functions.  The target of PI3K kinase activity is the phosphoinositides within cell membranes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMqItqgMiGp7Vg90H21EOLACvtfcHk0lirlIat6A-qAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1KjsrjL&md5=76fc05c3bf303174add4aca98f526f8f</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fjm300847w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300847w%26sid%3Dliteratum%253Aachs%26aulast%3DCushing%26aufirst%3DT.%2BD.%26aulast%3DMetz%26aufirst%3DD.%2BP.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DMcGee%26aufirst%3DL.%2BR.%26atitle%3DPI3K%25CE%25B4%2520and%2520PI3K%25CE%25B3%2520as%2520Targets%2520for%2520Autoimmune%2520and%2520Inflammatory%2520Diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D20%26spage%3D8559%26epage%3D8581%26doi%3D10.1021%2Fjm300847w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wymann, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirola, L.</span></span> <span> </span><span class="NLM_article-title">Structure and Function of Phosphoinositide 3-Kinases</span>. <i>Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>1436</i></span> (<span class="NLM_issue">1–2</span>),  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">150</span>, <span class="refDoi"> DOI: 10.1016/S0005-2760(98)00139-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2FS0005-2760%2898%2900139-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=9838078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADyaK1cXns1Klur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1436&publication_year=1998&pages=127-150&issue=1%E2%80%932&author=M.+P.+Wymannauthor=L.+Pirola&title=Structure+and+Function+of+Phosphoinositide+3-Kinases&doi=10.1016%2FS0005-2760%2898%2900139-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of phosphoinositide 3-kinases</span></div><div class="casAuthors">Wymann, Matthias P.; Pirola, Luciano</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">1436</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">127-150</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review with 311 refs.  Phosphoinositide kinases (PI3Ks) play an important role in mitogenic signaling and cell survival, cytoskeletal remodeling, metabolic control, and vesicular trafficking.  Here, the authors summarize structure-function relations delineating the activation process of class I PI3Ks involving various domains of adapter subunits, Ras, and interacting proteins.  The resulting product, phosphatidylinositol (PtdIns) 3,4,5-bisphosphate, targets Akt/protein kinase B (PKB), Bruton's tyrosine kinase (Btk), phosphoinositide-dependent kinases (PDK), integrin-linked kinase (ILK), atypical protein kinases C (PKC), phosphatidylinositol phospholipase Cγ, and more.  Surface receptor-activated PI3Ks function in mammals, insects, nematodes, and slime mold, but not yeast.  Whereas many members of the class II family have been identified and characterized biochem., it is presently unknown how these C2-domain contg. PI3Ks are activated, and which PI substrate they phosphorylate in vivo.  PtdIns 3-phosphate is produced by Vps34p/class III PI3Ks and operates via the PtdIns 3-phosphate-binding proteins, early endosomal antigen (EEA1) and yeast Vac1p, Vps27p, and Pip1p, in lysosomal protein targeting.  Besides the prodn. of D3 phosphorylated lipids, PI3Ks have an intrinsic protein kinase activity.  For trimeric GTP-binding protein-activated PI3Kγ, protein kinase activity seems to be sufficient to trigger mitogen-activated protein kinase (MAPK).  Recent disruption of PI3K genes in the slime mold, Caenorhabditis elegans, Drosophila melanogaster, and mice further underlines the importance of PI3K signaling systems and elucidates the role of PI3K signaling in multicellular organisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuKz1Hg1qwhLVg90H21EOLACvtfcHk0lictGOtHB9rRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXns1Klur8%253D&md5=b93d9a7245d3d09b6a3a938cceedc1c2</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0005-2760%2898%2900139-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0005-2760%252898%252900139-8%26sid%3Dliteratum%253Aachs%26aulast%3DWymann%26aufirst%3DM.%2BP.%26aulast%3DPirola%26aufirst%3DL.%26atitle%3DStructure%2520and%2520Function%2520of%2520Phosphoinositide%25203-Kinases%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D1998%26volume%3D1436%26issue%3D1%25E2%2580%25932%26spage%3D127%26epage%3D150%26doi%3D10.1016%2FS0005-2760%2898%2900139-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stephens, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, P. T.</span></span> <span> </span><span class="NLM_article-title">Agonist-Stimulated Synthesis of Phosphatidylinositol(3,4,5)-Trisphosphate: A New Intracellular Signalling System?</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>1179</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">75</span>, <span class="refDoi"> DOI: 10.1016/0167-4889(93)90072-W</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2F0167-4889%2893%2990072-W" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=8399352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADyaK2cXitlKltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1179&publication_year=1993&pages=27-75&issue=1&author=L.+R.+Stephensauthor=T.+R.+Jacksonauthor=P.+T.+Hawkins&title=Agonist-Stimulated+Synthesis+of+Phosphatidylinositol%283%2C4%2C5%29-Trisphosphate%3A+A+New+Intracellular+Signalling+System%3F&doi=10.1016%2F0167-4889%2893%2990072-W"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Agonist-stimulated synthesis of phosphatidylinositol(3,4,5)-trisphosphate: a new intracellular signalling system?</span></div><div class="casAuthors">Stephens, L. R.; Jackson, T. R.; Hawkins, P. T.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">1179</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-75</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review, with 348 refs., of the metab. and functions of the family of membrane phospholipids, the 3-phosphorylated phosphoinositides.  The integration of these phosphorylated phosphoinositides in the signal transduction pathways for receptors (e.g. those activated by cytokines, growth factors, small hormones, and antigens) is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQHYu3stFDt7Vg90H21EOLACvtfcHk0lictGOtHB9rRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitlKltg%253D%253D&md5=e54e47e570cc96df6b38794dcaabb818</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2F0167-4889%2893%2990072-W&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0167-4889%252893%252990072-W%26sid%3Dliteratum%253Aachs%26aulast%3DStephens%26aufirst%3DL.%2BR.%26aulast%3DJackson%26aufirst%3DT.%2BR.%26aulast%3DHawkins%26aufirst%3DP.%2BT.%26atitle%3DAgonist-Stimulated%2520Synthesis%2520of%2520Phosphatidylinositol%25283%252C4%252C5%2529-Trisphosphate%253A%2520A%2520New%2520Intracellular%2520Signalling%2520System%253F%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D1993%26volume%3D1179%26issue%3D1%26spage%3D27%26epage%3D75%26doi%3D10.1016%2F0167-4889%2893%2990072-W" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cantley, L. C.</span></span> <span> </span><span class="NLM_article-title">The Phosphoinositide 3-Kinase Pathway</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>296</i></span> (<span class="NLM_issue">5573</span>),  <span class="NLM_fpage">1655</span>– <span class="NLM_lpage">1657</span>, <span class="refDoi"> DOI: 10.1126/science.296.5573.1655</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1126%2Fscience.296.5573.1655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=12040186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BD38XktlChu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=1655-1657&issue=5573&author=L.+C.+Cantley&title=The+Phosphoinositide+3-Kinase+Pathway&doi=10.1126%2Fscience.296.5573.1655"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The phosphoinositide 3-kinase pathway</span></div><div class="casAuthors">Cantley, Lewis C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue">5573</span>),
    <span class="NLM_cas:pages">1655-1657</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review with 8 refs.  Phosphorylated lipids are produced at cellular membranes during signaling events and contribute to the recruitment and activation of various signaling components.  The role of phosphoinositide 3-kinase (PI3K), which catalyzes the prodn. of phosphatidylinositol 3,4,5-trisphosphate, in cell survival pathways; the regulation of gene expression and cell metab.; and cytoskeletal rearrangements are highlighted.  The PI3K pathway is implicated in human diseases including diabetes and cancer, and understanding the intricacies of this pathway may provide new avenues for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9pxSplxmS1rVg90H21EOLACvtfcHk0lib3bW4PcCslA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktlChu7s%253D&md5=110c8a351448aed6ab938b9ccf90a655</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscience.296.5573.1655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.296.5573.1655%26sid%3Dliteratum%253Aachs%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DThe%2520Phosphoinositide%25203-Kinase%2520Pathway%26jtitle%3DScience%26date%3D2002%26volume%3D296%26issue%3D5573%26spage%3D1655%26epage%3D1657%26doi%3D10.1126%2Fscience.296.5573.1655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suire, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coadwell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephens, L.</span></span> <span> </span><span class="NLM_article-title">p84, a New Gβγ-Activated Regulatory Subunit of the Type IB Phosphoinositide 3-Kinase p110γ</span>. <i>Curr. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">566</span>– <span class="NLM_lpage">570</span>, <span class="refDoi"> DOI: 10.1016/j.cub.2005.02.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.cub.2005.02.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=15797027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BD2MXis1Kmtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=566-570&issue=6&author=S.+Suireauthor=J.+Coadwellauthor=G.+J.+Fergusonauthor=K.+Davidsonauthor=P.+Hawkinsauthor=L.+Stephens&title=p84%2C+a+New+G%CE%B2%CE%B3-Activated+Regulatory+Subunit+of+the+Type+IB+Phosphoinositide+3-Kinase+p110%CE%B3&doi=10.1016%2Fj.cub.2005.02.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">p84, a New Gβγ-Activated Regulatory Subunit of the Type IB Phosphoinositide 3-Kinase p110γ</span></div><div class="casAuthors">Suire, Sabine; Coadwell, John; Ferguson, G. John; Davidson, Keith; Hawkins, Phillip; Stephens, Len</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">566-570</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: A variety of genetic and inhibitor studies have shown that phosphoinositide 3-kinase γ (PI3Kγ) plays an essential role in a no. of physiol. responses, including neutrophil chemotaxis, mast cell degranulation, and cardiac function.  PI3Kγ is currently thought to be composed of a p110γ catalytic subunit and a single regulatory subunit, p101.  The binding of p110γ to p101 dramatically increases the activation of the complex by Gβγ subunits and, hence, is thought to be crit. for the coupling of PI3Kγ to G protein coupled receptors.  Here, we characterize a new regulatory subunit for PI3Kγ.  P84 is present in human, mouse, chicken, frog, and fugu genomes and is located beside the p101 locus.  It is broadly expressed in cells of the murine immune system.  Both recombinant and endogenous p84 bind p110γ specifically and with high affinity.  Binding of p84 to p110γ substantially increases the ability of Gβγ to stimulate phosphatidylinositol (3,4,5)-trisphosphate (PtdIns(3,4,5)P3) prodn. both in vitro and in vivo.  However, the p84/p110γ heterodimer is approx. 4-fold less sensitive to Gβγs than p101/p110γ.  Endogenous murine p84 expression is substantially reduced in the absence of p110γ expression.  We conclude that p110γ has two potential regulatory subunits in vivo, p84 and p101.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQGpd-AMWRvrVg90H21EOLACvtfcHk0lib3bW4PcCslA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXis1Kmtb8%253D&md5=24a5c9e85ff28c30a4bc128478dd9df3</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2005.02.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2005.02.020%26sid%3Dliteratum%253Aachs%26aulast%3DSuire%26aufirst%3DS.%26aulast%3DCoadwell%26aufirst%3DJ.%26aulast%3DFerguson%26aufirst%3DG.%2BJ.%26aulast%3DDavidson%26aufirst%3DK.%26aulast%3DHawkins%26aufirst%3DP.%26aulast%3DStephens%26aufirst%3DL.%26atitle%3Dp84%252C%2520a%2520New%2520G%25CE%25B2%25CE%25B3-Activated%2520Regulatory%2520Subunit%2520of%2520the%2520Type%2520IB%2520Phosphoinositide%25203-Kinase%2520p110%25CE%25B3%26jtitle%3DCurr.%2520Biol.%26date%3D2005%26volume%3D15%26issue%3D6%26spage%3D566%26epage%3D570%26doi%3D10.1016%2Fj.cub.2005.02.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katanaev, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garlanda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azzolino, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirola, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silengo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sozzani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantovani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altruda, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wymann, M. P.</span></span> <span> </span><span class="NLM_article-title">Central Role for G Protein-Coupled Phosphoinositide 3-Kinase Gamma in Inflammation</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>287</i></span> (<span class="NLM_issue">5455</span>),  <span class="NLM_fpage">1049</span>– <span class="NLM_lpage">1053</span>, <span class="refDoi"> DOI: 10.1126/science.287.5455.1049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1126%2Fscience.287.5455.1049" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2000&pages=1049-1053&issue=5455&author=E.+Hirschauthor=V.+L.+Katanaevauthor=C.+Garlandaauthor=O.+Azzolinoauthor=L.+Pirolaauthor=L.+Silengoauthor=S.+Sozzaniauthor=A.+Mantovaniauthor=F.+Altrudaauthor=M.+P.+Wymann&title=Central+Role+for+G+Protein-Coupled+Phosphoinositide+3-Kinase+Gamma+in+Inflammation&doi=10.1126%2Fscience.287.5455.1049"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1126%2Fscience.287.5455.1049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.287.5455.1049%26sid%3Dliteratum%253Aachs%26aulast%3DHirsch%26aufirst%3DE.%26aulast%3DKatanaev%26aufirst%3DV.%2BL.%26aulast%3DGarlanda%26aufirst%3DC.%26aulast%3DAzzolino%26aufirst%3DO.%26aulast%3DPirola%26aufirst%3DL.%26aulast%3DSilengo%26aufirst%3DL.%26aulast%3DSozzani%26aufirst%3DS.%26aulast%3DMantovani%26aufirst%3DA.%26aulast%3DAltruda%26aufirst%3DF.%26aulast%3DWymann%26aufirst%3DM.%2BP.%26atitle%3DCentral%2520Role%2520for%2520G%2520Protein-Coupled%2520Phosphoinositide%25203-Kinase%2520Gamma%2520in%2520Inflammation%26jtitle%3DScience%26date%3D2000%26volume%3D287%26issue%3D5455%26spage%3D1049%26epage%3D1053%26doi%3D10.1126%2Fscience.287.5455.1049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghigo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perino, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zahradníková, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morello, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolaev, V. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damilano, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cimino, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Luca, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westenbroek, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catterall, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandecasteele, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischmeister, R.</span></span> <span> </span><span class="NLM_article-title">Phosphoinositide 3-Kinase γ Protects against Catecholamine-Induced Ventricular Arrhythmia through Protein Kinase A-Mediated Regulation of Distinct Phosphodiesterases</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>126</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">2073</span>– <span class="NLM_lpage">2083</span>, <span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.112.114074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1161%2FCIRCULATIONAHA.112.114074" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2012&pages=2073-2083&issue=17&author=A.+Ghigoauthor=A.+Perinoauthor=H.+Mehelauthor=A.+Zahradn%C3%ADkov%C3%A1author=F.+Morelloauthor=J.+Leroyauthor=V.+O.+Nikolaevauthor=F.+Damilanoauthor=J.+Ciminoauthor=E.+De+Lucaauthor=W.+Richterauthor=R.+Westenbroekauthor=W.+A.+Catterallauthor=J.+Zhangauthor=C.+Yanauthor=M.+Contiauthor=A.+M.+Gomezauthor=G.+Vandecasteeleauthor=E.+Hirschauthor=R.+Fischmeister&title=Phosphoinositide+3-Kinase+%CE%B3+Protects+against+Catecholamine-Induced+Ventricular+Arrhythmia+through+Protein+Kinase+A-Mediated+Regulation+of+Distinct+Phosphodiesterases&doi=10.1161%2FCIRCULATIONAHA.112.114074"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.112.114074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.112.114074%26sid%3Dliteratum%253Aachs%26aulast%3DGhigo%26aufirst%3DA.%26aulast%3DPerino%26aufirst%3DA.%26aulast%3DMehel%26aufirst%3DH.%26aulast%3DZahradn%25C3%25ADkov%25C3%25A1%26aufirst%3DA.%26aulast%3DMorello%26aufirst%3DF.%26aulast%3DLeroy%26aufirst%3DJ.%26aulast%3DNikolaev%26aufirst%3DV.%2BO.%26aulast%3DDamilano%26aufirst%3DF.%26aulast%3DCimino%26aufirst%3DJ.%26aulast%3DDe%2BLuca%26aufirst%3DE.%26aulast%3DRichter%26aufirst%3DW.%26aulast%3DWestenbroek%26aufirst%3DR.%26aulast%3DCatterall%26aufirst%3DW.%2BA.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DC.%26aulast%3DConti%26aufirst%3DM.%26aulast%3DGomez%26aufirst%3DA.%2BM.%26aulast%3DVandecasteele%26aufirst%3DG.%26aulast%3DHirsch%26aufirst%3DE.%26aulast%3DFischmeister%26aufirst%3DR.%26atitle%3DPhosphoinositide%25203-Kinase%2520%25CE%25B3%2520Protects%2520against%2520Catecholamine-Induced%2520Ventricular%2520Arrhythmia%2520through%2520Protein%2520Kinase%2520A-Mediated%2520Regulation%2520of%2520Distinct%2520Phosphodiesterases%26jtitle%3DCirculation%26date%3D2012%26volume%3D126%26issue%3D17%26spage%3D2073%26epage%3D2083%26doi%3D10.1161%2FCIRCULATIONAHA.112.114074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gili, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fruciano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korfei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fagone, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iemmolo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo Furno, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giuffrida, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crimi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guenther, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vancheri, C.</span></span> <span> </span><span class="NLM_article-title">PI3K p110γ Overexpression in Idiopathic Pulmonary Fibrosis Lung Tissue and Fibroblast Cells: In Vitro Effects of Its Inhibition</span>. <i>Lab. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>93</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">566</span>– <span class="NLM_lpage">576</span>, <span class="refDoi"> DOI: 10.1038/labinvest.2013.6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1038%2Flabinvest.2013.6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2013&pages=566-576&issue=5&author=E.+Conteauthor=E.+Giliauthor=M.+Frucianoauthor=M.+Korfeiauthor=E.+Fagoneauthor=M.+Iemmoloauthor=D.+Lo+Furnoauthor=R.+Giuffridaauthor=N.+Crimiauthor=A.+Guentherauthor=C.+Vancheri&title=PI3K+p110%CE%B3+Overexpression+in+Idiopathic+Pulmonary+Fibrosis+Lung+Tissue+and+Fibroblast+Cells%3A+In+Vitro+Effects+of+Its+Inhibition&doi=10.1038%2Flabinvest.2013.6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Flabinvest.2013.6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Flabinvest.2013.6%26sid%3Dliteratum%253Aachs%26aulast%3DConte%26aufirst%3DE.%26aulast%3DGili%26aufirst%3DE.%26aulast%3DFruciano%26aufirst%3DM.%26aulast%3DKorfei%26aufirst%3DM.%26aulast%3DFagone%26aufirst%3DE.%26aulast%3DIemmolo%26aufirst%3DM.%26aulast%3DLo%2BFurno%26aufirst%3DD.%26aulast%3DGiuffrida%26aufirst%3DR.%26aulast%3DCrimi%26aufirst%3DN.%26aulast%3DGuenther%26aufirst%3DA.%26aulast%3DVancheri%26aufirst%3DC.%26atitle%3DPI3K%2520p110%25CE%25B3%2520Overexpression%2520in%2520Idiopathic%2520Pulmonary%2520Fibrosis%2520Lung%2520Tissue%2520and%2520Fibroblast%2520Cells%253A%2520In%2520Vitro%2520Effects%2520of%2520Its%2520Inhibition%26jtitle%3DLab.%2520Invest.%26date%3D2013%26volume%3D93%26issue%3D5%26spage%3D566%26epage%3D576%26doi%3D10.1038%2Flabinvest.2013.6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Becattini, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marone, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arsenijevic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seydoux, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montani, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dulloo, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorens, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preitner, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wymann, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solinas, G.</span></span> <span> </span><span class="NLM_article-title">PI3Kγ within a Nonhematopoietic Cell Type Negatively Regulates Diet-Induced Thermogenesis and Promotes Obesity and Insulin Resistance</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span> (<span class="NLM_issue">42</span>),  <span class="NLM_fpage">E854</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1073/pnas.1106698108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1073%2Fpnas.1106698108" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=E854-63&issue=42&author=B.+Becattiniauthor=R.+Maroneauthor=F.+Zaniauthor=D.+Arsenijevicauthor=J.+Seydouxauthor=J.-P.+Montaniauthor=A.+G.+Dullooauthor=B.+Thorensauthor=F.+Preitnerauthor=M.+P.+Wymannauthor=G.+Solinas&title=PI3K%CE%B3+within+a+Nonhematopoietic+Cell+Type+Negatively+Regulates+Diet-Induced+Thermogenesis+and+Promotes+Obesity+and+Insulin+Resistance&doi=10.1073%2Fpnas.1106698108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1106698108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1106698108%26sid%3Dliteratum%253Aachs%26aulast%3DBecattini%26aufirst%3DB.%26aulast%3DMarone%26aufirst%3DR.%26aulast%3DZani%26aufirst%3DF.%26aulast%3DArsenijevic%26aufirst%3DD.%26aulast%3DSeydoux%26aufirst%3DJ.%26aulast%3DMontani%26aufirst%3DJ.-P.%26aulast%3DDulloo%26aufirst%3DA.%2BG.%26aulast%3DThorens%26aufirst%3DB.%26aulast%3DPreitner%26aufirst%3DF.%26aulast%3DWymann%26aufirst%3DM.%2BP.%26aulast%3DSolinas%26aufirst%3DG.%26atitle%3DPI3K%25CE%25B3%2520within%2520a%2520Nonhematopoietic%2520Cell%2520Type%2520Negatively%2520Regulates%2520Diet-Induced%2520Thermogenesis%2520and%2520Promotes%2520Obesity%2520and%2520Insulin%2520Resistance%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26issue%3D42%26spage%3DE854%26epage%3D63%26doi%3D10.1073%2Fpnas.1106698108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolliputi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. C.</span></span> <span> </span><span class="NLM_article-title">Phosphoinositide 3-Kinase-δ Regulates Fungus-Induced Allergic Lung Inflammation through Endoplasmic Reticulum Stress</span>. <i>Thorax</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>71</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">52</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1136/thoraxjnl-2015-207096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1136%2Fthoraxjnl-2015-207096" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2016&pages=52-63&issue=1&author=K.+S.+Leeauthor=J.+S.+Jeongauthor=S.+R.+Kimauthor=S.+H.+Choauthor=N.+Kolliputiauthor=Y.+H.+Koauthor=K.+B.+Leeauthor=S.+C.+Parkauthor=H.+J.+Parkauthor=Y.+C.+Lee&title=Phosphoinositide+3-Kinase-%CE%B4+Regulates+Fungus-Induced+Allergic+Lung+Inflammation+through+Endoplasmic+Reticulum+Stress&doi=10.1136%2Fthoraxjnl-2015-207096"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1136%2Fthoraxjnl-2015-207096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fthoraxjnl-2015-207096%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%2BS.%26aulast%3DJeong%26aufirst%3DJ.%2BS.%26aulast%3DKim%26aufirst%3DS.%2BR.%26aulast%3DCho%26aufirst%3DS.%2BH.%26aulast%3DKolliputi%26aufirst%3DN.%26aulast%3DKo%26aufirst%3DY.%2BH.%26aulast%3DLee%26aufirst%3DK.%2BB.%26aulast%3DPark%26aufirst%3DS.%2BC.%26aulast%3DPark%26aufirst%3DH.%2BJ.%26aulast%3DLee%26aufirst%3DY.%2BC.%26atitle%3DPhosphoinositide%25203-Kinase-%25CE%25B4%2520Regulates%2520Fungus-Induced%2520Allergic%2520Lung%2520Inflammation%2520through%2520Endoplasmic%2520Reticulum%2520Stress%26jtitle%3DThorax%26date%3D2016%26volume%3D71%26issue%3D1%26spage%3D52%26epage%3D63%26doi%3D10.1136%2Fthoraxjnl-2015-207096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koziol-White, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papanikolaou, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pushkarsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Himes, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damoiseaux, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liggett, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Carlo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurten, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panettieri, R. A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of PI3K Promotes Dilation of Human Small Airways in a Rho Kinase-Dependent Manner</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>173</i></span>,  <span class="NLM_fpage">2726</span>– <span class="NLM_lpage">2738</span>, <span class="refDoi"> DOI: 10.1111/bph.13542</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1111%2Fbph.13542" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=27352269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1ygtL%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2016&pages=2726-2738&author=C.+J.+Koziol-Whiteauthor=E.+J.+Yooauthor=G.+Caoauthor=J.+Zhangauthor=E.+Papanikolaouauthor=I.+Pushkarskyauthor=A.+Andrewsauthor=B.+E.+Himesauthor=R.+D.+Damoiseauxauthor=S.+B.+Liggettauthor=D.+Di+Carloauthor=R.+C.+Kurtenauthor=R.+A.+Panettieri&title=Inhibition+of+PI3K+Promotes+Dilation+of+Human+Small+Airways+in+a+Rho+Kinase-Dependent+Manner&doi=10.1111%2Fbph.13542"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of PI3K promotes dilation of human small airways in a rho kinase-dependent manner</span></div><div class="casAuthors">Koziol-White, Cynthia J.; Yoo, Edwin J.; Cao, Gaoyuan; Zhang, Jie; Papanikolaou, Eleni; Pushkarsky, Ivan; Andrews, Adam; Himes, Blanca E.; Damoiseaux, Robert D.; Liggett, Stephen B.; Di Carlo, Dino; Kurten, Richard C.; Panettieri, Reynold A., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2726-2738</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : Asthma manifests as a heterogeneous syndrome characterized by airway obstruction, inflammation and hyperresponsiveness (AHR).  Although the mol. mechanisms remain unclear, activation of specific PI3K isoforms mediate inflammation and AHR.  We aimed to det. whether inhibition of PI3Kδ evokes dilation of airways and to elucidate potential mechanisms.  Exptl. Approach : Human precision cut lung slices from non-asthma donors and primary human airway smooth muscle (HASM) cells from both non-asthma and asthma donors were utilized.  Phosphorylation of Akt, myosin phosphatase target subunit 1 (MYPT1) and myosin light chain (MLC) were assessed in HASM cells following either PI3K inhibitor or siRNA treatment.  HASM relaxation was assessed by micro-pattern deformation.  Reversal of constriction of airways was assessed following stimulation with PI3K or ROCK inhibitors.  Key Results : Sol. inhibitors or PI3Kδ knockdown reversed carbachol-induced constriction of human airways, relaxed agonist-contracted HASM and inhibited pAkt, pMYPT1 and pMLC in HASM.  Similarly, inhibition of Rho kinase also dilated human PCLS airways and suppressed pMYPT1 and pMLC.  Baseline pMYPT1 was significantly elevated in HASM cells derived from asthma donors in comparison with non-asthma donors.  After desensitization of the β2-adrenoceptors, a PI3Kδ inhibitor remained an effective dilator.  In the presence of IL-13, dilation by a β agonist, but not PI3K inhibitor, was attenuated.  Conclusion and Implications : PI3Kδ inhibitors act as dilators of human small airways.  Taken together, these findings provide alternative approaches to the clin. management of airway obstruction in asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOOSEc7OTND7Vg90H21EOLACvtfcHk0lgIia9MfePcWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1ygtL%252FF&md5=2120999fc20751655bba4f11faa6ace6</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1111%2Fbph.13542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.13542%26sid%3Dliteratum%253Aachs%26aulast%3DKoziol-White%26aufirst%3DC.%2BJ.%26aulast%3DYoo%26aufirst%3DE.%2BJ.%26aulast%3DCao%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DPapanikolaou%26aufirst%3DE.%26aulast%3DPushkarsky%26aufirst%3DI.%26aulast%3DAndrews%26aufirst%3DA.%26aulast%3DHimes%26aufirst%3DB.%2BE.%26aulast%3DDamoiseaux%26aufirst%3DR.%2BD.%26aulast%3DLiggett%26aufirst%3DS.%2BB.%26aulast%3DDi%2BCarlo%26aufirst%3DD.%26aulast%3DKurten%26aufirst%3DR.%2BC.%26aulast%3DPanettieri%26aufirst%3DR.%2BA.%26atitle%3DInhibition%2520of%2520PI3K%2520Promotes%2520Dilation%2520of%2520Human%2520Small%2520Airways%2520in%2520a%2520Rho%2520Kinase-Dependent%2520Manner%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2016%26volume%3D173%26spage%3D2726%26epage%3D2738%26doi%3D10.1111%2Fbph.13542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makondo, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, A. J.</span></span> <span> </span><span class="NLM_article-title">p110δ Phosphoinositide 3-Kinase Represses IgE Switch by Potentiating BCL6 Expression</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>188</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">3700</span>– <span class="NLM_lpage">3708</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1103302</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.4049%2Fjimmunol.1103302" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=188&publication_year=2012&pages=3700-3708&issue=8&author=T.+Zhangauthor=K.+J.+Makondoauthor=A.+J.+Marshall&title=p110%CE%B4+Phosphoinositide+3-Kinase+Represses+IgE+Switch+by+Potentiating+BCL6+Expression&doi=10.4049%2Fjimmunol.1103302"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1103302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1103302%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DMakondo%26aufirst%3DK.%2BJ.%26aulast%3DMarshall%26aufirst%3DA.%2BJ.%26atitle%3Dp110%25CE%25B4%2520Phosphoinositide%25203-Kinase%2520Represses%2520IgE%2520Switch%2520by%2520Potentiating%2520BCL6%2520Expression%26jtitle%3DJ.%2520Immunol.%26date%3D2012%26volume%3D188%26issue%3D8%26spage%3D3700%26epage%3D3708%26doi%3D10.4049%2Fjimmunol.1103302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avraamides, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dippold, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foubert, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellies, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acevedo, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manglicmot, J. R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrasidlo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blair, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ginsberg, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheresh, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Field, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varner, J. A.</span></span> <span> </span><span class="NLM_article-title">Receptor Tyrosine Kinases and TLR/IL1Rs Unexpectedly Activate Myeloid Cell PI3Kγ, a Single Convergent Point Promoting Tumor Inflammation and Progression</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">715</span>– <span class="NLM_lpage">727</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2011.04.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.ccr.2011.04.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=715-727&issue=6&author=M.+C.+Schmidauthor=C.+J.+Avraamidesauthor=H.+C.+Dippoldauthor=I.+Francoauthor=P.+Foubertauthor=L.+G.+Elliesauthor=L.+M.+Acevedoauthor=J.+R.+E.+Manglicmotauthor=X.+Songauthor=W.+Wrasidloauthor=S.+L.+Blairauthor=M.+H.+Ginsbergauthor=D.+A.+Chereshauthor=E.+Hirschauthor=S.+J.+Fieldauthor=J.+A.+Varner&title=Receptor+Tyrosine+Kinases+and+TLR%2FIL1Rs+Unexpectedly+Activate+Myeloid+Cell+PI3K%CE%B3%2C+a+Single+Convergent+Point+Promoting+Tumor+Inflammation+and+Progression&doi=10.1016%2Fj.ccr.2011.04.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2011.04.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2011.04.016%26sid%3Dliteratum%253Aachs%26aulast%3DSchmid%26aufirst%3DM.%2BC.%26aulast%3DAvraamides%26aufirst%3DC.%2BJ.%26aulast%3DDippold%26aufirst%3DH.%2BC.%26aulast%3DFranco%26aufirst%3DI.%26aulast%3DFoubert%26aufirst%3DP.%26aulast%3DEllies%26aufirst%3DL.%2BG.%26aulast%3DAcevedo%26aufirst%3DL.%2BM.%26aulast%3DManglicmot%26aufirst%3DJ.%2BR.%2BE.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DWrasidlo%26aufirst%3DW.%26aulast%3DBlair%26aufirst%3DS.%2BL.%26aulast%3DGinsberg%26aufirst%3DM.%2BH.%26aulast%3DCheresh%26aufirst%3DD.%2BA.%26aulast%3DHirsch%26aufirst%3DE.%26aulast%3DField%26aufirst%3DS.%2BJ.%26aulast%3DVarner%26aufirst%3DJ.%2BA.%26atitle%3DReceptor%2520Tyrosine%2520Kinases%2520and%2520TLR%252FIL1Rs%2520Unexpectedly%2520Activate%2520Myeloid%2520Cell%2520PI3K%25CE%25B3%252C%2520a%2520Single%2520Convergent%2520Point%2520Promoting%2520Tumor%2520Inflammation%2520and%2520Progression%26jtitle%3DCancer%2520Cell%26date%3D2011%26volume%3D19%26issue%3D6%26spage%3D715%26epage%3D727%26doi%3D10.1016%2Fj.ccr.2011.04.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okkenhaug, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burger, J. A.</span></span> <span> </span><span class="NLM_article-title">PI3K Signaling in Normal B Cells and Chronic Lymphocytic Leukemia (CLL)</span>. <i>Curr. Top. Microbiol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>393</i></span>,  <span class="NLM_fpage">123</span>– <span class="NLM_lpage">142</span>, <span class="refDoi"> DOI: 10.1007/82_2015_484</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1007%2F82_2015_484" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=393&publication_year=2015&pages=123-142&author=K.+Okkenhaugauthor=J.+A.+Burger&title=PI3K+Signaling+in+Normal+B+Cells+and+Chronic+Lymphocytic+Leukemia+%28CLL%29&doi=10.1007%2F82_2015_484"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1007%2F82_2015_484&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F82_2015_484%26sid%3Dliteratum%253Aachs%26aulast%3DOkkenhaug%26aufirst%3DK.%26aulast%3DBurger%26aufirst%3DJ.%2BA.%26atitle%3DPI3K%2520Signaling%2520in%2520Normal%2520B%2520Cells%2520and%2520Chronic%2520Lymphocytic%2520Leukemia%2520%2528CLL%2529%26jtitle%3DCurr.%2520Top.%2520Microbiol.%2520Immunol.%26date%3D2015%26volume%3D393%26spage%3D123%26epage%3D142%26doi%3D10.1007%2F82_2015_484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ali, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilancio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearce, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilfillan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tkaczyk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuehn, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giddings, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peskett, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruce, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawyer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okkenhaug, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanhaesebroeck, B.</span></span> <span> </span><span class="NLM_article-title">Essential Role for the p110δ Phosphoinositide 3-Kinase in the Allergic Response</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>431</i></span> (<span class="NLM_issue">7011</span>),  <span class="NLM_fpage">1007</span>– <span class="NLM_lpage">1011</span>, <span class="refDoi"> DOI: 10.1038/nature02991</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1038%2Fnature02991" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=431&publication_year=2004&pages=1007-1011&issue=7011&author=K.+Aliauthor=A.+Bilancioauthor=M.+Thomasauthor=W.+Pearceauthor=A.+M.+Gilfillanauthor=C.+Tkaczykauthor=N.+Kuehnauthor=A.+Grayauthor=J.+Giddingsauthor=E.+Peskettauthor=R.+Foxauthor=I.+Bruceauthor=C.+Walkerauthor=C.+Sawyerauthor=K.+Okkenhaugauthor=P.+Finanauthor=B.+Vanhaesebroeck&title=Essential+Role+for+the+p110%CE%B4+Phosphoinositide+3-Kinase+in+the+Allergic+Response&doi=10.1038%2Fnature02991"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnature02991&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02991%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DK.%26aulast%3DBilancio%26aufirst%3DA.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DPearce%26aufirst%3DW.%26aulast%3DGilfillan%26aufirst%3DA.%2BM.%26aulast%3DTkaczyk%26aufirst%3DC.%26aulast%3DKuehn%26aufirst%3DN.%26aulast%3DGray%26aufirst%3DA.%26aulast%3DGiddings%26aufirst%3DJ.%26aulast%3DPeskett%26aufirst%3DE.%26aulast%3DFox%26aufirst%3DR.%26aulast%3DBruce%26aufirst%3DI.%26aulast%3DWalker%26aufirst%3DC.%26aulast%3DSawyer%26aufirst%3DC.%26aulast%3DOkkenhaug%26aufirst%3DK.%26aulast%3DFinan%26aufirst%3DP.%26aulast%3DVanhaesebroeck%26aufirst%3DB.%26atitle%3DEssential%2520Role%2520for%2520the%2520p110%25CE%25B4%2520Phosphoinositide%25203-Kinase%2520in%2520the%2520Allergic%2520Response%26jtitle%3DNature%26date%3D2004%26volume%3D431%26issue%3D7011%26spage%3D1007%26epage%3D1011%26doi%3D10.1038%2Fnature02991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Collmann, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohnacker, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marone, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stringer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krombach, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkhart, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollingworth, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wymann, M. P.</span></span> <span> </span><span class="NLM_article-title">Transient Targeting of Phosphoinositide 3-Kinase Acts as a Roadblock in Mast Cells’ Route to Allergy</span>. <i>J. Allergy Clin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>132</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">959</span>– <span class="NLM_lpage">968</span>, <span class="refDoi"> DOI: 10.1016/j.jaci.2013.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.jaci.2013.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=23683463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnslerurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2013&pages=959-968&issue=4&author=E.+Collmannauthor=T.+Bohnackerauthor=R.+Maroneauthor=J.+Dawsonauthor=M.+Rehbergauthor=R.+Stringerauthor=F.+Krombachauthor=C.+Burkhartauthor=E.+Hirschauthor=G.+J.+Hollingworthauthor=M.+Thomasauthor=M.+P.+Wymann&title=Transient+Targeting+of+Phosphoinositide+3-Kinase+Acts+as+a+Roadblock+in+Mast+Cells%E2%80%99+Route+to+Allergy&doi=10.1016%2Fj.jaci.2013.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Transient targeting of phosphoinositide 3-kinase acts as a roadblock in mast cells' route to allergy</span></div><div class="casAuthors">Collmann, Emilie; Bohnacker, Thomas; Marone, Romina; Dawson, Janet; Rehberg, Markus; Stringer, Rowan; Krombach, Fritz; Burkhart, Christoph; Hirsch, Emilio; Hollingworth, Gregory J.; Thomas, Matthew; Wymann, Matthias P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">959-968</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Background: Tissue mast cell nos. are dynamically regulated by recruitment of progenitors from the vasculature.  It is unclear whether progenitors are recruited during allergic sensitization and whether recruitment promotes allergic responses.  Objective: We sought to (1) det. the effect of mast cell recruitment on acute allergic responses and (2) to define the role of phosphoinositide 3-kinase (PI3K) isoforms in sequential steps to allergic responses.  Methods: Gene-targeted mice for PI3Kγ or PI3Kδ or mice treated with isoform-specific PI3K inhibitors (a novel PI3Kγ-specific inhibitor [NVS-PI3-4] and the PI3Kδ inhibitor IC87114) were used to monitor IgE-mediated mast cell recruitment, migration, adhesion by means of intravital microscopy, degranulation, TNF-α release, and subsequent endothelial cell activation in vivo or in bone marrow-derived mast cells.  Results: Functional PI3Kγ, but not PI3Kδ, was crucial for mast cell accumulation in IgE-challenged skin, TNF-α release from IgE/antigen-stimulated mast cells, and mast cell/endothelial interactions and chemotaxis.  PI3Kγ-deficient bone marrow-derived mast cells did not adhere to the endothelium in TNF-α-treated cremaster muscle, whereas PI3Kδ was not required.  Depletion of TNF-α blocked IgE-induced mast cell recruitment, which links tissue mast cell-derived cytokine release to endothelial activation and mast cell recruitment.  Interference with mast cell recruitment protected against anaphylaxis and was superior to blockage of tissue mast cell degranulation.  Conclusions: Interference with mast cell recruitment to exacerbated tissues provides a novel strategy to alleviate allergic reactions and surpassed attenuation of tissue mast cell degranulation.  This results in prolonged drug action and allows for redn. of drug doses required to block anaphylaxis, an important feature for drugs targeting inflammatory disease in general.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRAijfMWMmaLVg90H21EOLACvtfcHk0libtp1JLD-JEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnslerurk%253D&md5=688f46658743dd6b6e6ca70dc5ba783b</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.jaci.2013.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaci.2013.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DCollmann%26aufirst%3DE.%26aulast%3DBohnacker%26aufirst%3DT.%26aulast%3DMarone%26aufirst%3DR.%26aulast%3DDawson%26aufirst%3DJ.%26aulast%3DRehberg%26aufirst%3DM.%26aulast%3DStringer%26aufirst%3DR.%26aulast%3DKrombach%26aufirst%3DF.%26aulast%3DBurkhart%26aufirst%3DC.%26aulast%3DHirsch%26aufirst%3DE.%26aulast%3DHollingworth%26aufirst%3DG.%2BJ.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DWymann%26aufirst%3DM.%2BP.%26atitle%3DTransient%2520Targeting%2520of%2520Phosphoinositide%25203-Kinase%2520Acts%2520as%2520a%2520Roadblock%2520in%2520Mast%2520Cells%25E2%2580%2599%2520Route%2520to%2520Allergy%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2013%26volume%3D132%26issue%3D4%26spage%3D959%26epage%3D968%26doi%3D10.1016%2Fj.jaci.2013.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Condliffe, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellson, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crabbe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okkenhaug, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanhaesebroeck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wymann, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruckle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camps, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rommel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chilvers, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephens, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, P. T.</span></span> <span> </span><span class="NLM_article-title">Sequential Activation of Class IB and Class IA PI3K Is Important for the Primed Respiratory Burst of Human but Not Murine Neutrophils</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>106</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1432</span>– <span class="NLM_lpage">1440</span>, <span class="refDoi"> DOI: 10.1182/blood-2005-03-0944</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1182%2Fblood-2005-03-0944" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2005&pages=1432-1440&issue=4&author=A.+M.+Condliffeauthor=K.+Davidsonauthor=K.+E.+Andersonauthor=C.+D.+Ellsonauthor=T.+Crabbeauthor=K.+Okkenhaugauthor=B.+Vanhaesebroeckauthor=M.+Turnerauthor=L.+Webbauthor=M.+P.+Wymannauthor=E.+Hirschauthor=T.+Ruckleauthor=M.+Campsauthor=C.+Rommelauthor=S.+P.+Jacksonauthor=E.+R.+Chilversauthor=L.+R.+Stephensauthor=P.+T.+Hawkins&title=Sequential+Activation+of+Class+IB+and+Class+IA+PI3K+Is+Important+for+the+Primed+Respiratory+Burst+of+Human+but+Not+Murine+Neutrophils&doi=10.1182%2Fblood-2005-03-0944"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1182%2Fblood-2005-03-0944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2005-03-0944%26sid%3Dliteratum%253Aachs%26aulast%3DCondliffe%26aufirst%3DA.%2BM.%26aulast%3DDavidson%26aufirst%3DK.%26aulast%3DAnderson%26aufirst%3DK.%2BE.%26aulast%3DEllson%26aufirst%3DC.%2BD.%26aulast%3DCrabbe%26aufirst%3DT.%26aulast%3DOkkenhaug%26aufirst%3DK.%26aulast%3DVanhaesebroeck%26aufirst%3DB.%26aulast%3DTurner%26aufirst%3DM.%26aulast%3DWebb%26aufirst%3DL.%26aulast%3DWymann%26aufirst%3DM.%2BP.%26aulast%3DHirsch%26aufirst%3DE.%26aulast%3DRuckle%26aufirst%3DT.%26aulast%3DCamps%26aufirst%3DM.%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DJackson%26aufirst%3DS.%2BP.%26aulast%3DChilvers%26aufirst%3DE.%2BR.%26aulast%3DStephens%26aufirst%3DL.%2BR.%26aulast%3DHawkins%26aufirst%3DP.%2BT.%26atitle%3DSequential%2520Activation%2520of%2520Class%2520IB%2520and%2520Class%2520IA%2520PI3K%2520Is%2520Important%2520for%2520the%2520Primed%2520Respiratory%2520Burst%2520of%2520Human%2520but%2520Not%2520Murine%2520Neutrophils%26jtitle%3DBlood%26date%3D2005%26volume%3D106%26issue%3D4%26spage%3D1432%26epage%3D1440%26doi%3D10.1182%2Fblood-2005-03-0944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heit, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colarusso, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puri, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubes, P.</span></span> <span> </span><span class="NLM_article-title">PI3K Accelerates, but Is Not Required for, Neutrophil Chemotaxis to FMLP</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>121</i></span> (<span class="NLM_issue">Part 2</span>),  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">214</span>, <span class="refDoi"> DOI: 10.1242/jcs.020412</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1242%2Fjcs.020412" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=18187452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitFWrsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2008&pages=205-214&issue=Part+2&author=B.+Heitauthor=L.+Liuauthor=P.+Colarussoauthor=K.+D.+Puriauthor=P.+Kubes&title=PI3K+Accelerates%2C+but+Is+Not+Required+for%2C+Neutrophil+Chemotaxis+to+FMLP&doi=10.1242%2Fjcs.020412"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">PI3K accelerates, but is not required for, neutrophil chemotaxis to fMLP</span></div><div class="casAuthors">Heit, Bryan; Liu, Lixin; Colarusso, Pina; Puri, Kamal D.; Kubes, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-214</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">PI3K activity, resulting in the accumulation of PIP3 along the leading edge of a chemotaxing cell, has been proposed to be an indispensable signaling event that is required for cells to undergo chemotaxis to endogenous and exogenous chemoattractants.  Some studies have suggested that this might be the case for chemoattractants such as IL8, whereas chemotaxis to other stimuli, such as the bacterial peptide N-formyl-methionyl-leucyl-phenylalanine (fMLP), might occur normally in the absence of PI3K activity.  Herein, the authors systematically analyze the role of PI3K in mediating chemotaxis to fMLP, both in vitro and in vivo.  Using short- and long-term in vitro assays, as well as an in vivo chemotaxis assay, the authors investigated the importance of PI3K in response to the prototypic chemoattractant fMLP.  Exposure of neutrophils to fMLP induced an immediate polarization, which resulted in directional migration towards fMLP within 2-3 min.  PI3K-inhibited cells also polarized and migrated in a directional fashion towards fMLP; however, this process was delayed by ∼15 min, demonstrating that PI3K accelerates the initial response to fMLP, but an alternative pathway replaces PI3K over time.  By contrast, p38-MAPK-inhibited cells, or cells lacking MK2, were unable to polarize in response to fMLP.  Long-term chemotaxis assays using a pan-PI3K inhibitor, a PI3Kδ-specific inhibitor or PI3Kγ-knockout neutrophils, demonstrated no role for PI3K in mediating chemotaxis to fMLP, regardless of the steepness of the fMLP gradient.  Similar results were obsd. in vivo, with PI3Kγ-/- cells displaying a delayed, but otherwise normal, chemotactic response to gradients of fMLP.  Together, these data demonstrate that, although PI3K can enhance early responses to the bacterial chemoattractant fMLP, it is not required for migration towards this chemoattractant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJDIR_4vZGnrVg90H21EOLACvtfcHk0libtp1JLD-JEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitFWrsrs%253D&md5=73aa9311d863135af1b1fb6e2d1796cd</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1242%2Fjcs.020412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.020412%26sid%3Dliteratum%253Aachs%26aulast%3DHeit%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DColarusso%26aufirst%3DP.%26aulast%3DPuri%26aufirst%3DK.%2BD.%26aulast%3DKubes%26aufirst%3DP.%26atitle%3DPI3K%2520Accelerates%252C%2520but%2520Is%2520Not%2520Required%2520for%252C%2520Neutrophil%2520Chemotaxis%2520to%2520FMLP%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2008%26volume%3D121%26issue%3DPart%25202%26spage%3D205%26epage%3D214%26doi%3D10.1242%2Fjcs.020412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milne, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crabbe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camps, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rommel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wymann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephens, L.</span></span> <span> </span><span class="NLM_article-title">PI(3)Kγ Has an Important Context-Dependent Role in Neutrophil Chemokinesis</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">86</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1038/ncb1517</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1038%2Fncb1517" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=17173040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltV2n" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=86-91&issue=1&author=G.+J.+Fergusonauthor=L.+Milneauthor=S.+Kulkarniauthor=T.+Sasakiauthor=S.+Walkerauthor=S.+Andrewsauthor=T.+Crabbeauthor=P.+Finanauthor=G.+Jonesauthor=S.+Jacksonauthor=M.+Campsauthor=C.+Rommelauthor=M.+Wymannauthor=E.+Hirschauthor=P.+Hawkinsauthor=L.+Stephens&title=PI%283%29K%CE%B3+Has+an+Important+Context-Dependent+Role+in+Neutrophil+Chemokinesis&doi=10.1038%2Fncb1517"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">PI(3)Kγ has an important context-dependent role in neutrophil chemokinesis</span></div><div class="casAuthors">Ferguson, G. John; Milne, Laura; Kulkarni, Suhasini; Sasaki, Takehiko; Walker, Simon; Andrews, Simon; Crabbe, Tom; Finan, Peter; Jones, Gareth; Jackson, Shaun; Camps, Montserrat; Rommel, Christian; Wymann, Matthias; Hirsch, Emilio; Hawkins, Phillip; Stephens, Len</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">86-91</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The directional movement of cells in a gradient of external stimulus is termed chemotaxis and is important in many aspects of development and differentiated cell function.  Phosphoinositide 3-kinases (PI(3)Ks) are thought to have crit. roles within the gradient-sensing machinery of a variety of highly motile cells, such as mammalian phagocytes, allowing these cells to respond quickly and efficiently to shallow gradients of sol. stimuli.  Our anal. of mammalian neutrophil migration towards ligands such as fMLP shows that, although PtdIns(3,4)P2 and PtdIns(3,4,5)P3 accumulate in a PI(3)Kγ-dependent fashion at the up-gradient leading-edge, this signal is not required for efficient gradient-sensing and gradient-biased movement.  PI(3)Kγ activity is however, a crit. determinant of the proportion of cells that can move, i.e., respond chemokinetically, in reaction to fMLP.  Furthermore, this dependence of chemokinesis on PI(3)Kγ activity is context dependent, both with respect to the state of priming of the neutrophils and the type of surface on which they are migrating.  We propose this effect of PI(3)Kγ is through roles in the regulation of some aspects of neutrophil polarization that are relevant to movement, such as integrin-based adhesion and the accumulation of polymd. (F)-actin at the leading-edge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8YzmdcdMuk7Vg90H21EOLACvtfcHk0lg_8LM6yznFsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltV2n&md5=f1eeab9aa59a08a896a5fc0c9464e0ad</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fncb1517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb1517%26sid%3Dliteratum%253Aachs%26aulast%3DFerguson%26aufirst%3DG.%2BJ.%26aulast%3DMilne%26aufirst%3DL.%26aulast%3DKulkarni%26aufirst%3DS.%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DWalker%26aufirst%3DS.%26aulast%3DAndrews%26aufirst%3DS.%26aulast%3DCrabbe%26aufirst%3DT.%26aulast%3DFinan%26aufirst%3DP.%26aulast%3DJones%26aufirst%3DG.%26aulast%3DJackson%26aufirst%3DS.%26aulast%3DCamps%26aufirst%3DM.%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DWymann%26aufirst%3DM.%26aulast%3DHirsch%26aufirst%3DE.%26aulast%3DHawkins%26aufirst%3DP.%26aulast%3DStephens%26aufirst%3DL.%26atitle%3DPI%25283%2529K%25CE%25B3%2520Has%2520an%2520Important%2520Context-Dependent%2520Role%2520in%2520Neutrophil%2520Chemokinesis%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2007%26volume%3D9%26issue%3D1%26spage%3D86%26epage%3D91%26doi%3D10.1038%2Fncb1517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mårdh, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Root, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uddin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenvall, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malmgren, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karabelas, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, M.</span></span> <span> </span><span class="NLM_article-title">Targets of Neutrophil Influx and Weaponry: Therapeutic Opportunities for Chronic Obstructive Airway Disease</span>. <i>J. Immunol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2017</i></span>,  <span class="NLM_fpage">5273201</span>, <span class="refDoi"> DOI: 10.1155/2017/5273201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1155%2F2017%2F5273201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=28596972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A280%3ADC%252BC1cnmsFGktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2017&publication_year=2017&pages=5273201&author=C.+K.+M%C3%A5rdhauthor=J.+Rootauthor=M.+Uddinauthor=K.+Stenvallauthor=A.+Malmgrenauthor=K.+Karabelasauthor=M.+Thomas&title=Targets+of+Neutrophil+Influx+and+Weaponry%3A+Therapeutic+Opportunities+for+Chronic+Obstructive+Airway+Disease&doi=10.1155%2F2017%2F5273201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Targets of Neutrophil Influx and Weaponry: Therapeutic Opportunities for Chronic Obstructive Airway Disease</span></div><div class="casAuthors">Mardh Carina Karrman; Root James; Uddin Mohib; Stenvall Kristina; Malmgren Anna; Karabelas Kostas; Thomas Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of immunology research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">2017</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5273201</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Neutrophils are important effector cells of antimicrobial immunity in an acute inflammatory response, with a primary role in the clearance of extracellular pathogens.  However, in respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD), there is excessive infiltration and activation of neutrophils, subsequent production of reactive oxygen species, and release of serine proteases, matrix metalloproteinases, and myeloperoxidase-resulting in collateral damage as the cells infiltrate into the tissue.  Increased neutrophil survival through dysregulated apoptosis facilitates continued release of neutrophil-derived mediators to perpetuate airway inflammation and tissue injury.  Several target mechanisms have been investigated to address pathologic neutrophil biology and thereby provide a novel therapy for respiratory disease.  These include neutrophil influx through inhibition of chemokine receptors CXCR2, CXCR1, and PI3Kγ signaling and neutrophil weaponry by protease inhibitors, targeting matrix metalloproteinases and neutrophil serine proteases.  In addition, neutrophil function can be modulated using selective PI3Kδ inhibitors.  This review highlights the latest advances in targeting neutrophils and their function, discusses the opportunities and risks of neutrophil inhibition, and explores how we might better develop future strategies to regulate neutrophil influx and function for respiratory diseases in dire need of novel effective therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS8tE7xBBHMvr0AGQpJZWpJfW6udTcc2eZ2UEh7Hp7h0Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cnmsFGktQ%253D%253D&md5=959897af161450bc2aa73a092cb20d0a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1155%2F2017%2F5273201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2017%252F5273201%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25A5rdh%26aufirst%3DC.%2BK.%26aulast%3DRoot%26aufirst%3DJ.%26aulast%3DUddin%26aufirst%3DM.%26aulast%3DStenvall%26aufirst%3DK.%26aulast%3DMalmgren%26aufirst%3DA.%26aulast%3DKarabelas%26aufirst%3DK.%26aulast%3DThomas%26aufirst%3DM.%26atitle%3DTargets%2520of%2520Neutrophil%2520Influx%2520and%2520Weaponry%253A%2520Therapeutic%2520Opportunities%2520for%2520Chronic%2520Obstructive%2520Airway%2520Disease%26jtitle%3DJ.%2520Immunol.%2520Res.%26date%3D2017%26volume%3D2017%26spage%3D5273201%26doi%3D10.1155%2F2017%2F5273201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sapey, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenwood, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walton, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Love, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aaronson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Insall, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockley, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, J. M.</span></span> <span> </span><span class="NLM_article-title">Phosphoinositide 3-Kinase Inhibition Restores Neutrophil Accuracy in the Elderly: Toward Targeted Treatments for Immunosenescence</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>123</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">239</span>– <span class="NLM_lpage">248</span>, <span class="refDoi"> DOI: 10.1182/blood-2013-08-519520</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1182%2Fblood-2013-08-519520" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2014&pages=239-248&issue=2&author=E.+Sapeyauthor=H.+Greenwoodauthor=G.+Waltonauthor=E.+Mannauthor=A.+Loveauthor=N.+Aaronsonauthor=R.+H.+Insallauthor=R.+A.+Stockleyauthor=J.+M.+Lord&title=Phosphoinositide+3-Kinase+Inhibition+Restores+Neutrophil+Accuracy+in+the+Elderly%3A+Toward+Targeted+Treatments+for+Immunosenescence&doi=10.1182%2Fblood-2013-08-519520"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1182%2Fblood-2013-08-519520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2013-08-519520%26sid%3Dliteratum%253Aachs%26aulast%3DSapey%26aufirst%3DE.%26aulast%3DGreenwood%26aufirst%3DH.%26aulast%3DWalton%26aufirst%3DG.%26aulast%3DMann%26aufirst%3DE.%26aulast%3DLove%26aufirst%3DA.%26aulast%3DAaronson%26aufirst%3DN.%26aulast%3DInsall%26aufirst%3DR.%2BH.%26aulast%3DStockley%26aufirst%3DR.%2BA.%26aulast%3DLord%26aufirst%3DJ.%2BM.%26atitle%3DPhosphoinositide%25203-Kinase%2520Inhibition%2520Restores%2520Neutrophil%2520Accuracy%2520in%2520the%2520Elderly%253A%2520Toward%2520Targeted%2520Treatments%2520for%2520Immunosenescence%26jtitle%3DBlood%26date%3D2014%26volume%3D123%26issue%3D2%26spage%3D239%26epage%3D248%26doi%3D10.1182%2Fblood-2013-08-519520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maus, U. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Backi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rückle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paton, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briles, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mack, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welte, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maus, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohle, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seeger, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rommel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohmeyer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preissner, K. T.</span></span> <span> </span><span class="NLM_article-title">Importance of Phosphoinositide 3-Kinase γ in the Host Defense against Pneumococcal Infection</span>. <i>Am. J. Respir. Crit. Care Med.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>175</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">958</span>– <span class="NLM_lpage">966</span>, <span class="refDoi"> DOI: 10.1164/rccm.200610-1533OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1164%2Frccm.200610-1533OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=17322108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BD2sXls12ru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2007&pages=958-966&issue=9&author=U.+A.+Mausauthor=M.+Backiauthor=C.+Winterauthor=M.+Srivastavaauthor=M.+K.+Schwarzauthor=T.+R%C3%BCckleauthor=J.+C.+Patonauthor=D.+Brilesauthor=M.+Mackauthor=T.+Welteauthor=R.+Mausauthor=R.+M.+Bohleauthor=W.+Seegerauthor=C.+Rommelauthor=E.+Hirschauthor=J.+Lohmeyerauthor=K.+T.+Preissner&title=Importance+of+Phosphoinositide+3-Kinase+%CE%B3+in+the+Host+Defense+against+Pneumococcal+Infection&doi=10.1164%2Frccm.200610-1533OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Importance of phosphoinositide 3-kinase γ in the host defense against pneumococcal infection</span></div><div class="casAuthors">Maus, Ulrich A.; Backi, Myriam; Winter, Christine; Srivastava, Mrigank; Schwarz, Matthias K.; Rueckle, Thomas; Paton, James C.; Briles, David; Mack, Matthias; Welte, Tobias; Maus, Regina; Bohle, Rainer M.; Seeger, Werner; Rommel, Christian; Hirsch, Emilio; Lohmeyer, Juergen; Preissner, Klaus T.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory and Critical Care Medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">958-966</span>CODEN:
                <span class="NLM_cas:coden">AJCMED</span>;
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Rationale: The pivotal role of phosphoinositide 3-kinase γ (PI3Kγ) in leukocyte recruitment makes it an attractive target for immunomodulatory therapy.  However, interfering with PI3Kγ signaling might increase the risk of bacterial infections in humans.  Objectives: We hypothesized that deletion or pharmacol. inhibition of PI3Kγ would impair the lung inflammatory response to the prototypic gram-pos. bacterial pathogen Streptococcus pneumoniae.  Methods: PI3Kγ knockout (KO) and wild-type mice were infected with S. pneumoniae or challenged with the pneumococcal virulence factor pneumolysin (PLY), and inflammatory leukocyte recruitment, bacterial pathogen elimination, and resoln./repair processes were detd.  Measurements and Main Results: PI3Kγ KO mice challenged with PLY responded with lung edema and neutrophilic alveolitis, but showed a drop in alveolar macrophages and failed to recruit exudate macrophages when compared with wild-type mice.  S. pneumoniae-infected PI3Kγ KO mice and wild-type mice pretreated with the pharmacol. inhibitor AS-605240 recruited similar nos. of neutrophils but substantially fewer exudate macrophages into their lungs than control animals.  They also displayed a significantly reduced lung pneumococcal clearance and showed an impaired resoln./repair process, leading to progressive pneumococcal pneumonia.  Conclusions: PI3Kγ gene deletion or pharmacol. inhibition of PI3Kγ leads to perturbations of crit. innate immune responses of the lung to challenge with S. pneumoniae.  These data are of clin. relevance for the treatment of chronic inflammatory diseases where pharmacol. inhibition of PI3Kγ signaling to attenuate effector cell recruitment may have implications for innate immune surveillance of remote organ systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9WofA-p6NnrVg90H21EOLACvtfcHk0lhb_N6OAEJBgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXls12ru7k%253D&md5=fc2ced3374d5191c75ff664dfa5036eb</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1164%2Frccm.200610-1533OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.200610-1533OC%26sid%3Dliteratum%253Aachs%26aulast%3DMaus%26aufirst%3DU.%2BA.%26aulast%3DBacki%26aufirst%3DM.%26aulast%3DWinter%26aufirst%3DC.%26aulast%3DSrivastava%26aufirst%3DM.%26aulast%3DSchwarz%26aufirst%3DM.%2BK.%26aulast%3DR%25C3%25BCckle%26aufirst%3DT.%26aulast%3DPaton%26aufirst%3DJ.%2BC.%26aulast%3DBriles%26aufirst%3DD.%26aulast%3DMack%26aufirst%3DM.%26aulast%3DWelte%26aufirst%3DT.%26aulast%3DMaus%26aufirst%3DR.%26aulast%3DBohle%26aufirst%3DR.%2BM.%26aulast%3DSeeger%26aufirst%3DW.%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DHirsch%26aufirst%3DE.%26aulast%3DLohmeyer%26aufirst%3DJ.%26aulast%3DPreissner%26aufirst%3DK.%2BT.%26atitle%3DImportance%2520of%2520Phosphoinositide%25203-Kinase%2520%25CE%25B3%2520in%2520the%2520Host%2520Defense%2520against%2520Pneumococcal%2520Infection%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2007%26volume%3D175%26issue%3D9%26spage%3D958%26epage%3D966%26doi%3D10.1164%2Frccm.200610-1533OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavares, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dias, A. C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehdy, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarado-Arnez, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Queiroz-Junior, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galvão, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lima, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matos, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonçalves, A. P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soriani, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraes, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marques, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siqueira, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machado, A. M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sousa, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teixeira, M. M.</span></span> <span> </span><span class="NLM_article-title">Phosphatidyl Inositol 3 Kinase-Gamma Balances Antiviral and Inflammatory Responses During Influenza A H1N1 Infection: From Murine Model to Genetic Association in Patients</span>. <i>Front. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">975</span>, <span class="refDoi"> DOI: 10.3389/fimmu.2018.00975</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.3389%2Ffimmu.2018.00975" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=29867955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1Cqu7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=975&author=C.+C.+Garciaauthor=L.+P.+Tavaresauthor=A.+C.+F.+Diasauthor=F.+Kehdyauthor=L.+E.+Alvarado-Arnezauthor=C.+M.+Queiroz-Juniorauthor=I.+Galv%C3%A3oauthor=B.+H.+Limaauthor=A.+R.+Matosauthor=A.+P.+F.+Gon%C3%A7alvesauthor=F.+M.+Sorianiauthor=M.+O.+Moraesauthor=J.+T.+Marquesauthor=M.+M.+Siqueiraauthor=A.+M.+V.+Machadoauthor=L.+P.+Sousaauthor=R.+C.+Russoauthor=M.+M.+Teixeira&title=Phosphatidyl+Inositol+3+Kinase-Gamma+Balances+Antiviral+and+Inflammatory+Responses+During+Influenza+A+H1N1+Infection%3A+From+Murine+Model+to+Genetic+Association+in+Patients&doi=10.3389%2Ffimmu.2018.00975"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphatidyl inositol 3 kinase-gamma balances antiviral and inflammatory responses during influenza A H1N1 infection: from murine model to genetic association in patients</span></div><div class="casAuthors">Garcia, Cristiana C.; Tavares, Luciana P.; Dias, Ana Carolina F.; Kehdy, Fernanda; Alvarado-Arnez, Lucia Elena; Queiroz-Junior, Celso M.; Galvao, Izabela; Lima, Braulio H.; Matos, Aline R.; Goncalves, Ana Paula F.; Soriani, Frederico M.; Moraes, Milton O.; Marques, Joao T.; Siqueira, Marilda M.; Machado, Alexandre M. V.; Sousa, Lirlandia P.; Russo, Remo C.; Teixeira, Mauro M.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Immunology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">975/1-975/18</span>CODEN:
                <span class="NLM_cas:coden">FIRMCW</span>;
        ISSN:<span class="NLM_cas:issn">1664-3224</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Influenza A virus (IAV) infection causes severe pulmonary disease characterized by intense leukocyte infiltration.  Phosphoinositide-3 kinases (PI3Ks) are central signaling enzymes, involved in cell growth, survival, and migration.  Class IB PI3K or phosphatidyl inositol 3 kinase-gamma (PI3K γ), mainly expressed by leukocytes, is involved in cell migration during inflammation.  Here, we investigated the contribution of PI3K γ for the inflammatory and antiviral responses to IAV.  PI3K γ knockout (KO) mice were highly susceptible to lethality following infection with influenza A/WSN/33 H1N1.  In the early time points of infection, infiltration of neutrophils was higher than WT mice whereas type-I and type-III IFN expression and p38 activation were reduced in PI3K γ KO mice resulting in higher viral loads when compared with WT mice.  Blockade of p38 in WT macrophages infected with IAV reduced levels of interferon-stimulated gene 15 protein to those induced in PI3K γ KO macrophages, suggesting that p38 is downstream of antiviral responses mediated by PI3K γ.  PI3K γ KO-derived fibroblasts or macrophages showed reduced type-I IFN transcription and altered pro-inflammatory cytokines suggesting a cell autonomous imbalance between inflammatory and antiviral responses.  Seven days after IAV infection, there were reduced infiltration of natural killer cells and CD8+ T lymphocytes, increased concn. of inflammatory cytokines in bronchoalveolar fluid, reduced nos. of resolving macrophages, and IL-10 levels in PI3K γ KO.  This imbalanced environment in PI3K γ KO-infected mice culminated in enhanced lung neutrophil infiltration, reactive oxygen species release, and lung damage that together with the increased viral loads, contributed to higher mortality in PI3K γ KO mice compared with WT mice.  In humans, we tested the genetic assocn. of disease severity in influenza A/H1N1pdm09-infected patients with three potentially functional PIK3CG single-nucleotide polymorphisms (SNPs), rs1129293, rs17847825, and rs2230460.  We obsd. that SNPs rs17847825 and rs2230460 (A and T alleles, resp.) were significantly assocd. with protection from severe disease using the recessive model in patients infected with influenza A(H1N1)pdm09.  Altogether, our results suggest that PI3K γ is crucial in balancing antiviral and inflammatory responses to IAV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIFUkPV_mYwrVg90H21EOLACvtfcHk0lhb_N6OAEJBgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1Cqu7rO&md5=a6539381a1e742799fa711785cc10eac</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2018.00975&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2018.00975%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia%26aufirst%3DC.%2BC.%26aulast%3DTavares%26aufirst%3DL.%2BP.%26aulast%3DDias%26aufirst%3DA.%2BC.%2BF.%26aulast%3DKehdy%26aufirst%3DF.%26aulast%3DAlvarado-Arnez%26aufirst%3DL.%2BE.%26aulast%3DQueiroz-Junior%26aufirst%3DC.%2BM.%26aulast%3DGalv%25C3%25A3o%26aufirst%3DI.%26aulast%3DLima%26aufirst%3DB.%2BH.%26aulast%3DMatos%26aufirst%3DA.%2BR.%26aulast%3DGon%25C3%25A7alves%26aufirst%3DA.%2BP.%2BF.%26aulast%3DSoriani%26aufirst%3DF.%2BM.%26aulast%3DMoraes%26aufirst%3DM.%2BO.%26aulast%3DMarques%26aufirst%3DJ.%2BT.%26aulast%3DSiqueira%26aufirst%3DM.%2BM.%26aulast%3DMachado%26aufirst%3DA.%2BM.%2BV.%26aulast%3DSousa%26aufirst%3DL.%2BP.%26aulast%3DRusso%26aufirst%3DR.%2BC.%26aulast%3DTeixeira%26aufirst%3DM.%2BM.%26atitle%3DPhosphatidyl%2520Inositol%25203%2520Kinase-Gamma%2520Balances%2520Antiviral%2520and%2520Inflammatory%2520Responses%2520During%2520Influenza%2520A%2520H1N1%2520Infection%253A%2520From%2520Murine%2520Model%2520to%2520Genetic%2520Association%2520in%2520Patients%26jtitle%3DFront.%2520Immunol.%26date%3D2018%26volume%3D9%26spage%3D975%26doi%3D10.3389%2Ffimmu.2018.00975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zelenetz, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrientos, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coiffier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egyed, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghia, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Illés, Á.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jurczak, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marlton, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montillo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morschhauser, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pristupa, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robak, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharman, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smolej, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tausch, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adewoye, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dreiling, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stilgenbauer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillmen, P.</span></span> <span> </span><span class="NLM_article-title">Idelalisib or Placebo in Combination with Bendamustine and Rituximab in Patients with Relapsed or Refractory Chronic Lymphocytic Leukaemia: Interim Results from a Phase 3, Randomised, Double-Blind, Placebo-Controlled Trial</span>. <i>Lancet Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">297</span>– <span class="NLM_lpage">311</span>, <span class="refDoi"> DOI: 10.1016/S1470-2045(16)30671-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2FS1470-2045%2816%2930671-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=28139405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslSlsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=297-311&issue=3&author=A.+D.+Zelenetzauthor=J.+C.+Barrientosauthor=J.+R.+Brownauthor=B.+Coiffierauthor=J.+Delgadoauthor=M.+Egyedauthor=P.+Ghiaauthor=%C3%81.+Ill%C3%A9sauthor=W.+Jurczakauthor=P.+Marltonauthor=M.+Montilloauthor=F.+Morschhauserauthor=A.+S.+Pristupaauthor=T.+Robakauthor=J.+P.+Sharmanauthor=D.+Simpsonauthor=L.+Smolejauthor=E.+Tauschauthor=A.+H.+Adewoyeauthor=L.+K.+Dreilingauthor=Y.+Kimauthor=S.+Stilgenbauerauthor=P.+Hillmen&title=Idelalisib+or+Placebo+in+Combination+with+Bendamustine+and+Rituximab+in+Patients+with+Relapsed+or+Refractory+Chronic+Lymphocytic+Leukaemia%3A+Interim+Results+from+a+Phase+3%2C+Randomised%2C+Double-Blind%2C+Placebo-Controlled+Trial&doi=10.1016%2FS1470-2045%2816%2930671-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial</span></div><div class="casAuthors">Zelenetz, Andrew D.; Barrientos, Jacqueline C.; Brown, Jennifer R.; Coiffier, Bertrand; Delgado, Julio; Egyed, Miklos; Ghia, Paolo; Illes, Arpad; Jurczak, Wojciech; Marlton, Paula; Montillo, Marco; Morschhauser, Franck; Pristupa, Alexander S.; Robak, Tadeusz; Sharman, Jeff P.; Simpson, David; Smolej, Lukas; Tausch, Eugen; Adewoye, Adeboye H.; Dreiling, Lyndah K.; Kim, Yeonhee; Stilgenbauer, Stephan; Hillmen, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-311</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Bendamustine plus rituximab is a std. of care for the management of patients with relapsed or refractory chronic lymphocytic leukemia.  New therapies are needed to improve clin. relevant outcomes in these patients.  We assessed the efficacy and safety of adding idelalisib, a first-in-class targeted phosphoinositide-3-kinase δ inhibitor, to bendamustine plus rituximab in this population.  For this international, multicentre, double-blind, placebo-controlled trial, adult patients (≥18 years) with relapsed or refractory chronic lymphocytic leukemia requiring treatment who had measurable lymphadenopathy by CT or MRI and disease progression within 36 mo since their last previous therapy were enrolled.  Patients were randomly assigned (1:1) by a central interactive web response system to receive bendamustine plus rituximab for a max. of six cycles (bendamustine: 70 mg/m2 i.v. on days 1 and 2 for six 28-day cycles; rituximab: 375 mg/m2 on day 1 of cycle 1, and 500 mg/m2 on day 1 of cycles 2-6) in addn. to either twice-daily oral idelalisib (150 mg) or placebo until disease progression or intolerable study drug-related toxicity.  Randomisation was stratified by high-risk features (IGHV, del[17p], or TP53 mutation) and refractory vs. relapsed disease.  The primary endpoint was progression-free survival assessed by an independent review committee in the intention-to-treat population.  This trial is ongoing and is registered with ClinicalTrials.gov, no. NCT01569295.  Between June 26, 2012, and Aug 21, 2014, 416 patients were enrolled and randomly assigned to the idelalisib (n=207) and placebo (n=209) groups.  At a median follow-up of 14 mo (IQR 7-18), median progression-free survival was 20·8 mo (95% CI 16·6-26·4) in the idelalisib group and 11·1 mo (8·9-11·1) in the placebo group (hazard ratio [HR] 0·33, 95% CI 0·25-0·44; p<0·0001).  The most frequent grade 3 or worse adverse events in the idelalisib group were neutropenia (124 [60%] of 207 patients) and febrile neutropenia (48 [23%]), whereas in the placebo group they were neutropenia (99 [47%] of 209) and thrombocytopenia (27 [13%]).  An increased risk of infection was reported in the idelalisib group compared with the placebo group (grade ≥3 infections and infestations: 80 [39%] of 207 vs 52 [25%] of 209).  Serious adverse events, including febrile neutropenia, pneumonia, and pyrexia, were more common in the idelalisib group (140 [68%] of 207 patients) than in the placebo group (92 [44%] of 209).  Treatment-emergent adverse events leading to death occurred in 23 (11%) patients in the idelalisib group and 15 (7%) in the placebo group, including six deaths from infections in the idelalisib group and three from infections in the placebo group.  Idelalisib in combination with bendamustine plus rituximab improved progression-free survival compared with bendamustine plus rituximab alone in patients with relapsed or refractory chronic lymphocytic leukemia.  However, careful attention needs to be paid to management of serious adverse events and infections assocd. with this regimen during treatment selection.Gilead Sciences Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2ueUBdljrRrVg90H21EOLACvtfcHk0lhb_N6OAEJBgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslSlsL8%253D&md5=42826c924d88962211c8c6a9a9b74ab5</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2816%2930671-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252816%252930671-4%26sid%3Dliteratum%253Aachs%26aulast%3DZelenetz%26aufirst%3DA.%2BD.%26aulast%3DBarrientos%26aufirst%3DJ.%2BC.%26aulast%3DBrown%26aufirst%3DJ.%2BR.%26aulast%3DCoiffier%26aufirst%3DB.%26aulast%3DDelgado%26aufirst%3DJ.%26aulast%3DEgyed%26aufirst%3DM.%26aulast%3DGhia%26aufirst%3DP.%26aulast%3DIll%25C3%25A9s%26aufirst%3D%25C3%2581.%26aulast%3DJurczak%26aufirst%3DW.%26aulast%3DMarlton%26aufirst%3DP.%26aulast%3DMontillo%26aufirst%3DM.%26aulast%3DMorschhauser%26aufirst%3DF.%26aulast%3DPristupa%26aufirst%3DA.%2BS.%26aulast%3DRobak%26aufirst%3DT.%26aulast%3DSharman%26aufirst%3DJ.%2BP.%26aulast%3DSimpson%26aufirst%3DD.%26aulast%3DSmolej%26aufirst%3DL.%26aulast%3DTausch%26aufirst%3DE.%26aulast%3DAdewoye%26aufirst%3DA.%2BH.%26aulast%3DDreiling%26aufirst%3DL.%2BK.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DStilgenbauer%26aufirst%3DS.%26aulast%3DHillmen%26aufirst%3DP.%26atitle%3DIdelalisib%2520or%2520Placebo%2520in%2520Combination%2520with%2520Bendamustine%2520and%2520Rituximab%2520in%2520Patients%2520with%2520Relapsed%2520or%2520Refractory%2520Chronic%2520Lymphocytic%2520Leukaemia%253A%2520Interim%2520Results%2520from%2520a%2520Phase%25203%252C%2520Randomised%252C%2520Double-Blind%252C%2520Placebo-Controlled%2520Trial%26jtitle%3DLancet%2520Oncol.%26date%3D2017%26volume%3D18%26issue%3D3%26spage%3D297%26epage%3D311%26doi%3D10.1016%2FS1470-2045%2816%2930671-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robak, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awan, F. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badoux, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coutre, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loscertales, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenberghe, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wach, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner-Johnston, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ysebaert, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dreiling, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubowy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flinn, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, C.</span></span> <span> </span><span class="NLM_article-title">Efficacy and Safety of Idelalisib in Combination with Ofatumumab for Previously Treated Chronic Lymphocytic Leukaemia: An Open-Label, Randomised Phase 3 Trial</span>. <i>Lancet. Haematol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">e114</span>– <span class="NLM_lpage">e126</span>, <span class="refDoi"> DOI: 10.1016/S2352-3026(17)30019-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2FS2352-3026%2817%2930019-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=28257752" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2017&pages=e114-e126&issue=3&author=J.+A.+Jonesauthor=T.+Robakauthor=J.+R.+Brownauthor=F.+T.+Awanauthor=X.+Badouxauthor=S.+Coutreauthor=J.+Loscertalesauthor=K.+Taylorauthor=E.+Vandenbergheauthor=M.+Wachauthor=N.+Wagner-Johnstonauthor=L.+Ysebaertauthor=L.+Dreilingauthor=R.+Dubowyauthor=G.+Xingauthor=I.+W.+Flinnauthor=C.+Owen&title=Efficacy+and+Safety+of+Idelalisib+in+Combination+with+Ofatumumab+for+Previously+Treated+Chronic+Lymphocytic+Leukaemia%3A+An+Open-Label%2C+Randomised+Phase+3+Trial&doi=10.1016%2FS2352-3026%2817%2930019-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2FS2352-3026%2817%2930019-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS2352-3026%252817%252930019-4%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DJ.%2BA.%26aulast%3DRobak%26aufirst%3DT.%26aulast%3DBrown%26aufirst%3DJ.%2BR.%26aulast%3DAwan%26aufirst%3DF.%2BT.%26aulast%3DBadoux%26aufirst%3DX.%26aulast%3DCoutre%26aufirst%3DS.%26aulast%3DLoscertales%26aufirst%3DJ.%26aulast%3DTaylor%26aufirst%3DK.%26aulast%3DVandenberghe%26aufirst%3DE.%26aulast%3DWach%26aufirst%3DM.%26aulast%3DWagner-Johnston%26aufirst%3DN.%26aulast%3DYsebaert%26aufirst%3DL.%26aulast%3DDreiling%26aufirst%3DL.%26aulast%3DDubowy%26aufirst%3DR.%26aulast%3DXing%26aufirst%3DG.%26aulast%3DFlinn%26aufirst%3DI.%2BW.%26aulast%3DOwen%26aufirst%3DC.%26atitle%3DEfficacy%2520and%2520Safety%2520of%2520Idelalisib%2520in%2520Combination%2520with%2520Ofatumumab%2520for%2520Previously%2520Treated%2520Chronic%2520Lymphocytic%2520Leukaemia%253A%2520An%2520Open-Label%252C%2520Randomised%2520Phase%25203%2520Trial%26jtitle%3DLancet.%2520Haematol.%26date%3D2017%26volume%3D4%26issue%3D3%26spage%3De114%26epage%3De126%26doi%3D10.1016%2FS2352-3026%2817%2930019-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Horwitz, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porcu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moskowitz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myskowski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Officer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaffe, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrow, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douglas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aster, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weaver, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foss, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstock, D. M.</span></span> <span> </span><span class="NLM_article-title">Activity of the PI3K-δ,γ Inhibitor Duvelisib in a Phase 1 Trial and Preclinical Models of T-Cell Lymphoma</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>131</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">888</span>– <span class="NLM_lpage">898</span>, <span class="refDoi"> DOI: 10.1182/blood-2017-08-802470</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1182%2Fblood-2017-08-802470" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2018&pages=888-898&issue=8&author=S.+M.+Horwitzauthor=R.+Kochauthor=P.+Porcuauthor=Y.+Okiauthor=A.+Moskowitzauthor=M.+Perezauthor=P.+Myskowskiauthor=A.+Officerauthor=J.+D.+Jaffeauthor=S.+N.+Morrowauthor=K.+Allenauthor=M.+Douglasauthor=H.+Sternauthor=J.+Sweeneyauthor=P.+Kellyauthor=V.+Kellyauthor=J.+C.+Asterauthor=D.+Weaverauthor=F.+M.+Fossauthor=D.+M.+Weinstock&title=Activity+of+the+PI3K-%CE%B4%2C%CE%B3+Inhibitor+Duvelisib+in+a+Phase+1+Trial+and+Preclinical+Models+of+T-Cell+Lymphoma&doi=10.1182%2Fblood-2017-08-802470"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1182%2Fblood-2017-08-802470&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2017-08-802470%26sid%3Dliteratum%253Aachs%26aulast%3DHorwitz%26aufirst%3DS.%2BM.%26aulast%3DKoch%26aufirst%3DR.%26aulast%3DPorcu%26aufirst%3DP.%26aulast%3DOki%26aufirst%3DY.%26aulast%3DMoskowitz%26aufirst%3DA.%26aulast%3DPerez%26aufirst%3DM.%26aulast%3DMyskowski%26aufirst%3DP.%26aulast%3DOfficer%26aufirst%3DA.%26aulast%3DJaffe%26aufirst%3DJ.%2BD.%26aulast%3DMorrow%26aufirst%3DS.%2BN.%26aulast%3DAllen%26aufirst%3DK.%26aulast%3DDouglas%26aufirst%3DM.%26aulast%3DStern%26aufirst%3DH.%26aulast%3DSweeney%26aufirst%3DJ.%26aulast%3DKelly%26aufirst%3DP.%26aulast%3DKelly%26aufirst%3DV.%26aulast%3DAster%26aufirst%3DJ.%2BC.%26aulast%3DWeaver%26aufirst%3DD.%26aulast%3DFoss%26aufirst%3DF.%2BM.%26aulast%3DWeinstock%26aufirst%3DD.%2BM.%26atitle%3DActivity%2520of%2520the%2520PI3K-%25CE%25B4%252C%25CE%25B3%2520Inhibitor%2520Duvelisib%2520in%2520a%2520Phase%25201%2520Trial%2520and%2520Preclinical%2520Models%2520of%2520T-Cell%2520Lymphoma%26jtitle%3DBlood%26date%3D2018%26volume%3D131%26issue%3D8%26spage%3D888%26epage%3D898%26doi%3D10.1182%2Fblood-2017-08-802470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheah, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fowler, N. H.</span></span> <span> </span><span class="NLM_article-title">Idelalisib in the Management of Lymphoma</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>128</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">331</span>– <span class="NLM_lpage">336</span>, <span class="refDoi"> DOI: 10.1182/blood-2016-02-702761</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1182%2Fblood-2016-02-702761" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2016&pages=331-336&issue=3&author=C.+Y.+Cheahauthor=N.+H.+Fowler&title=Idelalisib+in+the+Management+of+Lymphoma&doi=10.1182%2Fblood-2016-02-702761"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1182%2Fblood-2016-02-702761&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2016-02-702761%26sid%3Dliteratum%253Aachs%26aulast%3DCheah%26aufirst%3DC.%2BY.%26aulast%3DFowler%26aufirst%3DN.%2BH.%26atitle%3DIdelalisib%2520in%2520the%2520Management%2520of%2520Lymphoma%26jtitle%3DBlood%26date%3D2016%26volume%3D128%26issue%3D3%26spage%3D331%26epage%3D336%26doi%3D10.1182%2Fblood-2016-02-702761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span>TG Therapeutics,
Inc. Announces First Patient Enrolled in the Registration-Directed
UNITY-DLBCL Phase 2b Trial. TG Therapeutics, Inc. <a href="http://ir.tgtherapeutics.com/news-releases/news-release-details/tg-therapeutics-inc-announces-first-patient-enrolled?ReleaseID=974602" class="extLink">http://ir.tgtherapeutics.com/news-releases/news-release-details/tg-therapeutics-inc-announces-first-patient-enrolled?ReleaseID=974602</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=TG+Therapeutics%2C%0AInc.+Announces+First+Patient+Enrolled+in+the+Registration-Directed%0AUNITY-DLBCL+Phase+2b+Trial.+TG+Therapeutics%2C+Inc.+http%3A%2F%2Fir.tgtherapeutics.com%2Fnews-releases%2Fnews-release-details%2Ftg-therapeutics-inc-announces-first-patient-enrolled%3FReleaseID%3D974602+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span>Study
To Assess the Efficacy and Safety of Ublituximab + TGR-1202 with or
without Bendamustine and TGR-1202 Alone in Patients with Previously
Treated Non-Hodgkins Lymphoma. ClinicalTrials.gov. <a href="https://clinicaltrials.gov/ct2/show/NCT02793583" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02793583</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Study%0ATo+Assess+the+Efficacy+and+Safety+of+Ublituximab+%2B+TGR-1202+with+or%0Awithout+Bendamustine+and+TGR-1202+Alone+in+Patients+with+Previously%0ATreated+Non-Hodgkins+Lymphoma.+ClinicalTrials.gov.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02793583+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span>TG Therapeutics
Announces Orphan Drug Designation for the Combination of TG-1101 and
TGR-1202 for Treatment of Chronic Lymphocytic Leukemia. <a href="http://ir.tgtherapeutics.com/news-releases/news-release-details/tg-therapeutics-announces-orphan-drug-designation-combination-tg" class="extLink">ir.tgtherapeutics.com/news-releases/news-release-details/tg-therapeutics-announces-orphan-drug-designation-combination-tg</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=TG+Therapeutics%0AAnnounces+Orphan+Drug+Designation+for+the+Combination+of+TG-1101+and%0ATGR-1202+for+Treatment+of+Chronic+Lymphocytic+Leukemia.+ir.tgtherapeutics.com%2Fnews-releases%2Fnews-release-details%2Ftg-therapeutics-announces-orphan-drug-designation-combination-tg+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span>Ublituximab
+ TGR-1202 Compared to Obinutuzumab + Chlorambucil in Patients with
Untreated and Previously Treated Chronic Lymphocytic Leukemia. ClinicalTrials.gov. <a href="https://clinicaltrials.gov/ct2/show/NCT02612311" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02612311</a> (accessed Jun 19, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Ublituximab%0A%2B+TGR-1202+Compared+to+Obinutuzumab+%2B+Chlorambucil+in+Patients+with%0AUntreated+and+Previously+Treated+Chronic+Lymphocytic+Leukemia.+ClinicalTrials.gov.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02612311+%28accessed+Jun+19%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span>Acalabrutinib
in Combination with ACP-319, for Treatment of Chronic Lymphocytic
Leukemia. ClinicalTrials.gov. <a href="https://www.clinicaltrials.gov/ct2/show/NCT02157324" class="extLink">https://www.clinicaltrials.gov/ct2/show/NCT02157324</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Acalabrutinib%0Ain+Combination+with+ACP-319%2C+for+Treatment+of+Chronic+Lymphocytic%0ALeukemia.+ClinicalTrials.gov.+https%3A%2F%2Fwww.clinicaltrials.gov%2Fct2%2Fshow%2FNCT02157324+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span>ACP-196
in Combination with ACP-319, for Treatment of B-Cell Malignancies.
ClinicalTrials.gov. <a href="https://www.clinicaltrials.gov/ct2/show/NCT02328014" class="extLink">https://www.clinicaltrials.gov/ct2/show/NCT02328014</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ACP-196%0Ain+Combination+with+ACP-319%2C+for+Treatment+of+B-Cell+Malignancies.%0AClinicalTrials.gov.+https%3A%2F%2Fwww.clinicaltrials.gov%2Fct2%2Fshow%2FNCT02328014+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span>A Phase
1/2, Open-Label, Dose Escalation, Safety and Tolerability Study of
INCB050465 and Itacitinib (INCB039110) in Subjects with Previously
Treated B-Cell Malignancies (CITADEL-101). ClinicalTrials.gov. <a href="https://clinicaltrials.gov/ct2/show/NCT02018861" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02018861</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Phase%0A1%2F2%2C+Open-Label%2C+Dose+Escalation%2C+Safety+and+Tolerability+Study+of%0AINCB050465+and+Itacitinib+%28INCB039110%29+in+Subjects+with+Previously%0ATreated+B-Cell+Malignancies+%28CITADEL-101%29.+ClinicalTrials.gov.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02018861+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span>A Study
of HMPL-689 in Healthy Volunteers. ClinicalTrials.gov. <a href="https://clinicaltrials.gov/ct2/show/NCT02631642" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02631642</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Study%0Aof+HMPL-689+in+Healthy+Volunteers.+ClinicalTrials.gov.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02631642+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span>Assessment
of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of
Various Formulations and Doses of PWT-143. ClinicalTrials.gov. <a href="https://clinicaltrials.gov/ct2/show/NCT02521389" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02521389</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Assessment%0Aof+Safety%2C+Tolerability%2C+Pharmacokinetics+and+Pharmacodynamics+of%0AVarious+Formulations+and+Doses+of+PWT-143.+ClinicalTrials.gov.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02521389+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soumerai, J. D.</span>; <span class="NLM_string-name">Pagel, J. M.</span>; <span class="NLM_string-name">Jagadeesh, D.</span>; <span class="NLM_string-name">Salman, H. S.</span>; <span class="NLM_string-name">Kenkre, V. P.</span>; <span class="NLM_string-name">Asch, A. S.</span>; <span class="NLM_string-name">Stathis, A.</span>; <span class="NLM_string-name">Reddy, N.
M.</span>; <span class="NLM_string-name">Iasonos, A.</span>; <span class="NLM_string-name">Ghalie, R.</span>; <span class="NLM_string-name">Zelenetz, A. D.</span></span> <span> </span><span class="NLM_article-title">Initial Results of a Dose Escalation Study of a Selective and Structurally Differentiated PI3Kδ Inhibitor, ME-401, in Relapsed/Refractory (R/R) Follicular Lymphoma (FL) and Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)</span>. In  <i>Journal of Clinical Oncology</i>, 2018 Annual Meeting of the American Society of Clinical Oncology (ASCO); <span class="NLM_publisher-name">ASCO</span>, <span class="NLM_year">2018</span>; 7519, <a href="http://ascopubs.org/doi/abs/10.1200/JCO.2018.36.15_suppl.7519" class="extLink">http://ascopubs.org/doi/abs/10.1200/JCO.2018.36.15_suppl.7519</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1200%2FJCO.2018.36.15_suppl.7519" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=J.+D.+Soumerai&author=J.+M.+Pagel&author=D.+Jagadeesh&author=H.+S.+Salman&author=V.+P.+Kenkre&author=A.+S.+Asch&author=A.+Stathis&author=N.%0AM.+Reddy&author=A.+Iasonos&author=R.+Ghalie&author=A.+D.+Zelenetz&title=Journal+of+Clinical+Oncology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1200%2FJCO.2018.36.15_suppl.7519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1200%252FJCO.2018.36.15_suppl.7519%26sid%3Dliteratum%253Aachs%26aulast%3DSoumerai%26aufirst%3DJ.%2BD.%26atitle%3DInitial%2520Results%2520of%2520a%2520Dose%2520Escalation%2520Study%2520of%2520a%2520Selective%2520and%2520Structurally%2520Differentiated%2520PI3K%25CE%25B4%2520Inhibitor%252C%2520ME-401%252C%2520in%2520Relapsed%252FRefractory%2520%2528R%252FR%2529%2520Follicular%2520Lymphoma%2520%2528FL%2529%2520and%2520Chronic%2520Lymphocytic%2520Leukemia%2520%2528CLL%2529%252FSmall%2520Lymphocytic%2520Lymphoma%2520%2528SLL%2529%26btitle%3DJournal%2520of%2520Clinical%2520Oncology%26pub%3DASCO%26date%3D2018%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span>MEI Pharma
Reports Third Quarter Fiscal Year 2018 Results. May 9, 2018. <a href="http://investor.meipharma.com/2018-05-09-MEI-Pharma-Reports-Third-Quarter-Fiscal-Year-2018-Results" class="extLink">http://investor.meipharma.com/2018-05-09-MEI-Pharma-Reports-Third-Quarter-Fiscal-Year-2018-Results</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=MEI+Pharma%0AReports+Third+Quarter+Fiscal+Year+2018+Results.+May+9%2C+2018.+http%3A%2F%2Finvestor.meipharma.com%2F2018-05-09-MEI-Pharma-Reports-Third-Quarter-Fiscal-Year-2018-Results+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span>Study
of INCB040093 in Subjects with Previously Treated B-Cell Malignancies. <a href="https://clinicaltrials.gov/ct2/show/study/NCT01905813" class="extLink">https://clinicaltrials.gov/ct2/show/study/NCT01905813</a> (accessed May 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Study%0Aof+INCB040093+in+Subjects+with+Previously+Treated+B-Cell+Malignancies.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2Fstudy%2FNCT01905813+%28accessed+May+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span>A Study
To Investigate the Efficacy, Safety, and Tolerability of Repeat Doses
of Inhaled GSK2269557 in Adults with Persistent, Uncontrolled Asthma.
ClinicalTrials.gov. <a href="https://clinicaltrials.gov/ct2/show/NCT02567708" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02567708</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Study%0ATo+Investigate+the+Efficacy%2C+Safety%2C+and+Tolerability+of+Repeat+Doses%0Aof+Inhaled+GSK2269557+in+Adults+with+Persistent%2C+Uncontrolled+Asthma.%0AClinicalTrials.gov.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02567708+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span>A Study
To Evaluate the Safety, Efficacy and Changes in Induced Sputum and
Blood Biomarkers Following Daily Repeat Doses of Inhaled GSK2269557
in Chronic Obstructive Pulmonary Disease (COPD) Subjects with Acute
Exacerbation. ClinicalTrials.gov. <a href="https://clinicaltrials.gov/ct2/show/NCT02522299" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02522299</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Study%0ATo+Evaluate+the+Safety%2C+Efficacy+and+Changes+in+Induced+Sputum+and%0ABlood+Biomarkers+Following+Daily+Repeat+Doses+of+Inhaled+GSK2269557%0Ain+Chronic+Obstructive+Pulmonary+Disease+%28COPD%29+Subjects+with+Acute%0AExacerbation.+ClinicalTrials.gov.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02522299+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span>Safety,
Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Repeat Doses
of Inhaled GSK2269557 in Patients with APDS/PASLI. ClinicalTrials.gov. <a href="https://clinicaltrials.gov/ct2/show/NCT02593539" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02593539</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Safety%2C%0APharmacokinetic+%28PK%29+and+Pharmacodynamic+%28PD%29+Study+of+Repeat+Doses%0Aof+Inhaled+GSK2269557+in+Patients+with+APDS%2FPASLI.+ClinicalTrials.gov.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02593539+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span>Safety,
Tolerability and Pharmacokinetics of Single and Repeat Doses of GSK2292767
in Healthy Participants Who Smoke Cigarettes. ClinicalTrials.gov. <a href="https://clinicaltrials.gov/ct2/show/record/NCT03045887" class="extLink">https://clinicaltrials.gov/ct2/show/record/NCT03045887</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Safety%2C%0ATolerability+and+Pharmacokinetics+of+Single+and+Repeat+Doses+of+GSK2292767%0Ain+Healthy+Participants+Who+Smoke+Cigarettes.+ClinicalTrials.gov.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2Frecord%2FNCT03045887+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khindri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cahn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Begg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montembault, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leemereise, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wajdner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamblin, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludwig-Sengpiel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornmann, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hessel, E.</span></span> <span> </span><span class="NLM_article-title">A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Crossover Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of Repeat Doses of Inhaled Nemiralisib in Adults with Persistent, Uncontrolled Asthma</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>367</i></span>,  <span class="NLM_fpage">405</span>– <span class="NLM_lpage">413</span>, <span class="refDoi"> DOI: 10.1124/jpet.118.249516</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1124%2Fjpet.118.249516" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=30217958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVWgsr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2018&pages=405-413&author=S.+Khindriauthor=A.+Cahnauthor=M.+Beggauthor=M.+Montembaultauthor=C.+Leemereiseauthor=Y.+Cuiauthor=A.+Hoggauthor=H.+Wajdnerauthor=S.+Yangauthor=J.+Robertsonauthor=J.+N.+Hamblinauthor=A.+Ludwig-Sengpielauthor=O.+Kornmannauthor=E.+Hessel&title=A+Multicentre%2C+Randomised%2C+Double-Blind%2C+Placebo-Controlled%2C+Crossover+Study+to+Investigate+the+Efficacy%2C+Safety%2C+Tolerability+and+Pharmacokinetics+of+Repeat+Doses+of+Inhaled+Nemiralisib+in+Adults+with+Persistent%2C+Uncontrolled+Asthma&doi=10.1124%2Fjpet.118.249516"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">A multicentre, randomized, double-blind, placebo-controlled, crossover study to investigate the efficacy, safety, tolerability, and pharmacokinetics of repeat doses of inhaled nemiralisib in adults with persistent, uncontrolled asthma</span></div><div class="casAuthors">Khindri, Sanjeev; Cahn, Anthony; Begg, Malcolm; Montembault, Mickael; Leemereise, Claudia; Cui, Yi; Hogg, Annabel; Wajdner, Hannah; Yang, Shuying; Robertson, Jon; Hamblin, J. Nicole; Ludwig-Sengpiel, Andrea; Kornmann, Oliver; Hessel, Edith M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">405-413</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Phosphoinositide 3-kinase δ (PI3Kδ) is a lipid kinase involved in leukocyte recruitment and activation.  Activation of PI3Kδ has been linked to airway inflammation and asthma pathogenesis.  This randomized, double-blind, placebo-controlled, crossover study investigated the efficacy, safety, tolerability, and pharmacokinetics of a PI3Kδ inhibitor, nemiralisib (GSK2269557), in patients with persistent, uncontrolled asthma.  Patients (n = 50) received once-daily inhaled nemiralisib (1000 μg) or placebo for 28 days, with a crossover to the alternative treatment following a 4-wk washout period.  Spirometry demonstrated no discernible difference in trough forced expiratory vol. in 1 s (FEV1) from baseline (adjusted posterior median 7 mL; 95% credible interval -83, 102 mL) between nemiralisib and placebo treatment at day 28 (primary endpoint).  These results were supported by most secondary endpoints, including weighted mean FEV1 (0-4 h) and change in trough forced vital capacity at day 28.  Nemiralisib was generally well-tolerated, with few side effects except for post-inhalation cough (nemiralisib: 35%; placebo: 9%).  At day 14, sputum interleukin (IL)-5, IL-13, IL-6, and IL-8 levels were reduced by a median of 17%, 7%, 15%, and 8%, resp., when comparing nemiralisib with placebo [n = 15 (IL-5, IL-8) or 16 (IL-6, IL-13); posterior probability of a true ratio. >0%: 78%, 64%, 76%, and 63%, resp.].  These results suggest that nemiralisib inhibited PI3Kδ locally; however, this did not translate into meaningful clin. improvement.  Further studies will investigate the potential efficacy of nemiralisib in patients with asthma with other specific more severe phenotypes, including those who are colonized with bacteria and frequently exacerbate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYx837TIJvr7Vg90H21EOLACvtfcHk0liz09Vz0qR4NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVWgsr%252FO&md5=fbad4b66d64f945225b2bdccfd88dd57</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1124%2Fjpet.118.249516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.118.249516%26sid%3Dliteratum%253Aachs%26aulast%3DKhindri%26aufirst%3DS.%26aulast%3DCahn%26aufirst%3DA.%26aulast%3DBegg%26aufirst%3DM.%26aulast%3DMontembault%26aufirst%3DM.%26aulast%3DLeemereise%26aufirst%3DC.%26aulast%3DCui%26aufirst%3DY.%26aulast%3DHogg%26aufirst%3DA.%26aulast%3DWajdner%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DRobertson%26aufirst%3DJ.%26aulast%3DHamblin%26aufirst%3DJ.%2BN.%26aulast%3DLudwig-Sengpiel%26aufirst%3DA.%26aulast%3DKornmann%26aufirst%3DO.%26aulast%3DHessel%26aufirst%3DE.%26atitle%3DA%2520Multicentre%252C%2520Randomised%252C%2520Double-Blind%252C%2520Placebo-Controlled%252C%2520Crossover%2520Study%2520to%2520Investigate%2520the%2520Efficacy%252C%2520Safety%252C%2520Tolerability%2520and%2520Pharmacokinetics%2520of%2520Repeat%2520Doses%2520of%2520Inhaled%2520Nemiralisib%2520in%2520Adults%2520with%2520Persistent%252C%2520Uncontrolled%2520Asthma%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2018%26volume%3D367%26spage%3D405%26epage%3D413%26doi%3D10.1124%2Fjpet.118.249516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span>Dose
Finding Study of Nemiralisib (GSK2269557) in Subjects with an Acute
Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease
(COPD). ClinicalTrials.gov. <a href="https://www.clinicaltrials.gov/ct2/show/NCT03345407" class="extLink">https://www.clinicaltrials.gov/ct2/show/NCT03345407</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Dose%0AFinding+Study+of+Nemiralisib+%28GSK2269557%29+in+Subjects+with+an+Acute%0AModerate+or+Severe+Exacerbation+of+Chronic+Obstructive+Pulmonary+Disease%0A%28COPD%29.+ClinicalTrials.gov.+https%3A%2F%2Fwww.clinicaltrials.gov%2Fct2%2Fshow%2FNCT03345407+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rao, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalm, V. A. S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Šedivá, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Hagen, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holland, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenzweig, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christ, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sloth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabanski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Buck, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doucet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pylvaenaeinen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soldermann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashyap, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uzel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenardo, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkhart, C.</span></span> <span> </span><span class="NLM_article-title">Effective “Activated PI3Kδ Syndrome”-Targeted Therapy with the PI3Kδ Inhibitor Leniolisib</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>130</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">2307</span>– <span class="NLM_lpage">2316</span>, <span class="refDoi"> DOI: 10.1182/blood-2017-08-801191</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1182%2Fblood-2017-08-801191" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2017&pages=2307-2316&issue=21&author=V.+K.+Raoauthor=S.+Websterauthor=V.+A.+S.+H.+Dalmauthor=A.+%C5%A0ediv%C3%A1author=P.+M.+van+Hagenauthor=S.+Hollandauthor=S.+D.+Rosenzweigauthor=A.+D.+Christauthor=B.+Slothauthor=M.+Cabanskiauthor=A.+D.+Joshiauthor=S.+de+Buckauthor=J.+Doucetauthor=D.+Gueriniauthor=C.+Kalisauthor=I.+Pylvaenaeinenauthor=N.+Soldermannauthor=A.+Kashyapauthor=G.+Uzelauthor=M.+J.+Lenardoauthor=D.+D.+Patelauthor=C.+L.+Lucasauthor=C.+Burkhart&title=Effective+%E2%80%9CActivated+PI3K%CE%B4+Syndrome%E2%80%9D-Targeted+Therapy+with+the+PI3K%CE%B4+Inhibitor+Leniolisib&doi=10.1182%2Fblood-2017-08-801191"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1182%2Fblood-2017-08-801191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2017-08-801191%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DV.%2BK.%26aulast%3DWebster%26aufirst%3DS.%26aulast%3DDalm%26aufirst%3DV.%2BA.%2BS.%2BH.%26aulast%3D%25C5%25A0ediv%25C3%25A1%26aufirst%3DA.%26aulast%3Dvan%2BHagen%26aufirst%3DP.%2BM.%26aulast%3DHolland%26aufirst%3DS.%26aulast%3DRosenzweig%26aufirst%3DS.%2BD.%26aulast%3DChrist%26aufirst%3DA.%2BD.%26aulast%3DSloth%26aufirst%3DB.%26aulast%3DCabanski%26aufirst%3DM.%26aulast%3DJoshi%26aufirst%3DA.%2BD.%26aulast%3Dde%2BBuck%26aufirst%3DS.%26aulast%3DDoucet%26aufirst%3DJ.%26aulast%3DGuerini%26aufirst%3DD.%26aulast%3DKalis%26aufirst%3DC.%26aulast%3DPylvaenaeinen%26aufirst%3DI.%26aulast%3DSoldermann%26aufirst%3DN.%26aulast%3DKashyap%26aufirst%3DA.%26aulast%3DUzel%26aufirst%3DG.%26aulast%3DLenardo%26aufirst%3DM.%2BJ.%26aulast%3DPatel%26aufirst%3DD.%2BD.%26aulast%3DLucas%26aufirst%3DC.%2BL.%26aulast%3DBurkhart%26aufirst%3DC.%26atitle%3DEffective%2520%25E2%2580%259CActivated%2520PI3K%25CE%25B4%2520Syndrome%25E2%2580%259D-Targeted%2520Therapy%2520with%2520the%2520PI3K%25CE%25B4%2520Inhibitor%2520Leniolisib%26jtitle%3DBlood%26date%3D2017%26volume%3D130%26issue%3D21%26spage%3D2307%26epage%3D2316%26doi%3D10.1182%2Fblood-2017-08-801191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span>An Open-Label,
Exploratory, Multicenter, Extension Study To Evaluate the Long-Term
Safety, Tolerability, Pharmacokinetics and Efficacy of UCB5857 in
Subjects with Activated Phosphoinositide 3 Kinase (PI3K) Delta Syndrome. <a href="https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-005541-30" class="extLink">https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-005541-30</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=An+Open-Label%2C%0AExploratory%2C+Multicenter%2C+Extension+Study+To+Evaluate+the+Long-Term%0ASafety%2C+Tolerability%2C+Pharmacokinetics+and+Efficacy+of+UCB5857+in%0ASubjects+with+Activated+Phosphoinositide+3+Kinase+%28PI3K%29+Delta+Syndrome.+https%3A%2F%2Fwww.clinicaltrialsregister.eu%2Fctr-search%2Fsearch%3Fquery%3Deudract_number%3A2015-005541-30+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span>Safety,
Pharmacokinetics, and Preliminary Efficacy Study of CDZ173 in Patients
with Primary Sjögren’s Syndrome. ClinicalTrials.gov. <a href="https://clinicaltrials.gov/ct2/show/NCT02775916" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02775916</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Safety%2C%0APharmacokinetics%2C+and+Preliminary+Efficacy+Study+of+CDZ173+in+Patients%0Awith+Primary+Sj%C3%B6gren%E2%80%99s+Syndrome.+ClinicalTrials.gov.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02775916+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span>UCB Proof
of Concept Study in Patients with Primary Sjögren’s
Syndrome. ClinicalTrials.gov. <a href="https://clinicaltrials.gov/ct2/show/NCT02610543" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02610543</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=UCB+Proof%0Aof+Concept+Study+in+Patients+with+Primary+Sj%C3%B6gren%E2%80%99s%0ASyndrome.+ClinicalTrials.gov.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02610543+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span>Orphan
Drug Designations and Approvals. <a href="https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=504315" class="extLink">https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=504315</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Orphan%0ADrug+Designations+and+Approvals.+https%3A%2F%2Fwww.accessdata.fda.gov%2Fscripts%2Fopdlisting%2Foopd%2FdetailedIndex.cfm%3Fcfgridkey%3D504315+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span>Orphan
Drug Designations and Approvals. <a href="https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=579917" class="extLink">https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=579917</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Orphan%0ADrug+Designations+and+Approvals.+https%3A%2F%2Fwww.accessdata.fda.gov%2Fscripts%2Fopdlisting%2Foopd%2FdetailedIndex.cfm%3Fcfgridkey%3D579917+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span>Community
Register of Orphan Medicinal Products. <a href="http://ec.europa.eu/health/documents/community-register/html/o1986.htm" class="extLink">http://ec.europa.eu/health/documents/community-register/html/o1986.htm</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Community%0ARegister+of+Orphan+Medicinal+Products.+http%3A%2F%2Fec.europa.eu%2Fhealth%2Fdocuments%2Fcommunity-register%2Fhtml%2Fo1986.htm+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span>IPI-549.
Infinity Pharmaceuticals, Inc. <a href="http://www.infi.com/home/our-development-program/ipi-549/" class="extLink">http://www.infi.com/home/our-development-program/ipi-549/</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=IPI-549.%0AInfinity+Pharmaceuticals%2C+Inc.+http%3A%2F%2Fwww.infi.com%2Fhome%2Four-development-program%2Fipi-549%2F+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span>Bristol-Myers
Squibb and Infinity Pharmaceuticals Announce Clinical Collaboration
To Evaluate Opdivo (Nivolumab) in Combination with IPI-549 in Advanced
Solid Tumors. BMS Newsroom. <a href="https://news.bms.com/press-release/partnering-news/bristol-myers-squibb-and-infinity-pharmaceuticals-announce-clinical-co" class="extLink">https://news.bms.com/press-release/partnering-news/bristol-myers-squibb-and-infinity-pharmaceuticals-announce-clinical-co</a> (accessed Jun 19, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Bristol-Myers%0ASquibb+and+Infinity+Pharmaceuticals+Announce+Clinical+Collaboration%0ATo+Evaluate+Opdivo+%28Nivolumab%29+in+Combination+with+IPI-549+in+Advanced%0ASolid+Tumors.+BMS+Newsroom.+https%3A%2F%2Fnews.bms.com%2Fpress-release%2Fpartnering-news%2Fbristol-myers-squibb-and-infinity-pharmaceuticals-announce-clinical-co+%28accessed+Jun+19%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span>Arcus
Biosciences and Infinity Pharmaceuticals Announce Clinical Collaboration
To Evaluate Lead Programs in Triple-Combination Studies. <a href="https://www.prnewswire.com/news-releases/arcus-biosciences-and-infinity-pharmaceuticals-announce-clinical-collaboration-to-evaluate-lead-programs-in-triple-combination-studies-300672016.html" class="extLink">https://www.prnewswire.com/news-releases/arcus-biosciences-and-infinity-pharmaceuticals-announce-clinical-collaboration-to-evaluate-lead-programs-in-triple-combination-studies-300672016.html</a> (accessed Jul 5, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Arcus%0ABiosciences+and+Infinity+Pharmaceuticals+Announce+Clinical+Collaboration%0ATo+Evaluate+Lead+Programs+in+Triple-Combination+Studies.+https%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Farcus-biosciences-and-infinity-pharmaceuticals-announce-clinical-collaboration-to-evaluate-lead-programs-in-triple-combination-studies-300672016.html+%28accessed+Jul+5%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evans, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lescarbeau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grenier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pradeilles, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glenadel, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tibbitts, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowley, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiNitto, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brophy, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Hearn, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Hearn, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyt, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soglia, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pink, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proctor, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palombella, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremblay, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, A. C.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-γ Inhibitor (IPI-549) as an Immuno-Oncology Clinical Candidate</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">862</span>– <span class="NLM_lpage">867</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00238</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00238" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=862-867&issue=9&author=C.+A.+Evansauthor=T.+Liuauthor=A.+Lescarbeauauthor=S.+J.+Nairauthor=L.+Grenierauthor=J.+A.+Pradeillesauthor=Q.+Glenadelauthor=T.+Tibbittsauthor=A.+M.+Rowleyauthor=J.+P.+DiNittoauthor=E.+E.+Brophyauthor=E.+L.+O%E2%80%99Hearnauthor=J.+A.+Aliauthor=D.+G.+Winklerauthor=S.+I.+Goldsteinauthor=P.+O%E2%80%99Hearnauthor=C.+M.+Martinauthor=J.+G.+Hoytauthor=J.+R.+Sogliaauthor=C.+Cheungauthor=M.+M.+Pinkauthor=J.+L.+Proctorauthor=V.+J.+Palombellaauthor=M.+R.+Tremblayauthor=A.+C.+Castro&title=Discovery+of+a+Selective+Phosphoinositide-3-Kinase+%28PI3K%29-%CE%B3+Inhibitor+%28IPI-549%29+as+an+Immuno-Oncology+Clinical+Candidate&doi=10.1021%2Facsmedchemlett.6b00238"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00238%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DC.%2BA.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DLescarbeau%26aufirst%3DA.%26aulast%3DNair%26aufirst%3DS.%2BJ.%26aulast%3DGrenier%26aufirst%3DL.%26aulast%3DPradeilles%26aufirst%3DJ.%2BA.%26aulast%3DGlenadel%26aufirst%3DQ.%26aulast%3DTibbitts%26aufirst%3DT.%26aulast%3DRowley%26aufirst%3DA.%2BM.%26aulast%3DDiNitto%26aufirst%3DJ.%2BP.%26aulast%3DBrophy%26aufirst%3DE.%2BE.%26aulast%3DO%25E2%2580%2599Hearn%26aufirst%3DE.%2BL.%26aulast%3DAli%26aufirst%3DJ.%2BA.%26aulast%3DWinkler%26aufirst%3DD.%2BG.%26aulast%3DGoldstein%26aufirst%3DS.%2BI.%26aulast%3DO%25E2%2580%2599Hearn%26aufirst%3DP.%26aulast%3DMartin%26aufirst%3DC.%2BM.%26aulast%3DHoyt%26aufirst%3DJ.%2BG.%26aulast%3DSoglia%26aufirst%3DJ.%2BR.%26aulast%3DCheung%26aufirst%3DC.%26aulast%3DPink%26aufirst%3DM.%2BM.%26aulast%3DProctor%26aufirst%3DJ.%2BL.%26aulast%3DPalombella%26aufirst%3DV.%2BJ.%26aulast%3DTremblay%26aufirst%3DM.%2BR.%26aulast%3DCastro%26aufirst%3DA.%2BC.%26atitle%3DDiscovery%2520of%2520a%2520Selective%2520Phosphoinositide-3-Kinase%2520%2528PI3K%2529-%25CE%25B3%2520Inhibitor%2520%2528IPI-549%2529%2520as%2520an%2520Immuno-Oncology%2520Clinical%2520Candidate%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26issue%3D9%26spage%3D862%26epage%3D867%26doi%3D10.1021%2Facsmedchemlett.6b00238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span>Press
Release: Verastem. <a href="http://investor.verastem.com/phoenix.zhtml?c=250749&amp;p=irol-newsArticle&amp;ID=2341489" class="extLink">http://investor.verastem.com/phoenix.zhtml?c=250749&p=irol-newsArticle&ID=2341489</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Press%0ARelease%3A+Verastem.+http%3A%2F%2Finvestor.verastem.com%2Fphoenix.zhtml%3Fc%3D250749%26p%3Dirol-newsArticle%26ID%3D2341489+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmalbach, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuhr, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albayaty, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douglas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunbar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKee, C.</span></span> <span> </span><span class="NLM_article-title">Duvelisib, a PI3K-δ,γ Inhibitor, in Subjects with Mild Asthma</span>. <i>Eur. Respir. J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">Suppl. 59</span>),  <span class="NLM_fpage">PA2122</span>, <span class="refDoi"> DOI: 10.1183/13993003.congress-2015.PA2122</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1183%2F13993003.congress-2015.PA2122" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2015&pages=PA2122&issue=Suppl.+59&author=T.+Schmalbachauthor=R.+Fuhrauthor=M.+Albayatyauthor=K.+Allenauthor=M.+Douglasauthor=J.+Dunbarauthor=J.+McLaughlinauthor=L.+Alexanderauthor=C.+McKee&title=Duvelisib%2C+a+PI3K-%CE%B4%2C%CE%B3+Inhibitor%2C+in+Subjects+with+Mild+Asthma&doi=10.1183%2F13993003.congress-2015.PA2122"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1183%2F13993003.congress-2015.PA2122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1183%252F13993003.congress-2015.PA2122%26sid%3Dliteratum%253Aachs%26aulast%3DSchmalbach%26aufirst%3DT.%26aulast%3DFuhr%26aufirst%3DR.%26aulast%3DAlbayaty%26aufirst%3DM.%26aulast%3DAllen%26aufirst%3DK.%26aulast%3DDouglas%26aufirst%3DM.%26aulast%3DDunbar%26aufirst%3DJ.%26aulast%3DMcLaughlin%26aufirst%3DJ.%26aulast%3DAlexander%26aufirst%3DL.%26aulast%3DMcKee%26aufirst%3DC.%26atitle%3DDuvelisib%252C%2520a%2520PI3K-%25CE%25B4%252C%25CE%25B3%2520Inhibitor%252C%2520in%2520Subjects%2520with%2520Mild%2520Asthma%26jtitle%3DEur.%2520Respir.%2520J.%26date%3D2015%26volume%3D46%26issue%3DSuppl.%252059%26spage%3DPA2122%26doi%3D10.1183%2F13993003.congress-2015.PA2122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ojiaku, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunder, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panettieri, R. A.</span></span> <span> </span><span class="NLM_article-title">Phosphoinositide 3-Kinase in Asthma: Novel Roles and Therapeutic Approaches</span>. <i>Am. J. Respir. Cell Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">700</span>– <span class="NLM_lpage">707</span>, <span class="refDoi"> DOI: 10.1165/rcmb.2016-0308TR</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1165%2Frcmb.2016-0308TR" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=27977296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1artrrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=700-707&issue=6&author=E.+J.+Yooauthor=C.+A.+Ojiakuauthor=K.+Sunderauthor=R.+A.+Panettieri&title=Phosphoinositide+3-Kinase+in+Asthma%3A+Novel+Roles+and+Therapeutic+Approaches&doi=10.1165%2Frcmb.2016-0308TR"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphoinositide 3-kinase in asthma: novel roles and therapeutic approaches</span></div><div class="casAuthors">Yoo, Edwin J.; Ojiaku, Christie A.; Sunder, Krishna; Panettieri, Reynold A., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">700-707</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Asthma manifests as airway hyperresponsiveness and inflammation, including coughing, wheezing, and shortness of breath.  Immune cells and airway structural cells orchestrate asthma pathophysiol., leading to mucus secretion, airway narrowing, and obstruction.  Phosphoinositide 3-kinase, a lipid kinase, plays a crucial role in many of the cellular and mol. mechanisms driving asthma pathophysiol. and represents an attractive therapeutic target.  Here, we summarize the diverse roles of phosphoinositide 3-kinase in the pathogenesis of asthma and discuss novel therapeutic approaches to treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraWH_Lnj-6X7Vg90H21EOLACvtfcHk0liKYqMr3mvd-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1artrrI&md5=67d7e791406eae6be3ebb2a352a13e9d</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2016-0308TR&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2016-0308TR%26sid%3Dliteratum%253Aachs%26aulast%3DYoo%26aufirst%3DE.%2BJ.%26aulast%3DOjiaku%26aufirst%3DC.%2BA.%26aulast%3DSunder%26aufirst%3DK.%26aulast%3DPanettieri%26aufirst%3DR.%2BA.%26atitle%3DPhosphoinositide%25203-Kinase%2520in%2520Asthma%253A%2520Novel%2520Roles%2520and%2520Therapeutic%2520Approaches%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2017%26volume%3D56%26issue%3D6%26spage%3D700%26epage%3D707%26doi%3D10.1165%2Frcmb.2016-0308TR" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leff, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikulenkova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaidashev, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunbar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinblatt, M.</span></span> <span> </span><span class="NLM_article-title">Safety and Efficacy Results of a Phase 2, Double-Blind, Placebo-Controlled Clinical Study of Duvelisib with Background Methotrexate (MTX) in Adults with Moderate-to-Severe Rheumatoid Arthritis (RA) - ACR Meeting Abstracts</span>. <i>Arthritis Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">Suppl. 10</span>),  <span class="NLM_fpage">2138</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2015&pages=2138&issue=Suppl.+10&author=R.+Leffauthor=S.+Kumarauthor=N.+Nikulenkovaauthor=I.+Kaidashevauthor=K.+Allenauthor=J.+Dunbarauthor=H.+Sternauthor=J.+Adamsauthor=M.+Weinblatt&title=Safety+and+Efficacy+Results+of+a+Phase+2%2C+Double-Blind%2C+Placebo-Controlled+Clinical+Study+of+Duvelisib+with+Background+Methotrexate+%28MTX%29+in+Adults+with+Moderate-to-Severe+Rheumatoid+Arthritis+%28RA%29+-+ACR+Meeting+Abstracts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeff%26aufirst%3DR.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DNikulenkova%26aufirst%3DN.%26aulast%3DKaidashev%26aufirst%3DI.%26aulast%3DAllen%26aufirst%3DK.%26aulast%3DDunbar%26aufirst%3DJ.%26aulast%3DStern%26aufirst%3DH.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DWeinblatt%26aufirst%3DM.%26atitle%3DSafety%2520and%2520Efficacy%2520Results%2520of%2520a%2520Phase%25202%252C%2520Double-Blind%252C%2520Placebo-Controlled%2520Clinical%2520Study%2520of%2520Duvelisib%2520with%2520Background%2520Methotrexate%2520%2528MTX%2529%2520in%2520Adults%2520with%2520Moderate-to-Severe%2520Rheumatoid%2520Arthritis%2520%2528RA%2529%2520-%2520ACR%2520Meeting%2520Abstracts%26jtitle%3DArthritis%2520Rheumatol.%26date%3D2015%26volume%3D67%26issue%3DSuppl.%252010%26spage%3D2138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span>Safety
and Efficacy Study of Tenalisib (RP6530) in Combination with Pembrolizumab
in Relapsed or Refractory cHL. ClinicalTrials.gov. <a href="https://clinicaltrials.gov/ct2/show/NCT03471351" class="extLink">https://clinicaltrials.gov/ct2/show/NCT03471351</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Safety%0Aand+Efficacy+Study+of+Tenalisib+%28RP6530%29+in+Combination+with+Pembrolizumab%0Ain+Relapsed+or+Refractory+cHL.+ClinicalTrials.gov.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT03471351+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span>Rhizen
Pharmaceuticals S.A. Receives FDA Fast Track Designation for Tenalisib
(RP6530), a Highly Selective Dual PI3K Delta/Gamma Inhibitor for the
Treatment of Patients with Relapsed and/or Refractory Cutaneous T-cell
Lymphoma (CTCL). <a href="https://globenewswire.com/news-release/2018/04/13/1471290/0/en/Rhizen-Pharmaceuticals-S-A-receives-FDA-Fast-Track-Designation-for-Tenalisib-RP6530-a-highly-selective-dual-PI3K-delta-gamma-inhibitor-for-the-treatment-of-patients-with-relapsed-a.html" class="extLink">https://globenewswire.com/news-release/2018/04/13/1471290/0/en/Rhizen-Pharmaceuticals-S-A-receives-FDA-Fast-Track-Designation-for-Tenalisib-RP6530-a-highly-selective-dual-PI3K-delta-gamma-inhibitor-for-the-treatment-of-patients-with-relapsed-a.html</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Rhizen%0APharmaceuticals+S.A.+Receives+FDA+Fast+Track+Designation+for+Tenalisib%0A%28RP6530%29%2C+a+Highly+Selective+Dual+PI3K+Delta%2FGamma+Inhibitor+for+the%0ATreatment+of+Patients+with+Relapsed+and%2For+Refractory+Cutaneous+T-cell%0ALymphoma+%28CTCL%29.+https%3A%2F%2Fglobenewswire.com%2Fnews-release%2F2018%2F04%2F13%2F1471290%2F0%2Fen%2FRhizen-Pharmaceuticals-S-A-receives-FDA-Fast-Track-Designation-for-Tenalisib-RP6530-a-highly-selective-dual-PI3K-delta-gamma-inhibitor-for-the-treatment-of-patients-with-relapsed-a.html+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span>A Study
To Investigate the Safety, Tolerability and Pharmacokinetics of Single
and Repeat Doses of RV1729 for up to 28 Days. ClinicalTrials.gov. <a href="https://clinicaltrials.gov/ct2/show/study/NCT02140320" class="extLink">https://clinicaltrials.gov/ct2/show/study/NCT02140320</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Study%0ATo+Investigate+the+Safety%2C+Tolerability+and+Pharmacokinetics+of+Single%0Aand+Repeat+Doses+of+RV1729+for+up+to+28+Days.+ClinicalTrials.gov.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2Fstudy%2FNCT02140320+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span>A Study
To Investigate the Safety, Tolerability and Pharmacokinetics of Single
and Repeat Doses of RV1729. ClinicalTrials.gov. <a href="https://www.clinicaltrials.gov/ct2/show/NCT01813084" class="extLink">https://www.clinicaltrials.gov/ct2/show/NCT01813084</a> (accessed Jun 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Study%0ATo+Investigate+the+Safety%2C+Tolerability+and+Pharmacokinetics+of+Single%0Aand+Repeat+Doses+of+RV1729.+ClinicalTrials.gov.+https%3A%2F%2Fwww.clinicaltrials.gov%2Fct2%2Fshow%2FNCT01813084+%28accessed+Jun+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span>A Study
To Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics
of Repeat Doses of RV1729 for 28 Days in Patients with COPD. ClinicalTrials.gov <a href="https://www.clinicaltrials.gov/ct2/show/NCT02140346" class="extLink">https://www.clinicaltrials.gov/ct2/show/NCT02140346</a> (accessed Oct 12, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Study%0ATo+Investigate+Safety%2C+Tolerability%2C+Pharmacokinetics+and+Pharmacodynamics%0Aof+Repeat+Doses+of+RV1729+for+28+Days+in+Patients+with+COPD.+ClinicalTrials.gov+https%3A%2F%2Fwww.clinicaltrials.gov%2Fct2%2Fshow%2FNCT02140346+%28accessed+Oct+12%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Norman, P.</span></span> <span> </span><span class="NLM_article-title">Evaluation of WO2013136076: Two Crystalline Forms of the Phosphatidylinositol 3-Kinase-δ Inhibitor RV-1729</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">471</span>– <span class="NLM_lpage">475</span>, <span class="refDoi"> DOI: 10.1517/13543776.2014.865725</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1517%2F13543776.2014.865725" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=24283201" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC2cXksFOqu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=471-475&issue=4&author=P.+Norman&title=Evaluation+of+WO2013136076%3A+Two+Crystalline+Forms+of+the+Phosphatidylinositol+3-Kinase-%CE%B4+Inhibitor+RV-1729&doi=10.1517%2F13543776.2014.865725"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of WO2013136076: two crystalline forms of the phosphatidylinositol 3-kinase-δ inhibitor RV-1729</span></div><div class="casAuthors">Norman, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">471-475</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">This application claims two cryst. forms and inhaled formulations of a the selective phosphatidylinositol 3-kinase-δ inhibitor (PI3Kδ) inhibitor 6-(2-((4-amino-3-(3-hydroxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)-3-(2-chlorobenzyl)-4-oxo-3,4-dihydroquinazolin-5-yl)-N, N-bis(2-methoxyethyl)hex-5-ynamide.  These formulations are claimed to be useful in the treatment of respiratory diseases including asthma and chronic obstructive pulmonary disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZoor0AnthnbVg90H21EOLACvtfcHk0lhy5pvXuLrn8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXksFOqu7k%253D&md5=d3b0f3c4b492e3eae072793137b46fa2</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1517%2F13543776.2014.865725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2014.865725%26sid%3Dliteratum%253Aachs%26aulast%3DNorman%26aufirst%3DP.%26atitle%3DEvaluation%2520of%2520WO2013136076%253A%2520Two%2520Crystalline%2520Forms%2520of%2520the%2520Phosphatidylinositol%25203-Kinase-%25CE%25B4%2520Inhibitor%2520RV-1729%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2014%26volume%3D24%26issue%3D4%26spage%3D471%26epage%3D475%26doi%3D10.1517%2F13543776.2014.865725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span>A Study
To Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics
of Single and Repeat Doses of RV6153. ClinicalTrials.gov. <a href="https://www.clinicaltrials.gov/ct2/show/NCT02517359" class="extLink">https://www.clinicaltrials.gov/ct2/show/NCT02517359</a> (accessed Oct 18, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Study%0ATo+Investigate+the+Safety%2C+Tolerability%2C+Pharmacokinetics+and+Pharmacodynamics%0Aof+Single+and+Repeat+Doses+of+RV6153.+ClinicalTrials.gov.+https%3A%2F%2Fwww.clinicaltrials.gov%2Fct2%2Fshow%2FNCT02517359+%28accessed+Oct+18%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span>A Study
To Evaluate the Safety, Tolerability and Study Drug Absorption to
the Blood After Administration of Single Ascending Doses of AZD8154
in Healthy Subjects. ClinicalTrials.gov. <a href="https://www.clinicaltrials.gov/ct2/show/NCT03436316" class="extLink">https://www.clinicaltrials.gov/ct2/show/NCT03436316</a> (accessed Jul 5, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Study%0ATo+Evaluate+the+Safety%2C+Tolerability+and+Study+Drug+Absorption+to%0Athe+Blood+After+Administration+of+Single+Ascending+Doses+of+AZD8154%0Ain+Healthy+Subjects.+ClinicalTrials.gov.+https%3A%2F%2Fwww.clinicaltrials.gov%2Fct2%2Fshow%2FNCT03436316+%28accessed+Jul+5%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nair, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheson, B.</span></span> <span> </span><span class="NLM_article-title">The Role of Idelalisib in the Treatment of Relapsed and Refractory Chronic Lymphocytic Leukemia</span>. <i>Ther. Adv. Hematol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">69</span>– <span class="NLM_lpage">84</span>, <span class="refDoi"> DOI: 10.1177/2040620715625966</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1177%2F2040620715625966" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=27054023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvVWgsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=69-84&issue=2&author=K.+S.+Nairauthor=B.+Cheson&title=The+Role+of+Idelalisib+in+the+Treatment+of+Relapsed+and+Refractory+Chronic+Lymphocytic+Leukemia&doi=10.1177%2F2040620715625966"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">The role of idelalisib in the treatment of relapsed and refractory chronic lymphocytic leukemia</span></div><div class="casAuthors">Nair, Kruti Sheth; Cheson, Bruce</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutic Advances in Hematology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">69-84</span>CODEN:
                <span class="NLM_cas:coden">TAHHAT</span>;
        ISSN:<span class="NLM_cas:issn">2040-6207</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">Idelalisib is a first in class, delta isoform specific, PI3-kinase inhibitor.  Based on its high level of efficacy and acceptable safety profile, this oral drug has been approved by the US Food and Drug Administration as a single agent for the treatment of relapsed or refractory small lymphocytic lymphoma, and follicular non-Hodgkin lymphoma, and in combination with rituximab for patients with chronic lymphocytic leukemia.  Adverse effects of particular concern include diarrhea, pneumonitis, and transient elevations of hepatic transaminase levels.  Efforts to improve on the activity of this drug have included combinations with std. chemotherapy agents, such as bendamustine, and other targeted therapies, including checkpoint inhibitors.  However, other combinations have been assocd. with life-threatening and fatal toxicities.  Thus, the development of such regimens should be conducted carefully in the context of a clin. research study.  Idelalisib has a vital role as second-line therapy for chronic lymphocytic leukemia, esp. for patients with high-risk disease and multiple comorbidities, and studies are exploring the use of this agent as front-line therapy to improve the outcome of patients with indolent B-cell malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUxNiF55aL1bVg90H21EOLACvtfcHk0lhy5pvXuLrn8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvVWgsr8%253D&md5=295f67243254ea3ff1df0327c6bbedc1</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1177%2F2040620715625966&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F2040620715625966%26sid%3Dliteratum%253Aachs%26aulast%3DNair%26aufirst%3DK.%2BS.%26aulast%3DCheson%26aufirst%3DB.%26atitle%3DThe%2520Role%2520of%2520Idelalisib%2520in%2520the%2520Treatment%2520of%2520Relapsed%2520and%2520Refractory%2520Chronic%2520Lymphocytic%2520Leukemia%26jtitle%3DTher.%2520Adv.%2520Hematol.%26date%3D2016%26volume%3D7%26issue%3D2%26spage%3D69%26epage%3D84%26doi%3D10.1177%2F2040620715625966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamanna, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kipps, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flinn, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zelenetz, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burger, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keating, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dansey, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubowy, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coutre, S. E.</span></span> <span> </span><span class="NLM_article-title">A Phase 2 Study of Idelalisib plus Rituximab in Treatment-Naïve Older Patients with Chronic Lymphocytic Leukemia</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>126</i></span> (<span class="NLM_issue">25</span>),  <span class="NLM_fpage">2686</span>– <span class="NLM_lpage">2694</span>, <span class="refDoi"> DOI: 10.1182/blood-2015-03-630947</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1182%2Fblood-2015-03-630947" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2015&pages=2686-2694&issue=25&author=S.+M.+O%E2%80%99Brienauthor=N.+Lamannaauthor=T.+J.+Kippsauthor=I.+Flinnauthor=A.+D.+Zelenetzauthor=J.+A.+Burgerauthor=M.+Keatingauthor=S.+Mitraauthor=L.+Holesauthor=A.+S.+Yuauthor=D.+M.+Johnsonauthor=L.+L.+Millerauthor=Y.+Kimauthor=R.+D.+Danseyauthor=R.+L.+Dubowyauthor=S.+E.+Coutre&title=A+Phase+2+Study+of+Idelalisib+plus+Rituximab+in+Treatment-Na%C3%AFve+Older+Patients+with+Chronic+Lymphocytic+Leukemia&doi=10.1182%2Fblood-2015-03-630947"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1182%2Fblood-2015-03-630947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2015-03-630947%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DS.%2BM.%26aulast%3DLamanna%26aufirst%3DN.%26aulast%3DKipps%26aufirst%3DT.%2BJ.%26aulast%3DFlinn%26aufirst%3DI.%26aulast%3DZelenetz%26aufirst%3DA.%2BD.%26aulast%3DBurger%26aufirst%3DJ.%2BA.%26aulast%3DKeating%26aufirst%3DM.%26aulast%3DMitra%26aufirst%3DS.%26aulast%3DHoles%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DA.%2BS.%26aulast%3DJohnson%26aufirst%3DD.%2BM.%26aulast%3DMiller%26aufirst%3DL.%2BL.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DDansey%26aufirst%3DR.%2BD.%26aulast%3DDubowy%26aufirst%3DR.%2BL.%26aulast%3DCoutre%26aufirst%3DS.%2BE.%26atitle%3DA%2520Phase%25202%2520Study%2520of%2520Idelalisib%2520plus%2520Rituximab%2520in%2520Treatment-Na%25C3%25AFve%2520Older%2520Patients%2520with%2520Chronic%2520Lymphocytic%2520Leukemia%26jtitle%3DBlood%26date%3D2015%26volume%3D126%26issue%3D25%26spage%3D2686%26epage%3D2694%26doi%3D10.1182%2Fblood-2015-03-630947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span>Idelalisib
Pharmaprojects. <a href="https://pharmaintelligence.informa.com/products-and-services/data-and-analysis/pharmaprojects" class="extLink">https://pharmaintelligence.informa.com/products-and-services/data-and-analysis/pharmaprojects</a> (accessed Jun 22, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Idelalisib%0APharmaprojects.+https%3A%2F%2Fpharmaintelligence.informa.com%2Fproducts-and-services%2Fdata-and-analysis%2Fpharmaprojects+%28accessed+Jun+22%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span>Efficacy
and Safety of Idelalisib in Combination with Obinutuzumab Compared
to Chlorambucil in Combination with Obinutuzumab for Previously Untreated
Chronic Lymphocytic Leukemia. ClinicalTrials.gov. <a href="https://clinicaltrials.gov/ct2/show/NCT01980875" class="extLink">https://clinicaltrials.gov/ct2/show/NCT01980875</a> (accessed Jun 18, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Efficacy%0Aand+Safety+of+Idelalisib+in+Combination+with+Obinutuzumab+Compared%0Ato+Chlorambucil+in+Combination+with+Obinutuzumab+for+Previously+Untreated%0AChronic+Lymphocytic+Leukemia.+ClinicalTrials.gov.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01980875+%28accessed+Jun+18%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burris, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flinn, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenske, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brander, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutierrez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Essell, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miskin, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sportelli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vakkalanka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savona, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, O. A.</span></span> <span> </span><span class="NLM_article-title">Umbralisib, a Novel PI3Kδ and Casein Kinase-1ε Inhibitor, in Relapsed or Refractory Chronic Lymphocytic Leukaemia and Lymphoma: An Open-Label, Phase 1, Dose-Escalation, First-in-Human Study</span>. <i>Lancet Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">496</span>, <span class="refDoi"> DOI: 10.1016/S1470-2045(18)30082-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2FS1470-2045%2818%2930082-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=29475723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjs1eis78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=486-496&issue=4&author=H.+A.+Burrisauthor=I.+W.+Flinnauthor=M.+R.+Patelauthor=T.+S.+Fenskeauthor=C.+Dengauthor=D.+M.+Branderauthor=M.+Gutierrezauthor=J.+H.+Essellauthor=J.+G.+Kuhnauthor=H.+P.+Miskinauthor=P.+Sportelliauthor=M.+S.+Weissauthor=S.+Vakkalankaauthor=M.+R.+Savonaauthor=O.+A.+O%E2%80%99Connor&title=Umbralisib%2C+a+Novel+PI3K%CE%B4+and+Casein+Kinase-1%CE%B5+Inhibitor%2C+in+Relapsed+or+Refractory+Chronic+Lymphocytic+Leukaemia+and+Lymphoma%3A+An+Open-Label%2C+Phase+1%2C+Dose-Escalation%2C+First-in-Human+Study&doi=10.1016%2FS1470-2045%2818%2930082-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Umbralisib, a novel PI3Kδ and casein kinase-1ε inhibitor, in relapsed or refractory chronic lymphocytic leukaemia and lymphoma: an open-label, phase 1, dose-escalation, first-in-human study</span></div><div class="casAuthors">Burris, Howard A., III; Flinn, Ian W.; Patel, Manish R.; Fenske, Timothy S.; Deng, Changchun; Brander, Danielle M.; Gutierrez, Martin; Essell, James H.; Kuhn, John G.; Miskin, Hari P.; Sportelli, Peter; Weiss, Michael S.; Vakkalanka, Swaroop; Savona, Michael R.; O'Connor, Owen A.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-496</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Umbralisib (TGR-1202) is a novel next-generation inhibitor of phosphatidylinositol 3-kinase (PI3K) isoform p110δ (PI3Kδ), which is structurally distinct from other PI3Kδ inhibitors and shows improved isoform selectivity.  Umbralisib also uniquely inhibits casein kinase-1ε, a major regulator of protein translation.  The aim of this first-in-human phase 1 study was to establish the safety and preliminary activity profile of umbralisib in patients with haematol. malignancies.  We did an open-label, phase 1, dose-escalation study at seven clinics in the USA.  We recruited patients aged at least 18 years with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma, B-cell and T-cell non-Hodgkin lymphoma, or Hodgkin's lymphoma, who had received one or more previous lines of therapy, with measurable and assessable disease, and adequate organ system function.  Patients self-administered an umbralisib oral tablet once per day in 28-day cycles, with dose escalation done in a traditional 3 + 3 design to establish safety and det. the max. tolerated dose.  In initial cohorts, patients took umbralisib in a fasting state at a starting dose of 50 mg, increasing to 100, 200, 400, 800, 1200, and 1800 mg until the max. tolerated dose was reached, or the maximal dose cohort was accrued without a dose-limiting toxicity.  Subsequent cohorts self-administered a micronized formulation of umbralisib tablet in a fed state at an initial dose of 200 mg, increased in increments to 400, 800, 1200, and 1800 mg until the max. tolerated dose or the maximal dose level was accrued.  In August, 2014, all patients still on study were transitioned to 800 mg of the micronized formulation and dosing of the initial formulation was discontinued.  The primary endpoints of the study were investigator-assessed safety in all treated patients (the safety population), the max. tolerated dose, and the pharmacokinetics of umbralisib.  Secondary endpoints included preliminary assessments of anti-cancer activity (objective responses and duration of response).  Follow-up stopped for a patient once they discontinued therapy.  This study has been completed and is registered with ClinicalTrials.gov, no. NCT01767766.  Between Jan 17, 2013, and Jan 14, 2016, we enrolled and treated 90 patients with umbralisib.  The median duration of treatment and follow-up was 4·7 cycles (IQR 2·0-14·0) or 133 days (IQR 55-335).  The most common treatment-emergent adverse events irresp. of causality were diarrhea (in 39 [43%] of 90 patients), nausea (38 [42%]), and fatigue (28 [31%]).  The most common grade 3 or 4 adverse events were neutropenia (in 12 [13%] patients), anemia (eight [9%]) and thrombocytopenia (six [7%]).  Serious adverse events considered at least possibly related to umbralisib occurred in seven patients: pneumonia in three (3%) patients, lung infection in one (1%), febrile neutropenia in one (1%), and colitis in two (2%), one of whom also had febrile neutropenia.  The max. tolerated dose was 1200 mg of the micronized formulation, with 800 mg of this formulation selected as the recommended phase 2 dose.  Both cases of colitis occurred at above the recommended phase 2 dose. 33 (37%) of the 90 patients enrolled had an objective response to treatment with umbralisib.  Umbralisib was well tolerated and showed preliminary signs of activity in patients with relapsed or refractory haematol. malignancies.  The safety profile of umbralisib in this phase 1 study was distinct from that of other PI3Kδ inhibitors, with fewer occurrences of autoimmune-like toxicities such as colitis.  These findings warrant further evaluation of this agent in this setting.TG Therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6a2gayrthBrVg90H21EOLACvtfcHk0lhs9yJa1SBghw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjs1eis78%253D&md5=fc763abd079ae4d06a0a1ae977c5bddb</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2818%2930082-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252818%252930082-2%26sid%3Dliteratum%253Aachs%26aulast%3DBurris%26aufirst%3DH.%2BA.%26aulast%3DFlinn%26aufirst%3DI.%2BW.%26aulast%3DPatel%26aufirst%3DM.%2BR.%26aulast%3DFenske%26aufirst%3DT.%2BS.%26aulast%3DDeng%26aufirst%3DC.%26aulast%3DBrander%26aufirst%3DD.%2BM.%26aulast%3DGutierrez%26aufirst%3DM.%26aulast%3DEssell%26aufirst%3DJ.%2BH.%26aulast%3DKuhn%26aufirst%3DJ.%2BG.%26aulast%3DMiskin%26aufirst%3DH.%2BP.%26aulast%3DSportelli%26aufirst%3DP.%26aulast%3DWeiss%26aufirst%3DM.%2BS.%26aulast%3DVakkalanka%26aufirst%3DS.%26aulast%3DSavona%26aufirst%3DM.%2BR.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DO.%2BA.%26atitle%3DUmbralisib%252C%2520a%2520Novel%2520PI3K%25CE%25B4%2520and%2520Casein%2520Kinase-1%25CE%25B5%2520Inhibitor%252C%2520in%2520Relapsed%2520or%2520Refractory%2520Chronic%2520Lymphocytic%2520Leukaemia%2520and%2520Lymphoma%253A%2520An%2520Open-Label%252C%2520Phase%25201%252C%2520Dose-Escalation%252C%2520First-in-Human%2520Study%26jtitle%3DLancet%2520Oncol.%26date%3D2018%26volume%3D19%26issue%3D4%26spage%3D486%26epage%3D496%26doi%3D10.1016%2FS1470-2045%2818%2930082-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span>Umbralisib
Pharmaprojects. <a href="https://pharmaintelligence.informa.com/products-and-services/data-and-analysis/pharmaprojects" class="extLink">https://pharmaintelligence.informa.com/products-and-services/data-and-analysis/pharmaprojects</a> (accessed May 21, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Umbralisib%0APharmaprojects.+https%3A%2F%2Fpharmaintelligence.informa.com%2Fproducts-and-services%2Fdata-and-analysis%2Fpharmaprojects+%28accessed+May+21%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span>INCB-050465
Pharmaprojects. <a href="https://pharmaintelligence.informa.com/products-and-services/data-and-analysis/pharmaprojects" class="extLink">https://pharmaintelligence.informa.com/products-and-services/data-and-analysis/pharmaprojects</a> (accessed May 24, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=INCB-050465%0APharmaprojects.+https%3A%2F%2Fpharmaintelligence.informa.com%2Fproducts-and-services%2Fdata-and-analysis%2Fpharmaprojects+%28accessed+May+24%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span>ME-401
Pharmaprojects. <a href="https://pharmaintelligence.informa.com/products-and-services/data-and-analysis/pharmaprojects" class="extLink">https://pharmaintelligence.informa.com/products-and-services/data-and-analysis/pharmaprojects</a> (accessed May 28, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ME-401%0APharmaprojects.+https%3A%2F%2Fpharmaintelligence.informa.com%2Fproducts-and-services%2Fdata-and-analysis%2Fpharmaprojects+%28accessed+May+28%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kater, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonino, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiering, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chamuleau, M. E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adewoye, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dreiling, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doorduijn, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kersten, M. J.</span></span> <span> </span><span class="NLM_article-title">Final Results of a Phase 1b Study of the Safety and Efficacy of the PI3Kδ Inhibitor Acalisib (GS-9820) in Relapsed/Refractory Lymphoid Malignancies</span>. <i>Blood Cancer J.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">16</span>, <span class="refDoi"> DOI: 10.1038/s41408-018-0055-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1038%2Fs41408-018-0055-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=29434192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A280%3ADC%252BC1MrgslSjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=16&issue=2&author=A.+P.+Katerauthor=S.+H.+Toninoauthor=M.+Spieringauthor=M.+E.+D.+Chamuleauauthor=R.+Liuauthor=A.+H.+Adewoyeauthor=J.+Gaoauthor=L.+Dreilingauthor=Y.+Xinauthor=J.+K.+Doorduijnauthor=M.+J.+Kersten&title=Final+Results+of+a+Phase+1b+Study+of+the+Safety+and+Efficacy+of+the+PI3K%CE%B4+Inhibitor+Acalisib+%28GS-9820%29+in+Relapsed%2FRefractory+Lymphoid+Malignancies&doi=10.1038%2Fs41408-018-0055-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Final results of a phase 1b study of the safety and efficacy of the PI3Kδ inhibitor acalisib (GS-9820) in relapsed/refractory lymphoid malignancies</span></div><div class="casAuthors">Kater Arnon P; Tonino Sanne H; Spiering Marjolein; Kersten Marie Jose; Kater Arnon P; Tonino Sanne H; Kersten Marie Jose; Chamuleau Martine E D; Liu Roberto; Adewoye Adeboye Henry; Gao Jie; Dreiling Lyndah; Xin Yan; Doorduijn Jeanette K</div><div class="citationInfo"><span class="NLM_cas:title">Blood cancer journal</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">16</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT9xn_VdnX4CUBuFdjgVNKSfW6udTcc2eaWmhtoRJUNJLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MrgslSjtg%253D%253D&md5=6992eb2b0978baa671e6e172330f8b2f</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1038%2Fs41408-018-0055-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41408-018-0055-x%26sid%3Dliteratum%253Aachs%26aulast%3DKater%26aufirst%3DA.%2BP.%26aulast%3DTonino%26aufirst%3DS.%2BH.%26aulast%3DSpiering%26aufirst%3DM.%26aulast%3DChamuleau%26aufirst%3DM.%2BE.%2BD.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DAdewoye%26aufirst%3DA.%2BH.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DDreiling%26aufirst%3DL.%26aulast%3DXin%26aufirst%3DY.%26aulast%3DDoorduijn%26aufirst%3DJ.%2BK.%26aulast%3DKersten%26aufirst%3DM.%2BJ.%26atitle%3DFinal%2520Results%2520of%2520a%2520Phase%25201b%2520Study%2520of%2520the%2520Safety%2520and%2520Efficacy%2520of%2520the%2520PI3K%25CE%25B4%2520Inhibitor%2520Acalisib%2520%2528GS-9820%2529%2520in%2520Relapsed%252FRefractory%2520Lymphoid%2520Malignancies%26jtitle%3DBlood%2520Cancer%2520J.%26date%3D2018%26volume%3D8%26issue%3D2%26spage%3D16%26doi%3D10.1038%2Fs41408-018-0055-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span>An Efficacy
Study of GSK2269557 Added to Standard Care in Subjects with an Acute
Exacerbation of Chronic Obstructive Pulmonary Disease. Study Results.
ClinicalTrials.gov. <a href="https://clinicaltrials.gov/ct2/show/results/NCT02294734" class="extLink">https://clinicaltrials.gov/ct2/show/results/NCT02294734</a> (accessed Jul 7, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=An+Efficacy%0AStudy+of+GSK2269557+Added+to+Standard+Care+in+Subjects+with+an+Acute%0AExacerbation+of+Chronic+Obstructive+Pulmonary+Disease.+Study+Results.%0AClinicalTrials.gov.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2Fresults%2FNCT02294734+%28accessed+Jul+7%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span>Initial
Results From First-In-Human Study of IPI-549, a Tumor Macrophage-Targeting
Agent, Combined with Nivolumab in Advanced Solid Tumors. 2018 ASCO
Annual Meeting Abstracts. <a href="http://abstracts.asco.org/214/AbstView_214_230109.html" class="extLink">http://abstracts.asco.org/214/AbstView_214_230109.html</a> (accessed Jul 6, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Initial%0AResults+From+First-In-Human+Study+of+IPI-549%2C+a+Tumor+Macrophage-Targeting%0AAgent%2C+Combined+with+Nivolumab+in+Advanced+Solid+Tumors.+2018+ASCO%0AAnnual+Meeting+Abstracts.+http%3A%2F%2Fabstracts.asco.org%2F214%2FAbstView_214_230109.html+%28accessed+Jul+6%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span>Duvelisib.
Pharmaprojects. <a href="https://pharmaintelligence.informa.com/products-and-services/data-and-analysis/pharmaprojects" class="extLink">https://pharmaintelligence.informa.com/products-and-services/data-and-analysis/pharmaprojects</a> (accessed May 22, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Duvelisib.%0APharmaprojects.+https%3A%2F%2Fpharmaintelligence.informa.com%2Fproducts-and-services%2Fdata-and-analysis%2Fpharmaprojects+%28accessed+May+22%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coutre, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrientos, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furman, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keating, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagel, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poleski, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharman, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, N.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zelenetz, A. D.</span></span> <span> </span><span class="NLM_article-title">Management of Adverse Events Associated with Idelalisib Treatment:  Expert Panel Opinion</span>. <i>Leuk. Lymphoma</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2779</span>– <span class="NLM_lpage">2786</span>, <span class="refDoi"> DOI: 10.3109/10428194.2015.1022770</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.3109%2F10428194.2015.1022770" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=25726955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFKju73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2015&pages=2779-2786&issue=10&author=S.+E.+Coutreauthor=J.+C.+Barrientosauthor=J.+R.+Brownauthor=S.+de+Vosauthor=R.+R.+Furmanauthor=M.+J.+Keatingauthor=D.+Liauthor=S.+M.+O%E2%80%99Brienauthor=J.+M.+Pagelauthor=M.+H.+Poleskiauthor=J.+P.+Sharmanauthor=N.-S.+Yaoauthor=A.+D.+Zelenetz&title=Management+of+Adverse+Events+Associated+with+Idelalisib+Treatment%3A++Expert+Panel+Opinion&doi=10.3109%2F10428194.2015.1022770"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Management of adverse events associated with idelalisib treatment: expert panel opinion</span></div><div class="casAuthors">Coutre, Steven E.; Barrientos, Jacqueline C.; Brown, Jennifer R.; de Vos, Sven; Furman, Richard R.; Keating, Michael J.; Li, Daniel; O'Brien, Susan M.; Pagel, John M.; Poleski, Martin H.; Sharman, Jeff P.; Yao, Nai-Shun; Zelenetz, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia & Lymphoma</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2779-2786</span>CODEN:
                <span class="NLM_cas:coden">LELYEA</span>;
        ISSN:<span class="NLM_cas:issn">1029-2403</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Idelalisib is a first-in-class selective, oral, phosphatidylinositol 3-kinase delta (PI3Kδ) inhibitor approved for the treatment of several types of blood cancer.  Idelalisib has demonstrated significant efficacy and a tolerable safety profile in clin. trials.  However, the US prescribing information contains a black box warning for fatal and/or severe diarrhea or colitis, hepatotoxicity, pneumonitis and intestinal perforation.  An expert panel was convened to review the pathol. of these treatment-emergent adverse events (TEAEs) to propose key management tools for patients receiving idelalisib therapy.  This article provides an overview of idelalisib TEAEs reported in clin. trials, and a summary of the panel's recommendations for identification and management of idelalisib treatment-emergent diarrhea or colitis as well as a discussion of transaminitis and pneumonitis.  For idelalisib-related diarrhea or colitis (including unresolved grade 2 and grade ≥ 3), after exclusion of infectious causes, the panel recommends individualized treatment with budesonide or oral or i.v. steroid therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVGi1H-woJu7Vg90H21EOLACvtfcHk0lhK28JA8NAP1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFKju73O&md5=649cb8c3d6fe0a60f74b3f9413e4706a</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.3109%2F10428194.2015.1022770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10428194.2015.1022770%26sid%3Dliteratum%253Aachs%26aulast%3DCoutre%26aufirst%3DS.%2BE.%26aulast%3DBarrientos%26aufirst%3DJ.%2BC.%26aulast%3DBrown%26aufirst%3DJ.%2BR.%26aulast%3Dde%2BVos%26aufirst%3DS.%26aulast%3DFurman%26aufirst%3DR.%2BR.%26aulast%3DKeating%26aufirst%3DM.%2BJ.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DS.%2BM.%26aulast%3DPagel%26aufirst%3DJ.%2BM.%26aulast%3DPoleski%26aufirst%3DM.%2BH.%26aulast%3DSharman%26aufirst%3DJ.%2BP.%26aulast%3DYao%26aufirst%3DN.-S.%26aulast%3DZelenetz%26aufirst%3DA.%2BD.%26atitle%3DManagement%2520of%2520Adverse%2520Events%2520Associated%2520with%2520Idelalisib%2520Treatment%253A%2520%2520Expert%2520Panel%2520Opinion%26jtitle%3DLeuk.%2520Lymphoma%26date%3D2015%26volume%3D56%26issue%3D10%26spage%3D2779%26epage%3D2786%26doi%3D10.3109%2F10428194.2015.1022770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span>European
Medicines Agency. News and Events. EMA Recommends New Safety Measures
for Zydelig. <a href="http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/03/news_detail_002490.jsp&amp;mid=WC0b01ac058004d5c1" class="extLink">http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/03/news_detail_002490.jsp&mid=WC0b01ac058004d5c1</a> (accessed Jul 7, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=European%0AMedicines+Agency.+News+and+Events.+EMA+Recommends+New+Safety+Measures%0Afor+Zydelig.+http%3A%2F%2Fwww.ema.europa.eu%2Fema%2Findex.jsp%3Fcurl%3Dpages%2Fnews_and_events%2Fnews%2F2016%2F03%2Fnews_detail_002490.jsp%26mid%3DWC0b01ac058004d5c1+%28accessed+Jul+7%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berndt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houseman, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacold, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorrec, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hon, W.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rommel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaillard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rückle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R. L.</span></span> <span> </span><span class="NLM_article-title">The p110δ Structure: Mechanisms for Selectivity and Potency of New PI(3)K Inhibitors</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">117</span>– <span class="NLM_lpage">124</span>, <span class="refDoi"> DOI: 10.1038/nchembio.293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1038%2Fnchembio.293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=20081827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvFGrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=117-124&issue=2&author=A.+Berndtauthor=S.+Millerauthor=O.+Williamsauthor=D.+D.+Leauthor=B.+T.+Housemanauthor=J.+I.+Pacoldauthor=F.+Gorrecauthor=W.-C.+Honauthor=P.+Renauthor=Y.+Liuauthor=C.+Rommelauthor=P.+Gaillardauthor=T.+R%C3%BCckleauthor=M.+K.+Schwarzauthor=K.+M.+Shokatauthor=J.+P.+Shawauthor=R.+L.+Williams&title=The+p110%CE%B4+Structure%3A+Mechanisms+for+Selectivity+and+Potency+of+New+PI%283%29K+Inhibitors&doi=10.1038%2Fnchembio.293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">The p110δ structure: mechanisms for selectivity and potency of new PI(3)K inhibitors</span></div><div class="casAuthors">Berndt, Alex; Miller, Simon; Williams, Olusegun; Le, Daniel D.; Houseman, Benjamin T.; Pacold, Joseph I.; Gorrec, Fabrice; Hon, Wai-Ching; Liu, Yi; Rommel, Christian; Gaillard, Pascale; Rueckle, Thomas; Schwarz, Matthias K.; Shokat, Kevan M.; Shaw, Jeffrey P.; Williams, Roger L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">117-124</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Deregulation of the phosphoinositide-3-OH kinase (PI(3)K) pathway has been implicated in numerous pathologies including cancer, diabetes, thrombosis, rheumatoid arthritis, and asthma.  Recently, small-mol. and ATP-competitive PI(3)K inhibitors with a wide range of selectivities have entered clin. development.  To understand the mechanisms underlying the isoform selectivity of these inhibitors, we developed a new expression strategy that enabled us to det. to our knowledge the first crystal structure of the catalytic subunit of the class IA PI(3)K p110δ.  Structures of this enzyme in complex with a broad panel of isoform- and pan-selective class I PI(3)K inhibitors reveal that selectivity toward p110δ can be achieved by exploiting its conformational flexibility and the sequence diversity of active site residues that do not contact ATP.  We have used these observations to rationalize and synthesize highly selective inhibitors for p110δ with greatly improved potencies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL8d01cEl_y7Vg90H21EOLACvtfcHk0lhK28JA8NAP1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvFGrsw%253D%253D&md5=8a0ce73ab8ca88ea9a48a2cb7fdb1975</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.293%26sid%3Dliteratum%253Aachs%26aulast%3DBerndt%26aufirst%3DA.%26aulast%3DMiller%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DO.%26aulast%3DLe%26aufirst%3DD.%2BD.%26aulast%3DHouseman%26aufirst%3DB.%2BT.%26aulast%3DPacold%26aufirst%3DJ.%2BI.%26aulast%3DGorrec%26aufirst%3DF.%26aulast%3DHon%26aufirst%3DW.-C.%26aulast%3DRen%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DGaillard%26aufirst%3DP.%26aulast%3DR%25C3%25BCckle%26aufirst%3DT.%26aulast%3DSchwarz%26aufirst%3DM.%2BK.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DShaw%26aufirst%3DJ.%2BP.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26atitle%3DThe%2520p110%25CE%25B4%2520Structure%253A%2520Mechanisms%2520for%2520Selectivity%2520and%2520Potency%2520of%2520New%2520PI%25283%2529K%2520Inhibitors%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26issue%3D2%26spage%3D117%26epage%3D124%26doi%3D10.1038%2Fnchembio.293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrasekhar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evarts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forseth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haran, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ip, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashishian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koditek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koppenol, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lad, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepist, E.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perreault, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puri, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villaseñor, A.
G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somoza, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiner, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Therrien, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treiberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, G.</span></span> <span> </span><span class="NLM_article-title">Discovery of Orally Efficacious Phosphoinositide 3-Kinase δ Inhibitors with Improved Metabolic Stability</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">9228</span>– <span class="NLM_lpage">9242</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01169</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01169" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9228-9242&issue=19&author=L.+Patelauthor=J.+Chandrasekharauthor=J.+Evartsauthor=K.+Forsethauthor=A.+C.+Haranauthor=C.+Ipauthor=A.+Kashishianauthor=M.+Kimauthor=D.+Koditekauthor=S.+Koppenolauthor=L.+Ladauthor=E.-I.+Lepistauthor=M.+E.+McGrathauthor=S.+Perreaultauthor=K.+D.+Puriauthor=A.%0AG.+Villase%C3%B1orauthor=J.+R.+Somozaauthor=B.+H.+Steinerauthor=J.+Therrienauthor=J.+Treibergauthor=G.+Phillips&title=Discovery+of+Orally+Efficacious+Phosphoinositide+3-Kinase+%CE%B4+Inhibitors+with+Improved+Metabolic+Stability&doi=10.1021%2Facs.jmedchem.6b01169"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01169%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DL.%26aulast%3DChandrasekhar%26aufirst%3DJ.%26aulast%3DEvarts%26aufirst%3DJ.%26aulast%3DForseth%26aufirst%3DK.%26aulast%3DHaran%26aufirst%3DA.%2BC.%26aulast%3DIp%26aufirst%3DC.%26aulast%3DKashishian%26aufirst%3DA.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DKoditek%26aufirst%3DD.%26aulast%3DKoppenol%26aufirst%3DS.%26aulast%3DLad%26aufirst%3DL.%26aulast%3DLepist%26aufirst%3DE.-I.%26aulast%3DMcGrath%26aufirst%3DM.%2BE.%26aulast%3DPerreault%26aufirst%3DS.%26aulast%3DPuri%26aufirst%3DK.%2BD.%26aulast%3DVillase%25C3%25B1or%26aufirst%3DA.%2BG.%26aulast%3DSomoza%26aufirst%3DJ.%2BR.%26aulast%3DSteiner%26aufirst%3DB.%2BH.%26aulast%3DTherrien%26aufirst%3DJ.%26aulast%3DTreiberg%26aufirst%3DJ.%26aulast%3DPhillips%26aufirst%3DG.%26atitle%3DDiscovery%2520of%2520Orally%2520Efficacious%2520Phosphoinositide%25203-Kinase%2520%25CE%25B4%2520Inhibitors%2520with%2520Improved%2520Metabolic%2520Stability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D19%26spage%3D9228%26epage%3D9242%26doi%3D10.1021%2Facs.jmedchem.6b01169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Puri, K. D.</span>; <span class="NLM_string-name">Evarts, J. B.</span>; <span class="NLM_string-name">Lannutti, B.</span>; <span class="NLM_string-name">Giese, N.
A.</span></span> <span> </span><span class="NLM_article-title">Methods of Treatment for Solid Tumors</span>. <span class="NLM_patent">WO2010123931</span>, October 29, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=K.+D.+Puri&author=J.+B.+Evarts&author=B.+Lannutti&author=N.%0AA.+Giese&title=Methods+of+Treatment+for+Solid+Tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPuri%26aufirst%3DK.%2BD.%26atitle%3DMethods%2520of%2520Treatment%2520for%2520Solid%2520Tumors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">King-Underwood, J.</span>; <span class="NLM_string-name">Ito, K.</span>; <span class="NLM_string-name">Murray, P. J.</span>; <span class="NLM_string-name">Hardy, G.</span>; <span class="NLM_string-name">Brookfield, F. A.</span>; <span class="NLM_string-name">Brown, C. J.</span></span> <span> </span><span class="NLM_article-title">Quinazolin-4(3H)one Derivatives Used as PI3 Kinase Inhibitors</span>. <span class="NLM_patent">WO2012052753</span>, April 27, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=J.+King-Underwood&author=K.+Ito&author=P.+J.+Murray&author=G.+Hardy&author=F.+A.+Brookfield&author=C.+J.+Brown&title=Quinazolin-4%283H%29one+Derivatives+Used+as+PI3+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKing-Underwood%26aufirst%3DJ.%26atitle%3DQuinazolin-4%25283H%2529one%2520Derivatives%2520Used%2520as%2520PI3%2520Kinase%2520Inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Onions, S. T.</span>; <span class="NLM_string-name">Copmans, A. H.</span>; <span class="NLM_string-name">Broeckx, R. L. M.</span>; <span class="NLM_string-name">Smith, A. J.</span>; <span class="NLM_string-name">Taddei, D. M. A.</span></span> <span> </span><span class="NLM_article-title">2-((4-Amino-3-(3-fluoro-5-hydroxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)-3-(2-(trifluoromethyl)benzyl)quinazolin-4(3H)-one Derivatives and Their Use as Phosphoinositide 3-Kinase Inhibitors</span>. <span class="NLM_patent">WO2014140597</span>, September 19, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=S.+T.+Onions&author=A.+H.+Copmans&author=R.+L.+M.+Broeckx&author=A.+J.+Smith&author=D.+M.+A.+Taddei&title=2-%28%284-Amino-3-%283-fluoro-5-hydroxyphenyl%29-1H-pyrazolo%5B3%2C4-d%5Dpyrimidin-1-yl%29methyl%29-3-%282-%28trifluoromethyl%29benzyl%29quinazolin-4%283H%29-one+Derivatives+and+Their+Use+as+Phosphoinositide+3-Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DOnions%26aufirst%3DS.%2BT.%26atitle%3D2-%2528%25284-Amino-3-%25283-fluoro-5-hydroxyphenyl%2529-1H-pyrazolo%255B3%252C4-d%255Dpyrimidin-1-yl%2529methyl%2529-3-%25282-%2528trifluoromethyl%2529benzyl%2529quinazolin-4%25283H%2529-one%2520Derivatives%2520and%2520Their%2520Use%2520as%2520Phosphoinositide%25203-Kinase%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faia, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinitto, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brophy, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pink, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proctor, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lussier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyt, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tillotson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDougall, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jessen, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritz, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunbar, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rommel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palombella, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Changelian, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kutok, J. L.</span></span> <span> </span><span class="NLM_article-title">PI3K-δ and PI3K-γ Inhibition by IPI-145 Abrogates Immune Responses and Suppresses Activity in Autoimmune and Inflammatory Disease Models</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1364</span>– <span class="NLM_lpage">1374</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2013.09.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.chembiol.2013.09.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=24211136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslClsrvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=1364-1374&issue=11&author=D.+G.+Winklerauthor=K.+L.+Faiaauthor=J.+P.+Dinittoauthor=J.+A.+Aliauthor=K.+F.+Whiteauthor=E.+E.+Brophyauthor=M.+M.+Pinkauthor=J.+L.+Proctorauthor=J.+Lussierauthor=C.+M.+Martinauthor=J.+G.+Hoytauthor=B.+Tillotsonauthor=E.+L.+Murphyauthor=A.+R.+Limauthor=B.+D.+Thomasauthor=J.+R.+MacDougallauthor=P.+Renauthor=Y.+Liuauthor=L.+S.+Liauthor=K.+A.+Jessenauthor=C.+C.+Fritzauthor=J.+L.+Dunbarauthor=J.+R.+Porterauthor=C.+Rommelauthor=V.+J.+Palombellaauthor=P.+S.+Changelianauthor=J.+L.+Kutok&title=PI3K-%CE%B4+and+PI3K-%CE%B3+Inhibition+by+IPI-145+Abrogates+Immune+Responses+and+Suppresses+Activity+in+Autoimmune+and+Inflammatory+Disease+Models&doi=10.1016%2Fj.chembiol.2013.09.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">PI3K-δ and PI3K-γ Inhibition by IPI-145 Abrogates Immune Responses and Suppresses Activity in Autoimmune and Inflammatory Disease Models</span></div><div class="casAuthors">Winkler, David G.; Faia, Kerrie L.; DiNitto, Jonathan P.; Ali, Janid A.; White, Kerry F.; Brophy, Erin E.; Pink, Melissa M.; Proctor, Jennifer L.; Lussier, Jennifer; Martin, Christian M.; Hoyt, Jennifer G.; Tillotson, Bonnie; Murphy, Erin L.; Lim, Alice R.; Thomas, Brian D.; MacDougall, John R.; Ren, Pingda; Liu, Yi; Li, Lian-Sheng; Jessen, Katti A.; Fritz, Christian C.; Dunbar, Joi L.; Porter, James R.; Rommel, Christian; Palombella, Vito J.; Changelian, Paul S.; Kutok, Jeffery L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1364-1374</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Phosphoinositide-3 kinase (PI3K)-δ and PI3K-γ are preferentially expressed in immune cells, and inhibitors targeting these isoforms are hypothesized to have anti-inflammatory activity by affecting the adaptive and innate immune response.  We report on a potent oral PI3K-δ and PI3K-γ inhibitor (IPI-145) and characterize this compd. in biochem., cellular, and in vivo assays.  These studies demonstrate that IPI-145 exerts profound effects on adaptive and innate immunity by inhibiting B and T cell proliferation, blocking neutrophil migration, and inhibiting basophil activation.  We explored the therapeutic value of combined PI3K-δ and PI3K-γ blockade, and IPI-145 showed potent activity in collagen-induced arthritis, ovalbumin-induced asthma, and systemic lupus erythematosus rodent models.  These findings support the hypothesis that inhibition of immune function can be achieved through PI3K-δ and PI3K-γ blockade, potentially leading to significant therapeutic effects in multiple inflammatory, autoimmune, and hematol. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHLymau7LdZrVg90H21EOLACvtfcHk0lj9sTA-4KgDEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslClsrvN&md5=b9fdfd9444ac255430ff6c8a0fb71ab9</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2013.09.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2013.09.017%26sid%3Dliteratum%253Aachs%26aulast%3DWinkler%26aufirst%3DD.%2BG.%26aulast%3DFaia%26aufirst%3DK.%2BL.%26aulast%3DDinitto%26aufirst%3DJ.%2BP.%26aulast%3DAli%26aufirst%3DJ.%2BA.%26aulast%3DWhite%26aufirst%3DK.%2BF.%26aulast%3DBrophy%26aufirst%3DE.%2BE.%26aulast%3DPink%26aufirst%3DM.%2BM.%26aulast%3DProctor%26aufirst%3DJ.%2BL.%26aulast%3DLussier%26aufirst%3DJ.%26aulast%3DMartin%26aufirst%3DC.%2BM.%26aulast%3DHoyt%26aufirst%3DJ.%2BG.%26aulast%3DTillotson%26aufirst%3DB.%26aulast%3DMurphy%26aufirst%3DE.%2BL.%26aulast%3DLim%26aufirst%3DA.%2BR.%26aulast%3DThomas%26aufirst%3DB.%2BD.%26aulast%3DMacDougall%26aufirst%3DJ.%2BR.%26aulast%3DRen%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DL.%2BS.%26aulast%3DJessen%26aufirst%3DK.%2BA.%26aulast%3DFritz%26aufirst%3DC.%2BC.%26aulast%3DDunbar%26aufirst%3DJ.%2BL.%26aulast%3DPorter%26aufirst%3DJ.%2BR.%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DPalombella%26aufirst%3DV.%2BJ.%26aulast%3DChangelian%26aufirst%3DP.%2BS.%26aulast%3DKutok%26aufirst%3DJ.%2BL.%26atitle%3DPI3K-%25CE%25B4%2520and%2520PI3K-%25CE%25B3%2520Inhibition%2520by%2520IPI-145%2520Abrogates%2520Immune%2520Responses%2520and%2520Suppresses%2520Activity%2520in%2520Autoimmune%2520and%2520Inflammatory%2520Disease%2520Models%26jtitle%3DChem.%2520Biol.%26date%3D2013%26volume%3D20%26issue%3D11%26spage%3D1364%26epage%3D1374%26doi%3D10.1016%2Fj.chembiol.2013.09.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sneha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nivetha, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viswanadha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vakkalanka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, T.</span></span> <span> </span><span class="NLM_article-title">Abstract 3331: RP6530, a Dual PI3K δ/γ Inhibitor Attenuates Cancer Stem Cell Proliferation in Serous Adenocarcinoma of Ovary</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>76</i></span> (<span class="NLM_issue">14 Suppl.</span>),  <span class="NLM_fpage">3331</span>, <span class="refDoi"> DOI: 10.1158/1538-7445.AM2016-3331</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1158%2F1538-7445.AM2016-3331" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=3331&issue=14+Suppl.&author=S.+Snehaauthor=R.+Nivethaauthor=S.+Viswanadhaauthor=S.+Vakkalankaauthor=T.+Ganesan&title=Abstract+3331%3A+RP6530%2C+a+Dual+PI3K+%CE%B4%2F%CE%B3+Inhibitor+Attenuates+Cancer+Stem+Cell+Proliferation+in+Serous+Adenocarcinoma+of+Ovary&doi=10.1158%2F1538-7445.AM2016-3331"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2016-3331&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM2016-3331%26sid%3Dliteratum%253Aachs%26aulast%3DSneha%26aufirst%3DS.%26aulast%3DNivetha%26aufirst%3DR.%26aulast%3DViswanadha%26aufirst%3DS.%26aulast%3DVakkalanka%26aufirst%3DS.%26aulast%3DGanesan%26aufirst%3DT.%26atitle%3DAbstract%25203331%253A%2520RP6530%252C%2520a%2520Dual%2520PI3K%2520%25CE%25B4%252F%25CE%25B3%2520Inhibitor%2520Attenuates%2520Cancer%2520Stem%2520Cell%2520Proliferation%2520in%2520Serous%2520Adenocarcinoma%2520of%2520Ovary%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26issue%3D14%2520Suppl%26spage%3D3331%26doi%3D10.1158%2F1538-7445.AM2016-3331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vakkalanka, S. K. V. S.</span>; <span class="NLM_string-name">Muthuppalaniappan, M.</span>; <span class="NLM_string-name">Nagarathnam, D.</span></span> <span> </span><span class="NLM_article-title">Selective PI3K Delta Inhibitors</span>. <span class="NLM_patent">WO2014006572</span>, January 10, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=S.+K.+V.+S.+Vakkalanka&author=M.+Muthuppalaniappan&author=D.+Nagarathnam&title=Selective+PI3K+Delta+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVakkalanka%26aufirst%3DS.%2BK.%2BV.%2BS.%26atitle%3DSelective%2520PI3K%2520Delta%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cushing, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardozo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duquette, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Lopez
de Turiso, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henne, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hungate, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarter, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGee, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">San Miguel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pattaropong, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettus, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichelt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rzasa, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seganish, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tasker, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahl, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wannberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittington, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whoriskey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zalameda, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metz, D. P.</span></span> <span> </span><span class="NLM_article-title">Discovery and in Vivo Evaluation of (S)-N-(1-(7-Fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine (AMG319) and Related PI3Kδ Inhibitors for Inflammation and Autoimmune Disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">480</span>– <span class="NLM_lpage">511</span>, <span class="refDoi"> DOI: 10.1021/jm501624r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501624r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=480-511&issue=1&author=T.+D.+Cushingauthor=X.+Haoauthor=Y.+Shinauthor=K.+Andrewsauthor=M.+Brownauthor=M.+Cardozoauthor=Y.+Chenauthor=J.+Duquetteauthor=B.+Fisherauthor=F.+Gonzalez-Lopez%0Ade+Turisoauthor=X.+Heauthor=K.+R.+Henneauthor=Y.-L.+Huauthor=R.+Hungateauthor=M.+G.+Johnsonauthor=R.+C.+Kellyauthor=B.+Lucasauthor=J.+D.+McCarterauthor=L.+R.+McGeeauthor=J.+C.+Medinaauthor=T.+San+Miguelauthor=D.+Mohnauthor=V.+Pattaropongauthor=L.+H.+Pettusauthor=A.+Reicheltauthor=R.+M.+Rzasaauthor=J.+Seganishauthor=A.+S.+Taskerauthor=R.+C.+Wahlauthor=S.+Wannbergauthor=D.+A.+Whittingtonauthor=J.+Whoriskeyauthor=G.+Yuauthor=L.+Zalamedaauthor=D.+Zhangauthor=D.+P.+Metz&title=Discovery+and+in+Vivo+Evaluation+of+%28S%29-N-%281-%287-Fluoro-2-%28pyridin-2-yl%29quinolin-3-yl%29ethyl%29-9H-purin-6-amine+%28AMG319%29+and+Related+PI3K%CE%B4+Inhibitors+for+Inflammation+and+Autoimmune+Disease&doi=10.1021%2Fjm501624r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1021%2Fjm501624r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501624r%26sid%3Dliteratum%253Aachs%26aulast%3DCushing%26aufirst%3DT.%2BD.%26aulast%3DHao%26aufirst%3DX.%26aulast%3DShin%26aufirst%3DY.%26aulast%3DAndrews%26aufirst%3DK.%26aulast%3DBrown%26aufirst%3DM.%26aulast%3DCardozo%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DDuquette%26aufirst%3DJ.%26aulast%3DFisher%26aufirst%3DB.%26aulast%3DGonzalez-Lopez%2Bde%2BTuriso%26aufirst%3DF.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DHenne%26aufirst%3DK.%2BR.%26aulast%3DHu%26aufirst%3DY.-L.%26aulast%3DHungate%26aufirst%3DR.%26aulast%3DJohnson%26aufirst%3DM.%2BG.%26aulast%3DKelly%26aufirst%3DR.%2BC.%26aulast%3DLucas%26aufirst%3DB.%26aulast%3DMcCarter%26aufirst%3DJ.%2BD.%26aulast%3DMcGee%26aufirst%3DL.%2BR.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26aulast%3DSan%2BMiguel%26aufirst%3DT.%26aulast%3DMohn%26aufirst%3DD.%26aulast%3DPattaropong%26aufirst%3DV.%26aulast%3DPettus%26aufirst%3DL.%2BH.%26aulast%3DReichelt%26aufirst%3DA.%26aulast%3DRzasa%26aufirst%3DR.%2BM.%26aulast%3DSeganish%26aufirst%3DJ.%26aulast%3DTasker%26aufirst%3DA.%2BS.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWannberg%26aufirst%3DS.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DWhoriskey%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DG.%26aulast%3DZalameda%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DMetz%26aufirst%3DD.%2BP.%26atitle%3DDiscovery%2520and%2520in%2520Vivo%2520Evaluation%2520of%2520%2528S%2529-N-%25281-%25287-Fluoro-2-%2528pyridin-2-yl%2529quinolin-3-yl%2529ethyl%2529-9H-purin-6-amine%2520%2528AMG319%2529%2520and%2520Related%2520PI3K%25CE%25B4%2520Inhibitors%2520for%2520Inflammation%2520and%2520Autoimmune%2520Disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D1%26spage%3D480%26epage%3D511%26doi%3D10.1021%2Fjm501624r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allen, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brookings, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuttleworth, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merriman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fahy, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tewari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Healy, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, G. C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Twomey, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cutler, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crosby, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCluskey, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watt, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, A.</span></span> <span> </span><span class="NLM_article-title">Seletalisib: Characterization of a Novel, Potent, and Selective Inhibitor of PI3K δ</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>361</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">429</span>– <span class="NLM_lpage">440</span>, <span class="refDoi"> DOI: 10.1124/jpet.116.237347</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1124%2Fjpet.116.237347" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=28442583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFOqsLbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2017&pages=429-440&issue=3&author=R.+A.+Allenauthor=D.+C.+Brookingsauthor=M.+J.+Powellauthor=J.+Delgadoauthor=L.+K.+Shuttleworthauthor=M.+Merrimanauthor=I.+J.+Fahyauthor=R.+Tewariauthor=J.+P.+Silvaauthor=L.+J.+Healyauthor=G.+C.+G.+Daviesauthor=B.+Twomeyauthor=R.+M.+Cutlerauthor=A.+Kotianauthor=A.+Crosbyauthor=G.+McCluskeyauthor=G.+F.+Wattauthor=A.+Payne&title=Seletalisib%3A+Characterization+of+a+Novel%2C+Potent%2C+and+Selective+Inhibitor+of+PI3K+%CE%B4&doi=10.1124%2Fjpet.116.237347"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Seletalisib: characterization of a novel, potent, and selective inhibitor of PI3Kδ</span></div><div class="casAuthors">Allen, Rodger A.; Brookings, Daniel C.; Powell, Mark J.; Delgado, Jean; Shuttleworth, Lindsay K.; Merriman, Mark; Fahy, Ian J.; Tewari, Roohi; Silva, John P.; Healy, Louise J.; Davies, Gareth C. G.; Twomey, Breda; Cutler, Rona M.; Kotian, Apoorva; Crosby, Andrea; McCluskey, Gillian; Watt, Gillian F.; Payne, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">429-440</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Phosphoinositide 3-kinases (PI3K) are key signaling enzymes regulating cellular survival, development, and function.  Expression of the PI3Kδ isoform is largely restricted to leukocytes and it plays a key role in immune cell development and function.  Seletalisib is a novel small-mol. inhibitor of PI3Kδ that was evaluated in biochem. assays, cellular assays of adaptive and innate immunity, and an in vivo rat model of inflammation.  Our findings show that seletalisib is a potent, ATP-competitive, and selective PI3Kδ inhibitor able to block protein kinase B (AKT) phosphorylation following activation of the B-cell receptor in a B-cell line.  Moreover, seletalisib inhibited N-formyl peptide-stimulated but not phorbol myristate acetate-stimulated superoxide release from human neutrophils, consistent with a PI3Kδ-specific activity.  No indications of cytotoxicity were obsd. in peripheral blood mononuclear cells (PBMCs) or other cell types treated with seletalisib.  Findings from cellular assays of adaptive immunity demonstrated that seletalisib blocks human T-cell prodn. of several cytokines from activated T-cells.  Addnl., seletalisib inhibited B-cell proliferation and cytokine release.  In human whole blood assays, seletalisib inhibited CD69 expression upon B-cell activation and anti-IgE-mediated basophil degranulation.  Seletalisib showed dose-dependent inhibition in an in vivo rat model of anti-CD3-antibody-induced interleukin 2 release.  Collectively, these data characterize seletalisib as a selective PI3Kδ inhibitor and potential therapeutic candidate for the treatment of B-cell malignancies and autoimmune diseases driven by dysregulated proinflammatory cytokine secretion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyxgOubZ1Ic7Vg90H21EOLACvtfcHk0lgo2JVMEFbpHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFOqsLbI&md5=270c4866fe19b97aada323e9945715ab</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1124%2Fjpet.116.237347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.116.237347%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DR.%2BA.%26aulast%3DBrookings%26aufirst%3DD.%2BC.%26aulast%3DPowell%26aufirst%3DM.%2BJ.%26aulast%3DDelgado%26aufirst%3DJ.%26aulast%3DShuttleworth%26aufirst%3DL.%2BK.%26aulast%3DMerriman%26aufirst%3DM.%26aulast%3DFahy%26aufirst%3DI.%2BJ.%26aulast%3DTewari%26aufirst%3DR.%26aulast%3DSilva%26aufirst%3DJ.%2BP.%26aulast%3DHealy%26aufirst%3DL.%2BJ.%26aulast%3DDavies%26aufirst%3DG.%2BC.%2BG.%26aulast%3DTwomey%26aufirst%3DB.%26aulast%3DCutler%26aufirst%3DR.%2BM.%26aulast%3DKotian%26aufirst%3DA.%26aulast%3DCrosby%26aufirst%3DA.%26aulast%3DMcCluskey%26aufirst%3DG.%26aulast%3DWatt%26aufirst%3DG.%2BF.%26aulast%3DPayne%26aufirst%3DA.%26atitle%3DSeletalisib%253A%2520Characterization%2520of%2520a%2520Novel%252C%2520Potent%252C%2520and%2520Selective%2520Inhibitor%2520of%2520PI3K%2520%25CE%25B4%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2017%26volume%3D361%26issue%3D3%26spage%3D429%26epage%3D440%26doi%3D10.1124%2Fjpet.116.237347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span>; <span class="NLM_string-name">Liu, X.</span>; <span class="NLM_string-name">Huang, D.</span>; <span class="NLM_string-name">Zhang, Y.</span>; <span class="NLM_string-name">Kai, Y.</span></span> <span> </span><span class="NLM_article-title">Substituted Pyrimidine Compounds as Phosphatidylinositol 3-Kinase δ Inhibitor and Use Thereof</span>. <span class="NLM_patent">WO2016141855</span>, September 16, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=Y.+Wang&author=X.+Liu&author=D.+Huang&author=Y.+Zhang&author=Y.+Kai&title=Substituted+Pyrimidine+Compounds+as+Phosphatidylinositol+3-Kinase+%CE%B4+Inhibitor+and+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26atitle%3DSubstituted%2520Pyrimidine%2520Compounds%2520as%2520Phosphatidylinositol%25203-Kinase%2520%25CE%25B4%2520Inhibitor%2520and%2520Use%2520Thereof%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shukla, M. R.</span>; <span class="NLM_string-name">Jana, N. K.</span>; <span class="NLM_string-name">Mahangare, S. J.</span>; <span class="NLM_string-name">Vidhate, P. P.</span>; <span class="NLM_string-name">Lagad, D. R.</span>; <span class="NLM_string-name">Tarage, A. J.</span>; <span class="NLM_string-name">Kulkarni, S. A.</span>; <span class="NLM_string-name">Palle, V. P.</span>; <span class="NLM_string-name">Kamboj, R. K.</span></span> <span> </span><span class="NLM_article-title">Quinolizinone Derivatives as PI3K Inhibitors</span>. <span class="NLM_patent">WO2016001855</span>, January 8, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=M.+R.+Shukla&author=N.+K.+Jana&author=S.+J.+Mahangare&author=P.+P.+Vidhate&author=D.+R.+Lagad&author=A.+J.+Tarage&author=S.+A.+Kulkarni&author=V.+P.+Palle&author=R.+K.+Kamboj&title=Quinolizinone+Derivatives+as+PI3K+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DShukla%26aufirst%3DM.%2BR.%26atitle%3DQuinolizinone%2520Derivatives%2520as%2520PI3K%2520Inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shukla, M. R.</span>; <span class="NLM_string-name">Jana, N. K.</span>; <span class="NLM_string-name">Mahangare, S. J.</span>; <span class="NLM_string-name">Vidhate, P. P.</span>; <span class="NLM_string-name">Lagad, D. R.</span>; <span class="NLM_string-name">Tarage, A. J.</span>; <span class="NLM_string-name">Kulkarni, S. A.</span>; <span class="NLM_string-name">Palle, V. P.</span>; <span class="NLM_string-name">Kamboj, R. K.</span></span> <span> </span><span class="NLM_article-title">Quinolizinone Derivatives as PI3K Inhibitors</span>. <span class="NLM_patent">WO2017103825</span>, June 23, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=M.+R.+Shukla&author=N.+K.+Jana&author=S.+J.+Mahangare&author=P.+P.+Vidhate&author=D.+R.+Lagad&author=A.+J.+Tarage&author=S.+A.+Kulkarni&author=V.+P.+Palle&author=R.+K.+Kamboj&title=Quinolizinone+Derivatives+as+PI3K+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DShukla%26aufirst%3DM.%2BR.%26atitle%3DQuinolizinone%2520Derivatives%2520as%2520PI3K%2520Inhibitors%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, R.</span>; <span class="NLM_string-name">Hu, Y.</span>; <span class="NLM_string-name">Wei, J.</span>; <span class="NLM_string-name">Ma, X.</span></span> <span> </span><span class="NLM_article-title">Benzothiazine and Benzothiadiazine Compounds and Preparation and Use</span>. <span class="NLM_patent">WO2017133655</span>, August 11, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=R.+Sheng&author=Y.+Hu&author=J.+Wei&author=X.+Ma&title=Benzothiazine+and+Benzothiadiazine+Compounds+and+Preparation+and+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DR.%26atitle%3DBenzothiazine%2520and%2520Benzothiadiazine%2520Compounds%2520and%2520Preparation%2520and%2520Use%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biagetti, M.</span>; <span class="NLM_string-name">Capelli, A. M.</span>; <span class="NLM_string-name">Accetta, A.</span>; <span class="NLM_string-name">Carzaniga, L.</span></span> <span> </span><span class="NLM_article-title">Isochromene Derivatives as Phosphoinositide 3-Kinases Inhibitors</span>. <span class="NLM_patent">WO2015091685</span>, June 26, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+Biagetti&author=A.+M.+Capelli&author=A.+Accetta&author=L.+Carzaniga&title=Isochromene+Derivatives+as+Phosphoinositide+3-Kinases+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBiagetti%26aufirst%3DM.%26atitle%3DIsochromene%2520Derivatives%2520as%2520Phosphoinositide%25203-Kinases%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lannutti, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meadows, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herman, S. E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashishian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byrd, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyner, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loriaux, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deininger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Druker, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puri, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulrich, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giese, N. A.</span></span> <span> </span><span class="NLM_article-title">CAL-101, a p110delta Selective Phosphatidylinositol-3-Kinase Inhibitor for the Treatment of B-Cell Malignancies, Inhibits PI3K Signaling and Cellular Viability</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>117</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">591</span>– <span class="NLM_lpage">594</span>, <span class="refDoi"> DOI: 10.1182/blood-2010-03-275305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1182%2Fblood-2010-03-275305" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2011&pages=591-594&issue=2&author=B.+J.+Lannuttiauthor=S.+A.+Meadowsauthor=S.+E.+M.+Hermanauthor=A.+Kashishianauthor=B.+Steinerauthor=A.+J.+Johnsonauthor=J.+C.+Byrdauthor=J.+W.+Tynerauthor=M.+M.+Loriauxauthor=M.+Deiningerauthor=B.+J.+Drukerauthor=K.+D.+Puriauthor=R.+G.+Ulrichauthor=N.+A.+Giese&title=CAL-101%2C+a+p110delta+Selective+Phosphatidylinositol-3-Kinase+Inhibitor+for+the+Treatment+of+B-Cell+Malignancies%2C+Inhibits+PI3K+Signaling+and+Cellular+Viability&doi=10.1182%2Fblood-2010-03-275305"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1182%2Fblood-2010-03-275305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2010-03-275305%26sid%3Dliteratum%253Aachs%26aulast%3DLannutti%26aufirst%3DB.%2BJ.%26aulast%3DMeadows%26aufirst%3DS.%2BA.%26aulast%3DHerman%26aufirst%3DS.%2BE.%2BM.%26aulast%3DKashishian%26aufirst%3DA.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DJohnson%26aufirst%3DA.%2BJ.%26aulast%3DByrd%26aufirst%3DJ.%2BC.%26aulast%3DTyner%26aufirst%3DJ.%2BW.%26aulast%3DLoriaux%26aufirst%3DM.%2BM.%26aulast%3DDeininger%26aufirst%3DM.%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26aulast%3DPuri%26aufirst%3DK.%2BD.%26aulast%3DUlrich%26aufirst%3DR.%2BG.%26aulast%3DGiese%26aufirst%3DN.%2BA.%26atitle%3DCAL-101%252C%2520a%2520p110delta%2520Selective%2520Phosphatidylinositol-3-Kinase%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520B-Cell%2520Malignancies%252C%2520Inhibits%2520PI3K%2520Signaling%2520and%2520Cellular%2520Viability%26jtitle%3DBlood%26date%3D2011%26volume%3D117%26issue%3D2%26spage%3D591%26epage%3D594%26doi%3D10.1182%2Fblood-2010-03-275305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katiyar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rumberger, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leffet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rupar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Covington, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koblish, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soloviev, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuey, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamond, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fridman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Combs, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeleswaram, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaddi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherle, P.</span></span> <span> </span><span class="NLM_article-title">INCB040093 Is a Novel PI3Kδ Inhibitor for the Treatment of B Cell Lymphoid Malignancies</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>364</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">120</span>– <span class="NLM_lpage">130</span>, <span class="refDoi"> DOI: 10.1124/jpet.117.244947</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1124%2Fjpet.117.244947" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=29127109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsF2rtLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=364&publication_year=2018&pages=120-130&issue=1&author=N.+Shinauthor=Y.-L.+Liauthor=S.+Meiauthor=K.+H.+Wangauthor=L.+Hallauthor=K.+Katiyarauthor=Q.+Wangauthor=G.+Yangauthor=B.+Rumbergerauthor=L.+Leffetauthor=X.+Heauthor=M.+Ruparauthor=K.+Bowmanauthor=M.+Favataauthor=J.+Liauthor=M.+Liuauthor=Y.+Liauthor=M.+Covingtonauthor=H.+Koblishauthor=M.+Solovievauthor=D.+Shueyauthor=T.+Burnauthor=S.+Diamondauthor=J.+Fridmanauthor=A.+Combsauthor=W.+Yaoauthor=S.+Yeleswaramauthor=G.+Hollisauthor=K.+Vaddiauthor=R.+Huberauthor=R.+Newtonauthor=P.+Scherle&title=INCB040093+Is+a+Novel+PI3K%CE%B4+Inhibitor+for+the+Treatment+of+B+Cell+Lymphoid+Malignancies&doi=10.1124%2Fjpet.117.244947"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">INCB040093 is a novel PI3Kδ inhibitor for the treatment of B cell lymphoid malignancies</span></div><div class="casAuthors">Shin, Niu; Li, Yun-Long; Mei, Song; Wang, Kathy He; Hall, Leslie; Katiyar, Kamna; Wang, Qian; Yang, Gengjie; Rumberger, Beth; Leffet, Lynn; He, Xin; Rupar, Mark; Bowman, Kevin; Favata, Margaret; Li, Jun; Liu, Mike; Li, Yanlong; Covington, Maryanne; Koblish, Holly; Soloviev, Maxim; Shuey, Dana; Burn, Timothy; Diamond, Sharon; Fridman, Jordan; Combs, Andrew; Yao, Wenqing; Yeleswaram, Swamy; Hollis, Gregory; Vaddi, Kris; Huber, Reid; Newton, Robert; Scherle, Peggy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">364</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">120-130</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Phosphatidylinositol 3-kinase delta (PI3Kδ) is a crit. signaling mol. in B cells and is considered a target for development of therapies against various B cell malignancies.  INCB040093 is a novel PI3Kδ small-mol. inhibitor and has demonstrated promising efficacy in patients with Hodgkin's lymphoma in clin. studies.  In this study, we disclose the chem. structure and the preclin. activity of the compd.  In biochem. assays, INCB040093 potently inhibits the PI3Kδ kinase, with 74- to >900-fold selectivity against other PI3K family members.  In vitro and ex vivo studies using primary B cells, cell lines from B cell malignancies, and human whole blood show that INCB040093 inhibits PI3Kδ-mediated functions, including cell signaling and proliferation.  INCB040093 has no significant effect on the growth of nonlymphoid cell lines and was less potent in assays that measure human T and natural killer cell proliferation and neutrophil and monocyte functions, suggesting that the impact of INCB040093 on the human immune system will likely be restricted to B cells.  INCB040093 inhibits the prodn. of macrophage-inflammatory protein-1β (MIP-1beta) and tumor necrosis factor-β (TNF-beta) from a B cell line, suggesting a potential effect on the tumor microenvironment.  In vivo, INCB040093 demonstrates single-agent activity in inhibiting tumor growth and potentiates the antitumor growth effect of the clin. relevant chemotherapeutic agent, bendamustine, in the Pfeiffer cell xenograft model of non-Hodgkin's lymphoma.  INCB040093 has a favorable exposure profile in rats and an acceptable safety margin in rats and dogs.  Taken together, data presented in this report support the potential utility of orally administered INCB040093 in the treatment of B cell malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAfVvCSgFZrbVg90H21EOLACvtfcHk0liow0aFUO_WZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsF2rtLbE&md5=4d43da71159c3543090f9df59e377299</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1124%2Fjpet.117.244947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.117.244947%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DY.-L.%26aulast%3DMei%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DK.%2BH.%26aulast%3DHall%26aufirst%3DL.%26aulast%3DKatiyar%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DRumberger%26aufirst%3DB.%26aulast%3DLeffet%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DRupar%26aufirst%3DM.%26aulast%3DBowman%26aufirst%3DK.%26aulast%3DFavata%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DCovington%26aufirst%3DM.%26aulast%3DKoblish%26aufirst%3DH.%26aulast%3DSoloviev%26aufirst%3DM.%26aulast%3DShuey%26aufirst%3DD.%26aulast%3DBurn%26aufirst%3DT.%26aulast%3DDiamond%26aufirst%3DS.%26aulast%3DFridman%26aufirst%3DJ.%26aulast%3DCombs%26aufirst%3DA.%26aulast%3DYao%26aufirst%3DW.%26aulast%3DYeleswaram%26aufirst%3DS.%26aulast%3DHollis%26aufirst%3DG.%26aulast%3DVaddi%26aufirst%3DK.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DNewton%26aufirst%3DR.%26aulast%3DScherle%26aufirst%3DP.%26atitle%3DINCB040093%2520Is%2520a%2520Novel%2520PI3K%25CE%25B4%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520B%2520Cell%2520Lymphoid%2520Malignancies%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2018%26volume%3D364%26issue%3D1%26spage%3D120%26epage%3D130%26doi%3D10.1124%2Fjpet.117.244947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taltavull, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gréco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernal, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caturla, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gràcia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domínguez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabaté, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paris, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soria, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernández, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armengol, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabedo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bravo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calama, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miralpeix, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehner, M. D.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Potent, Selective, and Orally Available PI3Kδ Inhibitor for the Treatment of Inflammatory Diseases</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">118</span>– <span class="NLM_lpage">123</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00438</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00438" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=118-123&issue=1&author=M.+Erraauthor=J.+Taltavullauthor=A.+Gr%C3%A9coauthor=F.+J.+Bernalauthor=J.+F.+Caturlaauthor=J.+Gr%C3%A0ciaauthor=M.+Dom%C3%ADnguezauthor=M.+Sabat%C3%A9author=S.+Parisauthor=S.+Soriaauthor=B.+Hern%C3%A1ndezauthor=C.+Armengolauthor=J.+Cabedoauthor=M.+Bravoauthor=E.+Calamaauthor=M.+Miralpeixauthor=M.+D.+Lehner&title=Discovery+of+a+Potent%2C+Selective%2C+and+Orally+Available+PI3K%CE%B4+Inhibitor+for+the+Treatment+of+Inflammatory+Diseases&doi=10.1021%2Facsmedchemlett.6b00438"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00438%26sid%3Dliteratum%253Aachs%26aulast%3DErra%26aufirst%3DM.%26aulast%3DTaltavull%26aufirst%3DJ.%26aulast%3DGr%25C3%25A9co%26aufirst%3DA.%26aulast%3DBernal%26aufirst%3DF.%2BJ.%26aulast%3DCaturla%26aufirst%3DJ.%2BF.%26aulast%3DGr%25C3%25A0cia%26aufirst%3DJ.%26aulast%3DDom%25C3%25ADnguez%26aufirst%3DM.%26aulast%3DSabat%25C3%25A9%26aufirst%3DM.%26aulast%3DParis%26aufirst%3DS.%26aulast%3DSoria%26aufirst%3DS.%26aulast%3DHern%25C3%25A1ndez%26aufirst%3DB.%26aulast%3DArmengol%26aufirst%3DC.%26aulast%3DCabedo%26aufirst%3DJ.%26aulast%3DBravo%26aufirst%3DM.%26aulast%3DCalama%26aufirst%3DE.%26aulast%3DMiralpeix%26aufirst%3DM.%26aulast%3DLehner%26aufirst%3DM.%2BD.%26atitle%3DDiscovery%2520of%2520a%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Available%2520PI3K%25CE%25B4%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Inflammatory%2520Diseases%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26issue%3D1%26spage%3D118%26epage%3D123%26doi%3D10.1021%2Facsmedchemlett.6b00438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Su, W.-G.</span>; <span class="NLM_string-name">Dai, G.</span>; <span class="NLM_string-name">Xiao, K.</span>; <span class="NLM_string-name">Jia, H.</span>; <span class="NLM_string-name">Venable, J. D.</span>; <span class="NLM_string-name">Bembenek, S. D.</span></span> <span> </span><span class="NLM_article-title">Novel Heteroaryl and Heterocycle Compounds, Compositions and Methods</span>. <span class="NLM_patent">WO2014015523</span>, January 31, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=W.-G.+Su&author=G.+Dai&author=K.+Xiao&author=H.+Jia&author=J.+D.+Venable&author=S.+D.+Bembenek&title=Novel+Heteroaryl+and+Heterocycle+Compounds%2C+Compositions+and+Methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DW.-G.%26atitle%3DNovel%2520Heteroaryl%2520and%2520Heterocycle%2520Compounds%252C%2520Compositions%2520and%2520Methods%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Su, W.-G.</span>; <span class="NLM_string-name">Dai, G.</span>; <span class="NLM_string-name">Jia, H.</span>; <span class="NLM_string-name">Zhang, Z.</span>; <span class="NLM_string-name">Weng, J.</span>; <span class="NLM_string-name">Venable, J. D.</span>; <span class="NLM_string-name">Bembenek, S. D.</span>; <span class="NLM_string-name">Chai, W.</span>; <span class="NLM_string-name">Meduna, S. P.</span>; <span class="NLM_string-name">Keith, J. M.</span>; <span class="NLM_string-name">Eccles, W.</span>; <span class="NLM_string-name">Lebsack, A. D.</span>; <span class="NLM_string-name">Jones, W. M.</span>; <span class="NLM_string-name">Smith, R. C.</span></span> <span> </span><span class="NLM_article-title">Novel Heteroaryl and Heterocycle Compounds, Compositions and Methods</span>. <span class="NLM_patent">WO2016119707</span>, August 5, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=W.-G.+Su&author=G.+Dai&author=H.+Jia&author=Z.+Zhang&author=J.+Weng&author=J.+D.+Venable&author=S.+D.+Bembenek&author=W.+Chai&author=S.+P.+Meduna&author=J.+M.+Keith&author=W.+Eccles&author=A.+D.+Lebsack&author=W.+M.+Jones&author=R.+C.+Smith&title=Novel+Heteroaryl+and+Heterocycle+Compounds%2C+Compositions+and+Methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DW.-G.%26atitle%3DNovel%2520Heteroaryl%2520and%2520Heterocycle%2520Compounds%252C%2520Compositions%2520and%2520Methods%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Su, W.-G.</span>; <span class="NLM_string-name">Dai, G.</span>; <span class="NLM_string-name">Zhang, W.</span>; <span class="NLM_string-name">Deng, W.</span></span> <span> </span><span class="NLM_article-title">Novel Imidazopyridazine Compounds and Their Use</span>. <span class="NLM_patent">WO2016045591</span>, April 1, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=W.-G.+Su&author=G.+Dai&author=W.+Zhang&author=W.+Deng&title=Novel+Imidazopyridazine+Compounds+and+Their+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DW.-G.%26atitle%3DNovel%2520Imidazopyridazine%2520Compounds%2520and%2520Their%2520Use%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, B.</span></span> <span> </span><span class="NLM_article-title">Pyrazolopyrimidine Compound as PI3K Inhibitor and Use Thereof</span>. <span class="NLM_patent">WO2018082444</span>, May 12, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=B.+Ye&title=Pyrazolopyrimidine+Compound+as+PI3K+Inhibitor+and+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DB.%26atitle%3DPyrazolopyrimidine%2520Compound%2520as%2520PI3K%2520Inhibitor%2520and%2520Use%2520Thereof%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Imidazopyridine Compound and Uses in Preparation of PI3K Inhibitor</span>. <span class="NLM_patent">WO2017049498</span>, March 31, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=Z.+Liu&title=Imidazopyridine+Compound+and+Uses+in+Preparation+of+PI3K+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DImidazopyridine%2520Compound%2520and%2520Uses%2520in%2520Preparation%2520of%2520PI3K%2520Inhibitor%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, E.</span>; <span class="NLM_string-name">Smith, C.</span>; <span class="NLM_string-name">Wang, X.</span>; <span class="NLM_string-name">Wallace, M. B.</span></span> <span> </span><span class="NLM_article-title">Azaindole Derivatives</span>. <span class="NLM_patent">WO2015106012</span>, July 17, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=E.+Chang&author=C.+Smith&author=X.+Wang&author=M.+B.+Wallace&title=Azaindole+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DE.%26atitle%3DAzaindole%2520Derivatives%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span>; <span class="NLM_string-name">Ding, J.</span>; <span class="NLM_string-name">Meng, L.</span>; <span class="NLM_string-name">Geng, M.</span>; <span class="NLM_string-name">Li, T.</span>; <span class="NLM_string-name">Zhou, Z.</span>; <span class="NLM_string-name">Chen, L.</span>; <span class="NLM_string-name">Liu, Q.</span>; <span class="NLM_string-name">Wang, X.</span>; <span class="NLM_string-name">Yang, L.</span>; <span class="NLM_string-name">Rong, Y.</span>; <span class="NLM_string-name">Tan, R.</span>; <span class="NLM_string-name">Yu, C.</span>; <span class="NLM_string-name">Jiang, L.</span>; <span class="NLM_string-name">Liu, Y.</span>; <span class="NLM_string-name">Linghu, L.</span>; <span class="NLM_string-name">Sun, J.</span>; <span class="NLM_string-name">Wang, W.</span></span> <span> </span><span class="NLM_article-title">Certain Protein Kinase Inhibitors</span>. <span class="NLM_patent">WO2016066142</span>, May 7, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=X.+Zhao&author=J.+Ding&author=L.+Meng&author=M.+Geng&author=T.+Li&author=Z.+Zhou&author=L.+Chen&author=Q.+Liu&author=X.+Wang&author=L.+Yang&author=Y.+Rong&author=R.+Tan&author=C.+Yu&author=L.+Jiang&author=Y.+Liu&author=L.+Linghu&author=J.+Sun&author=W.+Wang&title=Certain+Protein+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DX.%26atitle%3DCertain%2520Protein%2520Kinase%2520Inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perry, M. W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Björhall, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlsson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eriksson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fredlund, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holden, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karabelas, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindmark, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pemberton, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigo Blomqvist, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svensson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terstiege, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyrchan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Öster, L.</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of Soluble and Cell-Permeable PI3Kδ Inhibitors for Long-Acting Inhaled Administration</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">5057</span>– <span class="NLM_lpage">5071</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00401</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00401" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotVGlu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5057-5071&issue=12&author=M.+W.+D.+Perryauthor=K.+Bj%C3%B6rhallauthor=B.+Bonnauthor=J.+Carlssonauthor=Y.+Chenauthor=A.+Erikssonauthor=L.+Fredlundauthor=H.+Haoauthor=N.+S.+Holdenauthor=K.+Karabelasauthor=H.+Lindmarkauthor=F.+Liuauthor=N.+Pembertonauthor=J.+Petersenauthor=S.+Rodrigo+Blomqvistauthor=R.+W.+Smithauthor=T.+Svenssonauthor=I.+Terstiegeauthor=C.+Tyrchanauthor=W.+Yangauthor=S.+Zhaoauthor=L.+%C3%96ster&title=Design+and+Synthesis+of+Soluble+and+Cell-Permeable+PI3K%CE%B4+Inhibitors+for+Long-Acting+Inhaled+Administration&doi=10.1021%2Facs.jmedchem.7b00401"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Soluble and Cell-Permeable PI3Kδ Inhibitors for Long-Acting Inhaled Administration</span></div><div class="casAuthors">Perry, Matthew W. D.; Bjoerhall, Karin; Bonn, Britta; Carlsson, Johan; Chen, Yunhua; Eriksson, Anders; Fredlund, Linda; Hao, Hai'e; Holden, Neil S.; Karabelas, Kostas; Lindmark, Helena; Liu, Feifei; Pemberton, Nils; Petersen, Jens; Rodrigo Blomqvist, Sandra; Smith, Reed W.; Svensson, Tor; Terstiege, Ina; Tyrchan, Christian; Yang, Wenzhen; Zhao, Shuchun; Oester, Linda</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5057-5071</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">PI3Kδ is a lipid kinase that is believed to be important in the migration and activation of cells of the immune system.  Inhibition is hypothesized to provide a powerful yet selective immunomodulatory effect that may be beneficial for the treatment of conditions such as asthma or rheumatoid arthritis.  In this work, identification of inhibitors based on a thiazolopyridone core structure and their subsequent optimization for inhalation is described.  The initially identified compd. I had good potency and isoform selectivity but was not suitable for inhalation.  Addn. of basic substituents to a region of the mol. pointing to solvent was tolerated (enzyme inhibition pIC50 > 9), and by careful manipulation of the pKa and lipophilicity, the authors were able to discover compds. II (R = Me or i-Bu) with good lung retention and cell potency that could be taken forward to in vivo studies where significant target engagement could be demonstrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4lo9sRrhhb7Vg90H21EOLACvtfcHk0ljU2ktxSTB3Jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotVGlu7w%253D&md5=dafb9cfdf6c06e30c599dcceec85497a</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00401%26sid%3Dliteratum%253Aachs%26aulast%3DPerry%26aufirst%3DM.%2BW.%2BD.%26aulast%3DBj%25C3%25B6rhall%26aufirst%3DK.%26aulast%3DBonn%26aufirst%3DB.%26aulast%3DCarlsson%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DEriksson%26aufirst%3DA.%26aulast%3DFredlund%26aufirst%3DL.%26aulast%3DHao%26aufirst%3DH.%26aulast%3DHolden%26aufirst%3DN.%2BS.%26aulast%3DKarabelas%26aufirst%3DK.%26aulast%3DLindmark%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DPemberton%26aufirst%3DN.%26aulast%3DPetersen%26aufirst%3DJ.%26aulast%3DRodrigo%2BBlomqvist%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DR.%2BW.%26aulast%3DSvensson%26aufirst%3DT.%26aulast%3DTerstiege%26aufirst%3DI.%26aulast%3DTyrchan%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3D%25C3%2596ster%26aufirst%3DL.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Soluble%2520and%2520Cell-Permeable%2520PI3K%25CE%25B4%2520Inhibitors%2520for%2520Long-Acting%2520Inhaled%2520Administration%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D12%26spage%3D5057%26epage%3D5071%26doi%3D10.1021%2Facs.jmedchem.7b00401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carrascal
Riera, M.</span>; <span class="NLM_string-name">Gracia
Ferrer, J.</span>; <span class="NLM_string-name">Matassa, V. G.</span>; <span class="NLM_string-name">Santacana, L. M. P.</span>; <span class="NLM_string-name">Terricabras
Belart, E.</span></span> <span> </span><span class="NLM_article-title">Imidazopyridine Derivatives as PI3K Inhibitors</span>. <span class="NLM_patent">WO2012146667</span>, November 2, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=M.+Carrascal%0ARiera&author=J.+Gracia%0AFerrer&author=V.+G.+Matassa&author=L.+M.+P.+Santacana&author=E.+Terricabras%0ABelart&title=Imidazopyridine+Derivatives+as+PI3K+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCarrascal%2BRiera%26aufirst%3DM.%26atitle%3DImidazopyridine%2520Derivatives%2520as%2520PI3K%2520Inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biagetti, M.</span>; <span class="NLM_string-name">Accetta, A.</span>; <span class="NLM_string-name">Capelli, A. M.</span>; <span class="NLM_string-name">Guala, M.</span>; <span class="NLM_string-name">Retini, M.</span></span> <span> </span><span class="NLM_article-title">Indolizine Derivatives as Phoshoinositide 3-Kinases Inhibitors</span>. <span class="NLM_patent">WO2015193263</span>, December 24, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+Biagetti&author=A.+Accetta&author=A.+M.+Capelli&author=M.+Guala&author=M.+Retini&title=Indolizine+Derivatives+as+Phoshoinositide+3-Kinases+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBiagetti%26aufirst%3DM.%26atitle%3DIndolizine%2520Derivatives%2520as%2520Phoshoinositide%25203-Kinases%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.-L.</span>; <span class="NLM_string-name">Combs, A. P.</span>; <span class="NLM_string-name">Yue, E. W.</span>; <span class="NLM_string-name">Maduskuie, T. P.,  Jr.</span>; <span class="NLM_string-name">Sparks, R. B.</span></span> <span> </span><span class="NLM_article-title">N-(1-(Substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K Inhibitors</span>. <span class="NLM_patent">WO2012087881</span>, June 29, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=Y.-L.+Li&author=A.+P.+Combs&author=E.+W.+Yue&author=T.+P.+Maduskuie&author=R.+B.+Sparks&title=N-%281-%28Substituted-phenyl%29ethyl%29-9H-purin-6-amines+as+PI3K+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.-L.%26atitle%3DN-%25281-%2528Substituted-phenyl%2529ethyl%2529-9H-purin-6-amines%2520as%2520PI3K%2520Inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Combs, A. P.</span>; <span class="NLM_string-name">Li, Y.-L.</span>; <span class="NLM_string-name">Yue, E. W.</span>; <span class="NLM_string-name">Mei, S.</span></span> <span> </span><span class="NLM_article-title">Pyrimidine-4,6-diamine Derivatives as PI3K Inhibitors</span>. <span class="NLM_patent">WO2012135009</span>, October 5, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+P.+Combs&author=Y.-L.+Li&author=E.+W.+Yue&author=S.+Mei&title=Pyrimidine-4%2C6-diamine+Derivatives+as+PI3K+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCombs%26aufirst%3DA.%2BP.%26atitle%3DPyrimidine-4%252C6-diamine%2520Derivatives%2520as%2520PI3K%2520Inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koblish, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Covington, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katiyar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maduskuie, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douty, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, C.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Combs, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamond-Fosbenner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeleswaram, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaddi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherle, P.</span></span> <span> </span><span class="NLM_article-title">INCB050465, a Novel PI3Kδ Inhibitor, Synergizes with PIM Protein Kinase Inhibition to Cause Tumor Regression in a Model of DLBCL</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>75</i></span> (<span class="NLM_issue">15 Suppl.</span>),  <span class="NLM_fpage">2671</span>, <span class="refDoi"> DOI: 10.1158/1538-7445.AM2015-2671</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1158%2F1538-7445.AM2015-2671" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=2671&issue=15+Suppl.&author=N.+Shinauthor=H.+Koblishauthor=M.+Covingtonauthor=Y.+Liauthor=K.+Wangauthor=Q.+Wangauthor=P.+Feldmanauthor=L.+Hallauthor=S.+O%E2%80%99Connorauthor=X.+Heauthor=K.+Katiyarauthor=Y.+Liauthor=E.+W.+Yueauthor=T.+P.+Maduskuieauthor=B.+Doutyauthor=S.+Meiauthor=Y.-L.+Liauthor=C.-B.+Xueauthor=A.+Combsauthor=W.+Yaoauthor=S.+Diamond-Fosbennerauthor=S.+Yeleswaramauthor=R.+Newtonauthor=K.+Vaddiauthor=R.+Huberauthor=P.+Scherle&title=INCB050465%2C+a+Novel+PI3K%CE%B4+Inhibitor%2C+Synergizes+with+PIM+Protein+Kinase+Inhibition+to+Cause+Tumor+Regression+in+a+Model+of+DLBCL&doi=10.1158%2F1538-7445.AM2015-2671"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2015-2671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM2015-2671%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DN.%26aulast%3DKoblish%26aufirst%3DH.%26aulast%3DCovington%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DFeldman%26aufirst%3DP.%26aulast%3DHall%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DKatiyar%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DYue%26aufirst%3DE.%2BW.%26aulast%3DMaduskuie%26aufirst%3DT.%2BP.%26aulast%3DDouty%26aufirst%3DB.%26aulast%3DMei%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DY.-L.%26aulast%3DXue%26aufirst%3DC.-B.%26aulast%3DCombs%26aufirst%3DA.%26aulast%3DYao%26aufirst%3DW.%26aulast%3DDiamond-Fosbenner%26aufirst%3DS.%26aulast%3DYeleswaram%26aufirst%3DS.%26aulast%3DNewton%26aufirst%3DR.%26aulast%3DVaddi%26aufirst%3DK.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DScherle%26aufirst%3DP.%26atitle%3DINCB050465%252C%2520a%2520Novel%2520PI3K%25CE%25B4%2520Inhibitor%252C%2520Synergizes%2520with%2520PIM%2520Protein%2520Kinase%2520Inhibition%2520to%2520Cause%2520Tumor%2520Regression%2520in%2520a%2520Model%2520of%2520DLBCL%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26issue%3D15%2520Suppl%26spage%3D2671%26doi%3D10.1158%2F1538-7445.AM2015-2671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Combs, A. P.</span>; <span class="NLM_string-name">Sparks, R. B.</span>; <span class="NLM_string-name">Maduskuie, T. P.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Bicyclic Azaheterocyclobenzylamines as PI3K Inhibitors</span>. <span class="NLM_patent">WO2013151930</span>, October 11, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=A.+P.+Combs&author=R.+B.+Sparks&author=T.+P.+Maduskuie&title=Bicyclic+Azaheterocyclobenzylamines+as+PI3K+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCombs%26aufirst%3DA.%2BP.%26atitle%3DBicyclic%2520Azaheterocyclobenzylamines%2520as%2520PI3K%2520Inhibitors%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biagetti, M.</span>; <span class="NLM_string-name">Capelli, A. M.</span>; <span class="NLM_string-name">Retini, M.</span></span> <span> </span><span class="NLM_article-title">Pyrazole Derivatives as Phosphoinositide 3-Kinases Inhibitors</span>. <span class="NLM_patent">WO2017134053</span>, August 11, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=M.+Biagetti&author=A.+M.+Capelli&author=M.+Retini&title=Pyrazole+Derivatives+as+Phosphoinositide+3-Kinases+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBiagetti%26aufirst%3DM.%26atitle%3DPyrazole%2520Derivatives%2520as%2520Phosphoinositide%25203-Kinases%2520Inhibitors%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayflick, J. S.</span>; <span class="NLM_string-name">Pefaur, N.</span>; <span class="NLM_string-name">Puri, K.
D.</span>; <span class="NLM_string-name">Tino, W.</span>; <span class="NLM_string-name">Kawakami, T.</span>; <span class="NLM_string-name">Kawakami, Y.</span></span> <span> </span><span class="NLM_article-title">Methods for Treating Mast Cell Disorders</span>. <span class="NLM_patent">WO2005120511</span>, December 23, <span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=J.+S.+Hayflick&author=N.+Pefaur&author=K.%0AD.+Puri&author=W.+Tino&author=T.+Kawakami&author=Y.+Kawakami&title=Methods+for+Treating+Mast+Cell+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHayflick%26aufirst%3DJ.%2BS.%26atitle%3DMethods%2520for%2520Treating%2520Mast%2520Cell%2520Disorders%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lodola, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertolini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biagetti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capacchi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Facchinetti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallo, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pappani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pala, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visentini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corsi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capelli, A. M.</span></span> <span> </span><span class="NLM_article-title">Atropisomerism and Conformational Equilibria: Impact on PI3Kδ Inhibition of 2-((6-Amino-9H-purin-9-yl)methyl)-5-methyl-3-(o-tolyl)quinazolin-4(3H)-one (IC87114) and Its Conformationally Restricted Analogs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">4304</span>– <span class="NLM_lpage">4315</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00247</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00247" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4304-4315&issue=10&author=A.+Lodolaauthor=S.+Bertoliniauthor=M.+Biagettiauthor=S.+Capacchiauthor=F.+Facchinettiauthor=P.+M.+Galloauthor=A.+Pappaniauthor=M.+Morauthor=D.+Palaauthor=S.+Rivaraauthor=F.+Visentiniauthor=M.+Corsiauthor=A.+M.+Capelli&title=Atropisomerism+and+Conformational+Equilibria%3A+Impact+on+PI3K%CE%B4+Inhibition+of+2-%28%286-Amino-9H-purin-9-yl%29methyl%29-5-methyl-3-%28o-tolyl%29quinazolin-4%283H%29-one+%28IC87114%29+and+Its+Conformationally+Restricted+Analogs&doi=10.1021%2Facs.jmedchem.7b00247"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00247%26sid%3Dliteratum%253Aachs%26aulast%3DLodola%26aufirst%3DA.%26aulast%3DBertolini%26aufirst%3DS.%26aulast%3DBiagetti%26aufirst%3DM.%26aulast%3DCapacchi%26aufirst%3DS.%26aulast%3DFacchinetti%26aufirst%3DF.%26aulast%3DGallo%26aufirst%3DP.%2BM.%26aulast%3DPappani%26aufirst%3DA.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DPala%26aufirst%3DD.%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DVisentini%26aufirst%3DF.%26aulast%3DCorsi%26aufirst%3DM.%26aulast%3DCapelli%26aufirst%3DA.%2BM.%26atitle%3DAtropisomerism%2520and%2520Conformational%2520Equilibria%253A%2520Impact%2520on%2520PI3K%25CE%25B4%2520Inhibition%2520of%25202-%2528%25286-Amino-9H-purin-9-yl%2529methyl%2529-5-methyl-3-%2528o-tolyl%2529quinazolin-4%25283H%2529-one%2520%2528IC87114%2529%2520and%2520Its%2520Conformationally%2520Restricted%2520Analogs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D10%26spage%3D4304%26epage%3D4315%26doi%3D10.1021%2Facs.jmedchem.7b00247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cushing, T. D.</span>; <span class="NLM_string-name">Hao, X.</span>; <span class="NLM_string-name">Lohman, J. W.</span>; <span class="NLM_string-name">Shin, Y.</span></span> <span> </span><span class="NLM_article-title">4H-Pyrido[1,2-a]pyrimidin-4-one Derivatives as PI3K Inhibitors</span>. <span class="NLM_patent">WO2010151735</span>, December 30, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=T.+D.+Cushing&author=X.+Hao&author=J.+W.+Lohman&author=Y.+Shin&title=4H-Pyrido%5B1%2C2-a%5Dpyrimidin-4-one+Derivatives+as+PI3K+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCushing%26aufirst%3DT.%2BD.%26atitle%3D4H-Pyrido%255B1%252C2-a%255Dpyrimidin-4-one%2520Derivatives%2520as%2520PI3K%2520Inhibitors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrasekhar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evarts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haran, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ip, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaplan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koditek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lad, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepist, E.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novikov, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perreault, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puri, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somoza, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiner, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Therrien, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treiberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villaseñor, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, G.</span></span> <span> </span><span class="NLM_article-title">2,4,6-Triaminopyrimidine as a Novel Hinge Binder in a Series of PI3Kδ Selective Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">3532</span>– <span class="NLM_lpage">3548</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00213</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00213" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3532-3548&issue=7&author=L.+Patelauthor=J.+Chandrasekharauthor=J.+Evartsauthor=A.+C.+Haranauthor=C.+Ipauthor=J.+A.+Kaplanauthor=M.+Kimauthor=D.+Koditekauthor=L.+Ladauthor=E.-I.+Lepistauthor=M.+E.+McGrathauthor=N.+Novikovauthor=S.+Perreaultauthor=K.+D.+Puriauthor=J.+R.+Somozaauthor=B.+H.+Steinerauthor=K.+L.+Stevensauthor=J.+Therrienauthor=J.+Treibergauthor=A.+G.+Villase%C3%B1orauthor=A.+Yeungauthor=G.+Phillips&title=2%2C4%2C6-Triaminopyrimidine+as+a+Novel+Hinge+Binder+in+a+Series+of+PI3K%CE%B4+Selective+Inhibitors&doi=10.1021%2Facs.jmedchem.6b00213"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00213%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DL.%26aulast%3DChandrasekhar%26aufirst%3DJ.%26aulast%3DEvarts%26aufirst%3DJ.%26aulast%3DHaran%26aufirst%3DA.%2BC.%26aulast%3DIp%26aufirst%3DC.%26aulast%3DKaplan%26aufirst%3DJ.%2BA.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DKoditek%26aufirst%3DD.%26aulast%3DLad%26aufirst%3DL.%26aulast%3DLepist%26aufirst%3DE.-I.%26aulast%3DMcGrath%26aufirst%3DM.%2BE.%26aulast%3DNovikov%26aufirst%3DN.%26aulast%3DPerreault%26aufirst%3DS.%26aulast%3DPuri%26aufirst%3DK.%2BD.%26aulast%3DSomoza%26aufirst%3DJ.%2BR.%26aulast%3DSteiner%26aufirst%3DB.%2BH.%26aulast%3DStevens%26aufirst%3DK.%2BL.%26aulast%3DTherrien%26aufirst%3DJ.%26aulast%3DTreiberg%26aufirst%3DJ.%26aulast%3DVillase%25C3%25B1or%26aufirst%3DA.%2BG.%26aulast%3DYeung%26aufirst%3DA.%26aulast%3DPhillips%26aufirst%3DG.%26atitle%3D2%252C4%252C6-Triaminopyrimidine%2520as%2520a%2520Novel%2520Hinge%2520Binder%2520in%2520a%2520Series%2520of%2520PI3K%25CE%25B4%2520Selective%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D7%26spage%3D3532%26epage%3D3548%26doi%3D10.1021%2Facs.jmedchem.6b00213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Du, Z.</span>; <span class="NLM_string-name">Hintermann, S.</span>; <span class="NLM_string-name">Hurth, K.</span>; <span class="NLM_string-name">Jacquier, S.</span>; <span class="NLM_string-name">Lehmann, H.</span>; <span class="NLM_string-name">Moebitz, H.</span>; <span class="NLM_string-name">Soldermann, N.</span>; <span class="NLM_string-name">Stojanovic, A.</span></span> <span> </span><span class="NLM_article-title">Substituted Quinazolin-4-one Derivatives</span>. <span class="NLM_patent">WO2015010641</span>, January 30, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=Z.+Du&author=S.+Hintermann&author=K.+Hurth&author=S.+Jacquier&author=H.+Lehmann&author=H.+Moebitz&author=N.+Soldermann&author=A.+Stojanovic&title=Substituted+Quinazolin-4-one+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DZ.%26atitle%3DSubstituted%2520Quinazolin-4-one%2520Derivatives%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bürli, R.</span>; <span class="NLM_string-name">Haughan, A. F.</span>; <span class="NLM_string-name">Matteucci, M.</span>; <span class="NLM_string-name">Owens, A. P.</span>; <span class="NLM_string-name">Raphy, G.</span>; <span class="NLM_string-name">Sharpe, A.</span></span> <span> </span><span class="NLM_article-title">Quinoline and Quinoxaline Derivatives as Kinase Inhibitors</span>. <span class="NLM_patent">WO2011058110</span>, May 20, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=R.+B%C3%BCrli&author=A.+F.+Haughan&author=M.+Matteucci&author=A.+P.+Owens&author=G.+Raphy&author=A.+Sharpe&title=Quinoline+and+Quinoxaline+Derivatives+as+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25BCrli%26aufirst%3DR.%26atitle%3DQuinoline%2520and%2520Quinoxaline%2520Derivatives%2520as%2520Kinase%2520Inhibitors%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knight, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldman, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zunder, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldenberg, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loewith, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stokoe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balla, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span> <span> </span><span class="NLM_article-title">A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>125</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">733</span>– <span class="NLM_lpage">747</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2006.03.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.cell.2006.03.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=16647110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BD28XltlSkt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2006&pages=733-747&issue=4&author=Z.+A.+Knightauthor=B.+Gonzalezauthor=M.+E.+Feldmanauthor=E.+R.+Zunderauthor=D.+D.+Goldenbergauthor=O.+Williamsauthor=R.+Loewithauthor=D.+Stokoeauthor=A.+Ballaauthor=B.+Tothauthor=T.+Ballaauthor=W.+A.+Weissauthor=R.+L.+Williamsauthor=K.+M.+Shokat&title=A+Pharmacological+Map+of+the+PI3-K+Family+Defines+a+Role+for+p110%CE%B1+in+Insulin+Signaling&doi=10.1016%2Fj.cell.2006.03.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">A pharmacological map of the PI3-K family defines a role for p110α in insulin signaling</span></div><div class="casAuthors">Knight, Zachary A.; Gonzalez, Beatriz; Feldman, Morri E.; Zunder, Eli R.; Goldenberg, David D.; Williams, Olusegun; Loewith, Robbie; Stokoe, David; Balla, Andras; Toth, Balazs; Balla, Tamas; Weiss, William A.; Williams, Roger L.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">733-747</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Phosphoinositide 3-kinases (PI3-Ks) are an important emerging class of drug targets, but the unique roles of PI3-K isoforms remain poorly defined.  We describe here an approach to pharmacol. interrogate the PI3-K family.  A chem. diverse panel of PI3-K inhibitors was synthesized, and their target selectivity was biochem. enumerated, revealing cryptic homologies across targets and chemotypes.  Crystal structures of three inhibitors bound to p110γ identify a conformationally mobile region that is uniquely exploited by selective compds.  This chem. array was then used to define the PI3-K isoforms required for insulin signaling.  We find that p110α is the primary insulin-responsive PI3-K in cultured cells, whereas p110β is dispensable but sets a phenotypic threshold for p110α activity.  Compds. targeting p110α block the acute effects of insulin treatment in vivo, whereas a p110β inhibitor has no effect.  These results illustrate systematic target validation using a matrix of inhibitors that span a protein family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrozjvOeMXP3bVg90H21EOLACvtfcHk0lj4T9TF4SooOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltlSkt7o%253D&md5=b95a8cb433927ff9a75b33fc4ac2c8a0</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.03.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.03.035%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DGonzalez%26aufirst%3DB.%26aulast%3DFeldman%26aufirst%3DM.%2BE.%26aulast%3DZunder%26aufirst%3DE.%2BR.%26aulast%3DGoldenberg%26aufirst%3DD.%2BD.%26aulast%3DWilliams%26aufirst%3DO.%26aulast%3DLoewith%26aufirst%3DR.%26aulast%3DStokoe%26aufirst%3DD.%26aulast%3DBalla%26aufirst%3DA.%26aulast%3DToth%26aufirst%3DB.%26aulast%3DBalla%26aufirst%3DT.%26aulast%3DWeiss%26aufirst%3DW.%2BA.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DA%2520Pharmacological%2520Map%2520of%2520the%2520PI3-K%2520Family%2520Defines%2520a%2520Role%2520for%2520p110%25CE%25B1%2520in%2520Insulin%2520Signaling%26jtitle%3DCell%26date%3D2006%26volume%3D125%26issue%3D4%26spage%3D733%26epage%3D747%26doi%3D10.1016%2Fj.cell.2006.03.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erra
Sola, M.</span>; <span class="NLM_string-name">Carrascal
Riera, M.</span>; <span class="NLM_string-name">Taltavull
Moll, J.</span>; <span class="NLM_string-name">Caturla
Javaloyes, J. F.</span>; <span class="NLM_string-name">Bernal Anchuela, F. J.</span>; <span class="NLM_string-name">Pages Santacana, L. M.</span>; <span class="NLM_string-name">Mir Cepeda, M.</span>; <span class="NLM_string-name">Casals Coll, G.</span>; <span class="NLM_string-name">Hernandez Olasagarre, M. B.</span></span> <span> </span><span class="NLM_article-title">Pyrrolotriazinone Derivatives as PI3K Inhibitors</span>. <span class="NLM_patent">WO2014060432</span>, April 25, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=M.+Erra%0ASola&author=M.+Carrascal%0ARiera&author=J.+Taltavull%0AMoll&author=J.+F.+Caturla%0AJavaloyes&author=F.+J.+Bernal+Anchuela&author=L.+M.+Pages+Santacana&author=M.+Mir+Cepeda&author=G.+Casals+Coll&author=M.+B.+Hernandez+Olasagarre&title=Pyrrolotriazinone+Derivatives+as+PI3K+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DErra%2BSola%26aufirst%3DM.%26atitle%3DPyrrolotriazinone%2520Derivatives%2520as%2520PI3K%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xi, N.</span>; <span class="NLM_string-name">Wang, L.</span>; <span class="NLM_string-name">Wang, T.</span></span> <span> </span><span class="NLM_article-title">Substituted Aminopyrimidine Compounds and Methods of Use</span>. <span class="NLM_patent">WO2015042078</span>, March 27, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=N.+Xi&author=L.+Wang&author=T.+Wang&title=Substituted+Aminopyrimidine+Compounds+and+Methods+of+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DXi%26aufirst%3DN.%26atitle%3DSubstituted%2520Aminopyrimidine%2520Compounds%2520and%2520Methods%2520of%2520Use%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evarts, J.</span>; <span class="NLM_string-name">Kaplan, J.</span>; <span class="NLM_string-name">Kim, M.</span>; <span class="NLM_string-name">Patel, L.</span>; <span class="NLM_string-name">Perreault, S.</span>; <span class="NLM_string-name">Phillips, G.</span>; <span class="NLM_string-name">Treiberg, J. A.</span>; <span class="NLM_string-name">Van Veldhuizen, J.</span></span> <span> </span><span class="NLM_article-title">Phosphatidylinositol 3-Kinase Inhibitors</span>. <span class="NLM_patent">WO2014201409</span>, December 19, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=J.+Evarts&author=J.+Kaplan&author=M.+Kim&author=L.+Patel&author=S.+Perreault&author=G.+Phillips&author=J.+A.+Treiberg&author=J.+Van+Veldhuizen&title=Phosphatidylinositol+3-Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEvarts%26aufirst%3DJ.%26atitle%3DPhosphatidylinositol%25203-Kinase%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gracia Ferrer, J.</span>; <span class="NLM_string-name">Erra Sola, M.</span></span> <span> </span><span class="NLM_article-title">Pyrrolopyrimidine Derivatives as PI3K Inhibitors</span>. <span class="NLM_patent">WO2015091532</span>, June 26, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=J.+Gracia+Ferrer&author=M.+Erra+Sola&title=Pyrrolopyrimidine+Derivatives+as+PI3K+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGracia%2BFerrer%26aufirst%3DJ.%26atitle%3DPyrrolopyrimidine%2520Derivatives%2520as%2520PI3K%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taltavull Moll, J.</span>; <span class="NLM_string-name">Mir Cepeda, M.</span>; <span class="NLM_string-name">Forns Berenguel, M. P.</span>; <span class="NLM_string-name">Erra Sola, M.</span></span> <span> </span><span class="NLM_article-title">Pyrrolotriazinone Derivatives as PI3K Inhibitors</span>. <span class="NLM_patent">WO2016202800</span>, December 23, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=J.+Taltavull+Moll&author=M.+Mir+Cepeda&author=M.+P.+Forns+Berenguel&author=M.+Erra+Sola&title=Pyrrolotriazinone+Derivatives+as+PI3K+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTaltavull%2BMoll%26aufirst%3DJ.%26atitle%3DPyrrolotriazinone%2520Derivatives%2520as%2520PI3K%2520Inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sadhu, C.</span>; <span class="NLM_string-name">Dick, K.</span>; <span class="NLM_string-name">Treiberg, J.</span>; <span class="NLM_string-name">Sowell, C. G.</span>; <span class="NLM_string-name">Kesicki, E. A.</span>; <span class="NLM_string-name">Oliver, A.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of Human Phosphatidyl-Inositol 3-Kinase Delta</span>. <span class="NLM_patent">WO2001081346</span>, November 2, <span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=C.+Sadhu&author=K.+Dick&author=J.+Treiberg&author=C.+G.+Sowell&author=E.+A.+Kesicki&author=A.+Oliver&title=Inhibitors+of+Human+Phosphatidyl-Inositol+3-Kinase+Delta"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSadhu%26aufirst%3DC.%26atitle%3DInhibitors%2520of%2520Human%2520Phosphatidyl-Inositol%25203-Kinase%2520Delta%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, E.</span>; <span class="NLM_string-name">Notz, W.
R. L.</span>; <span class="NLM_string-name">Wallace, M. B.</span></span> <span> </span><span class="NLM_article-title">Azaindole Derivatives Which Act as PI3K Inhibitors</span>. <span class="NLM_patent">WO2014011568</span>, January 17, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=E.+Chang&author=W.%0AR.+L.+Notz&author=M.+B.+Wallace&title=Azaindole+Derivatives+Which+Act+as+PI3K+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DE.%26atitle%3DAzaindole%2520Derivatives%2520Which%2520Act%2520as%2520PI3K%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perreault, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrasekhar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Z.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evarts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaplan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashishian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keegan, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenney, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koditek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lad, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepist, E.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Therrien, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treiberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yahiaoui, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, G.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Phosphoinositide 3-Kinase (PI3K) β/δ Inhibitor for the Treatment of Phosphatase and Tensin Homolog (PTEN) Deficient Tumors: Building PI3Kβ Potency in a PI3Kδ-Selective Template by Targeting Nonconserved Asp856</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1555</span>– <span class="NLM_lpage">1567</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01821</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01821" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1555-1567&issue=4&author=S.+Perreaultauthor=J.+Chandrasekharauthor=Z.-H.+Cuiauthor=J.+Evartsauthor=J.+Haoauthor=J.+A.+Kaplanauthor=A.+Kashishianauthor=K.+S.+Keeganauthor=T.+Kenneyauthor=D.+Koditekauthor=L.+Ladauthor=E.-I.+Lepistauthor=M.+E.+McGrathauthor=L.+Patelauthor=B.+Phillipsauthor=J.+Therrienauthor=J.+Treibergauthor=A.+Yahiaouiauthor=G.+Phillips&title=Discovery+of+a+Phosphoinositide+3-Kinase+%28PI3K%29+%CE%B2%2F%CE%B4+Inhibitor+for+the+Treatment+of+Phosphatase+and+Tensin+Homolog+%28PTEN%29+Deficient+Tumors%3A+Building+PI3K%CE%B2+Potency+in+a+PI3K%CE%B4-Selective+Template+by+Targeting+Nonconserved+Asp856&doi=10.1021%2Facs.jmedchem.6b01821"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01821%26sid%3Dliteratum%253Aachs%26aulast%3DPerreault%26aufirst%3DS.%26aulast%3DChandrasekhar%26aufirst%3DJ.%26aulast%3DCui%26aufirst%3DZ.-H.%26aulast%3DEvarts%26aufirst%3DJ.%26aulast%3DHao%26aufirst%3DJ.%26aulast%3DKaplan%26aufirst%3DJ.%2BA.%26aulast%3DKashishian%26aufirst%3DA.%26aulast%3DKeegan%26aufirst%3DK.%2BS.%26aulast%3DKenney%26aufirst%3DT.%26aulast%3DKoditek%26aufirst%3DD.%26aulast%3DLad%26aufirst%3DL.%26aulast%3DLepist%26aufirst%3DE.-I.%26aulast%3DMcGrath%26aufirst%3DM.%2BE.%26aulast%3DPatel%26aufirst%3DL.%26aulast%3DPhillips%26aufirst%3DB.%26aulast%3DTherrien%26aufirst%3DJ.%26aulast%3DTreiberg%26aufirst%3DJ.%26aulast%3DYahiaoui%26aufirst%3DA.%26aulast%3DPhillips%26aufirst%3DG.%26atitle%3DDiscovery%2520of%2520a%2520Phosphoinositide%25203-Kinase%2520%2528PI3K%2529%2520%25CE%25B2%252F%25CE%25B4%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Phosphatase%2520and%2520Tensin%2520Homolog%2520%2528PTEN%2529%2520Deficient%2520Tumors%253A%2520Building%2520PI3K%25CE%25B2%2520Potency%2520in%2520a%2520PI3K%25CE%25B4-Selective%2520Template%2520by%2520Targeting%2520Nonconserved%2520Asp856%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D4%26spage%3D1555%26epage%3D1567%26doi%3D10.1021%2Facs.jmedchem.6b01821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heald, R.</span>; <span class="NLM_string-name">Price, S.</span>; <span class="NLM_string-name">Safina, B.</span>; <span class="NLM_string-name">Savy, P. P. A.</span>; <span class="NLM_string-name">Seward, E. M.</span>; <span class="NLM_string-name">Sutherlin, D. P.</span>; <span class="NLM_string-name">Waszkowycz, B.</span></span> <span> </span><span class="NLM_article-title">Heterocyclic Compounds as PI3 Kinase Inhibitors</span>. <span class="NLM_patent">WO2012107465</span>, August 17, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=R.+Heald&author=S.+Price&author=B.+Safina&author=P.+P.+A.+Savy&author=E.+M.+Seward&author=D.+P.+Sutherlin&author=B.+Waszkowycz&title=Heterocyclic+Compounds+as+PI3+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHeald%26aufirst%3DR.%26atitle%3DHeterocyclic%2520Compounds%2520as%2520PI3%2520Kinase%2520Inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, S.</span>; <span class="NLM_string-name">Du, Z.</span>; <span class="NLM_string-name">Kaplan, J.</span>; <span class="NLM_string-name">Loyer-Drew, J. A.</span>; <span class="NLM_string-name">Naduthambi, D.</span>; <span class="NLM_string-name">Phillips, B. W.</span>; <span class="NLM_string-name">Phillips, G.</span>; <span class="NLM_string-name">Van Veldhuizen, J.</span>; <span class="NLM_string-name">Watxins, W. J.</span>; <span class="NLM_string-name">Yeung, S. C.</span></span> <span> </span><span class="NLM_article-title">Phosphatidylinositol 3-Kinase Inhibitors</span>. <span class="NLM_patent">WO2015191752</span>, December 18, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=S.+Cai&author=Z.+Du&author=J.+Kaplan&author=J.+A.+Loyer-Drew&author=D.+Naduthambi&author=B.+W.+Phillips&author=G.+Phillips&author=J.+Van+Veldhuizen&author=W.+J.+Watxins&author=S.+C.+Yeung&title=Phosphatidylinositol+3-Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DS.%26atitle%3DPhosphatidylinositol%25203-Kinase%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uehara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solhjou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banouni, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Routray, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiNitto, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkhal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turka, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strom, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tullius, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azzi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdi, R.</span></span> <span> </span><span class="NLM_article-title">Regulation of T Cell Alloimmunity by PI3Kγ and PI3Kδ</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">951</span>, <span class="refDoi"> DOI: 10.1038/s41467-017-00982-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1038%2Fs41467-017-00982-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=29038423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A280%3ADC%252BC1M7htlelsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=951&issue=1&author=M.+Ueharaauthor=M.+M.+McGrathauthor=S.+Ohoriauthor=Z.+Solhjouauthor=N.+Banouniauthor=S.+Routrayauthor=C.+Evansauthor=J.+P.+DiNittoauthor=A.+Elkhalauthor=L.+A.+Turkaauthor=T.+B.+Stromauthor=S.+G.+Tulliusauthor=D.+G.+Winklerauthor=J.+Azziauthor=R.+Abdi&title=Regulation+of+T+Cell+Alloimmunity+by+PI3K%CE%B3+and+PI3K%CE%B4&doi=10.1038%2Fs41467-017-00982-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of T cell alloimmunity by PI3Kγ and PI3Kδ</span></div><div class="casAuthors">Uehara Mayuko; McGrath Martina M; Ohori Shunsuke; Solhjou Zhabiz; Banouni Naima; Routray Sujit; Azzi Jamil; Abdi Reza; Evans Catherine; DiNitto Jonathan P; Winkler David G; Elkhal Abdallah; Tullius Stefan G; Turka Laurence A; Strom Terry B</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">951</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Phosphatidylinositol-3-kinases (PI3K) γ and δ are preferentially enriched in leukocytes, and defects in these signaling pathways have been shown to impair T cell activation.  The effects of PI3Kγ and PI3Kδ on alloimmunity remain underexplored.  Here, we show that both PI3Kγ (-/-) and PI3Kδ (D910A/D910A) mice receiving heart allografts have suppression of alloreactive T effector cells and delayed acute rejection.  However, PI3Kδ mutation also dampens regulatory T cells (Treg).  After treatment with low dose CTLA4-Ig, PI3Kγ (-/-) , but not PI3Κδ (D910A/D910A) , recipients exhibit indefinite prolongation of heart allograft survival.  PI3Kδ (D910A/D910A) Tregs have increased apoptosis and impaired survival.  Selective inhibition of PI3Kγ and PI3Kδ (using PI3Kδ and dual PI3Kγδ chemical inhibitors) shows that PI3Kγ inhibition compensates for the negative effect of PI3Kδ inhibition on long-term allograft survival.  These data serve as a basis for future PI3K-based immune therapies for transplantation.Phosphatidylinositol-3-kinases (PI3K) γ and δ are key regulators of T cell signaling.  Here the author show, using mouse heart allograft transplantation models, that PI3Kγ or PI3Kδ deficiency prolongs graft survival, but selective inhibition of PI3Kγ or PI3Kδ reveals alternative transplant survival outcomes post CTLA4-Ig treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSaaQcrZV62XC6Ufuk_1xoTfW6udTcc2ebrNtwwnujnRLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M7htlelsg%253D%253D&md5=e615c38cd030e11b35d90418d65b4ae3</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1038%2Fs41467-017-00982-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-017-00982-x%26sid%3Dliteratum%253Aachs%26aulast%3DUehara%26aufirst%3DM.%26aulast%3DMcGrath%26aufirst%3DM.%2BM.%26aulast%3DOhori%26aufirst%3DS.%26aulast%3DSolhjou%26aufirst%3DZ.%26aulast%3DBanouni%26aufirst%3DN.%26aulast%3DRoutray%26aufirst%3DS.%26aulast%3DEvans%26aufirst%3DC.%26aulast%3DDiNitto%26aufirst%3DJ.%2BP.%26aulast%3DElkhal%26aufirst%3DA.%26aulast%3DTurka%26aufirst%3DL.%2BA.%26aulast%3DStrom%26aufirst%3DT.%2BB.%26aulast%3DTullius%26aufirst%3DS.%2BG.%26aulast%3DWinkler%26aufirst%3DD.%2BG.%26aulast%3DAzzi%26aufirst%3DJ.%26aulast%3DAbdi%26aufirst%3DR.%26atitle%3DRegulation%2520of%2520T%2520Cell%2520Alloimmunity%2520by%2520PI3K%25CE%25B3%2520and%2520PI3K%25CE%25B4%26jtitle%3DNat.%2520Commun.%26date%3D2017%26volume%3D8%26issue%3D1%26spage%3D951%26doi%3D10.1038%2Fs41467-017-00982-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lv, B.</span>; <span class="NLM_string-name">Li, C.</span></span> <span> </span><span class="NLM_article-title">Deuterated Quinazolinone Compound and Pharmaceutical Composition Comprising Same</span>. <span class="NLM_patent">WO2015113521</span>, August 7, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=B.+Lv&author=C.+Li&title=Deuterated+Quinazolinone+Compound+and+Pharmaceutical+Composition+Comprising+Same"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLv%26aufirst%3DB.%26atitle%3DDeuterated%2520Quinazolinone%2520Compound%2520and%2520Pharmaceutical%2520Composition%2520Comprising%2520Same%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harbeson, S. L.</span></span> <span> </span><span class="NLM_article-title">Deuterated Phenylquinazolinone and Phenylisoquinolinone Compounds</span>. <span class="NLM_patent">WO2015179772</span>, November 27, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=S.+L.+Harbeson&title=Deuterated+Phenylquinazolinone+and+Phenylisoquinolinone+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26atitle%3DDeuterated%2520Phenylquinazolinone%2520and%2520Phenylisoquinolinone%2520Compounds%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span>; <span class="NLM_string-name">Cheng, C.</span></span> <span> </span><span class="NLM_article-title">Deuterated Compounds for Treating Blood Cancers, and Compositions and Methods Thereof</span>. <span class="NLM_patent">WO2017079003</span>, May 12, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=C.+Huang&author=C.+Cheng&title=Deuterated+Compounds+for+Treating+Blood+Cancers%2C+and+Compositions+and+Methods+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DC.%26atitle%3DDeuterated%2520Compounds%2520for%2520Treating%2520Blood%2520Cancers%252C%2520and%2520Compositions%2520and%2520Methods%2520Thereof%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, C.</span>; <span class="NLM_string-name">Huang, C.</span></span> <span> </span><span class="NLM_article-title">Deuterated Compounds for Treating Hematologic Malignant, Inflammatory and Autoimmune Diseases</span>. <span class="NLM_patent">WO2017087207</span>, May 27, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=C.+Cheng&author=C.+Huang&title=Deuterated+Compounds+for+Treating+Hematologic+Malignant%2C+Inflammatory+and+Autoimmune+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DC.%26atitle%3DDeuterated%2520Compounds%2520for%2520Treating%2520Hematologic%2520Malignant%252C%2520Inflammatory%2520and%2520Autoimmune%2520Diseases%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deng, C.</span>; <span class="NLM_string-name">Deng, S.-X.</span>; <span class="NLM_string-name">Landry, D. W.</span>; <span class="NLM_string-name">Lipstein, M.</span>; <span class="NLM_string-name">Mangone, M.</span>; <span class="NLM_string-name">O’Connor, O.</span>; <span class="NLM_string-name">Serrano, X. O. J.</span>; <span class="NLM_string-name">Scotto, L.</span>; <span class="NLM_string-name">Xu, X.</span></span> <span> </span><span class="NLM_article-title">Targeting Casein Kinase-1 and PI3K/AKT/mTOR Pathways for Treatment of c-Myc-Overexpressing Cancers, Organ Transplant Associated Complications and Autoimmune Diseases</span>. <span class="NLM_patent">WO2017079558</span>, May 12, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=C.+Deng&author=S.-X.+Deng&author=D.+W.+Landry&author=M.+Lipstein&author=M.+Mangone&author=O.+O%E2%80%99Connor&author=X.+O.+J.+Serrano&author=L.+Scotto&author=X.+Xu&title=Targeting+Casein+Kinase-1+and+PI3K%2FAKT%2FmTOR+Pathways+for+Treatment+of+c-Myc-Overexpressing+Cancers%2C+Organ+Transplant+Associated+Complications+and+Autoimmune+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DC.%26atitle%3DTargeting%2520Casein%2520Kinase-1%2520and%2520PI3K%252FAKT%252FmTOR%2520Pathways%2520for%2520Treatment%2520of%2520c-Myc-Overexpressing%2520Cancers%252C%2520Organ%2520Transplant%2520Associated%2520Complications%2520and%2520Autoimmune%2520Diseases%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Henley, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bax, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inglesby, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Champigny, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaines, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faulder, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Washio, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldwin, I. R.</span></span> <span> </span><span class="NLM_article-title">From PIM1 to PI3K δ via GSK3 Β : Target Hopping through the Kinome</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1093</span>– <span class="NLM_lpage">1098</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00296</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00296" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1093-1098&issue=10&author=Z.+A.+Henleyauthor=B.+D.+Baxauthor=L.+M.+Inglesbyauthor=A.+Champignyauthor=S.+Gainesauthor=P.+Faulderauthor=J.+Leauthor=D.+A.+Thomasauthor=Y.+Washioauthor=I.+R.+Baldwin&title=From+PIM1+to+PI3K+%CE%B4+via+GSK3+%CE%92%E2%80%AF%3A+Target+Hopping+through+the+Kinome&doi=10.1021%2Facsmedchemlett.7b00296"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00296%26sid%3Dliteratum%253Aachs%26aulast%3DHenley%26aufirst%3DZ.%2BA.%26aulast%3DBax%26aufirst%3DB.%2BD.%26aulast%3DInglesby%26aufirst%3DL.%2BM.%26aulast%3DChampigny%26aufirst%3DA.%26aulast%3DGaines%26aufirst%3DS.%26aulast%3DFaulder%26aufirst%3DP.%26aulast%3DLe%26aufirst%3DJ.%26aulast%3DThomas%26aufirst%3DD.%2BA.%26aulast%3DWashio%26aufirst%3DY.%26aulast%3DBaldwin%26aufirst%3DI.%2BR.%26atitle%3DFrom%2520PIM1%2520to%2520PI3K%2520%25CE%25B4%2520via%2520GSK3%2520%25CE%2592%25E2%2580%25AF%253A%2520Target%2520Hopping%2520through%2520the%2520Kinome%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26issue%3D10%26spage%3D1093%26epage%3D1098%26doi%3D10.1021%2Facsmedchemlett.7b00296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Down, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amour, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldwin, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, A. W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deakin, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felton, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guntrip, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keeling, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lunniss, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parr, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowland, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitulli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Washio, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamblin, J. N.</span></span> <span> </span><span class="NLM_article-title">Optimization of Novel Indazoles as Highly Potent and Selective Inhibitors of Phosphoinositide 3-Kinase δ for the Treatment of Respiratory Disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">7381</span>– <span class="NLM_lpage">7399</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00767</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00767" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlyjsrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7381-7399&issue=18&author=K.+Downauthor=A.+Amourauthor=I.+R.+Baldwinauthor=A.+W.+J.+Cooperauthor=A.+M.+Deakinauthor=L.+M.+Feltonauthor=S.+B.+Guntripauthor=C.+Hardyauthor=Z.+A.+Harrisonauthor=K.+L.+Jonesauthor=P.+Jonesauthor=S.+E.+Keelingauthor=J.+Leauthor=S.+Liviaauthor=F.+Lucasauthor=C.+J.+Lunnissauthor=N.+J.+Parrauthor=E.+Robinsonauthor=P.+Rowlandauthor=S.+Smithauthor=D.+A.+Thomasauthor=G.+Vitulliauthor=Y.+Washioauthor=J.+N.+Hamblin&title=Optimization+of+Novel+Indazoles+as+Highly+Potent+and+Selective+Inhibitors+of+Phosphoinositide+3-Kinase+%CE%B4+for+the+Treatment+of+Respiratory+Disease&doi=10.1021%2Facs.jmedchem.5b00767"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of Novel Indazoles as Highly Potent and Selective Inhibitors of Phosphoinositide 3-Kinase δ for the Treatment of Respiratory Disease</span></div><div class="casAuthors">Down, Kenneth; Amour, Augustin; Baldwin, Ian R.; Cooper, Anthony W. J.; Deakin, Angela M.; Felton, Leigh M.; Guntrip, Stephen B.; Hardy, Charlotte; Harrison, Zoe A.; Jones, Katherine L.; Jones, Paul; Keeling, Suzanne E.; Le, Joelle; Livia, Stefano; Lucas, Fiona; Lunniss, Christopher J.; Parr, Nigel J.; Robinson, Ed; Rowland, Paul; Smith, Sarah; Thomas, Daniel A.; Vitulli, Giovanni; Washio, Yoshiaki; Hamblin, J. Nicole</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7381-7399</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Optimization of lead compd., through extensive use of structure-based design and a focus on PI3Kδ potency, isoform selectivity, and inhaled PK properties, led to the discovery of clin. candidates I (GSK2269557) and II (GSK2292767) for the treatment of respiratory indications via inhalation.  Compds. I and II are both highly selective for PI3Kδ over the closely related isoforms and are active in a disease relevant brown Norway rat acute OVA model of Th2-driven lung inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUYzpPxn_ArbVg90H21EOLACvtfcHk0lh8dEcz_Hic2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlyjsrvJ&md5=2fe8e51a64e6f7c798bdcb63781d02ad</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00767&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00767%26sid%3Dliteratum%253Aachs%26aulast%3DDown%26aufirst%3DK.%26aulast%3DAmour%26aufirst%3DA.%26aulast%3DBaldwin%26aufirst%3DI.%2BR.%26aulast%3DCooper%26aufirst%3DA.%2BW.%2BJ.%26aulast%3DDeakin%26aufirst%3DA.%2BM.%26aulast%3DFelton%26aufirst%3DL.%2BM.%26aulast%3DGuntrip%26aufirst%3DS.%2BB.%26aulast%3DHardy%26aufirst%3DC.%26aulast%3DHarrison%26aufirst%3DZ.%2BA.%26aulast%3DJones%26aufirst%3DK.%2BL.%26aulast%3DJones%26aufirst%3DP.%26aulast%3DKeeling%26aufirst%3DS.%2BE.%26aulast%3DLe%26aufirst%3DJ.%26aulast%3DLivia%26aufirst%3DS.%26aulast%3DLucas%26aufirst%3DF.%26aulast%3DLunniss%26aufirst%3DC.%2BJ.%26aulast%3DParr%26aufirst%3DN.%2BJ.%26aulast%3DRobinson%26aufirst%3DE.%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DSmith%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DD.%2BA.%26aulast%3DVitulli%26aufirst%3DG.%26aulast%3DWashio%26aufirst%3DY.%26aulast%3DHamblin%26aufirst%3DJ.%2BN.%26atitle%3DOptimization%2520of%2520Novel%2520Indazoles%2520as%2520Highly%2520Potent%2520and%2520Selective%2520Inhibitors%2520of%2520Phosphoinositide%25203-Kinase%2520%25CE%25B4%2520for%2520the%2520Treatment%2520of%2520Respiratory%2520Disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D18%26spage%3D7381%26epage%3D7399%26doi%3D10.1021%2Facs.jmedchem.5b00767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dalton, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dittus, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Convery, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bush, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werner, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bantscheff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campos, S.</span></span> <span> </span><span class="NLM_article-title">Selectively Targeting the Kinome-Conserved Lysine of PI3Kδ as a General Approach to Covalent Kinase Inhibition</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>140</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">932</span>– <span class="NLM_lpage">939</span>, <span class="refDoi"> DOI: 10.1021/jacs.7b08979</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.7b08979" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFKitrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2018&pages=932-939&issue=3&author=S.+E.+Daltonauthor=L.+Dittusauthor=D.+A.+Thomasauthor=M.+A.+Converyauthor=J.+Nunesauthor=J.+T.+Bushauthor=J.+P.+Evansauthor=T.+Wernerauthor=M.+Bantscheffauthor=J.+A.+Murphyauthor=S.+Campos&title=Selectively+Targeting+the+Kinome-Conserved+Lysine+of+PI3K%CE%B4+as+a+General+Approach+to+Covalent+Kinase+Inhibition&doi=10.1021%2Fjacs.7b08979"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Selectively Targeting the Kinome-Conserved Lysine of PI3Kδ as a General Approach to Covalent Kinase Inhibition</span></div><div class="casAuthors">Dalton, Samuel E.; Dittus, Lars; Thomas, Daniel A.; Convery, Maire A.; Nunes, Joao; Bush, Jacob T.; Evans, John P.; Werner, Thilo; Bantscheff, Marcus; Murphy, John A.; Campos, Sebastien</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">932-939</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selective covalent inhibition of kinases by targeting poorly conserved cysteines has proven highly fruitful to date in the development of chem. probes and approved drugs.  However, this approach is limited to ∼200 kinases possessing such a cysteine near the ATP-binding pocket.  Herein, we report a novel approach to achieve selective, irreversible kinase inhibition, by targeting the conserved catalytic lysine residue.  We have illustrated our approach by developing selective, covalent PI3Kδ inhibitors that exhibit nanomolar potency in cellular assays, and a duration of action >48 h in CD4+ T cells.  Despite conservation of the lysine residue throughout the kinome, the lead compd. shows high levels of selectivity over a selection of lipid and protein kinases in biochem. assays, as well as covalent binding to very few off-target proteins in live-cell proteomic studies.  We anticipate this approach could offer a general strategy, as an alternative to targeting non-conserved cysteines, for the development of selective covalent kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGvT7h2D9zf7Vg90H21EOLACvtfcHk0ljA0wjdQvLSrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFKitrrK&md5=90bb399303a942fb87f1b9096eb8bdc6</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1021%2Fjacs.7b08979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.7b08979%26sid%3Dliteratum%253Aachs%26aulast%3DDalton%26aufirst%3DS.%2BE.%26aulast%3DDittus%26aufirst%3DL.%26aulast%3DThomas%26aufirst%3DD.%2BA.%26aulast%3DConvery%26aufirst%3DM.%2BA.%26aulast%3DNunes%26aufirst%3DJ.%26aulast%3DBush%26aufirst%3DJ.%2BT.%26aulast%3DEvans%26aufirst%3DJ.%2BP.%26aulast%3DWerner%26aufirst%3DT.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DMurphy%26aufirst%3DJ.%2BA.%26aulast%3DCampos%26aufirst%3DS.%26atitle%3DSelectively%2520Targeting%2520the%2520Kinome-Conserved%2520Lysine%2520of%2520PI3K%25CE%25B4%2520as%2520a%2520General%2520Approach%2520to%2520Covalent%2520Kinase%2520Inhibition%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2018%26volume%3D140%26issue%3D3%26spage%3D932%26epage%3D939%26doi%3D10.1021%2Fjacs.7b08979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amour, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, A. W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inglis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamieson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luscombe, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peace, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowland, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tame, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uddin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitulli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wellaway, N.</span></span> <span> </span><span class="NLM_article-title">Evolution of a Novel, Orally Bioavailable Series of PI3Kδ Inhibitors from an Inhaled Lead for the Treatment of Respiratory Disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">7239</span>– <span class="NLM_lpage">7251</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00799</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00799" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7239-7251&issue=15&author=A.+Amourauthor=N.+Bartonauthor=A.+W.+J.+Cooperauthor=G.+Inglisauthor=C.+Jamiesonauthor=C.+N.+Luscombeauthor=J.+Morrellauthor=S.+Peaceauthor=D.+Perezauthor=P.+Rowlandauthor=C.+Tameauthor=S.+Uddinauthor=G.+Vitulliauthor=N.+Wellaway&title=Evolution+of+a+Novel%2C+Orally+Bioavailable+Series+of+PI3K%CE%B4+Inhibitors+from+an+Inhaled+Lead+for+the+Treatment+of+Respiratory+Disease&doi=10.1021%2Facs.jmedchem.6b00799"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00799%26sid%3Dliteratum%253Aachs%26aulast%3DAmour%26aufirst%3DA.%26aulast%3DBarton%26aufirst%3DN.%26aulast%3DCooper%26aufirst%3DA.%2BW.%2BJ.%26aulast%3DInglis%26aufirst%3DG.%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DLuscombe%26aufirst%3DC.%2BN.%26aulast%3DMorrell%26aufirst%3DJ.%26aulast%3DPeace%26aufirst%3DS.%26aulast%3DPerez%26aufirst%3DD.%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DTame%26aufirst%3DC.%26aulast%3DUddin%26aufirst%3DS.%26aulast%3DVitulli%26aufirst%3DG.%26aulast%3DWellaway%26aufirst%3DN.%26atitle%3DEvolution%2520of%2520a%2520Novel%252C%2520Orally%2520Bioavailable%2520Series%2520of%2520PI3K%25CE%25B4%2520Inhibitors%2520from%2520an%2520Inhaled%2520Lead%2520for%2520the%2520Treatment%2520of%2520Respiratory%2520Disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D15%26spage%3D7239%26epage%3D7251%26doi%3D10.1021%2Facs.jmedchem.6b00799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, N. A.</span>; <span class="NLM_string-name">Barton, N. P.</span>; <span class="NLM_string-name">Campos, S. A.</span>; <span class="NLM_string-name">Cannons, E. P.</span>; <span class="NLM_string-name">Cooper, A. W. J.</span>; <span class="NLM_string-name">Down, K. D.</span>; <span class="NLM_string-name">Doyle, K. J.</span>; <span class="NLM_string-name">Hamblin, J. N.</span>; <span class="NLM_string-name">Inglis, G. G. A.</span>; <span class="NLM_string-name">Le Gall, A.</span>; <span class="NLM_string-name">Patel, V.
K.</span>; <span class="NLM_string-name">Peace, S.</span>; <span class="NLM_string-name">Sharpe, A.</span>; <span class="NLM_string-name">White, G. V.</span></span> <span> </span><span class="NLM_article-title">Chemical Compounds as Inhibitors of Kinase Activity</span>. <span class="NLM_patent">WO2017137535</span>, August 18, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=N.+A.+Anderson&author=N.+P.+Barton&author=S.+A.+Campos&author=E.+P.+Cannons&author=A.+W.+J.+Cooper&author=K.+D.+Down&author=K.+J.+Doyle&author=J.+N.+Hamblin&author=G.+G.+A.+Inglis&author=A.+Le+Gall&author=V.%0AK.+Patel&author=S.+Peace&author=A.+Sharpe&author=G.+V.+White&title=Chemical+Compounds+as+Inhibitors+of+Kinase+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DN.%2BA.%26atitle%3DChemical%2520Compounds%2520as%2520Inhibitors%2520of%2520Kinase%2520Activity%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamajima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukoyoshi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moritomo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamagami, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukahori, H.</span></span> <span> </span><span class="NLM_article-title">Discovery and Biological Evaluation of Novel Pyrazolopyridine Derivatives as Potent and Orally Available PI3Kδ Inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2410</span>– <span class="NLM_lpage">2419</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2018.03.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.bmc.2018.03.042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=2410-2419&issue=9&author=T.+Hamajimaauthor=F.+Takahashiauthor=K.+Katoauthor=K.+Mukoyoshiauthor=K.+Yoshiharaauthor=S.+Yamakiauthor=Y.+Suganoauthor=A.+Moritomoauthor=K.+Yamagamiauthor=K.+Yokooauthor=H.+Fukahori&title=Discovery+and+Biological+Evaluation+of+Novel+Pyrazolopyridine+Derivatives+as+Potent+and+Orally+Available+PI3K%CE%B4+Inhibitors&doi=10.1016%2Fj.bmc.2018.03.042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2018.03.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2018.03.042%26sid%3Dliteratum%253Aachs%26aulast%3DHamajima%26aufirst%3DT.%26aulast%3DTakahashi%26aufirst%3DF.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DMukoyoshi%26aufirst%3DK.%26aulast%3DYoshihara%26aufirst%3DK.%26aulast%3DYamaki%26aufirst%3DS.%26aulast%3DSugano%26aufirst%3DY.%26aulast%3DMoritomo%26aufirst%3DA.%26aulast%3DYamagami%26aufirst%3DK.%26aulast%3DYokoo%26aufirst%3DK.%26aulast%3DFukahori%26aufirst%3DH.%26atitle%3DDiscovery%2520and%2520Biological%2520Evaluation%2520of%2520Novel%2520Pyrazolopyridine%2520Derivatives%2520as%2520Potent%2520and%2520Orally%2520Available%2520PI3K%25CE%25B4%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26issue%3D9%26spage%3D2410%26epage%3D2419%26doi%3D10.1016%2Fj.bmc.2018.03.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoegenauer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soldermann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stauffer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graveleau, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hebach, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollingworth, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rummel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feifel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkhart, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zécri, F.</span></span> <span> </span><span class="NLM_article-title">Discovery and Pharmacological Characterization of Novel Quinazoline-Based PI3K Delta-Selective Inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">762</span>– <span class="NLM_lpage">767</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00119</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00119" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=762-767&issue=8&author=K.+Hoegenauerauthor=N.+Soldermannauthor=F.+Staufferauthor=P.+Furetauthor=N.+Graveleauauthor=A.+B.+Smithauthor=C.+Hebachauthor=G.+J.+Hollingworthauthor=I.+Lewisauthor=S.+Gutmannauthor=G.+Rummelauthor=M.+Knappauthor=R.+M.+Wolfauthor=J.+Blanzauthor=R.+Feifelauthor=C.+Burkhartauthor=F.+Z%C3%A9cri&title=Discovery+and+Pharmacological+Characterization+of+Novel+Quinazoline-Based+PI3K+Delta-Selective+Inhibitors&doi=10.1021%2Facsmedchemlett.6b00119"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00119%26sid%3Dliteratum%253Aachs%26aulast%3DHoegenauer%26aufirst%3DK.%26aulast%3DSoldermann%26aufirst%3DN.%26aulast%3DStauffer%26aufirst%3DF.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DGraveleau%26aufirst%3DN.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26aulast%3DHebach%26aufirst%3DC.%26aulast%3DHollingworth%26aufirst%3DG.%2BJ.%26aulast%3DLewis%26aufirst%3DI.%26aulast%3DGutmann%26aufirst%3DS.%26aulast%3DRummel%26aufirst%3DG.%26aulast%3DKnapp%26aufirst%3DM.%26aulast%3DWolf%26aufirst%3DR.%2BM.%26aulast%3DBlanz%26aufirst%3DJ.%26aulast%3DFeifel%26aufirst%3DR.%26aulast%3DBurkhart%26aufirst%3DC.%26aulast%3DZ%25C3%25A9cri%26aufirst%3DF.%26atitle%3DDiscovery%2520and%2520Pharmacological%2520Characterization%2520of%2520Novel%2520Quinazoline-Based%2520PI3K%2520Delta-Selective%2520Inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26issue%3D8%26spage%3D762%26epage%3D767%26doi%3D10.1021%2Facsmedchemlett.6b00119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoegenauer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soldermann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hebach, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollingworth, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Matt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilcken, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haasen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkhart, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zécri, F.</span></span> <span> </span><span class="NLM_article-title">Discovery of Novel Pyrrolidineoxy-Substituted Heteroaromatics as Potent and Selective PI3K Delta Inhibitors with Improved Physicochemical Properties</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">5657</span>– <span class="NLM_lpage">5662</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.10.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.bmcl.2016.10.069" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=5657-5662&issue=23&author=K.+Hoegenauerauthor=N.+Soldermannauthor=C.+Hebachauthor=G.+J.+Hollingworthauthor=I.+Lewisauthor=A.+von+Mattauthor=A.+B.+Smithauthor=R.+M.+Wolfauthor=R.+Wilckenauthor=D.+Haasenauthor=C.+Burkhartauthor=F.+Z%C3%A9cri&title=Discovery+of+Novel+Pyrrolidineoxy-Substituted+Heteroaromatics+as+Potent+and+Selective+PI3K+Delta+Inhibitors+with+Improved+Physicochemical+Properties&doi=10.1016%2Fj.bmcl.2016.10.069"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.10.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.10.069%26sid%3Dliteratum%253Aachs%26aulast%3DHoegenauer%26aufirst%3DK.%26aulast%3DSoldermann%26aufirst%3DN.%26aulast%3DHebach%26aufirst%3DC.%26aulast%3DHollingworth%26aufirst%3DG.%2BJ.%26aulast%3DLewis%26aufirst%3DI.%26aulast%3Dvon%2BMatt%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26aulast%3DWolf%26aufirst%3DR.%2BM.%26aulast%3DWilcken%26aufirst%3DR.%26aulast%3DHaasen%26aufirst%3DD.%26aulast%3DBurkhart%26aufirst%3DC.%26aulast%3DZ%25C3%25A9cri%26aufirst%3DF.%26atitle%3DDiscovery%2520of%2520Novel%2520Pyrrolidineoxy-Substituted%2520Heteroaromatics%2520as%2520Potent%2520and%2520Selective%2520PI3K%2520Delta%2520Inhibitors%2520with%2520Improved%2520Physicochemical%2520Properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26issue%3D23%26spage%3D5657%26epage%3D5662%26doi%3D10.1016%2Fj.bmcl.2016.10.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caravatti, G.</span>; <span class="NLM_string-name">Chamoin, S.</span>; <span class="NLM_string-name">Furet, P.</span>; <span class="NLM_string-name">Högenauer, K.</span>; <span class="NLM_string-name">Hurth, K.</span>; <span class="NLM_string-name">Kalis, C.</span>; <span class="NLM_string-name">Kammertoens, K.</span>; <span class="NLM_string-name">Lewis, I.</span>; <span class="NLM_string-name">Moebitz, H.</span>; <span class="NLM_string-name">Smith, A. B.</span>; <span class="NLM_string-name">Soldermann, N.</span>; <span class="NLM_string-name">Wolf, R.</span>; <span class="NLM_string-name">Zecri, F.</span></span> <span> </span><span class="NLM_article-title">Dihydro-benzo-oxazine and Dihydro-pyrido-oxazine Derivatives</span>. <span class="NLM_patent">WO2013093849</span>, June 28, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=G.+Caravatti&author=S.+Chamoin&author=P.+Furet&author=K.+H%C3%B6genauer&author=K.+Hurth&author=C.+Kalis&author=K.+Kammertoens&author=I.+Lewis&author=H.+Moebitz&author=A.+B.+Smith&author=N.+Soldermann&author=R.+Wolf&author=F.+Zecri&title=Dihydro-benzo-oxazine+and+Dihydro-pyrido-oxazine+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCaravatti%26aufirst%3DG.%26atitle%3DDihydro-benzo-oxazine%2520and%2520Dihydro-pyrido-oxazine%2520Derivatives%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoegenauer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soldermann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zécri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strang, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graveleau, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollingworth, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rummel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littlewood-Evans, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkhart, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of CDZ173 (Leniolisib), Representing a Structurally Novel Class of PI3K Delta-Selective Inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">975</span>– <span class="NLM_lpage">980</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00293</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00293" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=975-980&issue=9&author=K.+Hoegenauerauthor=N.+Soldermannauthor=F.+Z%C3%A9criauthor=R.+S.+Strangauthor=N.+Graveleauauthor=R.+M.+Wolfauthor=N.+G.+Cookeauthor=A.+B.+Smithauthor=G.+J.+Hollingworthauthor=J.+Blanzauthor=S.+Gutmannauthor=G.+Rummelauthor=A.+Littlewood-Evansauthor=C.+Burkhart&title=Discovery+of+CDZ173+%28Leniolisib%29%2C+Representing+a+Structurally+Novel+Class+of+PI3K+Delta-Selective+Inhibitors&doi=10.1021%2Facsmedchemlett.7b00293"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00293%26sid%3Dliteratum%253Aachs%26aulast%3DHoegenauer%26aufirst%3DK.%26aulast%3DSoldermann%26aufirst%3DN.%26aulast%3DZ%25C3%25A9cri%26aufirst%3DF.%26aulast%3DStrang%26aufirst%3DR.%2BS.%26aulast%3DGraveleau%26aufirst%3DN.%26aulast%3DWolf%26aufirst%3DR.%2BM.%26aulast%3DCooke%26aufirst%3DN.%2BG.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26aulast%3DHollingworth%26aufirst%3DG.%2BJ.%26aulast%3DBlanz%26aufirst%3DJ.%26aulast%3DGutmann%26aufirst%3DS.%26aulast%3DRummel%26aufirst%3DG.%26aulast%3DLittlewood-Evans%26aufirst%3DA.%26aulast%3DBurkhart%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520CDZ173%2520%2528Leniolisib%2529%252C%2520Representing%2520a%2520Structurally%2520Novel%2520Class%2520of%2520PI3K%2520Delta-Selective%2520Inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26issue%3D9%26spage%3D975%26epage%3D980%26doi%3D10.1021%2Facsmedchemlett.7b00293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Desai, R.</span>; <span class="NLM_string-name">Bahekar, R. H.</span>; <span class="NLM_string-name">Chopade, R.</span></span> <span> </span><span class="NLM_article-title">Novel Heterocyclic Compounds</span>. <span class="NLM_patent">IN2012MU02281</span>, June 6, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=R.+Desai&author=R.+H.+Bahekar&author=R.+Chopade&title=Novel+Heterocyclic+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDesai%26aufirst%3DR.%26atitle%3DNovel%2520Heterocyclic%2520Compounds%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hei, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.-Q.</span></span> <span> </span><span class="NLM_article-title">Novel 6-Aryl Substituted 4-Pyrrolidineaminoquinazoline Derivatives as Potent Phosphoinositide 3-Kinase Delta (PI3Kδ) Inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2028</span>– <span class="NLM_lpage">2040</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2018.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.bmc.2018.03.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=2028-2040&issue=8&author=M.+Xinauthor=W.+Duanauthor=Y.+Fengauthor=Y.-Y.+Heiauthor=H.+Zhangauthor=Y.+Shenauthor=H.-Y.+Zhaoauthor=S.+Maoauthor=S.-Q.+Zhang&title=Novel+6-Aryl+Substituted+4-Pyrrolidineaminoquinazoline+Derivatives+as+Potent+Phosphoinositide+3-Kinase+Delta+%28PI3K%CE%B4%29+Inhibitors&doi=10.1016%2Fj.bmc.2018.03.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2018.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2018.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DXin%26aufirst%3DM.%26aulast%3DDuan%26aufirst%3DW.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DHei%26aufirst%3DY.-Y.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DH.-Y.%26aulast%3DMao%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DS.-Q.%26atitle%3DNovel%25206-Aryl%2520Substituted%25204-Pyrrolidineaminoquinazoline%2520Derivatives%2520as%2520Potent%2520Phosphoinositide%25203-Kinase%2520Delta%2520%2528PI3K%25CE%25B4%2529%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26issue%3D8%26spage%3D2028%26epage%3D2040%26doi%3D10.1016%2Fj.bmc.2018.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hei, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.-Q.</span></span> <span> </span><span class="NLM_article-title">Introduction of Pyrrolidineoxy or Piperidineamino Group at the 4-Position of Quinazoline Leading to Novel Quinazoline-Based Phosphoinositide 3-Kinase Delta (PI3Kδ) Inhibitors</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">651</span>– <span class="NLM_lpage">656</span>, <span class="refDoi"> DOI: 10.1080/14756366.2018.1444608</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1080%2F14756366.2018.1444608" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=29536777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC1cXks12mu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2018&pages=651-656&issue=1&author=M.+Xinauthor=W.+Duanauthor=Y.+Fengauthor=Y.-Y.+Heiauthor=H.+Zhangauthor=Y.+Shenauthor=H.-Y.+Zhaoauthor=S.+Maoauthor=S.-Q.+Zhang&title=Introduction+of+Pyrrolidineoxy+or+Piperidineamino+Group+at+the+4-Position+of+Quinazoline+Leading+to+Novel+Quinazoline-Based+Phosphoinositide+3-Kinase+Delta+%28PI3K%CE%B4%29+Inhibitors&doi=10.1080%2F14756366.2018.1444608"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Introduction of pyrrolidineoxy or piperidineamino group at the 4-position of quinazoline leading to novel quinazoline-based phosphoinositide 3-kinase delta (PI3Kδ) inhibitors</span></div><div class="casAuthors">Xin, Minhang; Duan, Weiming; Feng, Yifan; Hei, Yuan-Yuan; Zhang, Hao; Shen, Ying; Zhao, Hong-Yi; Mao, Shuai; Zhang, San-Qi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">651-656</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Phosphoinositide 3-kinase Delta (PI3Kδ) plays a key role in B-cell signal transduction and inhibition of PI3Kδ was confirmed to have clin. benefit in certain types of activation of B-cell malignancies.  Herein, the authors reported a novel series of 4-pyrrolidineoxy or 4-piperidineamino substituted quinazolines, showing potent PI3Kδ inhibitory activities.  Among these compds., and demonstrated higher potency against PI3Kδ with the half maximal inhibitory concn. (IC50) values of 4.5, 3.0, and 3.9 nM, resp., which were comparable to idelalisib (IC50 = 2.7 nM).  The further PI3K isoforms selectivity evaluation showed that compds., and have excellent PI3Kδ selectivity over PI3Kα, PI3Kβ, and PI3Kγ.  Moreover, compds., and also displayed different antiproliferative profiles against a panel of four human B cell lines including Ramos, Raji, RPMI-8226, and SU-DHL-6.  The mol. docking simulation indicated several key hydrogen bonding interactions were formed.  This study suggests the introduction of pyrrolidineoxy or piperidineamino groups into the 4-position of quinazoline leads to new potent and selective PI3Kδ inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP2LRij6gn7LVg90H21EOLACvtfcHk0lgjUmnrwGqvEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXks12mu7w%253D&md5=c876559eb3ea3594c0a349c1f3b162e5</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1080%2F14756366.2018.1444608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756366.2018.1444608%26sid%3Dliteratum%253Aachs%26aulast%3DXin%26aufirst%3DM.%26aulast%3DDuan%26aufirst%3DW.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DHei%26aufirst%3DY.-Y.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DH.-Y.%26aulast%3DMao%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DS.-Q.%26atitle%3DIntroduction%2520of%2520Pyrrolidineoxy%2520or%2520Piperidineamino%2520Group%2520at%2520the%25204-Position%2520of%2520Quinazoline%2520Leading%2520to%2520Novel%2520Quinazoline-Based%2520Phosphoinositide%25203-Kinase%2520Delta%2520%2528PI3K%25CE%25B4%2529%2520Inhibitors%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2018%26volume%3D33%26issue%3D1%26spage%3D651%26epage%3D656%26doi%3D10.1080%2F14756366.2018.1444608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hei, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.-Q.</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of Novel 6-Aryl Substituted 4-Anilinequinazoline Derivatives as Potential PI3Kδ Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1972</span>– <span class="NLM_lpage">1977</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.03.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.bmcl.2017.03.020" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=1972-1977&issue=9&author=M.+Xinauthor=Y.-Y.+Heiauthor=H.+Zhangauthor=Y.+Shenauthor=S.-Q.+Zhang&title=Design+and+Synthesis+of+Novel+6-Aryl+Substituted+4-Anilinequinazoline+Derivatives+as+Potential+PI3K%CE%B4+Inhibitors&doi=10.1016%2Fj.bmcl.2017.03.020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.03.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.03.020%26sid%3Dliteratum%253Aachs%26aulast%3DXin%26aufirst%3DM.%26aulast%3DHei%26aufirst%3DY.-Y.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DS.-Q.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Novel%25206-Aryl%2520Substituted%25204-Anilinequinazoline%2520Derivatives%2520as%2520Potential%2520PI3K%25CE%25B4%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26issue%3D9%26spage%3D1972%26epage%3D1977%26doi%3D10.1016%2Fj.bmcl.2017.03.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xin, M.</span>; <span class="NLM_string-name">Zhang, S.</span>; <span class="NLM_string-name">Zhang, H.</span>; <span class="NLM_string-name">Xie, X.</span>; <span class="NLM_string-name">Hei, Y.</span>; <span class="NLM_string-name">Zuo, S.</span>; <span class="NLM_string-name">Mao, S.</span></span> <span> </span><span class="NLM_article-title">Preparation of 6-Arylquinoline Compounds as PI3Kδ Inhibitors for Treating Inflammation and Tumor</span>. <span class="NLM_patent">CN105237484</span>, January 13, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=M.+Xin&author=S.+Zhang&author=H.+Zhang&author=X.+Xie&author=Y.+Hei&author=S.+Zuo&author=S.+Mao&title=Preparation+of+6-Arylquinoline+Compounds+as+PI3K%CE%B4+Inhibitors+for+Treating+Inflammation+and+Tumor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DXin%26aufirst%3DM.%26atitle%3DPreparation%2520of%25206-Arylquinoline%2520Compounds%2520as%2520PI3K%25CE%25B4%2520Inhibitors%2520for%2520Treating%2520Inflammation%2520and%2520Tumor%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhide, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neels, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, L.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stachura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigelt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sack, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefanski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstine, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skala, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedicord, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruepp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, T. G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salter-Cid, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poss, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, P.</span></span> <span> </span><span class="NLM_article-title">Discovery and SAR of Pyrrolo[2,1-f][1,2,4]triazin-4-amines as Potent and Selective PI3Kδ Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">4256</span>– <span class="NLM_lpage">4260</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.07.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.bmcl.2016.07.047" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=4256-4260&issue=17&author=R.+S.+Bhideauthor=J.+Neelsauthor=L.-Y.+Qinauthor=Z.+Ruanauthor=S.+Stachuraauthor=C.+Weigeltauthor=J.+S.+Sackauthor=K.+Stefanskiauthor=X.+Guauthor=J.+H.+Xieauthor=C.+B.+Goldstineauthor=S.+Skalaauthor=D.+L.+Pedicordauthor=S.+Rueppauthor=T.+G.+M.+Dharauthor=P.+H.+Carterauthor=L.+M.+Salter-Cidauthor=M.+A.+Possauthor=P.+Davies&title=Discovery+and+SAR+of+Pyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazin-4-amines+as+Potent+and+Selective+PI3K%CE%B4+Inhibitors&doi=10.1016%2Fj.bmcl.2016.07.047"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.07.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.07.047%26sid%3Dliteratum%253Aachs%26aulast%3DBhide%26aufirst%3DR.%2BS.%26aulast%3DNeels%26aufirst%3DJ.%26aulast%3DQin%26aufirst%3DL.-Y.%26aulast%3DRuan%26aufirst%3DZ.%26aulast%3DStachura%26aufirst%3DS.%26aulast%3DWeigelt%26aufirst%3DC.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DStefanski%26aufirst%3DK.%26aulast%3DGu%26aufirst%3DX.%26aulast%3DXie%26aufirst%3DJ.%2BH.%26aulast%3DGoldstine%26aufirst%3DC.%2BB.%26aulast%3DSkala%26aufirst%3DS.%26aulast%3DPedicord%26aufirst%3DD.%2BL.%26aulast%3DRuepp%26aufirst%3DS.%26aulast%3DDhar%26aufirst%3DT.%2BG.%2BM.%26aulast%3DCarter%26aufirst%3DP.%2BH.%26aulast%3DSalter-Cid%26aufirst%3DL.%2BM.%26aulast%3DPoss%26aufirst%3DM.%2BA.%26aulast%3DDavies%26aufirst%3DP.%26atitle%3DDiscovery%2520and%2520SAR%2520of%2520Pyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazin-4-amines%2520as%2520Potent%2520and%2520Selective%2520PI3K%25CE%25B4%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26issue%3D17%26spage%3D4256%26epage%3D4260%26doi%3D10.1016%2Fj.bmcl.2016.07.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qin, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherney, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, T. G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neels, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigelt, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sack, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornelius, L. A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tino, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefanski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Susulic, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarde-Chinn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skala, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosnius, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruepp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salter-Cid, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhide, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poss, M. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of 7-(3-(Piperazin-1-yl)phenyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine Derivatives as Highly Potent and Selective PI3Kδ Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">855</span>– <span class="NLM_lpage">861</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.01.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.bmcl.2017.01.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=855-861&issue=4&author=L.+Y.+Qinauthor=Z.+Ruanauthor=R.+J.+Cherneyauthor=T.+G.+M.+Dharauthor=J.+Neelsauthor=C.+A.+Weigeltauthor=J.+S.+Sackauthor=A.+S.+Srivastavaauthor=L.+A.+M.+Corneliusauthor=J.+A.+Tinoauthor=K.+Stefanskiauthor=X.+Guauthor=J.+Xieauthor=V.+Susulicauthor=X.+Yangauthor=M.+Yarde-Chinnauthor=S.+Skalaauthor=R.+Bosniusauthor=C.+Goldsteinauthor=P.+Daviesauthor=S.+Rueppauthor=L.+Salter-Cidauthor=R.+S.+Bhideauthor=M.+A.+Poss&title=Discovery+of+7-%283-%28Piperazin-1-yl%29phenyl%29pyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazin-4-amine+Derivatives+as+Highly+Potent+and+Selective+PI3K%CE%B4+Inhibitors&doi=10.1016%2Fj.bmcl.2017.01.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.01.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.01.016%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DL.%2BY.%26aulast%3DRuan%26aufirst%3DZ.%26aulast%3DCherney%26aufirst%3DR.%2BJ.%26aulast%3DDhar%26aufirst%3DT.%2BG.%2BM.%26aulast%3DNeels%26aufirst%3DJ.%26aulast%3DWeigelt%26aufirst%3DC.%2BA.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DSrivastava%26aufirst%3DA.%2BS.%26aulast%3DCornelius%26aufirst%3DL.%2BA.%2BM.%26aulast%3DTino%26aufirst%3DJ.%2BA.%26aulast%3DStefanski%26aufirst%3DK.%26aulast%3DGu%26aufirst%3DX.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DSusulic%26aufirst%3DV.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DYarde-Chinn%26aufirst%3DM.%26aulast%3DSkala%26aufirst%3DS.%26aulast%3DBosnius%26aufirst%3DR.%26aulast%3DGoldstein%26aufirst%3DC.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DRuepp%26aufirst%3DS.%26aulast%3DSalter-Cid%26aufirst%3DL.%26aulast%3DBhide%26aufirst%3DR.%2BS.%26aulast%3DPoss%26aufirst%3DM.%2BA.%26atitle%3DDiscovery%2520of%25207-%25283-%2528Piperazin-1-yl%2529phenyl%2529pyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazin-4-amine%2520Derivatives%2520as%2520Highly%2520Potent%2520and%2520Selective%2520PI3K%25CE%25B4%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26issue%3D4%26spage%3D855%26epage%3D861%26doi%3D10.1016%2Fj.bmcl.2017.01.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marcoux, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigelt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schieven, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hynes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhide, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poss, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tino, J.</span></span> <span> </span><span class="NLM_article-title">Identification of Highly Potent and Selective PI3Kδ Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">2849</span>– <span class="NLM_lpage">2853</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.01.077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.bmcl.2017.01.077" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2849-2853&issue=13&author=D.+Marcouxauthor=L.+Y.+Qinauthor=Z.+Ruanauthor=Q.+Shiauthor=Q.+Ruanauthor=C.+Weigeltauthor=H.+Qiuauthor=G.+Schievenauthor=J.+Hynesauthor=R.+Bhideauthor=M.+Possauthor=J.+Tino&title=Identification+of+Highly+Potent+and+Selective+PI3K%CE%B4+Inhibitors&doi=10.1016%2Fj.bmcl.2017.01.077"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.01.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.01.077%26sid%3Dliteratum%253Aachs%26aulast%3DMarcoux%26aufirst%3DD.%26aulast%3DQin%26aufirst%3DL.%2BY.%26aulast%3DRuan%26aufirst%3DZ.%26aulast%3DShi%26aufirst%3DQ.%26aulast%3DRuan%26aufirst%3DQ.%26aulast%3DWeigelt%26aufirst%3DC.%26aulast%3DQiu%26aufirst%3DH.%26aulast%3DSchieven%26aufirst%3DG.%26aulast%3DHynes%26aufirst%3DJ.%26aulast%3DBhide%26aufirst%3DR.%26aulast%3DPoss%26aufirst%3DM.%26aulast%3DTino%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520Highly%2520Potent%2520and%2520Selective%2520PI3K%25CE%25B4%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26issue%3D13%26spage%3D2849%26epage%3D2853%26doi%3D10.1016%2Fj.bmcl.2017.01.077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcoux, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batt, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornelius, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neels, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudoin-Bertrand, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherney, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watterson, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigelt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillooly, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntyre, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obermeier, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sleczka, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefanski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fancher, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padmanabhan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">RP, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kundu, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajareddy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennan, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levesque, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedicord, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarde, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstine, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skala, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rampulla, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathur, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arunachalam, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sack, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muckelbauer, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cvijic, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salter-Cid, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhide, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poss, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hynes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macor, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruepp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schieven, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tino, J. A.</span></span> <span> </span><span class="NLM_article-title">Identification of a Potent, Selective, and Efficacious Phosphatidylinositol 3-Kinase δ (PI3Kδ) Inhibitor for the Treatment of Immunological Disorders</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">5193</span>– <span class="NLM_lpage">5208</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00618</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00618" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5193-5208&issue=12&author=Q.+Liuauthor=Q.+Shiauthor=D.+Marcouxauthor=D.+G.+Battauthor=L.+Corneliusauthor=L.+Y.+Qinauthor=Z.+Ruanauthor=J.+Neelsauthor=M.+Beaudoin-Bertrandauthor=A.+S.+Srivastavaauthor=L.+Liauthor=R.+J.+Cherneyauthor=H.+Gongauthor=S.+H.+Wattersonauthor=C.+Weigeltauthor=K.+M.+Gilloolyauthor=K.+W.+McIntyreauthor=J.+H.+Xieauthor=M.+T.+Obermeierauthor=A.+Furaauthor=B.+Sleczkaauthor=K.+Stefanskiauthor=R.+M.+Fancherauthor=S.+Padmanabhanauthor=T.+RPauthor=I.+Kunduauthor=K.+Rajareddyauthor=R.+Smithauthor=J.+K.+Hennanauthor=D.+Xingauthor=J.+Fanauthor=P.+C.+Levesqueauthor=Q.+Ruanauthor=S.+Pittauthor=R.+Zhangauthor=D.+Pedicordauthor=J.+Panauthor=M.+Yardeauthor=H.+Luauthor=J.+Lippyauthor=C.+Goldstineauthor=S.+Skalaauthor=R.+A.+Rampullaauthor=A.+Mathurauthor=A.+Guptaauthor=P.+N.+Arunachalamauthor=J.+S.+Sackauthor=J.+K.+Muckelbauerauthor=M.+E.+Cvijicauthor=L.+M.+Salter-Cidauthor=R.+S.+Bhideauthor=M.+A.+Possauthor=J.+Hynesauthor=P.+H.+Carterauthor=J.+E.+Macorauthor=S.+Rueppauthor=G.+L.+Schievenauthor=J.+A.+Tino&title=Identification+of+a+Potent%2C+Selective%2C+and+Efficacious+Phosphatidylinositol+3-Kinase+%CE%B4+%28PI3K%CE%B4%29+Inhibitor+for+the+Treatment+of+Immunological+Disorders&doi=10.1021%2Facs.jmedchem.7b00618"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00618%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DShi%26aufirst%3DQ.%26aulast%3DMarcoux%26aufirst%3DD.%26aulast%3DBatt%26aufirst%3DD.%2BG.%26aulast%3DCornelius%26aufirst%3DL.%26aulast%3DQin%26aufirst%3DL.%2BY.%26aulast%3DRuan%26aufirst%3DZ.%26aulast%3DNeels%26aufirst%3DJ.%26aulast%3DBeaudoin-Bertrand%26aufirst%3DM.%26aulast%3DSrivastava%26aufirst%3DA.%2BS.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DCherney%26aufirst%3DR.%2BJ.%26aulast%3DGong%26aufirst%3DH.%26aulast%3DWatterson%26aufirst%3DS.%2BH.%26aulast%3DWeigelt%26aufirst%3DC.%26aulast%3DGillooly%26aufirst%3DK.%2BM.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DXie%26aufirst%3DJ.%2BH.%26aulast%3DObermeier%26aufirst%3DM.%2BT.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DSleczka%26aufirst%3DB.%26aulast%3DStefanski%26aufirst%3DK.%26aulast%3DFancher%26aufirst%3DR.%2BM.%26aulast%3DPadmanabhan%26aufirst%3DS.%26aulast%3DRP%26aufirst%3DT.%26aulast%3DKundu%26aufirst%3DI.%26aulast%3DRajareddy%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DHennan%26aufirst%3DJ.%2BK.%26aulast%3DXing%26aufirst%3DD.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DLevesque%26aufirst%3DP.%2BC.%26aulast%3DRuan%26aufirst%3DQ.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DPedicord%26aufirst%3DD.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DYarde%26aufirst%3DM.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DLippy%26aufirst%3DJ.%26aulast%3DGoldstine%26aufirst%3DC.%26aulast%3DSkala%26aufirst%3DS.%26aulast%3DRampulla%26aufirst%3DR.%2BA.%26aulast%3DMathur%26aufirst%3DA.%26aulast%3DGupta%26aufirst%3DA.%26aulast%3DArunachalam%26aufirst%3DP.%2BN.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DMuckelbauer%26aufirst%3DJ.%2BK.%26aulast%3DCvijic%26aufirst%3DM.%2BE.%26aulast%3DSalter-Cid%26aufirst%3DL.%2BM.%26aulast%3DBhide%26aufirst%3DR.%2BS.%26aulast%3DPoss%26aufirst%3DM.%2BA.%26aulast%3DHynes%26aufirst%3DJ.%26aulast%3DCarter%26aufirst%3DP.%2BH.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DRuepp%26aufirst%3DS.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DTino%26aufirst%3DJ.%2BA.%26atitle%3DIdentification%2520of%2520a%2520Potent%252C%2520Selective%252C%2520and%2520Efficacious%2520Phosphatidylinositol%25203-Kinase%2520%25CE%25B4%2520%2528PI3K%25CE%25B4%2529%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Immunological%2520Disorders%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D12%26spage%3D5193%26epage%3D5208%26doi%3D10.1021%2Facs.jmedchem.7b00618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pomel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klicic, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Covini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Church, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roulin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgat-Charvillon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valognes, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camps, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chabert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillieron, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Françon, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gretener, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitte, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carboni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rommel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rückle, T.</span></span> <span> </span><span class="NLM_article-title">Furan-2-ylmethylene thiazolidinediones as Novel, Potent, and Selective Inhibitors of Phosphoinositide 3-Kinase γ</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">3857</span>– <span class="NLM_lpage">3871</span>, <span class="refDoi"> DOI: 10.1021/jm0601598</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0601598" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3857-3871&author=V.+Pomelauthor=J.+Klicicauthor=D.+Coviniauthor=D.+D.+Churchauthor=J.+P.+Shawauthor=K.+Roulinauthor=F.+Burgat-Charvillonauthor=D.+Valognesauthor=M.+Campsauthor=C.+Chabertauthor=C.+Gillieronauthor=B.+Fran%C3%A7onauthor=D.+Perrinauthor=D.+Leroyauthor=D.+Gretenerauthor=A.+Nicholsauthor=P.+A.+Vitteauthor=S.+Carboniauthor=C.+Rommelauthor=M.+K.+Schwarzauthor=T.+R%C3%BCckle&title=Furan-2-ylmethylene+thiazolidinediones+as+Novel%2C+Potent%2C+and+Selective+Inhibitors+of+Phosphoinositide+3-Kinase+%CE%B3&doi=10.1021%2Fjm0601598"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1021%2Fjm0601598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0601598%26sid%3Dliteratum%253Aachs%26aulast%3DPomel%26aufirst%3DV.%26aulast%3DKlicic%26aufirst%3DJ.%26aulast%3DCovini%26aufirst%3DD.%26aulast%3DChurch%26aufirst%3DD.%2BD.%26aulast%3DShaw%26aufirst%3DJ.%2BP.%26aulast%3DRoulin%26aufirst%3DK.%26aulast%3DBurgat-Charvillon%26aufirst%3DF.%26aulast%3DValognes%26aufirst%3DD.%26aulast%3DCamps%26aufirst%3DM.%26aulast%3DChabert%26aufirst%3DC.%26aulast%3DGillieron%26aufirst%3DC.%26aulast%3DFran%25C3%25A7on%26aufirst%3DB.%26aulast%3DPerrin%26aufirst%3DD.%26aulast%3DLeroy%26aufirst%3DD.%26aulast%3DGretener%26aufirst%3DD.%26aulast%3DNichols%26aufirst%3DA.%26aulast%3DVitte%26aufirst%3DP.%2BA.%26aulast%3DCarboni%26aufirst%3DS.%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DSchwarz%26aufirst%3DM.%2BK.%26aulast%3DR%25C3%25BCckle%26aufirst%3DT.%26atitle%3DFuran-2-ylmethylene%2520thiazolidinediones%2520as%2520Novel%252C%2520Potent%252C%2520and%2520Selective%2520Inhibitors%2520of%2520Phosphoinositide%25203-Kinase%2520%25CE%25B3%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3857%26epage%3D3871%26doi%3D10.1021%2Fjm0601598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andrs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korabecny, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodny, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuca, K.</span></span> <span> </span><span class="NLM_article-title">Phosphatidylinositol 3-Kinase (PI3K) and Phosphatidylinositol 3-Kinase-Related Kinase (PIKK) Inhibitors: Importance of the Morpholine Ring</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">41</span>– <span class="NLM_lpage">71</span>, <span class="refDoi"> DOI: 10.1021/jm501026z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501026z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=41-71&issue=1&author=M.+Andrsauthor=J.+Korabecnyauthor=D.+Junauthor=Z.+Hodnyauthor=J.+Bartekauthor=K.+Kuca&title=Phosphatidylinositol+3-Kinase+%28PI3K%29+and+Phosphatidylinositol+3-Kinase-Related+Kinase+%28PIKK%29+Inhibitors%3A+Importance+of+the+Morpholine+Ring&doi=10.1021%2Fjm501026z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1021%2Fjm501026z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501026z%26sid%3Dliteratum%253Aachs%26aulast%3DAndrs%26aufirst%3DM.%26aulast%3DKorabecny%26aufirst%3DJ.%26aulast%3DJun%26aufirst%3DD.%26aulast%3DHodny%26aufirst%3DZ.%26aulast%3DBartek%26aufirst%3DJ.%26aulast%3DKuca%26aufirst%3DK.%26atitle%3DPhosphatidylinositol%25203-Kinase%2520%2528PI3K%2529%2520and%2520Phosphatidylinositol%25203-Kinase-Related%2520Kinase%2520%2528PIKK%2529%2520Inhibitors%253A%2520Importance%2520of%2520the%2520Morpholine%2520Ring%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D1%26spage%3D41%26epage%3D71%26doi%3D10.1021%2Fjm501026z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fumie, T.</span>; <span class="NLM_string-name">Sunao, I.</span>; <span class="NLM_string-name">Toru, A.</span>; <span class="NLM_string-name">Yoshihiro, K.</span>; <span class="NLM_string-name">Junko, M.</span>; <span class="NLM_string-name">Koji, K.</span>; <span class="NLM_string-name">Hidehiko, F.</span>; <span class="NLM_string-name">Masahiko, S.</span></span> <span> </span><span class="NLM_article-title">Heterocyclic Compound</span>. <span class="NLM_patent">WO2012020762</span>, February 16, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=T.+Fumie&author=I.+Sunao&author=A.+Toru&author=K.+Yoshihiro&author=M.+Junko&author=K.+Koji&author=F.+Hidehiko&author=S.+Masahiko&title=Heterocyclic+Compound"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFumie%26aufirst%3DT.%26atitle%3DHeterocyclic%2520Compound%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marui, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukahori, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawashima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akamatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaneko, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morokata, T.</span></span> <span> </span><span class="NLM_article-title">Effects of AS2541019, a Novel Selective PI3Kδ Inhibitor, on Antibody Production and Hamster to Rat Xenotransplantation</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>826</i></span>,  <span class="NLM_fpage">179</span>– <span class="NLM_lpage">186</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2018.02.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.ejphar.2018.02.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=29518396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC1cXkslShs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=826&publication_year=2018&pages=179-186&author=T.+Maruiauthor=H.+Fukahoriauthor=T.+Kawashimaauthor=M.+Itoauthor=M.+Akamatsuauthor=Y.+Kanekoauthor=F.+Takahashiauthor=S.+Imadaauthor=T.+Morokata&title=Effects+of+AS2541019%2C+a+Novel+Selective+PI3K%CE%B4+Inhibitor%2C+on+Antibody+Production+and+Hamster+to+Rat+Xenotransplantation&doi=10.1016%2Fj.ejphar.2018.02.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of AS2541019, a novel selective PI3Kδ inhibitor, on antibody production and hamster to rat xenotransplantation</span></div><div class="casAuthors">Marui, Takanori; Fukahori, Hidehiko; Kawashima, Tomoko; Ito, Misato; Akamatsu, Masahiko; Kaneko, Yoko; Takahashi, Fumie; Imada, Sunao; Morokata, Tatsuaki</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">826</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">179-186</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">B cell-mediated antibodies play a crit. role in protecting the body from infections; however, excessive antibody prodn. is involved in the pathogenesis of autoimmune diseases and transplanted organ rejection.  Regulation of antibody prodn. is therefore crucial for overcoming these complications.  Phosphatidylinositol-3-kinase p110δ (PI3Kδ), a member of the family of PI3K lipid kinases, is a key mediator of B cell activation and proliferation, with a small mol. PI3Kδ inhibitor having been approved for the treatment of B cell lymphoma.  However, the effect of PI3Kδ inhibitors on B cell-mediated antibody prodn. has not been clearly elucidated.  In this study, we investigated the effect of the selective PI3Kδ inhibitor, AS2541019, on B cell immunity and antibody prodn.  Our results show that AS2541019 effectively prevented B cell activation and proliferation in vitro, and that oral administration of AS2541019 resulted in significant inhibition of both T-dependent and T-independent de novo antibody prodn. in peripheral blood.  Further, in a hamster to rat concordant xenotransplant model, AS2541019 significantly prolonged graft survival time by inhibiting xenoreactive antibody prodn.  Therefore, our study demonstrates that the selective PI3Kδ inhibitor AS2541019 inhibits antibody prodn. through potent inhibitory effects on B cell activation, and can protect against organ dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOY5eNJgY4S7Vg90H21EOLACvtfcHk0lgVWidQ0aX-Nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXkslShs7o%253D&md5=83f75d8a5efbb76420854f34ddf5ed63</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2018.02.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2018.02.046%26sid%3Dliteratum%253Aachs%26aulast%3DMarui%26aufirst%3DT.%26aulast%3DFukahori%26aufirst%3DH.%26aulast%3DKawashima%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DM.%26aulast%3DAkamatsu%26aufirst%3DM.%26aulast%3DKaneko%26aufirst%3DY.%26aulast%3DTakahashi%26aufirst%3DF.%26aulast%3DImada%26aufirst%3DS.%26aulast%3DMorokata%26aufirst%3DT.%26atitle%3DEffects%2520of%2520AS2541019%252C%2520a%2520Novel%2520Selective%2520PI3K%25CE%25B4%2520Inhibitor%252C%2520on%2520Antibody%2520Production%2520and%2520Hamster%2520to%2520Rat%2520Xenotransplantation%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2018%26volume%3D826%26spage%3D179%26epage%3D186%26doi%3D10.1016%2Fj.ejphar.2018.02.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, S. D.</span>; <span class="NLM_string-name">Matthews, D. J.</span></span>, <span> </span><span class="NLM_article-title">(Alpha- Substituted Aralkylamino and Heteroarylalkylamino) Pyrimidinyl and 1,3,5 -Triazinyl Benzimidazoles, Pharmaceutical Compositions Containing Them, and These Compounds for Use in Treating Proliferative Diseases</span>. <span class="NLM_patent">WO2012135160</span>, October 5, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=S.+D.+Brown&author=D.+J.+Matthews&title=%28Alpha-+Substituted+Aralkylamino+and+Heteroarylalkylamino%29+Pyrimidinyl+and+1%2C3%2C5+-Triazinyl+Benzimidazoles%2C+Pharmaceutical+Compositions+Containing+Them%2C+and+These+Compounds+for+Use+in+Treating+Proliferative+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DS.%2BD.%26atitle%3D%2528Alpha-%2520Substituted%2520Aralkylamino%2520and%2520Heteroarylalkylamino%2529%2520Pyrimidinyl%2520and%25201%252C3%252C5%2520-Triazinyl%2520Benzimidazoles%252C%2520Pharmaceutical%2520Compositions%2520Containing%2520Them%252C%2520and%2520These%2520Compounds%2520for%2520Use%2520in%2520Treating%2520Proliferative%2520Diseases%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, S. D.</span>; <span class="NLM_string-name">Matthews, D. J.</span></span>, <span> </span><span class="NLM_article-title">(Fused Ring Arylamino and Heterocyclylamino) Pyrimidynyl and 1,3,5-Triazinyl Benzimidazoles, Pharmaceutical Compositions Thereof, and Their Use in Treating Proliferative Diseases</span>. <span class="NLM_patent">WO2012135166</span>, October 5, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=S.+D.+Brown&author=D.+J.+Matthews&title=%28Fused+Ring+Arylamino+and+Heterocyclylamino%29+Pyrimidynyl+and+1%2C3%2C5-Triazinyl+Benzimidazoles%2C+Pharmaceutical+Compositions+Thereof%2C+and+Their+Use+in+Treating+Proliferative+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DS.%2BD.%26atitle%3D%2528Fused%2520Ring%2520Arylamino%2520and%2520Heterocyclylamino%2529%2520Pyrimidynyl%2520and%25201%252C3%252C5-Triazinyl%2520Benzimidazoles%252C%2520Pharmaceutical%2520Compositions%2520Thereof%252C%2520and%2520Their%2520Use%2520in%2520Treating%2520Proliferative%2520Diseases%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, S. D.</span>; <span class="NLM_string-name">Matthews, D. J.</span></span>, <span> </span><span class="NLM_article-title">(Alpha-Substituted Cycloalkylamino and Heterocyclylamino) Pyrimidinyl and 1,3,5-Triazinyl Benzimidazoles, Pharmaceutical Compositions Thereof, and Their Use in Treating Proliferative Diseases</span>. <span class="NLM_patent">WO2012135175</span>, October 5, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=S.+D.+Brown&author=D.+J.+Matthews&title=%28Alpha-Substituted+Cycloalkylamino+and+Heterocyclylamino%29+Pyrimidinyl+and+1%2C3%2C5-Triazinyl+Benzimidazoles%2C+Pharmaceutical+Compositions+Thereof%2C+and+Their+Use+in+Treating+Proliferative+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DS.%2BD.%26atitle%3D%2528Alpha-Substituted%2520Cycloalkylamino%2520and%2520Heterocyclylamino%2529%2520Pyrimidinyl%2520and%25201%252C3%252C5-Triazinyl%2520Benzimidazoles%252C%2520Pharmaceutical%2520Compositions%2520Thereof%252C%2520and%2520Their%2520Use%2520in%2520Treating%2520Proliferative%2520Diseases%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, S. D.</span>; <span class="NLM_string-name">Matthews, D. J.</span></span>, <span> </span><span class="NLM_article-title">(Sulfinyl and Sulfonyl Benzimidazolyl) Pyrimidines and Triazines, Pharmaceutical Compositions Thereof, and Their Use for Treating Proliferative Diseases</span>. <span class="NLM_patent">WO2014055647</span>, April 11, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=S.+D.+Brown&author=D.+J.+Matthews&title=%28Sulfinyl+and+Sulfonyl+Benzimidazolyl%29+Pyrimidines+and+Triazines%2C+Pharmaceutical+Compositions+Thereof%2C+and+Their+Use+for+Treating+Proliferative+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DS.%2BD.%26atitle%3D%2528Sulfinyl%2520and%2520Sulfonyl%2520Benzimidazolyl%2529%2520Pyrimidines%2520and%2520Triazines%252C%2520Pharmaceutical%2520Compositions%2520Thereof%252C%2520and%2520Their%2520Use%2520for%2520Treating%2520Proliferative%2520Diseases%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mountford, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinson, J.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Künzli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogg, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shortt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jennings, I. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, P. E.</span></span> <span> </span><span class="NLM_article-title">Development of Single and Mixed Isoform Selectivity PI3Kδ Inhibitors by Targeting Asn836 of PI3Kδ</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">4790</span>– <span class="NLM_lpage">4794</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.08.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.bmcl.2016.08.028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=4790-4794&issue=19&author=M.+S.+Millerauthor=S.+J.+Mountfordauthor=J.-A.+Pinsonauthor=Z.+Zhengauthor=M.+K%C3%BCnzliauthor=V.+Patelauthor=S.+J.+Hoggauthor=J.+Shorttauthor=I.+G.+Jenningsauthor=P.+E.+Thompson&title=Development+of+Single+and+Mixed+Isoform+Selectivity+PI3K%CE%B4+Inhibitors+by+Targeting+Asn836+of+PI3K%CE%B4&doi=10.1016%2Fj.bmcl.2016.08.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.08.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.08.028%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DM.%2BS.%26aulast%3DMountford%26aufirst%3DS.%2BJ.%26aulast%3DPinson%26aufirst%3DJ.-A.%26aulast%3DZheng%26aufirst%3DZ.%26aulast%3DK%25C3%25BCnzli%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DV.%26aulast%3DHogg%26aufirst%3DS.%2BJ.%26aulast%3DShortt%26aufirst%3DJ.%26aulast%3DJennings%26aufirst%3DI.%2BG.%26aulast%3DThompson%26aufirst%3DP.%2BE.%26atitle%3DDevelopment%2520of%2520Single%2520and%2520Mixed%2520Isoform%2520Selectivity%2520PI3K%25CE%25B4%2520Inhibitors%2520by%2520Targeting%2520Asn836%2520of%2520PI3K%25CE%25B4%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26issue%3D19%26spage%3D4790%26epage%3D4794%26doi%3D10.1016%2Fj.bmcl.2016.08.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, P. E.</span>; <span class="NLM_string-name">Pinson, J.-A.</span>; <span class="NLM_string-name">Jennings, I. G.</span>; <span class="NLM_string-name">Zheng, Z.</span></span> <span> </span><span class="NLM_article-title">Phosphoinositide 3-Kinase (PI3K) Inhibitors</span>. <span class="NLM_patent">WO2014005182</span>, January 10, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=P.+E.+Thompson&author=J.-A.+Pinson&author=I.+G.+Jennings&author=Z.+Zheng&title=Phosphoinositide+3-Kinase+%28PI3K%29+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DP.%2BE.%26atitle%3DPhosphoinositide%25203-Kinase%2520%2528PI3K%2529%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, E.</span>; <span class="NLM_string-name">Gibson, T.</span>; <span class="NLM_string-name">Jin, B.</span>; <span class="NLM_string-name">Scorah, N.</span>; <span class="NLM_string-name">Dong, Q.</span></span> <span> </span><span class="NLM_article-title">N-Substituted Oxazinopteridines and Oxazinopteridinones</span>. <span class="NLM_patent">WO2012148548</span>, November 2, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=E.+Chang&author=T.+Gibson&author=B.+Jin&author=N.+Scorah&author=Q.+Dong&title=N-Substituted+Oxazinopteridines+and+Oxazinopteridinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DE.%26atitle%3DN-Substituted%2520Oxazinopteridines%2520and%2520Oxazinopteridinones%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Farrell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ventura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyner, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loriaux, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahadevan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, D. J.</span></span> <span> </span><span class="NLM_article-title">Preclinical Characterization of PWT143, a Novel Selective and Potent Phosphatidylinositol 3-Kinase Delta (PI3K Delta) Inhibitor with Ex-Vivo Activity in Hematologic Malignancies</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>120</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">2907</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=2907&issue=21&author=M.+O%E2%80%99Farrellauthor=R.+Venturaauthor=A.+Taiauthor=J.+W.+Tynerauthor=M.+M.+Loriauxauthor=D.+Mahadevanauthor=C.+Moralesauthor=S.+D.+Brownauthor=D.+J.+Matthews&title=Preclinical+Characterization+of+PWT143%2C+a+Novel+Selective+and+Potent+Phosphatidylinositol+3-Kinase+Delta+%28PI3K+Delta%29+Inhibitor+with+Ex-Vivo+Activity+in+Hematologic+Malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Farrell%26aufirst%3DM.%26aulast%3DVentura%26aufirst%3DR.%26aulast%3DTai%26aufirst%3DA.%26aulast%3DTyner%26aufirst%3DJ.%2BW.%26aulast%3DLoriaux%26aufirst%3DM.%2BM.%26aulast%3DMahadevan%26aufirst%3DD.%26aulast%3DMorales%26aufirst%3DC.%26aulast%3DBrown%26aufirst%3DS.%2BD.%26aulast%3DMatthews%26aufirst%3DD.%2BJ.%26atitle%3DPreclinical%2520Characterization%2520of%2520PWT143%252C%2520a%2520Novel%2520Selective%2520and%2520Potent%2520Phosphatidylinositol%25203-Kinase%2520Delta%2520%2528PI3K%2520Delta%2529%2520Inhibitor%2520with%2520Ex-Vivo%2520Activity%2520in%2520Hematologic%2520Malignancies%26jtitle%3DBlood%26date%3D2012%26volume%3D120%26issue%3D21%26spage%3D2907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Folkes, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmadi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alderton, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alix, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Box, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuckowree, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Depledge, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancox, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kugendradas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lensun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivero, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pergl-Wilson, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saghir, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salphati, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sohal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ultsch, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H. J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiesmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhyvoloup, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zvelebil, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuttleworth, S. J.</span></span> <span> </span><span class="NLM_article-title">The Identification of 2-(1H-Indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a Potent, Selective, Orally Bioavailable Inhibitor of Class I PI3 Kinase for the Treatment of Cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">5522</span>– <span class="NLM_lpage">5532</span>, <span class="refDoi"> DOI: 10.1021/jm800295d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800295d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5522-5532&issue=18&author=A.+J.+Folkesauthor=K.+Ahmadiauthor=W.+K.+Aldertonauthor=S.+Alixauthor=S.+J.+Bakerauthor=G.+Boxauthor=I.+S.+Chuckowreeauthor=P.+A.+Clarkeauthor=P.+Depledgeauthor=S.+A.+Ecclesauthor=L.+S.+Friedmanauthor=A.+Hayesauthor=T.+C.+Hancoxauthor=A.+Kugendradasauthor=L.+Lensunauthor=P.+Mooreauthor=A.+G.+Oliveroauthor=J.+Pangauthor=S.+Patelauthor=G.+H.+Pergl-Wilsonauthor=F.+I.+Raynaudauthor=A.+Robsonauthor=N.+Saghirauthor=L.+Salphatiauthor=S.+Sohalauthor=M.+H.+Ultschauthor=M.+Valentiauthor=H.+J.+A.+Wallweberauthor=N.+C.+Wanauthor=C.+Wiesmannauthor=P.+Workmanauthor=A.+Zhyvoloupauthor=M.+J.+Zvelebilauthor=S.+J.+Shuttleworth&title=The+Identification+of+2-%281H-Indazol-4-yl%29-6-%284-methanesulfonyl-piperazin-1-ylmethyl%29-4-morpholin-4-yl-thieno%5B3%2C2-d%5Dpyrimidine+%28GDC-0941%29+as+a+Potent%2C+Selective%2C+Orally+Bioavailable+Inhibitor+of+Class+I+PI3+Kinase+for+the+Treatment+of+Cancer&doi=10.1021%2Fjm800295d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1021%2Fjm800295d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800295d%26sid%3Dliteratum%253Aachs%26aulast%3DFolkes%26aufirst%3DA.%2BJ.%26aulast%3DAhmadi%26aufirst%3DK.%26aulast%3DAlderton%26aufirst%3DW.%2BK.%26aulast%3DAlix%26aufirst%3DS.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DChuckowree%26aufirst%3DI.%2BS.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DDepledge%26aufirst%3DP.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DFriedman%26aufirst%3DL.%2BS.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHancox%26aufirst%3DT.%2BC.%26aulast%3DKugendradas%26aufirst%3DA.%26aulast%3DLensun%26aufirst%3DL.%26aulast%3DMoore%26aufirst%3DP.%26aulast%3DOlivero%26aufirst%3DA.%2BG.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DPergl-Wilson%26aufirst%3DG.%2BH.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DRobson%26aufirst%3DA.%26aulast%3DSaghir%26aufirst%3DN.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSohal%26aufirst%3DS.%26aulast%3DUltsch%26aufirst%3DM.%2BH.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%2BA.%26aulast%3DWan%26aufirst%3DN.%2BC.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DZhyvoloup%26aufirst%3DA.%26aulast%3DZvelebil%26aufirst%3DM.%2BJ.%26aulast%3DShuttleworth%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520Identification%2520of%25202-%25281H-Indazol-4-yl%2529-6-%25284-methanesulfonyl-piperazin-1-ylmethyl%2529-4-morpholin-4-yl-thieno%255B3%252C2-d%255Dpyrimidine%2520%2528GDC-0941%2529%2520as%2520a%2520Potent%252C%2520Selective%252C%2520Orally%2520Bioavailable%2520Inhibitor%2520of%2520Class%2520I%2520PI3%2520Kinase%2520for%2520the%2520Treatment%2520of%2520Cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D18%26spage%3D5522%26epage%3D5532%26doi%3D10.1021%2Fjm800295d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisconte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaney, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chantry, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castanedo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Depledge, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldsmith, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancox, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knowles, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondru, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesnick, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadin, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonomiya, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pegg, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reif, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safina, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salphati, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staben, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seward, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuttleworth, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sohal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, Z. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ultsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waszkowycz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, B.</span></span> <span> </span><span class="NLM_article-title">Potent and Selective Inhibitors of PI3Kδ: Obtaining Isoform Selectivity from the Affinity Pocket and Tryptophan Shelf</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">4296</span>– <span class="NLM_lpage">4302</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.05.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.bmcl.2012.05.027" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=4296-4302&issue=13&author=D.+P.+Sutherlinauthor=S.+Bakerauthor=A.+Bisconteauthor=P.+M.+Blaneyauthor=A.+Brownauthor=B.+K.+Chanauthor=D.+Chantryauthor=G.+Castanedoauthor=P.+Depledgeauthor=P.+Goldsmithauthor=D.+M.+Goldsteinauthor=T.+Hancoxauthor=J.+Kaurauthor=D.+Knowlesauthor=R.+Kondruauthor=J.+Lesnickauthor=M.+C.+Lucasauthor=C.+Lewisauthor=J.+Murrayauthor=A.+J.+Nadinauthor=J.+Nonomiyaauthor=J.+Pangauthor=N.+Peggauthor=S.+Priceauthor=K.+Reifauthor=B.+S.+Safinaauthor=L.+Salphatiauthor=S.+Stabenauthor=E.+M.+Sewardauthor=S.+Shuttleworthauthor=S.+Sohalauthor=Z.+K.+Sweeneyauthor=M.+Ultschauthor=B.+Waszkowyczauthor=B.+Wei&title=Potent+and+Selective+Inhibitors+of+PI3K%CE%B4%3A+Obtaining+Isoform+Selectivity+from+the+Affinity+Pocket+and+Tryptophan+Shelf&doi=10.1016%2Fj.bmcl.2012.05.027"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.05.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.05.027%26sid%3Dliteratum%253Aachs%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DBaker%26aufirst%3DS.%26aulast%3DBisconte%26aufirst%3DA.%26aulast%3DBlaney%26aufirst%3DP.%2BM.%26aulast%3DBrown%26aufirst%3DA.%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DChantry%26aufirst%3DD.%26aulast%3DCastanedo%26aufirst%3DG.%26aulast%3DDepledge%26aufirst%3DP.%26aulast%3DGoldsmith%26aufirst%3DP.%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DHancox%26aufirst%3DT.%26aulast%3DKaur%26aufirst%3DJ.%26aulast%3DKnowles%26aufirst%3DD.%26aulast%3DKondru%26aufirst%3DR.%26aulast%3DLesnick%26aufirst%3DJ.%26aulast%3DLucas%26aufirst%3DM.%2BC.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DNadin%26aufirst%3DA.%2BJ.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPegg%26aufirst%3DN.%26aulast%3DPrice%26aufirst%3DS.%26aulast%3DReif%26aufirst%3DK.%26aulast%3DSafina%26aufirst%3DB.%2BS.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DStaben%26aufirst%3DS.%26aulast%3DSeward%26aufirst%3DE.%2BM.%26aulast%3DShuttleworth%26aufirst%3DS.%26aulast%3DSohal%26aufirst%3DS.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26aulast%3DUltsch%26aufirst%3DM.%26aulast%3DWaszkowycz%26aufirst%3DB.%26aulast%3DWei%26aufirst%3DB.%26atitle%3DPotent%2520and%2520Selective%2520Inhibitors%2520of%2520PI3K%25CE%25B4%253A%2520Obtaining%2520Isoform%2520Selectivity%2520from%2520the%2520Affinity%2520Pocket%2520and%2520Tryptophan%2520Shelf%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26issue%3D13%26spage%3D4296%26epage%3D4302%26doi%3D10.1016%2Fj.bmcl.2012.05.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Safina, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumgardner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaney, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cartwright, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castanedo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chabot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheguillaume, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldsmith, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goyal, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancox, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Handa, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondru, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenny, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krintel, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesnick, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukadam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadin, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonomiya, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padilla, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pegg, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reif, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salphati, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savy, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seward, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuttleworth, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sohal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, Z. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tivitmahaisoon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waszkowycz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D. P.</span></span> <span> </span><span class="NLM_article-title">Discovery of Novel PI3-Kinase δ Specific Inhibitors for the Treatment of Rheumatoid Arthritis: Taming CYP3A4 Time-Dependent Inhibition</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">5887</span>– <span class="NLM_lpage">5900</span>, <span class="refDoi"> DOI: 10.1021/jm3003747</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3003747" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5887-5900&author=B.+S.+Safinaauthor=S.+Bakerauthor=M.+Baumgardnerauthor=P.+M.+Blaneyauthor=B.+K.+Chanauthor=Y.+Chenauthor=M.+W.+Cartwrightauthor=G.+Castanedoauthor=C.+Chabotauthor=A.+J.+Cheguillaumeauthor=P.+Goldsmithauthor=D.+M.+Goldsteinauthor=B.+Goyalauthor=T.+Hancoxauthor=R.+K.+Handaauthor=P.+S.+Iyerauthor=J.+Kaurauthor=R.+Kondruauthor=J.+R.+Kennyauthor=S.+L.+Krintelauthor=J.+Liauthor=J.+Lesnickauthor=M.+C.+Lucasauthor=C.+Lewisauthor=S.+Mukadamauthor=J.+Murrayauthor=A.+J.+Nadinauthor=J.+Nonomiyaauthor=F.+Padillaauthor=W.+S.+Palmerauthor=J.+Pangauthor=N.+Peggauthor=S.+Priceauthor=K.+Reifauthor=L.+Salphatiauthor=P.+A.+Savyauthor=E.+M.+Sewardauthor=S.+Shuttleworthauthor=S.+Sohalauthor=Z.+K.+Sweeneyauthor=S.+Tayauthor=P.+Tivitmahaisoonauthor=B.+Waszkowyczauthor=B.+Weiauthor=Q.+Yueauthor=C.+Zhangauthor=D.+P.+Sutherlin&title=Discovery+of+Novel+PI3-Kinase+%CE%B4+Specific+Inhibitors+for+the+Treatment+of+Rheumatoid+Arthritis%3A+Taming+CYP3A4+Time-Dependent+Inhibition&doi=10.1021%2Fjm3003747"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1021%2Fjm3003747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3003747%26sid%3Dliteratum%253Aachs%26aulast%3DSafina%26aufirst%3DB.%2BS.%26aulast%3DBaker%26aufirst%3DS.%26aulast%3DBaumgardner%26aufirst%3DM.%26aulast%3DBlaney%26aufirst%3DP.%2BM.%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DCartwright%26aufirst%3DM.%2BW.%26aulast%3DCastanedo%26aufirst%3DG.%26aulast%3DChabot%26aufirst%3DC.%26aulast%3DCheguillaume%26aufirst%3DA.%2BJ.%26aulast%3DGoldsmith%26aufirst%3DP.%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DGoyal%26aufirst%3DB.%26aulast%3DHancox%26aufirst%3DT.%26aulast%3DHanda%26aufirst%3DR.%2BK.%26aulast%3DIyer%26aufirst%3DP.%2BS.%26aulast%3DKaur%26aufirst%3DJ.%26aulast%3DKondru%26aufirst%3DR.%26aulast%3DKenny%26aufirst%3DJ.%2BR.%26aulast%3DKrintel%26aufirst%3DS.%2BL.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLesnick%26aufirst%3DJ.%26aulast%3DLucas%26aufirst%3DM.%2BC.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DMukadam%26aufirst%3DS.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DNadin%26aufirst%3DA.%2BJ.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DPadilla%26aufirst%3DF.%26aulast%3DPalmer%26aufirst%3DW.%2BS.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPegg%26aufirst%3DN.%26aulast%3DPrice%26aufirst%3DS.%26aulast%3DReif%26aufirst%3DK.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSavy%26aufirst%3DP.%2BA.%26aulast%3DSeward%26aufirst%3DE.%2BM.%26aulast%3DShuttleworth%26aufirst%3DS.%26aulast%3DSohal%26aufirst%3DS.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26aulast%3DTay%26aufirst%3DS.%26aulast%3DTivitmahaisoon%26aufirst%3DP.%26aulast%3DWaszkowycz%26aufirst%3DB.%26aulast%3DWei%26aufirst%3DB.%26aulast%3DYue%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26atitle%3DDiscovery%2520of%2520Novel%2520PI3-Kinase%2520%25CE%25B4%2520Specific%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Rheumatoid%2520Arthritis%253A%2520Taming%2520CYP3A4%2520Time-Dependent%2520Inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5887%26epage%3D5900%26doi%3D10.1021%2Fjm3003747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, Z. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balazs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castanedo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chabot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chantry, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flagella, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondru, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesnick, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonomiya, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salphati, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safina, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savy, P. P. a.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seward, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ultsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D. P.</span></span> <span> </span><span class="NLM_article-title">Potent and Highly Selective Benzimidazole Inhibitors of PI3-Kinase Delta</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">7686</span>– <span class="NLM_lpage">7695</span>, <span class="refDoi"> DOI: 10.1021/jm300717c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300717c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7686-7695&issue=17&author=J.+M.+Murrayauthor=Z.+K.+Sweeneyauthor=B.+K.+Chanauthor=M.+Balazsauthor=E.+Bradleyauthor=G.+Castanedoauthor=C.+Chabotauthor=D.+Chantryauthor=M.+Flagellaauthor=D.+M.+Goldsteinauthor=R.+Kondruauthor=J.+Lesnickauthor=J.+Liauthor=M.+C.+Lucasauthor=J.+Nonomiyaauthor=J.+Pangauthor=S.+Priceauthor=L.+Salphatiauthor=B.+Safinaauthor=P.+P.+a.+Savyauthor=E.+M.+Sewardauthor=M.+Ultschauthor=D.+P.+Sutherlin&title=Potent+and+Highly+Selective+Benzimidazole+Inhibitors+of+PI3-Kinase+Delta&doi=10.1021%2Fjm300717c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1021%2Fjm300717c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300717c%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DJ.%2BM.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DBalazs%26aufirst%3DM.%26aulast%3DBradley%26aufirst%3DE.%26aulast%3DCastanedo%26aufirst%3DG.%26aulast%3DChabot%26aufirst%3DC.%26aulast%3DChantry%26aufirst%3DD.%26aulast%3DFlagella%26aufirst%3DM.%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DKondru%26aufirst%3DR.%26aulast%3DLesnick%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLucas%26aufirst%3DM.%2BC.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DS.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSafina%26aufirst%3DB.%26aulast%3DSavy%26aufirst%3DP.%2BP.%2Ba.%26aulast%3DSeward%26aufirst%3DE.%2BM.%26aulast%3DUltsch%26aufirst%3DM.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26atitle%3DPotent%2520and%2520Highly%2520Selective%2520Benzimidazole%2520Inhibitors%2520of%2520PI3-Kinase%2520Delta%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D17%26spage%3D7686%26epage%3D7695%26doi%3D10.1021%2Fjm300717c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Safina, B.
S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, Z. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisconte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrera, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castanedo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flagella, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heald, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonomiya, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reif, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salphati, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seward, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D. P.</span></span> <span> </span><span class="NLM_article-title">Identification of GNE-293, a Potent and Selective PI3Kδ Inhibitor: Navigating in Vitro Genotoxicity While Improving Potency and Selectivity</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">4953</span>– <span class="NLM_lpage">4959</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.06.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.bmcl.2013.06.052" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4953-4959&issue=17&author=B.%0AS.+Safinaauthor=Z.+K.+Sweeneyauthor=J.+Liauthor=B.+K.+Chanauthor=A.+Bisconteauthor=D.+Carreraauthor=G.+Castanedoauthor=M.+Flagellaauthor=R.+Healdauthor=C.+Lewisauthor=J.+M.+Murrayauthor=J.+Nonomiyaauthor=J.+Pangauthor=S.+Priceauthor=K.+Reifauthor=L.+Salphatiauthor=E.+M.+Sewardauthor=B.+Weiauthor=D.+P.+Sutherlin&title=Identification+of+GNE-293%2C+a+Potent+and+Selective+PI3K%CE%B4+Inhibitor%3A+Navigating+in+Vitro+Genotoxicity+While+Improving+Potency+and+Selectivity&doi=10.1016%2Fj.bmcl.2013.06.052"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.06.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.06.052%26sid%3Dliteratum%253Aachs%26aulast%3DSafina%26aufirst%3DB.%2BS.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DBisconte%26aufirst%3DA.%26aulast%3DCarrera%26aufirst%3DD.%26aulast%3DCastanedo%26aufirst%3DG.%26aulast%3DFlagella%26aufirst%3DM.%26aulast%3DHeald%26aufirst%3DR.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DMurray%26aufirst%3DJ.%2BM.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DS.%26aulast%3DReif%26aufirst%3DK.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSeward%26aufirst%3DE.%2BM.%26aulast%3DWei%26aufirst%3DB.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26atitle%3DIdentification%2520of%2520GNE-293%252C%2520a%2520Potent%2520and%2520Selective%2520PI3K%25CE%25B4%2520Inhibitor%253A%2520Navigating%2520in%2520Vitro%2520Genotoxicity%2520While%2520Improving%2520Potency%2520and%2520Selectivity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26issue%3D17%26spage%3D4953%26epage%3D4959%26doi%3D10.1016%2Fj.bmcl.2013.06.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salphati, L.</span></span> <span> </span><span class="NLM_article-title">Investigation of Dose-Dependent Factors Limiting Oral Bioavailability: Case Study with the PI3K-δ Inhibitor</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>105</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1802</span>– <span class="NLM_lpage">1809</span>, <span class="refDoi"> DOI: 10.1016/j.xphs.2016.04.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.xphs.2016.04.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2016&pages=1802-1809&issue=6&author=P.+C.+Chiangauthor=D.+Sutherlinauthor=J.+Pangauthor=L.+Salphati&title=Investigation+of+Dose-Dependent+Factors+Limiting+Oral+Bioavailability%3A+Case+Study+with+the+PI3K-%CE%B4+Inhibitor&doi=10.1016%2Fj.xphs.2016.04.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1016%2Fj.xphs.2016.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.xphs.2016.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DChiang%26aufirst%3DP.%2BC.%26aulast%3DSutherlin%26aufirst%3DD.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DSalphati%26aufirst%3DL.%26atitle%3DInvestigation%2520of%2520Dose-Dependent%2520Factors%2520Limiting%2520Oral%2520Bioavailability%253A%2520Case%2520Study%2520with%2520the%2520PI3K-%25CE%25B4%2520Inhibitor%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2016%26volume%3D105%26issue%3D6%26spage%3D1802%26epage%3D1809%26doi%3D10.1016%2Fj.xphs.2016.04.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span> <span> </span><span class="NLM_article-title">Fused Pyrimidine Compound, Intermediate, Preparation Method Therefor, and Composition and Application Thereof</span>. <span class="NLM_patent">WO2015043398</span>, April 3, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=Z.+Xu&title=Fused+Pyrimidine+Compound%2C+Intermediate%2C+Preparation+Method+Therefor%2C+and+Composition+and+Application+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DZ.%26atitle%3DFused%2520Pyrimidine%2520Compound%252C%2520Intermediate%252C%2520Preparation%2520Method%2520Therefor%252C%2520and%2520Composition%2520and%2520Application%2520Thereof%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span>; <span class="NLM_string-name">Lou, Y.</span></span> <span> </span><span class="NLM_article-title">Fused Heterocyclic Compound, Preparation Method Therefor, Pharmaceutical Composition, and Uses Thereof</span>. <span class="NLM_patent">WO2015055071</span>, April 24, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=Z.+Xu&author=Y.+Lou&title=Fused+Heterocyclic+Compound%2C+Preparation+Method+Therefor%2C+Pharmaceutical+Composition%2C+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DZ.%26atitle%3DFused%2520Heterocyclic%2520Compound%252C%2520Preparation%2520Method%2520Therefor%252C%2520Pharmaceutical%2520Composition%252C%2520and%2520Uses%2520Thereof%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.</span>; <span class="NLM_string-name">Pei, Y.</span>; <span class="NLM_string-name">Lang, H.</span></span> <span> </span><span class="NLM_article-title">Pyrimidine Derivative, Cytotoxic Agent, Pharmaceutical Composition and Use Thereof</span>. <span class="NLM_patent">WO2016127455</span>, August 19, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=J.+Guo&author=Y.+Pei&author=H.+Lang&title=Pyrimidine+Derivative%2C+Cytotoxic+Agent%2C+Pharmaceutical+Composition+and+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DJ.%26atitle%3DPyrimidine%2520Derivative%252C%2520Cytotoxic%2520Agent%252C%2520Pharmaceutical%2520Composition%2520and%2520Use%2520Thereof%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Samby, K. K.</span>; <span class="NLM_string-name">Surase, Y. B.</span>; <span class="NLM_string-name">Amale, S. R.</span>; <span class="NLM_string-name">Gorla, S. K.</span>; <span class="NLM_string-name">Patel, P.</span>; <span class="NLM_string-name">Verma, A.
K.</span></span> <span> </span><span class="NLM_article-title">6-Morpholinyl-2-pyrazolyl-9H-purine Derivatives and Their Use as PI3K Inhibitors</span>. <span class="NLM_patent">WO2016157074</span>, October 7, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=K.+K.+Samby&author=Y.+B.+Surase&author=S.+R.+Amale&author=S.+K.+Gorla&author=P.+Patel&author=A.%0AK.+Verma&title=6-Morpholinyl-2-pyrazolyl-9H-purine+Derivatives+and+Their+Use+as+PI3K+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSamby%26aufirst%3DK.%2BK.%26atitle%3D6-Morpholinyl-2-pyrazolyl-9H-purine%2520Derivatives%2520and%2520Their%2520Use%2520as%2520PI3K%2520Inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref180"><div class="reference"><strong class="refLabel"><a href="#ref180" class="rightTabRefNumLink">180</a></strong><div class="NLM_citation" id="rightTab-cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dymek, B.</span>; <span class="NLM_string-name">Zagozda, M.</span>; <span class="NLM_string-name">Wieczorek, M.</span>; <span class="NLM_string-name">Dubiel, K.</span>; <span class="NLM_string-name">Stanczak, A.</span>; <span class="NLM_string-name">Zdzalik, D.</span>; <span class="NLM_string-name">Gunerka, P.</span>; <span class="NLM_string-name">Sekular, M.</span>; <span class="NLM_string-name">Dziachan, M.</span></span> <span> </span><span class="NLM_article-title">7-(Morpholin-4-yl)pyrazole[1,5-a]pyrimidine Derivatives Which Are Useful for the Treatment of Immune or Inflammatory Diseases or Cancer</span>. <span class="NLM_patent">WO2016157091</span>, October 7, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=B.+Dymek&author=M.+Zagozda&author=M.+Wieczorek&author=K.+Dubiel&author=A.+Stanczak&author=D.+Zdzalik&author=P.+Gunerka&author=M.+Sekular&author=M.+Dziachan&title=7-%28Morpholin-4-yl%29pyrazole%5B1%2C5-a%5Dpyrimidine+Derivatives+Which+Are+Useful+for+the+Treatment+of+Immune+or+Inflammatory+Diseases+or+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDymek%26aufirst%3DB.%26atitle%3D7-%2528Morpholin-4-yl%2529pyrazole%255B1%252C5-a%255Dpyrimidine%2520Derivatives%2520Which%2520Are%2520Useful%2520for%2520the%2520Treatment%2520of%2520Immune%2520or%2520Inflammatory%2520Diseases%2520or%2520Cancer%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref181"><div class="reference"><strong class="refLabel"><a href="#ref181" class="rightTabRefNumLink">181</a></strong><div class="NLM_citation" id="rightTab-cit181"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kearney, P.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of PI3K-δ and Methods of Their Use and Manufacture</span>. <span class="NLM_patent">WO2012037226</span>, March 23, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=P.+Kearney&title=Inhibitors+of+PI3K-%CE%B4+and+Methods+of+Their+Use+and+Manufacture"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKearney%26aufirst%3DP.%26atitle%3DInhibitors%2520of%2520PI3K-%25CE%25B4%2520and%2520Methods%2520of%2520Their%2520Use%2520and%2520Manufacture%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref182"><div class="reference"><strong class="refLabel"><a href="#ref182" class="rightTabRefNumLink">182</a></strong><div class="NLM_citation" id="rightTab-cit182"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Achab, A. A.</span>; <span class="NLM_string-name">Altman, M. D.</span>; <span class="NLM_string-name">Deng, Y.</span>; <span class="NLM_string-name">Guzi, T.</span>; <span class="NLM_string-name">Kattar, S.</span>; <span class="NLM_string-name">Katz, J. D.</span>; <span class="NLM_string-name">Methot, J. L.</span>; <span class="NLM_string-name">Zhou, H.</span>; <span class="NLM_string-name">McGowan, M.</span>; <span class="NLM_string-name">Christopher, M. P.</span>; <span class="NLM_string-name">Garcia, Y.</span>; <span class="NLM_string-name">Anthony, N. J.</span>; <span class="NLM_string-name">Fradera Llinas, F. X.</span>; <span class="NLM_string-name">Mu, C.</span>; <span class="NLM_string-name">Zhang, S.</span>; <span class="NLM_string-name">Zhang, R.</span>; <span class="NLM_string-name">Fong, K. C.</span>; <span class="NLM_string-name">Leng, X.</span></span> <span> </span><span class="NLM_article-title">Purine Inhibitors of Human Phosphatidylinositol 3-Kinase Delta</span>. <span class="NLM_patent">WO2014075392</span>, May 23, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=A.+A.+Achab&author=M.+D.+Altman&author=Y.+Deng&author=T.+Guzi&author=S.+Kattar&author=J.+D.+Katz&author=J.+L.+Methot&author=H.+Zhou&author=M.+McGowan&author=M.+P.+Christopher&author=Y.+Garcia&author=N.+J.+Anthony&author=F.+X.+Fradera+Llinas&author=C.+Mu&author=S.+Zhang&author=R.+Zhang&author=K.+C.+Fong&author=X.+Leng&title=Purine+Inhibitors+of+Human+Phosphatidylinositol+3-Kinase+Delta"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAchab%26aufirst%3DA.%2BA.%26atitle%3DPurine%2520Inhibitors%2520of%2520Human%2520Phosphatidylinositol%25203-Kinase%2520Delta%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref183"><div class="reference"><strong class="refLabel"><a href="#ref183" class="rightTabRefNumLink">183</a></strong><div class="NLM_citation" id="rightTab-cit183"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Achab, A. A.</span>; <span class="NLM_string-name">Altman, M. D.</span>; <span class="NLM_string-name">Deng, Y.</span>; <span class="NLM_string-name">Kattar, S.</span>; <span class="NLM_string-name">Katz, J.
D.</span>; <span class="NLM_string-name">Methot, J.
L.</span>; <span class="NLM_string-name">Zhou, H.</span>; <span class="NLM_string-name">McGowan, M.</span>; <span class="NLM_string-name">Christopher, M. P.</span>; <span class="NLM_string-name">Garcia, Y.</span>; <span class="NLM_string-name">Anthony, N. J.</span>; <span class="NLM_string-name">Fradera Llinas, F. X.</span>; <span class="NLM_string-name">Yang, L.</span>; <span class="NLM_string-name">Mu, C.</span>; <span class="NLM_string-name">Wang, X.</span>; <span class="NLM_string-name">Shi, F.</span>; <span class="NLM_string-name">Ye, B.</span>; <span class="NLM_string-name">Zhang, S.</span>; <span class="NLM_string-name">Zhao, X.</span>; <span class="NLM_string-name">Zhang, R.</span>; <span class="NLM_string-name">Fong, K. C.</span>; <span class="NLM_string-name">Leng, X.</span></span> <span> </span><span class="NLM_article-title">Purine Inhibitors of Human Phosphatidylinositol 3-Kinase Delta</span>. <span class="NLM_patent">WO2014075393</span>, May 23, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=A.+A.+Achab&author=M.+D.+Altman&author=Y.+Deng&author=S.+Kattar&author=J.%0AD.+Katz&author=J.%0AL.+Methot&author=H.+Zhou&author=M.+McGowan&author=M.+P.+Christopher&author=Y.+Garcia&author=N.+J.+Anthony&author=F.+X.+Fradera+Llinas&author=L.+Yang&author=C.+Mu&author=X.+Wang&author=F.+Shi&author=B.+Ye&author=S.+Zhang&author=X.+Zhao&author=R.+Zhang&author=K.+C.+Fong&author=X.+Leng&title=Purine+Inhibitors+of+Human+Phosphatidylinositol+3-Kinase+Delta"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAchab%26aufirst%3DA.%2BA.%26atitle%3DPurine%2520Inhibitors%2520of%2520Human%2520Phosphatidylinositol%25203-Kinase%2520Delta%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref184"><div class="reference"><strong class="refLabel"><a href="#ref184" class="rightTabRefNumLink">184</a></strong><div class="NLM_citation" id="rightTab-cit184"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, M. A.</span>; <span class="NLM_string-name">Fong, K. C.</span>; <span class="NLM_string-name">Anthony, N. J.</span>; <span class="NLM_string-name">Zhou, H.</span>; <span class="NLM_string-name">Katz, J.
D.</span>; <span class="NLM_string-name">Yang, L.</span>; <span class="NLM_string-name">Li, C.</span>; <span class="NLM_string-name">Tian, Y.</span>; <span class="NLM_string-name">Mu, C.</span>; <span class="NLM_string-name">Ye, B.</span>; <span class="NLM_string-name">Shi, F.</span>; <span class="NLM_string-name">Zhao, X.</span>; <span class="NLM_string-name">Fu, J.</span></span> <span> </span><span class="NLM_article-title">Purine Inhibitors of Human Phosphatidylinositol 3-Kinase Delta</span>. <span class="NLM_patent">WO2015188369</span>, December 18, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+A.+McGowan&author=K.+C.+Fong&author=N.+J.+Anthony&author=H.+Zhou&author=J.%0AD.+Katz&author=L.+Yang&author=C.+Li&author=Y.+Tian&author=C.+Mu&author=B.+Ye&author=F.+Shi&author=X.+Zhao&author=J.+Fu&title=Purine+Inhibitors+of+Human+Phosphatidylinositol+3-Kinase+Delta"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMcGowan%26aufirst%3DM.%2BA.%26atitle%3DPurine%2520Inhibitors%2520of%2520Human%2520Phosphatidylinositol%25203-Kinase%2520Delta%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref185"><div class="reference"><strong class="refLabel"><a href="#ref185" class="rightTabRefNumLink">185</a></strong><div class="NLM_citation" id="rightTab-cit185"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, M. A.</span>; <span class="NLM_string-name">Fong, K. C.</span>; <span class="NLM_string-name">Anthony, N. J.</span>; <span class="NLM_string-name">Zhou, H.</span>; <span class="NLM_string-name">Katz, J.
D.</span>; <span class="NLM_string-name">Yang, L.</span>; <span class="NLM_string-name">Li, C.</span>; <span class="NLM_string-name">Tian, Y.</span>; <span class="NLM_string-name">Mu, C.</span>; <span class="NLM_string-name">Ye, B.</span>; <span class="NLM_string-name">Shi, F.</span>; <span class="NLM_string-name">Zhao, X.</span>; <span class="NLM_string-name">Fu, J.</span>; <span class="NLM_string-name">Li, Y.</span></span> <span> </span><span class="NLM_article-title">Purine Inhibitors of Human Phosphatidylinositol 3-Kinase Delta</span>. <span class="NLM_patent">WO2016004807</span>, January 15, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=M.+A.+McGowan&author=K.+C.+Fong&author=N.+J.+Anthony&author=H.+Zhou&author=J.%0AD.+Katz&author=L.+Yang&author=C.+Li&author=Y.+Tian&author=C.+Mu&author=B.+Ye&author=F.+Shi&author=X.+Zhao&author=J.+Fu&author=Y.+Li&title=Purine+Inhibitors+of+Human+Phosphatidylinositol+3-Kinase+Delta"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMcGowan%26aufirst%3DM.%2BA.%26atitle%3DPurine%2520Inhibitors%2520of%2520Human%2520Phosphatidylinositol%25203-Kinase%2520Delta%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref186"><div class="reference"><strong class="refLabel"><a href="#ref186" class="rightTabRefNumLink">186</a></strong><div class="NLM_citation" id="rightTab-cit186"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, M. A.</span>; <span class="NLM_string-name">Zhou, H.</span>; <span class="NLM_string-name">Katz, J.
D.</span>; <span class="NLM_string-name">Yang, L.</span>; <span class="NLM_string-name">Methot, J. L.</span>; <span class="NLM_string-name">Lipford, K. A.</span>; <span class="NLM_string-name">Xu, S.</span>; <span class="NLM_string-name">Fu, N.</span>; <span class="NLM_string-name">Xu, G.</span>; <span class="NLM_string-name">Bian, D.</span>; <span class="NLM_string-name">Fu, J.</span>; <span class="NLM_string-name">Li, Y.</span>; <span class="NLM_string-name">Fong, K.
C.</span></span> <span> </span><span class="NLM_article-title">Purine Inhibitors of Human Phosphatidylinositol 3-Kinase Delta</span>. <span class="NLM_patent">WO2017003836</span>, January 6, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=M.+A.+McGowan&author=H.+Zhou&author=J.%0AD.+Katz&author=L.+Yang&author=J.+L.+Methot&author=K.+A.+Lipford&author=S.+Xu&author=N.+Fu&author=G.+Xu&author=D.+Bian&author=J.+Fu&author=Y.+Li&author=K.%0AC.+Fong&title=Purine+Inhibitors+of+Human+Phosphatidylinositol+3-Kinase+Delta"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMcGowan%26aufirst%3DM.%2BA.%26atitle%3DPurine%2520Inhibitors%2520of%2520Human%2520Phosphatidylinositol%25203-Kinase%2520Delta%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref187"><div class="reference"><strong class="refLabel"><a href="#ref187" class="rightTabRefNumLink">187</a></strong><div class="NLM_citation" id="rightTab-cit187"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Achab, A. A.</span>; <span class="NLM_string-name">Christopher, M. P.</span>; <span class="NLM_string-name">Fradera Llinas, F. X.</span>; <span class="NLM_string-name">Katz, J. D.</span>; <span class="NLM_string-name">Methot, J. L.</span>; <span class="NLM_string-name">Zhou, H.</span>; <span class="NLM_string-name">Xu, S.</span>; <span class="NLM_string-name">Fu, J.</span>; <span class="NLM_string-name">Fu, N.</span>; <span class="NLM_string-name">Li, Y.</span>; <span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">Purine Inhibitors of Human Phosphatidylinositol 3-Kinase Delta</span>. <span class="NLM_patent">WO2017166104</span>, October 6, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=A.+A.+Achab&author=M.+P.+Christopher&author=F.+X.+Fradera+Llinas&author=J.+D.+Katz&author=J.+L.+Methot&author=H.+Zhou&author=S.+Xu&author=J.+Fu&author=N.+Fu&author=Y.+Li&author=X.+Wang&title=Purine+Inhibitors+of+Human+Phosphatidylinositol+3-Kinase+Delta"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAchab%26aufirst%3DA.%2BA.%26atitle%3DPurine%2520Inhibitors%2520of%2520Human%2520Phosphatidylinositol%25203-Kinase%2520Delta%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref188"><div class="reference"><strong class="refLabel"><a href="#ref188" class="rightTabRefNumLink">188</a></strong><div class="NLM_citation" id="rightTab-cit188"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Norman, P.</span></span> <span> </span><span class="NLM_article-title">Evaluation of WO2012037204 and WO2012037226: Exelixis’ Selective PI3Kδ Inhibitors; the Basis of a US$251 Million Deal</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">971</span>– <span class="NLM_lpage">976</span>, <span class="refDoi"> DOI: 10.1517/13543776.2012.701282</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1517%2F13543776.2012.701282" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=22768915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVKgtb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=971-976&issue=8&author=P.+Norman&title=Evaluation+of+WO2012037204+and+WO2012037226%3A+Exelixis%E2%80%99+Selective+PI3K%CE%B4+Inhibitors%3B+the+Basis+of+a+US%24251+Million+Deal&doi=10.1517%2F13543776.2012.701282"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of WO2012037204 and WO2012037226: Exelixis' selective PI3Kδ inhibitors; the basis of a US$251 million deal</span></div><div class="casAuthors">Norman, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">971-976</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Two applications each claim compds. described as selective PI3Kδ inhibitors.  The first claims 2-amino-3-substituted-8-methylquinoline derivs.  The second, more substantial, application claims a broad range of cyclic amine derivs. of 6-aminopurines.  These are the first patent applications from Exelixis relating to its PI3Kδ inhibitor program despite its disclosure of the biol. profile of its lead inhibitor XL-499 in late 2010.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj1idcywNF_bVg90H21EOLACvtfcHk0lgNcFE-MfFiuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVKgtb7M&md5=2b0917ed7db219c2ca9aa55c527884ba</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1517%2F13543776.2012.701282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2012.701282%26sid%3Dliteratum%253Aachs%26aulast%3DNorman%26aufirst%3DP.%26atitle%3DEvaluation%2520of%2520WO2012037204%2520and%2520WO2012037226%253A%2520Exelixis%25E2%2580%2599%2520Selective%2520PI3K%25CE%25B4%2520Inhibitors%253B%2520the%2520Basis%2520of%2520a%2520US%2524251%2520Million%2520Deal%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2012%26volume%3D22%26issue%3D8%26spage%3D971%26epage%3D976%26doi%3D10.1517%2F13543776.2012.701282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref189"><div class="reference"><strong class="refLabel"><a href="#ref189" class="rightTabRefNumLink">189</a></strong><div class="NLM_citation" id="rightTab-cit189"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span>; <span class="NLM_string-name">Liu, J.</span>; <span class="NLM_string-name">Zhang, X.</span>; <span class="NLM_string-name">Liang, X.</span>; <span class="NLM_string-name">Liu, X.</span>; <span class="NLM_string-name">Liu, J.</span>; <span class="NLM_string-name">Chen, C.</span>; <span class="NLM_string-name">Zhao, Z.</span>; <span class="NLM_string-name">Wang, A.</span>; <span class="NLM_string-name">Wang, W.</span>; <span class="NLM_string-name">Wu, H.</span>; <span class="NLM_string-name">Wang, B.</span>; <span class="NLM_string-name">Wang, L.</span></span> <span> </span><span class="NLM_article-title">New PI3K Kinase Inhibitor</span>. <span class="NLM_patent">WO2016101553</span>, July 1,<span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=Q.+Liu&author=J.+Liu&author=X.+Zhang&author=X.+Liang&author=X.+Liu&author=J.+Liu&author=C.+Chen&author=Z.+Zhao&author=A.+Wang&author=W.+Wang&author=H.+Wu&author=B.+Wang&author=L.+Wang&title=New+PI3K+Kinase+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26atitle%3DNew%2520PI3K%2520Kinase%2520Inhibitor%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref190"><div class="reference"><strong class="refLabel"><a href="#ref190" class="rightTabRefNumLink">190</a></strong><div class="NLM_citation" id="rightTab-cit190"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perry, M.</span>; <span class="NLM_string-name">Karabelas, K.</span>; <span class="NLM_string-name">Mogemark, M.</span>; <span class="NLM_string-name">Bold, P.</span>; <span class="NLM_string-name">Tyrchan, C.</span>; <span class="NLM_string-name">Nikitidis, A.</span>; <span class="NLM_string-name">Petersen, J.</span>; <span class="NLM_string-name">Börjesson, U.</span></span> <span> </span><span class="NLM_article-title">5-[2-(Pyridin-2-ylamino)-1,3-thiazol-5-yl]-2,3-dihydro-1H-isoindol-1-one Derivatives and Their Use as Dual Inhibitors of Phosphatidylinositol 3-Kinase Delta & Gamma</span>. <span class="NLM_patent">WO2018055040</span>, March 30, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=M.+Perry&author=K.+Karabelas&author=M.+Mogemark&author=P.+Bold&author=C.+Tyrchan&author=A.+Nikitidis&author=J.+Petersen&author=U.+B%C3%B6rjesson&title=5-%5B2-%28Pyridin-2-ylamino%29-1%2C3-thiazol-5-yl%5D-2%2C3-dihydro-1H-isoindol-1-one+Derivatives+and+Their+Use+as+Dual+Inhibitors+of+Phosphatidylinositol+3-Kinase+Delta+%26+Gamma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPerry%26aufirst%3DM.%26atitle%3D5-%255B2-%2528Pyridin-2-ylamino%2529-1%252C3-thiazol-5-yl%255D-2%252C3-dihydro-1H-isoindol-1-one%2520Derivatives%2520and%2520Their%2520Use%2520as%2520Dual%2520Inhibitors%2520of%2520Phosphatidylinositol%25203-Kinase%2520Delta%2520%2526%2520Gamma%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref191"><div class="reference"><strong class="refLabel"><a href="#ref191" class="rightTabRefNumLink">191</a></strong><div class="NLM_citation" id="rightTab-cit191"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tesar, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Series of 5,11-Dihydro-6H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6-ones as Selective PI3K-δ/γ Inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">908</span>– <span class="NLM_lpage">912</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00209</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00209" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=908-912&issue=10&author=F.+M.+Fergusonauthor=J.+Niauthor=T.+Zhangauthor=B.+Tesarauthor=T.+Simauthor=N.+D.+Kimauthor=X.+Dengauthor=J.+R.+Brownauthor=J.+J.+Zhaoauthor=N.+S.+Gray&title=Discovery+of+a+Series+of+5%2C11-Dihydro-6H-benzo%5Be%5Dpyrimido%5B5%2C4-b%5D%5B1%2C4%5Ddiazepin-6-ones+as+Selective+PI3K-%CE%B4%2F%CE%B3+Inhibitors&doi=10.1021%2Facsmedchemlett.6b00209"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00209%26sid%3Dliteratum%253Aachs%26aulast%3DFerguson%26aufirst%3DF.%2BM.%26aulast%3DNi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DTesar%26aufirst%3DB.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DKim%26aufirst%3DN.%2BD.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DBrown%26aufirst%3DJ.%2BR.%26aulast%3DZhao%26aufirst%3DJ.%2BJ.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DDiscovery%2520of%2520a%2520Series%2520of%25205%252C11-Dihydro-6H-benzo%255Be%255Dpyrimido%255B5%252C4-b%255D%255B1%252C4%255Ddiazepin-6-ones%2520as%2520Selective%2520PI3K-%25CE%25B4%252F%25CE%25B3%2520Inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26issue%3D10%26spage%3D908%26epage%3D912%26doi%3D10.1021%2Facsmedchemlett.6b00209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref192"><div class="reference"><strong class="refLabel"><a href="#ref192" class="rightTabRefNumLink">192</a></strong><div class="NLM_citation" id="rightTab-cit192"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Terstiege, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyrchan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svensson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindmark, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Öster, L.</span></span> <span> </span><span class="NLM_article-title">Discovery of Triazole Aminopyrazines as a Highly Potent and Selective Series of PI3Kδ Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">679</span>– <span class="NLM_lpage">687</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.11.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.bmcl.2016.11.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=28017532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFCltr3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=679-687&issue=3&author=I.+Terstiegeauthor=M.+Perryauthor=J.+Petersenauthor=C.+Tyrchanauthor=T.+Svenssonauthor=H.+Lindmarkauthor=L.+%C3%96ster&title=Discovery+of+Triazole+Aminopyrazines+as+a+Highly+Potent+and+Selective+Series+of+PI3K%CE%B4+Inhibitors&doi=10.1016%2Fj.bmcl.2016.11.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of triazole aminopyrazines as a highly potent and selective series of PI3Kδ inhibitors</span></div><div class="casAuthors">Terstiege, Ina; Perry, Matthew; Petersen, Jens; Tyrchan, Christian; Svensson, Tor; Lindmark, Helena; Oester, Linda</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">679-687</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A novel class of potent PI3Kδ inhibitors with >1000-fold selectivity against other class I PI3K isoforms is described.  Optimization of the substituents on a triazole aminopyrazine scaffold, emerging from an inhouse PI3Kα program, turned moderately selective PI3Kδ compds. into highly potent and selective PI3Kδ inhibitors.  These efforts resulted in a series of aminopyrazines with PI3Kδ IC50 ≤ 1 nM in the enzyme assay, some of the most selective PI3Kδ inhibitors published to date, with a cell potency in a JeKo-cell assay of 20-120 nM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq30_ESCcDWabVg90H21EOLACvtfcHk0liLJkuy9xoqmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFCltr3M&md5=a23e39caed37cd7f969dc4bba666ede5</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.11.004%26sid%3Dliteratum%253Aachs%26aulast%3DTerstiege%26aufirst%3DI.%26aulast%3DPerry%26aufirst%3DM.%26aulast%3DPetersen%26aufirst%3DJ.%26aulast%3DTyrchan%26aufirst%3DC.%26aulast%3DSvensson%26aufirst%3DT.%26aulast%3DLindmark%26aufirst%3DH.%26aulast%3D%25C3%2596ster%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520Triazole%2520Aminopyrazines%2520as%2520a%2520Highly%2520Potent%2520and%2520Selective%2520Series%2520of%2520PI3K%25CE%25B4%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26issue%3D3%26spage%3D679%26epage%3D687%26doi%3D10.1016%2Fj.bmcl.2016.11.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref193"><div class="reference"><strong class="refLabel"><a href="#ref193" class="rightTabRefNumLink">193</a></strong><div class="NLM_citation" id="rightTab-cit193"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Safina, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forrest, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heald, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonomiya, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salphati, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seward, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staben, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ultsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D. P.</span></span> <span> </span><span class="NLM_article-title">Design of Selective Benzoxazepin PI3Kδ Inhibitors Through Control of Dihedral Angles</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">936</span>– <span class="NLM_lpage">940</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00170</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00170" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=936-940&issue=9&author=B.+S.+Safinaauthor=R.+L.+Elliottauthor=A.+K.+Forrestauthor=R.+A.+Healdauthor=J.+M.+Murrayauthor=J.+Nonomiyaauthor=J.+Pangauthor=L.+Salphatiauthor=E.+M.+Sewardauthor=S.+T.+Stabenauthor=M.+Ultschauthor=B.+Weiauthor=W.+Yangauthor=D.+P.+Sutherlin&title=Design+of+Selective+Benzoxazepin+PI3K%CE%B4+Inhibitors+Through+Control+of+Dihedral+Angles&doi=10.1021%2Facsmedchemlett.7b00170"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00170%26sid%3Dliteratum%253Aachs%26aulast%3DSafina%26aufirst%3DB.%2BS.%26aulast%3DElliott%26aufirst%3DR.%2BL.%26aulast%3DForrest%26aufirst%3DA.%2BK.%26aulast%3DHeald%26aufirst%3DR.%2BA.%26aulast%3DMurray%26aufirst%3DJ.%2BM.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSeward%26aufirst%3DE.%2BM.%26aulast%3DStaben%26aufirst%3DS.%2BT.%26aulast%3DUltsch%26aufirst%3DM.%26aulast%3DWei%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26atitle%3DDesign%2520of%2520Selective%2520Benzoxazepin%2520PI3K%25CE%25B4%2520Inhibitors%2520Through%2520Control%2520of%2520Dihedral%2520Angles%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26issue%3D9%26spage%3D936%26epage%3D940%26doi%3D10.1021%2Facsmedchemlett.7b00170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref194"><div class="reference"><strong class="refLabel"><a href="#ref194" class="rightTabRefNumLink">194</a></strong><div class="NLM_citation" id="rightTab-cit194"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knight, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldman, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zunder, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldenberg, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loewith, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stokoe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balla, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span> <span> </span><span class="NLM_article-title">A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>125</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">733</span>– <span class="NLM_lpage">747</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2006.03.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.cell.2006.03.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=16647110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BD28XltlSkt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2006&pages=733-747&issue=4&author=Z.+A.+Knightauthor=B.+Gonzalezauthor=M.+E.+Feldmanauthor=E.+R.+Zunderauthor=D.+D.+Goldenbergauthor=O.+Williamsauthor=R.+Loewithauthor=D.+Stokoeauthor=A.+Ballaauthor=B.+Tothauthor=T.+Ballaauthor=W.+A.+Weissauthor=R.+L.+Williamsauthor=K.+M.+Shokat&title=A+Pharmacological+Map+of+the+PI3-K+Family+Defines+a+Role+for+p110%CE%B1+in+Insulin+Signaling&doi=10.1016%2Fj.cell.2006.03.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">A pharmacological map of the PI3-K family defines a role for p110α in insulin signaling</span></div><div class="casAuthors">Knight, Zachary A.; Gonzalez, Beatriz; Feldman, Morri E.; Zunder, Eli R.; Goldenberg, David D.; Williams, Olusegun; Loewith, Robbie; Stokoe, David; Balla, Andras; Toth, Balazs; Balla, Tamas; Weiss, William A.; Williams, Roger L.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">733-747</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Phosphoinositide 3-kinases (PI3-Ks) are an important emerging class of drug targets, but the unique roles of PI3-K isoforms remain poorly defined.  We describe here an approach to pharmacol. interrogate the PI3-K family.  A chem. diverse panel of PI3-K inhibitors was synthesized, and their target selectivity was biochem. enumerated, revealing cryptic homologies across targets and chemotypes.  Crystal structures of three inhibitors bound to p110γ identify a conformationally mobile region that is uniquely exploited by selective compds.  This chem. array was then used to define the PI3-K isoforms required for insulin signaling.  We find that p110α is the primary insulin-responsive PI3-K in cultured cells, whereas p110β is dispensable but sets a phenotypic threshold for p110α activity.  Compds. targeting p110α block the acute effects of insulin treatment in vivo, whereas a p110β inhibitor has no effect.  These results illustrate systematic target validation using a matrix of inhibitors that span a protein family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrozjvOeMXP3bVg90H21EOLACvtfcHk0liLJkuy9xoqmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltlSkt7o%253D&md5=b95a8cb433927ff9a75b33fc4ac2c8a0</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.03.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.03.035%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DGonzalez%26aufirst%3DB.%26aulast%3DFeldman%26aufirst%3DM.%2BE.%26aulast%3DZunder%26aufirst%3DE.%2BR.%26aulast%3DGoldenberg%26aufirst%3DD.%2BD.%26aulast%3DWilliams%26aufirst%3DO.%26aulast%3DLoewith%26aufirst%3DR.%26aulast%3DStokoe%26aufirst%3DD.%26aulast%3DBalla%26aufirst%3DA.%26aulast%3DToth%26aufirst%3DB.%26aulast%3DBalla%26aufirst%3DT.%26aulast%3DWeiss%26aufirst%3DW.%2BA.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DA%2520Pharmacological%2520Map%2520of%2520the%2520PI3-K%2520Family%2520Defines%2520a%2520Role%2520for%2520p110%25CE%25B1%2520in%2520Insulin%2520Signaling%26jtitle%3DCell%26date%3D2006%26volume%3D125%26issue%3D4%26spage%3D733%26epage%3D747%26doi%3D10.1016%2Fj.cell.2006.03.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref195"><div class="reference"><strong class="refLabel"><a href="#ref195" class="rightTabRefNumLink">195</a></strong><div class="NLM_citation" id="rightTab-cit195"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laurent, P.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Séverin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hechler, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanhaesebroeck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payrastre, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gratacap, M.-P.</span></span> <span> </span><span class="NLM_article-title">Platelet PI3Kâ and GSK3 Regulate Thrombus Stability at a High Shear Rate</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>125</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">881</span>– <span class="NLM_lpage">888</span>, <span class="refDoi"> DOI: 10.1182/blood-2014-07-588335</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1182%2Fblood-2014-07-588335" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2015&pages=881-888&issue=5&author=P.-A.+Laurentauthor=S.+S%C3%A9verinauthor=B.+Hechlerauthor=B.+Vanhaesebroeckauthor=B.+Payrastreauthor=M.-P.+Gratacap&title=Platelet+PI3K%C3%A2+and+GSK3+Regulate+Thrombus+Stability+at+a+High+Shear+Rate&doi=10.1182%2Fblood-2014-07-588335"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1182%2Fblood-2014-07-588335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2014-07-588335%26sid%3Dliteratum%253Aachs%26aulast%3DLaurent%26aufirst%3DP.-A.%26aulast%3DS%25C3%25A9verin%26aufirst%3DS.%26aulast%3DHechler%26aufirst%3DB.%26aulast%3DVanhaesebroeck%26aufirst%3DB.%26aulast%3DPayrastre%26aufirst%3DB.%26aulast%3DGratacap%26aufirst%3DM.-P.%26atitle%3DPlatelet%2520PI3K%25C3%25A2%2520and%2520GSK3%2520Regulate%2520Thrombus%2520Stability%2520at%2520a%2520High%2520Shear%2520Rate%26jtitle%3DBlood%26date%3D2015%26volume%3D125%26issue%3D5%26spage%3D881%26epage%3D888%26doi%3D10.1182%2Fblood-2014-07-588335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref196"><div class="reference"><strong class="refLabel"><a href="#ref196" class="rightTabRefNumLink">196</a></strong><div class="NLM_citation" id="rightTab-cit196"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okabe, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nussbaum, R. L.</span></span> <span> </span><span class="NLM_article-title">Early Embryonic Lethality in Mice Deficient in the p110β Catalytic Subunit of PI3-Kinase</span>. <i>Mamm. Genome</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">172</span>, <span class="refDoi"> DOI: 10.1007/BF02684023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1007%2FBF02684023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=11919689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BD38Xislaltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2002&pages=169-172&author=L.+Biauthor=I.+Okabeauthor=D.+J.+Bernardauthor=R.+L.+Nussbaum&title=Early+Embryonic+Lethality+in+Mice+Deficient+in+the+p110%CE%B2+Catalytic+Subunit+of+PI3-Kinase&doi=10.1007%2FBF02684023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">Early embryonic lethality in mice deficient in the p110β catalytic subunit of PI 3-kinase</span></div><div class="casAuthors">Bi, Lei; Okabe, Ichiro; Bernard, David J.; Nussbaum, Robert L.</div><div class="citationInfo"><span class="NLM_cas:title">Mammalian Genome</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">169-172</span>CODEN:
                <span class="NLM_cas:coden">MAMGEC</span>;
        ISSN:<span class="NLM_cas:issn">0938-8990</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag New York Inc.</span>)
        </div><div class="casAbstract">Partial deletion of the allele for the p110β catalytic subunit of phosphatidylinositol 3-kinase causes death in mouse embryos.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxU7TUOwYNhbVg90H21EOLACvtfcHk0lgVrrY9au2gTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xislaltb0%253D&md5=d9b1b8b399d68722b9c2c1eab016d377</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1007%2FBF02684023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02684023%26sid%3Dliteratum%253Aachs%26aulast%3DBi%26aufirst%3DL.%26aulast%3DOkabe%26aufirst%3DI.%26aulast%3DBernard%26aufirst%3DD.%2BJ.%26aulast%3DNussbaum%26aufirst%3DR.%2BL.%26atitle%3DEarly%2520Embryonic%2520Lethality%2520in%2520Mice%2520Deficient%2520in%2520the%2520p110%25CE%25B2%2520Catalytic%2520Subunit%2520of%2520PI3-Kinase%26jtitle%3DMamm.%2520Genome%26date%3D2002%26volume%3D13%26spage%3D169%26epage%3D172%26doi%3D10.1007%2FBF02684023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref197"><div class="reference"><strong class="refLabel"><a href="#ref197" class="rightTabRefNumLink">197</a></strong><div class="NLM_citation" id="rightTab-cit197"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okabe, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wynshaw-Boris, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nussbaum, R. L.</span></span> <span> </span><span class="NLM_article-title">Proliferative Defect and Embryonic Lethality in Mice Homozygous for a Deletion in the p110alpha Subunit of Phosphoinositide 3-Kinase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>274</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">10963</span>– <span class="NLM_lpage">10968</span>, <span class="refDoi"> DOI: 10.1074/jbc.274.16.10963</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1074%2Fjbc.274.16.10963" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=10963-10968&issue=16&author=L.+Biauthor=I.+Okabeauthor=D.+J.+Bernardauthor=A.+Wynshaw-Borisauthor=R.+L.+Nussbaum&title=Proliferative+Defect+and+Embryonic+Lethality+in+Mice+Homozygous+for+a+Deletion+in+the+p110alpha+Subunit+of+Phosphoinositide+3-Kinase&doi=10.1074%2Fjbc.274.16.10963"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.16.10963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.16.10963%26sid%3Dliteratum%253Aachs%26aulast%3DBi%26aufirst%3DL.%26aulast%3DOkabe%26aufirst%3DI.%26aulast%3DBernard%26aufirst%3DD.%2BJ.%26aulast%3DWynshaw-Boris%26aufirst%3DA.%26aulast%3DNussbaum%26aufirst%3DR.%2BL.%26atitle%3DProliferative%2520Defect%2520and%2520Embryonic%2520Lethality%2520in%2520Mice%2520Homozygous%2520for%2520a%2520Deletion%2520in%2520the%2520p110alpha%2520Subunit%2520of%2520Phosphoinositide%25203-Kinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26issue%3D16%26spage%3D10963%26epage%3D10968%26doi%3D10.1074%2Fjbc.274.16.10963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref198"><div class="reference"><strong class="refLabel"><a href="#ref198" class="rightTabRefNumLink">198</a></strong><div class="NLM_citation" id="rightTab-cit198"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sunose, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellard, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergamini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubauer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werner, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsden, N.</span></span> <span> </span><span class="NLM_article-title">Discovery of 5-(2-Amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-(tert-butyl)pyridine-3-sulfonamide (CZC24758), as a Potent, Orally Bioavailable and Selective Inhibitor of PI3K for the Treatment of Inflammatory Disease</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">4613</span>– <span class="NLM_lpage">4618</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.05.090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.bmcl.2012.05.090" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=4613-4618&issue=14&author=M.+Sunoseauthor=K.+Bellauthor=K.+Ellardauthor=G.+Bergaminiauthor=G.+Neubauerauthor=T.+Wernerauthor=N.+Ramsden&title=Discovery+of+5-%282-Amino-%5B1%2C2%2C4%5Dtriazolo%5B1%2C5-a%5Dpyridin-7-yl%29-N-%28tert-butyl%29pyridine-3-sulfonamide+%28CZC24758%29%2C+as+a+Potent%2C+Orally+Bioavailable+and+Selective+Inhibitor+of+PI3K+for+the+Treatment+of+Inflammatory+Disease&doi=10.1016%2Fj.bmcl.2012.05.090"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.05.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.05.090%26sid%3Dliteratum%253Aachs%26aulast%3DSunose%26aufirst%3DM.%26aulast%3DBell%26aufirst%3DK.%26aulast%3DEllard%26aufirst%3DK.%26aulast%3DBergamini%26aufirst%3DG.%26aulast%3DNeubauer%26aufirst%3DG.%26aulast%3DWerner%26aufirst%3DT.%26aulast%3DRamsden%26aufirst%3DN.%26atitle%3DDiscovery%2520of%25205-%25282-Amino-%255B1%252C2%252C4%255Dtriazolo%255B1%252C5-a%255Dpyridin-7-yl%2529-N-%2528tert-butyl%2529pyridine-3-sulfonamide%2520%2528CZC24758%2529%252C%2520as%2520a%2520Potent%252C%2520Orally%2520Bioavailable%2520and%2520Selective%2520Inhibitor%2520of%2520PI3K%2520for%2520the%2520Treatment%2520of%2520Inflammatory%2520Disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26issue%3D14%26spage%3D4613%26epage%3D4618%26doi%3D10.1016%2Fj.bmcl.2012.05.090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref199"><div class="reference"><strong class="refLabel"><a href="#ref199" class="rightTabRefNumLink">199</a></strong><div class="NLM_citation" id="rightTab-cit199"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bell, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunose, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellard, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cansfield, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsden, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergamini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubauer, G.</span></span> <span> </span><span class="NLM_article-title">SAR Studies around a Series of Triazolopyridines as Potent and Selective PI3Kγ Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">5257</span>– <span class="NLM_lpage">5263</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.06.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.bmcl.2012.06.049" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5257-5263&issue=16&author=K.+Bellauthor=M.+Sunoseauthor=K.+Ellardauthor=A.+Cansfieldauthor=J.+Taylorauthor=W.+Millerauthor=N.+Ramsdenauthor=G.+Bergaminiauthor=G.+Neubauer&title=SAR+Studies+around+a+Series+of+Triazolopyridines+as+Potent+and+Selective+PI3K%CE%B3+Inhibitors&doi=10.1016%2Fj.bmcl.2012.06.049"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.06.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.06.049%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DK.%26aulast%3DSunose%26aufirst%3DM.%26aulast%3DEllard%26aufirst%3DK.%26aulast%3DCansfield%26aufirst%3DA.%26aulast%3DTaylor%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DW.%26aulast%3DRamsden%26aufirst%3DN.%26aulast%3DBergamini%26aufirst%3DG.%26aulast%3DNeubauer%26aufirst%3DG.%26atitle%3DSAR%2520Studies%2520around%2520a%2520Series%2520of%2520Triazolopyridines%2520as%2520Potent%2520and%2520Selective%2520PI3K%25CE%25B3%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26issue%3D16%26spage%3D5257%26epage%3D5263%26doi%3D10.1016%2Fj.bmcl.2012.06.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref200"><div class="reference"><strong class="refLabel"><a href="#ref200" class="rightTabRefNumLink">200</a></strong><div class="NLM_citation" id="rightTab-cit200"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lamb, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lunn, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Reilly, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilty, I.</span></span> <span> </span><span class="NLM_article-title">In Vitro and In Vivo Assessment of Pi3Kγ Inhibitors for Anti-Inflammatory Indications: Challenges of Selectivity over Pi3Kα</span>. <i>J. Pulm. Respir. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">157</span>, <span class="refDoi"> DOI: 10.4172/2161-105X.1000157</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.4172%2F2161-105X.1000157" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=157&author=D.+Lambauthor=G.+Lunnauthor=M.+O%E2%80%99Reillyauthor=C.+Butlerauthor=I.+Kilty&title=In+Vitro+and+In+Vivo+Assessment+of+Pi3K%CE%B3+Inhibitors+for+Anti-Inflammatory+Indications%3A+Challenges+of+Selectivity+over+Pi3K%CE%B1&doi=10.4172%2F2161-105X.1000157"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.4172%2F2161-105X.1000157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4172%252F2161-105X.1000157%26sid%3Dliteratum%253Aachs%26aulast%3DLamb%26aufirst%3DD.%26aulast%3DLunn%26aufirst%3DG.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DM.%26aulast%3DButler%26aufirst%3DC.%26aulast%3DKilty%26aufirst%3DI.%26atitle%3DIn%2520Vitro%2520and%2520In%2520Vivo%2520Assessment%2520of%2520Pi3K%25CE%25B3%2520Inhibitors%2520for%2520Anti-Inflammatory%2520Indications%253A%2520Challenges%2520of%2520Selectivity%2520over%2520Pi3K%25CE%25B1%26jtitle%3DJ.%2520Pulm.%2520Respir.%2520Med.%26date%3D2013%26volume%3D3%26spage%3D157%26doi%3D10.4172%2F2161-105X.1000157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref201"><div class="reference"><strong class="refLabel"><a href="#ref201" class="rightTabRefNumLink">201</a></strong><div class="NLM_citation" id="rightTab-cit201"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yabuuchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohtake, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakahara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sekiguchi, Y.</span></span> <span> </span><span class="NLM_article-title">Discovery and Optimization of a Series of 2-Aminothiazole-Oxazoles as Potent Phosphoinositide 3-Kinase γ Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">7534</span>– <span class="NLM_lpage">7538</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.10.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.bmcl.2012.10.028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=7534-7538&issue=24&author=Y.+Okaauthor=T.+Yabuuchiauthor=Y.+Fujiiauthor=H.+Ohtakeauthor=S.+Wakaharaauthor=K.+Matsumotoauthor=M.+Endoauthor=Y.+Tamuraauthor=Y.+Sekiguchi&title=Discovery+and+Optimization+of+a+Series+of+2-Aminothiazole-Oxazoles+as+Potent+Phosphoinositide+3-Kinase+%CE%B3+Inhibitors&doi=10.1016%2Fj.bmcl.2012.10.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.10.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.10.028%26sid%3Dliteratum%253Aachs%26aulast%3DOka%26aufirst%3DY.%26aulast%3DYabuuchi%26aufirst%3DT.%26aulast%3DFujii%26aufirst%3DY.%26aulast%3DOhtake%26aufirst%3DH.%26aulast%3DWakahara%26aufirst%3DS.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DEndo%26aufirst%3DM.%26aulast%3DTamura%26aufirst%3DY.%26aulast%3DSekiguchi%26aufirst%3DY.%26atitle%3DDiscovery%2520and%2520Optimization%2520of%2520a%2520Series%2520of%25202-Aminothiazole-Oxazoles%2520as%2520Potent%2520Phosphoinositide%25203-Kinase%2520%25CE%25B3%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26issue%3D24%26spage%3D7534%26epage%3D7538%26doi%3D10.1016%2Fj.bmcl.2012.10.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref202"><div class="reference"><strong class="refLabel"><a href="#ref202" class="rightTabRefNumLink">202</a></strong><div class="NLM_citation" id="rightTab-cit202"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yabuuchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuroda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohtake, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakahara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sekiguchi, Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of N-{5-[3-(3-Hydroxypiperidin-1-yl)-1,2,4-oxadiazol-5-yl]-4-methyl-1,3-thiazol-2-yl}acetamide (TASP0415914) as an Orally Potent Phosphoinositide 3-Kinase γ Inhibitor for the Treatment of Inflammatory Diseases</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">7578</span>– <span class="NLM_lpage">7583</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.10.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.bmc.2013.10.042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=7578-7583&issue=24&author=Y.+Okaauthor=T.+Yabuuchiauthor=T.+Oiauthor=S.+Kurodaauthor=Y.+Fujiiauthor=H.+Ohtakeauthor=T.+Inoueauthor=S.+Wakaharaauthor=K.+Kimuraauthor=K.+Fujitaauthor=M.+Endoauthor=K.+Taguchiauthor=Y.+Sekiguchi&title=Discovery+of+N-%7B5-%5B3-%283-Hydroxypiperidin-1-yl%29-1%2C2%2C4-oxadiazol-5-yl%5D-4-methyl-1%2C3-thiazol-2-yl%7Dacetamide+%28TASP0415914%29+as+an+Orally+Potent+Phosphoinositide+3-Kinase+%CE%B3+Inhibitor+for+the+Treatment+of+Inflammatory+Diseases&doi=10.1016%2Fj.bmc.2013.10.042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.10.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.10.042%26sid%3Dliteratum%253Aachs%26aulast%3DOka%26aufirst%3DY.%26aulast%3DYabuuchi%26aufirst%3DT.%26aulast%3DOi%26aufirst%3DT.%26aulast%3DKuroda%26aufirst%3DS.%26aulast%3DFujii%26aufirst%3DY.%26aulast%3DOhtake%26aufirst%3DH.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DWakahara%26aufirst%3DS.%26aulast%3DKimura%26aufirst%3DK.%26aulast%3DFujita%26aufirst%3DK.%26aulast%3DEndo%26aufirst%3DM.%26aulast%3DTaguchi%26aufirst%3DK.%26aulast%3DSekiguchi%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520N-%257B5-%255B3-%25283-Hydroxypiperidin-1-yl%2529-1%252C2%252C4-oxadiazol-5-yl%255D-4-methyl-1%252C3-thiazol-2-yl%257Dacetamide%2520%2528TASP0415914%2529%2520as%2520an%2520Orally%2520Potent%2520Phosphoinositide%25203-Kinase%2520%25CE%25B3%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Inflammatory%2520Diseases%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26issue%3D24%26spage%3D7578%26epage%3D7583%26doi%3D10.1016%2Fj.bmc.2013.10.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref203"><div class="reference"><strong class="refLabel"><a href="#ref203" class="rightTabRefNumLink">203</a></strong><div class="NLM_citation" id="rightTab-cit203"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, H.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, W.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.-L.</span></span> <span> </span><span class="NLM_article-title">Discovery of Fluoroquinolone Derivatives as Potent, Selective Inhibitors of PI3Kγ</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2029</span>– <span class="NLM_lpage">2035</span>, <span class="refDoi"> DOI: 10.1039/C5MD00364D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1039%2FC5MD00364D" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=2029-2035&issue=11&author=S.+Shaauthor=H.-W.+Hanauthor=F.+Gaoauthor=T.-B.+Liuauthor=Z.+Liauthor=C.+Xuauthor=W.-Q.+Zhongauthor=H.-L.+Zhu&title=Discovery+of+Fluoroquinolone+Derivatives+as+Potent%2C+Selective+Inhibitors+of+PI3K%CE%B3&doi=10.1039%2FC5MD00364D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.1039%2FC5MD00364D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5MD00364D%26sid%3Dliteratum%253Aachs%26aulast%3DSha%26aufirst%3DS.%26aulast%3DHan%26aufirst%3DH.-W.%26aulast%3DGao%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DT.-B.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DZhong%26aufirst%3DW.-Q.%26aulast%3DZhu%26aufirst%3DH.-L.%26atitle%3DDiscovery%2520of%2520Fluoroquinolone%2520Derivatives%2520as%2520Potent%252C%2520Selective%2520Inhibitors%2520of%2520PI3K%25CE%25B3%26jtitle%3DMedChemComm%26date%3D2015%26volume%3D6%26issue%3D11%26spage%3D2029%26epage%3D2035%26doi%3D10.1039%2FC5MD00364D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref204"><div class="reference"><strong class="refLabel"><a href="#ref204" class="rightTabRefNumLink">204</a></strong><div class="NLM_citation" id="rightTab-cit204"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, E. P.</span>; <span class="NLM_string-name">Reddy, M. V. R.</span></span> <span> </span><span class="NLM_article-title">3-Aminothieno[3,2-c]quinoline Derivatives, Methods of Preparation and Uses</span>. <span class="NLM_patent">WO2013142010</span>, September 27, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=E.+P.+Reddy&author=M.+V.+R.+Reddy&title=3-Aminothieno%5B3%2C2-c%5Dquinoline+Derivatives%2C+Methods+of+Preparation+and+Uses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DE.%2BP.%26atitle%3D3-Aminothieno%255B3%252C2-c%255Dquinoline%2520Derivatives%252C%2520Methods%2520of%2520Preparation%2520and%2520Uses%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref205"><div class="reference"><strong class="refLabel"><a href="#ref205" class="rightTabRefNumLink">205</a></strong><div class="NLM_citation" id="rightTab-cit205"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruce, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akhlaq, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloomfield, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budd, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuenoud, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gedeck, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatto, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayler, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Head, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblanc, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grand, D. Le</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarthy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oza, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilgrim, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Press, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sviridenko, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitehead, L.</span></span> <span> </span><span class="NLM_article-title">Development of Isoform Selective PI3-Kinase Inhibitors as Pharmacological Tools for Elucidating the PI3K Pathway</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">5445</span>– <span class="NLM_lpage">5450</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.07.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.bmcl.2012.07.042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5445-5450&issue=17&author=I.+Bruceauthor=M.+Akhlaqauthor=G.+C.+Bloomfieldauthor=E.+Buddauthor=B.+Coxauthor=B.+Cuenoudauthor=P.+Finanauthor=P.+Gedeckauthor=J.+Hattoauthor=J.+F.+Haylerauthor=D.+Headauthor=T.+Kellerauthor=L.+Kirmanauthor=C.+Leblancauthor=D.+Le+Grandauthor=C.+McCarthyauthor=D.+O%E2%80%99Connorauthor=C.+Owenauthor=M.+S.+Ozaauthor=G.+Pilgrimauthor=N.+E.+Pressauthor=L.+Sviridenkoauthor=L.+Whitehead&title=Development+of+Isoform+Selective+PI3-Kinase+Inhibitors+as+Pharmacological+Tools+for+Elucidating+the+PI3K+Pathway&doi=10.1016%2Fj.bmcl.2012.07.042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.07.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.07.042%26sid%3Dliteratum%253Aachs%26aulast%3DBruce%26aufirst%3DI.%26aulast%3DAkhlaq%26aufirst%3DM.%26aulast%3DBloomfield%26aufirst%3DG.%2BC.%26aulast%3DBudd%26aufirst%3DE.%26aulast%3DCox%26aufirst%3DB.%26aulast%3DCuenoud%26aufirst%3DB.%26aulast%3DFinan%26aufirst%3DP.%26aulast%3DGedeck%26aufirst%3DP.%26aulast%3DHatto%26aufirst%3DJ.%26aulast%3DHayler%26aufirst%3DJ.%2BF.%26aulast%3DHead%26aufirst%3DD.%26aulast%3DKeller%26aufirst%3DT.%26aulast%3DKirman%26aufirst%3DL.%26aulast%3DLeblanc%26aufirst%3DC.%26aulast%3DGrand%26aufirst%3DD.%2BLe%26aulast%3DMcCarthy%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DD.%26aulast%3DOwen%26aufirst%3DC.%26aulast%3DOza%26aufirst%3DM.%2BS.%26aulast%3DPilgrim%26aufirst%3DG.%26aulast%3DPress%26aufirst%3DN.%2BE.%26aulast%3DSviridenko%26aufirst%3DL.%26aulast%3DWhitehead%26aufirst%3DL.%26atitle%3DDevelopment%2520of%2520Isoform%2520Selective%2520PI3-Kinase%2520Inhibitors%2520as%2520Pharmacological%2520Tools%2520for%2520Elucidating%2520the%2520PI3K%2520Pathway%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26issue%3D17%26spage%3D5445%26epage%3D5450%26doi%3D10.1016%2Fj.bmcl.2012.07.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref206"><div class="reference"><strong class="refLabel"><a href="#ref206" class="rightTabRefNumLink">206</a></strong><div class="NLM_citation" id="rightTab-cit206"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bellenie, B. R.</span>; <span class="NLM_string-name">Bloomfield, G. C.</span>; <span class="NLM_string-name">Bruce, I.</span>; <span class="NLM_string-name">Culshaw, A. J.</span>; <span class="NLM_string-name">Hall, E. C.</span>; <span class="NLM_string-name">Hollingworth, G.</span>; <span class="NLM_string-name">Neef, J.</span>; <span class="NLM_string-name">Spendiff, M.</span>; <span class="NLM_string-name">Watson, S. J.</span></span> <span> </span><span class="NLM_article-title">Amino Pyrazine Derivatives as Phosphatidylinositol 3-Kinase Inhibitors</span>. <span class="NLM_patent">WO2015162459</span>, October 30, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=B.+R.+Bellenie&author=G.+C.+Bloomfield&author=I.+Bruce&author=A.+J.+Culshaw&author=E.+C.+Hall&author=G.+Hollingworth&author=J.+Neef&author=M.+Spendiff&author=S.+J.+Watson&title=Amino+Pyrazine+Derivatives+as+Phosphatidylinositol+3-Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBellenie%26aufirst%3DB.%2BR.%26atitle%3DAmino%2520Pyrazine%2520Derivatives%2520as%2520Phosphatidylinositol%25203-Kinase%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref207"><div class="reference"><strong class="refLabel"><a href="#ref207" class="rightTabRefNumLink">207</a></strong><div class="NLM_citation" id="rightTab-cit207"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Collier, P.
N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Botella, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornebise, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottrell, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahajan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maltais, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huck, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aronov, A. M.</span></span> <span> </span><span class="NLM_article-title">Structural Basis for Isoform Selectivity in a Class of Benzothiazole Inhibitors of Phosphoinositide 3-Kinase γ</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">517</span>– <span class="NLM_lpage">521</span>, <span class="refDoi"> DOI: 10.1021/jm500362j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500362j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=517-521&issue=1&author=P.%0AN.+Collierauthor=G.+Martinez-Botellaauthor=M.+Cornebiseauthor=K.+M.+Cottrellauthor=J.+D.+Doranauthor=J.+P.+Griffithauthor=S.+Mahajanauthor=F.+Maltaisauthor=C.+S.+Moodyauthor=E.+P.+Huckauthor=T.+Wangauthor=A.+M.+Aronov&title=Structural+Basis+for+Isoform+Selectivity+in+a+Class+of+Benzothiazole+Inhibitors+of+Phosphoinositide+3-Kinase+%CE%B3&doi=10.1021%2Fjm500362j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1021%2Fjm500362j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500362j%26sid%3Dliteratum%253Aachs%26aulast%3DCollier%26aufirst%3DP.%2BN.%26aulast%3DMartinez-Botella%26aufirst%3DG.%26aulast%3DCornebise%26aufirst%3DM.%26aulast%3DCottrell%26aufirst%3DK.%2BM.%26aulast%3DDoran%26aufirst%3DJ.%2BD.%26aulast%3DGriffith%26aufirst%3DJ.%2BP.%26aulast%3DMahajan%26aufirst%3DS.%26aulast%3DMaltais%26aufirst%3DF.%26aulast%3DMoody%26aufirst%3DC.%2BS.%26aulast%3DHuck%26aufirst%3DE.%2BP.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DAronov%26aufirst%3DA.%2BM.%26atitle%3DStructural%2520Basis%2520for%2520Isoform%2520Selectivity%2520in%2520a%2520Class%2520of%2520Benzothiazole%2520Inhibitors%2520of%2520Phosphoinositide%25203-Kinase%2520%25CE%25B3%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D1%26spage%3D517%26epage%3D521%26doi%3D10.1021%2Fjm500362j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref208"><div class="reference"><strong class="refLabel"><a href="#ref208" class="rightTabRefNumLink">208</a></strong><div class="NLM_citation" id="rightTab-cit208"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Collier, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messersmith, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Tiran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandarage, U. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boucher, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Come, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottrell, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damagnez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khare-Pandit, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krueger, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ledeboer, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ledford, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahajan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roday, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aronov, A. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of Highly Isoform Selective Thiazolopiperidine Inhibitors of Phosphoinositide 3-Kinase γ</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">5684</span>– <span class="NLM_lpage">5688</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00498</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00498" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5684-5688&issue=14&author=P.+N.+Collierauthor=D.+Messersmithauthor=A.+Le+Tiranauthor=U.+K.+Bandarageauthor=C.+Boucherauthor=J.+Comeauthor=K.+M.+Cottrellauthor=V.+Damagnezauthor=J.+D.+Doranauthor=J.+P.+Griffithauthor=S.+Khare-Panditauthor=E.+B.+Kruegerauthor=M.+W.+Ledeboerauthor=B.+Ledfordauthor=Y.+Liaoauthor=S.+Mahajanauthor=C.+S.+Moodyauthor=S.+Rodayauthor=T.+Wangauthor=J.+Xuauthor=A.+M.+Aronov&title=Discovery+of+Highly+Isoform+Selective+Thiazolopiperidine+Inhibitors+of+Phosphoinositide+3-Kinase+%CE%B3&doi=10.1021%2Facs.jmedchem.5b00498"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00498%26sid%3Dliteratum%253Aachs%26aulast%3DCollier%26aufirst%3DP.%2BN.%26aulast%3DMessersmith%26aufirst%3DD.%26aulast%3DLe%2BTiran%26aufirst%3DA.%26aulast%3DBandarage%26aufirst%3DU.%2BK.%26aulast%3DBoucher%26aufirst%3DC.%26aulast%3DCome%26aufirst%3DJ.%26aulast%3DCottrell%26aufirst%3DK.%2BM.%26aulast%3DDamagnez%26aufirst%3DV.%26aulast%3DDoran%26aufirst%3DJ.%2BD.%26aulast%3DGriffith%26aufirst%3DJ.%2BP.%26aulast%3DKhare-Pandit%26aufirst%3DS.%26aulast%3DKrueger%26aufirst%3DE.%2BB.%26aulast%3DLedeboer%26aufirst%3DM.%2BW.%26aulast%3DLedford%26aufirst%3DB.%26aulast%3DLiao%26aufirst%3DY.%26aulast%3DMahajan%26aufirst%3DS.%26aulast%3DMoody%26aufirst%3DC.%2BS.%26aulast%3DRoday%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DAronov%26aufirst%3DA.%2BM.%26atitle%3DDiscovery%2520of%2520Highly%2520Isoform%2520Selective%2520Thiazolopiperidine%2520Inhibitors%2520of%2520Phosphoinositide%25203-Kinase%2520%25CE%25B3%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D14%26spage%3D5684%26epage%3D5688%26doi%3D10.1021%2Facs.jmedchem.5b00498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref209"><div class="reference"><strong class="refLabel"><a href="#ref209" class="rightTabRefNumLink">209</a></strong><div class="NLM_citation" id="rightTab-cit209"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, M. J.</span>; <span class="NLM_string-name">Aronov, A.</span>; <span class="NLM_string-name">O’Dowd, H.</span>; <span class="NLM_string-name">Green, J.</span></span> <span> </span><span class="NLM_article-title">A Selective Inhibitor of Phosphatidylinositol 3-Kinase-Gamma</span>. <span class="NLM_patent">WO2015048318</span>, April 3, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+J.+Boyd&author=A.+Aronov&author=H.+O%E2%80%99Dowd&author=J.+Green&title=A+Selective+Inhibitor+of+Phosphatidylinositol+3-Kinase-Gamma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBoyd%26aufirst%3DM.%2BJ.%26atitle%3DA%2520Selective%2520Inhibitor%2520of%2520Phosphatidylinositol%25203-Kinase-Gamma%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref210"><div class="reference"><strong class="refLabel"><a href="#ref210" class="rightTabRefNumLink">210</a></strong><div class="NLM_citation" id="rightTab-cit210"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Come, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collier, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Tiran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Dowd, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandarage, U. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deininger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krueger, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messersmith, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nanthakumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sizensky, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damagnez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dworakowski, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khare-Pandit, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahajan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aronov, A. M.</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of a Novel Series of Orally Bioavailable, CNS-Penetrant, Isoform Selective Phosphoinositide 3-Kinase γ Inhibitors (PI3Kγ) with Potential for the Treatment of Multiple Sclerosis (MS)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">5245</span>– <span class="NLM_lpage">5256</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00085</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00085" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5245-5256&issue=12&author=J.+H.+Comeauthor=P.+N.+Collierauthor=J.+A.+Hendersonauthor=A.+C.+Pierceauthor=R.+J.+Daviesauthor=A.+Le+Tiranauthor=H.+O%E2%80%99Dowdauthor=U.+K.+Bandarageauthor=J.+Caoauthor=D.+Deiningerauthor=R.+Greyauthor=E.+B.+Kruegerauthor=D.+B.+Loweauthor=J.+Liangauthor=Y.+Liaoauthor=D.+Messersmithauthor=S.+Nanthakumarauthor=E.+Sizenskyauthor=J.+Wangauthor=J.+Xuauthor=E.+Y.+Chinauthor=V.+Damagnezauthor=J.+D.+Doranauthor=W.+Dworakowskiauthor=J.+P.+Griffithauthor=M.+D.+Jacobsauthor=S.+Khare-Panditauthor=S.+Mahajanauthor=C.+S.+Moodyauthor=A.+M.+Aronov&title=Design+and+Synthesis+of+a+Novel+Series+of+Orally+Bioavailable%2C+CNS-Penetrant%2C+Isoform+Selective+Phosphoinositide+3-Kinase+%CE%B3+Inhibitors+%28PI3K%CE%B3%29+with+Potential+for+the+Treatment+of+Multiple+Sclerosis+%28MS%29&doi=10.1021%2Facs.jmedchem.8b00085"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00085%26sid%3Dliteratum%253Aachs%26aulast%3DCome%26aufirst%3DJ.%2BH.%26aulast%3DCollier%26aufirst%3DP.%2BN.%26aulast%3DHenderson%26aufirst%3DJ.%2BA.%26aulast%3DPierce%26aufirst%3DA.%2BC.%26aulast%3DDavies%26aufirst%3DR.%2BJ.%26aulast%3DLe%2BTiran%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Dowd%26aufirst%3DH.%26aulast%3DBandarage%26aufirst%3DU.%2BK.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DDeininger%26aufirst%3DD.%26aulast%3DGrey%26aufirst%3DR.%26aulast%3DKrueger%26aufirst%3DE.%2BB.%26aulast%3DLowe%26aufirst%3DD.%2BB.%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DLiao%26aufirst%3DY.%26aulast%3DMessersmith%26aufirst%3DD.%26aulast%3DNanthakumar%26aufirst%3DS.%26aulast%3DSizensky%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DChin%26aufirst%3DE.%2BY.%26aulast%3DDamagnez%26aufirst%3DV.%26aulast%3DDoran%26aufirst%3DJ.%2BD.%26aulast%3DDworakowski%26aufirst%3DW.%26aulast%3DGriffith%26aufirst%3DJ.%2BP.%26aulast%3DJacobs%26aufirst%3DM.%2BD.%26aulast%3DKhare-Pandit%26aufirst%3DS.%26aulast%3DMahajan%26aufirst%3DS.%26aulast%3DMoody%26aufirst%3DC.%2BS.%26aulast%3DAronov%26aufirst%3DA.%2BM.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520a%2520Novel%2520Series%2520of%2520Orally%2520Bioavailable%252C%2520CNS-Penetrant%252C%2520Isoform%2520Selective%2520Phosphoinositide%25203-Kinase%2520%25CE%25B3%2520Inhibitors%2520%2528PI3K%25CE%25B3%2529%2520with%2520Potential%2520for%2520the%2520Treatment%2520of%2520Multiple%2520Sclerosis%2520%2528MS%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D12%26spage%3D5245%26epage%3D5256%26doi%3D10.1021%2Facs.jmedchem.8b00085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref211"><div class="reference"><strong class="refLabel"><a href="#ref211" class="rightTabRefNumLink">211</a></strong><div class="NLM_citation" id="rightTab-cit211"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sparks, R. B.</span>; <span class="NLM_string-name">Shepard, S.</span>; <span class="NLM_string-name">Combs, A.
P.</span>; <span class="NLM_string-name">Buesking, A. W.</span>; <span class="NLM_string-name">Shao, L.</span>; <span class="NLM_string-name">Wang, H.</span>; <span class="NLM_string-name">Falahatpisheh, N.</span></span> <span> </span><span class="NLM_article-title">Pyridine and Pyridimine Compounds as PI3K-Gamma Inhibitors</span>. <span class="NLM_patent">WO2017120194</span>, July 14, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=R.+B.+Sparks&author=S.+Shepard&author=A.%0AP.+Combs&author=A.+W.+Buesking&author=L.+Shao&author=H.+Wang&author=N.+Falahatpisheh&title=Pyridine+and+Pyridimine+Compounds+as+PI3K-Gamma+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSparks%26aufirst%3DR.%2BB.%26atitle%3DPyridine%2520and%2520Pyridimine%2520Compounds%2520as%2520PI3K-Gamma%2520Inhibitors%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref212"><div class="reference"><strong class="refLabel"><a href="#ref212" class="rightTabRefNumLink">212</a></strong><div class="NLM_citation" id="rightTab-cit212"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buesking, A. W.</span>; <span class="NLM_string-name">Sparks, R. B.</span>; <span class="NLM_string-name">Combs, A. P.</span>; <span class="NLM_string-name">Douty, B.</span>; <span class="NLM_string-name">Falahatpisheh, N.</span>; <span class="NLM_string-name">Shao, L.</span>; <span class="NLM_string-name">Shepard, S.</span>; <span class="NLM_string-name">Yue, E.
W.</span></span> <span> </span><span class="NLM_article-title">Heterocyclic Compounds as PI3K-γ Inhibitors</span>. <span class="NLM_patent">WO2017223414</span>, December 29, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=A.+W.+Buesking&author=R.+B.+Sparks&author=A.+P.+Combs&author=B.+Douty&author=N.+Falahatpisheh&author=L.+Shao&author=S.+Shepard&author=E.%0AW.+Yue&title=Heterocyclic+Compounds+as+PI3K-%CE%B3+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBuesking%26aufirst%3DA.%2BW.%26atitle%3DHeterocyclic%2520Compounds%2520as%2520PI3K-%25CE%25B3%2520Inhibitors%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref213"><div class="reference"><strong class="refLabel"><a href="#ref213" class="rightTabRefNumLink">213</a></strong><div class="NLM_citation" id="rightTab-cit213"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pemberton, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mogemark, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arlbrandt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bold, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holden, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karabelas, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlsson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lever, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindmark, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, M. W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigo Blomqvist, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyrchan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westin Eriksson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zlatoidsky, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Öster, L.</span></span> <span> </span><span class="NLM_article-title">Discovery of Highly Isoform Selective Orally Bioavailable Phosphoinositide-3-Kinase (PI3K)-γ Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5435</span>– <span class="NLM_lpage">5441</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00447</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00447" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5435-5441&author=N.+Pembertonauthor=M.+Mogemarkauthor=S.+Arlbrandtauthor=P.+Boldauthor=R.+J.+Coxauthor=C.+Gardelliauthor=N.+S.+Holdenauthor=K.+Karabelasauthor=J.+Karlssonauthor=S.+Leverauthor=X.+Liauthor=H.+Lindmarkauthor=M.+Norbergauthor=M.+W.+D.+Perryauthor=J.+Petersenauthor=S.+Rodrigo+Blomqvistauthor=M.+J.+Thomasauthor=C.+Tyrchanauthor=A.+Westin+Erikssonauthor=P.+Zlatoidskyauthor=L.+%C3%96ster&title=Discovery+of+Highly+Isoform+Selective+Orally+Bioavailable+Phosphoinositide-3-Kinase+%28PI3K%29-%CE%B3+Inhibitors&doi=10.1021%2Facs.jmedchem.8b00447"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit213&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00447%26sid%3Dliteratum%253Aachs%26aulast%3DPemberton%26aufirst%3DN.%26aulast%3DMogemark%26aufirst%3DM.%26aulast%3DArlbrandt%26aufirst%3DS.%26aulast%3DBold%26aufirst%3DP.%26aulast%3DCox%26aufirst%3DR.%2BJ.%26aulast%3DGardelli%26aufirst%3DC.%26aulast%3DHolden%26aufirst%3DN.%2BS.%26aulast%3DKarabelas%26aufirst%3DK.%26aulast%3DKarlsson%26aufirst%3DJ.%26aulast%3DLever%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLindmark%26aufirst%3DH.%26aulast%3DNorberg%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DM.%2BW.%2BD.%26aulast%3DPetersen%26aufirst%3DJ.%26aulast%3DRodrigo%2BBlomqvist%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DM.%2BJ.%26aulast%3DTyrchan%26aufirst%3DC.%26aulast%3DWestin%2BEriksson%26aufirst%3DA.%26aulast%3DZlatoidsky%26aufirst%3DP.%26aulast%3D%25C3%2596ster%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520Highly%2520Isoform%2520Selective%2520Orally%2520Bioavailable%2520Phosphoinositide-3-Kinase%2520%2528PI3K%2529-%25CE%25B3%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5435%26epage%3D5441%26doi%3D10.1021%2Facs.jmedchem.8b00447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref214"><div class="reference"><strong class="refLabel"><a href="#ref214" class="rightTabRefNumLink">214</a></strong><div class="NLM_citation" id="rightTab-cit214"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boyle, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Topolewski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartok, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestein, G. S.</span></span> <span> </span><span class="NLM_article-title">Novel Phosphoinositide 3-Kinase δ,γ Inhibitor: Potent Anti-Inflammatory Effects and Joint Protection in Models of Rheumatoid Arthritis</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>348</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">271</span>– <span class="NLM_lpage">280</span>, <span class="refDoi"> DOI: 10.1124/jpet.113.205955</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1124%2Fjpet.113.205955" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=24244039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtV2nsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2014&pages=271-280&issue=2&author=D.+L.+Boyleauthor=H.-R.+Kimauthor=K.+Topolewskiauthor=B.+Bartokauthor=G.+S.+Firestein&title=Novel+Phosphoinositide+3-Kinase+%CE%B4%2C%CE%B3+Inhibitor%3A+Potent+Anti-Inflammatory+Effects+and+Joint+Protection+in+Models+of+Rheumatoid+Arthritis&doi=10.1124%2Fjpet.113.205955"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit214R"><div class="casContent"><span class="casTitleNuber">214</span><div class="casTitle"><span class="NLM_cas:atitle">Novel phosphoinositide 3-kinase δ,γ inhibitor: potent anti-inflammatory effects and joint protection in models of rheumatoid arthritis</span></div><div class="casAuthors">Boyle, David L.; Kim, Hae-Rim; Topolewski, Katharyn; Bartok, Beatrix; Firestein, Gary S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">271-280, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Phosphoinositide 3-kinases γ and δ (PI3Kγ and PI3Kδ) are expressed in rheumatoid arthritis (RA) synovium and regulate innate and adaptive immune responses.  We detd. the effect of a potent PI3Kδ,γ inhibitor, IPI-145, in two preclin. models of RA.  IPI-145 was administered orally in rat adjuvant-induced arthritis (AA) and i.p. in mouse collagen-induced arthritis (CIA).  Efficacy was assessed by paw swelling, clin. scores, histopathol. and radiog., and microcomputed tomog. scanning.  Gene expression and Akt phosphorylation in joint tissues were detd. by quant. real-time polymerase chain reaction and Western blot anal.  Serum concns. of anti-type II collagen (CII) IgG and IgE were measured by immunoassay.  T-cell responses to CII were assayed using thymidine incorporation and immunoassay.  IPI-145 significantly reduced arthritis severity in both RA models using dosing regimens initiated before onset of clin. disease.  Treatment of established arthritis with IPI-145 in AA, but not CIA, significantly decreased arthritis progression.  In AA, histol. scores, radiog. joint damage, and matrix metalloproteinase (MMP)-13 expression were reduced in IPI-145 treated rats.  In CIA, joint histol. scores and expression of MMP-3 and MMP-13 mRNA were lower in the IPI-145 early treatment group than in the vehicle group.  The ratio of anti-CII IgG2a to total IgG in CIA was modestly reduced.  Interleukin-17 prodn. in response to CII was decreased in the IPI-145-treated group, suggesting an inhibitory effect on T-helper cell 17 differentiation.  These data show that PI3Kδ,γ inhibition suppresses inflammatory arthritis, as well as bone and cartilage damage, through effects on innate and adaptive immunity and that IPI-145 is a potential therapy for RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpITPLaidXBWrVg90H21EOLACvtfcHk0lijjBzeM0Q88g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtV2nsLk%253D&md5=46b5375d66642cac66008d80c76a5fee</span></div><a href="/servlet/linkout?suffix=cit214&amp;dbid=16384&amp;doi=10.1124%2Fjpet.113.205955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.113.205955%26sid%3Dliteratum%253Aachs%26aulast%3DBoyle%26aufirst%3DD.%2BL.%26aulast%3DKim%26aufirst%3DH.-R.%26aulast%3DTopolewski%26aufirst%3DK.%26aulast%3DBartok%26aufirst%3DB.%26aulast%3DFirestein%26aufirst%3DG.%2BS.%26atitle%3DNovel%2520Phosphoinositide%25203-Kinase%2520%25CE%25B4%252C%25CE%25B3%2520Inhibitor%253A%2520Potent%2520Anti-Inflammatory%2520Effects%2520and%2520Joint%2520Protection%2520in%2520Models%2520of%2520Rheumatoid%2520Arthritis%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D348%26issue%3D2%26spage%3D271%26epage%3D280%26doi%3D10.1124%2Fjpet.113.205955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref215"><div class="reference"><strong class="refLabel"><a href="#ref215" class="rightTabRefNumLink">215</a></strong><div class="NLM_citation" id="rightTab-cit215"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdul-Muneer, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span> <span> </span><span class="NLM_article-title">PI3Kγ Inhibition Alleviates Symptoms and Increases Axon Number in Experimental Autoimmune Encephalomyelitis Mice</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>253</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.1016/j.neuroscience.2013.08.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1016%2Fj.neuroscience.2013.08.051" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=253&publication_year=2013&pages=89-99&author=H.+Liauthor=D.+Parkauthor=P.+M.+Abdul-Muneerauthor=B.+Xuauthor=H.+Wangauthor=B.+Xingauthor=D.+Wuauthor=S.+Li&title=PI3K%CE%B3+Inhibition+Alleviates+Symptoms+and+Increases+Axon+Number+in+Experimental+Autoimmune+Encephalomyelitis+Mice&doi=10.1016%2Fj.neuroscience.2013.08.051"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit215&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2013.08.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2013.08.051%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DPark%26aufirst%3DD.%26aulast%3DAbdul-Muneer%26aufirst%3DP.%2BM.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DXing%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DS.%26atitle%3DPI3K%25CE%25B3%2520Inhibition%2520Alleviates%2520Symptoms%2520and%2520Increases%2520Axon%2520Number%2520in%2520Experimental%2520Autoimmune%2520Encephalomyelitis%2520Mice%26jtitle%3DNeuroscience%26date%3D2013%26volume%3D253%26spage%3D89%26epage%3D99%26doi%3D10.1016%2Fj.neuroscience.2013.08.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref216"><div class="reference"><strong class="refLabel"><a href="#ref216" class="rightTabRefNumLink">216</a></strong><div class="NLM_citation" id="rightTab-cit216"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nayar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fahy, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barone, F.</span></span> <span> </span><span class="NLM_article-title">Phosphatidylinositol-3-Kinase Delta Pathway a Novel Therapeutic Target for Sjogren’s Syndrome</span>. <i>Arthritis Rheumat.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">Suppl. 10</span>),  <span class="NLM_fpage">1053</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=25605296" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2015&pages=1053&issue=Suppl.+10&author=S.+Nayarauthor=J.+Camposauthor=C.+Buckleyauthor=R.+Allenauthor=W.+Fahyauthor=A.+Payneauthor=F.+Barone&title=Phosphatidylinositol-3-Kinase+Delta+Pathway+a+Novel+Therapeutic+Target+for+Sjogren%E2%80%99s+Syndrome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit216&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNayar%26aufirst%3DS.%26aulast%3DCampos%26aufirst%3DJ.%26aulast%3DBuckley%26aufirst%3DC.%26aulast%3DAllen%26aufirst%3DR.%26aulast%3DFahy%26aufirst%3DW.%26aulast%3DPayne%26aufirst%3DA.%26aulast%3DBarone%26aufirst%3DF.%26atitle%3DPhosphatidylinositol-3-Kinase%2520Delta%2520Pathway%2520a%2520Novel%2520Therapeutic%2520Target%2520for%2520Sjogren%25E2%2580%2599s%2520Syndrome%26jtitle%3DArthritis%2520Rheumat.%26date%3D2015%26volume%3D67%26issue%3DSuppl.%252010%26spage%3D1053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref217"><div class="reference"><strong class="refLabel"><a href="#ref217" class="rightTabRefNumLink">217</a></strong><div class="NLM_citation" id="rightTab-cit217"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rommel, C.</span></span> <span> </span><span class="NLM_article-title">Taking PI3Kδ and PI3Kγ One Step Ahead: Dual Active PI3Kδ/γ Inhibitors for the Treatment of Immune-Mediated Inflammatory Diseases</span>. In  <i>Phosphoinositide 3-Kinase in Health and Disease</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rommel, C.</span>, <span class="NLM_string-name">Vanhaesebroeck, B.</span>, <span class="NLM_string-name">Vogt, P. K.</span></span>, Eds.; Current Topics in Microbiology and Immunology, Vol. 346.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Berlin</span>, <span class="NLM_year">2010</span>; pp  <span class="NLM_fpage">279</span>– <span class="NLM_lpage">299</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;key=10.1007%2F82_2010_79" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=279-299&author=C.+Rommelauthor=C.+Rommel&author=B.+Vanhaesebroeck&author=P.+K.+Vogt&title=Phosphoinositide+3-Kinase+in+Health+and+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit217&amp;dbid=16384&amp;doi=10.1007%2F82_2010_79&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F82_2010_79%26sid%3Dliteratum%253Aachs%26aulast%3DRommel%26aufirst%3DC.%26atitle%3DTaking%2520PI3K%25CE%25B4%2520and%2520PI3K%25CE%25B3%2520One%2520Step%2520Ahead%253A%2520Dual%2520Active%2520PI3K%25CE%25B4%252F%25CE%25B3%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Immune-Mediated%2520Inflammatory%2520Diseases%26btitle%3DPhosphoinositide%25203-Kinase%2520in%2520Health%2520and%2520Disease%26aulast%3DRommel%26aufirst%3DC.%26pub%3DSpringer%26date%3D2010%26spage%3D279%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref218"><div class="reference"><strong class="refLabel"><a href="#ref218" class="rightTabRefNumLink">218</a></strong><div class="NLM_citation" id="rightTab-cit218"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ito, K.</span>; <span class="NLM_string-name">Coates, M.</span>; <span class="NLM_string-name">Murray, J.</span>; <span class="NLM_string-name">Davis, A.</span>; <span class="NLM_string-name">Strong, P.</span>; <span class="NLM_string-name">Rapeport, G.</span></span> <span> </span><span class="NLM_article-title">Effects of RV1729, a Phosphoinositide 3 Kinase γ and δ Inhibitor, on TNFα-Induced CXCL8 Release in Peripheral Blood Neutrophils Obtained from Patients with COPD</span>. In  <i>109th International Conference of the American Thoracic Society (ATS)</i>; <span class="NLM_publisher-name">ATS</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span>, <span class="NLM_year">2013</span>; p  <span class="NLM_fpage">F78</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=F78&author=K.+Ito&author=M.+Coates&author=J.+Murray&author=A.+Davis&author=P.+Strong&author=G.+Rapeport&title=109th+International+Conference+of+the+American+Thoracic+Society+%28ATS%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit218&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DIto%26aufirst%3DK.%26atitle%3DEffects%2520of%2520RV1729%252C%2520a%2520Phosphoinositide%25203%2520Kinase%2520%25CE%25B3%2520and%2520%25CE%25B4%2520Inhibitor%252C%2520on%2520TNF%25CE%25B1-Induced%2520CXCL8%2520Release%2520in%2520Peripheral%2520Blood%2520Neutrophils%2520Obtained%2520from%2520Patients%2520with%2520COPD%26btitle%3D109th%2520International%2520Conference%2520of%2520the%2520American%2520Thoracic%2520Society%2520%2528ATS%2529%26pub%3DATS%26date%3D2013%26spage%3DF78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2X38" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2X38','PDB','2X38'); return false;">PDB: 2X38</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WHX" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WHX','PDB','2WHX'); return false;">PDB: 2WHX</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T2M" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T2M','PDB','5T2M'); return false;">PDB: 5T2M</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EZJ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EZJ','PDB','4EZJ'); return false;">PDB: 4EZJ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5AE8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5AE8','PDB','5AE8'); return false;">PDB: 5AE8</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PS3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PS3','PDB','4PS3'); return false;">PDB: 4PS3</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6FTN" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6FTN','PDB','6FTN'); return false;">PDB: 6FTN</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i58"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01298">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_80007"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b01298">10.1021/acs.jmedchem.8b01298</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">List of patents (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01298/suppl_file/jm8b01298_si_001.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01298/suppl_file/jm8b01298_si_001.pdf">jm8b01298_si_001.pdf (484.83 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b01298&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-10%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01298" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b01298" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                8MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a663d3e1a3d8e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
